{"text_format":"2","workbook":"xlsx","n_sheets":6,"sheets":["Covering note","33900","1221","247","500 sample","138 out of 500 sample"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Covering note","index":0,"n_rows":23,"n_cols":4,"rows_kept":23,"cut":false,"hidden":false,"merged":[]}
[null,"S19 Table. Whether PI information is available from Responsible Party."]
[]
[null,"Please note:"]
[null,"Responsible party is referred to as RP."]
[null,"The RP is usually listed both at the top of the NCT ID record ('top RP’) and at the bottom (‘bottom RP’)"]
[]
[null,"Part (A)"]
[null,"Description","Number","Sheet name"]
[null,"All S8 NCT IDs",35121,"(In S8 Table)"]
[null,"The selected S8 NCT IDs, with both investigator’s name and role",31392,"(In S8 Table)"]
[null,"The rejected S8 NCT IDs, with investigator’s name or role missing",3729,"(In S8 Table)"]
[]
[null,"Either top RP or bottom RP present",33900,33900]
[null,"Neither top RP nor bottom RP present",1221,1221]
[null,null,{"$f":"SUM(C13:C14)","v":35121}]
[]
[null,"The NCT IDs of 1,221 which are part of 3,729",247,247]
[]
[null,"Part (B)"]
[null,"In a sample of 500 records which had the Responsible Party tag, 138 records listed an individual by name. All 138 cases are included in the S8 Table’s non-null records. \nThus, looking at the RP field did not yield any additional PI information."]
[]
[null,"Sample of 500 NCT IDs from ",500,"500 sample"]
[null,"138 of the 500 NCT IDs which provide PI information",138,"138 out of 500 sample"]

{"sheet":"33900","index":1,"n_rows":33901,"n_cols":5,"rows_kept":4500,"cut":true,"hidden":false,"merged":[],"bounds":{"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0}}
["nct_id","responsible_party_top","sponsor_top","urllist","responsible_party_bottom"]
["NCT00678379","[u'Jonathan R. Moss, Vanderbilt University Medical Center']","[u'Vanderbilt University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00678379","['Jonathan R. Moss, Resident Physician, Vanderbilt University Medical Center']"]
["NCT00678392","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00678392","['Pfizer']"]
["NCT00678418","[u'Alkermes, Inc.']","[u'Alkermes, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00678418","['Alkermes, Inc.']"]
["NCT00678457","[]","[u'University of Virginia']","https://clinicaltrials.gov/ct2/show/NCT00678457","['Bankole Johnson, DSc, M.D., Ph.D., University of Virginia']"]
["NCT00678561","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00678561","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00678652","[u'U.S. Army Medical Research and Materiel Command']","[u'U.S. Army Medical Research and Materiel Command']","https://clinicaltrials.gov/ct2/show/NCT00678652","['U.S. Army Medical Research and Materiel Command']"]
["NCT00678769","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00678769","['National Cancer Institute (NCI)']"]
["NCT00678886","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00678886","['GlaxoSmithKline']"]
["NCT00678977","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00678977","['GlaxoSmithKline']"]
["NCT00679094","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00679094","['National Cancer Institute (NCI)']"]
["NCT00679133","[u'Mirati Therapeutics Inc.']","[u'Mirati Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679133","['Mirati Therapeutics Inc.']"]
["NCT00679172","[u'Emergent BioSolutions']","[u'Emergent BioSolutions']","https://clinicaltrials.gov/ct2/show/NCT00679172","['Emergent BioSolutions']"]
["NCT00679211","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679211","['Genentech, Inc.']"]
["NCT00679263","[u'MediciNova']","[u'MediciNova']","https://clinicaltrials.gov/ct2/show/NCT00679263","['MediciNova']"]
["NCT00679302","[u'St. Louis University']","[u'St. Louis University']","https://clinicaltrials.gov/ct2/show/NCT00679302","['St. Louis University']"]
["NCT00679341","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00679341","['Hoffmann-La Roche']"]
["NCT00679354","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00679354","['National Cancer Institute (NCI)']"]
["NCT00679367","[u'Vaishali Sanchorawala, Boston Medical Center']","[u'Boston Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00679367","['Vaishali Sanchorawala, Principal Investigator, Boston Medical Center']"]
["NCT00679380","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679380","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00679432","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679432","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00679523","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00679523","['Karl Beutner, MD, PhD, Anacor Pharmaceuticals, Inc.']"]
["NCT00679588","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00679588","['Sanofi']"]
["NCT00679731","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00679731","['AbbVie (prior sponsor, Abbott)']"]
["NCT00679770","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00679770","['Pfizer']"]
["NCT00679939","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00679939","['GlaxoSmithKline']"]
["NCT00679965","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00679965","['Pfizer']"]
["NCT00680017","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00680017","['AstraZeneca']"]
["NCT00680043","[u'Affymax']","[u'Affymax']","https://clinicaltrials.gov/ct2/show/NCT00680043","['Affymax']"]
["NCT00680095","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00680095","['Pfizer']"]
["NCT00680121","[u'Ann Manzardo, PhD, University of Kansas']","[u'University of Kansas']","https://clinicaltrials.gov/ct2/show/NCT00680121","['Ann Manzardo, PhD, Assistant Professor, University of Kansas']"]
["NCT00680134","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00680134","['Pfizer']"]
["NCT00680186","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00680186","['Boehringer Ingelheim']"]
["NCT00680342","[u'National Center for Complementary and Integrative Health (NCCIH)']","[u'National Center for Complementary and Integrative Health (NCCIH)']","https://clinicaltrials.gov/ct2/show/NCT00680342","['National Center for Complementary and Integrative Health (NCCIH)']"]
["NCT00680407","[u'Madaus Inc']","[u'Madaus Inc']","https://clinicaltrials.gov/ct2/show/NCT00680407","['Madaus Inc']"]
["NCT00680472","[u'Hisamitsu Pharmaceutical Co., Inc.']","[u'Hisamitsu Pharmaceutical Co., Inc.']","https://clinicaltrials.gov/ct2/show/NCT00680472","['Hisamitsu Pharmaceutical Co., Inc.']"]
["NCT00680498","[u'Illinois Retina Associates']","[u'Illinois Retina Associates']","https://clinicaltrials.gov/ct2/show/NCT00680498","['Illinois Retina Associates']"]
["NCT00680589","[]","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00680589","['Jedd Wolchok, MD, Memorial Sloan-Kettering Cancer Center']"]
["NCT00680667","[u'Masonic Cancer Center, University of Minnesota']","[u'Masonic Cancer Center, University of Minnesota']","https://clinicaltrials.gov/ct2/show/NCT00680667","['Masonic Cancer Center, University of Minnesota']"]
["NCT00680706","[u'Howard Smithline, Baystate Medical Center']","[u'Baystate Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00680706","['Howard Smithline, Chief, Emergency Medicine Research, Baystate Medical Center']"]
["NCT00680758","[u'Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center']","[u'Vanderbilt-Ingram Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00680758","['Ingrid Mayer, MD, Assistant Professor of Medicine; Clinical Director, Breast Cancer Program; Medical Oncologist, Vanderbilt-Ingram Cancer Center']"]
["NCT00680784","[u'Hisamitsu Pharmaceutical Co., Inc.']","[u'Hisamitsu Pharmaceutical Co., Inc.']","https://clinicaltrials.gov/ct2/show/NCT00680784","['Hisamitsu Pharmaceutical Co., Inc.']"]
["NCT00680940","[u'Cadila Pharnmaceuticals']","[u'Cadila Pharnmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00680940","['Cadila Pharnmaceuticals']"]
["NCT00681109","[u'Reza Dana, MD, Massachusetts Eye and Ear Infirmary']","[u'Reza Dana, MD']","https://clinicaltrials.gov/ct2/show/NCT00681109","['Reza Dana, MD, Principal Investigator, Massachusetts Eye and Ear Infirmary']"]
["NCT00681317","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00681317","['Mark A. Smith, MD, PhD, Medical Science Sr.Director, AstraZeneca Pharmaceuticals']"]
["NCT00681356","[]","[u'Anesiva, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00681356","['Lisa Renick, CRA, Anesiva, Inc,']"]
["NCT00681395","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00681395","['AstraZeneca']"]
["NCT00681408","[u'Stephen Caldwell, MD, University of Virginia']","[u'University of Virginia']","https://clinicaltrials.gov/ct2/show/NCT00681408","['Stephen Caldwell, MD, Professor, Department of Gastroenterology, University of Virginia']"]
["NCT00681824","[u'Baxter Healthcare Corporation']","[u'Baxter Healthcare Corporation']","https://clinicaltrials.gov/ct2/show/NCT00681824","['Baxter Healthcare Corporation']"]
["NCT00681889","[u'Reza Dana, MD, Massachusetts Eye and Ear Infirmary']","[u'Reza Dana, MD']","https://clinicaltrials.gov/ct2/show/NCT00681889","['Reza Dana, MD, Professor of Ophthalmology, Massachusetts Eye and Ear Infirmary']"]
["NCT00681915","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00681915","['Mark A. Smith, MD, PhD Medical Science Sr. Director, AstraZeneca Pharmaceuticals']"]
["NCT00682097","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00682097","['Hoffmann-La Roche']"]
["NCT00682448","[u'Jeffrey Rado, MD, Rush University Medical Center']","[u'Rush University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00682448","['Jeffrey Rado, MD, MD, Rush University Medical Center']"]
["NCT00682461","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00682461","['GlaxoSmithKline']"]
["NCT00682643","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00682643","['GlaxoSmithKline']"]
["NCT00682734","[u'Benjamin W. Friedman, MD, Montefiore Medical Center']","[u'Montefiore Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00682734","['Benjamin W. Friedman, MD, Associate professor, Montefiore Medical Center']"]
["NCT00682981","[u'Teva Pharmaceutical Industries ( Gemin X )']","[u'Gemin X']","https://clinicaltrials.gov/ct2/show/NCT00682981","['Gemin X']"]
["NCT00683163","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00683163","['University of California, San Francisco']"]
["NCT00683241","[u'Abramson Cancer Center of the University of Pennsylvania']","[u'Abramson Cancer Center of the University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00683241","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT00683280","[u'UConn Health']","[u'UConn Health']","https://clinicaltrials.gov/ct2/show/NCT00683280","['UConn Health']"]
["NCT00683423","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00683423","['Study Director, Bristol-Myers Squibb']"]
["NCT00683475","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00683475","['Eli Lilly and Company']"]
["NCT00683592","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00683592","['Carol R. Reed, MD, PGxHealth, LLC']"]
["NCT00683657","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00683657","['AstraZeneca']"]
["NCT00683800","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00683800","['Director, Clinical Trial Disclosure Group, Pfizer, Inc']"]
["NCT00683852","[u'Maurizio Fava, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00683852","['Maurizio Fava, MD, Executive Vice Chair, Department of Psychiatry; Executive Director, Clinical Trials Network and Institute (CTNI); Director, Depression Clinical and Research Program (DCRP), Massachusetts General Hospital']"]
["NCT00683878","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00683878","['AstraZeneca']"]
["NCT00683956","[u'Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT00683956","['Stanford University']"]
["NCT00684008","[]","[u'Cytheris, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00684008","['Marcel R.M. van den Brink, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center']"]
["NCT00684021","[u'Dr Lemuel A Moye III, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00684021","['Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston']"]
["NCT00684060","[u'Dr Lemuel A Moye III, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00684060","['Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston']"]
["NCT00684177","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00684177","['GlaxoSmithKline']"]
["NCT00684554","[u'Frances R Levin, New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00684554","['Frances R Levin, Director of Substance Use Disorder, New York State Psychiatric Institute']"]
["NCT00684918","[u'Teva Pharmaceutical Industries ( Gemin X )']","[u'Gemin X']","https://clinicaltrials.gov/ct2/show/NCT00684918","['Gemin X']"]
["NCT00685113","[u'Teva Pharmaceutical Industries ( Duramed Research )']","[u'Duramed Research']","https://clinicaltrials.gov/ct2/show/NCT00685113","['Duramed Research']"]
["NCT00685178","[u'Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00685178","['Johns Hopkins University']"]
["NCT00685360","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00685360","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00685399","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00685399","['Novartis Pharmaceuticals']"]
["NCT00685412","[u'Inovio Pharmaceuticals']","[u'Inovio Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00685412","['Inovio Pharmaceuticals']"]
["NCT00685698","[u'TaiGen Biotechnology Co., Ltd.']","[u'TaiGen Biotechnology Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00685698","['TaiGen Biotechnology Co., Ltd.']"]
["NCT00685737","[]","[u'Pharmena North America']","https://clinicaltrials.gov/ct2/show/NCT00685737","['Charles Ballow, Pharm D. FACCP, Buffalo Clinical Research Center']"]
["NCT00685815","[u'American Regent, Inc.']","[u'American Regent, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00685815","['American Regent, Inc.']"]
["NCT00685906","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00685906","['Jay Horrow, MD, Medical Science Director, AZD6140, AstraZeneca Pharmaceuticals']"]
["NCT00686075","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00686075","['MedImmune LLC']"]
["NCT00686218","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00686218","['City of Hope Medical Center']"]
["NCT00686634","[u'Charles Drew University of Medicine and Science']","[u'Charles Drew University of Medicine and Science']","https://clinicaltrials.gov/ct2/show/NCT00686634","['Charles Drew University of Medicine and Science']"]
["NCT00686803","[u'Palatin Technologies']","[u'Palatin Technologies']","https://clinicaltrials.gov/ct2/show/NCT00686803","['Palatin Technologies']"]
["NCT00686855","[u'Nathaniel S. Treister, DMD, DMSc, Dana-Farber Cancer Institute']","[u\"Brigham and Women's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00686855","['Nathaniel S. Treister, DMD, DMSc, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00686868","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00686868","['GlaxoSmithKline']"]
["NCT00686933","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00686933","['AbbVie (prior sponsor, Abbott)']"]
["NCT00686959","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00686959","['Eli Lilly and Company']"]
["NCT00686998","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00686998","['AstraZeneca']"]
["NCT00687167","[]","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00687167","['Kristin Arnold, Vice President R&D, Mutual Pharmaceutical Company, Inc.']"]
["NCT00687245","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00687245","['Tore Lind, MD, Medical Science Director Nexium and GI Established Brands, AstraZeneca Pharmaceuticals']"]
["NCT00687271","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00687271","['Merck Sharp & Dohme Corp.']"]
["NCT00687297","[u'PrECOG, LLC.']","[u'PrECOG, LLC.']","https://clinicaltrials.gov/ct2/show/NCT00687297","['PrECOG, LLC.']"]
["NCT00687622","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00687622","['GlaxoSmithKline']"]
["NCT00687687","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00687687","['Sanofi']"]
["NCT00687739","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00687739","['University of Colorado, Denver']"]
["NCT00687765","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00687765","['Sanofi']"]
["NCT00687830","[u'The Cleveland Clinic ( Cleveland Clinic Florida )']","[u'Cleveland Clinic Florida']","https://clinicaltrials.gov/ct2/show/NCT00687830","['Cleveland Clinic Florida']"]
["NCT00687908","[]","[u'Galderma']","https://clinicaltrials.gov/ct2/show/NCT00687908","['Jean-Charles DHUIN Clinical Trial Manager, Galderma']"]
["NCT00688064","[]","[u'Galderma']","https://clinicaltrials.gov/ct2/show/NCT00688064","['Jean-Charles DHUIN Clinical Trial Manager, Galderma']"]
["NCT00688272","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00688272","['GlaxoSmithKline']"]
["NCT00688324","[u'Robert W. Buchanan, University of Maryland']","[u'University of Maryland']","https://clinicaltrials.gov/ct2/show/NCT00688324","['Robert W. Buchanan, Chief, Maryland Psychiatric Research Center, Outpatient Research Program, University of Maryland']"]
["NCT00688376","[]","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00688376","['Margaret Moline, PhD, Eisai Medical Research Inc.']"]
["NCT00688428","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00688428","['Tore Lind, MD, Medical Science Director NEXIUM and GI Established Brands, AstraZeneca Pharmaceuticals']"]
["NCT00688441","[]","[u'Capnia, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00688441","['Kristen Yen, Associate Director, Clinical, Capnia, Inc.']"]
["NCT00688493","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00688493","['AstraZeneca']"]
["NCT00688519","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00688519","['Stiefel, a GSK Company']"]
["NCT00688636","[u'Miguel Regueiro, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00688636","['Miguel Regueiro, Professor of Medicine, University of Pittsburgh']"]
["NCT00688688","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00688688","['Astellas Pharma Inc']"]
["NCT00688701","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00688701","['Sanofi']"]
["NCT00688753","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00688753","['Novartis Pharmaceuticals']"]
["NCT00688831","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00688831","['Helen Lunde, MD, Medical Science Director, Emerging Arrythmias & Lipids, AstraZeneca']"]
["NCT00688857","[]","[u'Essentialis, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00688857","['Neil M Cowen, PhD/Chief Scientific Officer, Essentialis, Inc']"]
["NCT00688909","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00688909","['Novartis Pharmaceuticals']"]
["NCT00689078","[u'ORA, Inc.']","[u'ORA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00689078","['ORA, Inc.']"]
["NCT00689104","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00689104","['Astellas Pharma Inc']"]
["NCT00689117","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00689117","['Stiefel, a GSK Company']"]
["NCT00689221","[u'EMD Serono']","[u'EMD Serono']","https://clinicaltrials.gov/ct2/show/NCT00689221","['EMD Serono']"]
["NCT00689273","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00689273","['Pfizer']"]
["NCT00689299","[u'Antigen Laboratories, Inc.']","[u'Antigen Laboratories, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00689299","['Antigen Laboratories, Inc.']"]
["NCT00689481","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00689481","['Stiefel, a GSK Company']"]
["NCT00689507","[u'Applied Molecular Evolution']","[u'Applied Molecular Evolution']","https://clinicaltrials.gov/ct2/show/NCT00689507","['Applied Molecular Evolution']"]
["NCT00689728","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00689728","['Eli Lilly and Company']"]
["NCT00690092","[]","[u'Nielsen BioSciences, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00690092","['Harry S. Nielsen, Ph.D., Allermed Laboratories, Inc.']"]
["NCT00690235","[u'Carol A. Tamminga, University of Texas Southwestern Medical Center']","[u'University of Texas Southwestern Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00690235","['Carol A. Tamminga, Principal Investigator, University of Texas Southwestern Medical Center']"]
["NCT00690378","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00690378","['Pfizer']"]
["NCT00690404","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00690404","['Rolf Karlsten, M.D., Medical Science Director, Emerging Neuroscience, AstraZeneca Pharmaceuticals']"]
["NCT00690430","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00690430","['Novartis Pharmaceuticals']"]
["NCT00690443","[u'Aegerion Pharmaceuticals, Inc.']","[u'Aegerion Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00690443","['Aegerion Pharmaceuticals, Inc.']"]
["NCT00690612","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00690612","['James Hainer, MD, Sr. Director - Medical Research, Study Team Physician, AstraZeneca, LP']"]
["NCT00690625","[]","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00690625","['Ashwini Khante, University Of Washington']"]
["NCT00690716","[u'Capnia, Inc.']","[u'Capnia, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00690716","['Capnia, Inc.']"]
["NCT00690807","[]","[u'Provectus Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00690807","['Eric Wachter, Vice President, Provectus Pharmaceuticals, Inc.']"]
["NCT00690820","[]","[u'Solvay Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00690820","['Djenane Bennett, Solvay Pharmaceuticals']"]
["NCT00690833","[u'Wake Forest University Health Sciences ( Wake Forest University )']","[u'Wake Forest University']","https://clinicaltrials.gov/ct2/show/NCT00690833","['Wake Forest University']"]
["NCT00691054","[u'University of Miami']","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00691054","['University of Miami']"]
["NCT00691210","[u\"Owen A. O'Connor, Columbia University\"]","[u'Columbia University']","https://clinicaltrials.gov/ct2/show/NCT00691210","[\"Owen A. O'Connor, Professor of Medicine and Experimental Therapeutics; Director, Center for Lymphoid Malignancies, Columbia University\"]"]
["NCT00691301","[u'Gynecologic Oncology Group']","[u'Gynecologic Oncology Group']","https://clinicaltrials.gov/ct2/show/NCT00691301","['Gynecologic Oncology Group']"]
["NCT00691392","[u'Centers for Disease Control and Prevention']","[u'Centers for Disease Control and Prevention']","https://clinicaltrials.gov/ct2/show/NCT00691392","['Centers for Disease Control and Prevention']"]
["NCT00691483","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00691483","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00691678","[u'Dawn L. Hershman, Columbia University']","[u'Dawn L. Hershman']","https://clinicaltrials.gov/ct2/show/NCT00691678","['Dawn L. Hershman, Associate Professor of Medicine & Epidemiology, Columbia University']"]
["NCT00691704","[u'Cristina Gasparetto, Duke University']","[u'Cristina Gasparetto']","https://clinicaltrials.gov/ct2/show/NCT00691704","['Cristina Gasparetto, Associate Professor of Medicine, Duke University']"]
["NCT00691873","[]","[u'University of Mississippi Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00691873","['Gailen D. Marshall, MD, PhD, University of Mississippi Medical Center']"]
["NCT00691938","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00691938","['Washington University School of Medicine']"]
["NCT00691964","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00691964","['AbbVie (prior sponsor, Abbott)']"]
["NCT00692016","[]","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00692016","['Therapeutic Area Head, Bayer Consumer Care Inc.']"]
["NCT00692159","[]","[u'Tracon Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00692159","['Bryan Leigh, MD, Medical Monitor, TRACON Pharmaceuticals Inc.']"]
["NCT00692185","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00692185","['New York State Psychiatric Institute']"]
["NCT00692341","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00692341","['Pfizer']"]
["NCT00692445","[u'Targacept Inc.']","[u'Targacept Inc.']","https://clinicaltrials.gov/ct2/show/NCT00692445","['Targacept Inc.']"]
["NCT00692484","[u'CareFusion']","[u'CareFusion']","https://clinicaltrials.gov/ct2/show/NCT00692484","['CareFusion']"]
["NCT00692640","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00692640","['Sanofi']"]
["NCT00692770","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00692770","['Bayer']"]
["NCT00692900","[u'Robert Edwards, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00692900","['Robert Edwards, Principal Investigator, University of Pittsburgh']"]
["NCT00692913","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00692913","['Merck Sharp & Dohme Corp.']"]
["NCT00692926","[u'Joanne Kurtzberg, MD, Duke University']","[u'Joanne Kurtzberg, MD']","https://clinicaltrials.gov/ct2/show/NCT00692926","['Joanne Kurtzberg, MD, Professor of Pediatrics, Duke University']"]
["NCT00693056","[]","[u'Rexahn Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00693056","['Hyungjoo Lee / Associate Director, Product Development Management, Rexahn Pharmaceuticals, Inc.']"]
["NCT00693095","[u'John Sampson, Duke University']","[u'John Sampson']","https://clinicaltrials.gov/ct2/show/NCT00693095","['John Sampson, Professor Neurosurgery, Duke University']"]
["NCT00693225","[u'Yvonne Romero, Mayo Clinic']","[u'Yvonne Romero']","https://clinicaltrials.gov/ct2/show/NCT00693225","['Yvonne Romero, Yvonne Romero, MD, Mayo Clinic']"]
["NCT00693420","[]","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00693420","['Therapeutic Area Head, Allergan, Inc.']"]
["NCT00693433","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00693433","['National Cancer Institute (NCI)']"]
["NCT00693485","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00693485","['Allergan']"]
["NCT00693602","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00693602","[\"St. Jude Children's Research Hospital\"]"]
["NCT00693667","[u'PhytoHealth Corporation']","[u'PhytoHealth Corporation']","https://clinicaltrials.gov/ct2/show/NCT00693667","['PhytoHealth Corporation']"]
["NCT00693706","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00693706","['GlaxoSmithKline']"]
["NCT00693719","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00693719","['University of Arizona']"]
["NCT00693992","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00693992","['National Cancer Institute (NCI)']"]
["NCT00694044","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00694044","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00694057","[]","[u'Harbor Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00694057","['Dwight Stickney, MD - Chief Medical Officer, Hollis-Eden Pharmaceuticals']"]
["NCT00694096","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00694096","['University of Utah']"]
["NCT00694109","[u'Kastle Therapeutics, LLC']","[u'Kastle Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00694109","['Kastle Therapeutics, LLC']"]
["NCT00694122","[u'David M. Nathan, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00694122","['David M. Nathan, MD, Director, Diabetes Center, Massachusetts General Hospital']"]
["NCT00694135","[]","[u'Eyegate Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00694135","['Stephen From, President and Chief Executive Officer, Eyegate Pharmaceuticals, Inc.']"]
["NCT00694161","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00694161","['Pfizer']"]
["NCT00694174","[]","[u\"Children's Hospital of Michigan\"]","https://clinicaltrials.gov/ct2/show/NCT00694174","[\"Victoria Tutag Lehr, Pharm.D., Children's Hospital of Michigan, The Detroit Medical Center\"]"]
["NCT00694213","[]","[u'Vical']","https://clinicaltrials.gov/ct2/show/NCT00694213","['Don Guterwill, BS, MT, Senior Clinical Project Manager, Vical Incorporated']"]
["NCT00694369","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00694369","['Merck Sharp & Dohme Corp.']"]
["NCT00694382","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00694382","['Sanofi']"]
["NCT00694590","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00694590","['Genzyme, a Sanofi Company']"]
["NCT00694629","[u'Centers for Disease Control and Prevention']","[u'Centers for Disease Control and Prevention']","https://clinicaltrials.gov/ct2/show/NCT00694629","['Centers for Disease Control and Prevention']"]
["NCT00694707","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00694707","['Forest Laboratories']"]
["NCT00694798","[u'Cadila Pharnmaceuticals']","[u'Cadila Pharnmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00694798","['Cadila Pharnmaceuticals']"]
["NCT00694928","[u'Lumara Health, Inc.']","[u'Lumara Health, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00694928","['Lumara Health, Inc.']"]
["NCT00694980","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00694980","['Genentech, Inc.']"]
["NCT00695071","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00695071","['Stiefel, a GSK Company']"]
["NCT00695110","[]","[u'Clarus Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00695110","['Robert E. Dudley, PhD, President and CEO, Clarus Therapeutics, Inc., Clarus Therapeutics, Inc.']"]
["NCT00695292","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00695292","['SCRI Development Innovations, LLC']"]
["NCT00695305","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00695305","['GlaxoSmithKline']"]
["NCT00695500","[u'Vijay Ramchandani, Ph.D., National Institute on Alcohol Abuse and Alcoholism (NIAAA)']","[u'Vijay Ramchandani, Ph.D.']","https://clinicaltrials.gov/ct2/show/NCT00695500","['Vijay Ramchandani, Ph.D., Clinical Investigator and Chief, Section on Human Psychopharmacology, National Institute on Alcohol Abuse and Alcoholism (NIAAA)']"]
["NCT00695578","[u'Wake Forest University Health Sciences ( Wake Forest University )']","[u'Wake Forest University']","https://clinicaltrials.gov/ct2/show/NCT00695578","['Wake Forest University']"]
["NCT00695604","[u'University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00695604","['University of Chicago']"]
["NCT00695630","[]","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00695630","['Peter Milgrom/Professor of Dental Public Health Sciences, University of Washington']"]
["NCT00695669","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00695669","['GlaxoSmithKline']"]
["NCT00695851","[]","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00695851","['Susan Slovin, MD, Memorial Sloan-Kettering Cancer Center']"]
["NCT00695955","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00695955","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00696020","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00696020","['Boehringer Ingelheim']"]
["NCT00696072","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00696072","['Bristol-Myers Squibb']"]
["NCT00696137","[u'BioDelivery Sciences International']","[u'BioDelivery Sciences International']","https://clinicaltrials.gov/ct2/show/NCT00696137","['BioDelivery Sciences International']"]
["NCT00696176","[u'University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00696176","['University of Pittsburgh']"]
["NCT00696241","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00696241","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00696293","[u'Jordan F. Karp, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00696293","['Jordan F. Karp, Associate professor, University of Pittsburgh']"]
["NCT00696384","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00696384","['Takeda']"]
["NCT00696410","[u'Jennifer Cowger , MD, MS, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00696410","['Jennifer Cowger , MD, MS, Assistant Professor, study Coinvestigator, University of Michigan']"]
["NCT00696436","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00696436","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00696475","[]","[u'Essentialis, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00696475","['Neil M Cowen, PhD/Chief Scientific Officer, Essentialis']"]
["NCT00696488","[u'Wake Forest University Health Sciences ( Wake Forest University )']","[u'Wake Forest University']","https://clinicaltrials.gov/ct2/show/NCT00696488","['Wake Forest University']"]
["NCT00696696","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00696696","['New York University School of Medicine']"]
["NCT00696709","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00696709","['Merck Sharp & Dohme Corp.']"]
["NCT00696800","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00696800","['Merck Sharp & Dohme Corp.']"]
["NCT00696878","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00696878","['Merck Sharp & Dohme Corp.']"]
["NCT00697073","[u'Santhera Pharmaceuticals']","[u'Santhera Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00697073","['Santhera Pharmaceuticals']"]
["NCT00697099","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00697099","['Sanofi']"]
["NCT00697138","[u'Craig Rush, University of Kentucky']","[u'University of Kentucky']","https://clinicaltrials.gov/ct2/show/NCT00697138","['Craig Rush, Princpal Investigator, University of Kentucky']"]
["NCT00697203","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00697203","['Hoffmann-La Roche']"]
["NCT00697515","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00697515","['Shire']"]
["NCT00697541","[u'Galderma']","[u'Galderma']","https://clinicaltrials.gov/ct2/show/NCT00697541","['Galderma']"]
["NCT00697671","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00697671","[\"St. Jude Children's Research Hospital\"]"]
["NCT00697710","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00697710","['Shionogi']"]
["NCT00697788","[u'Erik S. Shank, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00697788","['Erik S. Shank, MD, Pediatric Anesthesiologist, Massachusetts General Hospital']"]
["NCT00697801","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00697801","['Allergan']"]
["NCT00697892","[u'Fran Aweeka, University of California, San Francisco']","[u'Fran Aweeka']","https://clinicaltrials.gov/ct2/show/NCT00697892","['Fran Aweeka, Sponsor-Investigator, University of California, San Francisco']"]
["NCT00698022","[u'Corcept Therapeutics']","[u'Corcept Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00698022","['Corcept Therapeutics']"]
["NCT00698035","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00698035","['University of California, San Francisco']"]
["NCT00698230","[u'Incyte Corporation']","[u'Incyte Corporation']","https://clinicaltrials.gov/ct2/show/NCT00698230","['Incyte Corporation']"]
["NCT00698243","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00698243","['Astellas Pharma Inc']"]
["NCT00698451","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00698451","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00698464","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00698464","['Novartis Pharmaceuticals']"]
["NCT00698516","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00698516","['GlaxoSmithKline']"]
["NCT00698724","[]","[u'Bp Consulting, Inc']","https://clinicaltrials.gov/ct2/show/NCT00698724","[\"Dr. Gills, St. Luke's Cataract and Laser Institute\"]"]
["NCT00698763","[]","[u'Orion Corporation, Orion Pharma']","https://clinicaltrials.gov/ct2/show/NCT00698763","['Juha Ellmen, Clinical Program Leader, Orion Pharma']"]
["NCT00698776","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00698776","['Yale University']"]
["NCT00698841","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00698841","['Eli Lilly and Company']"]
["NCT00698945","[]","[u'Bp Consulting, Inc']","https://clinicaltrials.gov/ct2/show/NCT00698945","['Dr. Bacharach, North Bay Eye Associates, Inc.']"]
["NCT00699010","[u'Acura Pharmaceuticals Inc.']","[u'Acura Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00699010","['Acura Pharmaceuticals Inc.']"]
["NCT00699153","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00699153","['Bausch & Lomb Incorporated']"]
["NCT00699517","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00699517","['Sanofi']"]
["NCT00699582","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00699582","['Eisai Inc.']"]
["NCT00699751","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00699751","['Bayer']"]
["NCT00699777","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00699777","['Warner Chilcott']"]
["NCT00699803","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00699803","['Bausch & Lomb Incorporated']"]
["NCT00699907","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00699907","['University of Arizona']"]
["NCT00699972","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00699972","['Eisai Inc.']"]
["NCT00699998","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00699998","['Eli Lilly and Company']"]
["NCT00700115","[u'Ighovwerha Ofotokun, Emory University']","[u'Emory University']","https://clinicaltrials.gov/ct2/show/NCT00700115","['Ighovwerha Ofotokun, Associate Professor of Medicine, Emory University']"]
["NCT00700206","[u'Telik']","[u'Telik']","https://clinicaltrials.gov/ct2/show/NCT00700206","['Telik']"]
["NCT00700310","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00700310","['Eisai Inc.']"]
["NCT00700375","[]","[u'Osaka General Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00700375","['Hiromichi Ueda, Osaka General Medical Center']"]
["NCT00700427","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00700427","['Eli Lilly and Company']"]
["NCT00700479","[]","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00700479","['Stuart Katz, Yale School of Medicine']"]
["NCT00700635","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00700635","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00700713","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00700713","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00700817","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00700817","['Novo Nordisk A/S']"]
["NCT00700921","[u'E Rand Sutherland, National Jewish Health']","[u'National Jewish Health']","https://clinicaltrials.gov/ct2/show/NCT00700921","['E Rand Sutherland, Chair of Pulmonary Medicine, National Jewish Health']"]
["NCT00700999","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00700999","['US Department of Veterans Affairs']"]
["NCT00701129","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00701129","['Genzyme, a Sanofi Company']"]
["NCT00701220","[]","[u'Ohio State University']","https://clinicaltrials.gov/ct2/show/NCT00701220","['Philip Binkley, MD, MPH, The Ohio State University/ Division of Cardiovascular Medicine']"]
["NCT00701311","[u'Kenneth Peters, MD, William Beaumont Hospitals']","[u'Kenneth Peters, MD']","https://clinicaltrials.gov/ct2/show/NCT00701311","['Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals']"]
["NCT00701389","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00701389","['Merck Sharp & Dohme Corp.']"]
["NCT00701415","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00701415","['Genzyme, a Sanofi Company']"]
["NCT00701636","[u'Los Angeles Biomedical Research Institute']","[u'Los Angeles Biomedical Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00701636","['Los Angeles Biomedical Research Institute']"]
["NCT00701675","[u'VA Office of Research and Development']","[u'VA Office of Research and Development']","https://clinicaltrials.gov/ct2/show/NCT00701675","['VA Office of Research and Development']"]
["NCT00701688","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00701688","[\"St. Jude Children's Research Hospital\"]"]
["NCT00701727","[]","[u'Radiant Research']","https://clinicaltrials.gov/ct2/show/NCT00701727","['Michael H. Davidson, MD, FACC, Radiant Research']"]
["NCT00701779","[u'Paul F. Siami, MD, Siami, Paul F., M.D.']","[u'Siami, Paul F., M.D.']","https://clinicaltrials.gov/ct2/show/NCT00701779","['Paul F. Siami, MD, Medical Director, Research Institute of Deaconess Clinic, Siami, Paul F., M.D.']"]
["NCT00701857","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00701857","['University of Arizona']"]
["NCT00701883","[u'CymaBay Therapeutics, Inc.']","[u'CymaBay Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00701883","['CymaBay Therapeutics, Inc.']"]
["NCT00701909","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00701909","['University of California, San Francisco']"]
["NCT00702052","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00702052","['Novartis Pharmaceuticals']"]
["NCT00702143","[u'Avid Radiopharmaceuticals']","[u'Avid Radiopharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00702143","['Avid Radiopharmaceuticals']"]
["NCT00702299","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00702299","['University of Arizona']"]
["NCT00702325","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00702325","['AstraZeneca']"]
["NCT00702403","[u'Paul Carpenter, Fred Hutchinson Cancer Research Center']","[u'Fred Hutchinson Cancer Research Center']","https://clinicaltrials.gov/ct2/show/NCT00702403","['Paul Carpenter, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT00702507","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00702507","['Stiefel, a GSK Company']"]
["NCT00702650","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00702650","['Chief Medical Officer, Eli Lilly']"]
["NCT00702676","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00702676","['Hans A Eriksson, MD, Medical Science Director, AstraZeneca Pharmaceuticals']"]
["NCT00702689","[u'Edward Cowen, M.D., National Institutes of Health Clinical Center (CC)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00702689","['Edward Cowen, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT00702884","[u'Tony Bekaii-Saab, Ohio State University Comprehensive Cancer Center']","[u'Tony Bekaii-Saab']","https://clinicaltrials.gov/ct2/show/NCT00702884","['Tony Bekaii-Saab, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00702949","[u'Alliance for Clinical Trials in Oncology']","[u'Alliance for Clinical Trials in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00702949","['Alliance for Clinical Trials in Oncology']"]
["NCT00703118","[u'Tibotec BVBA']","[u'Tibotec BVBA']","https://clinicaltrials.gov/ct2/show/NCT00703118","['Tibotec BVBA']"]
["NCT00703170","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00703170","['Washington University School of Medicine']"]
["NCT00703183","[u'Acucela Inc.']","[u'Acucela Inc.']","https://clinicaltrials.gov/ct2/show/NCT00703183","['Acucela Inc.']"]
["NCT00703261","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00703261","['Merck Sharp & Dohme Corp.']"]
["NCT00703300","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00703300","['National Cancer Institute (NCI)']"]
["NCT00703391","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00703391","['AstraZeneca']"]
["NCT00703469","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00703469","['Study Director, Bristol-Myers Squibb']"]
["NCT00703534","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00703534","['Debra Silberg, MD, Director of Clinical Research, AstraZeneca Pharmaceuticals']"]
["NCT00703573","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00703573","['Shionogi']"]
["NCT00703586","[u'Rockefeller University']","[u'Rockefeller University']","https://clinicaltrials.gov/ct2/show/NCT00703586","['Rockefeller University']"]
["NCT00703638","[u'Masonic Cancer Center, University of Minnesota']","[u'Masonic Cancer Center, University of Minnesota']","https://clinicaltrials.gov/ct2/show/NCT00703638","['Masonic Cancer Center, University of Minnesota']"]
["NCT00703677","[u'Westat']","[u'Westat']","https://clinicaltrials.gov/ct2/show/NCT00703677","['Westat']"]
["NCT00703703","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00703703","['Novartis']"]
["NCT00703807","[u'Maysa Abu-Khalaf, Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00703807","['Maysa Abu-Khalaf, Principal Investigator, Yale University']"]
["NCT00703846","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00703846","['Stiefel, a GSK Company']"]
["NCT00703885","[u'Murray B. Stein, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00703885","['Murray B. Stein, Professor, University of California, San Diego']"]
["NCT00703976","[u'University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00703976","['University of Pittsburgh']"]
["NCT00704054","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00704054","['Merck Sharp & Dohme Corp.']"]
["NCT00704080","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00704080","['Sanofi']"]
["NCT00704184","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00704184","['Merck Sharp & Dohme Corp.']"]
["NCT00704262","[u'LEO Pharma']","[u'LEO Pharma']","https://clinicaltrials.gov/ct2/show/NCT00704262","['LEO Pharma']"]
["NCT00704379","[u'Ricardo Jorge, MD, Baylor College of Medicine']","[u'Baylor College of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00704379","['Ricardo Jorge, MD, Professor, Baylor College of Medicine']"]
["NCT00704405","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00704405","['Merck Sharp & Dohme Corp.']"]
["NCT00704431","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00704431","['GlaxoSmithKline']"]
["NCT00704483","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00704483","['Novartis Pharmaceuticals']"]
["NCT00704912","[u'Richard S. Legro, M.D., Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00704912","['Richard S. Legro, M.D., Professor, Obstetrics and Gynecology and Public Health Sciences, Milton S. Hershey Medical Center']"]
["NCT00705003","[u'Maurizio Fava, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00705003","['Maurizio Fava, MD, Fava, Maurizio MD., Massachusetts General Hospital']"]
["NCT00705250","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00705250","['Memorial Sloan Kettering Cancer Center']"]
["NCT00705341","[u'Janet Holbrook, Johns Hopkins Bloomberg School of Public Health']","[u'Johns Hopkins Bloomberg School of Public Health']","https://clinicaltrials.gov/ct2/show/NCT00705341","['Janet Holbrook, Associate Professor, Johns Hopkins Bloomberg School of Public Health']"]
["NCT00705523","[u'Jennifer Plebani, National Institute on Drug Abuse (NIDA)']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00705523","['Jennifer Plebani, Principal Investigator, National Institute on Drug Abuse (NIDA)']"]
["NCT00705536","[u'Halozyme Therapeutics']","[u'Halozyme Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00705536","['Halozyme Therapeutics']"]
["NCT00705653","[u'Progen Pharmaceuticals']","[u'Progen Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00705653","['Progen Pharmaceuticals']"]
["NCT00705679","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00705679","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00705757","[u'Deepak P. Edward, Summa Health System']","[u'Summa Health System']","https://clinicaltrials.gov/ct2/show/NCT00705757","['Deepak P. Edward, PI, Summa Health System']"]
["NCT00705783","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00705783","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00705874","[u'Progen Pharmaceuticals']","[u'Progen Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00705874","['Progen Pharmaceuticals']"]
["NCT00705939","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00705939","['Pfizer']"]
["NCT00706121","[u'Southwest Oncology Group']","[u'Southwest Oncology Group']","https://clinicaltrials.gov/ct2/show/NCT00706121","['Southwest Oncology Group']"]
["NCT00706225","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00706225","['Director, Clinical Trial Disclosure Group, Pfizer, Inc']"]
["NCT00706342","[u'Rigel Pharmaceuticals']","[u'Rigel Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00706342","['Rigel Pharmaceuticals']"]
["NCT00706433","[u'DUSA Pharmaceuticals, Inc.']","[u'DUSA Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706433","['DUSA Pharmaceuticals, Inc.']"]
["NCT00706537","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00706537","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00706654","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706654","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00706719","[u'Repros Therapeutics Inc.']","[u'Repros Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706719","['Repros Therapeutics Inc.']"]
["NCT00706732","[u'AlphaVax, Inc.']","[u'AlphaVax, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706732","['AlphaVax, Inc.']"]
["NCT00706810","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00706810","['University of Utah']"]
["NCT00706836","[u'Murray B. Stein, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00706836","['Murray B. Stein, Professor, University of California, San Diego']"]
["NCT00706849","[u'Kastle Therapeutics, LLC']","[u'Kastle Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00706849","['Kastle Therapeutics, LLC']"]
["NCT00706914","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00706914","['AstraZeneca']"]
["NCT00707031","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00707031","['Sanofi']"]
["NCT00707057","[]","[u'SCOLR Pharma, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00707057","['Stephen Turner, President & CEO, SCOLR Pharma, Inc.']"]
["NCT00707278","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00707278","['University of Utah']"]
["NCT00707499","[u'Lantheus Medical Imaging']","[u'Lantheus Medical Imaging']","https://clinicaltrials.gov/ct2/show/NCT00707499","['Lantheus Medical Imaging']"]
["NCT00707538","[]","[u'Lantheus Medical Imaging']","https://clinicaltrials.gov/ct2/show/NCT00707538","['Dana Washburn, MD, Lantheus Medical Imaging']"]
["NCT00707642","[]","[u'Hawaii Biotech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00707642","['Beth-Ann Coller, Ph.D., Hawaii Biotech']"]
["NCT00707863","[u'Indiana University ( Indiana University School of Medicine )']","[u'Indiana University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00707863","['Indiana University School of Medicine']"]
["NCT00707889","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00707889","['AbbVie (prior sponsor, Abbott)']"]
["NCT00707980","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00707980","['Takeda']"]
["NCT00707993","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00707993","['Takeda']"]
["NCT00708006","[u'Human Genome Sciences Inc.']","[u'Human Genome Sciences Inc.']","https://clinicaltrials.gov/ct2/show/NCT00708006","['Human Genome Sciences Inc.']"]
["NCT00708071","[u'Baxter Healthcare Corporation']","[u'Baxter Healthcare Corporation']","https://clinicaltrials.gov/ct2/show/NCT00708071","['Baxter Healthcare Corporation']"]
["NCT00708084","[u'Crucell Holland BV']","[u'Crucell Holland BV']","https://clinicaltrials.gov/ct2/show/NCT00708084","['Crucell Holland BV']"]
["NCT00708097","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00708097","['GlaxoSmithKline']"]
["NCT00708110","[u'ViiV Healthcare']","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00708110","['ViiV Healthcare']"]
["NCT00708123","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00708123","['GlaxoSmithKline']"]
["NCT00708149","[u'Far Eastern Memorial Hospital']","[u'Far Eastern Memorial Hospital']","https://clinicaltrials.gov/ct2/show/NCT00708149","['Far Eastern Memorial Hospital']"]
["NCT00708162","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00708162","['Gilead Sciences']"]
["NCT00708175","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00708175","['Takeda']"]
["NCT00708201","[u'Cubist Pharmaceuticals LLC']","[u'Cubist Pharmaceuticals LLC']","https://clinicaltrials.gov/ct2/show/NCT00708201","['Cubist Pharmaceuticals LLC']"]
["NCT00708227","[u\"Kathryn Blake, PharmD, Nemours Children's Clinic\"]","[u\"Nemours Children's Clinic\"]","https://clinicaltrials.gov/ct2/show/NCT00708227","[\"Kathryn Blake, PharmD, Senior Research Scientist, Nemours Children's Clinic\"]"]
["NCT00708292","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00708292","['Novartis Pharmaceuticals']"]
["NCT00708305","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00708305","['GlaxoSmithKline']"]
["NCT00708422","[u'Alcon Research']","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT00708422","['Alcon Research']"]
["NCT00708435","[u'CSL Behring']","[u'CSL Behring']","https://clinicaltrials.gov/ct2/show/NCT00708435","['CSL Behring']"]
["NCT00708604","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00708604","['City of Hope Medical Center']"]
["NCT00708682","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00708682","['Wyeth is now a wholly owned subsidiary of Pfizer']"]
["NCT00708721","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00708721","['University of Utah']"]
["NCT00708903","[u'Puma Biotechnology, Inc.']","[u'Puma Biotechnology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00708903","['Puma Biotechnology, Inc.']"]
["NCT00708916","[u'Elizabeth Camacho, New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00708916","['Elizabeth Camacho, PRS, New York University School of Medicine']"]
["NCT00709020","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00709020","['City of Hope Medical Center']"]
["NCT00709098","[u'Actelion']","[u'Actelion']","https://clinicaltrials.gov/ct2/show/NCT00709098","['Actelion']"]
["NCT00709371","[u'Orexigen Therapeutics, Inc']","[u'Orexigen Therapeutics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00709371","['Orexigen Therapeutics, Inc']"]
["NCT00709436","[u'Hospira, now a wholly owned subsidiary of Pfizer']","[u'Hospira, now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00709436","['Hospira, now a wholly owned subsidiary of Pfizer']"]
["NCT00709488","[u'Light Sciences Oncology']","[u'Light Sciences Oncology']","https://clinicaltrials.gov/ct2/show/NCT00709488","['Light Sciences Oncology']"]
["NCT00709514","[u'Oneness Biotech Co., Ltd.']","[u'Oneness Biotech Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00709514","['Oneness Biotech Co., Ltd.']"]
["NCT00709540","[]","[u'Acceleron Pharma, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00709540","['Matthew L Sherman MD, Acceleron Pharma Inc.']"]
["NCT00709800","[]","[u'Vical']","https://clinicaltrials.gov/ct2/show/NCT00709800","['Don Guterwill, BS, MT, Senior Clinical Project Manager, Vical Incorporated']"]
["NCT00709826","[u'Tragara Pharmaceuticals, Inc.']","[u'Tragara Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00709826","['Tragara Pharmaceuticals, Inc.']"]
["NCT00709852","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00709852","['Bayer']"]
["NCT00709865","[u'Biogen']","[u'Biogen']","https://clinicaltrials.gov/ct2/show/NCT00709865","['Biogen']"]
["NCT00709904","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00709904","['Sanofi']"]
["NCT00709956","[u'Actelion']","[u'Actelion']","https://clinicaltrials.gov/ct2/show/NCT00709956","['Actelion']"]
["NCT00710021","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00710021","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00710034","[u'University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00710034","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00710125","[u'Gem Pharmaceuticals']","[u'Gem Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00710125","['Gem Pharmaceuticals']"]
["NCT00710333","[]","[u'Renovo']","https://clinicaltrials.gov/ct2/show/NCT00710333","['Amanda Hilton Senior Clinical Research Manager, Renovo Ltd']"]
["NCT00710385","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00710385","['New York State Psychiatric Institute']"]
["NCT00710580","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00710580","['AbbVie (prior sponsor, Abbott)']"]
["NCT00710593","[u'University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00710593","['University of North Carolina, Chapel Hill']"]
["NCT00710684","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00710684","['GlaxoSmithKline']"]
["NCT00710710","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00710710","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00710814","[u'Judith Korner, Columbia University']","[u'Columbia University']","https://clinicaltrials.gov/ct2/show/NCT00710814","['Judith Korner, Associate Professor of Medicine, Columbia University']"]
["NCT00710970","[u'Seth Lerner, Baylor College of Medicine']","[u'Seth Lerner']","https://clinicaltrials.gov/ct2/show/NCT00710970","['Seth Lerner, Professor, Baylor College of Medicine']"]
["NCT00711009","[u'Abbott']","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00711009","['Abbott']"]
["NCT00711035","[u'Helen Heslop, Baylor College of Medicine']","[u'Baylor College of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00711035","['Helen Heslop, Principal Investigator, Baylor College of Medicine']"]
["NCT00711165","[]","[u'Creighton University']","https://clinicaltrials.gov/ct2/show/NCT00711165","['Thomas B. Casale, MD, Creighton University']"]
["NCT00711191","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00711191","['Hoffmann-La Roche']"]
["NCT00711386","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00711386","['GlaxoSmithKline']"]
["NCT00711464","[u'Michael Minzenberg, MD, University of California, Davis']","[u'University of California, Los Angeles']","https://clinicaltrials.gov/ct2/show/NCT00711464","['Michael Minzenberg, MD, Associate Professor of Clinical Psychiatry, University of California, Davis']"]
["NCT00711477","[u'Orexigen Therapeutics, Inc']","[u'Orexigen Therapeutics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00711477","['Orexigen Therapeutics, Inc']"]
["NCT00711490","[u'National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )']","[u'National Eye Institute (NEI)']","https://clinicaltrials.gov/ct2/show/NCT00711490","['National Eye Institute (NEI)']"]
["NCT00711516","[u'Teva Pharmaceutical Industries ( Cephalon )']","[u'Cephalon']","https://clinicaltrials.gov/ct2/show/NCT00711516","['Cephalon']"]
["NCT00711529","[u'Shannon MacLaughlan, Women and Infants Hospital of Rhode Island']","[u'Women and Infants Hospital of Rhode Island']","https://clinicaltrials.gov/ct2/show/NCT00711529","['Shannon MacLaughlan, Shannon MacLaughlan, M.D., Women and Infants Hospital of Rhode Island']"]
["NCT00711802","[u'Cubist Pharmaceuticals LLC']","[u'Cubist Pharmaceuticals LLC']","https://clinicaltrials.gov/ct2/show/NCT00711802","['Cubist Pharmaceuticals LLC']"]
["NCT00711971","[u'Ellen Mozurkewich, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00711971","['Ellen Mozurkewich, Adjunct Assistant Professor, University of Michigan']"]
["NCT00712114","[]","[u'Harbor Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00712114","['Nanette Onizuka-Handa/Sr. Vice President, Regulatory Affairs and Quality, Hollis-Eden Pharmaceuticals']"]
["NCT00712166","[]","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00712166","['Mark Bresnik, MD, Director, Clinical Research, Gilead Sciences, Inc.']"]
["NCT00712348","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00712348","['Pfizer']"]
["NCT00712439","[]","[u'Depomed']","https://clinicaltrials.gov/ct2/show/NCT00712439","['Lynne Rowe, Depomed']"]
["NCT00712465","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00712465","['Helen Lunde, MD, Medical Science Director, Emerging Arrhythmia and Lipids, AstraZeneca']"]
["NCT00712673","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00712673","['Sanofi']"]
["NCT00712725","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00712725","['Merck Sharp & Dohme Corp.']"]
["NCT00712803","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00712803","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00712855","[u'GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )']","[u'Human Genome Sciences Inc., a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00712855","['Human Genome Sciences Inc., a GSK Company']"]
["NCT00712985","[u'Allan Lipton, Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00712985","['Allan Lipton, MD, Milton S. Hershey Medical Center']"]
["NCT00713284","[u'V. Ram Peddi, California Pacific Medical Center Research Institute']","[u'California Pacific Medical Center Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00713284","['V. Ram Peddi, Medical Doctor, California Pacific Medical Center Research Institute']"]
["NCT00713310","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00713310","['Warner Chilcott']"]
["NCT00713336","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00713336","['Dr Thomas Morris, Medical Science Director, AstraZeneca, AstraZeneca Pharmaceuticals']"]
["NCT00713349","[u'Healthpoint']","[u'Healthpoint']","https://clinicaltrials.gov/ct2/show/NCT00713349","['Healthpoint']"]
["NCT00713479","[u'Steve Shoptaw, University of California, Los Angeles']","[u'University of California, Los Angeles']","https://clinicaltrials.gov/ct2/show/NCT00713479","['Steve Shoptaw, Professor, University of California, Los Angeles']"]
["NCT00713518","[u'Quark Pharmaceuticals']","[u'Quark Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00713518","['Quark Pharmaceuticals']"]
["NCT00713544","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00713544","['AstraZeneca']"]
["NCT00713583","[u'Joy Schmitz, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00713583","['Joy Schmitz, Professor - Psychiatry, Behavioral Sciences, The University of Texas Health Science Center, Houston']"]
["NCT00713609","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00713609","['Stiefel, a GSK Company']"]
["NCT00713648","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00713648","['Novo Nordisk A/S']"]
["NCT00713791","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00713791","['Dr Thomas Morris, Medical Science Director, AstraZeneca, AstraZeneca Pharmaceuticals']"]
["NCT00713830","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00713830","['Sanofi']"]
["NCT00714103","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00714103","['M.D. Anderson Cancer Center']"]
["NCT00714116","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00714116","['Pfizer']"]
["NCT00714181","[u'Abramson Cancer Center of the University of Pennsylvania']","[u'Abramson Cancer Center of the University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00714181","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT00714493","[u'Centocor Ortho Biotech Services, L.L.C.']","[u'Centocor Ortho Biotech Services, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00714493","['Centocor Ortho Biotech Services, L.L.C.']"]
["NCT00714714","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00714714","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00715078","[u'Dendreon']","[u'Dendreon']","https://clinicaltrials.gov/ct2/show/NCT00715078","['Dendreon']"]
["NCT00715104","[u'Dendreon']","[u'Dendreon']","https://clinicaltrials.gov/ct2/show/NCT00715104","['Dendreon']"]
["NCT00715117","[u'Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00715117","['Milton S. Hershey Medical Center']"]
["NCT00715182","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00715182","['Novartis Pharmaceuticals']"]
["NCT00715208","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00715208","['Millennium Pharmaceuticals, Inc.']"]
["NCT00715624","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00715624","['Sanofi']"]
["NCT00715676","[]","[u'Deltanoid Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00715676","['Hector F. DeLuca, President and Chief Executive Officer, Deltanoid Pharmaceuticals']"]
["NCT00715793","[u'Hussein Tawbi, University of Pittsburgh']","[u'Hussein Tawbi']","https://clinicaltrials.gov/ct2/show/NCT00715793","['Hussein Tawbi, Principal Investigator, University of Pittsburgh']"]
["NCT00715871","[u'Smoke-Break, Inc.']","[u'Smoke-Break, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00715871","['Smoke-Break, Inc.']"]
["NCT00715910","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00715910","['GlaxoSmithKline']"]
["NCT00716014","[]","[u'Pachyonychia Congenita Project']","https://clinicaltrials.gov/ct2/show/NCT00716014","['Sancy Leachman/Principal Investigator, PC Project']"]
["NCT00716092","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00716092","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00716274","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00716274","['Eli Lilly and Company']"]
["NCT00716456","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00716456","['Memorial Sloan Kettering Cancer Center']"]
["NCT00716521","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00716521","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00716534","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00716534","['AbbVie (prior sponsor, Abbott)']"]
["NCT00716547","[]","[u'IDEA AG']","https://clinicaltrials.gov/ct2/show/NCT00716547","['Dr. Claudia Himly / Director of Clinical Operations, IDEA AG']"]
["NCT00716716","[u'Bioverativ Therapeutics Inc.']","[u'Bioverativ Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00716716","['Bioverativ Therapeutics Inc.']"]
["NCT00716859","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00716859","['Director, Clinical Trial Disclosure Group, Pfizer Inc']"]
["NCT00717067","[]","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00717067","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00717197","[u'University of Florida']","[u'University of Florida']","https://clinicaltrials.gov/ct2/show/NCT00717197","['University of Florida']"]
["NCT00717236","[u'UCB Pharma']","[u'UCB Pharma']","https://clinicaltrials.gov/ct2/show/NCT00717236","['UCB Pharma']"]
["NCT00717262","[]","[u'HemaQuest Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00717262","['Susan Perrine, MD/ Chief Scientific Officer, HemaQuest Pharmaceuticals, Inc.']"]
["NCT00717288","[u'Kathleen Dungan, Ohio State University']","[u'Ohio State University']","https://clinicaltrials.gov/ct2/show/NCT00717288","['Kathleen Dungan, Assistant Professor of Medicine, Ohio State University']"]
["NCT00717340","[u'AVEO Pharmaceuticals, Inc.']","[u'AVEO Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00717340","['AVEO Pharmaceuticals, Inc.']"]
["NCT00717366","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00717366","['Hoffmann-La Roche']"]
["NCT00717457","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00717457","['Hoffmann-La Roche']"]
["NCT00717704","[u'Washington Hospital Center']","[u'Washington Hospital Center']","https://clinicaltrials.gov/ct2/show/NCT00717704","['Washington Hospital Center']"]
["NCT00717756","[u'howard safran, Brown University']","[u'Brown University']","https://clinicaltrials.gov/ct2/show/NCT00717756","['howard safran, Principle Investigator, Brown University']"]
["NCT00718094","[u'Gerald W. Dryden, Jr., University of Louisville']","[u'University of Louisville']","https://clinicaltrials.gov/ct2/show/NCT00718094","['Gerald W. Dryden, Jr., Principal investigator, University of Louisville']"]
["NCT00718159","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00718159","['Eli Lilly and Company']"]
["NCT00718172","[u'National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) )']","[u'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","https://clinicaltrials.gov/ct2/show/NCT00718172","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT00718224","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00718224","['Sanofi']"]
["NCT00718419","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00718419","['Eli Lilly and Company']"]
["NCT00718601","[u'Geron Corporation']","[u'Geron Corporation']","https://clinicaltrials.gov/ct2/show/NCT00718601","['Geron Corporation']"]
["NCT00718666","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00718666","['GlaxoSmithKline']"]
["NCT00718692","[u'Symphogen A/S']","[u'Symphogen A/S']","https://clinicaltrials.gov/ct2/show/NCT00718692","['Symphogen A/S']"]
["NCT00718718","[u'Centocor, Inc.']","[u'Centocor, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00718718","['Centocor, Inc.']"]
["NCT00718731","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00718731","['Director, Clinical Trial Disclosure Group, Wyeth']"]
["NCT00718757","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00718757","[\"St. Jude Children's Research Hospital\"]"]
["NCT00718770","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00718770","['University of Colorado, Denver']"]
["NCT00718861","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00718861","['Novartis Pharmaceuticals']"]
["NCT00719043","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00719043","['GlaxoSmithKline']"]
["NCT00719095","[]","[u'University of Vermont Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00719095","['Stacey C. Sigmon, Ph.D., University of Vermont']"]
["NCT00719108","[u'Wockhardt']","[u'Wockhardt']","https://clinicaltrials.gov/ct2/show/NCT00719108","['Wockhardt']"]
["NCT00719134","[u'Rami Burstein, Beth Israel Deaconess Medical Center']","[u'Beth Israel Deaconess Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00719134","['Rami Burstein, Professor, Beth Israel Deaconess Medical Center']"]
["NCT00719160","[u'Karl Insogna, Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00719160","['Karl Insogna, Professor of Medicine, Yale University']"]
["NCT00719186","[u'Heping Zhang, Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00719186","['Heping Zhang, Principal Investigator, Yale University']"]
["NCT00719212","[u'Translational Research in Oncology']","[u'Translational Research in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00719212","['Translational Research in Oncology']"]
["NCT00719264","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00719264","['Novartis Pharmaceuticals']"]
["NCT00719381","[u'Paul Beringer, University of Southern California']","[u'Paul Beringer']","https://clinicaltrials.gov/ct2/show/NCT00719381","['Paul Beringer, Associate Professor, University of Southern California']"]
["NCT00719407","[u'Yvonne Wu, University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00719407","['Yvonne Wu, Professor of Neurology and Pediatrics, University of California, San Francisco']"]
["NCT00719420","[]","[u'University of North Texas Health Science Center']","https://clinicaltrials.gov/ct2/show/NCT00719420","['Dr. Lori A. Fischbach, University of North Texas Health Science Center']"]
["NCT00719472","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00719472","['Genentech, Inc.']"]
["NCT00719550","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00719550","['Amgen']"]
["NCT00719563","[u'Alliance for Clinical Trials in Oncology']","[u'Alliance for Clinical Trials in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00719563","['Alliance for Clinical Trials in Oncology']"]
["NCT00719602","[u'International Maternal Pediatric Adolescent AIDS Clinical Trials Group']","[u'International Maternal Pediatric Adolescent AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT00719602","['International Maternal Pediatric Adolescent AIDS Clinical Trials Group']"]
["NCT00719680","[u'CSL Behring']","[u'CSL Behring']","https://clinicaltrials.gov/ct2/show/NCT00719680","['CSL Behring']"]
["NCT00719693","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00719693","['AstraZeneca']"]
["NCT00719706","[u'Brian P. Brennan, MD, Mclean Hospital']","[u'Mclean Hospital']","https://clinicaltrials.gov/ct2/show/NCT00719706","['Brian P. Brennan, MD, Associate Director of Translational Neuroscience Research, Mclean Hospital']"]
["NCT00719810","[u'Melinta Therapeutics, Inc.']","[u'Melinta Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00719810","['Melinta Therapeutics, Inc.']"]
["NCT00719862","[]","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00719862","['Harry Sacks, MD Vice President, Medical and Scientific Affairs']"]
["NCT00720018","[u'Teva Pharmaceutical Industries ( NuPathe Inc. )']","[u'NuPathe Inc.']","https://clinicaltrials.gov/ct2/show/NCT00720018","['NuPathe Inc.']"]
["NCT00720057","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00720057","['Bayer']"]
["NCT00720109","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00720109","['National Cancer Institute (NCI)']"]
["NCT00720122","[u'Madhusmita Misra, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00720122","['Madhusmita Misra, Asssociate Professor of Pediatrics, Massachusetts General Hospital']"]
["NCT00720135","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00720135","['City of Hope Medical Center']"]
["NCT00720174","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00720174","['National Cancer Institute (NCI)']"]
["NCT00720304","[u'Case Comprehensive Cancer Center']","[u'Case Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00720304","['Case Comprehensive Cancer Center']"]
["NCT00720382","[u'Meda Pharmaceuticals']","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00720382","['Meda Pharmaceuticals']"]
["NCT00720434","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00720434","['Pfizer']"]
["NCT00720499","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00720499","['Boehringer Ingelheim']"]
["NCT00720564","[]","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00720564","['Jana Portnow, City of Hope Comprehensive Cancer Center']"]
["NCT00720577","[]","[u'ev3']","https://clinicaltrials.gov/ct2/show/NCT00720577","['Neil Hattangadi M.D. , Vice President, Molecular Programs, FoxHollow Technologies ( Ev3)']"]
["NCT00720759","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00720759","['US Department of Veterans Affairs']"]
["NCT00720798","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00720798","['Hoffmann-La Roche']"]
["NCT00721006","[u'TCA Cellular Therapy']","[u'TCA Cellular Therapy']","https://clinicaltrials.gov/ct2/show/NCT00721006","['TCA Cellular Therapy']"]
["NCT00721045","[u'Mesoblast, Ltd.']","[u'Mesoblast, Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00721045","['Mesoblast, Ltd.']"]
["NCT00721123","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00721123","['Hoffmann-La Roche']"]
["NCT00721162","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00721162","['Eli Lilly and Company']"]
["NCT00721214","[u'Virginia Commonwealth University']","[u'Virginia Commonwealth University']","https://clinicaltrials.gov/ct2/show/NCT00721214","['Virginia Commonwealth University']"]
["NCT00721396","[u'Novartis ( Novartis Vaccines )']","[u'Novartis Vaccines']","https://clinicaltrials.gov/ct2/show/NCT00721396","['Novartis Vaccines']"]
["NCT00721461","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00721461","['Merck Sharp & Dohme Corp.']"]
["NCT00721474","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00721474","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00721526","[u'Michael Bogenschutz, University of New Mexico']","[u'University of New Mexico']","https://clinicaltrials.gov/ct2/show/NCT00721526","['Michael Bogenschutz, Professor of Psychiatry, University of New Mexico']"]
["NCT00721630","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00721630","['Memorial Sloan Kettering Cancer Center']"]
["NCT00721695","[u'Omeros Corporation']","[u'Omeros Corporation']","https://clinicaltrials.gov/ct2/show/NCT00721695","['Omeros Corporation']"]
["NCT00721734","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00721734","['Amgen']"]
["NCT00721760","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00721760","['Sanofi']"]
["NCT00721877","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00721877","['National Cancer Institute (NCI)']"]
["NCT00721955","[u'Alexza Pharmaceuticals, Inc.']","[u'Alexza Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00721955","['Alexza Pharmaceuticals, Inc.']"]
["NCT00722046","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00722046","['Pfizer']"]
["NCT00722124","[]","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00722124","['Amit Sood, M.D., Mayo Clinic']"]
["NCT00722176","[]","[u'BioLineRx, Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00722176","['BioLineRx']"]
["NCT00722306","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00722306","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00722358","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00722358","['Study Director, Bristol-Myers Squibb']"]
["NCT00722488","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00722488","['Millennium Pharmaceuticals, Inc.']"]
["NCT00722501","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00722501","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00722566","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00722566","['Millennium Pharmaceuticals, Inc.']"]
["NCT00722722","[u'Mark Stegall, Mayo Clinic']","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00722722","['Mark Stegall, PI, Mayo Clinic']"]
["NCT00722761","[u'Alexandra Kimball, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00722761","['Alexandra Kimball, Director, Clinical Unit for Research Trials in Skin, Massachusetts General Hospital']"]
["NCT00722839","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00722839","['City of Hope Medical Center']"]
["NCT00722852","[]","[u'IDEA AG']","https://clinicaltrials.gov/ct2/show/NCT00722852","['Dr. med. Matthias Rother, IDEA AG']"]
["NCT00723021","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00723021","['Pfizer']"]
["NCT00723125","[u'William Sikov MD, Brown University']","[u'William Sikov MD']","https://clinicaltrials.gov/ct2/show/NCT00723125","['William Sikov MD, Principle Investigator, Brown University']"]
["NCT00723190","[]","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00723190","['Shionogi Clinical Trials Administrator, Shionogi']"]
["NCT00723359","[u'Biotest Pharmaceuticals Corporation']","[u'Biotest Pharmaceuticals Corporation']","https://clinicaltrials.gov/ct2/show/NCT00723359","['Biotest Pharmaceuticals Corporation']"]
["NCT00723450","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00723450","['GlaxoSmithKline']"]
["NCT00723489","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00723489","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00723775","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00723775","['GlaxoSmithKline']"]
["NCT00723801","[u\"Mark Alan Creager, MD, Brigham and Women's Hospital\"]","[u\"Brigham and Women's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00723801","[\"Mark Alan Creager, MD, Principal Investigator, Brigham and Women's Hospital\"]"]
["NCT00723957","[u'R-Pharm']","[u'R-Pharm']","https://clinicaltrials.gov/ct2/show/NCT00723957","['R-Pharm']"]
["NCT00723983","[u'Teva Pharmaceutical Industries ( NuPathe Inc. )']","[u'NuPathe Inc.']","https://clinicaltrials.gov/ct2/show/NCT00723983","['NuPathe Inc.']"]
["NCT00724009","[u'University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00724009","['University of Chicago']"]
["NCT00724048","[u'Teva Pharmaceutical Industries']","[u'Teva Pharmaceutical Industries']","https://clinicaltrials.gov/ct2/show/NCT00724048","['Teva Pharmaceutical Industries']"]
["NCT00724126","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00724126","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00724282","[u'University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00724282","['University of Chicago']"]
["NCT00724334","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00724334","['Sanofi']"]
["NCT00724594","[u'Dorothea D. Jenkins, Medical University of South Carolina']","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT00724594","['Dorothea D. Jenkins, Associate Professor, Medical University of South Carolina']"]
["NCT00724711","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00724711","['Gilead Sciences']"]
["NCT00724815","[u'Teva Pharmaceutical Industries ( NuPathe Inc. )']","[u'NuPathe Inc.']","https://clinicaltrials.gov/ct2/show/NCT00724815","['NuPathe Inc.']"]
["NCT00724867","[u'GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )']","[u'Human Genome Sciences Inc., a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00724867","['Human Genome Sciences Inc., a GSK Company']"]
["NCT00724984","[u'Pharmacyclics LLC.']","[u'Pharmacyclics LLC.']","https://clinicaltrials.gov/ct2/show/NCT00724984","['Pharmacyclics LLC.']"]
["NCT00725283","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00725283","['GlaxoSmithKline']"]
["NCT00725361","[u'Lorinda S Chung, Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT00725361","['Lorinda S Chung, Associate Professor of Medicine, Stanford University']"]
["NCT00725426","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00725426","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00725582","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00725582","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00725634","[u'AVEO Pharmaceuticals, Inc.']","[u'AVEO Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00725634","['AVEO Pharmaceuticals, Inc.']"]
["NCT00725712","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00725712","['GlaxoSmithKline']"]
["NCT00725764","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00725764","['GlaxoSmithKline']"]
["NCT00725803","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00725803","['Gilead Sciences']"]
["NCT00725985","[u'EMD Serono']","[u'EMD Serono']","https://clinicaltrials.gov/ct2/show/NCT00725985","['EMD Serono']"]
["NCT00726115","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00726115","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00726323","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00726323","['GlaxoSmithKline']"]
["NCT00726336","[]","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00726336","['Study Director, GSK']"]
["NCT00726375","[u'University of Michigan Rogel Cancer Center']","[u'University of Michigan Rogel Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00726375","['University of Michigan Rogel Cancer Center']"]
["NCT00726427","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00726427","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00726726","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00726726","['Study Director, Bristol-Myers Squibb']"]
["NCT00726752","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00726752","['Pfizer']"]
["NCT00726882","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00726882","['AbbVie (prior sponsor, Abbott)']"]
["NCT00727064","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00727064","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00727246","[u'Patricia M. Arenth, University of Pittsburgh']","[u'Patricia M. Arenth']","https://clinicaltrials.gov/ct2/show/NCT00727246","['Patricia M. Arenth, Assistant Professor, University of Pittsburgh']"]
["NCT00727506","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00727506","['Boehringer Ingelheim']"]
["NCT00727597","[u'Princy Kumar, MD, Georgetown University']","[u'Georgetown University']","https://clinicaltrials.gov/ct2/show/NCT00727597","['Princy Kumar, MD, Principal Investigator, Georgetown University']"]
["NCT00727649","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00727649","['US Department of Veterans Affairs']"]
["NCT00727766","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00727766","['Washington University School of Medicine']"]
["NCT00727844","[u'Clifton E. Barry III, Ph.D., National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00727844","['Clifton E. Barry III, Ph.D., Principal Investigator, Tuberculosis Research Section (TRS), National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00727857","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00727857","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00728182","[u'NoNO Inc.']","[u'NoNO Inc.']","https://clinicaltrials.gov/ct2/show/NCT00728182","['NoNO Inc.']"]
["NCT00728351","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00728351","['Novartis Pharmaceuticals']"]
["NCT00728390","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00728390","['Pfizer']"]
["NCT00728416","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00728416","['Merck Sharp & Dohme Corp.']"]
["NCT00728468","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00728468","['Pfizer']"]
["NCT00728481","[u'Amy Foxx-Orenstein, Mayo Clinic']","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00728481","['Amy Foxx-Orenstein, Associate Professor of Medicine, Mayo Clinic']"]
["NCT00728689","[u'SIGA Technologies']","[u'SIGA Technologies']","https://clinicaltrials.gov/ct2/show/NCT00728689","['SIGA Technologies']"]
["NCT00728780","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00728780","['AstraZeneca']"]
["NCT00728910","[u'Richard Dunbar, University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00728910","['Richard Dunbar, Assistant Professor, University of Pennsylvania']"]
["NCT00728923","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00728923","['New York State Psychiatric Institute']"]
["NCT00728936","[u'Idera Pharmaceuticals, Inc.']","[u'Idera Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00728936","['Idera Pharmaceuticals, Inc.']"]
["NCT00728949","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00728949","['Eli Lilly and Company']"]
["NCT00729157","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00729157","['National Cancer Institute (NCI)']"]
["NCT00729183","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00729183","['Merck Sharp & Dohme Corp.']"]
["NCT00729222","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00729222","['Merck Sharp & Dohme Corp.']"]
["NCT00729326","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00729326","['AstraZeneca']"]
["NCT00729430","[u\"Raymond Y. Kwong, MD, Brigham and Women's Hospital\"]","[u\"Brigham and Women's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00729430","[\"Raymond Y. Kwong, MD, Principal Investigator, Brigham and Women's Hospital\"]"]
["NCT00729469","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00729469","['Shionogi']"]
["NCT00729495","[]","[u'POZEN']","https://clinicaltrials.gov/ct2/show/NCT00729495","['Mark Sostek, MD, Medical Science Director, Development Project, AstraZeneca Pharmaceuticals']"]
["NCT00729638","[u'Noopur Raje, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00729638","['Noopur Raje, Director, Center for Multiple Myeloma, Massachusetts General Hospital']"]
["NCT00729664","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00729664","['Bristol-Myers Squibb']"]
["NCT00729690","[u'Asokumar Buvanendran, Rush University Medical Center']","[u'Asokumar Buvanendran']","https://clinicaltrials.gov/ct2/show/NCT00729690","['Asokumar Buvanendran, Attending Physician, Rush University Medical Center']"]
["NCT00729742","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00729742","['Merck Sharp & Dohme Corp.']"]
["NCT00729846","[u'Dante Pieramici, California Retina Consultants']","[u'California Retina Consultants']","https://clinicaltrials.gov/ct2/show/NCT00729846","['Dante Pieramici, Director of Research, California Retina Consultants']"]
["NCT00729859","[u'Stephanie T. Page, University of Washington']","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00729859","['Stephanie T. Page, Associate Professor, University of Washington']"]
["NCT00729924","[u'David Haas, Vanderbilt University']","[u'Vanderbilt University']","https://clinicaltrials.gov/ct2/show/NCT00729924","['David Haas, Professor of Medicine, Vanderbilt University']"]
["NCT00730015","[u'Ironwood Pharmaceuticals, Inc.']","[u'Ironwood Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00730015","['Ironwood Pharmaceuticals, Inc.']"]
["NCT00730145","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00730145","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00730171","[u'Ironwood Pharmaceuticals, Inc.']","[u'Ironwood Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00730171","['Ironwood Pharmaceuticals, Inc.']"]
["NCT00730197","[]","[u'Mylan Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00730197","['Will Sullvan, Global Head of Product Risk and Safety Management, Mylan Inc.']"]
["NCT00730236","[u'Aegerion Pharmaceuticals, Inc.']","[u'Aegerion Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00730236","['Aegerion Pharmaceuticals, Inc.']"]
["NCT00730275","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00730275","['Merck Sharp & Dohme Corp.']"]
["NCT00730353","[u'Nasser Hanna, M.D., Hoosier Cancer Research Network']","[u'Hoosier Cancer Research Network']","https://clinicaltrials.gov/ct2/show/NCT00730353","['Nasser Hanna, M.D., Professor, IU School of Medicine, Hoosier Cancer Research Network']"]
["NCT00730379","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00730379","['Merck Sharp & Dohme Corp.']"]
["NCT00730405","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00730405","['Stiefel, a GSK Company']"]
["NCT00730431","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00730431","['Merck Sharp & Dohme Corp.']"]
["NCT00730457","[u'VaxInnate Corporation']","[u'VaxInnate Corporation']","https://clinicaltrials.gov/ct2/show/NCT00730457","['VaxInnate Corporation']"]
["NCT00730691","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00730691","['Takeda']"]
["NCT00730756","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00730756","['GlaxoSmithKline']"]
["NCT00730821","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00730821","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00730964","[u'GE Healthcare']","[u'GE Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00730964","['GE Healthcare']"]
["NCT00731042","[u'3M']","[u'3M']","https://clinicaltrials.gov/ct2/show/NCT00731042","['3M']"]
["NCT00731055","[u'Adam Bisaga, New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00731055","['Adam Bisaga, Research Psychiatrist, New York State Psychiatric Institute']"]
["NCT00731120","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00731120","['Takeda']"]
["NCT00731133","[u'University of Arkansas']","[u'University of Arkansas']","https://clinicaltrials.gov/ct2/show/NCT00731133","['University of Arkansas']"]
["NCT00731211","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00731211","['SCRI Development Innovations, LLC']"]
["NCT00731224","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00731224","['Novartis Pharmaceuticals']"]
["NCT00731263","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00731263","['AstraZeneca']"]
["NCT00731562","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00731562","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00731588","[u'University of Iowa']","[u'University of Iowa']","https://clinicaltrials.gov/ct2/show/NCT00731588","['University of Iowa']"]
["NCT00731653","[u'Maurizio Fava, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00731653","['Maurizio Fava, MD, Fava, Maurizio, MD, Massachusetts General Hospital']"]
["NCT00731679","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00731679","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00731692","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00731692","['Novartis Pharmaceuticals']"]
["NCT00731861","[u'Indiana University ( Indiana University School of Medicine )']","[u'Indiana University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00731861","['Indiana University School of Medicine']"]
["NCT00732056","[u'Geron Corporation']","[u'Geron Corporation']","https://clinicaltrials.gov/ct2/show/NCT00732056","['Geron Corporation']"]
["NCT00732069","[u'Nancy J. Brown, Vanderbilt University']","[u'Vanderbilt University']","https://clinicaltrials.gov/ct2/show/NCT00732069","['Nancy J. Brown, Professor, Vanderbilt University']"]
["NCT00732251","[u'Itai Danovitch, Cedars-Sinai Medical Center']","[u'Cedars-Sinai Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00732251","['Itai Danovitch, Chairman, Department of Psychiatry, Cedars-Sinai Medical Center']"]
["NCT00732420","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00732420","['GlaxoSmithKline']"]
["NCT00732615","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00732615","['Shire']"]
["NCT00732784","[u'Jan Beumer, University of Pittsburgh']","[u'Jan Beumer']","https://clinicaltrials.gov/ct2/show/NCT00732784","['Jan Beumer, Principal Investigator, University of Pittsburgh']"]
["NCT00732836","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00732836","['M.D. Anderson Cancer Center']"]
["NCT00732888","[u'Jan Beumer, University of Pittsburgh']","[u'Jan Beumer']","https://clinicaltrials.gov/ct2/show/NCT00732888","['Jan Beumer, Principal Investigator, University of Pittsburgh']"]
["NCT00732901","[u'Virginia Commonwealth University']","[u'Virginia Commonwealth University']","https://clinicaltrials.gov/ct2/show/NCT00732901","['Virginia Commonwealth University']"]
["NCT00733187","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00733187","['AbbVie (prior sponsor, Abbott)']"]
["NCT00733239","[u'University of Arkansas']","[u'University of Arkansas']","https://clinicaltrials.gov/ct2/show/NCT00733239","['University of Arkansas']"]
["NCT00733265","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00733265","['Jay Horrow, MD, Medical Science Director, AZD6140, AstraZeneca Pharmaceuticals']"]
["NCT00733304","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00733304","['GlaxoSmithKline']"]
["NCT00733356","[u'Kimberley Lakes, University of California, Irvine']","[u'Kimberley Lakes']","https://clinicaltrials.gov/ct2/show/NCT00733356","['Kimberley Lakes, Associate Professor, University of California, Irvine']"]
["NCT00733460","[u'Fluoropharma, Inc.']","[u'Fluoropharma, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00733460","['Fluoropharma, Inc.']"]
["NCT00733577","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00733577","['GlaxoSmithKline']"]
["NCT00733642","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00733642","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00733824","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00733824","['Washington University School of Medicine']"]
["NCT00733850","[u'KangLaiTe USA']","[u'KangLaiTe USA']","https://clinicaltrials.gov/ct2/show/NCT00733850","['KangLaiTe USA']"]
["NCT00733876","[u'AlloCure Inc.']","[u'AlloCure Inc.']","https://clinicaltrials.gov/ct2/show/NCT00733876","['AlloCure Inc.']"]
["NCT00733902","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00733902","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00733954","[u'Galderma Laboratories, L.P.']","[u'Galderma Laboratories, L.P.']","https://clinicaltrials.gov/ct2/show/NCT00733954","['Galderma Laboratories, L.P.']"]
["NCT00733980","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00733980","['GlaxoSmithKline']"]
["NCT00733993","[u'Frederick Gerard Moeller, Virginia Commonwealth University']","[u'Virginia Commonwealth University']","https://clinicaltrials.gov/ct2/show/NCT00733993","['Frederick Gerard Moeller, Professor - Division Chair, Addiction Psychiatry, Virginia Commonwealth University']"]
["NCT00734071","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00734071","['Takeda']"]
["NCT00734162","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00734162","['Gilead Sciences']"]
["NCT00734175","[]","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00734175","['Kawsar Talaat, MD, Johns Hopkins Bloomberg School of Public Health']"]
["NCT00734253","[u'NephroGenex, Inc.']","[u'NephroGenex, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00734253","['NephroGenex, Inc.']"]
["NCT00734305","[u'Merrimack Pharmaceuticals']","[u'Merrimack Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00734305","['Merrimack Pharmaceuticals']"]
["NCT00734461","[u'Pain Therapeutics']","[u'Pain Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00734461","['Pain Therapeutics']"]
["NCT00734474","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00734474","['Eli Lilly and Company']"]
["NCT00734526","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00734526","['M.D. Anderson Cancer Center']"]
["NCT00734539","[u'Daniel Benjamin, Duke University']","[u'Daniel Benjamin']","https://clinicaltrials.gov/ct2/show/NCT00734539","['Daniel Benjamin, Professor of Pediatrics, Duke University']"]
["NCT00734578","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00734578","['Shire']"]
["NCT00734604","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00734604","['Chief Medical Officer, Eli Lilly']"]
["NCT00734617","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00734617","['Duke University']"]
["NCT00734630","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00734630","['Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism, Forest Research Institute, a Subsidairy of Forest Laboratories, Inc.']"]
["NCT00734682","[u'Michael Prados, University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00734682","['Michael Prados, Professor, University of California, San Francisco']"]
["NCT00734929","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00734929","['Duke University']"]
["NCT00734968","[u'University of Missouri-Columbia']","[u'University of Missouri-Columbia']","https://clinicaltrials.gov/ct2/show/NCT00734968","['University of Missouri-Columbia']"]
["NCT00734994","[u'Mark Dewhirst, Duke University']","[u'Mark Dewhirst']","https://clinicaltrials.gov/ct2/show/NCT00734994","['Mark Dewhirst, Professor, Duke University']"]
["NCT00735007","[u'EMD Serono']","[u'EMD Serono']","https://clinicaltrials.gov/ct2/show/NCT00735007","['EMD Serono']"]
["NCT00735072","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00735072","['University of California, San Francisco']"]
["NCT00735306","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00735306","['Duke University']"]
["NCT00735371","[]","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00735371","['Timothy Whitaker, MD/Clinical Research & Development -VP of Global Clinical Medicine, Shire Pharmaceutical Development']"]
["NCT00735397","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00735397","['Eisai Inc.']"]
["NCT00735449","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00735449","['Allergan']"]
["NCT00735462","[]","[u'Graceway Pharmaceuticals, LLC']","https://clinicaltrials.gov/ct2/show/NCT00735462","['Jason Wu, MD / Executive Director, Product Development, Graceway Pharmaceuticals']"]
["NCT00735475","[u'Seqirus']","[u'Seqirus']","https://clinicaltrials.gov/ct2/show/NCT00735475","['Seqirus']"]
["NCT00735696","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00735696","['Eli Lilly and Company']"]
["NCT00735761","[]","[u'Medivir']","https://clinicaltrials.gov/ct2/show/NCT00735761","[u'B\\xf6rje Darp\\xf6, MD, PhD, Development']"]
["NCT00735787","[]","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00735787","['Martin Okun MD, Director, Abbott']"]
["NCT00735891","[u'Pharmatech']","[u'Pharmatech']","https://clinicaltrials.gov/ct2/show/NCT00735891","['Pharmatech']"]
["NCT00735904","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00735904","['Pfizer']"]
["NCT00735917","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00735917","['National Cancer Institute (NCI)']"]
["NCT00735930","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00735930","['National Cancer Institute (NCI)']"]
["NCT00735969","[u'Marc Ghany, M.D., National Institutes of Health Clinical Center (CC)']","[u'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","https://clinicaltrials.gov/ct2/show/NCT00735969","['Marc Ghany, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT00736099","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00736099","['Boehringer Ingelheim']"]
["NCT00736229","[u\"Saint Luke's Health System\"]","[u\"Saint Luke's Health System\"]","https://clinicaltrials.gov/ct2/show/NCT00736229","[\"Saint Luke's Health System\"]"]
["NCT00736658","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00736658","[u'Rolf Karlsten, MD, PhD, Medical Science Director Emerging Analgesia Clinical Neuroscience, AstraZeneca R&D S\\xf6dert\\xe4lje']"]
["NCT00736879","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00736879","['AstraZeneca']"]
["NCT00736931","[u'UCB Pharma']","[u'UCB Pharma']","https://clinicaltrials.gov/ct2/show/NCT00736931","['UCB Pharma']"]
["NCT00736996","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00736996","['University of Colorado, Denver']"]
["NCT00737100","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00737100","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00737204","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00737204","['New York State Psychiatric Institute']"]
["NCT00737243","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00737243","['SCRI Development Innovations, LLC']"]
["NCT00737438","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00737438","['Memorial Sloan Kettering Cancer Center']"]
["NCT00737568","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00737568","['Gilead Sciences']"]
["NCT00737737","[u'National Institutes of Health Clinical Center (CC) ( National Institute of Nursing Research (NINR) )']","[u'National Institute of Nursing Research (NINR)']","https://clinicaltrials.gov/ct2/show/NCT00737737","['National Institute of Nursing Research (NINR)']"]
["NCT00738049","[u'K.Lance Gould, The University of Texas Health Science Center, Houston']","[u'K.Lance Gould']","https://clinicaltrials.gov/ct2/show/NCT00738049","['K.Lance Gould, Martin Bucksbaum distinguished University chair, Professor of Cardiovascualr MEdicine and Executive Director, Weatherhead P.E.T. Center for Preventing and Reversing Atherosclerosis, The University of Texas Health Science Center, Houston']"]
["NCT00738062","[u'Chelsea Therapeutics']","[u'Chelsea Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00738062","['Chelsea Therapeutics']"]
["NCT00738361","[u'Thomas Olencki, Ohio State University Comprehensive Cancer Center']","[u'Ohio State University Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00738361","['Thomas Olencki, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00738582","[u'Morphotek']","[u'Morphotek']","https://clinicaltrials.gov/ct2/show/NCT00738582","['Morphotek']"]
["NCT00738621","[]","[u'Scott and White Hospital & Clinic']","https://clinicaltrials.gov/ct2/show/NCT00738621","['Richard Beswick, Scott and White Healthcare']"]
["NCT00738751","[u'H. Lee Moffitt Cancer Center and Research Institute']","[u'H. Lee Moffitt Cancer Center and Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00738751","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00738764","[u'Abbott']","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00738764","['Abbott']"]
["NCT00738842","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00738842","['Jay Horrow, MD, Medical Science Director, AZD6140, AstraZeneca Pharmaceuticals']"]
["NCT00738959","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00738959","[u'Didier Meulien, MD, Medical Science Director, Emerging AD & Cognition, AstraZeneca R&D, S\\xf6dert\\xe4lje, Sweden']"]
["NCT00739232","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00739232","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00739297","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00739297","['Merck Sharp & Dohme Corp.']"]
["NCT00739453","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00739453","['Astellas Pharma Inc']"]
["NCT00739583","[u'Simon Mears, Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00739583","['Simon Mears, Associate Professor, Johns Hopkins University']"]
["NCT00739596","[]","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00739596","['External Affairs, Novartis']"]
["NCT00739648","[u'Horizon Pharma USA, Inc.']","[u'Horizon Pharma USA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00739648","['Horizon Pharma USA, Inc.']"]
["NCT00739661","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00739661","['Genentech, Inc.']"]
["NCT00739739","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00739739","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00739908","[u'CeNeRx BioPharma Inc.']","[u'CeNeRx BioPharma Inc.']","https://clinicaltrials.gov/ct2/show/NCT00739908","['CeNeRx BioPharma Inc.']"]
["NCT00739934","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00739934","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00739973","[]","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00739973","['External Affairs, Novartis Pharmaceuticals']"]
["NCT00740051","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00740051","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00740207","[]","[u'Bracco Diagnostics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00740207","['Carmela Houston/ Sr. Manager Corporate Clinical Research, Bracco Diagnostics']"]
["NCT00740610","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00740610","['Gilead Sciences']"]
["NCT00740623","[u'SK Life Science, Inc.']","[u'SK Life Science, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00740623","['SK Life Science, Inc.']"]
["NCT00740636","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00740636","['Memorial Sloan Kettering Cancer Center']"]
["NCT00740727","[]","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00740727","['Stephen H. Thomas MD MPH, Massachusetts General Hospital/Harvard Medical School']"]
["NCT00740779","[u'Watson Pharmaceuticals']","[u'Watson Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00740779","['Watson Pharmaceuticals']"]
["NCT00740792","[u'Meda Pharmaceuticals']","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00740792","['Meda Pharmaceuticals']"]
["NCT00740857","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00740857","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00741013","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00741013","['Washington University School of Medicine']"]
["NCT00741039","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00741039","['Memorial Sloan Kettering Cancer Center']"]
["NCT00741169","[u'Tibotec Pharmaceuticals, Ireland']","[u'Tibotec Pharmaceuticals, Ireland']","https://clinicaltrials.gov/ct2/show/NCT00741169","['Tibotec Pharmaceuticals, Ireland']"]
["NCT00741234","[u'S*BIO']","[u'S*BIO']","https://clinicaltrials.gov/ct2/show/NCT00741234","['S*BIO']"]
["NCT00741273","[u'Repros Therapeutics Inc.']","[u'Repros Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00741273","['Repros Therapeutics Inc.']"]
["NCT00741338","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00741338","['Genzyme, a Sanofi Company']"]
["NCT00741377","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00741377","['Novartis Pharmaceuticals']"]
["NCT00741468","[u'Repros Therapeutics Inc.']","[u'Repros Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00741468","['Repros Therapeutics Inc.']"]
["NCT00741598","[u'Dan V. Iosifescu, Icahn School of Medicine at Mount Sinai']","[u'Icahn School of Medicine at Mount Sinai']","https://clinicaltrials.gov/ct2/show/NCT00741598","['Dan V. Iosifescu, M.D., M.Sc., Icahn School of Medicine at Mount Sinai']"]
["NCT00741689","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00741689","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00741988","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00741988","['SCRI Development Innovations, LLC']"]
["NCT00742027","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00742027","['Novartis Pharmaceuticals']"]
["NCT00742079","[u'Donald C. Goff, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00742079","['Donald C. Goff, MD, Director of the Schizophrenia Clinical and Research Program, Massachusetts General Hospital']"]
["NCT00742105","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00742105","['Novartis Pharmaceuticals']"]
["NCT00742131","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00742131","['GlaxoSmithKline']"]
["NCT00742209","[u'XenoPort, Inc.']","[u'XenoPort, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00742209","['XenoPort, Inc.']"]
["NCT00742261","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00742261","['GlaxoSmithKline']"]
["NCT00742417","[u'Grifols Biologicals Inc. ( Instituto Grifols, S.A. )']","[u'Instituto Grifols, S.A.']","https://clinicaltrials.gov/ct2/show/NCT00742417","['Instituto Grifols, S.A.']"]
["NCT00742443","[]","[u'Renovo']","https://clinicaltrials.gov/ct2/show/NCT00742443","['Julia Cook (Clinical Trial Manager), Renovo']"]
["NCT00742625","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00742625","['National Cancer Institute (NCI)']"]
["NCT00742716","[u'OPKO Health, Inc. ( OPKO IP Holdings II, Inc. )']","[u'OPKO IP Holdings II, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00742716","['OPKO IP Holdings II, Inc.']"]
["NCT00742820","[]","[u'Fresenius Medical Care North America']","https://clinicaltrials.gov/ct2/show/NCT00742820","['Jonathan Greenberg, MD, Director Clinical Research, Fresenius USA Manufacturing Inc., d/b/a Fresenius Medical Care North America']"]
["NCT00742859","[u'Portola Pharmaceuticals']","[u'Portola Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00742859","['Portola Pharmaceuticals']"]
["NCT00742911","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00742911","['University of Utah']"]
["NCT00742924","[u\"Children's Oncology Group\"]","[u\"Children's Oncology Group\"]","https://clinicaltrials.gov/ct2/show/NCT00742924","[\"Children's Oncology Group\"]"]
["NCT00742963","[u'Threshold Pharmaceuticals']","[u'Threshold Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00742963","['Threshold Pharmaceuticals']"]
["NCT00743067","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00743067","['GlaxoSmithKline']"]
["NCT00743093","[u'Kennon Heard, Denver Health and Hospital Authority']","[u'Denver Health and Hospital Authority']","https://clinicaltrials.gov/ct2/show/NCT00743093","['Kennon Heard, Fellowship Director, Denver Health and Hospital Authority']"]
["NCT00743119","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00743119","['New York State Psychiatric Institute']"]
["NCT00743145","[u'Margaret Haney, New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00743145","['Margaret Haney, Clinical Psychaitrist, New York State Psychiatric Institute']"]
["NCT00743210","[u'Robert Powers, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00743210","['Robert Powers, Associate Professor, University of Pittsburgh']"]
["NCT00743275","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00743275","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00743288","[u'Oncotherapeutics']","[u'Oncotherapeutics']","https://clinicaltrials.gov/ct2/show/NCT00743288","['Oncotherapeutics']"]
["NCT00743353","[]","[u'Siemens Molecular Imaging']","https://clinicaltrials.gov/ct2/show/NCT00743353","['James Zhang, MD, PhD, MBA, Senior Director, Medical Monitor, Global Head of Clinical Development']"]
["NCT00743366","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00743366","['New York State Psychiatric Institute']"]
["NCT00743379","[u'Threshold Pharmaceuticals']","[u'Threshold Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00743379","['Threshold Pharmaceuticals']"]
["NCT00743509","[u'University of Michigan Rogel Cancer Center']","[u'University of Michigan Rogel Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00743509","['University of Michigan Rogel Cancer Center']"]
["NCT00743652","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00743652","['Pfizer']"]
["NCT00743769","[u'RegeneRx Biopharmaceuticals, Inc.']","[u'RegeneRx Biopharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00743769","['RegeneRx Biopharmaceuticals, Inc.']"]
["NCT00743795","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00743795","['Gilead Sciences']"]
["NCT00743860","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00743860","['GlaxoSmithKline']"]
["NCT00743912","[]","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00743912","['Audrey Shaw, Director Clinical Development, Salix Pharmaceuticals, Inc.']"]
["NCT00743938","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00743938","['Bristol-Myers Squibb']"]
["NCT00744055","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00744055","['Yale University']"]
["NCT00744146","[]","[u'PharmAthene, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00744146","['Valerie Riddle, M.D., Vice President and Medical Director, PharmAthene, Inc.']"]
["NCT00744237","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00744237","['John Whalen, MD, Executive Director, Clinical Development, Cardiovascular, Forest Research Institute, a Subsidiary of Forest Laboratories Inc.']"]
["NCT00744263","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00744263","['Pfizer']"]
["NCT00744276","[]","[u'FemmePharma Global Healthcare, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00744276","['Peter K. Mays, Ph.D. / Vice President, Pharmaceutical Development, FemmePharma Global Healthcare, Inc.']"]
["NCT00744367","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00744367","['Hoffmann-La Roche']"]
["NCT00744419","[u'Janice E. Sullivan, University of Louisville']","[u'University of Louisville']","https://clinicaltrials.gov/ct2/show/NCT00744419","['Janice E. Sullivan, Professor, University of Louisville']"]
["NCT00744471","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00744471","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00744497","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00744497","['Bristol-Myers Squibb']"]
["NCT00744536","[u'Dr. Rena Buckstein, Sunnybrook Health Sciences Centre']","[u'Sunnybrook Health Sciences Centre']","https://clinicaltrials.gov/ct2/show/NCT00744536","['Dr. Rena Buckstein, Head Hematology Site Group, Sunnybrook Health Sciences Centre']"]
["NCT00744679","[u'Biogen']","[u'Biogen']","https://clinicaltrials.gov/ct2/show/NCT00744679","['Biogen']"]
["NCT00744692","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00744692","['Duke University']"]
["NCT00744731","[u'SK Life Science, Inc.']","[u'SK Life Science, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00744731","['SK Life Science, Inc.']"]
["NCT00744848","[u'Pacira Pharmaceuticals, Inc']","[u'Pacira Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT00744848","['Pacira Pharmaceuticals, Inc']"]
["NCT00744926","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00744926","['Hoffmann-La Roche']"]
["NCT00744991","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00744991","['Chief Medical Officer, Eli Lilly']"]
["NCT00745095","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00745095","['US Department of Veterans Affairs']"]
["NCT00745173","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00745173","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00745186","[u'Hospira, now a wholly owned subsidiary of Pfizer']","[u'Hospira, now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00745186","['Hospira, now a wholly owned subsidiary of Pfizer']"]
["NCT00745251","[u'VIVUS, Inc.']","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00745251","['VIVUS, Inc.']"]
["NCT00745277","[]","[u'Oregon Health and Science University']","https://clinicaltrials.gov/ct2/show/NCT00745277","['John Nutt, MD, Oregon Health & Science University']"]
["NCT00745290","[u'Pacira Pharmaceuticals, Inc']","[u'Pacira Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT00745290","['Pacira Pharmaceuticals, Inc']"]
["NCT00745576","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00745576","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00746317","[u'Chugai Pharmaceutical']","[u'Chugai Pharmaceutical']","https://clinicaltrials.gov/ct2/show/NCT00746317","['Chugai Pharmaceutical']"]
["NCT00746395","[u'Jack DiPalma, University of South Alabama']","[u'University of South Alabama']","https://clinicaltrials.gov/ct2/show/NCT00746395","['Jack DiPalma, Professor of Medicine, University of South Alabama']"]
["NCT00746499","[u'University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00746499","['University of North Carolina, Chapel Hill']"]
["NCT00746512","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00746512","['Merck Sharp & Dohme Corp.']"]
["NCT00746733","[]","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00746733","['Gerald Tremblay, M.D., Shire Pharmaceutical']"]
["NCT00746798","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00746798","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00747175","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00747175","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00747318","[]","[u'SkyePharma AG']","https://clinicaltrials.gov/ct2/show/NCT00747318","['Kirsten Kaiser, MD, SkyePharma AG']"]
["NCT00747474","[u'Taiwan Liposome Company']","[u'Taiwan Liposome Company']","https://clinicaltrials.gov/ct2/show/NCT00747474","['Taiwan Liposome Company']"]
["NCT00747526","[u'Janssen Research & Development, LLC']","[u'Janssen Research & Development, LLC']","https://clinicaltrials.gov/ct2/show/NCT00747526","['Janssen Research & Development, LLC']"]
["NCT00747617","[u'Jeffrey Chang, MD, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00747617","['Jeffrey Chang, MD, Principal investigator, University of California, San Diego']"]
["NCT00747929","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00747929","['Shionogi']"]
["NCT00748046","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00748046","['Bayer']"]
["NCT00748098","[u'XenoPort, Inc.']","[u'XenoPort, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00748098","['XenoPort, Inc.']"]
["NCT00748215","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00748215","['M.D. Anderson Cancer Center']"]
["NCT00748501","[u'Sangamo Therapeutics']","[u'Sangamo Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00748501","['Sangamo Therapeutics']"]
["NCT00748553","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00748553","['University of Utah']"]
["NCT00748605","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00748605","['Shionogi']"]
["NCT00748956","[u'Dennis Charney, Icahn School of Medicine at Mount Sinai']","[u'Dennis Charney']","https://clinicaltrials.gov/ct2/show/NCT00748956","['Dennis Charney, Dean, Icahn School of Medicine at Mount Sinai']"]
["NCT00749021","[u'Clement K. Chan, Southern California Desert Retina Consultants, MC']","[u'Clement K. Chan']","https://clinicaltrials.gov/ct2/show/NCT00749021","['Clement K. Chan, Principal Investigator, Southern California Desert Retina Consultants, MC']"]
["NCT00749138","[]","[u'Bader, Ted, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00749138","['Ted Bader, MD']"]
["NCT00749190","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00749190","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00749359","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00749359","['GlaxoSmithKline']"]
["NCT00749411","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00749411","['GlaxoSmithKline']"]
["NCT00749632","[]","[u'FemmePharma Global Healthcare, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00749632","['Peter K. Mays, Ph.D. / V.P. Pharmaceutical Development, FemmePharma Global Healthcare, Inc.']"]
["NCT00749658","[u'University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00749658","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00749879","[]","[u'Repros Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00749879","['Andre vanAs, MD, PhD, Repros Therapeutics, Inc.']"]
["NCT00749944","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00749944","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00750139","[u'Merz North America, Inc.']","[u'Merz North America, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00750139","['Merz North America, Inc.']"]
["NCT00750152","[u'Merz North America, Inc.']","[u'Merz North America, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00750152","['Merz North America, Inc.']"]
["NCT00750256","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00750256","['GlaxoSmithKline']"]
["NCT00750295","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00750295","['Novartis Pharmaceuticals']"]
["NCT00750399","[u'Paul T. Finger, MD, The New York Eye Cancer Center']","[u'The New York Eye Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00750399","['Paul T. Finger, MD, Director, The New York Eye Cancer Center']"]
["NCT00750620","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00750620","['Astellas Pharma Inc']"]
["NCT00750633","[u'Alcon Research']","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT00750633","['Alcon Research']"]
["NCT00750698","[]","[u'Syndax Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00750698","['Jeannette Hasapidis, Executive Director of Clinical Operations, Syndax Pharmaceuticals, Inc.']"]
["NCT00750737","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00750737","['M.D. Anderson Cancer Center']"]
["NCT00750815","[u'H. Lee Moffitt Cancer Center and Research Institute']","[u'H. Lee Moffitt Cancer Center and Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00750815","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00750867","[u'Peter Novak, University of Massachusetts, Worcester']","[u'University of Massachusetts, Worcester']","https://clinicaltrials.gov/ct2/show/NCT00750867","['Peter Novak, Study Principle Investigator, University of Massachusetts, Worcester']"]
["NCT00751023","[]","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT00751023","['Bryan K. Tolliver, M.D., Ph.D., MUSC Department of Psychiatry, Division of Clinical Neuroscience']"]
["NCT00751114","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00751114","['Sanofi']"]
["NCT00751231","[u'Portola Pharmaceuticals']","[u'Portola Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00751231","['Portola Pharmaceuticals']"]
["NCT00751270","[u'Advantagene, Inc.']","[u'Advantagene, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00751270","['Advantagene, Inc.']"]
["NCT00751400","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00751400","['Bayer']"]
["NCT00751413","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00751413","['Merck Sharp & Dohme Corp.']"]
["NCT00751478","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00751478","['Pfizer']"]
["NCT00751556","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00751556","['Bayer']"]
["NCT00751699","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00751699","['Warner Chilcott']"]
["NCT00751777","[u'Intercell USA, Inc.']","[u'Intercell USA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00751777","['Intercell USA, Inc.']"]
["NCT00751881","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00751881","['Sanofi']"]
["NCT00751907","[]","[u'University of Wisconsin, Madison']","https://clinicaltrials.gov/ct2/show/NCT00751907","['Cynthia M. Carlsson, MD, MS, University of Wisconsin School of Medicine and Public Health']"]
["NCT00752011","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00752011","['M.D. Anderson Cancer Center']"]
["NCT00752037","[]","[u\"Saint Michael's Medical Center\"]","https://clinicaltrials.gov/ct2/show/NCT00752037","[\"JIhad Slim,Md, Saint Michael's Medical Center\"]"]
["NCT00752050","[u'Mentor Worldwide, LLC']","[u'Mentor Worldwide, LLC']","https://clinicaltrials.gov/ct2/show/NCT00752050","['Mentor Worldwide, LLC']"]
["NCT00752102","[u'Joslin Diabetes Center']","[u'Joslin Diabetes Center']","https://clinicaltrials.gov/ct2/show/NCT00752102","['Joslin Diabetes Center']"]
["NCT00752180","[u'Wockhardt']","[u'Wockhardt']","https://clinicaltrials.gov/ct2/show/NCT00752180","['Wockhardt']"]
["NCT00752258","[u'Mentor Worldwide, LLC']","[u'Mentor Worldwide, LLC']","https://clinicaltrials.gov/ct2/show/NCT00752258","['Mentor Worldwide, LLC']"]
["NCT00752297","[u'Mentor Worldwide, LLC']","[u'Mentor Worldwide, LLC']","https://clinicaltrials.gov/ct2/show/NCT00752297","['Mentor Worldwide, LLC']"]
["NCT00752414","[u'Horizon Pharma USA, Inc.']","[u'Horizon Pharma USA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00752414","['Horizon Pharma USA, Inc.']"]
["NCT00752505","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00752505","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00752557","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00752557","['Pfizer']"]
["NCT00752570","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00752570","['Amgen']"]
["NCT00752596","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00752596","['Stephen R Marcello, MD, Procter and Gamble Pharmaceuticals']"]
["NCT00752609","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00752609","['Takeda']"]
["NCT00752726","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00752726","['GlaxoSmithKline']"]
["NCT00752791","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00752791","['Takeda']"]
["NCT00752843","[u'Corcept Therapeutics']","[u'Corcept Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00752843","['Corcept Therapeutics']"]
["NCT00752869","[u'Martin M. Miner, MD, The Miriam Hospital']","[u'The Miriam Hospital']","https://clinicaltrials.gov/ct2/show/NCT00752869","['Martin M. Miner, MD, Principal Investigator, The Miriam Hospital']"]
["NCT00753012","[u'Paul Hammerness, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00753012","['Paul Hammerness, MD, Assistant Professor Psychiatry, Massachusetts General Hospital']"]
["NCT00753064","[]","[u'Haffkine Bio-Pharmaceutical Corporation Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00753064","['Dr. Vivek Shridhar Natu., Vijayshree hospital, Umroli, Chiplun, Ratnagiri, Maharashtra, India. 415702.']"]
["NCT00753402","[u'Rutgers, The State University of New Jersey']","[u'Rutgers, The State University of New Jersey']","https://clinicaltrials.gov/ct2/show/NCT00753402","['Rutgers, The State University of New Jersey']"]
["NCT00753454","[u'UCB Pharma']","[u'UCB Pharma']","https://clinicaltrials.gov/ct2/show/NCT00753454","['UCB Pharma']"]
["NCT00753493","[u'University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00753493","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00753545","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00753545","['AstraZeneca']"]
["NCT00753636","[u'Tanya Simuni, Northwestern University']","[u'Northwestern University']","https://clinicaltrials.gov/ct2/show/NCT00753636","['Tanya Simuni, Professor of Neurology, Northwestern University']"]
["NCT00753688","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00753688","['GlaxoSmithKline']"]
["NCT00753896","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00753896","['AstraZeneca']"]
["NCT00753948","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00753948","['US Department of Veterans Affairs']"]
["NCT00754065","[]","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00754065","['Therapeutic Area Head, Bayer HealthCare Pharmaceuticals Inc.']"]
["NCT00754247","[]","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00754247","['Brian Berman, M.D., Ph.D., University of Miami Miller School of Medicine']"]
["NCT00754325","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00754325","['Bristol-Myers Squibb']"]
["NCT00754403","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00754403","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00754455","[u'Novavax']","[u'Novavax']","https://clinicaltrials.gov/ct2/show/NCT00754455","['Novavax']"]
["NCT00754494","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00754494","['National Cancer Institute (NCI)']"]
["NCT00754546","[u'Dartmouth-Hitchcock Medical Center']","[u'Dartmouth-Hitchcock Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00754546","['Dartmouth-Hitchcock Medical Center']"]
["NCT00754832","[u'Ruth Whitham, Oregon Health and Science University']","[u'Oregon Health and Science University']","https://clinicaltrials.gov/ct2/show/NCT00754832","['Ruth Whitham, Professor of Neurology, Oregon Health and Science University']"]
["NCT00754988","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00754988","['Hoffmann-La Roche']"]
["NCT00755079","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00755079","['US Department of Veterans Affairs']"]
["NCT00755183","[u'H. Jerome Crampton, ORA, Inc.']","[u'H. Jerome Crampton']","https://clinicaltrials.gov/ct2/show/NCT00755183","['H. Jerome Crampton, Doctor, ORA, Inc.']"]
["NCT00755196","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00755196","['Pfizer']"]
["NCT00755222","[u'Endo Pharmaceuticals']","[u'Endo Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00755222","['Endo Pharmaceuticals']"]
["NCT00755274","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00755274","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00755287","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00755287","['Hoffmann-La Roche']"]
["NCT00755326","[u'Brian Berman, MD, University of Maryland']","[u'University of Maryland']","https://clinicaltrials.gov/ct2/show/NCT00755326","['Brian Berman, MD, Director, Center for Integrative Medicine, University of Maryland']"]
["NCT00755378","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00755378","['Mark A. Smith, MD, AStraZeneca']"]
["NCT00755495","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00755495","['Takeda']"]
["NCT00755508","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00755508","['Takeda']"]
["NCT00755703","[u'Altimmune, Inc.']","[u'Altimmune, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00755703","['Altimmune, Inc.']"]
["NCT00755716","[u'Cheryl Oncken, UConn Health']","[u'UConn Health']","https://clinicaltrials.gov/ct2/show/NCT00755716","['Cheryl Oncken, Professor, UConn Health']"]
["NCT00755781","[u'APT Pharmaceuticals, Inc.']","[u'APT Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00755781","['APT Pharmaceuticals, Inc.']"]
["NCT00755807","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00755807","['Eli Lilly and Company']"]
["NCT00755846","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00755846","['Takeda']"]
["NCT00755872","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00755872","['Warner Chilcott']"]
["NCT00755911","[u'Darnell Kaigler, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00755911","['Darnell Kaigler, Principal Investigator, University of Michigan']"]
["NCT00756340","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00756340","[\"St. Jude Children's Research Hospital\"]"]
["NCT00756444","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00756444","['Amgen']"]
["NCT00756678","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00756678","['Allergan']"]
["NCT00756730","[u'Community Research Initiative of New England']","[u'Community Research Initiative of New England']","https://clinicaltrials.gov/ct2/show/NCT00756730","['Community Research Initiative of New England']"]
["NCT00756847","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00756847","['Sanofi']"]
["NCT00756860","[]","[u'Amgen Research (Munich) GmbH']","https://clinicaltrials.gov/ct2/show/NCT00756860","['Global Development Leader, Amgen Inc.']"]
["NCT00756938","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00756938","['Merck Sharp & Dohme Corp.']"]
["NCT00756964","[u'University of Florida']","[u'University of Florida']","https://clinicaltrials.gov/ct2/show/NCT00756964","['University of Florida']"]
["NCT00756977","[u'Braintree Laboratories']","[u'Braintree Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00756977","['Braintree Laboratories']"]
["NCT00757042","[]","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00757042","['Global Development Leader, Amgen Inc.']"]
["NCT00757172","[u'Alliance for Clinical Trials in Oncology']","[u'Alliance for Clinical Trials in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00757172","['Alliance for Clinical Trials in Oncology']"]
["NCT00757185","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00757185","['Yale University']"]
["NCT00757237","[]","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00757237","['Mark Bresnik, MD/Medical Monitor, GSI']"]
["NCT00757341","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00757341","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00757367","[u'Mannkind Corporation']","[u'Mannkind Corporation']","https://clinicaltrials.gov/ct2/show/NCT00757367","['Mannkind Corporation']"]
["NCT00757588","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00757588","['AstraZeneca']"]
["NCT00757601","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00757601","['Merck Sharp & Dohme Corp.']"]
["NCT00757783","[u'Tibotec, Inc']","[u'Tibotec, Inc']","https://clinicaltrials.gov/ct2/show/NCT00757783","['Tibotec, Inc']"]
["NCT00757809","[u'Puma Biotechnology, Inc.']","[u'Puma Biotechnology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00757809","['Puma Biotechnology, Inc.']"]
["NCT00758004","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00758004","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00758043","[u'Vertex Pharmaceuticals Incorporated']","[u'Vertex Pharmaceuticals Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00758043","['Vertex Pharmaceuticals Incorporated']"]
["NCT00758290","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00758290","['William DeVizio/VP- Clinical Research, Colgate Palmolive']"]
["NCT00758303","[u'Cortria Corporation']","[u'Cortria Corporation']","https://clinicaltrials.gov/ct2/show/NCT00758303","['Cortria Corporation']"]
["NCT00758394","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00758394","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00758420","[u'BTG International Inc.']","[u'BTG International Inc.']","https://clinicaltrials.gov/ct2/show/NCT00758420","['BTG International Inc.']"]
["NCT00758433","[]","[u'Winston Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00758433","['Scott B. Phillips, M.D., Study Director, Winston Laboratories, Inc.']"]
["NCT00758498","[u'Teva Pharmaceutical Industries ( Cephalon )']","[u'Cephalon']","https://clinicaltrials.gov/ct2/show/NCT00758498","['Cephalon']"]
["NCT00758524","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00758524","['Novartis Pharmaceuticals']"]
["NCT00758563","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00758563","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00758784","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00758784","['Bausch & Lomb Incorporated']"]
["NCT00758836","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00758836","['Merck Sharp & Dohme Corp.']"]
["NCT00758862","[u'LEO Pharma']","[u'LEO Pharma']","https://clinicaltrials.gov/ct2/show/NCT00758862","['LEO Pharma']"]
["NCT00758953","[u'Lumara Health, Inc.']","[u'Lumara Health, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00758953","['Lumara Health, Inc.']"]
["NCT00759031","[u'Colgate Palmolive']","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00759031","['Colgate Palmolive']"]
["NCT00759083","[u'The Medicines Company']","[u'The Medicines Company']","https://clinicaltrials.gov/ct2/show/NCT00759083","['The Medicines Company']"]
["NCT00759161","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00759161","['Pfizer']"]
["NCT00759187","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00759187","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00759330","[u'Teikoku Pharma USA, Inc.']","[u'Teikoku Pharma USA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00759330","['Teikoku Pharma USA, Inc.']"]
["NCT00759395","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00759395","['AstraZeneca']"]
["NCT00759473","[u'Kathleen Brady, MD, PhD, Medical University of South Carolina']","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT00759473","['Kathleen Brady, MD, PhD, Professor, Medical University of South Carolina']"]
["NCT00759564","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00759564","['Pfizer']"]
["NCT00759603","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00759603","['M.D. Anderson Cancer Center']"]
["NCT00759785","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00759785","['Merck Sharp & Dohme Corp.']"]
["NCT00759902","[]","[u'Actavis Inc.']","https://clinicaltrials.gov/ct2/show/NCT00759902","['Meena Venugopal, Director, Clinical R&D, Actavis Inc']"]
["NCT00759915","[]","[u'Actavis Inc.']","https://clinicaltrials.gov/ct2/show/NCT00759915","['Meena Venugopal, Director, Clinical R&D, Actavis Inc']"]
["NCT00759928","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00759928","['SCRI Development Innovations, LLC']"]
["NCT00760006","[u'Joseph Losee, University of Pittsburgh']","[u'Joseph Losee']","https://clinicaltrials.gov/ct2/show/NCT00760006","['Joseph Losee, Ross H. Musgrave Professor of Pediatric Plastic Surgery Executive Vice-Chair and Program Director Department of Plastic Surgery University of Pittsburgh Medical Center, University of Pittsburgh']"]
["NCT00760019","[u\"Joshua A. Beckman, MD, Brigham and Women's Hospital\"]","[u\"Brigham and Women's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00760019","[\"Joshua A. Beckman, MD, MD, Brigham and Women's Hospital\"]"]
["NCT00760084","[]","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00760084","['Eisai Medical Services, Eisai Inc.']"]
["NCT00760344","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00760344","['Takeda']"]
["NCT00760396","[]","[u'VGX Pharmaceuticals, LLC']","https://clinicaltrials.gov/ct2/show/NCT00760396","['C. Jo White, MD, VGX Pharmaceuticals, Inc.']"]
["NCT00760435","[u'Jane C. Burns, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00760435","['Jane C. Burns, Professor, University of California, San Diego']"]
["NCT00760474","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00760474","['Pfizer']"]
["NCT00760565","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00760565","['Hoffmann-La Roche']"]
["NCT00760578","[u'Metabolic Solutions Development Company']","[u'Metabolic Solutions Development Company']","https://clinicaltrials.gov/ct2/show/NCT00760578","['Metabolic Solutions Development Company']"]
["NCT00760734","[u'Paul G. Harch, M.D., Louisiana State University Health Sciences Center in New Orleans']","[u'Paul G. Harch, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00760734","['Paul G. Harch, M.D., Clinical Professor of Medicine, Louisiana State University Health Sciences Center in New Orleans']"]
["NCT00760929","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00760929","['Hoffmann-La Roche']"]
["NCT00760955","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00760955","['Takeda']"]
["NCT00761137","[u'NeuroHealing Pharmaceuticals Inc.']","[u'NeuroHealing Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00761137","['NeuroHealing Pharmaceuticals Inc.']"]
["NCT00761150","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00761150","['AbbVie (prior sponsor, Abbott)']"]
["NCT00761215","[u'Trius Therapeutics LLC']","[u'Trius Therapeutics LLC']","https://clinicaltrials.gov/ct2/show/NCT00761215","['Trius Therapeutics LLC']"]
["NCT00761345","[u'Fox Chase Cancer Center']","[u'Fox Chase Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00761345","['Fox Chase Cancer Center']"]
["NCT00761631","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00761631","['Pfizer']"]
["NCT00761644","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00761644","['M.D. Anderson Cancer Center']"]
["NCT00761696","[u'Infinity Pharmaceuticals, Inc.']","[u'Infinity Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00761696","['Infinity Pharmaceuticals, Inc.']"]
["NCT00761709","[u'Alcon Research']","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT00761709","['Alcon Research']"]
["NCT00761761","[u'K.N. Roy Chengappa, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00761761","['K.N. Roy Chengappa, Professor of Psychiatry, University of Pittsburgh']"]
["NCT00761930","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00761930","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00762034","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00762034","['Eli Lilly and Company']"]
["NCT00762151","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00762151","['Kirk R Maples, PhD, Anacor Pharmaceuticals, Inc.']"]
["NCT00762164","[u'Lawrence Baruch, Bronx VA Medical Center']","[u'Bronx VA Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00762164","['Lawrence Baruch, Staff Physician, Bronx VA Medical Center']"]
["NCT00762177","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762177","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00762255","[u'H. Lee Moffitt Cancer Center and Research Institute']","[u'H. Lee Moffitt Cancer Center and Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00762255","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00762411","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00762411","['Eli Lilly and Company']"]
["NCT00762450","[u'Colgate Palmolive']","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762450","['Colgate Palmolive']"]
["NCT00762476","[u'The Dial Corporation']","[u'The Dial Corporation']","https://clinicaltrials.gov/ct2/show/NCT00762476","['The Dial Corporation']"]
["NCT00762515","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762515","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00762528","[u'Colgate Palmolive']","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762528","['Colgate Palmolive']"]
["NCT00762567","[u'Johnson & Johnson Consumer and Personal Products Worldwide']","[u'Johnson & Johnson Consumer and Personal Products Worldwide']","https://clinicaltrials.gov/ct2/show/NCT00762567","['Johnson & Johnson Consumer and Personal Products Worldwide']"]
["NCT00762619","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762619","['Willaim DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00762658","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00762658","['Pfizer']"]
["NCT00762749","[u'Johnson & Johnson Consumer and Personal Products Worldwide']","[u'Johnson & Johnson Consumer and Personal Products Worldwide']","https://clinicaltrials.gov/ct2/show/NCT00762749","['Johnson & Johnson Consumer and Personal Products Worldwide']"]
["NCT00762762","[u'Colgate Palmolive']","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762762","['Colgate Palmolive']"]
["NCT00762827","[u\"Joshua A. Beckman, MD, Brigham and Women's Hospital\"]","[u\"Brigham and Women's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00762827","[\"Joshua A. Beckman, MD, MD, Brigham and Women's Hospital\"]"]
["NCT00762853","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00762853","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00762892","[u'Tanvir K. Bell, MD, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00762892","['Tanvir K. Bell, MD, Associate Professor, The University of Texas Health Science Center, Houston']"]
["NCT00763048","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00763048","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00763178","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00763178","['Yale University']"]
["NCT00763204","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00763204","['Pfizer']"]
["NCT00763256","[u'Colgate Palmolive']","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00763256","['Colgate Palmolive']"]
["NCT00763269","[u'Colgate Palmolive']","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00763269","['Colgate Palmolive']"]
["NCT00763321","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00763321","['AbbVie (prior sponsor, Abbott)']"]
["NCT00763451","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00763451","['Sanofi']"]
["NCT00763490","[u'University of Michigan Rogel Cancer Center']","[u'University of Michigan Rogel Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00763490","['University of Michigan Rogel Cancer Center']"]
["NCT00763750","[u'howard safran, Brown University']","[u'howard safran']","https://clinicaltrials.gov/ct2/show/NCT00763750","['howard safran, Principle Investigator, Brown University']"]
["NCT00763815","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00763815","['Sanofi']"]
["NCT00763867","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00763867","['Duke University']"]
["NCT00764309","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00764309","['Bristol-Myers Squibb']"]
["NCT00764361","[u'NanoSHIFT LLC']","[u'NanoSHIFT LLC']","https://clinicaltrials.gov/ct2/show/NCT00764361","['NanoSHIFT LLC']"]
["NCT00764465","[u'Garden State Infectious Disease Associates, PA']","[u'Garden State Infectious Disease Associates, PA']","https://clinicaltrials.gov/ct2/show/NCT00764465","['Garden State Infectious Disease Associates, PA']"]
["NCT00764478","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00764478","['Merck Sharp & Dohme Corp.']"]
["NCT00764634","[u'DynPort Vaccine Company LLC, A GDIT Company']","[u'DynPort Vaccine Company LLC, A GDIT Company']","https://clinicaltrials.gov/ct2/show/NCT00764634","['DynPort Vaccine Company LLC, A GDIT Company']"]
["NCT00764790","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00764790","['GlaxoSmithKline']"]
["NCT00764868","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00764868","['Shire']"]
["NCT00764946","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00764946","['Merck Sharp & Dohme Corp.']"]
["NCT00765076","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00765076","['GlaxoSmithKline']"]
["NCT00765115","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00765115","['Chief Medical Office, Eli Lilly']"]
["NCT00765128","[]","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00765128","['Mitchell R. Humphreys, M.D., Mayo Clinic']"]
["NCT00765167","[]","[u'Colgate Palmolive']","https://clinicaltrials.gov/ct2/show/NCT00765167","['William DeVizio/VP - Clinical Research, Colgate Palmolive']"]
["NCT00765232","[]","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00765232","['Mitchell R. Humphreys, M.D., Mayo Clinic']"]
["NCT00765245","[u'Nishitha Reddy, MD, Vanderbilt-Ingram Cancer Center']","[u'Vanderbilt-Ingram Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00765245","['Nishitha Reddy, MD, Assistant Professor of Medicine; Hematologist/Oncologist, Vanderbilt-Ingram Cancer Center']"]
["NCT00765336","[u'Medicis Pharmaceutical Corporation']","[u'Medicis Pharmaceutical Corporation']","https://clinicaltrials.gov/ct2/show/NCT00765336","['Medicis Pharmaceutical Corporation']"]
["NCT00765492","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00765492","['Mark A. Smith, MD; Medical Science Director, AstraZeneca']"]
["NCT00765518","[u'Vericel Corporation']","[u'Vericel Corporation']","https://clinicaltrials.gov/ct2/show/NCT00765518","['Vericel Corporation']"]
["NCT00765583","[u'Medicis Aesthetics, Inc.']","[u'Medicis Aesthetics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00765583","['Medicis Aesthetics, Inc.']"]
["NCT00765648","[u'The Cleveland Clinic']","[u'The Cleveland Clinic']","https://clinicaltrials.gov/ct2/show/NCT00765648","['The Cleveland Clinic']"]
["NCT00765661","[u'Veloxis Pharmaceuticals']","[u'Veloxis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00765661","['Veloxis Pharmaceuticals']"]
["NCT00765700","[u'Imprimis Pharmaceuticals, Inc.']","[u'Imprimis Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00765700","['Imprimis Pharmaceuticals, Inc.']"]
["NCT00765804","[]","[u'Eyegate Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00765804","['Stephen From/Chief Executive Officer, Eyegate Pharmaceuticals, Inc.']"]
["NCT00765817","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00765817","['AstraZeneca']"]
["NCT00765882","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00765882","['Forest Laboratories']"]
["NCT00765895","[u'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","[u'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","https://clinicaltrials.gov/ct2/show/NCT00765895","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT00765999","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00765999","['Forest Laboratories']"]
["NCT00766038","[u'Ramon Diaz-Arrastia, University of Texas Southwestern Medical Center']","[u'University of Texas Southwestern Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00766038","['Ramon Diaz-Arrastia, Professor of Neurology, University of Texas Southwestern Medical Center']"]
["NCT00766090","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00766090","['GlaxoSmithKline']"]
["NCT00766116","[u'Edward Ball, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00766116","['Edward Ball, Professor of medicine, University of California, San Diego']"]
["NCT00766155","[u'European Organisation for Research and Treatment of Cancer - EORTC']","[u'European Organisation for Research and Treatment of Cancer - EORTC']","https://clinicaltrials.gov/ct2/show/NCT00766155","['European Organisation for Research and Treatment of Cancer - EORTC']"]
["NCT00766363","[u'FORUM Pharmaceuticals Inc']","[u'FORUM Pharmaceuticals Inc']","https://clinicaltrials.gov/ct2/show/NCT00766363","['FORUM Pharmaceuticals Inc']"]
["NCT00766467","[u\"Eudocia Quant Lee, MD, Dana-Farber/Brigham and Women's Cancer Center\"]","[u'Eudocia Quant Lee, MD']","https://clinicaltrials.gov/ct2/show/NCT00766467","[\"Eudocia Quant Lee, MD, Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center\"]"]
["NCT00766532","[u'University of Wisconsin, Madison']","[u'University of Wisconsin, Madison']","https://clinicaltrials.gov/ct2/show/NCT00766532","['University of Wisconsin, Madison']"]
["NCT00766597","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00766597","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00766649","[u'National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )']","[u'National Eye Institute (NEI)']","https://clinicaltrials.gov/ct2/show/NCT00766649","['National Eye Institute (NEI)']"]
["NCT00766818","[]","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00766818","['Angela Kashuba, PharmD, University of North Carolina']"]
["NCT00767364","[u\"Eric McGrath, Children's Hospital of Michigan\"]","[u\"Children's Hospital of Michigan\"]","https://clinicaltrials.gov/ct2/show/NCT00767364","[\"Eric McGrath, Principle Investigator, Children's Hospital of Michigan\"]"]
["NCT00767416","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00767416","['MedImmune LLC']"]
["NCT00767507","[u'The Medicines Company']","[u'The Medicines Company']","https://clinicaltrials.gov/ct2/show/NCT00767507","['The Medicines Company']"]
["NCT00767520","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00767520","['Bristol-Myers Squibb']"]
["NCT00767793","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00767793","['Merck Sharp & Dohme Corp.']"]
["NCT00767806","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00767806","['Chief Medical Officer, Eli Lilly']"]
["NCT00768066","[u'Joshua M Hare, University of Miami']","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00768066","['Joshua M Hare, Director, Interdisciplinary Stem Cell Institute, University of Miami']"]
["NCT00768079","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00768079","['MedImmune LLC']"]
["NCT00768105","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00768105","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00768144","[u'Susana M. Campos, MD, Dana-Farber Cancer Institute']","[u'Dana-Farber Cancer Institute']","https://clinicaltrials.gov/ct2/show/NCT00768144","['Susana M. Campos, MD, Medical Oncologist, Dana-Farber Cancer Institute']"]
["NCT00768209","[]","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00768209","['Wesley Day, VP Clinical, Vivus, Inc.']"]
["NCT00768274","[u'Resverlogix Corp']","[u'Resverlogix Corp']","https://clinicaltrials.gov/ct2/show/NCT00768274","['Resverlogix Corp']"]
["NCT00768391","[]","[u'ImClone LLC']","https://clinicaltrials.gov/ct2/show/NCT00768391","['Chief Medical Officer, ImClone LLC']"]
["NCT00768404","[]","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00768404","['Wesley Day, VP Clinical, Vivus, Inc.']"]
["NCT00768430","[u'Sanjay Johan Mathew, Baylor College of Medicine']","[u'Baylor College of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00768430","['Sanjay Johan Mathew, MD, Baylor College of Medicine']"]
["NCT00768508","[u'Bankole Johnson, University of Virginia']","[u'Bankole Johnson']","https://clinicaltrials.gov/ct2/show/NCT00768508","['Bankole Johnson, Chair of Psychiatry and NB Sciences, University of Virginia']"]
["NCT00768521","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00768521","['Merck Sharp & Dohme Corp.']"]
["NCT00768664","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00768664","['Pfizer']"]
["NCT00768729","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00768729","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00768755","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00768755","['Pfizer']"]
["NCT00768963","[u'Sonia Yoo, University of Miami']","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00768963","['Sonia Yoo, Professor, University of Miami']"]
["NCT00769041","[]","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00769041","['Wesley Day, VP Clinical, VIvus, Inc.']"]
["NCT00769067","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00769067","['Pfizer']"]
["NCT00769132","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00769132","['Merck Sharp & Dohme Corp.']"]
["NCT00769145","[u'Sonia Yoo, University of Miami']","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00769145","['Sonia Yoo, Professor, University of Miami']"]
["NCT00769158","[u'Bankole Johnson, University of Virginia']","[u'Bankole Johnson']","https://clinicaltrials.gov/ct2/show/NCT00769158","['Bankole Johnson, Chair of Psychiatry and Neurobehavioral Sciences, University of Virginia']"]
["NCT00769210","[u'mark munger, University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00769210","['mark munger, Professor, University of Utah']"]
["NCT00769288","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00769288","['National Cancer Institute (NCI)']"]
["NCT00769470","[u'Translational Oncology Research International']","[u'Translational Oncology Research International']","https://clinicaltrials.gov/ct2/show/NCT00769470","['Translational Oncology Research International']"]
["NCT00769704","[u'BioVex Limited']","[u'BioVex Limited']","https://clinicaltrials.gov/ct2/show/NCT00769704","['BioVex Limited']"]
["NCT00769795","[u'Bruce Montgomery, Fred Hutchinson Cancer Research Center']","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00769795","['Bruce Montgomery, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT00769899","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00769899","['Mark A. Smith, MD, PhD Senior Medical Science Director, AstraZeneca LP']"]
["NCT00770029","[u'Merz Pharmaceuticals GmbH']","[u'Merz Pharmaceuticals GmbH']","https://clinicaltrials.gov/ct2/show/NCT00770029","['Merz Pharmaceuticals GmbH']"]
["NCT00770042","[]","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00770042","['Wesley Day, VP Clinical, Vivus, Inc.']"]
["NCT00770081","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00770081","['Novartis']"]
["NCT00770133","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00770133","['Bausch & Lomb Incorporated']"]
["NCT00770146","[u'Kastle Therapeutics, LLC']","[u'Kastle Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00770146","['Kastle Therapeutics, LLC']"]
["NCT00770211","[u'Merz Pharmaceuticals GmbH']","[u'Merz Pharmaceuticals GmbH']","https://clinicaltrials.gov/ct2/show/NCT00770211","['Merz Pharmaceuticals GmbH']"]
["NCT00770263","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00770263","['Washington University School of Medicine']"]
["NCT00770367","[u'Medical University of South Carolina']","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT00770367","['Medical University of South Carolina']"]
["NCT00770471","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","https://clinicaltrials.gov/ct2/show/NCT00770471","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT00770536","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00770536","['Amgen']"]
["NCT00770666","[]","[u'University of Medicine and Dentistry of New Jersey']","https://clinicaltrials.gov/ct2/show/NCT00770666","['Michael Steinberg, MD, MPH, UMDNJ-Robert Wood Johnson Medical School']"]
["NCT00770731","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00770731","['M.D. Anderson Cancer Center']"]
["NCT00770757","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00770757","['Washington University School of Medicine']"]
["NCT00770848","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00770848","['Amgen']"]
["NCT00770861","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00770861","['John Whalen, MD, Executive Director, Clinical Development, Cardiovascular, Forest Research Institute, a Subsidiary of Forest Laboratories Inc.']"]
["NCT00770965","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00770965","['Novartis Pharmaceuticals']"]
["NCT00770978","[u'Basilea Pharmaceutica']","[u'Basilea Pharmaceutica']","https://clinicaltrials.gov/ct2/show/NCT00770978","['Basilea Pharmaceutica']"]
["NCT00770991","[u'Carol Burke, MD, The Cleveland Clinic']","[u'The Cleveland Clinic']","https://clinicaltrials.gov/ct2/show/NCT00770991","['Carol Burke, MD, Principal Investigator, The Cleveland Clinic']"]
["NCT00771030","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00771030","['Amgen']"]
["NCT00771173","[u'Linda Brubaker, Loyola University']","[u'Loyola University']","https://clinicaltrials.gov/ct2/show/NCT00771173","['Linda Brubaker, Professor of Medicine and Dean and Chief Diversity Officer, Stritch School of Medicine, Loyola University']"]
["NCT00771446","[u'Vital Therapies, Inc.']","[u'Vital Therapies, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00771446","['Vital Therapies, Inc.']"]
["NCT00771485","[u'C.B. Fleet Company, Inc.']","[u'C.B. Fleet Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00771485","['C.B. Fleet Company, Inc.']"]
["NCT00771524","[u'Basilea Pharmaceutica']","[u'Basilea Pharmaceutica']","https://clinicaltrials.gov/ct2/show/NCT00771524","['Basilea Pharmaceutica']"]
["NCT00771615","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00771615","['GlaxoSmithKline']"]
["NCT00771667","[]","[u'Centocor, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00771667","['Director, Clinical Research, Janssen R&D US']"]
["NCT00771745","[u'E. Steve Woodle, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT00771745","['E. Steve Woodle, MD, FACS, University of Cincinnati']"]
["NCT00771758","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","https://clinicaltrials.gov/ct2/show/NCT00771758","['Ortho-McNeil Janssen Scientific Affairs, LLC']"]
["NCT00771875","[u'E. Steve Woodle, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT00771875","['E. Steve Woodle, MD, FACS, University of Cincinnati']"]
["NCT00771914","[u'Robert Block, University of Rochester']","[u'University of Rochester']","https://clinicaltrials.gov/ct2/show/NCT00771914","['Robert Block, Principal Investigator, University of Rochester']"]
["NCT00771953","[u'University of Maryland']","[u'University of Maryland']","https://clinicaltrials.gov/ct2/show/NCT00771953","['University of Maryland']"]
["NCT00772005","[u'Teva Pharmaceutical Industries ( Cephalon )']","[u'Cephalon']","https://clinicaltrials.gov/ct2/show/NCT00772005","['Cephalon']"]
["NCT00772031","[u'Anne Lindblad, The EMMES Corporation']","[u'Anne Lindblad']","https://clinicaltrials.gov/ct2/show/NCT00772031","['Anne Lindblad, Executive Vice President, The EMMES Corporation, The EMMES Corporation']"]
["NCT00772109","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00772109","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00772148","[u'Veloxis Pharmaceuticals']","[u'Veloxis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00772148","['Veloxis Pharmaceuticals']"]
["NCT00772265","[u'Wockhardt']","[u'Wockhardt']","https://clinicaltrials.gov/ct2/show/NCT00772265","['Wockhardt']"]
["NCT00772343","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00772343","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00772382","[u'Mitsubishi Tanabe Pharma Corporation']","[u'Mitsubishi Tanabe Pharma Corporation']","https://clinicaltrials.gov/ct2/show/NCT00772382","['Mitsubishi Tanabe Pharma Corporation']"]
["NCT00772512","[]","[u'Taisho Pharmaceutical Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00772512","['Taisho Pharmaceutical Co., Ltd.']"]
["NCT00772525","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00772525","['Sanofi']"]
["NCT00772538","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00772538","['Boehringer Ingelheim']"]
["NCT00772577","[]","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00772577","['External Affairs, Novartis']"]
["NCT00772603","[u'Supernus Pharmaceuticals, Inc.']","[u'Supernus Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00772603","['Supernus Pharmaceuticals, Inc.']"]
["NCT00772772","[u'Manish Ponda, Rockefeller University']","[u'Rockefeller University']","https://clinicaltrials.gov/ct2/show/NCT00772772","['Manish Ponda, Assistant Professor of Clinical Investigation, Rockefeller University']"]
["NCT00772889","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00772889","['GlaxoSmithKline']"]
["NCT00772967","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00772967","['Merck Sharp & Dohme Corp.']"]
["NCT00773097","[u'Robert Schoen, University of Pittsburgh']","[u'Robert Schoen']","https://clinicaltrials.gov/ct2/show/NCT00773097","['Robert Schoen, Principal Investigator, University of Pittsburgh']"]
["NCT00773175","[u'Halozyme Therapeutics']","[u'Halozyme Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00773175","['Halozyme Therapeutics']"]
["NCT00773253","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00773253","['University of California, San Francisco']"]
["NCT00773344","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00773344","['Bristol-Myers Squibb']"]
["NCT00773526","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00773526","['Hoffmann-La Roche']"]
["NCT00773734","[u'Celgene Corporation']","[u'Celgene Corporation']","https://clinicaltrials.gov/ct2/show/NCT00773734","['Celgene Corporation']"]
["NCT00773786","[u'Saint Francis Care']","[u'Saint Francis Care']","https://clinicaltrials.gov/ct2/show/NCT00773786","['Saint Francis Care']"]
["NCT00773812","[u'L. Eugene Arnold, Ohio State University']","[u'Ohio State University']","https://clinicaltrials.gov/ct2/show/NCT00773812","['L. Eugene Arnold, Interim Director of Nisonger Center, Ohio State University']"]
["NCT00773929","[]","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00773929","['Clinical Research Monitor, Millennium Pharmaceuticals, Inc.']"]
["NCT00773955","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00773955","['National Cancer Institute (NCI)']"]
["NCT00774111","[]","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00774111","['Study Director, GSK']"]
["NCT00774163","[u'Richard A. Oberhelman, Tulane University School of Medicine']","[u'Tulane University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00774163","['Richard A. Oberhelman, Professor, Tulane University School of Medicine']"]
["NCT00774358","[u\"Soma Jyonouchi, Children's Hospital of Philadelphia\"]","[u'Soma Jyonouchi']","https://clinicaltrials.gov/ct2/show/NCT00774358","[\"Soma Jyonouchi, Soma Jyonouchi,MD, Children's Hospital of Philadelphia\"]"]
["NCT00774397","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00774397","['Boehringer Ingelheim']"]
["NCT00774553","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00774553","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00774605","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00774605","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00774787","[u'Darrell S. Rigel, Rigel Dermatology']","[u'Rigel Dermatology']","https://clinicaltrials.gov/ct2/show/NCT00774787","['Darrell S. Rigel, PI, Rigel Dermatology']"]
["NCT00774800","[u'Halozyme Therapeutics']","[u'Halozyme Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00774800","['Halozyme Therapeutics']"]
["NCT00774813","[]","[u'Kalaco Scientific, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00774813","['Evgeny Kruptisky, MD, PhD, Leningrad Regional Center of Addiction']"]
["NCT00774852","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00774852","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00774930","[u'Ipsen']","[u'Ipsen']","https://clinicaltrials.gov/ct2/show/NCT00774930","['Ipsen']"]
["NCT00774943","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00774943","['Amgen']"]
["NCT00775138","[u'Insmed Incorporated']","[u'Insmed Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00775138","['Insmed Incorporated']"]
["NCT00775229","[u'Jon Grant, University of Minnesota - Clinical and Translational Science Institute']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00775229","['Jon Grant, Professor of Psychiatry, University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00775294","[]","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00775294","['Angela Kashuba, UNC Eshelman School of Pharmacy']"]
["NCT00775411","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00775411","['Allergan']"]
["NCT00775424","[u'University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00775424","['University of Pennsylvania']"]
["NCT00775437","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00775437","['AbbVie (prior sponsor, Abbott)']"]
["NCT00775450","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00775450","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00775463","[u'United Therapeutics']","[u'United Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00775463","['United Therapeutics']"]
["NCT00775528","[]","[u'Solvay Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00775528","['Djenane Bennett, Solvay Pharmaceuticals']"]
["NCT00775671","[u'Nancy J. Brown, Vanderbilt University']","[u'Vanderbilt University']","https://clinicaltrials.gov/ct2/show/NCT00775671","['Nancy J. Brown, Professor of Medicine and Pharmacology, Vanderbilt University']"]
["NCT00776009","[]","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00776009","['Study Director Novartis Pharmaceuticals, Novartis Pharmaceuticals']"]
["NCT00776516","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00776516","['Astellas Pharma Inc']"]
["NCT00776919","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00776919","['Stiefel, a GSK Company']"]
["NCT00776984","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00776984","['Boehringer Ingelheim']"]
["NCT00777049","[u'Translational Research in Oncology']","[u'Translational Research in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00777049","['Translational Research in Oncology']"]
["NCT00777062","[u'Kyle Kampman, University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00777062","['Kyle Kampman, Principal Investigator, University of Pennsylvania']"]
["NCT00777257","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00777257","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00777296","[u'Insmed Incorporated']","[u'Insmed Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00777296","['Insmed Incorporated']"]
["NCT00777517","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00777517","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00777556","[u'Teva Pharmaceutical Industries ( Duramed Research )']","[u'Duramed Research']","https://clinicaltrials.gov/ct2/show/NCT00777556","['Duramed Research']"]
["NCT00777569","[]","[u'National Institute on Drug Abuse (NIDA)']","https://clinicaltrials.gov/ct2/show/NCT00777569","['Dorothy Hatsukami, Ph.D. Principal Investigator, University of Minnesota']"]
["NCT00777595","[]","[u'Chiesi Farmaceutici S.p.A.']","https://clinicaltrials.gov/ct2/show/NCT00777595","['Steven E. Linberg, Ph.D., Chiesi Pharmaceuticals Inc.']"]
["NCT00777699","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00777699","['Sanofi']"]
["NCT00777764","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00777764","['Genentech, Inc.']"]
["NCT00777959","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00777959","['Merck Sharp & Dohme Corp.']"]
["NCT00778011","[]","[u'WellSpan Health']","https://clinicaltrials.gov/ct2/show/NCT00778011","['Marc Pollack, MD, PhD, York Hospital Emergency Medicine Physician']"]
["NCT00778167","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00778167","['National Cancer Institute (NCI)']"]
["NCT00778193","[]","[u'Research Associates of New York, LLP']","https://clinicaltrials.gov/ct2/show/NCT00778193","['James Asienberg, MD, Research Associates of New York']"]
["NCT00778258","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00778258","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00778310","[u'The University of Texas Health Science Center at San Antonio']","[u'The University of Texas Health Science Center at San Antonio']","https://clinicaltrials.gov/ct2/show/NCT00778310","['The University of Texas Health Science Center at San Antonio']"]
["NCT00778375","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00778375","['M.D. Anderson Cancer Center']"]
["NCT00778700","[u'Incyte Corporation']","[u'Incyte Corporation']","https://clinicaltrials.gov/ct2/show/NCT00778700","['Incyte Corporation']"]
["NCT00779181","[]","[u'Addrenex Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00779181","['Moise Khayrallah, PhD / President and CEO, Addrenex Pharmaceuticals, Inc.']"]
["NCT00779259","[]","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00779259","['Vice President, Branded Products and Medical Affairs, Mutual Pharmaceutical Company, Inc.']"]
["NCT00779389","[u'University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00779389","['University of Pittsburgh']"]
["NCT00779428","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00779428","['Bristol-Myers Squibb']"]
["NCT00779519","[]","[u'vTv Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00779519","['Jane Shen, Pharm.D., TransTech Pharma']"]
["NCT00779701","[u'Temple University']","[u'Temple University']","https://clinicaltrials.gov/ct2/show/NCT00779701","['Temple University']"]
["NCT00780182","[]","[u'Chimerix']","https://clinicaltrials.gov/ct2/show/NCT00780182","['Neil Frazer/ Chief Medical Officer, Chimerix']"]
["NCT00780442","[u'Aimee McRae-Clark, Medical University of South Carolina']","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT00780442","['Aimee McRae-Clark, Professor of Psychiatry and Behavioral Sciences, Medical University of South Carolina']"]
["NCT00780598","[u'Chroma Therapeutics']","[u'Chroma Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00780598","['Chroma Therapeutics']"]
["NCT00781001","[u'Center for Medicinal Cannabis Research']","[u'Center for Medicinal Cannabis Research']","https://clinicaltrials.gov/ct2/show/NCT00781001","['Center for Medicinal Cannabis Research']"]
["NCT00781339","[u'NovaBay Pharmaceuticals, Inc.']","[u'NovaBay Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00781339","['NovaBay Pharmaceuticals, Inc.']"]
["NCT00781443","[]","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00781443","['Clinical Trials Posting Group, Genentech, Inc.']"]
["NCT00781456","[u'Teva Pharmaceutical Industries ( Duramed Research )']","[u'Duramed Research']","https://clinicaltrials.gov/ct2/show/NCT00781456","['Duramed Research']"]
["NCT00781508","[u'Robert Bahler, MetroHealth Medical Center']","[u'MetroHealth Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00781508","['Robert Bahler, Cardiologist Professor of Medicine CWRU, MetroHealth Medical Center']"]
["NCT00781586","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00781586","['Bayer']"]
["NCT00781664","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00781664","['Lee Zane, M.D., M.A.S., Anacor Pharmaceuticals, Inc.']"]
["NCT00781742","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00781742","['AstraZeneca']"]
["NCT00781846","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00781846","['Merck Sharp & Dohme Corp.']"]
["NCT00781898","[u'University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00781898","['University of Pennsylvania']"]
["NCT00781911","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00781911","['Eli Lilly and Company']"]
["NCT00781937","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00781937","['Novo Nordisk A/S']"]
["NCT00782002","[]","[u'ImClone LLC']","https://clinicaltrials.gov/ct2/show/NCT00782002","['Chief Medical Officer, ImClone LLC']"]
["NCT00782184","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00782184","['Merck Sharp & Dohme Corp.']"]
["NCT00782210","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00782210","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00782275","[u'David F. McDermott, MD, Dana-Farber Cancer Institute']","[u'Beth Israel Deaconess Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00782275","['David F. McDermott, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00782340","[u'Chelsea Therapeutics']","[u'Chelsea Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00782340","['Chelsea Therapeutics']"]
["NCT00782379","[u'Northside Hospital, Inc.']","[u'Northside Hospital, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00782379","['Northside Hospital, Inc.']"]
["NCT00782509","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00782509","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00782535","[u'Chiesi USA']","[u'Chiesi USA']","https://clinicaltrials.gov/ct2/show/NCT00782535","['Chiesi USA']"]
["NCT00782587","[]","[u'Halozyme Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00782587","['Jonathan Leff, M.D., Halozyme Therapeutics']"]
["NCT00782600","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00782600","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00782626","[u'Karen D. Wright MD, Dana-Farber Cancer Institute']","[u'Dana-Farber Cancer Institute']","https://clinicaltrials.gov/ct2/show/NCT00782626","['Karen D. Wright MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00782769","[u'Teva Pharmaceutical Industries ( Duramed Research )']","[u'Duramed Research']","https://clinicaltrials.gov/ct2/show/NCT00782769","['Duramed Research']"]
["NCT00782795","[u'Matthew DiMagno, MD, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00782795","['Matthew DiMagno, MD, Assistant Professor of Internal Medicine, University of Michigan']"]
["NCT00782821","[u'E. Steve Woodle, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT00782821","['E. Steve Woodle, MD, FACS, University of Cincinnati']"]
["NCT00783081","[u'Kowa Research Institute, Inc.']","[u'Kowa Research Institute, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00783081","['Kowa Research Institute, Inc.']"]
["NCT00783107","[u'University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00783107","['University of Pittsburgh']"]
["NCT00783263","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00783263","['Merck Sharp & Dohme Corp.']"]
["NCT00783276","[u'Frederick Gerard Moeller, Virginia Commonwealth University']","[u'Virginia Commonwealth University']","https://clinicaltrials.gov/ct2/show/NCT00783276","['Frederick Gerard Moeller, Professor - Psychiatry, Behavioral Sciences, Virginia Commonwealth University']"]
["NCT00783289","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00783289","['MedImmune LLC']"]
["NCT00783341","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00783341","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00783523","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00783523","['University of California, San Francisco']"]
["NCT00783549","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00783549","['GlaxoSmithKline']"]
["NCT00783692","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00783692","['Millennium Pharmaceuticals, Inc.']"]
["NCT00783705","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00783705","['National Cancer Institute (NCI)']"]
["NCT00783718","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00783718","['Millennium Pharmaceuticals, Inc.']"]
["NCT00783926","[]","[u'Ology Bioservices']","https://clinicaltrials.gov/ct2/show/NCT00783926","['Karen Near, MD; Medical Director, Baxter Healthcare Corporation']"]
["NCT00784134","[u'Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00784134","['Johns Hopkins University']"]
["NCT00784147","[u'TaiMed Biologics Inc.']","[u'TaiMed Biologics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00784147","['TaiMed Biologics Inc.']"]
["NCT00784212","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00784212","['Novartis Pharmaceuticals']"]
["NCT00784277","[]","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00784277","['Senior Director, Clinical Leader, Johnson & Johnson Pharmaceutical Research and Development, L.L.C.']"]
["NCT00784420","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00784420","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00784459","[u'Jonathan Green, MD, Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00784459","['Jonathan Green, MD, Professor of Medicine, Washington University School of Medicine']"]
["NCT00784550","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00784550","['GlaxoSmithKline']"]
["NCT00784719","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00784719","['Pfizer']"]
["NCT00784823","[u'Hackensack Meridian Health']","[u'Hackensack Meridian Health']","https://clinicaltrials.gov/ct2/show/NCT00784823","['Hackensack Meridian Health']"]
["NCT00784875","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00784875","['Eli Lilly and Company']"]
["NCT00784927","[u'Mayo Clinic']","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00784927","['Mayo Clinic']"]
["NCT00785213","[u'Mutual Pharmaceutical Company, Inc.']","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00785213","['Mutual Pharmaceutical Company, Inc.']"]
["NCT00785226","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00785226","['Bayer']"]
["NCT00785408","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00785408","['AstraZeneca']"]
["NCT00785486","[u'Mutual Pharmaceutical Company, Inc.']","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00785486","['Mutual Pharmaceutical Company, Inc.']"]
["NCT00785512","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00785512","['John Whalen, MD, Executive Director, Clinical Development, Cardiovascular, Forest Research Institute, a subsidiary of Forest Laboratories Inc']"]
["NCT00785538","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00785538","['Eli Lilly and Company']"]
["NCT00785577","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00785577","['Eli Lilly and Company']"]
["NCT00785785","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00785785","['Novartis Pharmaceuticals']"]
["NCT00785915","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00785915","['AstraZeneca']"]
["NCT00785928","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00785928","['Eli Lilly and Company']"]
["NCT00785941","[u'ImClone LLC']","[u'ImClone LLC']","https://clinicaltrials.gov/ct2/show/NCT00785941","['ImClone LLC']"]
["NCT00785954","[u'KAI Pharmaceuticals']","[u'KAI Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00785954","['KAI Pharmaceuticals']"]
["NCT00785980","[u'Mutual Pharmaceutical Company, Inc.']","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00785980","['Mutual Pharmaceutical Company, Inc.']"]
["NCT00786188","[u'Noven Therapeutics']","[u'Noven Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00786188","['Noven Therapeutics']"]
["NCT00786201","[u'Centocor, Inc.']","[u'Centocor, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00786201","['Centocor, Inc.']"]
["NCT00786370","[]","[u'The Cooper Health System']","https://clinicaltrials.gov/ct2/show/NCT00786370","['Jeffrey Littman, MD, Cooper University Hospital']"]
["NCT00786383","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00786383","['Eli Lilly and Company']"]
["NCT00786422","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00786422","['Bayer']"]
["NCT00786474","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00786474","['Duke University']"]
["NCT00786643","[u'Accelerated Community Oncology Research Network']","[u'Accelerated Community Oncology Research Network']","https://clinicaltrials.gov/ct2/show/NCT00786643","['Accelerated Community Oncology Research Network']"]
["NCT00786669","[u\"Children's Hospital Medical Center, Cincinnati\"]","[u\"Children's Hospital Medical Center, Cincinnati\"]","https://clinicaltrials.gov/ct2/show/NCT00786669","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT00786812","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00786812","['Novartis Pharmaceuticals']"]
["NCT00786838","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00786838","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00786916","[u\"Michael D. Reed, Akron Children's Hospital\"]","[u\"Akron Children's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00786916","[\"Michael D. Reed, Pharm.D., Akron Children's Hospital\"]"]
["NCT00787033","[u'Verastem, Inc.']","[u'Verastem, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00787033","['Verastem, Inc.']"]
["NCT00787501","[u'Greg Siegle, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00787501","['Greg Siegle, Associate Professor, University of Pittsburgh']"]
["NCT00787527","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00787527","['M.D. Anderson Cancer Center']"]
["NCT00787605","[]","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00787605","['External Affairs, Novartis']"]
["NCT00787761","[u'Northside Hospital, Inc.']","[u'Northside Hospital, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00787761","['Northside Hospital, Inc.']"]
["NCT00787891","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00787891","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00788047","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00788047","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00788060","[u'Daniel George, MD, Duke University']","[u'Daniel George, MD']","https://clinicaltrials.gov/ct2/show/NCT00788060","['Daniel George, MD, Associate Professor of Medicine, Duke University']"]
["NCT00788073","[u'Seaside Therapeutics, Inc.']","[u'Seaside Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00788073","['Seaside Therapeutics, Inc.']"]
["NCT00788099","[]","[u'PharmaMar']","https://clinicaltrials.gov/ct2/show/NCT00788099","['Pharmamar USA']"]
["NCT00788294","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00788294","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00788528","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00788528","['Shionogi']"]
["NCT00788593","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00788593","['Forest Laboratories']"]
["NCT00788697","[u'Bracco Diagnostics, Inc']","[u'Bracco Diagnostics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00788697","['Bracco Diagnostics, Inc']"]
["NCT00788710","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00788710","['Merck Sharp & Dohme Corp.']"]
["NCT00788892","[u'Jazz Pharmaceuticals']","[u'Jazz Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00788892","['Jazz Pharmaceuticals']"]
["NCT00788931","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00788931","['Novartis Pharmaceuticals']"]
["NCT00788957","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00788957","['Amgen']"]
["NCT00789113","[u'University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00789113","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00789191","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00789191","['Novo Nordisk A/S']"]
["NCT00789308","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00789308","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00789321","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00789321","['Merck Sharp & Dohme Corp.']"]
["NCT00789360","[]","[u'Alexza Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00789360","['Robert Fishman, MD., Vice President, Clinical Development, Alexza Pharmaceuticals, Inc.']"]
["NCT00789477","[u'Regeneron Pharmaceuticals']","[u'Regeneron Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00789477","['Regeneron Pharmaceuticals']"]
["NCT00789568","[u'BioMarin Pharmaceutical']","[u'BioMarin Pharmaceutical']","https://clinicaltrials.gov/ct2/show/NCT00789568","['BioMarin Pharmaceutical']"]
["NCT00789672","[u'Ray Kraker, Jaeb Center for Health Research']","[u'Jaeb Center for Health Research']","https://clinicaltrials.gov/ct2/show/NCT00789672","['Ray Kraker, Director, PEDIG Coordinating Center, Jaeb Center for Health Research']"]
["NCT00789698","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT00789698","['Sunovion']"]
["NCT00789724","[u'Virginia Commonwealth University']","[u'Virginia Commonwealth University']","https://clinicaltrials.gov/ct2/show/NCT00789724","['Virginia Commonwealth University']"]
["NCT00789828","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00789828","['Novartis Pharmaceuticals']"]
["NCT00789880","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00789880","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00790036","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00790036","['Novartis Pharmaceuticals']"]
["NCT00790062","[u'Alan Tita, University of Alabama at Birmingham']","[u'University of Alabama at Birmingham']","https://clinicaltrials.gov/ct2/show/NCT00790062","['Alan Tita, Associate Professor, University of Alabama at Birmingham']"]
["NCT00790127","[]","[u'HemaQuest Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00790127","['Susan Perrine, M.D. Chief Scientific Officer, VP Clinical Affairs, HemaQuest Pharmaceuticals Inc.']"]
["NCT00790153","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00790153","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00790192","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT00790192","['Sunovion']"]
["NCT00790205","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00790205","['Merck Sharp & Dohme Corp.']"]
["NCT00790218","[u'Can-Fite BioPharma']","[u'Can-Fite BioPharma']","https://clinicaltrials.gov/ct2/show/NCT00790218","['Can-Fite BioPharma']"]
["NCT00790374","[u'Ipsen']","[u'Ipsen']","https://clinicaltrials.gov/ct2/show/NCT00790374","['Eric Chetaille MD, Ipsen']"]
["NCT00790400","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00790400","['Novartis Pharmaceuticals']"]
["NCT00790426","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00790426","['Novartis Pharmaceuticals']"]
["NCT00790556","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00790556","['Merck Sharp & Dohme Corp.']"]
["NCT00790595","[u'Jonsson Comprehensive Cancer Center']","[u'Jonsson Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00790595","['Jonsson Comprehensive Cancer Center']"]
["NCT00790647","[u'Vaishali Sanchorawala, Boston Medical Center']","[u'Boston Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00790647","['Vaishali Sanchorawala, Principal Investigator, Boston Medical Center']"]
["NCT00790660","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00790660","['Astellas Pharma Inc']"]
["NCT00790738","[u'Raphael Braga, Northwell Health']","[u'Northwell Health']","https://clinicaltrials.gov/ct2/show/NCT00790738","['Raphael Braga, MD, Northwell Health']"]
["NCT00790751","[u'VIVUS, Inc.']","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00790751","['VIVUS, Inc.']"]
["NCT00790790","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00790790","['Eli Lilly and Company']"]
["NCT00790907","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00790907","['GlaxoSmithKline']"]
["NCT00791011","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00791011","['Amgen']"]
["NCT00791102","[u'Robert Naclerio, University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00791102","['Robert Naclerio, Professor, University of Chicago']"]
["NCT00791154","[u'NantCell, Inc.']","[u'NantCell, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00791154","['NantCell, Inc.']"]
["NCT00791219","[u'Halcygen Pharmaceuticals Limited']","[u'Halcygen Pharmaceuticals Limited']","https://clinicaltrials.gov/ct2/show/NCT00791219","['Halcygen Pharmaceuticals Limited']"]
["NCT00791271","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00791271","['M.D. Anderson Cancer Center']"]
["NCT00791323","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00791323","['Allergan']"]
["NCT00791388","[]","[u'Procter and Gamble']","https://clinicaltrials.gov/ct2/show/NCT00791388","['William S Aronstein, PhD, MD, Procter and Gamble Pharmaceuticals']"]
["NCT00791479","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00791479","['Eli Lilly and Company']"]
["NCT00791492","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00791492","['Pfizer']"]
["NCT00791752","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00791752","[u'Jan Eriksson MD PhD / Medical Science Director, AstraZeneca R&D M\\xf6lndal, Sweden']"]
["NCT00791765","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00791765","['Amgen']"]
["NCT00791778","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00791778","['Bayer']"]
["NCT00791817","[]","[u'Procter and Gamble']","https://clinicaltrials.gov/ct2/show/NCT00791817","['William S Aronstein, PhD, MD, Procter and Gamble Pharmaceuticals']"]
["NCT00791856","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00791856","['Warner Chilcott']"]
["NCT00791973","[u'Robert Naclerio, University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00791973","['Robert Naclerio, MD, University of Chicago']"]
["NCT00792012","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00792012","['University of Colorado, Denver']"]
["NCT00792103","[u'Teva Pharmaceutical Industries ( NuPathe Inc. )']","[u'NuPathe Inc.']","https://clinicaltrials.gov/ct2/show/NCT00792103","['NuPathe Inc.']"]
["NCT00792246","[u'Phillip Brian Smith, Duke University']","[u'Phillip Brian Smith']","https://clinicaltrials.gov/ct2/show/NCT00792246","['Phillip Brian Smith, Associate Professor of Pediatrics, Duke University']"]
["NCT00792298","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00792298","['Merck Sharp & Dohme Corp.']"]
["NCT00792571","[u'Lung Biotechnology PBC']","[u'Lung Biotechnology PBC']","https://clinicaltrials.gov/ct2/show/NCT00792571","['Lung Biotechnology PBC']"]
["NCT00792636","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00792636","['GlaxoSmithKline']"]
["NCT00792688","[]","[u'Glycotex, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00792688","['John H. Joseph, MD/ Principal Investigator, The Clinical Testing Center of Beverly Hills']"]
["NCT00792727","[u'Hisamitsu Pharmaceutical Co., Inc.']","[u'Hisamitsu Pharmaceutical Co., Inc.']","https://clinicaltrials.gov/ct2/show/NCT00792727","['Hisamitsu Pharmaceutical Co., Inc.']"]
["NCT00792766","[u\"Children's Hospital Medical Center, Cincinnati\"]","[u\"Children's Hospital Medical Center, Cincinnati\"]","https://clinicaltrials.gov/ct2/show/NCT00792766","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT00792857","[u'OPKO Health, Inc. ( OPKO IP Holdings II, Inc. )']","[u'OPKO IP Holdings II, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00792857","['OPKO IP Holdings II, Inc.']"]
["NCT00792922","[u'Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00792922","['Johns Hopkins University']"]
["NCT00792935","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00792935","['Merck Sharp & Dohme Corp.']"]
["NCT00793000","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00793000","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00793793","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00793793","['Boehringer Ingelheim']"]
["NCT00793819","[u'Watson Pharmaceuticals']","[u'Watson Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00793819","['Watson Pharmaceuticals']"]
["NCT00793871","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00793871","['Pfizer']"]
["NCT00793923","[u'Subhransu K. Ray, M.D., Ph.D., Bay Area Retina Associates']","[u'Subhransu K. Ray, M.D., Ph.D.']","https://clinicaltrials.gov/ct2/show/NCT00793923","['Subhransu K. Ray, M.D., Ph.D., Principal Investigator, Bay Area Retina Associates']"]
["NCT00793975","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00793975","['Eli Lilly and Company']"]
["NCT00794144","[]","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT00794144","['Cynthia M. Rusk\\\\Manager, Development, Alcon Research']"]
["NCT00794274","[u'Robert P Baughman, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT00794274","['Robert P Baughman, Professor of Medicine, University of Cincinnati']"]
["NCT00794417","[u'Regeneron Pharmaceuticals']","[u'Regeneron Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00794417","['Regeneron Pharmaceuticals']"]
["NCT00794430","[u'Vernalis (R&D) Ltd']","[u'Vernalis (R&D) Ltd']","https://clinicaltrials.gov/ct2/show/NCT00794430","['Vernalis (R&D) Ltd']"]
["NCT00794508","[u'Donald B. Kohn, M.D., University of California, Los Angeles']","[u'Donald B. Kohn, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00794508","['Donald B. Kohn, M.D., Professor, University of California, Los Angeles']"]
["NCT00794573","[u'Mark Eisenberg, McGill University']","[u'Mark Eisenberg']","https://clinicaltrials.gov/ct2/show/NCT00794573","['Mark Eisenberg, Professor of Medicine, Divisions of Cardiology and Clinical Epidemiology, McGill University']"]
["NCT00794586","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00794586","['Gilead Sciences']"]
["NCT00794664","[u'Kastle Therapeutics, LLC']","[u'Kastle Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00794664","['Kastle Therapeutics, LLC']"]
["NCT00794677","[]","[u\"Children's Hospital & Research Center Oakland\"]","https://clinicaltrials.gov/ct2/show/NCT00794677","[\"Ronald Krauss, M.D., Children's Hospital Oakland Research Institute\"]"]
["NCT00794716","[u'Norgine']","[u'Norgine']","https://clinicaltrials.gov/ct2/show/NCT00794716","['Norgine']"]
["NCT00794976","[u'Travanti Pharma Inc.']","[u'Travanti Pharma Inc.']","https://clinicaltrials.gov/ct2/show/NCT00794976","['Travanti Pharma Inc.']"]
["NCT00795002","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00795002","['National Cancer Institute (NCI)']"]
["NCT00795015","[]","[u'Rush University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00795015","['David Baldwin MD, Rush University Medical Center']"]
["NCT00795145","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00795145","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00795288","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00795288","['Washington University School of Medicine']"]
["NCT00795418","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00795418","['Novartis']"]
["NCT00795457","[u'Ian F. Pollack, M.D., University of Pittsburgh']","[u'Ian F. Pollack, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00795457","['Ian F. Pollack, M.D., Chief, Pediatric Neurosurgery, University of Pittsburgh']"]
["NCT00795574","[]","[u'Florida Academic Dermatology Centers']","https://clinicaltrials.gov/ct2/show/NCT00795574","['Francisco A Kerdel,M.D., Florida Academic Dermatology Centers']"]
["NCT00795665","[u'University of California, Davis']","[u'University of California, Davis']","https://clinicaltrials.gov/ct2/show/NCT00795665","['University of California, Davis']"]
["NCT00795704","[u'Daniel Riche, University of Mississippi Medical Center']","[u'University of Mississippi Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00795704","['Daniel Riche, Assistant Professor of Pharmacy Practice and Medicine, University of Mississippi Medical Center']"]
["NCT00795717","[u'Todd Conley, Tufts University']","[u'Todd Conley']","https://clinicaltrials.gov/ct2/show/NCT00795717","['Todd Conley, Associate Director, Office of Research Administration, Tufts University']"]
["NCT00795769","[u'Leona Holmberg, Fred Hutchinson Cancer Research Center']","[u'Fred Hutchinson Cancer Research Center']","https://clinicaltrials.gov/ct2/show/NCT00795769","['Leona Holmberg, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT00795821","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00795821","['Eli Lilly and Company']"]
["NCT00795886","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00795886","['University of Utah']"]
["NCT00795938","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00795938","['Pfizer']"]
["NCT00795951","[u'Allerderm']","[u'Allerderm']","https://clinicaltrials.gov/ct2/show/NCT00795951","['Allerderm']"]
["NCT00796107","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00796107","['Hoffmann-La Roche']"]
["NCT00796120","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00796120","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00796224","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00796224","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00796289","[u'Ferring Pharmaceuticals']","[u'Ferring Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00796289","['Ferring Pharmaceuticals']"]
["NCT00796302","[u'Michael Aman, Ohio State University']","[u'Michael Aman']","https://clinicaltrials.gov/ct2/show/NCT00796302","['Michael Aman, Retiree-Faculty, Ohio State University']"]
["NCT00796315","[u'Procter and Gamble']","[u'Procter and Gamble']","https://clinicaltrials.gov/ct2/show/NCT00796315","['Procter and Gamble']"]
["NCT00796367","[u'VIVUS, Inc.']","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00796367","['VIVUS, Inc.']"]
["NCT00796744","[u'US Biotest, Inc.']","[u'US Biotest, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00796744","['US Biotest, Inc.']"]
["NCT00796770","[u'Baylor Research Institute']","[u'Baylor Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00796770","['Baylor Research Institute']"]
["NCT00796796","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00796796","['Washington University School of Medicine']"]
["NCT00796822","[u'Samir K Gupta, MD, MS, Indiana University']","[u'Indiana University']","https://clinicaltrials.gov/ct2/show/NCT00796822","['Samir K Gupta, MD, MS, Associate Professor of Medicine, Indiana University']"]
["NCT00796887","[u'Andrew N. Russman, Henry Ford Health System']","[u'Henry Ford Health System']","https://clinicaltrials.gov/ct2/show/NCT00796887","['Andrew N. Russman, Senior Staff Neurologist, Henry Ford Health System']"]
["NCT00796965","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00796965","['Mark A. Smith, M.D, AstraZeneca Pharmaceuticals']"]
["NCT00796991","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00796991","['Bristol-Myers Squibb']"]
["NCT00797056","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00797056","['Washington University School of Medicine']"]
["NCT00797108","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00797108","['Pfizer']"]
["NCT00797225","[u'AbbVie']","[u'AbbVie']","https://clinicaltrials.gov/ct2/show/NCT00797225","['AbbVie']"]
["NCT00797316","[]","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00797316","['External Affairs, Novartis']"]
["NCT00797420","[u'Daniel Benjamin, Duke University']","[u'Daniel Benjamin']","https://clinicaltrials.gov/ct2/show/NCT00797420","['Daniel Benjamin, Professor of Pediatrics, Duke University']"]
["NCT00797797","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00797797","['James Perhach, Executive Director, Clinical Development, Forest Research Institute Inc (A Subsidiary of Forest Laboratories Inc)']"]
["NCT00797823","[u'W. Kenneth Ward, Legacy Health System']","[u'Legacy Health System']","https://clinicaltrials.gov/ct2/show/NCT00797823","['W. Kenneth Ward, Senior Scientist, Legacy Health System']"]
["NCT00797953","[u'Tasly Pharmaceuticals, Inc.']","[u'Tasly Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00797953","['Tasly Pharmaceuticals, Inc.']"]
["NCT00798096","[u'Rigel Pharmaceuticals']","[u'Rigel Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00798096","['Rigel Pharmaceuticals']"]
["NCT00798252","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00798252","['Bristol-Myers Squibb']"]
["NCT00798265","[u'National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00798265","['National Cancer Institute (NCI)']"]
["NCT00798603","[u'Alliance for Clinical Trials in Oncology']","[u'Alliance for Clinical Trials in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00798603","['Alliance for Clinical Trials in Oncology']"]
["NCT00798629","[u'H. Lee Moffitt Cancer Center and Research Institute']","[u'H. Lee Moffitt Cancer Center and Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00798629","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00798694","[u'L. Jay Katz MD, Wills Eye']","[u'Wills Eye']","https://clinicaltrials.gov/ct2/show/NCT00798694","['L. Jay Katz MD, Principal Investigator, Wills Eye']"]
["NCT00798707","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00798707","['Director, Clinical Trial Disclosure Group, Pfizer, Inc']"]
["NCT00798915","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00798915","['Washington University School of Medicine']"]
["NCT00798967","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00798967","['Shire']"]
["NCT00799006","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00799006","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00799058","[u'International Partnership for Microbicides, Inc.']","[u'International Partnership for Microbicides, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00799058","['International Partnership for Microbicides, Inc.']"]
["NCT00799227","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00799227","['Allergan']"]
["NCT00799240","[u'University of Kansas Medical Center ( University of Kansas )']","[u'University of Kansas']","https://clinicaltrials.gov/ct2/show/NCT00799240","['University of Kansas']"]
["NCT00799396","[u'Alan Shuldiner, University of Maryland']","[u'University of Maryland']","https://clinicaltrials.gov/ct2/show/NCT00799396","['Alan Shuldiner, Associate Dean for Personalized Medicine; Director, Program in Personalized and Genomic Medicine; Head, Division of Endocrinology, Diabetes and Nutrition, University of Maryland']"]
["NCT00799409","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","https://clinicaltrials.gov/ct2/show/NCT00799409","['Ortho-McNeil Janssen Scientific Affairs, LLC']"]
["NCT00799487","[]","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","https://clinicaltrials.gov/ct2/show/NCT00799487","['Vice President, Medical Affairs, CNS, Ortho-McNeil Janssen Scientific Affairs, LLC']"]
["NCT00799552","[]","[u'Resolvyx Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT00799552","['Per Gjorstrup, Chief Medical Officier, Resolvyx Pharmaceuticals, Inc']"]
["NCT00799604","[u'The Medicines Company']","[u'The Medicines Company']","https://clinicaltrials.gov/ct2/show/NCT00799604","['The Medicines Company']"]
["NCT00799643","[u'Joslin Diabetes Center']","[u'Joslin Diabetes Center']","https://clinicaltrials.gov/ct2/show/NCT00799643","['Joslin Diabetes Center']"]
["NCT00799682","[]","[u'Ophthalmic Consultants of Long Island']","https://clinicaltrials.gov/ct2/show/NCT00799682","['Marguerite McDonald, M.D., Ophthalmic Consultants of Long Island']"]
["NCT00799708","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00799708","['Merck Sharp & Dohme Corp.']"]
["NCT00799812","[u'CareFusion']","[u'CareFusion']","https://clinicaltrials.gov/ct2/show/NCT00799812","['CareFusion']"]
["NCT00799825","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00799825","['GlaxoSmithKline']"]
["NCT00799903","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00799903","['GlaxoSmithKline']"]
["NCT00800098","[u'Anne Friedlander, Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT00800098","['Anne Friedlander, Consulting Professor, Stanford University']"]
["NCT00800176","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00800176","['Hoffmann-La Roche']"]
["NCT00800319","[u'Alkermes, Inc.']","[u'Alkermes, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00800319","['Alkermes, Inc.']"]
["NCT00800345","[u'Vector Oncology']","[u'Vector Oncology']","https://clinicaltrials.gov/ct2/show/NCT00800345","['Vector Oncology']"]
["NCT00800605","[]","[u'Ology Bioservices']","https://clinicaltrials.gov/ct2/show/NCT00800605","['Karen Near, MD; Medical Director, Baxter Healthcare Corporation']"]
["NCT00800618","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00800618","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00800683","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00800683","['Boehringer Ingelheim']"]
["NCT00800722","[u'Beckman Laser Institute and Medical Center, University of California, Irvine']","[u'University of California, Irvine']","https://clinicaltrials.gov/ct2/show/NCT00800722","['Beckman Laser Institute and Medical Center, J S Nelson, M.D., Ph.D.,Professor of Surgery and Biomedical Engineering, University of California, Irvine']"]
["NCT00800735","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00800735","['Hoffmann-La Roche']"]
["NCT00800839","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00800839","['M.D. Anderson Cancer Center']"]
["NCT00800956","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00800956","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00801021","[]","[u'Biomedical Development Corporation']","https://clinicaltrials.gov/ct2/show/NCT00801021","['Barbara Wells Trautner, M.D., Ph.D., Baylor College of Medicine']"]
["NCT00801164","[u'Biomedical Development Corporation']","[u'Biomedical Development Corporation']","https://clinicaltrials.gov/ct2/show/NCT00801164","['Biomedical Development Corporation']"]
["NCT00801203","[u'Pneumoflex Systems, LLC']","[u'Pneumoflex Systems, LLC']","https://clinicaltrials.gov/ct2/show/NCT00801203","['Pneumoflex Systems, LLC']"]
["NCT00801229","[u'Joseph Biederman, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00801229","['Joseph Biederman, MD, Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital']"]
["NCT00801294","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00801294","['Boehringer Ingelheim']"]
["NCT00801398","[u'Endo Pharmaceuticals']","[u'Endo Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00801398","['Endo Pharmaceuticals']"]
["NCT00801632","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00801632","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00801684","[]","[u'Alkermes, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00801684","['Bernard L. Silverman, MD / VP, Clinical Development, Alkermes, Inc.']"]
["NCT00801697","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00801697","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00801723","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00801723","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00801853","[]","[u'Aerovance, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00801853","['Babatunde Otulana, M.D., Aerovance, Inc.']"]
["NCT00802035","[u'Alkermes, Inc.']","[u'Alkermes, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00802035","['Alkermes, Inc.']"]
["NCT00802100","[u'National Institute of Mental Health (NIMH)']","[u'National Institute of Mental Health (NIMH)']","https://clinicaltrials.gov/ct2/show/NCT00802100","['National Institute of Mental Health (NIMH)']"]
["NCT00802282","[u'Roland Griffiths, Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00802282","['Roland Griffiths, Professor, Department of Psychiatry, Johns Hopkins University']"]
["NCT00802347","[u'Quark Pharmaceuticals']","[u'Quark Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00802347","['Quark Pharmaceuticals']"]
["NCT00802360","[u'Ferring Pharmaceuticals']","[u'Ferring Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00802360","['Ferring Pharmaceuticals']"]
["NCT00802464","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00802464","['GlaxoSmithKline']"]
["NCT00802737","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00802737","['GlaxoSmithKline']"]
["NCT00802802","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00802802","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00802815","[u'Glenn Lopate, Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00802815","['Glenn Lopate, Associate Professor of Neurology, Washington University School of Medicine']"]
["NCT00802841","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00802841","['Novartis Pharmaceuticals']"]
["NCT00802880","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00802880","['Washington University School of Medicine']"]
["NCT00802945","[u'Nektar Therapeutics']","[u'Nektar Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00802945","['Nektar Therapeutics']"]
["NCT00803010","[u'H. Lee Moffitt Cancer Center and Research Institute']","[u'H. Lee Moffitt Cancer Center and Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00803010","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00803023","[]","[u'Jazz Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00803023","['Sr. Director of Clinical Development - Psychiatry, Jazz Pharmaceuticals']"]
["NCT00803049","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00803049","['Sanofi']"]
["NCT00803062","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00803062","['National Cancer Institute (NCI)']"]
["NCT00803101","[u'CSL Behring']","[u'CSL Behring']","https://clinicaltrials.gov/ct2/show/NCT00803101","['CSL Behring']"]
["NCT00803205","[u'PTC Therapeutics']","[u'PTC Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00803205","['PTC Therapeutics']"]
["NCT00803335","[u'TriHealth Inc.']","[u'TriHealth Inc.']","https://clinicaltrials.gov/ct2/show/NCT00803335","['TriHealth Inc.']"]
["NCT00803556","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00803556","['Study Director, Bristol-Myers Squibb']"]
["NCT00803634","[u'The Medicines Company']","[u'The Medicines Company']","https://clinicaltrials.gov/ct2/show/NCT00803634","['The Medicines Company']"]
["NCT00803647","[u'NSABP Foundation Inc']","[u'NSABP Foundation Inc']","https://clinicaltrials.gov/ct2/show/NCT00803647","['NSABP Foundation Inc']"]
["NCT00803686","[u'Tarsa Therapeutics, Inc.']","[u'Tarsa Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00803686","['Tarsa Therapeutics, Inc.']"]
["NCT00803712","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00803712","['Amgen']"]
["NCT00803790","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00803790","['Merck Sharp & Dohme Corp.']"]
["NCT00803894","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00803894","['Merck Sharp & Dohme Corp.']"]
["NCT00804076","[u'Diamyd Inc']","[u'Diamyd Inc']","https://clinicaltrials.gov/ct2/show/NCT00804076","['Diamyd Inc']"]
["NCT00804141","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00804141","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00804245","[u'Wake Forest University Health Sciences']","[u'Wake Forest University Health Sciences']","https://clinicaltrials.gov/ct2/show/NCT00804245","['Wake Forest University Health Sciences']"]
["NCT00804570","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00804570","['Eli Lilly and Company']"]
["NCT00804648","[u'Vistakon Pharmaceuticals']","[u'Vistakon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00804648","['Vistakon Pharmaceuticals']"]
["NCT00804843","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00804843","['Merck Sharp & Dohme Corp.']"]
["NCT00804908","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00804908","['AbbVie (prior sponsor, Abbott)']"]
["NCT00804986","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00804986","['Chief Medical Officer, Eli Lilly']"]
["NCT00805025","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00805025","['Gilead Sciences']"]
["NCT00805090","[]","[u'Javelin Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00805090","['Cynthia Ernst, Javelin Pharmaceuticals']"]
["NCT00805233","[]","[u'Oregon Health and Science University']","https://clinicaltrials.gov/ct2/show/NCT00805233","['Peter J. Francis, MD, PhD, Oregon Health & Science University']"]
["NCT00805350","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00805350","['Sanofi']"]
["NCT00805376","[u'DNAtrix, Inc.']","[u'DNAtrix, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00805376","['DNAtrix, Inc.']"]
["NCT00805441","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00805441","['Eli Lilly and Company']"]
["NCT00805480","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00805480","['Novartis Pharmaceuticals']"]
["NCT00805701","[u'Bay State Clinical Trials, Inc.']","[u'Bay State Clinical Trials, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00805701","['Bay State Clinical Trials, Inc.']"]
["NCT00805753","[u'Fernando Fervenza, Mayo Clinic']","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00805753","['Fernando Fervenza, M.D., Ph.D., Mayo Clinic']"]
["NCT00805792","[u'James F. Meschia, Mayo Clinic']","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00805792","['James F. Meschia, Principal Investigator, Mayo Clinic']"]
["NCT00805818","[u'Neuren Pharmaceuticals Limited']","[u'Neuren Pharmaceuticals Limited']","https://clinicaltrials.gov/ct2/show/NCT00805818","['Neuren Pharmaceuticals Limited']"]
["NCT00805870","[u'Christopher Cheatham, Western Michigan University']","[u'Western Michigan University']","https://clinicaltrials.gov/ct2/show/NCT00805870","['Christopher Cheatham, Chair and Associate Professor, Western Michigan University']"]
["NCT00805935","[u'Ferring Pharmaceuticals']","[u'Ferring Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00805935","['Ferring Pharmaceuticals']"]
["NCT00805961","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00805961","['SCRI Development Innovations, LLC']"]
["NCT00806026","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00806026","['Pfizer']"]
["NCT00806078","[u'Mutual Pharmaceutical Company, Inc.']","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00806078","['Mutual Pharmaceutical Company, Inc.']"]
["NCT00806156","[u'Nektar Therapeutics']","[u'Nektar Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00806156","['Nektar Therapeutics']"]
["NCT00806234","[u'Mark Riddle, MD, Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00806234","['Mark Riddle, MD, Principal Investigator, Johns Hopkins University']"]
["NCT00806260","[u'VIVUS, Inc.']","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00806260","['VIVUS, Inc.']"]
["NCT00806299","[u'Johnson & Johnson Consumer and Personal Products Worldwide']","[u'Johnson & Johnson Consumer and Personal Products Worldwide']","https://clinicaltrials.gov/ct2/show/NCT00806299","['Johnson & Johnson Consumer and Personal Products Worldwide']"]
["NCT00806338","[]","[u'Genaera Corporation']","https://clinicaltrials.gov/ct2/show/NCT00806338","['Michael Gast, MD, PhD, Genaera Corporation']"]
["NCT00806546","[u'Teva Pharmaceutical Industries ( NuPathe Inc. )']","[u'NuPathe Inc.']","https://clinicaltrials.gov/ct2/show/NCT00806546","['NuPathe Inc.']"]
["NCT00806598","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00806598","['M.D. Anderson Cancer Center']"]
["NCT00806754","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00806754","['AstraZeneca']"]
["NCT00806806","[]","[u'Pacira Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT00806806","['Marius Ardeleanu, MD, Director, Clinical Research, Pacira Pharmaceucticals, Inc.']"]
["NCT00806819","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00806819","['Boehringer Ingelheim']"]
["NCT00806962","[u'Takeda ( LigoCyte Pharmaceuticals, Inc. )']","[u'LigoCyte Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00806962","['LigoCyte Pharmaceuticals, Inc.']"]
["NCT00807053","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00807053","['AstraZeneca']"]
["NCT00807495","[u'Takeda ( Millennium Pharmaceuticals, Inc. )']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00807495","['Millennium Pharmaceuticals, Inc.']"]
["NCT00807573","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00807573","['Memorial Sloan Kettering Cancer Center']"]
["NCT00807677","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00807677","['Millennium Pharmaceuticals, Inc.']"]
["NCT00807781","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00807781","['Washington University School of Medicine']"]
["NCT00807846","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00807846","['Pfizer']"]
["NCT00807859","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00807859","['Amgen']"]
["NCT00807872","[u'Alan Solomon, University of Tennessee']","[u'University of Tennessee']","https://clinicaltrials.gov/ct2/show/NCT00807872","['Alan Solomon, Alan Solomon, M.D., University of Tennessee']"]
["NCT00807885","[u'Baxter Healthcare Corporation']","[u'Baxter Healthcare Corporation']","https://clinicaltrials.gov/ct2/show/NCT00807885","['Baxter Healthcare Corporation']"]
["NCT00807937","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00807937","['Mark A. Smith, MD PhD, Medical Science Director, Emerging Psychiatry, AstraZeneca Pharmaceuticals']"]
["NCT00808067","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00808067","['Boehringer Ingelheim']"]
["NCT00808093","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00808093","['GlaxoSmithKline']"]
["NCT00808132","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00808132","['Pfizer']"]
["NCT00808223","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00808223","['Astellas Pharma Inc']"]
["NCT00808249","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00808249","['Mark A. Smith, MD PhD, Medical Science Director, Emerging Psychiatry, AstraZeneca Pharmaceuticals']"]
["NCT00808288","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00808288","['Pfizer']"]
["NCT00808470","[u'Glenn Green, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00808470","['Glenn Green, Associate Professor of Otolaryngology, University of Michigan']"]
["NCT00808665","[u'Vanderbilt University Medical Center']","[u'Vanderbilt University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00808665","['Vanderbilt University Medical Center']"]
["NCT00808678","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00808678","['AstraZeneca']"]
["NCT00808769","[u'Procter and Gamble']","[u'Procter and Gamble']","https://clinicaltrials.gov/ct2/show/NCT00808769","['Procter and Gamble']"]
["NCT00809055","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00809055","['Washington University School of Medicine']"]
["NCT00809094","[u'Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT00809094","['Stanford University']"]
["NCT00809146","[u'Robert Silbergleit, University of Michigan']","[u'Robert Silbergleit']","https://clinicaltrials.gov/ct2/show/NCT00809146","['Robert Silbergleit, Principal Investigator, Professor, University of Michigan']"]
["NCT00809159","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00809159","['Novartis Pharmaceuticals']"]
["NCT00809289","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00809289","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00809471","[u'VIVUS, Inc.']","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00809471","['VIVUS, Inc.']"]
["NCT00809562","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00809562","['Hoffmann-La Roche']"]
["NCT00809614","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00809614","['Novartis Pharmaceuticals']"]
["NCT00809718","[u'The University of Texas Health Science Center at San Antonio']","[u'The University of Texas Health Science Center at San Antonio']","https://clinicaltrials.gov/ct2/show/NCT00809718","['The University of Texas Health Science Center at San Antonio']"]
["NCT00809757","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT00809757","['Sunovion']"]
["NCT00809809","[u'Integrative Medicine Institute']","[u'Integrative Medicine Institute']","https://clinicaltrials.gov/ct2/show/NCT00809809","['Integrative Medicine Institute']"]
["NCT00809835","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00809835","['Yale University']"]
["NCT00809848","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00809848","['Allergan']"]
["NCT00809926","[]","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00809926","['External Affairs, Novartis']"]
["NCT00809965","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00809965","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00810108","[u'Brookie Best, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']","[u'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']","https://clinicaltrials.gov/ct2/show/NCT00810108","['Brookie Best, PharmD, MAS, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']"]
["NCT00810147","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00810147","['Bristol-Myers Squibb']"]
["NCT00810199","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00810199","['Hoffmann-La Roche']"]
["NCT00810368","[u'James Baraniuk, MD, Georgetown University']","[u'Georgetown University']","https://clinicaltrials.gov/ct2/show/NCT00810368","['James Baraniuk, MD, Professor of Medicine, Georgetown University']"]
["NCT00810394","[u'University of California, Davis']","[u'University of California, Davis']","https://clinicaltrials.gov/ct2/show/NCT00810394","['University of California, Davis']"]
["NCT00810602","[u'Pavan Reddy, MD, University of Michigan Rogel Cancer Center']","[u'Pavan Reddy, MD']","https://clinicaltrials.gov/ct2/show/NCT00810602","['Pavan Reddy, MD, Professor, University of Michigan Rogel Cancer Center']"]
["NCT00810693","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00810693","['Bayer']"]
["NCT00810719","[u'University of California, Davis']","[u'University of California, Davis']","https://clinicaltrials.gov/ct2/show/NCT00810719","['University of California, Davis']"]
["NCT00810732","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00810732","['Pfizer']"]
["NCT00810758","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00810758","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00810810","[u'Karen Nelson, University of Washington']","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00810810","['Karen Nelson, Director, University of Washington']"]
["NCT00811070","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00811070","['Pfizer']"]
["NCT00811083","[]","[u'Southwest College of Naturopathic Medicine']","https://clinicaltrials.gov/ct2/show/NCT00811083","['Matthew Baral and James B. Adams, Southwest College of Naturopathic Medicine']"]
["NCT00811096","[u'Walter Reed Army Institute of Research (WRAIR)']","[u'Walter Reed Army Institute of Research (WRAIR)']","https://clinicaltrials.gov/ct2/show/NCT00811096","['Walter Reed Army Institute of Research (WRAIR)']"]
["NCT00811252","[u'H. Lundbeck A/S']","[u'H. Lundbeck A/S']","https://clinicaltrials.gov/ct2/show/NCT00811252","['H. Lundbeck A/S']"]
["NCT00811395","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00811395","['Sanofi']"]
["NCT00811473","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00811473","['AstraZeneca']"]
["NCT00811564","[]","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00811564","['Medical Affairs Director, Allergan, Inc.']"]
["NCT00811603","[]","[u'MemorialCare']","https://clinicaltrials.gov/ct2/show/NCT00811603","['Leo Pevzner, University of California, Irvine']"]
["NCT00811733","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00811733","['GlaxoSmithKline']"]
["NCT00811850","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00811850","['Allergan']"]
["NCT00811902","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00811902","['Sanofi']"]
["NCT00811954","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT00811954","['AIDS Clinical Trials Group']"]
["NCT00812006","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00812006","['Merck Sharp & Dohme Corp.']"]
["NCT00812058","[]","[u'Repligen Corporation']","https://clinicaltrials.gov/ct2/show/NCT00812058","['Hedy Dion, Repligen Corporation']"]
["NCT00812214","[]","[u'MedVadis Research Corporation']","https://clinicaltrials.gov/ct2/show/NCT00812214","['Egilius L.H. Spierings, M.D., Ph.D., Medvadis Research Corporation']"]
["NCT00812253","[u'Kathleen Dungan, Ohio State University']","[u'Kathleen Dungan']","https://clinicaltrials.gov/ct2/show/NCT00812253","['Kathleen Dungan, Assistant Professor, Ohio State University']"]
["NCT00812305","[]","[u'Pacira Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT00812305","['Ronald M. Burch, MD, PhD, CMO, Pacira Pharmaceuticals, Inc.']"]
["NCT00812318","[u'ViiV Healthcare']","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00812318","['ViiV Healthcare']"]
["NCT00812370","[u\"Guy Young, Children's Hospital Los Angeles\"]","[u\"Children's Hospital Los Angeles\"]","https://clinicaltrials.gov/ct2/show/NCT00812370","[\"Guy Young, Director, Hemostasis and Thrombosis Center, Children's Hospital Los Angeles\"]"]
["NCT00812487","[u'Kathleen Dungan, Ohio State University']","[u'Kathleen Dungan']","https://clinicaltrials.gov/ct2/show/NCT00812487","['Kathleen Dungan, Assistant Professor, Ohio State University']"]
["NCT00812565","[u'Octapharma']","[u'Octapharma']","https://clinicaltrials.gov/ct2/show/NCT00812565","['Octapharma']"]
["NCT00812630","[u'Population Council']","[u'Population Council']","https://clinicaltrials.gov/ct2/show/NCT00812630","['Population Council']"]
["NCT00812929","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00812929","['GlaxoSmithKline']"]
["NCT00812955","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00812955","['AstraZeneca']"]
["NCT00813098","[]","[u'Lexicon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00813098","['Joel P. Freiman, MD, MPH / Medical Director Drug Safety, Lexicon Pharmaceuticals, Inc.']"]
["NCT00813124","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00813124","['M.D. Anderson Cancer Center']"]
["NCT00813163","[u'PharmaEngine']","[u'PharmaEngine']","https://clinicaltrials.gov/ct2/show/NCT00813163","['PharmaEngine']"]
["NCT00813228","[u'National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) )']","[u'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","https://clinicaltrials.gov/ct2/show/NCT00813228","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT00813384","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00813384","['Amgen']"]
["NCT00813488","[u'Teva Pharmaceutical Industries ( Cephalon )']","[u'Cephalon']","https://clinicaltrials.gov/ct2/show/NCT00813488","['Cephalon']"]
["NCT00813527","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00813527","['Takeda']"]
["NCT00813605","[u'NantCell, Inc.']","[u'NantCell, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00813605","['NantCell, Inc.']"]
["NCT00813735","[u'Lehigh Center for Clinical Research']","[u'Lehigh Center for Clinical Research']","https://clinicaltrials.gov/ct2/show/NCT00813735","['Lehigh Center for Clinical Research']"]
["NCT00813813","[u'DePuy Spine']","[u'DePuy Spine']","https://clinicaltrials.gov/ct2/show/NCT00813813","['DePuy Spine']"]
["NCT00813865","[u'Amicus Therapeutics']","[u'Amicus Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00813865","['Amicus Therapeutics']"]
["NCT00813904","[u'ZymoGenetics']","[u'ZymoGenetics']","https://clinicaltrials.gov/ct2/show/NCT00813904","['ZymoGenetics']"]
["NCT00813943","[u'EMD Serono']","[u'EMD Serono']","https://clinicaltrials.gov/ct2/show/NCT00813943","['EMD Serono']"]
["NCT00813956","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00813956","['Sanofi']"]
["NCT00813969","[u'The Cleveland Clinic']","[u'The Cleveland Clinic']","https://clinicaltrials.gov/ct2/show/NCT00813969","['The Cleveland Clinic']"]
["NCT00814060","[u'Puma Biotechnology, Inc.']","[u'Puma Biotechnology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00814060","['Puma Biotechnology, Inc.']"]
["NCT00814086","[u'Gynecologic Oncology Group']","[u'Gynecologic Oncology Group']","https://clinicaltrials.gov/ct2/show/NCT00814086","['Gynecologic Oncology Group']"]
["NCT00814138","[u'Richard Barohn, MD, University of Kansas Medical Center']","[u'University of Kansas Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00814138","['Richard Barohn, MD, Gertrude and Dewey Zeigler Professor of Neurology, Chairman Deptartment of Neurology, University of Kansas Medical Center']"]
["NCT00814255","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00814255","['New York University School of Medicine']"]
["NCT00814307","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00814307","['Pfizer']"]
["NCT00814320","[u'Shire ( Baxalta now part of Shire )']","[u'Baxalta now part of Shire']","https://clinicaltrials.gov/ct2/show/NCT00814320","['Baxalta now part of Shire']"]
["NCT00814580","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","https://clinicaltrials.gov/ct2/show/NCT00814580","['Ortho-McNeil Janssen Scientific Affairs, LLC']"]
["NCT00814632","[u'Kenneth Peters, MD, William Beaumont Hospitals']","[u'Kenneth Peters, MD']","https://clinicaltrials.gov/ct2/show/NCT00814632","['Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals']"]
["NCT00814645","[u'Aires Pharmaceuticals, Inc.']","[u'Aires Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00814645","['Aires Pharmaceuticals, Inc.']"]
["NCT00814671","[u'Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00814671","['Johns Hopkins University']"]
["NCT00814788","[u'University of California, Davis']","[u'University of California, Davis']","https://clinicaltrials.gov/ct2/show/NCT00814788","['University of California, Davis']"]
["NCT00814931","[]","[u'CeNeRx BioPharma Inc.']","https://clinicaltrials.gov/ct2/show/NCT00814931","['Carlos Santana, MD, USF Physicians Group']"]
["NCT00814944","[u'Santen Inc.']","[u'Santen Inc.']","https://clinicaltrials.gov/ct2/show/NCT00814944","['Santen Inc.']"]
["NCT00815295","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00815295","['Duke University']"]
["NCT00815360","[u'Ivan J. Suner, MD, Retina Associates of Florida, P.A.']","[u'Retina Associates of Florida, P.A.']","https://clinicaltrials.gov/ct2/show/NCT00815360","['Ivan J. Suner, MD, Director of Clinical Research, Retina Associates of Florida, P.A.']"]
["NCT00815646","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00815646","['Duke University']"]
["NCT00815919","[u'John Koreth, MD, Dana-Farber Cancer Institute']","[u'Dana-Farber Cancer Institute']","https://clinicaltrials.gov/ct2/show/NCT00815919","['John Koreth, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00816023","[u'Cubist Pharmaceuticals LLC']","[u'Cubist Pharmaceuticals LLC']","https://clinicaltrials.gov/ct2/show/NCT00816023","['Cubist Pharmaceuticals LLC']"]
["NCT00816335","[u'Stephen Povoski, Ohio State University Comprehensive Cancer Center']","[u'Ohio State University Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00816335","['Stephen Povoski, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00816361","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00816361","['MedImmune LLC']"]
["NCT00816400","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00816400","['MedImmune LLC']"]
["NCT00816426","[u'National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00816426","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00816517","[u'University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00816517","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00816660","[u'Shire ( Baxalta now part of Shire )']","[u'Baxalta now part of Shire']","https://clinicaltrials.gov/ct2/show/NCT00816660","['Baxalta now part of Shire']"]
["NCT00816764","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00816764","['Astellas Pharma Inc']"]
["NCT00816907","[u'National Institute of Mental Health (NIMH)']","[u'National Institute of Mental Health (NIMH)']","https://clinicaltrials.gov/ct2/show/NCT00816907","['National Institute of Mental Health (NIMH)']"]
["NCT00817063","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00817063","['Stiefel, a GSK Company']"]
["NCT00817089","[]","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00817089","['David Oslin, M.D., University of Pennsylvania']"]
["NCT00817206","[u'Veloxis Pharmaceuticals']","[u'Veloxis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00817206","['Veloxis Pharmaceuticals']"]
["NCT00817219","[u'LEO Pharma']","[u'LEO Pharma']","https://clinicaltrials.gov/ct2/show/NCT00817219","['LEO Pharma']"]
["NCT00817271","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00817271","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00817336","[u'Nathan Kline Institute for Psychiatric Research']","[u'Nathan Kline Institute for Psychiatric Research']","https://clinicaltrials.gov/ct2/show/NCT00817336","['Nathan Kline Institute for Psychiatric Research']"]
["NCT00817414","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00817414","['Novartis']"]
["NCT00817505","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00817505","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00817635","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00817635","['Novartis']"]
["NCT00817778","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00817778","['AstraZeneca']"]
["NCT00817986","[u'Indivior Inc.']","[u'Indivior Inc.']","https://clinicaltrials.gov/ct2/show/NCT00817986","['Indivior Inc.']"]
["NCT00817999","[u'Creighton University']","[u'Creighton University']","https://clinicaltrials.gov/ct2/show/NCT00817999","['Creighton University']"]
["NCT00818415","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00818415","['Bayer']"]
["NCT00818441","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00818441","['Pfizer']"]
["NCT00818454","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00818454","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00818480","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00818480","['Astellas Pharma Inc']"]
["NCT00818493","[u'QRxPharma Inc.']","[u'QRxPharma Inc.']","https://clinicaltrials.gov/ct2/show/NCT00818493","['QRxPharma Inc.']"]
["NCT00818571","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00818571","['Novartis Pharmaceuticals']"]
["NCT00818584","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00818584","['Astellas Pharma Inc']"]
["NCT00818662","[u'Shire ( Baxalta now part of Shire )']","[u'Baxalta now part of Shire']","https://clinicaltrials.gov/ct2/show/NCT00818662","['Baxalta now part of Shire']"]
["NCT00818779","[u'Texas Tech University Health Sciences Center']","[u'Texas Tech University Health Sciences Center']","https://clinicaltrials.gov/ct2/show/NCT00818779","['Texas Tech University Health Sciences Center']"]
["NCT00818870","[]","[u'Vecta Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00818870","['Richard E. Lowenthal, Vecta']"]
["NCT00818883","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00818883","['Takeda']"]
["NCT00818948","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00818948","['Amgen']"]
["NCT00819013","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00819013","['Sanofi']"]
["NCT00819039","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00819039","['Merck Sharp & Dohme Corp.']"]
["NCT00819052","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00819052","['Boehringer Ingelheim']"]
["NCT00819091","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00819091","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00819234","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00819234","['AstraZeneca']"]
["NCT00819390","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT00819390","['AIDS Clinical Trials Group']"]
["NCT00819403","[u'Michael Miller, University of Maryland']","[u'University of Maryland']","https://clinicaltrials.gov/ct2/show/NCT00819403","['Michael Miller, Dr., University of Maryland']"]
["NCT00819468","[]","[u'NPS Pharma']","https://clinicaltrials.gov/ct2/show/NCT00819468","['John Wallens, NPS Pharmaceuticals']"]
["NCT00819585","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00819585","['Novartis Pharmaceuticals']"]
["NCT00819650","[u'ShenFeng, Eastern Hepatobiliary Surgery Hospital']","[u'Eastern Hepatobiliary Surgery Hospital']","https://clinicaltrials.gov/ct2/show/NCT00819650","['ShenFeng, vice president of the Eastern Hepatobiliary Surgery Hospotal, Eastern Hepatobiliary Surgery Hospital']"]
["NCT00819780","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00819780","['Amgen']"]
["NCT00819806","[u'Hassane M. Zarour, MD, University of Pittsburgh']","[u'Hassane M. Zarour, MD']","https://clinicaltrials.gov/ct2/show/NCT00819806","['Hassane M. Zarour, MD, Professor, University of Pittsburgh']"]
["NCT00819884","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00819884","['Klas Malmberg, MD, PhD, Prof. Medical Science Director, Emerging Products, AstraZeneca Pharmaceuticals']"]
["NCT00820053","[u'ShenFeng, Eastern Hepatobiliary Surgery Hospital']","[u'Eastern Hepatobiliary Surgery Hospital']","https://clinicaltrials.gov/ct2/show/NCT00820053","['ShenFeng, vice president of the Eastern Hepatobiliary Surgery Hospotal, Eastern Hepatobiliary Surgery Hospital']"]
["NCT00820196","[u'OcuNexus Therapeutics, Inc.']","[u'OcuNexus Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00820196","['OcuNexus Therapeutics, Inc.']"]
["NCT00820300","[u'Mati Therapeutics Inc.']","[u'Mati Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00820300","['Mati Therapeutics Inc.']"]
["NCT00820404","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00820404","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00820560","[u'Incyte Corporation']","[u'Incyte Corporation']","https://clinicaltrials.gov/ct2/show/NCT00820560","['Incyte Corporation']"]
["NCT00820573","[u'Eugenio Cersosimo, The University of Texas Health Science Center at San Antonio']","[u'The University of Texas Health Science Center at San Antonio']","https://clinicaltrials.gov/ct2/show/NCT00820573","['Eugenio Cersosimo, Associate Professor Medicine, The University of Texas Health Science Center at San Antonio']"]
["NCT00820664","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00820664","['Merck Sharp & Dohme Corp.']"]
["NCT00820846","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00820846","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00820885","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00820885","['Shire']"]
["NCT00820898","[u'Gynecologic Oncology Group']","[u'Gynecologic Oncology Group']","https://clinicaltrials.gov/ct2/show/NCT00820898","['Gynecologic Oncology Group']"]
["NCT00820950","[u'Incyte Corporation']","[u'Incyte Corporation']","https://clinicaltrials.gov/ct2/show/NCT00820950","['Incyte Corporation']"]
["NCT00821002","[u'Mati Therapeutics Inc.']","[u'Mati Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00821002","['Mati Therapeutics Inc.']"]
["NCT00821054","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00821054","['GlaxoSmithKline']"]
["NCT00821080","[u'Tracy T. Batchelor, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00821080","['Tracy T. Batchelor, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT00821093","[]","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00821093","['External Affairs, Novartis Pharmaceuticals']"]
["NCT00821327","[u'US Oncology Research']","[u'US Oncology Research']","https://clinicaltrials.gov/ct2/show/NCT00821327","['US Oncology Research']"]
["NCT00821444","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00821444","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00821496","[]","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00821496","['Wesley Day, VP Clinical, Vivus, Inc.']"]
["NCT00821600","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00821600","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00821652","[u'Nina Bhardwaj, Icahn School of Medicine at Mount Sinai']","[u'Nina Bhardwaj']","https://clinicaltrials.gov/ct2/show/NCT00821652","['Nina Bhardwaj, Director, Immunotherapy Program, Icahn School of Medicine at Mount Sinai']"]
["NCT00821795","[u'Dennis G. Karounos, M.D., Lexington VA Medical Center']","[u'Dennis G. Karounos, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00821795","['Dennis G. Karounos, M.D., Chief, Endocrinology Section, Staff Physician, Lexington VA Medical Center']"]
["NCT00821886","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00821886","['SCRI Development Innovations, LLC']"]
["NCT00821951","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00821951","['Yale University']"]
["NCT00822094","[u'Jazz Pharmaceuticals']","[u'Jazz Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00822094","['Jazz Pharmaceuticals']"]
["NCT00822172","[u'Colorado Prevention Center']","[u'Colorado Prevention Center']","https://clinicaltrials.gov/ct2/show/NCT00822172","['Colorado Prevention Center']"]
["NCT00822237","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00822237","['Merck Sharp & Dohme Corp.']"]
["NCT00822458","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00822458","['National Cancer Institute (NCI)']"]
["NCT00822757","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00822757","['Merck Sharp & Dohme Corp.']"]
["NCT00822770","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00822770","['M.D. Anderson Cancer Center']"]
["NCT00822835","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00822835","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00822861","[u'Pharmaxis']","[u'Pharmaxis']","https://clinicaltrials.gov/ct2/show/NCT00822861","['Pharmaxis']"]
["NCT00822887","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00822887","['University of Colorado, Denver']"]
["NCT00822978","[u'Achaogen, Inc.']","[u'Achaogen, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00822978","['Achaogen, Inc.']"]
["NCT00823108","[]","[u'Carolinas Healthcare System']","https://clinicaltrials.gov/ct2/show/NCT00823108","['Alan E. Jones, MD, Carolinas Medical Center']"]
["NCT00823303","[u'Daniel W. Coyne, Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00823303","['Daniel W. Coyne, Professor of Medicine, Washington University School of Medicine']"]
["NCT00823459","[u'Susan Chang, University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00823459","['Susan Chang, Principal Investigator, University of California, San Francisco']"]
["NCT00823680","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00823680","['Hoffmann-La Roche']"]
["NCT00823719","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00823719","['GlaxoSmithKline']"]
["NCT00823745","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00823745","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00823862","[u'Dynavax Technologies Corporation']","[u'Dynavax Technologies Corporation']","https://clinicaltrials.gov/ct2/show/NCT00823862","['Dynavax Technologies Corporation']"]
["NCT00823901","[u'Alexandra Kimball, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00823901","['Alexandra Kimball, Director, Clinical Unit for Research Trials in Skin, Massachusetts General Hospital']"]
["NCT00823940","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00823940","['GlaxoSmithKline']"]
["NCT00823992","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00823992","['Hoffmann-La Roche']"]
["NCT00824005","[u'Dr Lemuel A Moye III, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00824005","['Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston']"]
["NCT00824070","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00824070","['Bausch & Lomb Incorporated']"]
["NCT00824291","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00824291","['Director, Clinical Trial Disclosure Group, Pfizer, Inc']"]
["NCT00824460","[u'Vifor Inc.']","[u'Vifor Inc.']","https://clinicaltrials.gov/ct2/show/NCT00824460","['Vifor Inc.']"]
["NCT00824473","[]","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00824473","['Harry Sacks, MD Vice President, Medical and Scientific Affairs, Meda Pharmaceuticals']"]
["NCT00824538","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00824538","['University of California, San Francisco']"]
["NCT00824590","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00824590","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00824616","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00824616","['Merck Sharp & Dohme Corp.']"]
["NCT00824850","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00824850","['Pfizer']"]
["NCT00824863","[u'Wayne Fujita, M.D., Fujita, Wayne, M.D.']","[u'Wayne Fujita, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00824863","['Wayne Fujita, M.D., Principal Investigator, Fujita, Wayne, M.D.']"]
["NCT00825084","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00825084","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00825162","[u'Seqirus']","[u'Seqirus']","https://clinicaltrials.gov/ct2/show/NCT00825162","['Seqirus']"]
["NCT00825370","[u'Andrew Chang, MD, Montefiore Medical Center']","[u'Montefiore Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00825370","['Andrew Chang, MD, MD, Montefiore Medical Center']"]
["NCT00825500","[u'Alexza Pharmaceuticals, Inc.']","[u'Alexza Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00825500","['Alexza Pharmaceuticals, Inc.']"]
["NCT00825539","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00825539","['Novartis Pharmaceuticals']"]
["NCT00825565","[u'Amy Paller, Northwestern University']","[u'Northwestern University']","https://clinicaltrials.gov/ct2/show/NCT00825565","['Amy Paller, Professor and Chair of Deparment of Dermatology, Professor of Pediatrics, Northwestern University']"]
["NCT00825734","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00825734","['SCRI Development Innovations, LLC']"]
["NCT00825786","[u'The Cleveland Clinic']","[u'The Cleveland Clinic']","https://clinicaltrials.gov/ct2/show/NCT00825786","['The Cleveland Clinic']"]
["NCT00825825","[u\"Michael Henry, MD, Steward St. Elizabeth's Medical Center of Boston, Inc.\"]","[u'Michael Henry, MD']","https://clinicaltrials.gov/ct2/show/NCT00825825","[\"Michael Henry, MD, Principal Investigator, Steward St. Elizabeth's Medical Center of Boston, Inc.\"]"]
["NCT00826085","[u'Celsion']","[u'Celsion']","https://clinicaltrials.gov/ct2/show/NCT00826085","['Celsion']"]
["NCT00826098","[u'Exactech']","[u'Exactech']","https://clinicaltrials.gov/ct2/show/NCT00826098","['Exactech']"]
["NCT00826111","[u\"Steward St. Elizabeth's Medical Center of Boston, Inc.\"]","[u\"Steward St. Elizabeth's Medical Center of Boston, Inc.\"]","https://clinicaltrials.gov/ct2/show/NCT00826111","[\"Steward St. Elizabeth's Medical Center of Boston, Inc.\"]"]
["NCT00826150","[u'Anchiano Therapeutics Israel Ltd.']","[u'Anchiano Therapeutics Israel Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00826150","['Anchiano Therapeutics Israel Ltd.']"]
["NCT00826228","[u'Thomas J. Schnitzer, Northwestern University']","[u'Thomas J. Schnitzer']","https://clinicaltrials.gov/ct2/show/NCT00826228","['Thomas J. Schnitzer, professor, Northwestern University']"]
["NCT00826267","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00826267","['Boehringer Ingelheim']"]
["NCT00826280","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00826280","['Astellas Pharma Inc']"]
["NCT00826358","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00826358","['AstraZeneca']"]
["NCT00826449","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00826449","['M.D. Anderson Cancer Center']"]
["NCT00826514","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00826514","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00826618","[u'Thomas Albini, University of Miami']","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00826618","['Thomas Albini, Associate Professor of Clinical Ophthalmology, University of Miami']"]
["NCT00826748","[u'Weill Medical College of Cornell University']","[u'Weill Medical College of Cornell University']","https://clinicaltrials.gov/ct2/show/NCT00826748","['Weill Medical College of Cornell University']"]
["NCT00826878","[u'AVEO Pharmaceuticals, Inc.']","[u'AVEO Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00826878","['AVEO Pharmaceuticals, Inc.']"]
["NCT00826943","[u'Douglas Tzanetos, Vanderbilt University']","[u'Vanderbilt University']","https://clinicaltrials.gov/ct2/show/NCT00826943","['Douglas Tzanetos, Fellow, Vanderbilt University']"]
["NCT00827034","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00827034","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00827112","[u'ViiV Healthcare']","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00827112","['ViiV Healthcare']"]
["NCT00827138","[u'Deciphera Pharmaceuticals LLC']","[u'Deciphera Pharmaceuticals LLC']","https://clinicaltrials.gov/ct2/show/NCT00827138","['Deciphera Pharmaceuticals LLC']"]
["NCT00827190","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00827190","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00827242","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00827242","['Chief Medical Officer, Eli Lilly']"]
["NCT00827372","[u'Indiana University']","[u'Indiana University']","https://clinicaltrials.gov/ct2/show/NCT00827372","['Indiana University']"]
["NCT00827606","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00827606","['Pfizer']"]
["NCT00827632","[u'Carolyn L. Westhoff, Columbia University']","[u'Columbia University']","https://clinicaltrials.gov/ct2/show/NCT00827632","['Carolyn L. Westhoff, Professor of Obstetrics and Gynecology, Population and Family Health and Epidemiology at the New York-Presbyterian Hospital at the Columbia University Medical Center, Columbia University']"]
["NCT00827775","[u'Jula K Inrig, University of Texas Southwestern Medical Center']","[u'University of Texas Southwestern Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00827775","['Jula K Inrig, Assistant Professor of Medicine, University of Texas Southwestern Medical Center']"]
["NCT00827892","[u'Nicole Gonzales, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00827892","['Nicole Gonzales, Assistant Professor - Neurology, The University of Texas Health Science Center, Houston']"]
["NCT00828074","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00828074","['City of Hope Medical Center']"]
["NCT00828139","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00828139","['National Cancer Institute (NCI)']"]
["NCT00828178","[u'Michelle Petri M.D.,MPH, Johns Hopkins University']","[u'Michelle Petri M.D.,MPH']","https://clinicaltrials.gov/ct2/show/NCT00828178","['Michelle Petri M.D.,MPH, Principal investigator, Johns Hopkins University']"]
["NCT00828204","[u'Biogen']","[u'Biogen']","https://clinicaltrials.gov/ct2/show/NCT00828204","['Biogen']"]
["NCT00828282","[u'John Haslip, University of Kentucky']","[u'John Haslip']","https://clinicaltrials.gov/ct2/show/NCT00828282","['John Haslip, Director, Clinical Research and Data Management Shared Resource Facility, University of Kentucky']"]
["NCT00828412","[u'Promius Pharma, LLC']","[u'Promius Pharma, LLC']","https://clinicaltrials.gov/ct2/show/NCT00828412","['Promius Pharma, LLC']"]
["NCT00828464","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00828464","['Stiefel, a GSK Company']"]
["NCT00828477","[]","[u'Bp Consulting, Inc']","https://clinicaltrials.gov/ct2/show/NCT00828477","['Nate Kleinfeldt, Coburn-Kleinfeldt Eye Clinic']"]
["NCT00828711","[u'Ferring Pharmaceuticals']","[u'Ferring Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00828711","['Ferring Pharmaceuticals']"]
["NCT00828763","[]","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00828763","['Study Director, GSK']"]
["NCT00828802","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00828802","['Duke University']"]
["NCT00828841","[u'Accelerated Community Oncology Research Network']","[u'Accelerated Community Oncology Research Network']","https://clinicaltrials.gov/ct2/show/NCT00828841","['Accelerated Community Oncology Research Network']"]
["NCT00828984","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00828984","['National Cancer Institute (NCI)']"]
["NCT00829114","[u'FHI 360']","[u'FHI 360']","https://clinicaltrials.gov/ct2/show/NCT00829114","['FHI 360']"]
["NCT00829140","[]","[u'Arena Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00829140","['Christen Anderson MD, PhD, Arena Pharmaceuticals, Inc.']"]
["NCT00829231","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00829231","['Bayer']"]
["NCT00829296","[u'University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00829296","['University of Chicago']"]
["NCT00829413","[u'Bracco Diagnostics, Inc']","[u'Bracco Diagnostics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00829413","['Bracco Diagnostics, Inc']"]
["NCT00829439","[u'Wen-Hann Tan, Boston Children\\u2019s Hospital']","[u'Boston Children\\u2019s Hospital']","https://clinicaltrials.gov/ct2/show/NCT00829439","[u'Wen-Hann Tan, Attending Physician in Genetics, Boston Children\\u2019s Hospital']"]
["NCT00829582","[]","[u'Elusys Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00829582","['Irena Kirman, MD, PhD, Elusys Therapeutics']"]
["NCT00829881","[]","[u'P2D, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00829881","['Charles H. Pierce, MD, PhD, CPI, P2D, Inc.']"]
["NCT00829985","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00829985","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00830063","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00830063","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00830076","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00830076","['Merck Sharp & Dohme Corp.']"]
["NCT00830180","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00830180","['Pfizer']"]
["NCT00830206","[]","[u'Teva Pharmaceuticals USA']","https://clinicaltrials.gov/ct2/show/NCT00830206","['Vice President Global Generic Biopharmaceutics, TEVA Pharmaceuticals USA']"]
["NCT00830362","[u'Medical University of South Carolina']","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT00830362","['Medical University of South Carolina']"]
["NCT00830375","[u'Jon E. Grant, University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00830375","['Jon E. Grant, Professor of Psychiatry, University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00830388","[u'Boni Elewski, MD, University of Alabama at Birmingham']","[u'Boni Elewski, MD']","https://clinicaltrials.gov/ct2/show/NCT00830388","['Boni Elewski, MD, Principal Investigator, University of Alabama at Birmingham']"]
["NCT00830466","[u'Beckman Laser Institute and Medical Center, University of California, Irvine']","[u'University of California, Irvine']","https://clinicaltrials.gov/ct2/show/NCT00830466","['Beckman Laser Institute and Medical Center, J S Nelson, M.D., Ph.D.,Professor of Surgery and Biomedical Engineering, University of California, Irvine']"]
["NCT00830518","[u'Takeda ( Millennium Pharmaceuticals, Inc. )']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00830518","['Millennium Pharmaceuticals, Inc.']"]
["NCT00830674","[u'Kyowa Kirin Pharmaceutical Development, Inc. ( Kyowa Hakko Kirin Pharma, Inc. )']","[u'Kyowa Hakko Kirin Pharma, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00830674","['Kyowa Hakko Kirin Pharma, Inc.']"]
["NCT00830804","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT00830804","['AIDS Clinical Trials Group']"]
["NCT00830869","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00830869","['Millennium Pharmaceuticals, Inc.']"]
["NCT00831012","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00831012","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00831051","[u'QRxPharma Inc.']","[u'QRxPharma Inc.']","https://clinicaltrials.gov/ct2/show/NCT00831051","['QRxPharma Inc.']"]
["NCT00831103","[u'Epiphany Biosciences']","[u'Epiphany Biosciences']","https://clinicaltrials.gov/ct2/show/NCT00831103","['Epiphany Biosciences']"]
["NCT00831129","[u'University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00831129","['University of Chicago']"]
["NCT00831155","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT00831155","['Duke University']"]
["NCT00831272","[u'David Oslin, University of Pennsylvania']","[u'David Oslin']","https://clinicaltrials.gov/ct2/show/NCT00831272","['David Oslin, Sponsor-Investigator, University of Pennsylvania']"]
["NCT00831415","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00831415","['Pfizer']"]
["NCT00831506","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00831506","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00831532","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00831532","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00831597","[u'Pharmatech']","[u'Pharmatech']","https://clinicaltrials.gov/ct2/show/NCT00831597","['Pharmatech']"]
["NCT00831636","[u'Clavis Pharma']","[u'Clavis Pharma']","https://clinicaltrials.gov/ct2/show/NCT00831636","['Clavis Pharma']"]
["NCT00831662","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00831662","['Merck Sharp & Dohme Corp.']"]
["NCT00831779","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00831779","['AstraZeneca']"]
["NCT00831844","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00831844","['National Cancer Institute (NCI)']"]
["NCT00831896","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00831896","['Millennium Pharmaceuticals, Inc.']"]
["NCT00832052","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00832052","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00832091","[]","[u'RegeneRx Biopharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00832091","[\"Dr Giorgio Guarnera, Istituto Dermopatico dell'Immacolata (IDI), Rome, ITaly\"]"]
["NCT00832117","[u'R-Pharm']","[u'R-Pharm']","https://clinicaltrials.gov/ct2/show/NCT00832117","['R-Pharm']"]
["NCT00832156","[]","[u'Association of Dutch Burn Centres']","https://clinicaltrials.gov/ct2/show/NCT00832156","['M.Bloemen/M.Ulrich, Association of Dutch Burn Centres']"]
["NCT00832546","[]","[u'TorreyPines Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00832546","['Susan Mellberg, R.N., M.B.A.; VP, Project Management, TorreyPines Therapeutics, Inc.']"]
["NCT00832585","[]","[u'Rush University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00832585","['Michael D. Tharp, Rush University Medical Center']"]
["NCT00832884","[u\"James W. Wheless, Le Bonheur Children's Hospital\"]","[u\"Le Bonheur Children's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00832884","[\"James W. Wheless, Principal Investigator, Le Bonheur Children's Hospital\"]"]
["NCT00833248","[u'Ferring Pharmaceuticals']","[u'Ferring Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00833248","['Ferring Pharmaceuticals']"]
["NCT00833378","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00833378","['GlaxoSmithKline']"]
["NCT00833391","[]","[u'XenoPort, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00833391","['Study Director, GSK']"]
["NCT00833404","[u'Christopher Harte, Ph.D., University of Texas at Austin']","[u'University of Texas at Austin']","https://clinicaltrials.gov/ct2/show/NCT00833404","['Christopher Harte, Ph.D., Postdoctoral fellow, University of Texas at Austin']"]
["NCT00833417","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00833417","['Genentech, Inc.']"]
["NCT00833443","[u'Keith Heinzerling, University of California, Los Angeles']","[u'University of California, Los Angeles']","https://clinicaltrials.gov/ct2/show/NCT00833443","['Keith Heinzerling, Assistant Clinical Professor, University of California, Los Angeles']"]
["NCT00833469","[u'Marlene P. Freeman, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00833469","[\"Marlene P. Freeman, MD, Clinical Director, Center for Women's Mental Health, Massachusetts General Hospital\"]"]
["NCT00833482","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00833482","['Bristol-Myers Squibb']"]
["NCT00833495","[u'Fovea Pharmaceuticals SA']","[u'Fovea Pharmaceuticals SA']","https://clinicaltrials.gov/ct2/show/NCT00833495","['Fovea Pharmaceuticals SA']"]
["NCT00833638","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00833638","['Chief Medical Officer, Eli Lilly']"]
["NCT00833690","[u'Michael Schwarzschild, The Parkinson Study Group']","[u'The Parkinson Study Group']","https://clinicaltrials.gov/ct2/show/NCT00833690","['Michael Schwarzschild, Principal Investigator, The Parkinson Study Group']"]
["NCT00833703","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00833703","['Sanofi']"]
["NCT00833716","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00833716","['Novo Nordisk A/S']"]
["NCT00833781","[u'Rajesh T. Gandhi, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00833781","['Rajesh T. Gandhi, MD, Director of Education, Massachusetts General Hospital']"]
["NCT00833807","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00833807","['M.D. Anderson Cancer Center']"]
["NCT00833833","[u'Celgene Corporation']","[u'Celgene Corporation']","https://clinicaltrials.gov/ct2/show/NCT00833833","['Celgene Corporation']"]
["NCT00833976","[u'Marlene P. Freeman, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00833976","[\"Marlene P. Freeman, MD, Director of Clinical Services, MGH Center for Women's Mental Health, Massachusetts General Hospital\"]"]
["NCT00833989","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00833989","['GlaxoSmithKline']"]
["NCT00834041","[]","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00834041","['External Affairs, Novartis']"]
["NCT00834080","[u'Alkermes, Inc.']","[u'Alkermes, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00834080","['Alkermes, Inc.']"]
["NCT00834184","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00834184","['University of Arizona']"]
["NCT00834210","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00834210","['Allergan']"]
["NCT00834652","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00834652","['Washington University School of Medicine']"]
["NCT00834678","[u'Ohio State University Comprehensive Cancer Center']","[u'Ohio State University Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00834678","['Ohio State University Comprehensive Cancer Center']"]
["NCT00834704","[u'Halozyme Therapeutics']","[u'Halozyme Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00834704","['Halozyme Therapeutics']"]
["NCT00835120","[u'Joseph Calabrese, MD, University Hospitals Cleveland Medical Center']","[u'University Hospitals Cleveland Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00835120","['Joseph Calabrese, MD, Director, Mood Disorders Program, University Hospitals Cleveland Medical Center']"]
["NCT00835159","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00835159","['New York University School of Medicine']"]
["NCT00835185","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00835185","['Eli Lilly and Company']"]
["NCT00835198","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00835198","['Allergan']"]
["NCT00835224","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00835224","['US Department of Veterans Affairs']"]
["NCT00835237","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00835237","['GlaxoSmithKline']"]
["NCT00835627","[u'W. Curt LaFrance Jr., M.D., Rhode Island Hospital']","[u'Rhode Island Hospital']","https://clinicaltrials.gov/ct2/show/NCT00835627","['W. Curt LaFrance Jr., M.D., Director, Neuropsychiatry and Behavioral Neurology, Rhode Island Hospital']"]
["NCT00835861","[u'University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00835861","['University of North Carolina, Chapel Hill']"]
["NCT00835900","[u'Roswell Park Cancer Institute']","[u'Roswell Park Cancer Institute']","https://clinicaltrials.gov/ct2/show/NCT00835900","['Roswell Park Cancer Institute']"]
["NCT00835952","[]","[u'Kythera Biopharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00835952","['Director, Clinical Affairs, Kythera Biopharmaceuticals, Inc.']"]
["NCT00835978","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00835978","['Pfizer']"]
["NCT00836147","[]","[u'Renovo']","https://clinicaltrials.gov/ct2/show/NCT00836147","['Amanda Hilton Senior Clinical Research Manager, Renovo Ltd']"]
["NCT00836199","[u'Nabi Biopharmaceuticals']","[u'Nabi Biopharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00836199","['Nabi Biopharmaceuticals']"]
["NCT00836277","[u'Weijing Sun, MD, FACP, University of Pittsburgh']","[u'Weijing Sun, MD, FACP']","https://clinicaltrials.gov/ct2/show/NCT00836277","['Weijing Sun, MD, FACP, Professor of Medicine, University of Pittsburgh']"]
["NCT00836407","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","https://clinicaltrials.gov/ct2/show/NCT00836407","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT00836485","[]","[u'Senju USA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00836485","['Takahiro Ogawa, PhD, Senju USA, Inc.']"]
["NCT00836719","[u'Jesus Lovera MD, Louisiana State University Health Sciences Center in New Orleans']","[u'Louisiana State University Health Sciences Center in New Orleans']","https://clinicaltrials.gov/ct2/show/NCT00836719","['Jesus Lovera MD, Assistant Profesor, Louisiana State University Health Sciences Center in New Orleans']"]
["NCT00837031","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00837031","['SCRI Development Innovations, LLC']"]
["NCT00837148","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00837148","['Memorial Sloan Kettering Cancer Center']"]
["NCT00837200","[u'Joseph Drabick, Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00837200","['Joseph Drabick, Professor of Medicine, Milton S. Hershey Medical Center']"]
["NCT00837239","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00837239","['M.D. Anderson Cancer Center']"]
["NCT00837252","[u'National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )']","[u'National Eye Institute (NEI)']","https://clinicaltrials.gov/ct2/show/NCT00837252","['National Eye Institute (NEI)']"]
["NCT00837330","[u'Dennis M. Marcus, M.D., Southeast Retina Center, Georgia']","[u'Southeast Retina Center, Georgia']","https://clinicaltrials.gov/ct2/show/NCT00837330","['Dennis M. Marcus, M.D., Dr. Dennis M. Marcus Principal Investigator, Southeast Retina Center, Georgia']"]
["NCT00837434","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00837434","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00837616","[u\"Nelly Mauras, Nemours Children's Clinic\"]","[u\"Nemours Children's Clinic\"]","https://clinicaltrials.gov/ct2/show/NCT00837616","[\"Nelly Mauras, Chief, Division of Endocrinology, Diabetes & Metabolism, Nemours Children's Clinic\"]"]
["NCT00837811","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00837811","['Eli Lilly and Company']"]
["NCT00837837","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00837837","['Wyeth is now a wholly owned subsidiary of Pfizer']"]
["NCT00837876","[u'Jordan Berlin, MD, Vanderbilt-Ingram Cancer Center']","[u'Vanderbilt-Ingram Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00837876","['Jordan Berlin, MD, Professor of Medicine; Clinical Director, GI Oncology Program; Director, Phase I Program; Medical Director, Clinical Trials Shared Resources; Medical Oncologist, Vanderbilt-Ingram Cancer Center']"]
["NCT00838058","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00838058","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00838084","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00838084","['Chief Medical Officer, Eli Lilly']"]
["NCT00838110","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00838110","['Pfizer']"]
["NCT00838201","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00838201","['Amgen']"]
["NCT00838331","[u'John D Roback, Emory University']","[u'Emory University']","https://clinicaltrials.gov/ct2/show/NCT00838331","['John D Roback, Professor, Emory University']"]
["NCT00838383","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00838383","['Pfizer']"]
["NCT00838396","[u'Indivior Inc.']","[u'Indivior Inc.']","https://clinicaltrials.gov/ct2/show/NCT00838396","['Indivior Inc.']"]
["NCT00838461","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00838461","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00838526","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00838526","['Eisai Inc.']"]
["NCT00838539","[u'Puma Biotechnology, Inc.']","[u'Puma Biotechnology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00838539","['Puma Biotechnology, Inc.']"]
["NCT00838565","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00838565","['Pfizer']"]
["NCT00838591","[u'MediciNova']","[u'MediciNova']","https://clinicaltrials.gov/ct2/show/NCT00838591","['MediciNova']"]
["NCT00838799","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00838799","['James Perhach, Ph.D., Executive Director, Clinical Development, Forest Research Institute, a subsidiary of Forest Laboratories, Inc.']"]
["NCT00838903","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00838903","['GlaxoSmithKline']"]
["NCT00838916","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00838916","['GlaxoSmithKline']"]
["NCT00838929","[u'Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )']","[u'Sidney Kimmel Cancer Center at Thomas Jefferson University']","https://clinicaltrials.gov/ct2/show/NCT00838929","['Sidney Kimmel Cancer Center at Thomas Jefferson University']"]
["NCT00839007","[]","[u'Nile Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00839007","['Hsiao Lieu, MD, Vice President, Clinical Research, Nile Therapeutics, Inc.']"]
["NCT00839124","[u'University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00839124","['University of North Carolina, Chapel Hill']"]
["NCT00839176","[u'Rexahn Pharmaceuticals, Inc.']","[u'Rexahn Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00839176","['Rexahn Pharmaceuticals, Inc.']"]
["NCT00839293","[]","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00839293","['Maureen Kelly, MD/Senior Medical Director, Abbott']"]
["NCT00839306","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00839306","['Eisai Inc.']"]
["NCT00839319","[u'John Amory, University of Washington']","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00839319","['John Amory, Professor, Department of Medicine, University of Washington']"]
["NCT00839332","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00839332","['Eli Lilly and Company']"]
["NCT00839527","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00839527","['GlaxoSmithKline']"]
["NCT00839540","[u'Gary E. Stein, Pharm.D., Michigan State University']","[u'Gary E. Stein, Pharm.D.']","https://clinicaltrials.gov/ct2/show/NCT00839540","['Gary E. Stein, Pharm.D., Professor of Medicine, Michigan State University']"]
["NCT00839683","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00839683","['AstraZeneca']"]
["NCT00839891","[]","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00839891","['Wesley Day, VP Clinical, Vivus, inc.']"]
["NCT00839982","[u'Fred Hutchinson Cancer Research Center']","[u'Fred Hutchinson Cancer Research Center']","https://clinicaltrials.gov/ct2/show/NCT00839982","['Fred Hutchinson Cancer Research Center']"]
["NCT00840034","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00840034","['Eli Lilly and Company']"]
["NCT00840086","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00840086","['Novo Nordisk A/S']"]
["NCT00840268","[u'Alcon Research']","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT00840268","['Alcon Research']"]
["NCT00840827","[]","[u'Weill Medical College of Cornell University']","https://clinicaltrials.gov/ct2/show/NCT00840827","['Eric Feldman, MD, Weill Cornell Medical Colelge']"]
["NCT00841191","[u'Centocor, Inc.']","[u'Centocor, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00841191","['Centocor, Inc.']"]
["NCT00841204","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00841204","['National Cancer Institute (NCI)']"]
["NCT00841269","[u'Douglas Kondo, MD, University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00841269","['Douglas Kondo, MD, MD, University of Utah']"]
["NCT00841321","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00841321","['US Department of Veterans Affairs']"]
["NCT00841555","[u'Ohio State University Comprehensive Cancer Center']","[u'Ohio State University Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00841555","['Ohio State University Comprehensive Cancer Center']"]
["NCT00841919","[]","[u'John H. Stroger Hospital']","https://clinicaltrials.gov/ct2/show/NCT00841919","['Leon Fogelfeld, John H. Stroger Jr. Hospital of Cook County']"]
["NCT00841971","[u'Nina Singh, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00841971","['Nina Singh, MD, University of Pittsburgh']"]
["NCT00842023","[u'Sheryl Chow, Western University of Health Sciences']","[u'Western University of Health Sciences']","https://clinicaltrials.gov/ct2/show/NCT00842023","['Sheryl Chow, Associate Professor, Western University of Health Sciences']"]
["NCT00842088","[]","[u'HemaQuest Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00842088","['Susan Perrine, M.D., HemaQuest Pharmaceuticals, Inc.']"]
["NCT00842244","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00842244","['Pfizer']"]
["NCT00842348","[u'Ipsen']","[u'Ipsen']","https://clinicaltrials.gov/ct2/show/NCT00842348","['Ipsen']"]
["NCT00842452","[u'Steven Waggoner, MD, Case Comprehensive Cancer Center']","[u'Steven Waggoner, MD']","https://clinicaltrials.gov/ct2/show/NCT00842452","['Steven Waggoner, MD, Principal Investigator, Case Comprehensive Cancer Center']"]
["NCT00842504","[u\"Children's Hospital Medical Center, Cincinnati\"]","[u\"Children's Hospital Medical Center, Cincinnati\"]","https://clinicaltrials.gov/ct2/show/NCT00842504","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT00842556","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00842556","['AstraZeneca']"]
["NCT00842634","[u'University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00842634","['University of Pennsylvania']"]
["NCT00842751","[u'John Amory, University of Washington']","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00842751","['John Amory, Professor, University of Washington']"]
["NCT00843011","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00843011","['GlaxoSmithKline']"]
["NCT00843024","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00843024","['GlaxoSmithKline']"]
["NCT00843193","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00843193","['GlaxoSmithKline']"]
["NCT00843518","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00843518","['Eli Lilly and Company']"]
["NCT00843622","[u'Swedish Match AB']","[u'Swedish Match AB']","https://clinicaltrials.gov/ct2/show/NCT00843622","['Swedish Match AB']"]
["NCT00843713","[u'Priscilla Hsue, University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00843713","['Priscilla Hsue, Associate Professor, University of California, San Francisco']"]
["NCT00844168","[u'University of Washington']","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00844168","['University of Washington']"]
["NCT00844207","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00844207","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00844376","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00844376","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00844493","[u'Johns Hopkins Bloomberg School of Public Health']","[u'Johns Hopkins Bloomberg School of Public Health']","https://clinicaltrials.gov/ct2/show/NCT00844493","['Johns Hopkins Bloomberg School of Public Health']"]
["NCT00844649","[u'Celgene']","[u'Celgene']","https://clinicaltrials.gov/ct2/show/NCT00844649","['Celgene']"]
["NCT00844753","[u'tristram smith, University of Rochester']","[u'University of Rochester']","https://clinicaltrials.gov/ct2/show/NCT00844753","['tristram smith, Associate Professor, University of Rochester']"]
["NCT00844857","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00844857","['Eli Lilly and Company']"]
["NCT00845000","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00845000","['Merck Sharp & Dohme Corp.']"]
["NCT00845026","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00845026","['Chief Medical Officer, Eli Lilly']"]
["NCT00845039","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00845039","['Eli Lilly and Company']"]
["NCT00845182","[u'The University of Texas Health Science Center at San Antonio']","[u'The University of Texas Health Science Center at San Antonio']","https://clinicaltrials.gov/ct2/show/NCT00845182","['The University of Texas Health Science Center at San Antonio']"]
["NCT00845299","[u'Mati Therapeutics Inc.']","[u'Mati Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00845299","['Mati Therapeutics Inc.']"]
["NCT00845429","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00845429","['Sanofi']"]
["NCT00845507","[u'Melissa Delbello, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT00845507","['Melissa Delbello, Professor, University of Cincinnati']"]
["NCT00845533","[u'Sunil Parikh, University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00845533","['Sunil Parikh, Assistant Professor, University of California, San Francisco']"]
["NCT00845650","[u'Emergent BioSolutions']","[u'Emergent BioSolutions']","https://clinicaltrials.gov/ct2/show/NCT00845650","['Emergent BioSolutions']"]
["NCT00845676","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00845676","['University of California, San Francisco']"]
["NCT00845728","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00845728","['Novartis Pharmaceuticals']"]
["NCT00845871","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00845871","['Novartis Pharmaceuticals']"]
["NCT00845923","[u'Winston Laboratories']","[u'Winston Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00845923","['Winston Laboratories']"]
["NCT00846131","[u'Laura Kulik, Northwestern University']","[u'Northwestern University']","https://clinicaltrials.gov/ct2/show/NCT00846131","['Laura Kulik, Associate Professor, Northwestern University']"]
["NCT00846196","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00846196","['Warner Chilcott']"]
["NCT00846365","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00846365","['Takeda']"]
["NCT00846495","[u'Clinvest, Cady, Roger, M.D.']","[u'Clinvest']","https://clinicaltrials.gov/ct2/show/NCT00846495","['Clinvest, CEO, Cady, Roger, M.D.']"]
["NCT00846547","[u'Seaside Therapeutics, Inc.']","[u'Seaside Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00846547","['Seaside Therapeutics, Inc.']"]
["NCT00846586","[]","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00846586","['External Affairs, Novartis Pharmaceuticals']"]
["NCT00846612","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00846612","['New York University School of Medicine']"]
["NCT00846989","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00846989","['Novartis Pharmaceuticals']"]
["NCT00847015","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00847015","['Memorial Sloan Kettering Cancer Center']"]
["NCT00847054","[u'Morphotek']","[u'Morphotek']","https://clinicaltrials.gov/ct2/show/NCT00847054","['Morphotek']"]
["NCT00847093","[]","[u'Ferndale Laboratories, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00847093","[\"Santhanam Suresh, MD, Children's Memorial Hospital\"]"]
["NCT00847145","[u'Novartis ( Novartis Vaccines )']","[u'Novartis Vaccines']","https://clinicaltrials.gov/ct2/show/NCT00847145","['Novartis Vaccines']"]
["NCT00847197","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00847197","['Merck Sharp & Dohme Corp.']"]
["NCT00847210","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00847210","['Takeda']"]
["NCT00847522","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00847522","['University of Utah']"]
["NCT00847535","[u'Cook Group Incorporated ( Cook MyoSite )']","[u'Cook MyoSite']","https://clinicaltrials.gov/ct2/show/NCT00847535","['Cook MyoSite']"]
["NCT00847587","[u'David Turok, University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00847587","['David Turok, M.D., University of Utah']"]
["NCT00847613","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00847613","['Pfizer']"]
["NCT00847626","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00847626","['Takeda']"]
["NCT00847639","[u'Center for International Blood and Marrow Transplant Research']","[u'Center for International Blood and Marrow Transplant Research']","https://clinicaltrials.gov/ct2/show/NCT00847639","['Center for International Blood and Marrow Transplant Research']"]
["NCT00847808","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00847808","['Takeda']"]
["NCT00847886","[]","[u'Lexicon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00847886","['Joel P. Freiman, MD, MPH (Medical Director, Drug Safety), Lexicon Pharmaceuticals, Inc.']"]
["NCT00848016","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00848016","['National Cancer Institute (NCI)']"]
["NCT00848055","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00848055","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00848081","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00848081","['Chief medical officer, Eli Lilly']"]
["NCT00848211","[]","[u'Thymon, LLC']","https://clinicaltrials.gov/ct2/show/NCT00848211","['Gideon Goldstein, MD, PhD, THYMON, LLC']"]
["NCT00848302","[u'The Cleveland Clinic']","[u'The Cleveland Clinic']","https://clinicaltrials.gov/ct2/show/NCT00848302","['The Cleveland Clinic']"]
["NCT00848484","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00848484","['Merck Sharp & Dohme Corp.']"]
["NCT00848510","[u'Merck KGaA, Darmstadt, Germany']","[u'Merck KGaA, Darmstadt, Germany']","https://clinicaltrials.gov/ct2/show/NCT00848510","['Merck KGaA, Darmstadt, Germany']"]
["NCT00848926","[u'Seattle Genetics, Inc.']","[u'Seattle Genetics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00848926","['Seattle Genetics, Inc.']"]
["NCT00848939","[u'United Therapeutics']","[u'United Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00848939","['United Therapeutics']"]
["NCT00848991","[]","[u'The Cooper Health System']","https://clinicaltrials.gov/ct2/show/NCT00848991","['Dr. Michael Misbin, Cooper University Hospital']"]
["NCT00849017","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00849017","['GlaxoSmithKline']"]
["NCT00849056","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00849056","['GlaxoSmithKline']"]
["NCT00849108","[u'Lantheus Medical Imaging']","[u'Lantheus Medical Imaging']","https://clinicaltrials.gov/ct2/show/NCT00849108","['Lantheus Medical Imaging']"]
["NCT00849147","[u'Medical College of Wisconsin']","[u'Medical College of Wisconsin']","https://clinicaltrials.gov/ct2/show/NCT00849147","['Medical College of Wisconsin']"]
["NCT00849329","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00849329","['GlaxoSmithKline']"]
["NCT00849472","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00849472","['GlaxoSmithKline']"]
["NCT00849550","[u'Herbert Hurwitz, Duke University']","[u'Herbert Hurwitz']","https://clinicaltrials.gov/ct2/show/NCT00849550","['Herbert Hurwitz, Associate Professor of Medicine, Duke University']"]
["NCT00849576","[u'Biodel']","[u'Biodel']","https://clinicaltrials.gov/ct2/show/NCT00849576","['Biodel']"]
["NCT00849654","[u'Pharmacyclics LLC.']","[u'Pharmacyclics LLC.']","https://clinicaltrials.gov/ct2/show/NCT00849654","['Pharmacyclics LLC.']"]
["NCT00849693","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00849693","['Eli Lilly and Company']"]
["NCT00849901","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00849901","['Eli Lilly and Company']"]
["NCT00850044","[]","[u'AbbVie']","https://clinicaltrials.gov/ct2/show/NCT00850044","['Adebayo Lawal, M.D./Medical Director, Abbott']"]
["NCT00850070","[u\"Glen R. Elliott, The Children's Health Council\"]","[u\"The Children's Health Council\"]","https://clinicaltrials.gov/ct2/show/NCT00850070","[\"Glen R. Elliott, Chief Psychiatrist and Medical Director, The Children's Health Council\"]"]
["NCT00850096","[u'CPEX Pharmaceuticals Inc.']","[u'CPEX Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00850096","['CPEX Pharmaceuticals Inc.']"]
["NCT00850616","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00850616","['Merck Sharp & Dohme Corp.']"]
["NCT00850668","[u'National Institute of Allergy and Infectious Diseases (NIAID) ( Allertein Therapeutics, LLC )']","[u'Allertein Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00850668","['Allertein Therapeutics, LLC']"]
["NCT00850681","[]","[u'Peplin']","https://clinicaltrials.gov/ct2/show/NCT00850681","['Robert Whitfield, Peplin']"]
["NCT00850746","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00850746","['Astellas Pharma Inc']"]
["NCT00850811","[]","[u'Peplin']","https://clinicaltrials.gov/ct2/show/NCT00850811","['Robert Whitfield, Peplin']"]
["NCT00851006","[u'Douglas Kondo, MD, University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00851006","['Douglas Kondo, MD, MD, University of Utah']"]
["NCT00851045","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00851045","['Bristol-Myers Squibb']"]
["NCT00851136","[]","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00851136","['Clinical Trials Posting Group, Genentech, Inc.']"]
["NCT00851227","[u'Cumberland Pharmaceuticals']","[u'Cumberland Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00851227","['Cumberland Pharmaceuticals']"]
["NCT00851266","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00851266","['Merck Sharp & Dohme Corp.']"]
["NCT00851357","[u'Shu-Hong Zhu, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00851357","['Shu-Hong Zhu, Professor, University of California, San Diego']"]
["NCT00851383","[u'International AIDS Vaccine Initiative']","[u'International AIDS Vaccine Initiative']","https://clinicaltrials.gov/ct2/show/NCT00851383","['International AIDS Vaccine Initiative']"]
["NCT00851721","[u'Shire ( Baxalta now part of Shire )']","[u'Baxalta now part of Shire']","https://clinicaltrials.gov/ct2/show/NCT00851721","['Baxalta now part of Shire']"]
["NCT00851786","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00851786","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00851890","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00851890","['AbbVie (prior sponsor, Abbott)']"]
["NCT00851903","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00851903","['Sanofi']"]
["NCT00852137","[u'Peplin']","[u'Peplin']","https://clinicaltrials.gov/ct2/show/NCT00852137","['Peplin']"]
["NCT00852163","[u'Baylor Research Institute']","[u'Baylor Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00852163","['Baylor Research Institute']"]
["NCT00852202","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00852202","['Forest Laboratories']"]
["NCT00852540","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00852540","['Stiefel, a GSK Company']"]
["NCT00852761","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00852761","['Stiefel, a GSK Company']"]
["NCT00852969","[u'Tufts Medical Center']","[u'Tufts Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00852969","['Tufts Medical Center']"]
["NCT00852995","[u'Healthpoint']","[u'Healthpoint']","https://clinicaltrials.gov/ct2/show/NCT00852995","['Healthpoint']"]
["NCT00853021","[u'Jorge Garcia, MD, Case Comprehensive Cancer Center']","[u'Jorge Garcia, MD']","https://clinicaltrials.gov/ct2/show/NCT00853021","['Jorge Garcia, MD, Principal Investigator, Case Comprehensive Cancer Center']"]
["NCT00853047","[u'Lexicon Pharmaceuticals']","[u'Lexicon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00853047","['Lexicon Pharmaceuticals']"]
["NCT00853073","[u'Marlene Moster, MD, Wills Eye']","[u'Wills Eye']","https://clinicaltrials.gov/ct2/show/NCT00853073","['Marlene Moster, MD, Principal Investigator, Wills Eye']"]
["NCT00853151","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00853151","['Eli Lilly and Company']"]
["NCT00853242","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00853242","['Genzyme, a Sanofi Company']"]
["NCT00853255","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00853255","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00853307","[u'Takeda ( Millennium Pharmaceuticals, Inc. )']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00853307","['Millennium Pharmaceuticals, Inc.']"]
["NCT00853385","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00853385","['Pfizer']"]
["NCT00853606","[u'VIVUS, Inc.']","[u'VIVUS, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00853606","['VIVUS, Inc.']"]
["NCT00853658","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00853658","['Novartis Pharmaceuticals']"]
["NCT00853723","[u'Mara Horwitz, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00853723","['Mara Horwitz, Associate Professor, University of Pittsburgh School of Medicine, University of Pittsburgh']"]
["NCT00853827","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00853827","['Novartis Pharmaceuticals']"]
["NCT00853840","[u'ViiV Healthcare']","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00853840","['ViiV Healthcare']"]
["NCT00853905","[u'Marlene Moster, MD, Wills Eye']","[u'Wills Eye']","https://clinicaltrials.gov/ct2/show/NCT00853905","['Marlene Moster, MD, Attending Surgeon Wills Eye Institute; Professor Jefferson Medical College, Wills Eye']"]
["NCT00853957","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00853957","['Novartis']"]
["NCT00853970","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00853970","['Bausch & Lomb Incorporated']"]
["NCT00853996","[u'Carol Fabian, MD, University of Kansas Medical Center']","[u'University of Kansas Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00853996","['Carol Fabian, MD, Professor, University of Kansas Medical Center']"]
["NCT00854061","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00854061","['Bausch & Lomb Incorporated']"]
["NCT00854087","[u'Tarek Hassanein, SCTI Research Foundation']","[u'Tarek Hassanein']","https://clinicaltrials.gov/ct2/show/NCT00854087","['Tarek Hassanein, Medical Director, SCTI Research Foundation']"]
["NCT00854100","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00854100","['Forest Laboratories']"]
["NCT00854113","[]","[u'Theracos']","https://clinicaltrials.gov/ct2/show/NCT00854113","['Albert Collinson Ph.D, President and CEO, Theracos']"]
["NCT00854126","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00854126","['Genentech, Inc.']"]
["NCT00854152","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00854152","['Genentech, Inc.']"]
["NCT00854308","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00854308","['Genentech, Inc.']"]
["NCT00854360","[u'Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )']","[u'Teva Branded Pharmaceutical Products, R&D Inc.']","https://clinicaltrials.gov/ct2/show/NCT00854360","['Teva Branded Pharmaceutical Products, R&D Inc.']"]
["NCT00854373","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00854373","['University of California, San Francisco']"]
["NCT00854620","[u'Sandy Srinivas, Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT00854620","['Sandy Srinivas, Associate Professor of Medicine, Stanford University']"]
["NCT00854646","[u'Onconova Therapeutics, Inc.']","[u'Onconova Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00854646","['Onconova Therapeutics, Inc.']"]
["NCT00854724","[u'David M. Penetar, Mclean Hospital']","[u'Mclean Hospital']","https://clinicaltrials.gov/ct2/show/NCT00854724","['David M. Penetar, Psychologist, Mclean Hospital']"]
["NCT00854945","[u'Onconova Therapeutics, Inc.']","[u'Onconova Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00854945","['Onconova Therapeutics, Inc.']"]
["NCT00855088","[]","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00855088","['Angela Kashuba, PharmD, UNC Chapel Hill Eshelman School of Pharmacy']"]
["NCT00855101","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00855101","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00855205","[u'Robert P Baughman, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT00855205","['Robert P Baughman, Professor of Medicine, University of Cincinnati']"]
["NCT00855218","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00855218","['Bayer']"]
["NCT00855283","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00855283","['US Department of Veterans Affairs']"]
["NCT00855309","[u'Wake Forest University Health Sciences']","[u'Wake Forest University Health Sciences']","https://clinicaltrials.gov/ct2/show/NCT00855309","['Wake Forest University Health Sciences']"]
["NCT00855361","[u'Janssen Research & Development, LLC']","[u'Janssen Research & Development, LLC']","https://clinicaltrials.gov/ct2/show/NCT00855361","['Janssen Research & Development, LLC']"]
["NCT00855413","[u'Cynthia L Gay, MD, University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00855413","['Cynthia L Gay, MD, Clinical Assistant Professor, University of North Carolina, Chapel Hill']"]
["NCT00855465","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00855465","['Bayer']"]
["NCT00855582","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00855582","['Chief Medical Officer, Eli Lilly']"]
["NCT00857168","[]","[u'Acrux DDS Pty Ltd']","https://clinicaltrials.gov/ct2/show/NCT00857168","['Tina Soulis, Director, CLinical Devleopment, Acrux Pharma Pty Ltd']"]
["NCT00858455","[]","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00858455","['Study Director, GSK']"]
["NCT00859040","[u\"Patrick Y. Wen, MD, Dana-Farber/Brigham and Women's Cancer Center\"]","[u'Patrick Y. Wen, MD']","https://clinicaltrials.gov/ct2/show/NCT00859040","[\"Patrick Y. Wen, MD, Directory, Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center\"]"]
["NCT00861458","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00861458","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00863304","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00863304","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00863746","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00863746","['Bayer']"]
["NCT00864240","[]","[u'Actavis Inc.']","https://clinicaltrials.gov/ct2/show/NCT00864240","['Christine Winslow, Director of Clinical Development, Actavis Inc']"]
["NCT00864942","[u'Georgetown University']","[u'Georgetown University']","https://clinicaltrials.gov/ct2/show/NCT00864942","['Georgetown University']"]
["NCT00866177","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00866177","['National Cancer Institute (NCI)']"]
["NCT00867503","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00867503","['University of Arizona']"]
["NCT00868699","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT00868699","['Sunovion']"]
["NCT00870571","[]","[u'Actavis Inc.']","https://clinicaltrials.gov/ct2/show/NCT00870571","['Meena Venugopal, Director, Clinical R&D, Actavis Inc']"]
["NCT00871572","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00871572","['Eli Lilly and Company']"]
["NCT00873197","[]","[u'Prostrakan Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00873197","[\"Dr Bridget O'Mahony/Clinical Research Manager, Strakan Pharmaceuticals Ltd\"]"]
["NCT00874861","[u'Ian F. Pollack, M.D., University of Pittsburgh']","[u'Ian F. Pollack, M.D.']","https://clinicaltrials.gov/ct2/show/NCT00874861","['Ian F. Pollack, M.D., Chief, Pediatric Neurosurgery, University of Pittsburgh']"]
["NCT00876304","[]","[u'Taisho Pharmaceutical Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00876304","['Taisho Pharmaceutical Co., Ltd.']"]
["NCT00878306","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00878306","['University of California, San Francisco']"]
["NCT00879684","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00879684","['Pfizer']"]
["NCT00880698","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00880698","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00881868","[u'Galderma Laboratories, L.P.']","[u'Galderma Laboratories, L.P.']","https://clinicaltrials.gov/ct2/show/NCT00881868","['Galderma Laboratories, L.P.']"]
["NCT00883168","[u'Meda Pharmaceuticals']","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00883168","['Meda Pharmaceuticals']"]
["NCT00884845","[u'PharmaMar']","[u'PharmaMar']","https://clinicaltrials.gov/ct2/show/NCT00884845","['PharmaMar']"]
["NCT00885742","[u'CSL Behring']","[u'CSL Behring']","https://clinicaltrials.gov/ct2/show/NCT00885742","['CSL Behring']"]
["NCT00887224","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00887224","['Pfizer']"]
["NCT00888134","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00888134","['National Cancer Institute (NCI)']"]
["NCT00890747","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00890747","['National Cancer Institute (NCI)']"]
["NCT00891202","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00891202","['Genzyme, a Sanofi Company']"]
["NCT00892281","[u'Galderma Laboratories, L.P.']","[u'Galderma Laboratories, L.P.']","https://clinicaltrials.gov/ct2/show/NCT00892281","['Galderma Laboratories, L.P.']"]
["NCT00894231","[]","[u'AAADRS Clinical Research Center']","https://clinicaltrials.gov/ct2/show/NCT00894231","['Miguel J Lanz MD FAAAAI, AAADRS']"]
["NCT00895934","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00895934","['National Cancer Institute (NCI)']"]
["NCT00896974","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00896974","['National Cancer Institute (NCI)']"]
["NCT00902291","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00902291","['Astellas Pharma Inc']"]
["NCT00903617","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00903617","['GlaxoSmithKline']"]
["NCT00904826","[]","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT00904826","['Sean J. Pittock, M.D., Mayo Clinic']"]
["NCT00906334","[u'Onconova Therapeutics, Inc.']","[u'Onconova Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00906334","['Onconova Therapeutics, Inc.']"]
["NCT00907894","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00907894","['Novartis Pharmaceuticals']"]
["NCT00909311","[]","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00909311","['Adebayo Lawal, MD/Medical Director, Abbott']"]
["NCT00910806","[u'Tibotec BVBA']","[u'Tibotec BVBA']","https://clinicaltrials.gov/ct2/show/NCT00910806","['Tibotec BVBA']"]
["NCT00910845","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00910845","['Allergan']"]
["NCT00912119","[u\"Paul Stricker, Children's Hospital of Philadelphia\"]","[u'Paul Stricker']","https://clinicaltrials.gov/ct2/show/NCT00912119","[\"Paul Stricker, Assistant Professor for the University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia, Children's Hospital of Philadelphia\"]"]
["NCT00914186","[u'Taisho Pharmaceutical R&D Inc.']","[u'Taisho Pharmaceutical R&D Inc.']","https://clinicaltrials.gov/ct2/show/NCT00914186","['Taisho Pharmaceutical R&D Inc.']"]
["NCT00915603","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00915603","['SCRI Development Innovations, LLC']"]
["NCT00917384","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00917384","['Eli Lilly and Company']"]
["NCT00919113","[u'Watson Pharmaceuticals']","[u'Watson Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00919113","['Watson Pharmaceuticals']"]
["NCT00920582","[u'MacroGenics']","[u'MacroGenics']","https://clinicaltrials.gov/ct2/show/NCT00920582","['MacroGenics']"]
["NCT00921518","[u'Judith L. Kristeller, Community Medical Center, Scranton, PA']","[u'Community Medical Center, Scranton, PA']","https://clinicaltrials.gov/ct2/show/NCT00921518","['Judith L. Kristeller, Associate Professor, Community Medical Center, Scranton, PA']"]
["NCT00924313","[u'Peter Choyke, M.D., National Institutes of Health Clinical Center (CC)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00924313","['Peter Choyke, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT00925353","[u'Mountain States Tumor and Medical Research Institute']","[u'Mountain States Tumor and Medical Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00925353","['Mountain States Tumor and Medical Research Institute']"]
["NCT00926614","[u'Stephen A Harrison, Brooke Army Medical Center']","[u'Brooke Army Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00926614","['Stephen A Harrison, Principal Investigator, Brooke Army Medical Center']"]
["NCT00927875","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00927875","['Bristol-Myers Squibb']"]
["NCT00929695","[u'Marco Mielcarek, Fred Hutchinson Cancer Research Center']","[u'Fred Hutchinson Cancer Research Center']","https://clinicaltrials.gov/ct2/show/NCT00929695","['Marco Mielcarek, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT00931281","[]","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00931281","['Isabelle Gaultier, Scientific Director, Abbott']"]
["NCT00931918","[u'Takeda ( Millennium Pharmaceuticals, Inc. )']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00931918","['Millennium Pharmaceuticals, Inc.']"]
["NCT00934375","[]","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00934375","['James Prodafikas, Study Director, Eisai Inc.']"]
["NCT00934453","[u'Patricia L. Hibberd, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00934453","['Patricia L. Hibberd, Chief, Division of Global Health, Massachusetts General Hospital']"]
["NCT00936715","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00936715","['Gilead Sciences']"]
["NCT00937495","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00937495","['National Cancer Institute (NCI)']"]
["NCT00939510","[u'Robert Dreicer MD, Case Comprehensive Cancer Center']","[u'Robert Dreicer MD']","https://clinicaltrials.gov/ct2/show/NCT00939510","['Robert Dreicer MD, Principal Investigator, Case Comprehensive Cancer Center']"]
["NCT00941278","[]","[u'Provectus Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00941278","['Eric Wachter/Vice President, Provectus Pharmaceuticals']"]
["NCT00942968","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00942968","['Pfizer']"]
["NCT00943852","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00943852","['Merck Sharp & Dohme Corp.']"]
["NCT00946335","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00946335","['National Cancer Institute (NCI)']"]
["NCT00948155","[u'Andrew Strasser, University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00948155","['Andrew Strasser, Associate Professor Department of Psychiatry, University of Pennsylvania']"]
["NCT00949247","[u'Case Comprehensive Cancer Center']","[u'Case Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00949247","['Case Comprehensive Cancer Center']"]
["NCT00952081","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00952081","['New York University School of Medicine']"]
["NCT00953121","[u'Annick Desjardins, Duke University']","[u'Annick Desjardins']","https://clinicaltrials.gov/ct2/show/NCT00953121","['Annick Desjardins, Assist Professor of Medicine-Neurology, Duke University']"]
["NCT00955357","[u'UCB Pharma']","[u'UCB Pharma']","https://clinicaltrials.gov/ct2/show/NCT00955357","['UCB Pharma']"]
["NCT00956371","[u'Ono Pharmaceutical Co. Ltd']","[u'Ono Pharmaceutical Co. Ltd']","https://clinicaltrials.gov/ct2/show/NCT00956371","['Ono Pharmaceutical Co. Ltd']"]
["NCT00958438","[u'Regeneron Pharmaceuticals']","[u'Regeneron Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00958438","['Regeneron Pharmaceuticals']"]
["NCT00959842","[u'William S. Harris, Sanford Research']","[u'Sanford Research']","https://clinicaltrials.gov/ct2/show/NCT00959842","['William S. Harris, Adjunct Senior Scientist, Sanford Research']"]
["NCT00959959","[u'Novus Therapeutics, Inc']","[u'Novus Therapeutics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00959959","['Novus Therapeutics, Inc']"]
["NCT00961662","[u'Robert Lodder, Spherix Incorporated']","[u'Robert Lodder']","https://clinicaltrials.gov/ct2/show/NCT00961662","['Robert Lodder, PhD, Spherix Incorporated']"]
["NCT00964795","[u'Regeneron Pharmaceuticals']","[u'Regeneron Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00964795","['Regeneron Pharmaceuticals']"]
["NCT00965887","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00965887","['Merck Sharp & Dohme Corp.']"]
["NCT00968071","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00968071","['M.D. Anderson Cancer Center']"]
["NCT00968981","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00968981","['Genentech, Inc.']"]
["NCT00972179","[]","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00972179","['Global Development Leader, Amgen Inc.']"]
["NCT00973817","[u'Vital Therapies, Inc.']","[u'Vital Therapies, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00973817","['Vital Therapies, Inc.']"]
["NCT00975936","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00975936","['GlaxoSmithKline']"]
["NCT00976599","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00976599","['Pfizer']"]
["NCT00979654","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00979654","['MedImmune LLC']"]
["NCT00981162","[u'Roswell Park Cancer Institute']","[u'Roswell Park Cancer Institute']","https://clinicaltrials.gov/ct2/show/NCT00981162","['Roswell Park Cancer Institute']"]
["NCT00981968","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00981968","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00984256","[u'U.S. Army Medical Research and Materiel Command']","[u'U.S. Army Medical Research and Materiel Command']","https://clinicaltrials.gov/ct2/show/NCT00984256","['U.S. Army Medical Research and Materiel Command']"]
["NCT00986180","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","[u'Ortho-McNeil Janssen Scientific Affairs, LLC']","https://clinicaltrials.gov/ct2/show/NCT00986180","['Ortho-McNeil Janssen Scientific Affairs, LLC']"]
["NCT00986674","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00986674","['National Cancer Institute (NCI)']"]
["NCT00988247","[u'Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )']","[u'Teva Branded Pharmaceutical Products, R&D Inc.']","https://clinicaltrials.gov/ct2/show/NCT00988247","['Teva Branded Pharmaceutical Products, R&D Inc.']"]
["NCT00989586","[u'Beth Christian, Ohio State University Comprehensive Cancer Center']","[u'Beth Christian']","https://clinicaltrials.gov/ct2/show/NCT00989586","['Beth Christian, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00991107","[]","[u'Harbor Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00991107","['Dwight R. Stickney, MD - Chief Medical Officer, Hollis-Eden Pharmaceuticals']"]
["NCT00992225","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00992225","['Eli Lilly and Company']"]
["NCT00993148","[u'Babafemi Taiwo, Northwestern University']","[u'Northwestern University']","https://clinicaltrials.gov/ct2/show/NCT00993148","['Babafemi Taiwo, Associate Professor, Northwestern University']"]
["NCT00994591","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00994591","['University of California, San Francisco']"]
["NCT00996164","[u'Sprout Pharmaceuticals, Inc']","[u'Sprout Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT00996164","['Sprout Pharmaceuticals, Inc']"]
["NCT00996931","[u'Michael G. Chez, MD, Sutter Medical Foundation']","[u'Sutter Medical Foundation']","https://clinicaltrials.gov/ct2/show/NCT00996931","['Michael G. Chez, MD, MD, Sutter Medical Foundation']"]
["NCT00998933","[]","[u'Solvay Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00998933","['Barbara Parker, Solvay Pharmaceuticals']"]
["NCT01000974","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01000974","['GlaxoSmithKline']"]
["NCT01002417","[u'Health Ever Bio-Tech Co., Ltd.']","[u'Health Ever Bio-Tech Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT01002417","['Health Ever Bio-Tech Co., Ltd.']"]
["NCT01004393","[u'Steven Ades, University of Vermont']","[u'University of Vermont']","https://clinicaltrials.gov/ct2/show/NCT01004393","['Steven Ades, Associate Professor, University of Vermont']"]
["NCT01006876","[u'Andrea Natale, Texas Cardiac Arrhythmia Research Foundation']","[u'Texas Cardiac Arrhythmia Research Foundation']","https://clinicaltrials.gov/ct2/show/NCT01006876","['Andrea Natale, Medical director, Texas Cardiac Arrhythmia Research Foundation']"]
["NCT01008319","[u'University of Oklahoma']","[u'University of Oklahoma']","https://clinicaltrials.gov/ct2/show/NCT01008319","['University of Oklahoma']"]
["NCT01010750","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT01010750","['Shire']"]
["NCT01011933","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01011933","['National Cancer Institute (NCI)']"]
["NCT01012895","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT01012895","['Bristol-Myers Squibb']"]
["NCT01013766","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01013766","['GlaxoSmithKline']"]
["NCT01015638","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT01015638","['Stiefel, a GSK Company']"]
["NCT01018186","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01018186","['GlaxoSmithKline']"]
["NCT01018680","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01018680","['Eli Lilly and Company']"]
["NCT01020214","[]","[u'Mylan Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01020214","['Wayne Talton, Mylan Inc.']"]
["NCT01022346","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT01022346","['Hoffmann-La Roche']"]
["NCT01025635","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT01025635","['Bayer']"]
["NCT01026636","[u'Basilea Pharmaceutica']","[u'Basilea Pharmaceutica']","https://clinicaltrials.gov/ct2/show/NCT01026636","['Basilea Pharmaceutica']"]
["NCT01028391","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01028391","['Merck Sharp & Dohme Corp.']"]
["NCT01030731","[u'Basilea Pharmaceutica']","[u'Basilea Pharmaceutica']","https://clinicaltrials.gov/ct2/show/NCT01030731","['Basilea Pharmaceutica']"]
["NCT01031979","[u'VA Office of Research and Development']","[u'VA Office of Research and Development']","https://clinicaltrials.gov/ct2/show/NCT01031979","['VA Office of Research and Development']"]
["NCT01034267","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT01034267","['Forest Laboratories']"]
["NCT01034553","[u'Mayo Clinic']","[u'Mayo Clinic']","https://clinicaltrials.gov/ct2/show/NCT01034553","['Mayo Clinic']"]
["NCT01038609","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT01038609","['AbbVie (prior sponsor, Abbott)']"]
["NCT01040091","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT01040091","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01040728","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01040728","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT01042106","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT01042106","['Sunovion']"]
["NCT01043926","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01043926","['Merck Sharp & Dohme Corp.']"]
["NCT01045642","[]","[u\"Dr. Reddy's Laboratories Limited\"]","https://clinicaltrials.gov/ct2/show/NCT01045642","[\"Sr. Director - R&D, Dr. Reddy's Laboratories Limited\"]"]
["NCT01047475","[u'Microbio Co Ltd']","[u'Microbio Co Ltd']","https://clinicaltrials.gov/ct2/show/NCT01047475","['Microbio Co Ltd']"]
["NCT01049165","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT01049165","['Study Director, Bristol-Myers Squibb']"]
["NCT01051596","[u'Michael J Pishvaian, Georgetown University']","[u'Georgetown University']","https://clinicaltrials.gov/ct2/show/NCT01051596","['Michael J Pishvaian, Assistant Professor of Medicine, Georgetown University']"]
["NCT01052779","[u'AMAG Pharmaceuticals, Inc.']","[u'AMAG Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01052779","['AMAG Pharmaceuticals, Inc.']"]
["NCT01054313","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT01054313","['M.D. Anderson Cancer Center']"]
["NCT01055444","[u'ZARS Pharma Inc.']","[u'ZARS Pharma Inc.']","https://clinicaltrials.gov/ct2/show/NCT01055444","['ZARS Pharma Inc.']"]
["NCT01057121","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01057121","['National Cancer Institute (NCI)']"]
["NCT01058096","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT01058096","['Forest Laboratories']"]
["NCT01060566","[]","[u'Vertex Pharmaceuticals Incorporated']","https://clinicaltrials.gov/ct2/show/NCT01060566","['Medical Monitor, Vertex Pharmaceuticals Incorporated']"]
["NCT01062568","[u'Jeffrey Chang, MD, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT01062568","['Jeffrey Chang, MD, Principal Investigator, University of California, San Diego']"]
["NCT01063816","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT01063816","['AbbVie (prior sponsor, Abbott)']"]
["NCT01065506","[u'Jasper Smits, Ph.D., University of Texas at Austin']","[u'Southern Methodist University']","https://clinicaltrials.gov/ct2/show/NCT01065506","['Jasper Smits, Ph.D., Principal Investigator, University of Texas at Austin']"]
["NCT01065558","[u'Psyadon Pharma']","[u'Psyadon Pharma']","https://clinicaltrials.gov/ct2/show/NCT01065558","['Psyadon Pharma']"]
["NCT01068717","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01068717","['AstraZeneca']"]
["NCT01069328","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT01069328","['Bayer']"]
["NCT01071252","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01071252","['Novartis Pharmaceuticals']"]
["NCT01072643","[u\"Aruna Nathan, Children's Hospital of Philadelphia\"]","[u'Aruna Nathan']","https://clinicaltrials.gov/ct2/show/NCT01072643","[\"Aruna Nathan, Attending Physician, Children's Hospital of Philadelphia\"]"]
["NCT01074372","[u'Regeneron Pharmaceuticals']","[u'Regeneron Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01074372","['Regeneron Pharmaceuticals']"]
["NCT01075906","[u'Mutual Pharmaceutical Company, Inc.']","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01075906","['Mutual Pharmaceutical Company, Inc.']"]
["NCT01078298","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01078298","['Pfizer']"]
["NCT01080677","[u'S. Charles Cho, Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT01080677","['S. Charles Cho, Principle Investigator, Stanford University']"]
["NCT01081782","[u'Ono Pharmaceutical Co. Ltd ( Ono Pharma USA Inc )']","[u'Ono Pharma USA Inc']","https://clinicaltrials.gov/ct2/show/NCT01081782","['Ono Pharma USA Inc']"]
["NCT01082549","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT01082549","['Sanofi']"]
["NCT01084135","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT01084135","['Duke University']"]
["NCT01085422","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT01085422","['AbbVie (prior sponsor, Abbott)']"]
["NCT01087567","[u'Jay Shubrook, Ohio University']","[u'Ohio University']","https://clinicaltrials.gov/ct2/show/NCT01087567","['Jay Shubrook, Associate Professor, Ohio University']"]
["NCT01088919","[]","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT01088919","['Sr Manager Clinical Trials Registry, Astellas Pharma Global Development']"]
["NCT01090921","[u'Nikhil Munshi, M.D., Boston VA Research Institute, Inc.']","[u'Boston VA Research Institute, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01090921","['Nikhil Munshi, M.D., Principal Invesetigator -- Coordinating Site, Boston VA Research Institute, Inc.']"]
["NCT01091142","[]","[u'Neuraltus Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01091142","['Nancy E. Isaac/VP Regulatory Affairs, Neuraltus Pharmaceuticals, Inc.']"]
["NCT01093222","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01093222","['National Cancer Institute (NCI)']"]
["NCT01096186","[u'IMPAX Laboratories, Inc.']","[u'IMPAX Laboratories, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01096186","['IMPAX Laboratories, Inc.']"]
["NCT01096667","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01096667","['Merck Sharp & Dohme Corp.']"]
["NCT01098318","[u'University of Pennsylvania']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT01098318","['University of Pennsylvania']"]
["NCT01099631","[u'Masonic Cancer Center, University of Minnesota']","[u'Masonic Cancer Center, University of Minnesota']","https://clinicaltrials.gov/ct2/show/NCT01099631","['Masonic Cancer Center, University of Minnesota']"]
["NCT01101841","[u'Noven Therapeutics']","[u'Noven Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT01101841","['Noven Therapeutics']"]
["NCT01103622","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01103622","['MSD, AstraZeneca']"]
["NCT01105130","[u'Wake Forest University Health Sciences']","[u'Wake Forest University Health Sciences']","https://clinicaltrials.gov/ct2/show/NCT01105130","['Wake Forest University Health Sciences']"]
["NCT01106040","[u'Navidea Biopharmaceuticals']","[u'Navidea Biopharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01106040","['Navidea Biopharmaceuticals']"]
["NCT01107444","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01107444","['Eli Lilly and Company']"]
["NCT01109940","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01109940","['Novartis Pharmaceuticals']"]
["NCT01110486","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT01110486","['AbbVie (prior sponsor, Abbott)']"]
["NCT01113931","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT01113931","['Warner Chilcott']"]
["NCT01115062","[u'Carol Morreale, CAMC Health System']","[u'Carol Morreale']","https://clinicaltrials.gov/ct2/show/NCT01115062","['Carol Morreale, Clinical Pharmacist Specialist, CAMC Health System']"]
["NCT01115582","[u'Retrophin, Inc.']","[u'Retrophin, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01115582","['Retrophin, Inc.']"]
["NCT01116687","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01116687","['National Cancer Institute (NCI)']"]
["NCT01118351","[u'Case Comprehensive Cancer Center']","[u'Case Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT01118351","['Case Comprehensive Cancer Center']"]
["NCT01119898","[]","[u'Mallinckrodt']","https://clinicaltrials.gov/ct2/show/NCT01119898","['Joseph Pierro, MD, VP Medical Sciences, Mallinckrodt']"]
["NCT01121276","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT01121276","['Novo Nordisk A/S']"]
["NCT01122667","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01122667","['Merck Sharp & Dohme Corp.']"]
["NCT01124747","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT01124747","['Astellas Pharma Inc']"]
["NCT01126970","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT01126970","['Shionogi']"]
["NCT01128556","[]","[u'North Texas Institute for Clinical Trials']","https://clinicaltrials.gov/ct2/show/NCT01128556","['Bob Q. Lanier, M.D., North Texas Institute for Clinical Trials']"]
["NCT01129258","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01129258","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT01130493","[u'IMPAX Laboratories, Inc.']","[u'IMPAX Laboratories, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01130493","['IMPAX Laboratories, Inc.']"]
["NCT01132183","[]","[u\"Dr. Reddy's Laboratories Limited\"]","https://clinicaltrials.gov/ct2/show/NCT01132183","[\"Mr. Indu Bhushan / Sr. Director R & D, Dr.Reddy's Laboratories Limited,\"]"]
["NCT01133522","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT01133522","['Amgen']"]
["NCT01134965","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01134965","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT01136941","[u\"Children's Hospital Medical Center, Cincinnati\"]","[u\"Children's Hospital Medical Center, Cincinnati\"]","https://clinicaltrials.gov/ct2/show/NCT01136941","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT01138475","[u'Kerstyn C. Zalesin, M.D., William Beaumont Hospitals']","[u'Kerstyn C. Zalesin, M.D.']","https://clinicaltrials.gov/ct2/show/NCT01138475","['Kerstyn C. Zalesin, M.D., Principal Investigator, William Beaumont Hospitals']"]
["NCT01140347","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01140347","['Eli Lilly and Company']"]
["NCT01142154","[]","[u'DNage B.V.']","https://clinicaltrials.gov/ct2/show/NCT01142154","['Lia Dam/Director Clinical Operations, DNage']"]
["NCT01143077","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT01143077","['Sunovion']"]
["NCT01145456","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01145456","['National Cancer Institute (NCI)']"]
["NCT01147718","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01147718","['GlaxoSmithKline']"]
["NCT01147939","[u'Clavis Pharma']","[u'Clavis Pharma']","https://clinicaltrials.gov/ct2/show/NCT01147939","['Clavis Pharma']"]
["NCT01149616","[u'Lauren J. Fisher, Beth Israel Deaconess Medical Center']","[u'Beth Israel Deaconess Medical Center']","https://clinicaltrials.gov/ct2/show/NCT01149616","['Lauren J. Fisher, Attending Physician, Beth Israel Deaconess Medical Center']"]
["NCT01151410","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01151410","['Novartis Pharmaceuticals']"]
["NCT01154062","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01154062","['GlaxoSmithKline']"]
["NCT01154426","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01154426","['National Cancer Institute (NCI)']"]
["NCT01156311","[u'Biogen']","[u'Biogen']","https://clinicaltrials.gov/ct2/show/NCT01156311","['Biogen']"]
["NCT01159015","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT01159015","['Bausch & Lomb Incorporated']"]
["NCT01160289","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01160289","['Eli Lilly and Company']"]
["NCT01161628","[u'Northside Hospital, Inc.']","[u'Northside Hospital, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01161628","['Northside Hospital, Inc.']"]
["NCT01162122","[u'Novartis ( Novartis Vaccines )']","[u'Novartis Vaccines']","https://clinicaltrials.gov/ct2/show/NCT01162122","['Novartis Vaccines']"]
["NCT01164826","[]","[u\"Dr. Reddy's Laboratories Limited\"]","https://clinicaltrials.gov/ct2/show/NCT01164826","[\"Mr. M.S. Mohan/ Vice President - R & D, Dr. Reddy's Laboratories Limited\"]"]
["NCT01165996","[u'Case Comprehensive Cancer Center']","[u'Case Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT01165996","['Case Comprehensive Cancer Center']"]
["NCT01166087","[]","[u\"Dr. Reddy's Laboratories Limited\"]","https://clinicaltrials.gov/ct2/show/NCT01166087","[\"Mr. M.S. Mohan / Vice President (Research and Development), Dr. Reddy's Laboratories Limited\"]"]
["NCT01167894","[]","[u\"Dr. Reddy's Laboratories Limited\"]","https://clinicaltrials.gov/ct2/show/NCT01167894","[\"Mr. M.S. Mohan / Vice President (Research and Development), Dr. Reddy's Laboratories Limited\"]"]
["NCT01169844","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01169844","['Novartis Pharmaceuticals']"]
["NCT01171664","[u'Magna Pharmaceuticals, Inc.']","[u'Magna Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01171664","['Magna Pharmaceuticals, Inc.']"]
["NCT01173055","[u'Daniel Clauw, MD, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT01173055","['Daniel Clauw, MD, Daniel Clauw, Professor of Anesthesiology, University of Michigan, University of Michigan']"]
["NCT01174888","[u'Alison Walker, Ohio State University Comprehensive Cancer Center']","[u'Alison Walker']","https://clinicaltrials.gov/ct2/show/NCT01174888","['Alison Walker, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT01177150","[]","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT01177150","['Study Physician, Johnson & Johnson Pharmaceutical Research and Development, L.L.C.']"]
["NCT01178827","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT01178827","['Allergan']"]
["NCT01181258","[u'Masonic Cancer Center, University of Minnesota']","[u'Masonic Cancer Center, University of Minnesota']","https://clinicaltrials.gov/ct2/show/NCT01181258","['Masonic Cancer Center, University of Minnesota']"]
["NCT01183715","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01183715","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT01186484","[u'Janssen Pharmaceutical K.K.']","[u'Janssen Pharmaceutical K.K.']","https://clinicaltrials.gov/ct2/show/NCT01186484","['Janssen Pharmaceutical K.K.']"]
["NCT01187186","[]","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT01187186","['Sr Manager Clinical Trials Registry, Astellas Pharma Global Development']"]
["NCT01188811","[u'VA Office of Research and Development']","[u'VA Office of Research and Development']","https://clinicaltrials.gov/ct2/show/NCT01188811","['VA Office of Research and Development']"]
["NCT01191021","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT01191021","['University of California, San Francisco']"]
["NCT01192139","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01192139","['AstraZeneca']"]
["NCT01194414","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT01194414","['Hoffmann-La Roche']"]
["NCT01194440","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","https://clinicaltrials.gov/ct2/show/NCT01194440","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01196676","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01196676","['Medical Science Director, AstraZeneca']"]
["NCT01199289","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT01199289","['Amgen']"]
["NCT01200290","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01200290","['Eli Lilly and Company']"]
["NCT01202188","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01202188","['Novartis Pharmaceuticals']"]
["NCT01204710","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01204710","['Eli Lilly and Company']"]
["NCT01205373","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01205373","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT01207414","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT01207414","['Novartis']"]
["NCT01209351","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT01209351","['Shire']"]
["NCT01211795","[]","[u'Behar, Caren, M.D.']","https://clinicaltrials.gov/ct2/show/NCT01211795","['Caren Behar MD FACP, NYMC']"]
["NCT01213355","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01213355","['Pfizer']"]
["NCT01215747","[u'C.T. Development America, Inc.']","[u'C.T. Development America, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01215747","['C.T. Development America, Inc.']"]
["NCT01217749","[u'Pharmacyclics LLC.']","[u'Pharmacyclics LLC.']","https://clinicaltrials.gov/ct2/show/NCT01217749","['Pharmacyclics LLC.']"]
["NCT01218659","[u'Amicus Therapeutics']","[u'Amicus Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT01218659","['Amicus Therapeutics']"]
["NCT01221285","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT01221285","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01222585","[u'Michael Cohen-Wolkowiez, Duke University']","[u'Michael Cohen-Wolkowiez']","https://clinicaltrials.gov/ct2/show/NCT01222585","['Michael Cohen-Wolkowiez, Assistant Professor of Pediatrics, Duke University']"]
["NCT01222715","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01222715","['National Cancer Institute (NCI)']"]
["NCT01224639","[u'Takeda ( Inviragen Inc. )']","[u'Inviragen Inc.']","https://clinicaltrials.gov/ct2/show/NCT01224639","['Inviragen Inc.']"]
["NCT01227577","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01227577","['Novartis Pharmaceuticals']"]
["NCT01227993","[u'National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )']","[u'National Eye Institute (NEI)']","https://clinicaltrials.gov/ct2/show/NCT01227993","['National Eye Institute (NEI)']"]
["NCT01230801","[u'BioMarin Pharmaceutical']","[u'BioMarin Pharmaceutical']","https://clinicaltrials.gov/ct2/show/NCT01230801","['BioMarin Pharmaceutical']"]
["NCT01232452","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01232452","['Eli Lilly and Company']"]
["NCT01234012","[u'ImmunoFrontier, Inc.']","[u'ImmunoFrontier, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01234012","['ImmunoFrontier, Inc.']"]
["NCT01235923","[u'University of New Mexico']","[u'University of New Mexico']","https://clinicaltrials.gov/ct2/show/NCT01235923","['University of New Mexico']"]
["NCT01239004","[u'Radiant Research']","[u'Radiant Research']","https://clinicaltrials.gov/ct2/show/NCT01239004","['Radiant Research']"]
["NCT01240538","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01240538","['National Cancer Institute (NCI)']"]
["NCT01242527","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01242527","['AstraZeneca']"]
["NCT01243983","[u'Lux Biosciences, Inc.']","[u'Lux Biosciences, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01243983","['Lux Biosciences, Inc.']"]
["NCT01245205","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01245205","['National Cancer Institute (NCI)']"]
["NCT01248416","[u\"Nelly Mauras, Nemours Children's Clinic\"]","[u\"Nemours Children's Clinic\"]","https://clinicaltrials.gov/ct2/show/NCT01248416","[\"Nelly Mauras, Chief, Division of Endocrinology, Diabetes & Metabolism, Nemours Children's Clinic\"]"]
["NCT01250548","[u'Baylor Research Institute']","[u'Baylor Research Institute']","https://clinicaltrials.gov/ct2/show/NCT01250548","['Baylor Research Institute']"]
["NCT01252693","[u'Spectrum Pharmaceuticals, Inc']","[u'Spectrum Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT01252693","['Spectrum Pharmaceuticals, Inc']"]
["NCT01253317","[u'Mustafa Sahin, Boston Children\\u2019s Hospital']","[u'Boston Children\\u2019s Hospital']","https://clinicaltrials.gov/ct2/show/NCT01253317","[u'Mustafa Sahin, Professor in Neurology, Harvard Medical School, Boston Children\\u2019s Hospital']"]
["NCT01253902","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT01253902","['Allergan']"]
["NCT01255423","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT01255423","['Novartis']"]
["NCT01257230","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01257230","['Boehringer Ingelheim']"]
["NCT01258530","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01258530","['GlaxoSmithKline']"]
["NCT01260584","[u'Daiichi Sankyo, Inc.']","[u'Daiichi Sankyo, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01260584","['Daiichi Sankyo, Inc.']"]
["NCT01262352","[u'Vertex Pharmaceuticals Incorporated']","[u'Vertex Pharmaceuticals Incorporated']","https://clinicaltrials.gov/ct2/show/NCT01262352","['Vertex Pharmaceuticals Incorporated']"]
["NCT01263353","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01263353","['Novartis Pharmaceuticals']"]
["NCT01265745","[u'PharmAthene, Inc.']","[u'PharmAthene, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01265745","['PharmAthene, Inc.']"]
["NCT01267227","[u'Daniel Riche, University of Mississippi Medical Center']","[u'University of Mississippi Medical Center']","https://clinicaltrials.gov/ct2/show/NCT01267227","['Daniel Riche, Assistant Professor of Pharmacy Practice and Medicine, University of Mississippi Medical Center']"]
["NCT01269047","[u'Rubina Heptulla, Albert Einstein College of Medicine']","[u'Albert Einstein College of Medicine']","https://clinicaltrials.gov/ct2/show/NCT01269047","['Rubina Heptulla, Division Chief of Pediatric Endocrinology & Diabetes, Albert Einstein College of Medicine, Inc.']"]
["NCT01270945","[u'XBiotech, Inc.']","[u'XBiotech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01270945","['XBiotech, Inc.']"]
["NCT01272635","[u'dave mauger, Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT01272635","['dave mauger, Principal Investigator, AsthmaNet Data Coordinating Center, Milton S. Hershey Medical Center']"]
["NCT01273727","[u'John Khadem, Retina Specialists, PC']","[u'Retina Specialists, PC']","https://clinicaltrials.gov/ct2/show/NCT01273727","['John Khadem, Principal Investigator, Retina Specialists, PC']"]
["NCT01276587","[u'Gary M Brittenham, MD, Columbia University']","[u'Gary M Brittenham, MD']","https://clinicaltrials.gov/ct2/show/NCT01276587","['Gary M Brittenham, MD, James A. Wolff Professor of Pediatrics, Columbia University']"]
["NCT01278394","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01278394","['Pfizer']"]
["NCT01281150","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01281150","['National Cancer Institute (NCI)']"]
["NCT01281579","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT01281579","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT01283360","[u'CONRAD']","[u'CONRAD']","https://clinicaltrials.gov/ct2/show/NCT01283360","['CONRAD']"]
["NCT01284530","[u'Supernus Pharmaceuticals, Inc.']","[u'Supernus Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01284530","['Supernus Pharmaceuticals, Inc.']"]
["NCT01287897","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01287897","['Pfizer']"]
["NCT01289015","[u'Merz North America, Inc.']","[u'Merz North America, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01289015","['Merz North America, Inc.']"]
["NCT01290042","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT01290042","['Amgen']"]
["NCT01291901","[u'Diamyd Inc']","[u'Diamyd Inc']","https://clinicaltrials.gov/ct2/show/NCT01291901","['Diamyd Inc']"]
["NCT01292798","[u'California Retina Consultants']","[u'California Retina Consultants']","https://clinicaltrials.gov/ct2/show/NCT01292798","['California Retina Consultants']"]
["NCT01294826","[u'Swedish Medical Center']","[u'Swedish Medical Center']","https://clinicaltrials.gov/ct2/show/NCT01294826","['Swedish Medical Center']"]
["NCT01296152","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT01296152","['AIDS Clinical Trials Group']"]
["NCT01299558","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01299558","['GlaxoSmithKline']"]
["NCT01301456","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01301456","['Pfizer']"]
["NCT01303861","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT01303861","['Duke University']"]
["NCT01304589","[u'Candace Brown, MSN, Pharm.D., University of Tennessee']","[u'University of Tennessee']","https://clinicaltrials.gov/ct2/show/NCT01304589","['Candace Brown, MSN, Pharm.D., Professor, Departments of Clinical Pharmacy, Psychiatry and Obstetrics/Gynecology, University of Tennessee']"]
["NCT01309828","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT01309828","['Takeda']"]
["NCT01309841","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01309841","['AstraZeneca']"]
["NCT01311661","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01311661","['Boehringer Ingelheim']"]
["NCT01313299","[u'Ipsen']","[u'Ipsen']","https://clinicaltrials.gov/ct2/show/NCT01313299","['Ipsen']"]
["NCT01314898","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01314898","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT01317615","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01317615","['Novartis Pharmaceuticals']"]
["NCT01319383","[u'University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT01319383","['University of North Carolina, Chapel Hill']"]
["NCT01322386","[u'Kenneth L. Cox, Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT01322386","['Kenneth L. Cox, Professor of Pediatrics, Stanford University']"]
["NCT01324128","[u'Vifor Inc.']","[u'Vifor Inc.']","https://clinicaltrials.gov/ct2/show/NCT01324128","['Vifor Inc.']"]
["NCT01325415","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01325415","['AstraZeneca']"]
["NCT01327677","[u'Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT01327677","['Johns Hopkins University']"]
["NCT01329965","[u'Penny Kris-Etherton, Penn State University']","[u'Penn State University']","https://clinicaltrials.gov/ct2/show/NCT01329965","['Penny Kris-Etherton, Distinguished Professor of Nutrition, Penn State University']"]
["NCT01331291","[u'Tracy T. Batchelor, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT01331291","['Tracy T. Batchelor, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT01333111","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT01333111","['Novo Nordisk A/S']"]
["NCT01334944","[u'Cumberland Pharmaceuticals']","[u'Cumberland Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01334944","['Cumberland Pharmaceuticals']"]
["NCT01335607","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01335607","['Merck Sharp & Dohme Corp.']"]
["NCT01338792","[u'University of Southern California']","[u'University of Southern California']","https://clinicaltrials.gov/ct2/show/NCT01338792","['University of Southern California']"]
["NCT01338805","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01338805","['Novartis Pharmaceuticals']"]
["NCT01340820","[u'Aeras']","[u'Aeras']","https://clinicaltrials.gov/ct2/show/NCT01340820","['Aeras']"]
["NCT01343888","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01343888","['Boehringer Ingelheim']"]
["NCT01345188","[u'Dr. Nicolas Shammas, Midwest Cardiovascular Research Foundation']","[u'Midwest Cardiovascular Research Foundation']","https://clinicaltrials.gov/ct2/show/NCT01345188","['Dr. Nicolas Shammas, Principal Investigator, MD, Midwest Cardiovascular Research Foundation']"]
["NCT01347879","[u'Photocure']","[u'Photocure']","https://clinicaltrials.gov/ct2/show/NCT01347879","['Photocure']"]
["NCT01351025","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT01351025","['AIDS Clinical Trials Group']"]
["NCT01353209","[u'Francis McCormack, University of Cincinnati']","[u'University of Cincinnati']","https://clinicaltrials.gov/ct2/show/NCT01353209","['Francis McCormack, Pulmonary Director, University of Cincinnati']"]
["NCT01355289","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT01355289","['Eisai Inc.']"]
["NCT01357759","[u'Morphotek']","[u'Morphotek']","https://clinicaltrials.gov/ct2/show/NCT01357759","['Morphotek']"]
["NCT01358864","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01358864","['Boehringer Ingelheim']"]
["NCT01360840","[u'EMD Serono']","[u'EMD Serono']","https://clinicaltrials.gov/ct2/show/NCT01360840","['EMD Serono']"]
["NCT01363050","[u'Egalet Ltd']","[u'Egalet Ltd']","https://clinicaltrials.gov/ct2/show/NCT01363050","['Egalet Ltd']"]
["NCT01364974","[]","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT01364974","['Clinical Trials Registry, Astellas Pharma Global Development']"]
["NCT01366131","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01366131","['Genentech, Inc.']"]
["NCT01367535","[]","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01367535","['Tage Ramakrishna, M.D.;, Progenics Pharmaceuticals, Inc.']"]
["NCT01369511","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01369511","['Eli Lilly and Company']"]
["NCT01369602","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01369602","['Pfizer']"]
["NCT01371565","[u'Corcept Therapeutics']","[u'Corcept Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT01371565","['Corcept Therapeutics']"]
["NCT01372618","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT01372618","['New York University School of Medicine']"]
["NCT01375582","[u'James V. Aquavella, MD, University of Rochester']","[u'University of Rochester']","https://clinicaltrials.gov/ct2/show/NCT01375582","['James V. Aquavella, MD, Principal Investigator, University of Rochester']"]
["NCT01376726","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT01376726","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01378975","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT01378975","['Hoffmann-La Roche']"]
["NCT01380704","[u'AbbVie']","[u'AbbVie']","https://clinicaltrials.gov/ct2/show/NCT01380704","['AbbVie']"]
["NCT01382719","[u'Palatin Technologies']","[u'Palatin Technologies']","https://clinicaltrials.gov/ct2/show/NCT01382719","['Palatin Technologies']"]
["NCT01386112","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT01386112","['Forest Laboratories']"]
["NCT01387321","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01387321","['Novartis Pharmaceuticals']"]
["NCT01390337","[u'Daiichi Sankyo, Inc.']","[u'Daiichi Sankyo, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01390337","['Daiichi Sankyo, Inc.']"]
["NCT01392755","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT01392755","['Hoffmann-La Roche']"]
["NCT01393626","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01393626","['Pfizer']"]
["NCT01396187","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01396187","['Pfizer']"]
["NCT01397604","[u'Rockefeller University']","[u'Rockefeller University']","https://clinicaltrials.gov/ct2/show/NCT01397604","['Rockefeller University']"]
["NCT01399619","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01399619","['Boehringer Ingelheim']"]
["NCT01400412","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT01400412","['AIDS Clinical Trials Group']"]
["NCT01401543","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01401543","['Eli Lilly and Company']"]
["NCT01403636","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT01403636","['Sanofi']"]
["NCT01406223","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT01406223","['Duke University']"]
["NCT01407276","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01407276","['Merck Sharp & Dohme Corp.']"]
["NCT01409239","[u'Kathleen Dungan, Ohio State University']","[u'Kathleen Dungan']","https://clinicaltrials.gov/ct2/show/NCT01409239","['Kathleen Dungan, Assistant Professor, Ohio State University']"]
["NCT01411930","[u'Jonathan M. Meyer, MD, Veterans Medical Research Foundation']","[u'Veterans Medical Research Foundation']","https://clinicaltrials.gov/ct2/show/NCT01411930","['Jonathan M. Meyer, MD, Research Scientist, Veterans Medical Research Foundation']"]
["NCT01413932","[u'Dart NeuroScience, LLC']","[u'Dart NeuroScience, LLC']","https://clinicaltrials.gov/ct2/show/NCT01413932","['Dart NeuroScience, LLC']"]
["NCT01416441","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01416441","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT01419041","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01419041","['Pfizer']"]
["NCT01421134","[u'Sunovion']","[u'Sunovion']","https://clinicaltrials.gov/ct2/show/NCT01421134","['Sunovion']"]
["NCT01422330","[u'Janssen R&D Ireland']","[u'Janssen R&D Ireland']","https://clinicaltrials.gov/ct2/show/NCT01422330","['Janssen R&D Ireland']"]
["NCT01425528","[u'Kathryn Swoboda, University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT01425528","['Kathryn Swoboda, Associate Professor, Neurology and Pediatrics Director, Pediatric Motor Disorders Research Program, University of Utah']"]
["NCT01427309","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT01427309","['Sanofi Pasteur, a Sanofi Company']"]
["NCT01429259","[u'Joseph Kuti, Hartford Hospital']","[u'Joseph Kuti']","https://clinicaltrials.gov/ct2/show/NCT01429259","['Joseph Kuti, Associate Director, Center for Anti-Infective Research and Development, Hartford Hospital']"]
["NCT01431339","[u'Durata Therapeutics Inc., an affiliate of Allergan plc']","[u'Durata Therapeutics Inc., an affiliate of Allergan plc']","https://clinicaltrials.gov/ct2/show/NCT01431339","['Durata Therapeutics Inc., an affiliate of Allergan plc']"]
["NCT01432457","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01432457","['Pfizer']"]
["NCT01433263","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01433263","['Novartis Pharmaceuticals']"]
["NCT01435499","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[u'Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","https://clinicaltrials.gov/ct2/show/NCT01435499","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01436500","[u'Cumberland Pharmaceuticals']","[u'Cumberland Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01436500","['Cumberland Pharmaceuticals']"]
["NCT01439230","[u'Teva Pharmaceuticals USA']","[u'Teva Pharmaceuticals USA']","https://clinicaltrials.gov/ct2/show/NCT01439230","['Teva Pharmaceuticals USA']"]
["NCT01439971","[u'Catalyst Biosciences']","[u'Catalyst Biosciences']","https://clinicaltrials.gov/ct2/show/NCT01439971","['Catalyst Biosciences']"]
["NCT01442038","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT01442038","['Gilead Sciences']"]
["NCT01444651","[u'Thomas J. Wang, MD, Massachusetts General Hospital']","[u'Thomas J. Wang, MD']","https://clinicaltrials.gov/ct2/show/NCT01444651","['Thomas J. Wang, MD, Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital']"]
["NCT01445548","[u'National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )']","[u'National Eye Institute (NEI)']","https://clinicaltrials.gov/ct2/show/NCT01445548","['National Eye Institute (NEI)']"]
["NCT01448200","[u'Presidio Pharmaceuticals, Inc.']","[u'Presidio Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01448200","['Presidio Pharmaceuticals, Inc.']"]
["NCT01448824","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01448824","['Eli Lilly and Company']"]
["NCT01452607","[u'Sound Pharmaceuticals, Incorporated']","[u'Sound Pharmaceuticals, Incorporated']","https://clinicaltrials.gov/ct2/show/NCT01452607","['Sound Pharmaceuticals, Incorporated']"]
["NCT01453725","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT01453725","['Merck Sharp & Dohme Corp.']"]
["NCT01455493","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01455493","['Genentech, Inc.']"]
["NCT01456052","[u'Lexicon Pharmaceuticals']","[u'Lexicon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01456052","['Lexicon Pharmaceuticals']"]
["NCT01458288","[u'TaiGen Biotechnology Co., Ltd.']","[u'TaiGen Biotechnology Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT01458288","['TaiGen Biotechnology Co., Ltd.']"]
["NCT01458327","[u'Multidisciplinary Association for Psychedelic Studies']","[u'Multidisciplinary Association for Psychedelic Studies']","https://clinicaltrials.gov/ct2/show/NCT01458327","['Multidisciplinary Association for Psychedelic Studies']"]
["NCT01460407","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01460407","['Eli Lilly and Company']"]
["NCT01462318","[u'Biogen']","[u'Biogen']","https://clinicaltrials.gov/ct2/show/NCT01462318","['Biogen']"]
["NCT01464099","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT01464099","['Novo Nordisk A/S']"]
["NCT01465802","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01465802","['Pfizer']"]
["NCT01467882","[u'Debiopharm International SA']","[u'Debiopharm International SA']","https://clinicaltrials.gov/ct2/show/NCT01467882","['Debiopharm International SA']"]
["NCT01469637","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT01469637","['Shire']"]
["NCT01471717","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT01471717","['Bristol-Myers Squibb']"]
["NCT01473589","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01473589","['Eli Lilly and Company']"]
["NCT01474993","[u'Andrew Zimmerman, University of Massachusetts, Worcester']","[u'Andrew Zimmerman']","https://clinicaltrials.gov/ct2/show/NCT01474993","['Andrew Zimmerman, Pediatric Neurologist, University of Massachusetts, Worcester']"]
["NCT01476202","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01476202","['GlaxoSmithKline']"]
["NCT01478568","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT01478568","['Astellas Pharma Inc']"]
["NCT01481129","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01481129","['National Cancer Institute (NCI)']"]
["NCT01483963","[u'Endo Pharmaceuticals']","[u'Endo Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01483963","['Endo Pharmaceuticals']"]
["NCT01484912","[u'Sinphar Pharmaceutical Co., Ltd']","[u'Sinphar Pharmaceutical Co., Ltd']","https://clinicaltrials.gov/ct2/show/NCT01484912","['Sinphar Pharmaceutical Co., Ltd']"]
["NCT01487161","[u'Flexion Therapeutics, Inc.']","[u'Flexion Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01487161","['Flexion Therapeutics, Inc.']"]
["NCT01487239","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01487239","['Genentech, Inc.']"]
["NCT01489644","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT01489644","['Novo Nordisk A/S']"]
["NCT01492426","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT01492426","['Bristol-Myers Squibb']"]
["NCT01493843","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01493843","['Genentech, Inc.']"]
["NCT01495858","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT01495858","['Bayer']"]
["NCT01498718","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT01498718","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01499303","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01499303","['AstraZeneca']"]
["NCT01502410","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT01502410","['National Cancer Institute (NCI)']"]
["NCT01504906","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT01504906","['AstraZeneca']"]
["NCT01506154","[u'MEDRx USA, Inc.']","[u'MEDRx USA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01506154","['MEDRx USA, Inc.']"]
["NCT01507831","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT01507831","['Sanofi']"]
["NCT01510704","[u'Acacia Pharma Ltd']","[u'Acacia Pharma Ltd']","https://clinicaltrials.gov/ct2/show/NCT01510704","['Acacia Pharma Ltd']"]
["NCT01513057","[u\"Dr. Reddy's Laboratories Limited\"]","[u\"Dr. Reddy's Laboratories Limited\"]","https://clinicaltrials.gov/ct2/show/NCT01513057","[\"Dr. Reddy's Laboratories Limited\"]"]
["NCT01514929","[u'Achaogen, Inc.']","[u'Achaogen, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01514929","['Achaogen, Inc.']"]
["NCT01516879","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT01516879","['Amgen']"]
["NCT01518699","[u'Hatchtech Pty Ltd']","[u'Hatchtech Pty Ltd']","https://clinicaltrials.gov/ct2/show/NCT01518699","['Hatchtech Pty Ltd']"]
["NCT01518712","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT01518712","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT01520649","[u'Neuralstem Inc.']","[u'Neuralstem Inc.']","https://clinicaltrials.gov/ct2/show/NCT01520649","['Neuralstem Inc.']"]
["NCT01522664","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01522664","['Genentech, Inc.']"]
["NCT01525043","[u'International Clinical Research Institute']","[u'International Clinical Research Institute']","https://clinicaltrials.gov/ct2/show/NCT01525043","['International Clinical Research Institute']"]
["NCT01527994","[u'Stephen Ross, New York University']","[u'New York University']","https://clinicaltrials.gov/ct2/show/NCT01527994","['Stephen Ross, Director, Division of Alcoholism & Drug Abuse, NYU/Bellevue Hospital Center, New York University']"]
["NCT01530022","[u'UCB Pharma']","[u'UCB Pharma']","https://clinicaltrials.gov/ct2/show/NCT01530022","['UCB Pharma']"]
["NCT01531699","[u'Altacor Ltd.']","[u'Altacor Ltd.']","https://clinicaltrials.gov/ct2/show/NCT01531699","['Altacor Ltd.']"]
["NCT01534208","[u'Repros Therapeutics Inc.']","[u'Repros Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT01534208","['Repros Therapeutics Inc.']"]
["NCT01536704","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT01536704","['GlaxoSmithKline']"]
["NCT01537692","[u'Teva Pharmaceutical Industries']","[u'Teva Pharmaceutical Industries']","https://clinicaltrials.gov/ct2/show/NCT01537692","['Teva Pharmaceutical Industries']"]
["NCT01540591","[u'Waleed El-khayat, Cairo University']","[u'Cairo University']","https://clinicaltrials.gov/ct2/show/NCT01540591","['Waleed El-khayat, Assisstant professor, Cairo University']"]
["NCT01543958","[u'AIDS Clinical Trials Group']","[u'AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT01543958","['AIDS Clinical Trials Group']"]
["NCT01545440","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01545440","['Genentech, Inc.']"]
["NCT01546415","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01546415","['Novartis Pharmaceuticals']"]
["NCT01550523","[u'Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )']","[u'Sidney Kimmel Cancer Center at Thomas Jefferson University']","https://clinicaltrials.gov/ct2/show/NCT01550523","['Sidney Kimmel Cancer Center at Thomas Jefferson University']"]
["NCT01552863","[u'Pain Therapeutics']","[u'Pain Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT01552863","['Pain Therapeutics']"]
["NCT01555008","[u'Lexicon Pharmaceuticals']","[u'Lexicon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01555008","['Lexicon Pharmaceuticals']"]
["NCT01556594","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT01556594","['Eli Lilly and Company']"]
["NCT01558661","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT01558661","['Memorial Sloan Kettering Cancer Center']"]
["NCT01561274","[u'Albert Moore, McGill University Health Center']","[u'McGill University Health Center']","https://clinicaltrials.gov/ct2/show/NCT01561274","['Albert Moore, Assistant professor, principal investigator, McGill University Health Center']"]
["NCT01562938","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT01562938","['MedImmune LLC']"]
["NCT01565668","[u'Daiichi Sankyo, Inc.']","[u'Daiichi Sankyo, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01565668","['Daiichi Sankyo, Inc.']"]
["NCT01791855","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01791855","['Pfizer']"]
["NCT01798225","[u'Medical University of South Carolina']","[u'Medical University of South Carolina']","https://clinicaltrials.gov/ct2/show/NCT01798225","['Medical University of South Carolina']"]
["NCT01801124","[u'Pacira Pharmaceuticals, Inc']","[u'Pacira Pharmaceuticals, Inc']","https://clinicaltrials.gov/ct2/show/NCT01801124","['Pacira Pharmaceuticals, Inc']"]
["NCT01804829","[u'Biotest Pharmaceuticals Corporation']","[u'Biotest Pharmaceuticals Corporation']","https://clinicaltrials.gov/ct2/show/NCT01804829","['Biotest Pharmaceuticals Corporation']"]
["NCT01807871","[u'John Hughes, University of Vermont']","[u'University of Vermont']","https://clinicaltrials.gov/ct2/show/NCT01807871","['John Hughes, Faculty Department of Psychiatry, University of Vermont']"]
["NCT01812057","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT01812057","['Duke University']"]
["NCT01814800","[u'ADMA Biologics, Inc.']","[u'ADMA Biologics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01814800","['ADMA Biologics, Inc.']"]
["NCT01818232","[u'Lexicon Pharmaceuticals']","[u'Lexicon Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01818232","['Lexicon Pharmaceuticals']"]
["NCT01821118","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01821118","['Pfizer']"]
["NCT01824342","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT01824342","['Amgen']"]
["NCT01824901","[u'Eastern Cooperative Oncology Group ( ECOG-ACRIN Cancer Research Group )']","[u'ECOG-ACRIN Cancer Research Group']","https://clinicaltrials.gov/ct2/show/NCT01824901","['ECOG-ACRIN Cancer Research Group']"]
["NCT01828476","[u'Rutgers, The State University of New Jersey']","[u'Rutgers, The State University of New Jersey']","https://clinicaltrials.gov/ct2/show/NCT01828476","['Rutgers, The State University of New Jersey']"]
["NCT01829243","[u'Duke University']","[u'Duke University']","https://clinicaltrials.gov/ct2/show/NCT01829243","['Duke University']"]
["NCT01831661","[u'IPCA Laboratories Ltd.']","[u'IPCA Laboratories Ltd.']","https://clinicaltrials.gov/ct2/show/NCT01831661","['IPCA Laboratories Ltd.']"]
["NCT01835665","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT01835665","['University of California, San Francisco']"]
["NCT01836393","[u'Weerachai Kosuwon, Khon Kaen University']","[u'Khon Kaen University']","https://clinicaltrials.gov/ct2/show/NCT01836393","['Weerachai Kosuwon, Department of Orthopedics, Faculty of Medicine, Khon Kaen University']"]
["NCT01841489","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT01841489","['Gilead Sciences']"]
["NCT01843634","[u'Cantex Pharmaceuticals']","[u'Cantex Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01843634","['Cantex Pharmaceuticals']"]
["NCT01846143","[u'Craig L Slingluff, Jr, University of Virginia']","[u'Craig L Slingluff, Jr']","https://clinicaltrials.gov/ct2/show/NCT01846143","['Craig L Slingluff, Jr, Director, Human Immune Therapy Center, University of Virginia']"]
["NCT01849991","[u'J. Marc Rhoads, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT01849991","['J. Marc Rhoads, Director, Pediatric Gastroentrologist, The University of Texas Health Science Center, Houston']"]
["NCT01854047","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT01854047","['Sanofi']"]
["NCT01855490","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT01855490","['Yale University']"]
["NCT01859988","[u'Regeneron Pharmaceuticals']","[u'Regeneron Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01859988","['Regeneron Pharmaceuticals']"]
["NCT01866033","[u'Janssen Research & Development, LLC']","[u'Janssen Research & Development, LLC']","https://clinicaltrials.gov/ct2/show/NCT01866033","['Janssen Research & Development, LLC']"]
["NCT01867021","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT01867021","['Novartis']"]
["NCT01872611","[u'Alcon Research']","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT01872611","['Alcon Research']"]
["NCT01872832","[u'Ardea Biosciences, Inc.']","[u'Ardea Biosciences, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01872832","['Ardea Biosciences, Inc.']"]
["NCT01876719","[u'Arbor Pharmaceuticals, Inc.']","[u'Arbor Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01876719","['Arbor Pharmaceuticals, Inc.']"]
["NCT01879618","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT01879618","['Pfizer']"]
["NCT01884571","[u'Jonathan D. Glass, M.D., Emory University']","[u'Emory University']","https://clinicaltrials.gov/ct2/show/NCT01884571","['Jonathan D. Glass, M.D., Director, Emory ALS Clinic, Emory University']"]
["NCT01887470","[u'Cumberland Pharmaceuticals']","[u'Cumberland Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT01887470","['Cumberland Pharmaceuticals']"]
["NCT01889173","[u'Tonix Pharmaceuticals, Inc.']","[u'Tonix Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01889173","['Tonix Pharmaceuticals, Inc.']"]
["NCT01892384","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT01892384","['Boehringer Ingelheim']"]
["NCT01894672","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT01894672","['Memorial Sloan Kettering Cancer Center']"]
["NCT01896934","[u'Warren Taylor, Vanderbilt University']","[u'Vanderbilt University']","https://clinicaltrials.gov/ct2/show/NCT01896934","['Warren Taylor, Associate Professor of Psychiatry, Vanderbilt University']"]
["NCT01900587","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT01900587","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT01903265","[u'Tonix Pharmaceuticals, Inc.']","[u'Tonix Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01903265","['Tonix Pharmaceuticals, Inc.']"]
["NCT01905553","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT01905553","['Shire']"]
["NCT01909401","[u'Indiana University']","[u'Indiana University']","https://clinicaltrials.gov/ct2/show/NCT01909401","['Indiana University']"]
["NCT00635557",null,"[' Myrexis Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00635557","Andrew P. Beelen, MD / Sr. Director of Clinical Research, Myrexis Inc. "]
["NCT00117429",null,"[' Marcus Altfeld, M.D., Ph.D. ']","https://clinicaltrials.gov/ct2/show/NCT00117429","Marcus Altfeld, Massachusetts General Hosptial "]
["NCT00322751",null,"[' University of New Mexico ']","https://clinicaltrials.gov/ct2/show/NCT00322751","Dennie Jones, MD; Principal Investigator, University of New Mexico - CRTC "]
["NCT00379132",null,"[' TransMolecular ']","https://clinicaltrials.gov/ct2/show/NCT00379132","Susan Stewart, Vice President, Regulatory Affairs, TransMolecular, Inc. "]
["NCT00435669",null,"[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00435669","Study Director, Bristol-Myers Squibb "]
["NCT00569374",null,"[' University of Arkansas ']","https://clinicaltrials.gov/ct2/show/NCT00569374","Carole Hamon, University of Arkansas for Medical Sciences "]
["NCT00609167",null,"[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00609167","Alexander Keith Stewart, M.B.Ch.B, Mayo Clinic Cancer Center "]
["NCT00850057",null,"[' University of California, San Diego ']","https://clinicaltrials.gov/ct2/show/NCT00850057","University of California, San Diego Moores Cancer Center (Dr. Januario Castro, M.D./Assistant Clinical Professor in the Blood and Marrow Transplantation Division), University of California, San Diego Moores Cancer Center "]
["NCT00547300",null,"[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00547300","Carol Satler MD, PhD Vice President, Clinical Development, Cardiovascular & Respiratory, Forest Research Institute, a subsidiary of Forest Laboratories Inc. "]
["NCT00292955",null,"[' University of Virginia ']","https://clinicaltrials.gov/ct2/show/NCT00292955","Linda R. Duska, M.D, University of Virginia "]
["NCT01132989",null,"[' Florida Academic Dermatology Centers ']","https://clinicaltrials.gov/ct2/show/NCT01132989","Francisco a Kerdel,M.D, Florida Academic Dermtology Center "]
["NCT00418678",null,"[' Veeda Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00418678","Ralph Boccia, MD, CENTER FOR CANCER AND BLOOD DISORDERS "]
["NCT00968097",null,"[' Institute for Neurodegenerative Disorders ']","https://clinicaltrials.gov/ct2/show/NCT00968097","Danna Jennings, MD, Institute for Neurodegenerative Disorders "]
["NCT01312376","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01312376","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT00251524","['Veeda Oncology']","[' Veeda Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00251524","['Veeda Oncology']"]
["NCT00462072","['Christopher Ritchlin, University of Rochester']","[' University of Rochester ']","https://clinicaltrials.gov/ct2/show/NCT00462072","['University of Rochester']"]
["NCT00690677","['Swedish Medical Center']","[' Swedish Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00690677","['Swedish Medical Center']"]
["NCT01221506","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01221506","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT01239212","[\"Stephanie Merhar, MD, Children's Hospital Medical Center, Cincinnati\"]","[\" Children's Hospital Medical Center, Cincinnati \"]","https://clinicaltrials.gov/ct2/show/NCT01239212","[\"Cincinnati Children's Hospital Medical Center\"]"]
["NCT00721669","['ImmunoGen, Inc.']","[' ImmunoGen, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00721669","['Florida Cancer Specialists']"]
["NCT01845961","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01845961","['855-216-0098']"]
["NCT00407407","['Celgene ( Celgene Corporation )']","[' Celgene Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00407407","['University of Texas, MD Anderson Cancer Center']"]
["NCT01317017","['Rockefeller University']","[' Rockefeller University ']","https://clinicaltrials.gov/ct2/show/NCT01317017","['Rockefeller University']"]
["NCT00099437","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00099437","['AstraZeneca']"]
["NCT00129740","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00129740","['M.D. Anderson Cancer Center']"]
["NCT00183872","['University of Southern California']","[' University of Southern California ']","https://clinicaltrials.gov/ct2/show/NCT00183872","['University of Southern California']"]
["NCT00239746","[]","[' National Institute on Aging (NIA) ']","https://clinicaltrials.gov/ct2/show/NCT00239746","['John C.S. Breitner, MD MPH, University of Washington/VA Puget Sound Health Care System']"]
["NCT00265850","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00265850","['Alliance for Clinical Trials in Oncology']"]
["NCT00278343","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00278343","['National Cancer Institute (NCI)']"]
["NCT00304031","['Radiation Therapy Oncology Group']","[' Radiation Therapy Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00304031","['Radiation Therapy Oncology Group']"]
["NCT00317603","['Beth Overmoyer MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00317603","['Beth Overmoyer MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00331760","['Radiation Therapy Oncology Group']","[' Radiation Therapy Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00331760","['Radiation Therapy Oncology Group']"]
["NCT00338286","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00338286","['Janssen Research & Development, LLC']"]
["NCT00372619","[\"Children's Oncology Group\"]","[\" Children's Oncology Group \"]","https://clinicaltrials.gov/ct2/show/NCT00372619","[\"Children's Oncology Group\"]"]
["NCT00382109","[\"Children's Oncology Group\"]","[\" Children's Oncology Group \"]","https://clinicaltrials.gov/ct2/show/NCT00382109","[\"Children's Oncology Group\"]"]
["NCT00390000","['Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00390000","['Mayo Clinic']"]
["NCT00393783","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00393783","['Memorial Sloan Kettering Cancer Center']"]
["NCT00407381","['Johns Hopkins University']","[' Johns Hopkins University ']","https://clinicaltrials.gov/ct2/show/NCT00407381","['Johns Hopkins University']"]
["NCT00418886","['Sanofi ( Genzyme, a Sanofi Company )']","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00418886","['Genzyme, a Sanofi Company']"]
["NCT00424515","['F. Stephen Hodi, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00424515","['F. Stephen Hodi, MD, Melanoma Disease Center Director, Dana-Farber Cancer Institute']"]
["NCT00438841","[]","[' Fred Hutchinson Cancer Research Center ']","https://clinicaltrials.gov/ct2/show/NCT00438841","['Phyllis Potts, Aptium Oncology']"]
["NCT00452023","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00452023","['M.D. Anderson Cancer Center']"]
["NCT00465491","[]","[' Poniard Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00465491","['Hazel Breitz, MD, Poniard Pharmaceuticals, Inc.']"]
["NCT00474747","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00474747","['M.D. Anderson Cancer Center']"]
["NCT00485264","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00485264","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00494182","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00494182","['M.D. Anderson Cancer Center']"]
["NCT00500344","['Rajendra S. Apte, Washington University School of Medicine']","[' Washington University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00500344","['Rajendra S. Apte, Rajendra S. Apte MD, PHD, Washington University School of Medicine']"]
["NCT00513747","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00513747","['Alliance for Clinical Trials in Oncology']"]
["NCT00520910","[]","[' University of Miami ']","https://clinicaltrials.gov/ct2/show/NCT00520910","['Brian Berman, M.D., Ph.D., University of Miami Miller School of Medicine']"]
["NCT00538720","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00538720","['M.D. Anderson Cancer Center']"]
["NCT00553410","['International Breast Cancer Study Group']","[' International Breast Cancer Study Group ']","https://clinicaltrials.gov/ct2/show/NCT00553410","['International Breast Cancer Study Group']"]
["NCT00553462","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00553462","['Alliance for Clinical Trials in Oncology']"]
["NCT00569127","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00569127","['National Cancer Institute (NCI)']"]
["NCT00572065","['Weill Medical College of Cornell University']","[' Weill Medical College of Cornell University ']","https://clinicaltrials.gov/ct2/show/NCT00572065","['Weill Medical College of Cornell University']"]
["NCT00577278","['City of Hope Medical Center']","[' City of Hope Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00577278","['City of Hope Medical Center']"]
["NCT00593242","['Michael Cotten, Duke University']","[' Michael Cotten ']","https://clinicaltrials.gov/ct2/show/NCT00593242","['Michael Cotten, Associate Professor of Pediatrics, Duke University']"]
["NCT00599170","['University of Southern California']","[' University of Southern California ']","https://clinicaltrials.gov/ct2/show/NCT00599170","['University of Southern California']"]
["NCT00610493","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00610493","['M.D. Anderson Cancer Center']"]
["NCT00617981","['Celsion']","[' Celsion ']","https://clinicaltrials.gov/ct2/show/NCT00617981","['Celsion']"]
["NCT00633594","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00633594","['SCRI Development Innovations, LLC']"]
["NCT00651261","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00651261","['Alliance for Clinical Trials in Oncology']"]
["NCT00662506","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00662506","['National Cancer Institute (NCI)']"]
["NCT00668421","['Ronald Hoffman, Icahn School of Medicine at Mount Sinai']","[' Ronald Hoffman ']","https://clinicaltrials.gov/ct2/show/NCT00668421","['Ronald Hoffman, Professor, Icahn School of Medicine at Mount Sinai']"]
["NCT00685919","['Emily M. Garland, Vanderbilt University']","[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT00685919","['Emily M. Garland, Research Associate Professor, Vanderbilt University']"]
["NCT00699491","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00699491","['National Cancer Institute (NCI)']"]
["NCT00703222","['Andras Heczey, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00703222","['Andras Heczey, Assistant Professor, Baylor College of Medicine']"]
["NCT00721409","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00721409","['Pfizer']"]
["NCT00721513","['Wake Forest University Health Sciences']","[' Wake Forest University Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT00721513","['Wake Forest University Health Sciences']"]
["NCT00731952","['Benjamin Kozower, MD, University of Virginia']","[' University of Virginia ']","https://clinicaltrials.gov/ct2/show/NCT00731952","['Benjamin Kozower, MD, Principal Investigator, University of Virginia']"]
["NCT00742560","['AbbVie ( AbbVie (prior sponsor, Abbott) )']","[' AbbVie (prior sponsor, Abbott) ']","https://clinicaltrials.gov/ct2/show/NCT00742560","['AbbVie (prior sponsor, Abbott)']"]
["NCT00759772","['Pouneh K. Fazeli, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00759772","['Pouneh K. Fazeli, MD, Assistant Professor of Medicine, Massachusetts General Hospital']"]
["NCT00775931","['Masonic Cancer Center, University of Minnesota']","[' Masonic Cancer Center, University of Minnesota ']","https://clinicaltrials.gov/ct2/show/NCT00775931","['Masonic Cancer Center, University of Minnesota']"]
["NCT00788125","['City of Hope Medical Center']","[' City of Hope Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00788125","['City of Hope Medical Center']"]
["NCT00791700","['ViiV Healthcare']","[' ViiV Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT00791700","['ViiV Healthcare']"]
["NCT00805129","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00805129","['Memorial Sloan Kettering Cancer Center']"]
["NCT00819546","['Richard Stone, MD, Dana-Farber Cancer Institute']","[' Richard Stone, MD ']","https://clinicaltrials.gov/ct2/show/NCT00819546","['Richard Stone, MD, Professor of Medicine, Dana-Farber Cancer Institute']"]
["NCT00826202","['Nathan Kline Institute for Psychiatric Research']","[' Nathan Kline Institute for Psychiatric Research ']","https://clinicaltrials.gov/ct2/show/NCT00826202","['Nathan Kline Institute for Psychiatric Research']"]
["NCT00841802","['Robert Schleimer, Northwestern University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT00841802","['Robert Schleimer, Professor of Medicine, Northwestern University']"]
["NCT00856401","['John P Bilezikian, MD, Columbia University']","[' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ']","https://clinicaltrials.gov/ct2/show/NCT00856401","['John P Bilezikian, MD, MD, Columbia University']"]
["NCT00866749","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00866749","['M.D. Anderson Cancer Center']"]
["NCT00873275","['City of Hope Medical Center']","[' City of Hope Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00873275","['City of Hope Medical Center']"]
["NCT00885326","['New Approaches to Neuroblastoma Therapy Consortium']","[' New Approaches to Neuroblastoma Therapy Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00885326","['New Approaches to Neuroblastoma Therapy Consortium']"]
["NCT00889408","['Masonic Cancer Center, University of Minnesota']","[' Masonic Cancer Center, University of Minnesota ']","https://clinicaltrials.gov/ct2/show/NCT00889408","['Masonic Cancer Center, University of Minnesota']"]
["NCT00892177","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00892177","['Alliance for Clinical Trials in Oncology']"]
["NCT00909090","[]","[' University of Georgia ']","https://clinicaltrials.gov/ct2/show/NCT00909090","['Billy R. Hammond, Jr., Professor, PI, University of Georgia']"]
["NCT00924326","['National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00924326","['National Cancer Institute (NCI)']"]
["NCT00930579","['Dawn L. Hershman, Columbia University']","[' Columbia University ']","https://clinicaltrials.gov/ct2/show/NCT00930579","['Dawn L. Hershman, Associate Professor of Medicine & Epidemiology, Columbia University']"]
["NCT00942331","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00942331","['National Cancer Institute (NCI)']"]
["NCT00951496","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00951496","['National Cancer Institute (NCI)']"]
["NCT00960752","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00960752","['M.D. Anderson Cancer Center']"]
["NCT00968968","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00968968","['Novartis Pharmaceuticals']"]
["NCT00981058","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00981058","['Eli Lilly and Company']"]
["NCT00997035","['Thomas M. Lietman, University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00997035","['Thomas M. Lietman, Professor in Residence, University of California, San Francisco']"]
["NCT01002755","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01002755","['M.D. Anderson Cancer Center']"]
["NCT01011010","['UNC Lineberger Comprehensive Cancer Center']","[' UNC Lineberger Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01011010","['UNC Lineberger Comprehensive Cancer Center']"]
["NCT01024036","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01024036","['Janssen Research & Development, LLC']"]
["NCT01031069","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01031069","['GlaxoSmithKline']"]
["NCT01042535","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01042535","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT01044433","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01044433","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT01055028","['Kristen Ganjoo, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT01055028","['Kristen Ganjoo, Assistant Professor of Medicine, Stanford University']"]
["NCT01062425","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01062425","['National Cancer Institute (NCI)']"]
["NCT01071941","['Kenneth K. Tanabe, MD, Massachusetts General Hospital']","[' Kenneth K. Tanabe, MD ']","https://clinicaltrials.gov/ct2/show/NCT01071941","['Kenneth K. Tanabe, MD, Chief, Surgical Oncology, Massachusetts General Hospital']"]
["NCT01083316","['Vaishali Sanchorawala, Boston Medical Center']","[' Boston Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01083316","['Vaishali Sanchorawala, Principal Investigator, Boston Medical Center']"]
["NCT01093183","['James Schwarz, MD, University of Nebraska']","[' University of Nebraska ']","https://clinicaltrials.gov/ct2/show/NCT01093183","['James Schwarz, MD, Principal Investigator, University of Nebraska']"]
["NCT01100775","['L. Elliot Hong, University of Maryland']","[' University of Maryland ']","https://clinicaltrials.gov/ct2/show/NCT01100775","['L. Elliot Hong, L. Elliot Hong, M.D., University of Maryland']"]
["NCT01106872","['Mohammed M Milhem, University of Iowa']","[' Mohammed M Milhem ']","https://clinicaltrials.gov/ct2/show/NCT01106872","['Mohammed M Milhem, Clinical Associate Professor, University of Iowa']"]
["NCT01121120","['Tarix Pharmaceuticals']","[' Tarix Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01121120","['Tarix Pharmaceuticals']"]
["NCT01132612","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01132612","['Novartis Pharmaceuticals']"]
["NCT01137682","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01137682","['Novartis Pharmaceuticals']"]
["NCT01146652","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01146652","['Sanofi']"]
["NCT01155180","['Christos Mantzoros, Beth Israel Deaconess Medical Center']","[' Beth Israel Deaconess Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01155180","['Christos Mantzoros, Professor of Medicine, Beth Israel Deaconess Medical Center']"]
["NCT01159522","['SynCore Biotechnology Co., Ltd.']","[' SynCore Biotechnology Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01159522","['SynCore Biotechnology Co., Ltd.']"]
["NCT01167114","['Jeffrey W. Clark, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01167114","['Jeffrey W. Clark, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT01176461","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01176461","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT01183884","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01183884","['Memorial Sloan Kettering Cancer Center']"]
["NCT01188252","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01188252","['Bayer']"]
["NCT01191801","['Sunesis Pharmaceuticals']","[' Sunesis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01191801","['Sunesis Pharmaceuticals']"]
["NCT01199614","['John P. Bilezikian, Columbia University']","[' John P. Bilezikian ']","https://clinicaltrials.gov/ct2/show/NCT01199614","['John P. Bilezikian, Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology, Columbia University']"]
["NCT01211262","['Immunocore Ltd']","[' Immunocore Ltd ']","https://clinicaltrials.gov/ct2/show/NCT01211262","['Immunocore Ltd']"]
["NCT01215136","['Matthew Galsky, Hoosier Cancer Research Network']","[' Matthew Galsky ']","https://clinicaltrials.gov/ct2/show/NCT01215136","['Matthew Galsky, Sponsor-Investigator, Hoosier Cancer Research Network']"]
["NCT01221402","['Emmanouil Brilakis, North Texas Veterans Healthcare System']","[' North Texas Veterans Healthcare System ']","https://clinicaltrials.gov/ct2/show/NCT01221402","['Emmanouil Brilakis, Director, Cardiac Catheterization Laboratories, North Texas Veterans Healthcare System']"]
["NCT01229566","['Trygg Pharma, Inc.']","[' Trygg Pharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01229566","['Trygg Pharma, Inc.']"]
["NCT01237951","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01237951","['M.D. Anderson Cancer Center']"]
["NCT01243944","['Incyte Corporation']","[' Incyte Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01243944","['Incyte Corporation']"]
["NCT01253473","['Jennifer Brandorff, National Jewish Health']","[' National Jewish Health ']","https://clinicaltrials.gov/ct2/show/NCT01253473","['Jennifer Brandorff, Manager, Clinical Research Services, Regulatory, National Jewish Health']"]
["NCT01263951","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01263951","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT01270321","['Taofeek K. Owonikoko, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT01270321","['Taofeek K. Owonikoko, Principal Investigator, Emory University']"]
["NCT01276704","['Carol Fabian, MD, University of Kansas Medical Center']","[' Carol Fabian, MD ']","https://clinicaltrials.gov/ct2/show/NCT01276704","['Carol Fabian, MD, Professor, Director Breast Cancer Prevention Unit, University of Kansas Medical Center']"]
["NCT01282424","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT01282424","['Gilead Sciences']"]
["NCT01288911","['Astellas Pharma Inc']","[' Astellas Pharma Inc ']","https://clinicaltrials.gov/ct2/show/NCT01288911","['Astellas Pharma Inc']"]
["NCT01297309","['Shire']","[' Shire ']","https://clinicaltrials.gov/ct2/show/NCT01297309","['Shire']"]
["NCT01297413","['Stemedica Cell Technologies, Inc.']","[' Stemedica Cell Technologies, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01297413","['Stemedica Cell Technologies, Inc.']"]
["NCT01309230","['Gradalis, Inc.']","[' Gradalis, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01309230","['Gradalis, Inc.']"]
["NCT01309802","['Southern Illinois University']","[' Southern Illinois University ']","https://clinicaltrials.gov/ct2/show/NCT01309802","['Southern Illinois University']"]
["NCT01322048","['Mayur Patel, Vanderbilt University']","[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT01322048","['Mayur Patel, Assistant Professor of Surgery and Neurosurgery, Vanderbilt University']"]
["NCT01328249","['Eisai Inc.']","[' Eisai Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01328249","['Eisai Inc.']"]
["NCT01336842","['University of California, Davis']","[' University of California, Davis ']","https://clinicaltrials.gov/ct2/show/NCT01336842","['University of California, Davis']"]
["NCT01345175","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01345175","['Memorial Sloan Kettering Cancer Center']"]
["NCT01351896","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01351896","['National Cancer Institute (NCI)']"]
["NCT01361113","['UNC Lineberger Comprehensive Cancer Center']","[' UNC Lineberger Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01361113","['UNC Lineberger Comprehensive Cancer Center']"]
["NCT01372202","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01372202","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01377389","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01377389","['M.D. Anderson Cancer Center']"]
["NCT01381692","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01381692","['National Cancer Institute (NCI)']"]
["NCT01395316","['University of Chicago']","[' University of Chicago ']","https://clinicaltrials.gov/ct2/show/NCT01395316","['University of Chicago']"]
["NCT01407094","['Madhukar H. Trivedi, University of Texas Southwestern Medical Center']","[' University of Texas Southwestern Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01407094","['Madhukar H. Trivedi, Principal Investigator, University of Texas Southwestern Medical Center']"]
["NCT01411774","['University of South Florida']","[' University of South Florida ']","https://clinicaltrials.gov/ct2/show/NCT01411774","['University of South Florida']"]
["NCT01429025","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT01429025","['Alliance for Clinical Trials in Oncology']"]
["NCT01429350","['Penumbra Inc.']","[' Penumbra Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01429350","['Penumbra Inc.']"]
["NCT01436214","['Adamis Pharmaceuticals Corporation']","[' Adamis Pharmaceuticals Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01436214","['Adamis Pharmaceuticals Corporation']"]
["NCT01443728","['Gary M Brittenham, MD, Columbia University']","[' Gary M Brittenham, MD ']","https://clinicaltrials.gov/ct2/show/NCT01443728","['Gary M Brittenham, MD, James A. Wolff Professor of Pediatrics, Columbia University']"]
["NCT01450761","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT01450761","['Bristol-Myers Squibb']"]
["NCT01463072","['City of Hope Medical Center']","[' City of Hope Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01463072","['City of Hope Medical Center']"]
["NCT01469520","['Elim Pediatric Pharmaceuticals Inc.']","[' Elim Pediatric Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01469520","['Elim Pediatric Pharmaceuticals Inc.']"]
["NCT01475513","['Virginia Commonwealth University']","[' Virginia Commonwealth University ']","https://clinicaltrials.gov/ct2/show/NCT01475513","['Virginia Commonwealth University']"]
["NCT01483118","['Rogerio A. Lobo, Columbia University']","[' Rogerio A. Lobo ']","https://clinicaltrials.gov/ct2/show/NCT01483118","['Rogerio A. Lobo, Professor of Obstetrics and Gynecology, Columbia University']"]
["NCT01491958","['Yvonne Efebera, Ohio State University Comprehensive Cancer Center']","[' Ohio State University Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01491958","['Yvonne Efebera, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT01497496","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01497496","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT01508312","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01508312","['Memorial Sloan Kettering Cancer Center']"]
["NCT01518972","['Seattle Institute for Biomedical and Clinical Research']","[' Seattle Institute for Biomedical and Clinical Research ']","https://clinicaltrials.gov/ct2/show/NCT01518972","['Seattle Institute for Biomedical and Clinical Research']"]
["NCT01523548","['Roberto Machado, M.D., University of Illinois at Chicago']","[' University of Illinois at Chicago ']","https://clinicaltrials.gov/ct2/show/NCT01523548","['Roberto Machado, M.D., Associate Professor of Pulmonary Medicine, University of Illinois at Chicago']"]
["NCT01534494","['Michael Bogenschutz, University of New Mexico']","[' University of New Mexico ']","https://clinicaltrials.gov/ct2/show/NCT01534494","['Michael Bogenschutz, Professor of Psychiatry, University of New Mexico']"]
["NCT01546571","['Polynoma LLC']","[' Polynoma LLC ']","https://clinicaltrials.gov/ct2/show/NCT01546571","['Polynoma LLC']"]
["NCT01551745","['Gradalis, Inc.']","[' Gradalis, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01551745","['Gradalis, Inc.']"]
["NCT01555125","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01555125","['Novartis Pharmaceuticals']"]
["NCT01565616","['Lakshmanan Krishnamurti, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT01565616","['Lakshmanan Krishnamurti, Professor, Emory University']"]
["NCT01578707","['Pharmacyclics LLC.']","[' Pharmacyclics LLC. ']","https://clinicaltrials.gov/ct2/show/NCT01578707","['Pharmacyclics LLC.']"]
["NCT01580410","['Wake Forest University Health Sciences']","[' Wake Forest University Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT01580410","['Wake Forest University Health Sciences']"]
["NCT01588821","['Rebecca Suk Heist, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01588821","['Rebecca Suk Heist, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT01595048","['Gustave Roussy, Cancer Campus, Grand Paris']","[' Gustave Roussy, Cancer Campus, Grand Paris ']","https://clinicaltrials.gov/ct2/show/NCT01595048","['Gustave Roussy, Cancer Campus, Grand Paris']"]
["NCT01606241","['Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01606241","['Mayo Clinic']"]
["NCT01611090","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01611090","['Janssen Research & Development, LLC']"]
["NCT01621178","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01621178","['Eli Lilly and Company']"]
["NCT01631383","['MPRC, University of Maryland']","[' University of Maryland ']","https://clinicaltrials.gov/ct2/show/NCT01631383","['MPRC, Deanna L. Kelly, Pharm.D., BCPP, University of Maryland']"]
["NCT01636687","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01636687","['Novartis Pharmaceuticals']"]
["NCT01643278","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01643278","['National Cancer Institute (NCI)']"]
["NCT01646762","['Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01646762","['Mayo Clinic']"]
["NCT01660971","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01660971","['National Cancer Institute (NCI)']"]
["NCT01666652","['U.S. Army Medical Research and Materiel Command']","[' U.S. Army Medical Research and Materiel Command ']","https://clinicaltrials.gov/ct2/show/NCT01666652","['U.S. Army Medical Research and Materiel Command']"]
["NCT01673347","['Paul Fortin, MD, William Beaumont Hospitals']","[' Paul Fortin, MD ']","https://clinicaltrials.gov/ct2/show/NCT01673347","['Paul Fortin, MD, Orthopedic Surgeon, William Beaumont Hospitals']"]
["NCT01675765","['Aduro Biotech, Inc.']","[' Aduro Biotech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01675765","['Aduro Biotech, Inc.']"]
["NCT01682512","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT01682512","['Boehringer Ingelheim']"]
["NCT01686165","['University of Arizona']","[' University of Arizona ']","https://clinicaltrials.gov/ct2/show/NCT01686165","['University of Arizona']"]
["NCT01693523","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01693523","['M.D. Anderson Cancer Center']"]
["NCT01697579","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT01697579","['Merck Sharp & Dohme Corp.']"]
["NCT01707264","['Prothena Therapeutics Ltd.']","[' Prothena Therapeutics Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01707264","['Prothena Therapeutics Ltd.']"]
["NCT01713400","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01713400","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT01721603","['Alain Algazi, University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT01721603","['Alain Algazi, Assistant Clinical Professor, University of California, San Francisco']"]
["NCT01728805","['Kyowa Kirin Pharmaceutical Development, Inc. ( Kyowa Hakko Kirin Pharma, Inc. )']","[' Kyowa Hakko Kirin Pharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01728805","['Kyowa Hakko Kirin Pharma, Inc.']"]
["NCT01732874","[\"Children's Hospital Medical Center, Cincinnati\"]","[\" Children's Hospital Medical Center, Cincinnati \"]","https://clinicaltrials.gov/ct2/show/NCT01732874","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT01737762","['Healthpoint']","[' Healthpoint ']","https://clinicaltrials.gov/ct2/show/NCT01737762","['Healthpoint']"]
["NCT01747551","['Peter C. Enzinger, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01747551","['Peter C. Enzinger, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT01756040","['Rose Viscardi, University of Maryland']","[' University of Maryland ']","https://clinicaltrials.gov/ct2/show/NCT01756040","['Rose Viscardi, University of Maryland']"]
["NCT01764633","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT01764633","['Amgen']"]
["NCT01775618","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01775618","['Bayer']"]
["NCT01782495","['AbbVie']","[' AbbVie ']","https://clinicaltrials.gov/ct2/show/NCT01782495","['AbbVie']"]
["NCT01785810","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01785810","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT01788969","['T. George Hornby, Shirley Ryan AbilityLab']","[' Shirley Ryan AbilityLab ']","https://clinicaltrials.gov/ct2/show/NCT01788969","['T. George Hornby, Principle Investigator, Shirley Ryan AbilityLab']"]
["NCT01794663","['Opsona Therapeutics Ltd.']","[' Opsona Therapeutics Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01794663","['Opsona Therapeutics Ltd.']"]
["NCT01804218","['Invion, Inc.']","[' Invion, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01804218","['Invion, Inc.']"]
["NCT01815840","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01815840","['Hoffmann-La Roche']"]
["NCT01821001","['Elizabeth A. Stewart, Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01821001","['Elizabeth A. Stewart, MD, Mayo Clinic']"]
["NCT01829503","['Annie Im, M.D., University of Pittsburgh']","[' Annie Im, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT01829503","['Annie Im, M.D., MD, University of Pittsburgh']"]
["NCT01836029","['VentiRx Pharmaceuticals Inc.']","[' VentiRx Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01836029","['VentiRx Pharmaceuticals Inc.']"]
["NCT01840540","['Stephen C. Textor, M.D., Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01840540","['Stephen C. Textor, M.D., PI, Mayo Clinic']"]
["NCT01847027","['Meharvan Singh, University of North Texas Health Science Center']","[' University of North Texas Health Science Center ']","https://clinicaltrials.gov/ct2/show/NCT01847027","['Meharvan Singh, Chairman and Professor, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center']"]
["NCT01855360","[\"Rodney H. Falk, MD, Brigham and Women's Hospital\"]","[\" Brigham and Women's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT01855360","[\"Rodney H. Falk, MD, Director, Brigham and Women's Hospital Cardiac Amyloidosis Program, Brigham and Women's Hospital\"]"]
["NCT01860664","['Koffler Vision Group']","[' Koffler Vision Group ']","https://clinicaltrials.gov/ct2/show/NCT01860664","['Koffler Vision Group']"]
["NCT01867294","['Academic and Community Cancer Research United']","[' Academic and Community Cancer Research United ']","https://clinicaltrials.gov/ct2/show/NCT01867294","['Academic and Community Cancer Research United']"]
["NCT01877083","['Eisai Inc. ( Eisai Co., Ltd. )']","[' Eisai Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01877083","['Eisai Co., Ltd.']"]
["NCT01887717","['BTG International Inc.']","[' BTG International Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01887717","['BTG International Inc.']"]
["NCT01893320","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01893320","['M.D. Anderson Cancer Center']"]
["NCT01893372","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01893372","['M.D. Anderson Cancer Center']"]
["NCT01905813","['Incyte Corporation']","[' Incyte Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01905813","['Incyte Corporation']"]
["NCT01907815","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01907815","['National Cancer Institute (NCI)']"]
["NCT01915602","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01915602","['Bayer']"]
["NCT01926587","['Onconova Therapeutics, Inc.']","[' Onconova Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01926587","['Onconova Therapeutics, Inc.']"]
["NCT01934790","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01934790","['Bayer']"]
["NCT01941056","['City of Hope Medical Center']","[' City of Hope Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01941056","['City of Hope Medical Center']"]
["NCT01949519","['Medical University of South Carolina']","[' Medical University of South Carolina ']","https://clinicaltrials.gov/ct2/show/NCT01949519","['Medical University of South Carolina']"]
["NCT01953783","['Millennium Pharmaceuticals, Inc.']","[' Millennium Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01953783","['Millennium Pharmaceuticals, Inc.']"]
["NCT01966302","['ronald oudiz, m.d., Los Angeles Biomedical Research Institute']","[' Los Angeles Biomedical Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01966302","['ronald oudiz, m.d., Professor of Medicine, Los Angeles Biomedical Research Institute']"]
["NCT01972464","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT01972464","['Yale University']"]
["NCT01976078","[\"Michael Neely, Children's Hospital Los Angeles\"]","[\" Children's Hospital Los Angeles \"]","https://clinicaltrials.gov/ct2/show/NCT01976078","[\"Michael Neely, Associate Professor of Pediatrics, Children's Hospital Los Angeles\"]"]
["NCT01984242","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01984242","['Hoffmann-La Roche']"]
["NCT01993186","['Ultragenyx Pharmaceutical Inc']","[' Ultragenyx Pharmaceutical Inc ']","https://clinicaltrials.gov/ct2/show/NCT01993186","['Ultragenyx Pharmaceutical Inc']"]
["NCT01997190","['Advantagene, Inc.']","[' Advantagene, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01997190","['Advantagene, Inc.']"]
["NCT02010645","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02010645","['M.D. Anderson Cancer Center']"]
["NCT02011464","['Maimonides Medical Center']","[' Maimonides Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT02011464","['Maimonides Medical Center']"]
["NCT02018315","['Juan Pascual, University of Texas Southwestern Medical Center']","[' Juan Pascual ']","https://clinicaltrials.gov/ct2/show/NCT02018315","['Juan Pascual, Associate Professor, Director of the Rare Brain Disorders Program, University of Texas Southwestern Medical Center']"]
["NCT02029443","['Acerta Pharma BV']","[' Acerta Pharma BV ']","https://clinicaltrials.gov/ct2/show/NCT02029443","['Acerta Pharma BV']"]
["NCT02038647","['Takeda ( Millennium Pharmaceuticals, Inc. )']","[' Millennium Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02038647","['Millennium Pharmaceuticals, Inc.']"]
["NCT02042950","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02042950","['M.D. Anderson Cancer Center']"]
["NCT02052960","['Glycotope GmbH']","[' Glycotope GmbH ']","https://clinicaltrials.gov/ct2/show/NCT02052960","['Glycotope GmbH']"]
["NCT02061423","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT02061423","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT02078180","['Duxin Sun, University of Michigan']","[' University of Michigan ']","https://clinicaltrials.gov/ct2/show/NCT02078180","['Duxin Sun, Professor of Pharmaceutical Sciences, University of Michigan']"]
["NCT02092298","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02092298","['M.D. Anderson Cancer Center']"]
["NCT02103270","['Kari Christine Nadeau, MD PhD, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT02103270","['Kari Christine Nadeau, MD PhD, Principal Investigator, Stanford University']"]
["NCT02106832","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT02106832","['Bayer']"]
["NCT02116894","['Jeffrey Clarke, Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT02116894","['Jeffrey Clarke, Principal Investigator, Duke University']"]
["NCT02125084","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02125084","['SCRI Development Innovations, LLC']"]
["NCT02136134","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02136134","['Janssen Research & Development, LLC']"]
["NCT02144675","['Roger Strair, MD, PhD, Rutgers Cancer Institute of New Jersey']","[' Rutgers, The State University of New Jersey ']","https://clinicaltrials.gov/ct2/show/NCT02144675","['Roger Strair, MD, PhD, Professor of Medicine, RWJMS, Rutgers Cancer Institute of New Jersey']"]
["NCT02156908","['Nathan Kline Institute for Psychiatric Research']","[' Nathan Kline Institute for Psychiatric Research ']","https://clinicaltrials.gov/ct2/show/NCT02156908","['Nathan Kline Institute for Psychiatric Research']"]
["NCT02158520","['Academic and Community Cancer Research United']","[' Academic and Community Cancer Research United ']","https://clinicaltrials.gov/ct2/show/NCT02158520","['Academic and Community Cancer Research United']"]
["NCT02168907","['Wake Forest University Health Sciences']","[' Wake Forest University Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT02168907","['Wake Forest University Health Sciences']"]
["NCT02187861","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT02187861","['Hoffmann-La Roche']"]
["NCT02194985","['Amicus Therapeutics']","[' Amicus Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT02194985","['Amicus Therapeutics']"]
["NCT02203838","['Indivior Inc.']","[' Indivior Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02203838","['Indivior Inc.']"]
["NCT02215200","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","[' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ']","https://clinicaltrials.gov/ct2/show/NCT02215200","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT02231775","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02231775","['M.D. Anderson Cancer Center']"]
["NCT02237053","['Translational Research Institute for Metabolism and Diabetes, Florida']","[' Translational Research Institute for Metabolism and Diabetes, Florida ']","https://clinicaltrials.gov/ct2/show/NCT02237053","['Translational Research Institute for Metabolism and Diabetes, Florida']"]
["NCT02252796","['West Virginia University']","[' West Virginia University ']","https://clinicaltrials.gov/ct2/show/NCT02252796","['West Virginia University']"]
["NCT02275598","['Massimo Federico, MD, University of Modena and Reggio Emilia']","[' University of Modena and Reggio Emilia ']","https://clinicaltrials.gov/ct2/show/NCT02275598","['Massimo Federico, MD, Full Professor, University of Modena and Reggio Emilia']"]
["NCT02282293","['Diana Havlir, University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT02282293","['Diana Havlir, Professor, University of California, San Francisco']"]
["NCT02299336","['Charles C Wykoff, PhD, MD, Greater Houston Retina Research']","[' Greater Houston Retina Research ']","https://clinicaltrials.gov/ct2/show/NCT02299336","['Charles C Wykoff, PhD, MD, Principal Investigator, Greater Houston Retina Research']"]
["NCT02304211","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT02304211","['Duke University']"]
["NCT02349295","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT02349295","['Eli Lilly and Company']"]
["NCT02474901","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT02474901","['University of Colorado, Denver']"]
["NCT02744456","['Ian Kronish, Columbia University']","[' Columbia University ']","https://clinicaltrials.gov/ct2/show/NCT02744456","['Ian Kronish, Associate Professor of Medicine, Columbia University']"]
["NCT02784002","['Summit Therapeutics']","[' Summit Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT02784002","['Summit Therapeutics']"]
["NCT00526253","[]","[' Bioheart, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00526253","['Warren Sherman, MN, Center for Interventional Vascular Therapy']"]
["NCT00768287","['Aptevo Therapeutics ( Aptevo BioTherapeutics )']","[' Aptevo BioTherapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00768287","['Aptevo BioTherapeutics']"]
["NCT00983619","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT00983619","['MedImmune LLC']"]
["NCT01156584","['Tocagen Inc.']","[' Tocagen Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01156584","['Tocagen Inc.']"]
["NCT01246999","['John Treanor, University of Rochester']","[' University of Rochester ']","https://clinicaltrials.gov/ct2/show/NCT01246999","['John Treanor, M.D., University of Rochester']"]
["NCT01319331","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT01319331","['University of Colorado, Denver']"]
["NCT01397968","['SK Life Science, Inc.']","[' SK Life Science, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01397968","['SK Life Science, Inc.']"]
["NCT01475331","['Matthew T. Moyer, Milton S. Hershey Medical Center']","[' Milton S. Hershey Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01475331","['Matthew T. Moyer, Assistant Professor, Milton S. Hershey Medical Center']"]
["NCT01574274","['Lewis B. Silverman, M.D., Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01574274","['Lewis B. Silverman, M.D., Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT01615120","['GTx']","[' GTx ']","https://clinicaltrials.gov/ct2/show/NCT01615120","['GTx']"]
["NCT01696084","['Jazz Pharmaceuticals']","[' Jazz Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01696084","['Jazz Pharmaceuticals']"]
["NCT01751126","['Santen SAS']","[' Santen SAS ']","https://clinicaltrials.gov/ct2/show/NCT01751126","['Santen SAS']"]
["NCT01790503","['Plexxikon']","[' Plexxikon ']","https://clinicaltrials.gov/ct2/show/NCT01790503","['Plexxikon']"]
["NCT01910012","['Polaris Group']","[' Polaris Group ']","https://clinicaltrials.gov/ct2/show/NCT01910012","['Polaris Group']"]
["NCT01951157","['PharmaMar']","[' PharmaMar ']","https://clinicaltrials.gov/ct2/show/NCT01951157","['PharmaMar']"]
["NCT01978938","['Tetraphase Pharmaceuticals, Inc.']","[' Tetraphase Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01978938","['Tetraphase Pharmaceuticals, Inc.']"]
["NCT02013804","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT02013804","['MedImmune LLC']"]
["NCT02047734","['Celgene']","[' Celgene ']","https://clinicaltrials.gov/ct2/show/NCT02047734","['Celgene']"]
["NCT02098473","['Celgene']","[' Celgene ']","https://clinicaltrials.gov/ct2/show/NCT02098473","['Celgene']"]
["NCT02186301","['Clovis Oncology, Inc.']","[' Clovis Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02186301","['Clovis Oncology, Inc.']"]
["NCT02229396","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT02229396","['AstraZeneca']"]
["NCT02447224","['David A. Talan, Olive View-UCLA Education & Research Institute']","[' Olive View-UCLA Education & Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT02447224","['David A. Talan, Principal Investigator, Olive View-UCLA Education & Research Institute']"]
["NCT00077441","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00077441","['National Cancer Institute (NCI)']"]
["NCT00085852","[]","[' Aeris Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00085852","['Edward P Ingenito, MD, PhD, Medical Director & CSO, Aeris Therapeutics Inc']"]
["NCT00094861","['Swedish Orphan Biovitrum']","[' Swedish Orphan Biovitrum ']","https://clinicaltrials.gov/ct2/show/NCT00094861","['Swedish Orphan Biovitrum']"]
["NCT00099580","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00099580","['AstraZeneca']"]
["NCT00101439","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00101439","['Merck Sharp & Dohme Corp.']"]
["NCT00103012","['National Institutes of Health Clinical Center (CC)']","[' National Institutes of Health Clinical Center (CC) ']","https://clinicaltrials.gov/ct2/show/NCT00103012","['National Institutes of Health Clinical Center (CC)']"]
["NCT00104520","[]","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT00104520","['Mark Bresnik, MD, Director, Clinical Research, Gilead Sciences, Inc.']"]
["NCT00105989","[]","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00105989","['Chief Medical Officer, Eli Lilly']"]
["NCT00106704","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00106704","['Merck Sharp & Dohme Corp.']"]
["NCT00107016","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00107016","['Novartis Pharmaceuticals']"]
["NCT00107887","[]","[' Johns Hopkins University ']","https://clinicaltrials.gov/ct2/show/NCT00107887","['Dr. Richard Chaisson, Center for Tuberculosis Research, Johns Hopkins University']"]
["NCT00109473","[\"Children's Hospital Medical Center, Cincinnati\"]","[\" Children's Hospital Medical Center, Cincinnati \"]","https://clinicaltrials.gov/ct2/show/NCT00109473","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT00110214","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00110214","['National Cancer Institute (NCI)']"]
["NCT00110747","['ZARS Pharma Inc.']","[' ZARS Pharma Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00110747","['ZARS Pharma Inc.']"]
["NCT00111722","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00111722","['Merck Sharp & Dohme Corp.']"]
["NCT00112502","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00112502","['M.D. Anderson Cancer Center']"]
["NCT00113516","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00113516","['Director, Clinical Trial Disclosure Group, Pfizer Inc']"]
["NCT00114452","[u'Mesoblast, Ltd. ( Mesoblast International S\\xe0rl )']","[u' Mesoblast International S\\xe0rl ']","https://clinicaltrials.gov/ct2/show/NCT00114452","[u'Mesoblast International S\\xe0rl']"]
["NCT00117273","[]","[' Duramed Research ']","https://clinicaltrials.gov/ct2/show/NCT00117273","['Duramed Protocol Chair, Duramed Research, Inc.']"]
["NCT00118040","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00118040","['National Cancer Institute (NCI)']"]
["NCT00118703","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00118703","['GlaxoSmithKline']"]
["NCT00121225","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00121225","['National Cancer Institute (NCI)']"]
["NCT00123162","['Richard S. Legro, M.D., Milton S. Hershey Medical Center']","[' Milton S. Hershey Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00123162","['Richard S. Legro, M.D., Professor, Obstetrics and Gynecology and Public Health Sciences, Milton S. Hershey Medical Center']"]
["NCT00124020","[]","[' Cumberland Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00124020","['Steven L. Barriere, Pharm.D., Vice President, Clinical and Medical Affairs, Theravance, Inc.']"]
["NCT00125970","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00125970","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00126373","['Altschuler, Eric, M.D.']","[' Altschuler, Eric, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00126373","['Altschuler, Eric, M.D.']"]
["NCT00127933","[]","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00127933","['Disclosures Group, Hoffmann-La Roche']"]
["NCT00130702","['Daniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00130702","['Daniel J. DeAngelo, MD, PhD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00131989","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00131989","['National Cancer Institute (NCI)']"]
["NCT00134719","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00134719","['GlaxoSmithKline']"]
["NCT00137436","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00137436","['Pfizer']"]
["NCT00141271","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00141271","['Director, Clinical Trial Disclosure Group, Pfizer Inc']"]
["NCT00143559","[]","[\" St. Jude Children's Research Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00143559","[\"G. Hale, Principal Investigator, St. Jude Children's Research Hospital\"]"]
["NCT00147498","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00147498","['Pfizer']"]
["NCT00151489","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00151489","['Director, Clinical Trials Disclosure Group, Pfizer, Inc']"]
["NCT00158600","[]","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00158600","['Medical Monitor, Genzyme Corporation']"]
["NCT00162734","['Valeant Pharmaceuticals International, Inc.']","[' Valeant Pharmaceuticals International, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00162734","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00168064","['Yaupon Therapeutics']","[' Yaupon Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00168064","['Yaupon Therapeutics']"]
["NCT00174785","[]","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00174785","['International Clinical Development - Study Director, sanofi-aventis']"]
["NCT00179179","[]","[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT00179179","['Alp Ikizler, MD, Vanderbilt University Medical Center']"]
["NCT00182702","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00182702","['National Cancer Institute (NCI)']"]
["NCT00183092","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00183092","['University of California, San Francisco']"]
["NCT00193414","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00193414","['SCRI Development Innovations, LLC']"]
["NCT00202696","[]","[' Somaxon Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00202696","['Somaxon Pharmaceuticals']"]
["NCT00203567","[]","[' Tuscaloosa Research & Education Advancement Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00203567","['Lori L. Davis, M.D.; Chief, Research Service, Tuscaloosa Research Education & Advancement Corporation']"]
["NCT00208156","['Corcept Therapeutics']","[' Corcept Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00208156","['Corcept Therapeutics']"]
["NCT00211978","[]","[' Nabi Biopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00211978","['Paul Kessler, MD, Sr. VP, Clinical, Medical, & Regulatory Affairs, Nabi Biopharmaceuticals']"]
["NCT00217672","['Translational Oncology Research International']","[' Translational Oncology Research International ']","https://clinicaltrials.gov/ct2/show/NCT00217672","['Translational Oncology Research International']"]
["NCT00218517","[]","[' National Institute on Drug Abuse (NIDA) ']","https://clinicaltrials.gov/ct2/show/NCT00218517","['Ivan Montoya, Program Official, NIDA']"]
["NCT00220636","[\"St. Luke's-Roosevelt Hospital Center\"]","[\" St. Luke's-Roosevelt Hospital Center \"]","https://clinicaltrials.gov/ct2/show/NCT00220636","[\"St. Luke's-Roosevelt Hospital Center\"]"]
["NCT00222729","['University of Pittsburgh']","[' University of Pittsburgh ']","https://clinicaltrials.gov/ct2/show/NCT00222729","['University of Pittsburgh']"]
["NCT00225784","['Dartmouth-Hitchcock Medical Center']","[' Dartmouth-Hitchcock Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00225784","['Dartmouth-Hitchcock Medical Center']"]
["NCT00229008","['Basilea Pharmaceutica']","[' Basilea Pharmaceutica ']","https://clinicaltrials.gov/ct2/show/NCT00229008","['Basilea Pharmaceutica']"]
["NCT00230542","['Ursula A. Matulonis, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00230542","['Ursula A. Matulonis, MD, Medical Oncologist, Dana-Farber Cancer Institute']"]
["NCT00234091","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00234091","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00238212","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00238212","['National Cancer Institute (NCI)']"]
["NCT00240617","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00240617","['GlaxoSmithKline']"]
["NCT00240994","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00240994","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00243074","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00243074","['National Cancer Institute (NCI)']"]
["NCT00244543","['Vistakon Pharmaceuticals']","[' Vistakon Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00244543","['Vistakon Pharmaceuticals']"]
["NCT00246337","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00246337","['Merck Sharp & Dohme Corp.']"]
["NCT00247676","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00247676","['Director, Clinical Trial Disclosure Group, Pfizer Inc']"]
["NCT00250458","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00250458","['Merck Sharp & Dohme Corp.']"]
["NCT00251758","[]","[' Takeda ']","https://clinicaltrials.gov/ct2/show/NCT00251758","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00254293","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00254293","['Bristol-Myers Squibb']"]
["NCT00255762","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00255762","['National Cancer Institute (NCI)']"]
["NCT00257673","[]","[' Memory Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00257673","['Amy S. Domanowski, Ph.D., Head Regulatory Affairs, Memory Pharmaceuticals Corp.']"]
["NCT00259012","[]","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00259012","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00261443","[]","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00261443","['Study Director, Bristol-Myers Squibb']"]
["NCT00262860","['Jonathan Friedberg, University of Rochester']","[' University of Rochester ']","https://clinicaltrials.gov/ct2/show/NCT00262860","['Jonathan Friedberg, Professor, University of Rochester']"]
["NCT00264290","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00264290","['University of California, San Francisco']"]
["NCT00266279","['University of Louisville']","[' University of Louisville ']","https://clinicaltrials.gov/ct2/show/NCT00266279","['University of Louisville']"]
["NCT00267670","['Mary Rinella, Northwestern University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT00267670","['Mary Rinella, Mary E. Rinella, MD, Northwestern University, Northwestern University']"]
["NCT00267696","['Larry Copeland, Ohio State University Comprehensive Cancer Center']","[' Ohio State University Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00267696","['Larry Copeland, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00270634","['Aurinia Pharmaceuticals Inc.']","[' Aurinia Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00270634","['Aurinia Pharmaceuticals Inc.']"]
["NCT00271817","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00271817","['Merck Sharp & Dohme Corp.']"]
["NCT00274287","['Dr. Sigrun Hallmeyer, Oncology Specialists, S.C.']","[' Oncology Specialists, S.C. ']","https://clinicaltrials.gov/ct2/show/NCT00274287","['Dr. Sigrun Hallmeyer, Principal Investigator, Oncology Specialists, S.C.']"]
["NCT00276549","['Case Comprehensive Cancer Center']","[' Case Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00276549","['Case Comprehensive Cancer Center']"]
["NCT00277472","[]","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00277472","['Study Director, Novartis Pharma']"]
["NCT00279916","['Laura Orvidas, Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00279916","['Laura Orvidas, MD, Mayo Clinic']"]
["NCT00282048","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00282048","['Pfizer']"]
["NCT00283114","['Seattle Genetics, Inc.']","[' Seattle Genetics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00283114","['Seattle Genetics, Inc.']"]
["NCT00284908","[]","[' STEBA France ']","https://clinicaltrials.gov/ct2/show/NCT00284908","['Christof Kreutz/Project leader, STEBA France']"]
["NCT00286455","['Takeda']","[' Takeda ']","https://clinicaltrials.gov/ct2/show/NCT00286455","['Takeda']"]
["NCT00288431","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00288431","['Merck Sharp & Dohme Corp.']"]
["NCT00290147","['U.S. Army Medical Research and Materiel Command']","[' U.S. Army Medical Research and Materiel Command ']","https://clinicaltrials.gov/ct2/show/NCT00290147","['U.S. Army Medical Research and Materiel Command']"]
["NCT00292981","['CSL Behring']","[' CSL Behring ']","https://clinicaltrials.gov/ct2/show/NCT00292981","['CSL Behring']"]
["NCT00294515","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00294515","['Hoffmann-La Roche']"]
["NCT00295919","[\"Nant Operations Center, Children's Hospital Los Angeles\"]","[\" Children's Hospital Los Angeles \"]","https://clinicaltrials.gov/ct2/show/NCT00295919","[\"Nant Operations Center, NANT Consortium, Children's Hospital Los Angeles\"]"]
["NCT00295958","[]","[' National Institutes of Health Clinical Center (CC) ']","https://clinicaltrials.gov/ct2/show/NCT00295958","['Steven A. Rosenberg, M.D./National Cancer Institute, National Institutes of Health']"]
["NCT00297167","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00297167","['Forest Laboratories']"]
["NCT00298896","['Sunesis Pharmaceuticals']","[' Sunesis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00298896","['Sunesis Pharmaceuticals']"]
["NCT00300079","['Alcon Research']","[' Alcon Research ']","https://clinicaltrials.gov/ct2/show/NCT00300079","['Alcon Research']"]
["NCT00301834","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00301834","['University of California, San Francisco']"]
["NCT00303056","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00303056","['Sanofi']"]
["NCT00304278","['Southern Illinois University']","[' Southern Illinois University ']","https://clinicaltrials.gov/ct2/show/NCT00304278","['Southern Illinois University']"]
["NCT00305760","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT00305760","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT00307021","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00307021","['GlaxoSmithKline']"]
["NCT00309699","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00309699","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00311883","[]","[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT00311883","['Bonnie Slovis, M.D., Vanderbilt University']"]
["NCT00312728","[]","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00312728","['Jane Huang, M.D., Study Director, Genentech, Inc.']"]
["NCT00314340","['University of California, Davis']","[' University of California, Davis ']","https://clinicaltrials.gov/ct2/show/NCT00314340","['University of California, Davis']"]
["NCT00316082","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00316082","['AstraZeneca']"]
["NCT00316992","[]","[' Takeda ']","https://clinicaltrials.gov/ct2/show/NCT00316992","['Sr. VP, Clinical Science, Takeda Global Research & Development, Inc.']"]
["NCT00318201","[]","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00318201","['Stephen D. Hall, Indiana University']"]
["NCT00319501","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00319501","['Pfizer']"]
["NCT00320749","['Tony Bekaii-Saab, Ohio State University Comprehensive Cancer Center']","[' Tony Bekaii-Saab ']","https://clinicaltrials.gov/ct2/show/NCT00320749","['Tony Bekaii-Saab, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00322231","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00322231","['Merck Sharp & Dohme Corp.']"]
["NCT00323297","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00323297","['Pfizer']"]
["NCT00324896","['Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey )']","[' University of Medicine and Dentistry of New Jersey ']","https://clinicaltrials.gov/ct2/show/NCT00324896","['University of Medicine and Dentistry of New Jersey']"]
["NCT00326248","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00326248","['GlaxoSmithKline']"]
["NCT00326963","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00326963","['Hoffmann-La Roche']"]
["NCT00328627","['Takeda']","[' Takeda ']","https://clinicaltrials.gov/ct2/show/NCT00328627","['Takeda']"]
["NCT00329901","['Novartis ( Novartis Vaccines )']","[' Novartis Vaccines ']","https://clinicaltrials.gov/ct2/show/NCT00329901","['Novartis Vaccines']"]
["NCT00331409","['Christopher Ryan, OHSU Knight Cancer Institute']","[' OHSU Knight Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00331409","['Christopher Ryan, Principal Investigator, OHSU Knight Cancer Institute']"]
["NCT00332917","[]","[' Solvay Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00332917","['Erik van Leeuwen, Solvay Pharmaceuticals']"]
["NCT00334347","[]","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00334347","['John D. Matthews, MD, Massachusetts General Hospital, Boston, Massachusetts 02114']"]
["NCT00335504","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00335504","['National Cancer Institute (NCI)']"]
["NCT00337077","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00337077","['National Cancer Institute (NCI)']"]
["NCT00338130","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00338130","['AstraZeneca']"]
["NCT00343252","[]","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00343252","['Chief Medical Officer, Eli Lilly']"]
["NCT00343460","['Heron Therapeutics']","[' Heron Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00343460","['Heron Therapeutics']"]
["NCT00345371","['National Institute on Drug Abuse (NIDA)']","[' National Institute on Drug Abuse (NIDA) ']","https://clinicaltrials.gov/ct2/show/NCT00345371","['National Institute on Drug Abuse (NIDA)']"]
["NCT00346853","[]","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT00346853","['Dr. Randall Olson, Chair, Department of Ophthalmology']"]
["NCT00349531","[]","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT00349531","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00350051","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT00350051","['Bayer']"]
["NCT00351273","['University of South Florida']","[' University of South Florida ']","https://clinicaltrials.gov/ct2/show/NCT00351273","['University of South Florida']"]
["NCT00353301","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT00353301","['University of Colorado, Denver']"]
["NCT00354224","['Medical University of South Carolina']","[' Medical University of South Carolina ']","https://clinicaltrials.gov/ct2/show/NCT00354224","['Medical University of South Carolina']"]
["NCT00355134","['Novartis']","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00355134","['Novartis']"]
["NCT00355888","['Mebiopharm Co., Ltd']","[' Mebiopharm Co., Ltd ']","https://clinicaltrials.gov/ct2/show/NCT00355888","['Mebiopharm Co., Ltd']"]
["NCT00358150","['Sanofi ( Genzyme, a Sanofi Company )']","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00358150","['Genzyme, a Sanofi Company']"]
["NCT00359892","['Teva Pharmaceutical Industries ( Gemin X )']","[' Gemin X ']","https://clinicaltrials.gov/ct2/show/NCT00359892","['Gemin X']"]
["NCT00360724","['New York State Psychiatric Institute']","[' New York State Psychiatric Institute ']","https://clinicaltrials.gov/ct2/show/NCT00360724","['New York State Psychiatric Institute']"]
["NCT00361309","['Andrew X. Zhu, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00361309","['Andrew X. Zhu, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT00363415","[]","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00363415","['Chief Medical Officer, Eli Lilly']"]
["NCT00365053","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00365053","['National Cancer Institute (NCI)']"]
["NCT00365300","[]","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00365300","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00366145","['Osiris Therapeutics']","[' Osiris Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00366145","['Osiris Therapeutics']"]
["NCT00367679","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00367679","['GlaxoSmithKline']"]
["NCT00369122","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00369122","['National Cancer Institute (NCI)']"]
["NCT00369928","[]","[' Procter and Gamble ']","https://clinicaltrials.gov/ct2/show/NCT00369928","['Muhammad Rehman, MD, Procter and Gamble Pharmaceuticals']"]
["NCT00371254","[]","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00371254","['Study Director, Bristol-Myers Squibb']"]
["NCT00373386","['Robert Hoffman, Ohio State University']","[' Ohio State University ']","https://clinicaltrials.gov/ct2/show/NCT00373386","['Robert Hoffman, Professor, Ohio State University']"]
["NCT00374647","[]","[' University of Cincinnati ']","https://clinicaltrials.gov/ct2/show/NCT00374647","['E. Steve Woodle, MD, FACS, University of Cincinnati']"]
["NCT00376090","['U.S. Army Medical Research and Materiel Command']","[' U.S. Army Medical Research and Materiel Command ']","https://clinicaltrials.gov/ct2/show/NCT00376090","['U.S. Army Medical Research and Materiel Command']"]
["NCT00377572","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00377572","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00379353","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00379353","['M.D. Anderson Cancer Center']"]
["NCT00381004","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00381004","['M.D. Anderson Cancer Center']"]
["NCT00382304","[]","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00382304","['Medical Monitor, Genzyme Corporation']"]
["NCT00383370","[]","[' Regeneron Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00383370","['Avner Ingerman, MD, Regeneron Pharmaceuticals']"]
["NCT00384956","['Washington University School of Medicine']","[' Washington University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00384956","['Washington University School of Medicine']"]
["NCT00386100","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00386100","['GlaxoSmithKline']"]
["NCT00386139","['Novartis']","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00386139","['Novartis']"]
["NCT00387764","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00387764","['GlaxoSmithKline']"]
["NCT00387946","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00387946","['Sanofi']"]
["NCT00389077","['AEterna Zentaris']","[' AEterna Zentaris ']","https://clinicaltrials.gov/ct2/show/NCT00389077","['AEterna Zentaris']"]
["NCT00390650","[]","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00390650","['ICD Study Director, sanofi-aventis']"]
["NCT00391430","['New York University School of Medicine']","[' New York University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00391430","['New York University School of Medicine']"]
["NCT00392652","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00392652","['National Cancer Institute (NCI)']"]
["NCT00394277","[]","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00394277","['Disclosures Group, Hoffmann-La Roche']"]
["NCT00395304","['Vernon M. Chinchilli, PhD, Milton S. Hershey Medical Center']","[' Milton S. Hershey Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00395304","['Vernon M. Chinchilli, PhD, Professor and Chair, Department of Public Health Sciences, Milton S. Hershey Medical Center']"]
["NCT00396357","[]","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00396357","['External Affairs, Novartis Pharmaceuticals']"]
["NCT00397982","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00397982","['National Cancer Institute (NCI)']"]
["NCT00399542","['Sucampo Pharma Americas, LLC ( Sucampo Pharmaceuticals, Inc. )']","[' Sucampo Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00399542","['Sucampo Pharmaceuticals, Inc.']"]
["NCT00400829","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00400829","['National Cancer Institute (NCI)']"]
["NCT00402025","['BioVex Limited']","[' BioVex Limited ']","https://clinicaltrials.gov/ct2/show/NCT00402025","['BioVex Limited']"]
["NCT00402116","[]","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00402116","['Chief Medical Officer, Eli Lilly']"]
["NCT00404066","['George Albert Fisher, Stanford University']","[' George Albert Fisher ']","https://clinicaltrials.gov/ct2/show/NCT00404066","['George Albert Fisher, Associate Professor of Medicine, Stanford University']"]
["NCT00404170","['Danna Jennings, MD, Institute for Neurodegenerative Disorders']","[' Institute for Neurodegenerative Disorders ']","https://clinicaltrials.gov/ct2/show/NCT00404170","['Danna Jennings, MD, Principal Investigator, Institute for Neurodegenerative Disorders']"]
["NCT00405704","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","[' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ']","https://clinicaltrials.gov/ct2/show/NCT00405704","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT00406692","[]","[' Boston University ']","https://clinicaltrials.gov/ct2/show/NCT00406692","['Clifford Knapp, PhD, Boston University']"]
["NCT00408317","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00408317","['Forest Laboratories']"]
["NCT00409578","[]","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00409578","['External Affairs, Novartis']"]
["NCT00410384","['Human Genome Sciences Inc.']","[' Human Genome Sciences Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00410384","['Human Genome Sciences Inc.']"]
["NCT00411762","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT00411762","['Yale University']"]
["NCT00412893","['Astellas Pharma Inc']","[' Astellas Pharma Inc ']","https://clinicaltrials.gov/ct2/show/NCT00412893","['Astellas Pharma Inc']"]
["NCT00413296","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00413296","['Duke University']"]
["NCT00415051","['U.S. Army Medical Research and Materiel Command']","[' U.S. Army Medical Research and Materiel Command ']","https://clinicaltrials.gov/ct2/show/NCT00415051","['U.S. Army Medical Research and Materiel Command']"]
["NCT00417079","[]","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00417079","['International Clinical Development Study Director, sanofi-aventis']"]
["NCT00418483","['Grifols Therapeutics LLC']","[' Grifols Therapeutics LLC ']","https://clinicaltrials.gov/ct2/show/NCT00418483","['Grifols Therapeutics LLC']"]
["NCT00419757","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00419757","['AstraZeneca']"]
["NCT00420615","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00420615","['Novartis Pharmaceuticals']"]
["NCT00421889","['Onxeo']","[' Onxeo ']","https://clinicaltrials.gov/ct2/show/NCT00421889","['Onxeo']"]
["NCT00422292","['Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[' Sanofi Pasteur, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00422292","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00422903","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00422903","['GlaxoSmithKline']"]
["NCT00424190","[]","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00424190","['Senior Vice President, Clinical Development, Cerexa, Inc']"]
["NCT00425594","[]","[' Braintree Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00425594","['John McGowan, Clinical Operations Manager, Braintree Laboratories, Inc.']"]
["NCT00426556","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00426556","['Novartis Pharmaceuticals']"]
["NCT00428389","['Novartis']","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00428389","['Novartis']"]
["NCT00429364","['New England Research Institutes']","[' New England Research Institutes ']","https://clinicaltrials.gov/ct2/show/NCT00429364","['New England Research Institutes']"]
["NCT00430781","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00430781","['GlaxoSmithKline']"]
["NCT00432861","['Digestive Care, Inc.']","[' Digestive Care, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00432861","['Digestive Care, Inc.']"]
["NCT00434148","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00434148","['Novartis Pharmaceuticals']"]
["NCT00435409","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00435409","['Pfizer']"]
["NCT00436553","[]","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00436553","['External Affairs, Novartis']"]
["NCT00437502","['Michael Morse, MD, Duke University']","[' Michael Morse, MD ']","https://clinicaltrials.gov/ct2/show/NCT00437502","['Michael Morse, MD, Professor of Medicine, Duke University']"]
["NCT00439270","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00439270","['Bristol-Myers Squibb']"]
["NCT00440466","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00440466","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00441545","['Shire']","[' Shire ']","https://clinicaltrials.gov/ct2/show/NCT00441545","['Shire']"]
["NCT00442871","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00442871","['GlaxoSmithKline']"]
["NCT00442962","['AIDS Clinical Trials Group']","[' AIDS Clinical Trials Group ']","https://clinicaltrials.gov/ct2/show/NCT00442962","['AIDS Clinical Trials Group']"]
["NCT00444314","[]","[' CASI Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00444314","['Chief Medical Officer, EntreMed, Inc.']"]
["NCT00445484","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT00445484","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT00447811","[]","[' Valeant Pharmaceuticals International, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00447811","['Jeff Cohn, Salix Pharmaceuticals']"]
["NCT00448110","[]","[' Javelin Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00448110","['Javelin Pharmaceuticals']"]
["NCT00449176","[]","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00449176","['Vice President, Compound Developmen Team Leader, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00450255","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00450255","['National Cancer Institute (NCI)']"]
["NCT00452335","['Sucampo Pharma Americas, LLC ( Sucampo Pharmaceuticals, Inc. )']","[' Sucampo Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00452335","['Sucampo Pharmaceuticals, Inc.']"]
["NCT00454142","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00454142","['National Cancer Institute (NCI)']"]
["NCT00454649","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00454649","['Pfizer']"]
["NCT00457197","['University of Texas Southwestern Medical Center']","[' University of Texas Southwestern Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00457197","['University of Texas Southwestern Medical Center']"]
["NCT00458679","['Malcolm Brenner, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00458679","['Malcolm Brenner, Professor/Director Center for Cell and Gene Therapy, Baylor College of Medicine']"]
["NCT00459381","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00459381","['National Cancer Institute (NCI)']"]
["NCT00459979","['Case Comprehensive Cancer Center']","[' Case Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00459979","['Case Comprehensive Cancer Center']"]
["NCT00462553","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00462553","['National Cancer Institute (NCI)']"]
["NCT00463580","['Andrew H Miller, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT00463580","['Andrew H Miller, Professor, Emory University']"]
["NCT00464243","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00464243","['Sanofi']"]
["NCT00464737","['UCB Pharma']","[' UCB Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00464737","['UCB Pharma']"]
["NCT00466466","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00466466","['Novartis Pharmaceuticals']"]
["NCT00468143","['New York University School of Medicine']","[' New York University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00468143","['New York University School of Medicine']"]
["NCT00469079","['University of Minnesota - Clinical and Translational Science Institute']","[' University of Minnesota - Clinical and Translational Science Institute ']","https://clinicaltrials.gov/ct2/show/NCT00469079","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00470366","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00470366","['Memorial Sloan Kettering Cancer Center']"]
["NCT00471445","['Gary Morrow, University of Rochester NCORP Research Base']","[' Gary Morrow ']","https://clinicaltrials.gov/ct2/show/NCT00471445","['Gary Morrow, Director, URCC NCORP Research Base, University of Rochester NCORP Research Base']"]
["NCT00472758","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT00472758","['MedImmune LLC']"]
["NCT00474175","['Wyeth is now a wholly owned subsidiary of Pfizer']","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00474175","['Wyeth is now a wholly owned subsidiary of Pfizer']"]
["NCT00475085","['Joseph Roscoe, University of Rochester NCORP Research Base']","[' Joseph Roscoe ']","https://clinicaltrials.gov/ct2/show/NCT00475085","['Joseph Roscoe, Research Associate Professor, University of Rochester NCORP Research Base']"]
["NCT00476151","[]","[' EpiCept Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00476151","['Stephane Allard, Chief Medical Officer, EpiCept Corporation']"]
["NCT00477594","['Kastle Therapeutics, LLC']","[' Kastle Therapeutics, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00477594","['Kastle Therapeutics, LLC']"]
["NCT00478725","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00478725","['GlaxoSmithKline']"]
["NCT00480584","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00480584","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00482963","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT00482963","['University of Colorado, Denver']"]
["NCT00484666","['Carilion Clinic']","[' Carilion Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00484666","['Carilion Clinic']"]
["NCT00484679","['University of Minnesota - Clinical and Translational Science Institute']","[' University of Minnesota - Clinical and Translational Science Institute ']","https://clinicaltrials.gov/ct2/show/NCT00484679","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00487539","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00487539","['Janssen Research & Development, LLC']"]
["NCT00488267","['ZARS Pharma Inc.']","[' ZARS Pharma Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00488267","['ZARS Pharma Inc.']"]
["NCT00489489","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00489489","['Sanofi']"]
["NCT00492206","['Ahmad Tarhini, University of Pittsburgh']","[' University of Pittsburgh ']","https://clinicaltrials.gov/ct2/show/NCT00492206","['Ahmad Tarhini, Associate Professor of Medicine and Translational Science, University of Pittsburgh']"]
["NCT00492869","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00492869","['Novartis Pharmaceuticals']"]
["NCT00494585","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00494585","['M.D. Anderson Cancer Center']"]
["NCT00497081","['Phillip Coffin, MD, MIA, San Francisco Department of Public Health']","[' San Francisco Department of Public Health ']","https://clinicaltrials.gov/ct2/show/NCT00497081","['Phillip Coffin, MD, MIA, Principal Investigator, San Francisco Department of Public Health']"]
["NCT00498628","['National Institute on Alcohol Abuse and Alcoholism (NIAAA)']","[' National Institute on Alcohol Abuse and Alcoholism (NIAAA) ']","https://clinicaltrials.gov/ct2/show/NCT00498628","['National Institute on Alcohol Abuse and Alcoholism (NIAAA)']"]
["NCT00499863","['Noven Therapeutics']","[' Noven Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00499863","['Noven Therapeutics']"]
["NCT00501202","['SK Life Science, Inc.']","[' SK Life Science, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00501202","['SK Life Science, Inc.']"]
["NCT00503113","[]","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00503113","['Disclosures Group, Hoffmann-La Roche']"]
["NCT00504010","[]","[' The University of Texas Health Science Center, Houston ']","https://clinicaltrials.gov/ct2/show/NCT00504010","['David W. Bauer, MD, Memorial Hermann Healthcare System']"]
["NCT00505778","['Warner Chilcott']","[' Warner Chilcott ']","https://clinicaltrials.gov/ct2/show/NCT00505778","['Warner Chilcott']"]
["NCT00506142","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00506142","['Spectrum Pharmaceuticals, Inc']"]
["NCT00508287","[]","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00508287","['Study Director, Bristol-Myers Squibb']"]
["NCT00508326","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00508326","['M.D. Anderson Cancer Center']"]
["NCT00509353","[\"Nant Operations Center, Children's Hospital Los Angeles\"]","[\" Children's Hospital Los Angeles \"]","https://clinicaltrials.gov/ct2/show/NCT00509353","[\"Nant Operations Center, NANT Operations Center, Children's Hospital Los Angeles\"]"]
["NCT00510484","[]","[' Solvay Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00510484","['Djenane Bennett, Solvay Pharmaceuticals']"]
["NCT00511706","['Allergan']","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT00511706","['Allergan']"]
["NCT00513162","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00513162","['M.D. Anderson Cancer Center']"]
["NCT00514501","['Molecular Insight Pharmaceuticals, Inc.']","[' Molecular Insight Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00514501","['Molecular Insight Pharmaceuticals, Inc.']"]
["NCT00515827","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00515827","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00516919","['Carlos Grilo, Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT00516919","['Carlos Grilo, Professor of Psychiatry and Psychology, Yale University']"]
["NCT00517868","['Urigen']","[' Urigen ']","https://clinicaltrials.gov/ct2/show/NCT00517868","['Urigen']"]
["NCT00519389","['Novavax']","[' Novavax ']","https://clinicaltrials.gov/ct2/show/NCT00519389","['Novavax']"]
["NCT00520741","['UCB Pharma ( UCB BIOSCIENCES, Inc. )']","[' UCB BIOSCIENCES, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00520741","['UCB BIOSCIENCES, Inc.']"]
["NCT00521456","[]","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT00521456","['Therapeutic Area Head, Allergan, Inc.']"]
["NCT00524121","['Roswell Park Cancer Institute']","[' Roswell Park Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00524121","['Roswell Park Cancer Institute']"]
["NCT00525902","['Eric B. Suhler, Oregon Health and Science University']","[' Oregon Health and Science University ']","https://clinicaltrials.gov/ct2/show/NCT00525902","['Eric B. Suhler, Associate Professor, Oregon Health and Science University']"]
["NCT00527488","['Ferring Pharmaceuticals']","[' Ferring Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00527488","['Ferring Pharmaceuticals']"]
["NCT00527904","[]","[' POZEN ']","https://clinicaltrials.gov/ct2/show/NCT00527904","['Senior Vice President, Clinical Research, Pozen Inc.']"]
["NCT00528411","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00528411","['AstraZeneca']"]
["NCT00529191","[\"Children's Hospital of Philadelphia\"]","[\" Children's Hospital of Philadelphia \"]","https://clinicaltrials.gov/ct2/show/NCT00529191","[\"Children's Hospital of Philadelphia\"]"]
["NCT00531232","['Sanofi ( Genzyme, a Sanofi Company )']","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00531232","['Genzyme, a Sanofi Company']"]
["NCT00532233","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00532233","['Novartis Pharmaceuticals']"]
["NCT00533429","[]","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00533429","['Chief Medical Officer, Eli Lilly']"]
["NCT00534976","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00534976","['Merck Sharp & Dohme Corp.']"]
["NCT00536939","[]","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00536939","['Chief Medical Officer, Eli Lilly']"]
["NCT00537719","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00537719","['GlaxoSmithKline']"]
["NCT00539006","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00539006","['GlaxoSmithKline']"]
["NCT00541164","['Memorial Medical Center']","[' Memorial Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00541164","['Memorial Medical Center']"]
["NCT00542685","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00542685","['Pfizer']"]
["NCT00544297","['Peplin']","[' Peplin ']","https://clinicaltrials.gov/ct2/show/NCT00544297","['Peplin']"]
["NCT00545766","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00545766","['SCRI Development Innovations, LLC']"]
["NCT00546793","['Immunomedics, Inc.']","[' Immunomedics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00546793","['Immunomedics, Inc.']"]
["NCT00548249","[]","[' Rockwell Medical Technologies, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00548249","['Robert Chioini, President and CEO, Rockwell Medical Technologies, Inc.']"]
["NCT00549549","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00549549","['Director Clinical Trial Disclosure Group, Pfizer']"]
["NCT00550381","[]","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00550381","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT00550459","[]","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00550459","['Dorothee Oberdhan, Manager, Global Clinical Development, Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00551694","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00551694","['GlaxoSmithKline']"]
["NCT00554268","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00554268","['M.D. Anderson Cancer Center']"]
["NCT00554853","['Mariana Kaplan, University of Michigan']","[' University of Michigan ']","https://clinicaltrials.gov/ct2/show/NCT00554853","['Mariana Kaplan, Associate Professor, University of Michigan']"]
["NCT00556504","['TCM Biotech International Corp.']","[' TCM Biotech International Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00556504","['TCM Biotech International Corp.']"]
["NCT00557362","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00557362","['University of California, San Francisco']"]
["NCT00559299","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00559299","['GlaxoSmithKline']"]
["NCT00560573","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00560573","['Pfizer']"]
["NCT00561834","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT00561834","['University of Colorado, Denver']"]
["NCT00562861","['Tufts Medical Center']","[' Tufts Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00562861","['Tufts Medical Center']"]
["NCT00565201","['Steven L. Wolf, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT00565201","['Steven L. Wolf, Professor, Emory University']"]
["NCT00566501","['Eisai Inc.']","[' Eisai Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00566501","['Eisai Inc.']"]
["NCT00567034","['Igor Elman, MD, Mclean Hospital']","[' Mclean Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00567034","['Igor Elman, MD, MD, Mclean Hospital']"]
["NCT00569270","['Gelb, Arthur F., M.D.']","[' Gelb, Arthur F., M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00569270","['Gelb, Arthur F., M.D.']"]
["NCT00570479","['Texas Retina Associates']","[' Texas Retina Associates ']","https://clinicaltrials.gov/ct2/show/NCT00570479","['Texas Retina Associates']"]
["NCT00570752","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00570752","['Bristol-Myers Squibb']"]
["NCT00571675","[]","[' Ascenta Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00571675","['Melissa Brookes, Sr. Project Manager, Clinical Development, Ascenta Therapeutics']"]
["NCT00573443","['Avanir Pharmaceuticals']","[' Avanir Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00573443","['Avanir Pharmaceuticals']"]
["NCT00574951","['Gynecologic Oncology Group']","[' Gynecologic Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00574951","['Gynecologic Oncology Group']"]
["NCT00577135","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00577135","['Duke University']"]
["NCT00578552","[]","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00578552","['Amit Sood, MD, Mayo Clinic']"]
["NCT00580073","['University of Wisconsin, Madison']","[' University of Wisconsin, Madison ']","https://clinicaltrials.gov/ct2/show/NCT00580073","['University of Wisconsin, Madison']"]
["NCT00581828","['University of Wisconsin, Madison']","[' University of Wisconsin, Madison ']","https://clinicaltrials.gov/ct2/show/NCT00581828","['University of Wisconsin, Madison']"]
["NCT00583674","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT00583674","['Amgen']"]
["NCT00585104","['University of Utah']","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT00585104","['University of Utah']"]
["NCT00586196","['Edward Marcantonio, Beth Israel Deaconess Medical Center']","[' Beth Israel Deaconess Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00586196","['Edward Marcantonio, Principal Investigator, Beth Israel Deaconess Medical Center']"]
["NCT00588731","['Mohini Ranganathan, Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT00588731","['Mohini Ranganathan, Assistant Professor, Yale University']"]
["NCT00590577","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00590577","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00592124","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00592124","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00593138","['Thomas J. Spencer, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00593138","['Thomas J. Spencer, MD, Associate Chief, Clinical and Research Program, Pediatric Psychopharmacology, Massachusetts General Hospital']"]
["NCT00594958","['Valneva Austria GmbH']","[' Valneva Austria GmbH ']","https://clinicaltrials.gov/ct2/show/NCT00594958","['Valneva Austria GmbH']"]
["NCT00594984","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00594984","['Bristol-Myers Squibb']"]
["NCT00596934","['Elif Oral, University of Michigan']","[' Elif Oral ']","https://clinicaltrials.gov/ct2/show/NCT00596934","['Elif Oral, Associate Prof of Medicine, University of Michigan']"]
["NCT00597519","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00597519","['Memorial Sloan Kettering Cancer Center']"]
["NCT00598689","['David Bogorad, Augusta University']","[' Augusta University ']","https://clinicaltrials.gov/ct2/show/NCT00598689","['David Bogorad, Professor and Vice Chairman, Director, Refractive Surgery Service, Department of Ophthalmology, Augusta University']"]
["NCT00600743","[\"St. Luke's-Roosevelt Hospital Center\"]","[\" St. Luke's-Roosevelt Hospital Center \"]","https://clinicaltrials.gov/ct2/show/NCT00600743","[\"St. Luke's-Roosevelt Hospital Center\"]"]
["NCT00601250","[]","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT00601250","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00602472","[]","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT00602472","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00603902","['Arena Pharmaceuticals']","[' Arena Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00603902","['Arena Pharmaceuticals']"]
["NCT00605449","[]","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00605449","['Study Director, GSK']"]
["NCT00606034","['Wendy Lane MD, Mountain Diabetes and Endocrine Center']","[' Mountain Diabetes and Endocrine Center ']","https://clinicaltrials.gov/ct2/show/NCT00606034","['Wendy Lane MD, Director of Research, Principal Investigator, Mountain Diabetes and Endocrine Center']"]
["NCT00607542","['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","https://clinicaltrials.gov/ct2/show/NCT00607542","['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']"]
["NCT00607763","['Astellas Pharma Inc']","[' Astellas Pharma Inc ']","https://clinicaltrials.gov/ct2/show/NCT00607763","['Astellas Pharma Inc']"]
["NCT00609804","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00609804","['SCRI Development Innovations, LLC']"]
["NCT00611247","['Bruno C. Medeiros, Stanford University']","[' Bruno C. Medeiros ']","https://clinicaltrials.gov/ct2/show/NCT00611247","['Bruno C. Medeiros, PI, Stanford University']"]
["NCT00611468","['Accelerated Community Oncology Research Network']","[' Accelerated Community Oncology Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00611468","['Accelerated Community Oncology Research Network']"]
["NCT00613054","['Annick Desjardins, Duke University']","[' Annick Desjardins ']","https://clinicaltrials.gov/ct2/show/NCT00613054","['Annick Desjardins, Assistant Professor of Medicine, Duke University']"]
["NCT00613132","['Annick Desjardins, Duke University']","[' Annick Desjardins ']","https://clinicaltrials.gov/ct2/show/NCT00613132","['Annick Desjardins, Assistant Professor of Medicine, Duke University']"]
["NCT00614523","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT00614523","['Amgen']"]
["NCT00615927","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00615927","['Duke University']"]
["NCT00616655","['Sunovion']","[' Sunovion ']","https://clinicaltrials.gov/ct2/show/NCT00616655","['Sunovion']"]
["NCT00617669","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00617669","['AstraZeneca']"]
["NCT00618527","['Aaron Boster, Ohio State University']","[' Aaron Boster ']","https://clinicaltrials.gov/ct2/show/NCT00618527","['Aaron Boster, Assistant Professor-Clinical, Ohio State University']"]
["NCT00619801","['UCB Pharma']","[' UCB Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00619801","['UCB Pharma']"]
["NCT00620620","['Alexza Pharmaceuticals, Inc.']","[' Alexza Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00620620","['Alexza Pharmaceuticals, Inc.']"]
["NCT00621361","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00621361","['AstraZeneca']"]
["NCT00622440","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00622440","['University of California, San Francisco']"]
["NCT00623636","['Allergan']","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT00623636","['Allergan']"]
["NCT00624910","['Innocoll']","[' Innocoll ']","https://clinicaltrials.gov/ct2/show/NCT00624910","['Innocoll']"]
["NCT00625664","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00625664","['Sanofi']"]
["NCT00627016","[]","[' Takeda ']","https://clinicaltrials.gov/ct2/show/NCT00627016","['Sr. VP Clinical Sciences, Takeda Global Research & Development Center, Inc.']"]
["NCT00628732","[]","[\" Children's Medical Center Dallas \"]","https://clinicaltrials.gov/ct2/show/NCT00628732","['Daniel C. Bowers M.D./ Associate Professor of Pediatrics, UT Southwestern Medical Center of Dallas']"]
["NCT00629837","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT00629837","['Bayer']"]
["NCT00630552","['NantCell, Inc.']","[' NantCell, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00630552","['NantCell, Inc.']"]
["NCT00631475","['Actelion']","[' Actelion ']","https://clinicaltrials.gov/ct2/show/NCT00631475","['Actelion']"]
["NCT00633529","['EMD Serono']","[' EMD Serono ']","https://clinicaltrials.gov/ct2/show/NCT00633529","['EMD Serono']"]
["NCT00634504","['BTG International Inc.']","[' BTG International Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00634504","['BTG International Inc.']"]
["NCT00635791","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT00635791","['University of Colorado, Denver']"]
["NCT00638079","['Endo Pharmaceuticals']","[' Endo Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00638079","['Endo Pharmaceuticals']"]
["NCT00640185","['AbbVie ( AbbVie (prior sponsor, Abbott) )']","[' AbbVie (prior sponsor, Abbott) ']","https://clinicaltrials.gov/ct2/show/NCT00640185","['AbbVie (prior sponsor, Abbott)']"]
["NCT00641108","['Jay Amsterdam, University of Pennsylvania']","[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT00641108","['Jay Amsterdam, Professor, University of Pennsylvania']"]
["NCT00642941","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00642941","['Hoffmann-La Roche']"]
["NCT00645593","['University of Michigan Rogel Cancer Center']","[' University of Michigan Rogel Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00645593","['University of Michigan Rogel Cancer Center']"]
["NCT00647296","['Knopp Biosciences']","[' Knopp Biosciences ']","https://clinicaltrials.gov/ct2/show/NCT00647296","['Knopp Biosciences']"]
["NCT00648154","[]","[' Mylan Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00648154","['Wayne Talton, Mylan Inc.']"]
["NCT00648973","['Johnson & Johnson Consumer and Personal Products Worldwide']","[' Johnson & Johnson Consumer and Personal Products Worldwide ']","https://clinicaltrials.gov/ct2/show/NCT00648973","['Johnson & Johnson Consumer and Personal Products Worldwide']"]
["NCT00649779","[]","[' Mylan Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00649779","['Will Sullvan, Global Head of Product Risk and Safety Management, Mylan Inc.']"]
["NCT00650923","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00650923","['National Cancer Institute (NCI)']"]
["NCT00652340","['Tragara Pharmaceuticals, Inc.']","[' Tragara Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00652340","['Tragara Pharmaceuticals, Inc.']"]
["NCT00654238","['Marcia Brose, University of Pennsylvania']","[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT00654238","['Marcia Brose, Associate Professor, University of Pennsylvania']"]
["NCT00654381","[]","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT00654381","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00655629","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT00655629","['Bayer']"]
["NCT00656513","['Radiation Therapy Oncology Group']","[' Radiation Therapy Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00656513","['Radiation Therapy Oncology Group']"]
["NCT00658086","[]","[' Alnylam Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00658086","['Jared Gollob, MD Sr. Director Clinical Research, Alnylam Pharmaceuticals']"]
["NCT00659269","['New Mexico Cancer Care Alliance']","[' New Mexico Cancer Care Alliance ']","https://clinicaltrials.gov/ct2/show/NCT00659269","['New Mexico Cancer Care Alliance']"]
["NCT00660153","['AVEO Pharmaceuticals, Inc.']","[' AVEO Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00660153","['AVEO Pharmaceuticals, Inc.']"]
["NCT00661583","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT00661583","['University of Colorado, Denver']"]
["NCT00662883","[]","[' Javelin Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00662883","['Javelin Pharmaceuticals, Inc.']"]
["NCT00664560","['POZEN']","[' POZEN ']","https://clinicaltrials.gov/ct2/show/NCT00664560","['POZEN']"]
["NCT00665626","['Rigel Pharmaceuticals']","[' Rigel Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00665626","['Rigel Pharmaceuticals']"]
["NCT00667394","['Katherine E. Warren, M.D., National Institutes of Health Clinical Center (CC)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00667394","['Katherine E. Warren, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT00668525","[]","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00668525","['Carl Gommoll, Study Director, Forest Laboratories']"]
["NCT00669279","['University of Florida']","[' University of Florida ']","https://clinicaltrials.gov/ct2/show/NCT00669279","['University of Florida']"]
["NCT00671515","['Joseph Calabrese, MD, University Hospitals Cleveland Medical Center']","[' Joseph Calabrese, MD ']","https://clinicaltrials.gov/ct2/show/NCT00671515","['Joseph Calabrese, MD, Director, Mood Disorders Program, University Hospitals Cleveland Medical Center']"]
["NCT00672295","['AA Secord, Duke University']","[' AA Secord ']","https://clinicaltrials.gov/ct2/show/NCT00672295","['AA Secord, Associate Professor, Gynecologic Oncology, Duke University']"]
["NCT00672594","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00672594","['Duke University']"]
["NCT00673387","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00673387","['AstraZeneca']"]
["NCT00674752","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00674752","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00676585","['Michael Donnino, Beth Israel Deaconess Medical Center']","[' Beth Israel Deaconess Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00676585","['Michael Donnino, Michael Donnino, MD, Beth Israel Deaconess Medical Center']"]
["NCT01911325","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01911325","['Novartis Pharmaceuticals']"]
["NCT01914796","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01914796","['Pfizer']"]
["NCT01919216","['New York State Psychiatric Institute']","[' New York State Psychiatric Institute ']","https://clinicaltrials.gov/ct2/show/NCT01919216","['New York State Psychiatric Institute']"]
["NCT01922128","['MacuCLEAR, Inc.']","[' MacuCLEAR, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01922128","['MacuCLEAR, Inc.']"]
["NCT01924949","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT01924949","['Gilead Sciences']"]
["NCT01926977","['Arshad Khanani, Sierra Eye Associates']","[' Arshad Khanani ']","https://clinicaltrials.gov/ct2/show/NCT01926977","['Arshad Khanani, Vitreo-Retinal Surgeon, Sierra Eye Associates']"]
["NCT01929707","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01929707","['Eli Lilly and Company']"]
["NCT01933048","['Timothy Burgess, MD, MPH, Uniformed Services University of the Health Sciences']","[' Uniformed Services University of the Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT01933048","['Timothy Burgess, MD, MPH, Captain, Medical Corps, US Navy, Uniformed Services University of the Health Sciences']"]
["NCT01937975","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT01937975","['Merck Sharp & Dohme Corp.']"]
["NCT01941511","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01941511","['Pfizer']"]
["NCT01945034","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01945034","['Pfizer']"]
["NCT01951235","['Poxel SA']","[' Poxel SA ']","https://clinicaltrials.gov/ct2/show/NCT01951235","['Poxel SA']"]
["NCT01951274","['Menlo Therapeutics Inc.']","[' Menlo Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01951274","['Menlo Therapeutics Inc.']"]
["NCT01957839","[u'Osman A\\u015f\\u0131c\\u0131o\\u011flu, Istanbul Bakirkoy Maternity and Children Diseases Hospital']","[' Istanbul Bakirkoy Maternity and Children Diseases Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01957839","[u'Osman A\\u015f\\u0131c\\u0131o\\u011flu, sisli etfal teaching hospital department gynecology and obstetric, Istanbul Bakirkoy Maternity and Children Diseases Hospital']"]
["NCT01959282","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01959282","['Janssen Research & Development, LLC']"]
["NCT01961323","['Partho Sengupta, Icahn School of Medicine at Mount Sinai']","[' Icahn School of Medicine at Mount Sinai ']","https://clinicaltrials.gov/ct2/show/NCT01961323","['Partho Sengupta, Associate Professor, Icahn School of Medicine at Mount Sinai']"]
["NCT01966679","['James McCracken, University of California, Los Angeles']","[' University of California, Los Angeles ']","https://clinicaltrials.gov/ct2/show/NCT01966679","['James McCracken, Department Chair, University of California, Los Angeles']"]
["NCT01968070","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01968070","['Eli Lilly and Company']"]
["NCT01970553","['PharmaMar']","[' PharmaMar ']","https://clinicaltrials.gov/ct2/show/NCT01970553","['PharmaMar']"]
["NCT01975220","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT01975220","['Boehringer Ingelheim']"]
["NCT01979445","['The Medicines Company']","[' The Medicines Company ']","https://clinicaltrials.gov/ct2/show/NCT01979445","['The Medicines Company']"]
["NCT01981005","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01981005","['Hoffmann-La Roche']"]
["NCT01984229","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01984229","['Hoffmann-La Roche']"]
["NCT01986283","['Pain Therapeutics']","[' Pain Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01986283","['Pain Therapeutics']"]
["NCT01992094","['Novartis ( Novartis Vaccines )']","[' Novartis Vaccines ']","https://clinicaltrials.gov/ct2/show/NCT01992094","['Novartis Vaccines']"]
["NCT01995617","['Genocea Biosciences, Inc.']","[' Genocea Biosciences, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01995617","['Genocea Biosciences, Inc.']"]
["NCT01997411","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01997411","['Eli Lilly and Company']"]
["NCT02006732","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT02006732","['Boehringer Ingelheim']"]
["NCT02007434","['Kythera Biopharmaceuticals']","[' Kythera Biopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02007434","['Kythera Biopharmaceuticals']"]
["NCT02013310","['Dart NeuroScience, LLC']","[' Dart NeuroScience, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02013310","['Dart NeuroScience, LLC']"]
["NCT02016482","['AbbVie']","[' AbbVie ']","https://clinicaltrials.gov/ct2/show/NCT02016482","['AbbVie']"]
["NCT02019472","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02019472","['Janssen Research & Development, LLC']"]
["NCT02023931","['Julie E. Bauman, MD, MPH, University of Pittsburgh']","[' Julie E. Bauman, MD, MPH ']","https://clinicaltrials.gov/ct2/show/NCT02023931","['Julie E. Bauman, MD, MPH, Assistant Professor of Medicine,Director of the Section of Head and Neck Cancer, University of Pittsburgh']"]
["NCT02028065","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT02028065","['Merck Sharp & Dohme Corp.']"]
["NCT02032875","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT02032875","['Bristol-Myers Squibb']"]
["NCT02036645","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT02036645","['AstraZeneca']"]
["NCT02040298","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT02040298","['University of California, San Francisco']"]
["NCT02044341","['Arbor Pharmaceuticals, Inc.']","[' Arbor Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02044341","['Arbor Pharmaceuticals, Inc.']"]
["NCT02046850","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT02046850","['AstraZeneca']"]
["NCT02052557","['Des Moines University']","[' Des Moines University ']","https://clinicaltrials.gov/ct2/show/NCT02052557","['Des Moines University']"]
["NCT02055274","['Luye Pharma Group Ltd.']","[' Luye Pharma Group Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT02055274","['Luye Pharma Group Ltd.']"]
["NCT02059590","['Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )']","[' Astellas Pharma Global Development, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02059590","['Astellas Pharma Global Development, Inc.']"]
["NCT02063360","['ViiV Healthcare']","[' ViiV Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT02063360","['ViiV Healthcare']"]
["NCT02066402","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT02066402","['Bayer']"]
["NCT02067520","['Thomas Jefferson University']","[' Thomas Jefferson University ']","https://clinicaltrials.gov/ct2/show/NCT02067520","['Thomas Jefferson University']"]
["NCT02071368","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02071368","['Janssen Research & Development, LLC']"]
["NCT02077374","['Conatus Pharmaceuticals Inc.']","[' Conatus Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02077374","['Conatus Pharmaceuticals Inc.']"]
["NCT02079168","['RXi Pharmaceuticals, Corp.']","[' RXi Pharmaceuticals, Corp. ']","https://clinicaltrials.gov/ct2/show/NCT02079168","['RXi Pharmaceuticals, Corp.']"]
["NCT02082652","['Catherine Chappell, University of Pittsburgh']","[' University of Pittsburgh ']","https://clinicaltrials.gov/ct2/show/NCT02082652","['Catherine Chappell, Assistant Professor, University of Pittsburgh']"]
["NCT02085473","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT02085473","['MedImmune LLC']"]
["NCT02092831","['Genentech, Inc.']","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02092831","['Genentech, Inc.']"]
["NCT02095860","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT02095860","['Bristol-Myers Squibb']"]
["NCT02098174","['MediBeacon']","[' MediBeacon ']","https://clinicaltrials.gov/ct2/show/NCT02098174","['MediBeacon']"]
["NCT02102828","['TriHealth Inc.']","[' TriHealth Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02102828","['TriHealth Inc.']"]
["NCT02105454","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT02105454","['Merck Sharp & Dohme Corp.']"]
["NCT02108262","['CSL Behring']","[' CSL Behring ']","https://clinicaltrials.gov/ct2/show/NCT02108262","['CSL Behring']"]
["NCT02114151","['Janssen Infectious Diseases BVBA']","[' Janssen Infectious Diseases BVBA ']","https://clinicaltrials.gov/ct2/show/NCT02114151","['Janssen Infectious Diseases BVBA']"]
["NCT02117752","['Almirall, S.A.']","[' Almirall, S.A. ']","https://clinicaltrials.gov/ct2/show/NCT02117752","['Almirall, S.A.']"]
["NCT02121210","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT02121210","['Sanofi']"]
["NCT02125877","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02125877","['Novartis Pharmaceuticals']"]
["NCT02128932","['Novo Nordisk A/S']","[' Novo Nordisk A/S ']","https://clinicaltrials.gov/ct2/show/NCT02128932","['Novo Nordisk A/S']"]
["NCT02129660","['Dermira, Inc.']","[' Dermira, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02129660","['Dermira, Inc.']"]
["NCT02133625","['James Cleary, MD, PhD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT02133625","['James Cleary, MD, PhD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT02136914","['Adamas Pharmaceuticals, Inc.']","[' Adamas Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02136914","['Adamas Pharmaceuticals, Inc.']"]
["NCT02140762","['Novartis ( Novartis Vaccines )']","[' Novartis Vaccines ']","https://clinicaltrials.gov/ct2/show/NCT02140762","['Novartis Vaccines']"]
["NCT02144272","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT02144272","['Eli Lilly and Company']"]
["NCT02149966","['Agios Pharmaceuticals, Inc.']","[' Agios Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02149966","['Agios Pharmaceuticals, Inc.']"]
["NCT02155543","['Allergan']","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT02155543","['Allergan']"]
["NCT02159469","['Antares Pharma Inc.']","[' Antares Pharma Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02159469","['Antares Pharma Inc.']"]
["NCT02163824","['Kala Pharmaceuticals, Inc.']","[' Kala Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02163824","['Kala Pharmaceuticals, Inc.']"]
["NCT02165293","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT02165293","['Hoffmann-La Roche']"]
["NCT02171208","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT02171208","['Biogen']"]
["NCT02177786","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT02177786","['Gilead Sciences']"]
["NCT02181582","['National Institutes of Health Clinical Center (CC) ( National Institute of Mental Health (NIMH) )']","[' National Institute of Mental Health (NIMH) ']","https://clinicaltrials.gov/ct2/show/NCT02181582","['National Institute of Mental Health (NIMH)']"]
["NCT02189317","['John Xerogeanes, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT02189317","['John Xerogeanes, Associate Professor, Emory University']"]
["NCT02195635","['Lexicon Pharmaceuticals']","[' Lexicon Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02195635","['Lexicon Pharmaceuticals']"]
["NCT02196714","['Pearl Therapeutics, Inc.']","[' Pearl Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02196714","['Pearl Therapeutics, Inc.']"]
["NCT02201238","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT02201238","['GlaxoSmithKline']"]
["NCT02205528","['Novo Nordisk A/S']","[' Novo Nordisk A/S ']","https://clinicaltrials.gov/ct2/show/NCT02205528","['Novo Nordisk A/S']"]
["NCT02208284","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT02208284","['Pfizer']"]
["NCT02213094","['University of North Carolina, Chapel Hill']","[' University of North Carolina, Chapel Hill ']","https://clinicaltrials.gov/ct2/show/NCT02213094","['University of North Carolina, Chapel Hill']"]
["NCT02216331","['Global Alliance for TB Drug Development']","[' Global Alliance for TB Drug Development ']","https://clinicaltrials.gov/ct2/show/NCT02216331","['Global Alliance for TB Drug Development']"]
["NCT02220998","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT02220998","['Gilead Sciences']"]
["NCT02224664","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT02224664","['Pfizer']"]
["NCT02229214","['VIVUS, Inc.']","[' VIVUS, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02229214","['VIVUS, Inc.']"]
["NCT02234999","['Celgene Corporation']","[' Celgene Corporation ']","https://clinicaltrials.gov/ct2/show/NCT02234999","['Celgene Corporation']"]
["NCT02240628","['Samia Khalil, The University of Texas Health Science Center, Houston']","[' The University of Texas Health Science Center, Houston ']","https://clinicaltrials.gov/ct2/show/NCT02240628","['Samia Khalil, Professor Of Pediatric Anesthesia, The University of Texas Health Science Center, Houston']"]
["NCT02245672","['Mylan Inc.']","[' Mylan Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02245672","['Mylan Inc.']"]
["NCT02253342","['Wockhardt']","[' Wockhardt ']","https://clinicaltrials.gov/ct2/show/NCT02253342","['Wockhardt']"]
["NCT02257983","['Edison Pharmaceuticals Inc']","[' Edison Pharmaceuticals Inc ']","https://clinicaltrials.gov/ct2/show/NCT02257983","['Edison Pharmaceuticals Inc']"]
["NCT02262533","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT02262533","['Bristol-Myers Squibb']"]
["NCT02270983","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT02270983","['Forest Laboratories']"]
["NCT02271282","['Johannes D. Veldhuis, Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT02271282","['Johannes D. Veldhuis, Professor, Mayo Clinic']"]
["NCT02276768","['gicare Pharma Inc.']","[' gicare Pharma Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02276768","['gicare Pharma Inc.']"]
["NCT02279641","['Ardea Biosciences, Inc.']","[' Ardea Biosciences, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02279641","['Ardea Biosciences, Inc.']"]
["NCT02285777","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT02285777","['GlaxoSmithKline']"]
["NCT02291679","['Ironwood Pharmaceuticals, Inc.']","[' Ironwood Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02291679","['Ironwood Pharmaceuticals, Inc.']"]
["NCT02302716","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT02302716","['Eli Lilly and Company']"]
["NCT02310750","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT02310750","['Pfizer']"]
["NCT02319772","['BioCryst Pharmaceuticals']","[' BioCryst Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02319772","['BioCryst Pharmaceuticals']"]
["NCT02323594","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT02323594","['Bristol-Myers Squibb']"]
["NCT02348879","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT02348879","['Amgen']"]
["NCT02391844","['International Clinical Research Institute']","[' International Clinical Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT02391844","['International Clinical Research Institute']"]
["NCT02411136","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT02411136","['Amgen']"]
["NCT02504931","['John Roache, The University of Texas Health Science Center at San Antonio']","[' The University of Texas Health Science Center at San Antonio ']","https://clinicaltrials.gov/ct2/show/NCT02504931","['John Roache, Professor, The University of Texas Health Science Center at San Antonio']"]
["NCT02612948","['Brian Daley, University of Tennessee Graduate School of Medicine']","[' University of Tennessee Graduate School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT02612948","['Brian Daley, Professor, University of Tennessee Graduate School of Medicine']"]
["NCT02697188","['Clarus Therapeutics, Inc.']","[' Clarus Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02697188","['Clarus Therapeutics, Inc.']"]
["NCT02726113","['Medical University of South Carolina']","[' Medical University of South Carolina ']","https://clinicaltrials.gov/ct2/show/NCT02726113","['Medical University of South Carolina']"]
["NCT02807207","['CTI BioPharma']","[' CTI BioPharma ']","https://clinicaltrials.gov/ct2/show/NCT02807207","['CTI BioPharma']"]
["NCT00828581","[]","[' Arena Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00828581","['Christen Anderson, MD, PhD, Arena Pharmaceuticals, Inc.']"]
["NCT00427219","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00427219","['Spectrum Pharmaceuticals, Inc']"]
["NCT00960193","[]","[' Mutual Pharmaceutical Company, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00960193","['Vice President, Branded Products and Medical Affairs, Mutual Pharmaceutical Company, Inc.']"]
["NCT00640926","['Melinta Therapeutics, Inc.']","[' Melinta Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00640926","['Melinta Therapeutics, Inc.']"]
["NCT01020799","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01020799","['AstraZeneca']"]
["NCT01001234","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT01001234","['Merck Sharp & Dohme Corp.']"]
["NCT00421213","['Ziopharm']","[' Ziopharm ']","https://clinicaltrials.gov/ct2/show/NCT00421213","['Ziopharm']"]
["NCT01536249","['Knopp Biosciences']","[' Knopp Biosciences ']","https://clinicaltrials.gov/ct2/show/NCT01536249","['Knopp Biosciences']"]
["NCT01759446","['Acura Pharmaceuticals Inc.']","[' Acura Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01759446","['Acura Pharmaceuticals Inc.']"]
["NCT01957280","['Daiichi Sankyo, Inc.']","[' Daiichi Sankyo, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01957280","['Daiichi Sankyo, Inc.']"]
["NCT02676830","['Kowa Research Institute, Inc.']","[' Kowa Research Institute, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02676830","['Kowa Research Institute, Inc.']"]
["NCT01873677","['Maruho North America Inc.']","[' Maruho North America Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01873677","['Maruho North America Inc.']"]
["NCT00325715","[]","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT00325715","['Therapeutic Area Head, Allergan, Inc']"]
["NCT00308308","['Mannkind Corporation']","[' Mannkind Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00308308","['Mannkind Corporation']"]
["NCT00383552","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00383552","['Merck Sharp & Dohme Corp.']"]
["NCT01001975","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01001975","['Bayer']"]
["NCT00487656","[]","[' Artisan Pharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00487656","['Inder Kaul, Chief Medical Officer, Artisan Pharma, Inc']"]
["NCT01272934","['Novartis']","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT01272934","['Novartis']"]
["NCT01668524","['Altheos, Inc.']","[' Altheos, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01668524","['Altheos, Inc.']"]
["NCT01673009","['Indiana University']","[' Indiana University ']","https://clinicaltrials.gov/ct2/show/NCT01673009","['Indiana University']"]
["NCT01479621","['Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )']","[' Teva Branded Pharmaceutical Products, R&D Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01479621","['Teva Branded Pharmaceutical Products, R&D Inc.']"]
["NCT01710072","['David Hasan, University of Iowa']","[' University of Iowa ']","https://clinicaltrials.gov/ct2/show/NCT01710072","['David Hasan, Assistant Professor and Section Chief, University of Iowa']"]
["NCT01915069","['Laura Sech, University of Southern California']","[' University of Southern California ']","https://clinicaltrials.gov/ct2/show/NCT01915069","['Laura Sech, Family Planning Research Fellow, Department OBGYN, University of Southern California']"]
["NCT02313376","['Seattle Biomedical Research Institute']","[' Seattle Biomedical Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT02313376","['Seattle Biomedical Research Institute']"]
["NCT00414336","[]","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00414336","['RCHSPB']"]
["NCT00145574","[]","[' Daiichi Sankyo, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00145574","['Michael Melino, Daiichi Sankyo']"]
["NCT00707135","['University of Chicago']","[' University of Chicago ']","https://clinicaltrials.gov/ct2/show/NCT00707135","['University of Chicago']"]
["NCT00743002","['Transition Therapeutics']","[' Transition Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00743002","['Transition Therapeutics']"]
["NCT00397345","[]","[' Oxford BioMedica ']","https://clinicaltrials.gov/ct2/show/NCT00397345","['Dr Mike McDonald, Oxford BioMedica']"]
["NCT00811577","['Capstone Therapeutics']","[' Capstone Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00811577","['Capstone Therapeutics']"]
["NCT01113619","['Ritter Pharmaceuticals, Inc.']","[' Ritter Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01113619","['Ritter Pharmaceuticals, Inc.']"]
["NCT02561650","['Mallinckrodt']","[' Mallinckrodt ']","https://clinicaltrials.gov/ct2/show/NCT02561650","['Mallinckrodt']"]
["NCT00657592","['George I. Papakostas, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00657592","['George I. Papakostas, Director of Treatment-Resistant Studies, Depression Clinical and Research Program, Massachusetts General Hospital']"]
["NCT01417780","['Atox Bio Ltd']","[' Atox Bio Ltd ']","https://clinicaltrials.gov/ct2/show/NCT01417780","['Atox Bio Ltd']"]
["NCT00647426","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT00647426","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT01702181","['Otsuka Pharmaceutical Development & Commercialization, Inc.']","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01702181","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT01698320","['Teva Pharmaceutical Industries']","[' Teva Pharmaceutical Industries ']","https://clinicaltrials.gov/ct2/show/NCT01698320","['Teva Pharmaceutical Industries']"]
["NCT02030925","['Ironwood Pharmaceuticals, Inc.']","[' Ironwood Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02030925","['Ironwood Pharmaceuticals, Inc.']"]
["NCT01270698","['Immunomedics, Inc.']","[' Immunomedics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01270698","['Immunomedics, Inc.']"]
["NCT01424566","['GW Pharmaceuticals Ltd.']","[' GW Pharmaceuticals Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01424566","['GW Pharmaceuticals Ltd.']"]
["NCT02289846","['Ironwood Pharmaceuticals, Inc.']","[' Ironwood Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02289846","['Ironwood Pharmaceuticals, Inc.']"]
["NCT00113438","['Mateon Therapeutics']","[' Mateon Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00113438","['Mateon Therapeutics']"]
["NCT00546585","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00546585","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01904162","['MerLion Pharmaceuticals GmbH']","[' MerLion Pharmaceuticals GmbH ']","https://clinicaltrials.gov/ct2/show/NCT01904162","['MerLion Pharmaceuticals GmbH']"]
["NCT00063635","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","[' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ']","https://clinicaltrials.gov/ct2/show/NCT00063635","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT01399008","['CymaBay Therapeutics, Inc.']","[' CymaBay Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01399008","['CymaBay Therapeutics, Inc.']"]
["NCT01769677","['Teva Pharmaceutical Industries']","[' Teva Pharmaceutical Industries ']","https://clinicaltrials.gov/ct2/show/NCT01769677","['Teva Pharmaceutical Industries']"]
["NCT01146002","['Neurology Group of Bergen County, P.A.']","[' Neurology Group of Bergen County, P.A. ']","https://clinicaltrials.gov/ct2/show/NCT01146002","['Neurology Group of Bergen County, P.A.']"]
["NCT02075749","['Mehdi Nasr Isfahani, Isfahan University of Medical Sciences']","[' Isfahan University of Medical Sciences ']","https://clinicaltrials.gov/ct2/show/NCT02075749","['Mehdi Nasr Isfahani, Dr. Nasr, Isfahan University of Medical Sciences']"]
["NCT01949363","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT01949363","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT02462850","['Joseph Hazelton, Charleston Laboratories, Inc']","[' Charleston Laboratories, Inc ']","https://clinicaltrials.gov/ct2/show/NCT02462850","['Joseph Hazelton, Vice President, Regulatory Affairs, Charleston Laboratories, Inc']"]
["NCT00473694","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00473694","['Merck Sharp & Dohme Corp.']"]
["NCT00327249","[]","[' AmpliMed Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00327249","['Evan Hersh, AmpliMed']"]
["NCT00949884","[]","[' Daiichi Sankyo, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00949884","['Director, Medical Affairs, Daiichi Sankyo, Inc.']"]
["NCT01337804","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01337804","['Bayer']"]
["NCT00968357","['SciClone Pharmaceuticals']","[' SciClone Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00968357","['SciClone Pharmaceuticals']"]
["NCT01123785","['Inotek Pharmaceuticals Corporation']","[' Inotek Pharmaceuticals Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01123785","['Inotek Pharmaceuticals Corporation']"]
["NCT00676507","['NovaRx Corporation']","[' NovaRx Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00676507","['NovaRx Corporation']"]
["NCT01759875","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT01759875","['University of California, San Francisco']"]
["NCT01938352","['Crucell Holland BV']","[' Crucell Holland BV ']","https://clinicaltrials.gov/ct2/show/NCT01938352","['Crucell Holland BV']"]
["NCT02063997","['CymaBay Therapeutics, Inc.']","[' CymaBay Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02063997","['CymaBay Therapeutics, Inc.']"]
["NCT01520389","['Merrimack Pharmaceuticals']","[' Merrimack Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01520389","['Merrimack Pharmaceuticals']"]
["NCT01101165","[]","[' Purdue Pharma LP ']","https://clinicaltrials.gov/ct2/show/NCT01101165","['Medical Monitor, Purdue Pharma LP']"]
["NCT01100320","[]","[' Purdue Pharma LP ']","https://clinicaltrials.gov/ct2/show/NCT01100320","['Medical Monitor, Purdue Pharma L.P.']"]
["NCT01468025","['Targeted Medical Pharma']","[' Targeted Medical Pharma ']","https://clinicaltrials.gov/ct2/show/NCT01468025","['Targeted Medical Pharma']"]
["NCT00683462","[]","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00683462","[u'Hans-G\\xf6ran H\\xe5rdemark, MD, PhD, Medical Science Director AZD3480, AstraZeneca R&D, S\\xf6dert\\xe4lje']"]
["NCT01018732","['Novartis ( Novartis Vaccines )']","[' Novartis Vaccines ']","https://clinicaltrials.gov/ct2/show/NCT01018732","['Novartis Vaccines']"]
["NCT00617305","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT00617305","['Gilead Sciences']"]
["NCT00986947","['Johns Hopkins University']","[' Johns Hopkins University ']","https://clinicaltrials.gov/ct2/show/NCT00986947","['Johns Hopkins University']"]
["NCT00457418","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00457418","['Merck Sharp & Dohme Corp.']"]
["NCT01799824","['Anterios Inc.']","[' Anterios Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01799824","['Anterios Inc.']"]
["NCT01844830","['St. Renatus, LLC']","[' St. Renatus, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01844830","['St. Renatus, LLC']"]
["NCT01896583","['Seldar Pharma, Inc.']","[' Seldar Pharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01896583","['Seldar Pharma, Inc.']"]
["NCT01778439","['OncoMed Pharmaceuticals, Inc.']","[' OncoMed Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01778439","['OncoMed Pharmaceuticals, Inc.']"]
["NCT01969084","['Aristidis Veves, Beth Israel Deaconess Medical Center']","[' Beth Israel Deaconess Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01969084","['Aristidis Veves, Research Director, Microcirculation Lab and Joslin-Beth Israel Deaconess Foot Center, Beth Israel Deaconess Medical Center']"]
["NCT00367458","[]","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00367458","['Frank Maldarelli, M.D./National Cancer Institute, National Institutes of Health']"]
["NCT00567255","['Orexigen Therapeutics, Inc']","[' Orexigen Therapeutics, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00567255","['Orexigen Therapeutics, Inc']"]
["NCT01043393","['Taro Pharmaceuticals USA']","[' Taro Pharmaceuticals USA ']","https://clinicaltrials.gov/ct2/show/NCT01043393","['Taro Pharmaceuticals USA']"]
["NCT00818844","['Alcon Research']","[' Alcon Research ']","https://clinicaltrials.gov/ct2/show/NCT00818844","['Alcon Research']"]
["NCT01059383","['Vecta Ltd.']","[' Vecta Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01059383","['Vecta Ltd.']"]
["NCT02018133","['Alan Lau, University of Illinois at Chicago']","[' University of Illinois at Chicago ']","https://clinicaltrials.gov/ct2/show/NCT02018133","['Alan Lau, Professor, University of Illinois at Chicago']"]
["NCT00945958","['Sun Pharma Advanced Research Company Limited']","[' Sun Pharma Advanced Research Company Limited ']","https://clinicaltrials.gov/ct2/show/NCT00945958","['Sun Pharma Advanced Research Company Limited']"]
["NCT01743235","['Emotional Brain NY Inc.']","[' Emotional Brain NY Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01743235","['Emotional Brain NY Inc.']"]
["NCT01445951","['Mannkind Corporation']","[' Mannkind Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01445951","['Mannkind Corporation']"]
["NCT01569438","['Afferent Pharmaceuticals, Inc.']","[' Afferent Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01569438","['Afferent Pharmaceuticals, Inc.']"]
["NCT01814319","['Jack Rubinstein, University of Cincinnati']","[' University of Cincinnati ']","https://clinicaltrials.gov/ct2/show/NCT01814319","['Jack Rubinstein, Asst Professor, University of Cincinnati']"]
["NCT01163149","['Alexion Pharma GmbH']","[' Alexion Pharma GmbH ']","https://clinicaltrials.gov/ct2/show/NCT01163149","['Alexion Pharma GmbH']"]
["NCT00145470","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00145470","['Merck Sharp & Dohme Corp.']"]
["NCT00841594","[]","[' MediQuest Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00841594","['Fredrick Dechow, President and CEO, MediQuest Therapeutics, Inc.']"]
["NCT00632073","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00632073","['Merck Sharp & Dohme Corp.']"]
["NCT00523211","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00523211","['Merck Sharp & Dohme Corp.']"]
["NCT00243230","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00243230","['Merck Sharp & Dohme Corp.']"]
["NCT00988741","['ArQule']","[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT00988741","['ArQule']"]
["NCT01526538","['Matthew Johnson, Johns Hopkins University']","[' Johns Hopkins University ']","https://clinicaltrials.gov/ct2/show/NCT01526538","['Matthew Johnson, Assistant Professor, Johns Hopkins University']"]
["NCT01910415","['Vertex Pharmaceuticals Incorporated']","[' Vertex Pharmaceuticals Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01910415","['Vertex Pharmaceuticals Incorporated']"]
["NCT01617200","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT01617200","['Forest Laboratories']"]
["NCT01623323","['Optinose US Inc.']","[' Optinose US Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01623323","['Optinose US Inc.']"]
["NCT00280371","[]","[' Dey ']","https://clinicaltrials.gov/ct2/show/NCT00280371","['Director, Clinical Affairs, Dey']"]
["NCT00787566","[]","[' Shin Nippon Biomedical Laboratories, Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT00787566","['Vanaja Ragavan, MD, Aviana Consulting, LLC']"]
["NCT01132703","['Remedy Pharmaceuticals, Inc.']","[' Remedy Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01132703","['Remedy Pharmaceuticals, Inc.']"]
["NCT00954538","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00954538","['Merck Sharp & Dohme Corp.']"]
["NCT00770315","[u'ALK-Abell\\xf3 A/S']","[u' ALK-Abell\\xf3 A/S ']","https://clinicaltrials.gov/ct2/show/NCT00770315","[u'ALK-Abell\\xf3 A/S']"]
["NCT01511029","['Knopp Biosciences']","[' Knopp Biosciences ']","https://clinicaltrials.gov/ct2/show/NCT01511029","['Knopp Biosciences']"]
["NCT01745380","['St. Renatus, LLC']","[' St. Renatus, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01745380","['St. Renatus, LLC']"]
["NCT01428661","['Vanda Pharmaceuticals']","[' Vanda Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01428661","['Vanda Pharmaceuticals']"]
["NCT02055703","['Eisai Inc.']","[' Eisai Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02055703","['Eisai Inc.']"]
["NCT02530541","['Medline Industries']","[' Medline Industries ']","https://clinicaltrials.gov/ct2/show/NCT02530541","['Medline Industries']"]
["NCT02062190","[u'Karine Zort\\xe9a, Federal University of Rio Grande do Sul']","[' Federal University of Rio Grande do Sul ']","https://clinicaltrials.gov/ct2/show/NCT02062190","[u'Karine Zort\\xe9a, Master, Federal University of Rio Grande do Sul']"]
["NCT01689233","['TauRx Therapeutics Ltd']","[' TauRx Therapeutics Ltd ']","https://clinicaltrials.gov/ct2/show/NCT01689233","['TauRx Therapeutics Ltd']"]
["NCT00353587","['CymaBay Therapeutics, Inc.']","[' CymaBay Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00353587","['CymaBay Therapeutics, Inc.']"]
["NCT00699504","['The Medicines Company']","[' The Medicines Company ']","https://clinicaltrials.gov/ct2/show/NCT00699504","['The Medicines Company']"]
["NCT00456157","[]","[' Stryker Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00456157","['Gina Smith, Stryker Biotech']"]
["NCT00579085","[]","[' Drexel University College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00579085","['Dr. Robert J. Schwartzman MD, Drexel University College of Medicine']"]
["NCT00812019","['Seqirus']","[' Seqirus ']","https://clinicaltrials.gov/ct2/show/NCT00812019","['Seqirus']"]
["NCT01052077","['Otsuka Pharmaceutical Development & Commercialization, Inc.']","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01052077","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT01308424","['Beech Tree Labs, Inc.']","[' Beech Tree Labs, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01308424","['Beech Tree Labs, Inc.']"]
["NCT01218516","['Morphotek']","[' Morphotek ']","https://clinicaltrials.gov/ct2/show/NCT01218516","['Morphotek']"]
[]
["NCT00748904","[]","[' Weill Medical College of Cornell University ']","https://clinicaltrials.gov/ct2/show/NCT00748904","['Samuel Sigal, Center for Liver Diseases and Transplantation']"]
["NCT00799513","['Andres J. M. Ferreri, IRCCS San Raffaele']","[' IRCCS San Raffaele ']","https://clinicaltrials.gov/ct2/show/NCT00799513","['Andres J. M. Ferreri, Unit Head, IRCCS San Raffaele']"]
["NCT00822679","['Sairam Parthasarathy, University of Arizona']","[' University of Arizona ']","https://clinicaltrials.gov/ct2/show/NCT00822679","['Sairam Parthasarathy, Professor, University of Arizona']"]
["NCT00838955","['Loyola University']","[' Loyola University ']","https://clinicaltrials.gov/ct2/show/NCT00838955","['Loyola University']"]
["NCT00870974","['David Russell, MD, PhD, Institute for Neurodegenerative Disorders']","[' Institute for Neurodegenerative Disorders ']","https://clinicaltrials.gov/ct2/show/NCT00870974","['David Russell, MD, PhD, Principal Investigator, Institute for Neurodegenerative Disorders']"]
["NCT00892385","['Case Comprehensive Cancer Center']","[' Case Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00892385","['Case Comprehensive Cancer Center']"]
["NCT00902044","['Nabil Ahmed, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00902044","['Nabil Ahmed, Associate Professor, Pediatric Hematology Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine']"]
["NCT00930072","['Miriam Treggiari, University of Washington']","[' University of Washington ']","https://clinicaltrials.gov/ct2/show/NCT00930072","['Miriam Treggiari, Professor, University of Washington']"]
["NCT00950677","['Luisa M. Rodriguez, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00950677","['Luisa M. Rodriguez, Principal Investigator, Baylor College of Medicine']"]
["NCT00951743","[]","[' Rapid Laboratories Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00951743","['Richard Elion/Prinicpal Investigator, Whitman Walker Clinic']"]
["NCT00980954","['Radiation Therapy Oncology Group']","[' Radiation Therapy Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00980954","['Radiation Therapy Oncology Group']"]
["NCT00996385","['Columbia University']","[' Columbia University ']","https://clinicaltrials.gov/ct2/show/NCT00996385","['Columbia University']"]
["NCT01016340","['Health Ever Bio-Tech Co., Ltd.']","[' Health Ever Bio-Tech Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01016340","['Health Ever Bio-Tech Co., Ltd.']"]
["NCT01041313","[]","[' University of Washington ']","https://clinicaltrials.gov/ct2/show/NCT01041313","['Gregory Terman, MD, PhD, Professor, University of Washington, Department of Anesthesiology and Pain Medicine, Division of Pain Medicine']"]
["NCT01050114","['Christopher Patrick Smith, Baylor College of Medicine']","[' Christopher Patrick Smith ']","https://clinicaltrials.gov/ct2/show/NCT01050114","['Christopher Patrick Smith, Associate Professor, Baylor College of Medicine']"]
["NCT01066702","['Histogenics Corporation']","[' Histogenics Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01066702","['Histogenics Corporation']"]
["NCT01094860","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01094860","['M.D. Anderson Cancer Center']"]
["NCT01112072","['Cornea and Laser Eye Institute']","[' Cornea and Laser Eye Institute ']","https://clinicaltrials.gov/ct2/show/NCT01112072","['Cornea and Laser Eye Institute']"]
["NCT01129713","['Effexus Pharmaceutical']","[' Effexus Pharmaceutical ']","https://clinicaltrials.gov/ct2/show/NCT01129713","['Effexus Pharmaceutical']"]
["NCT01169337","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01169337","['National Cancer Institute (NCI)']"]
["NCT01188096","['Donald Durden, M.D., University of California, San Diego']","[' Donald Durden, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT01188096","['Donald Durden, M.D., Professor of Pediatrics, University of California, San Diego']"]
["NCT01210053","[]","[' Third Military Medical University ']","https://clinicaltrials.gov/ct2/show/NCT01210053","['yangzhenzhou, Third Military Medical University']"]
["NCT01229319","[]","[' Frankel, Amylynne, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT01229319","['Gary S Goldenberg, MD/Assistant Clinical Professor Dermatology and Dermatopathology, Mount Sinai School of Medicine']"]
["NCT01246986","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01246986","['Eli Lilly and Company']"]
["NCT01265017","['Kristin Castorino, DO, Sansum Diabetes Research Institute']","[' Sansum Diabetes Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01265017","['Kristin Castorino, DO, Principal Investigator, Sansum Diabetes Research Institute']"]
["NCT01265030","['Aaron Weiss, Maine Medical Center']","[' Maine Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01265030","['Aaron Weiss, Principal Investigator, Maine Medical Center']"]
["NCT01294176","['Vijayshree Yadav, Oregon Health and Science University']","[' Oregon Health and Science University ']","https://clinicaltrials.gov/ct2/show/NCT01294176","['Vijayshree Yadav, Principal Investigator, Oregon Health and Science University']"]
["NCT01297764","['Hackensack Meridian Health']","[' Hackensack Meridian Health ']","https://clinicaltrials.gov/ct2/show/NCT01297764","['Hackensack Meridian Health']"]
["NCT01307579","[\"Children's Oncology Group\"]","[\" Children's Oncology Group \"]","https://clinicaltrials.gov/ct2/show/NCT01307579","[\"Children's Oncology Group\"]"]
["NCT01325298","[]","[' Mercy Center for Corrective Eye Surgery ']","https://clinicaltrials.gov/ct2/show/NCT01325298","['Robert L. Epstein, MD, Mercy Center for Corrective Eye Surgery']"]
["NCT01333046","['George Carrum, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT01333046","['George Carrum, Associate Professor, Baylor College of Medicine']"]
["NCT01351753","['Gary L. Pierce, University of Iowa']","[' University of Iowa ']","https://clinicaltrials.gov/ct2/show/NCT01351753","['Gary L. Pierce, Associate Professor, University of Iowa']"]
["NCT01364467","['Virginia Commonwealth University']","[' Virginia Commonwealth University ']","https://clinicaltrials.gov/ct2/show/NCT01364467","['Virginia Commonwealth University']"]
["NCT01371981","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01371981","['National Cancer Institute (NCI)']"]
["NCT01391143","['MacroGenics']","[' MacroGenics ']","https://clinicaltrials.gov/ct2/show/NCT01391143","['MacroGenics']"]
["NCT01409993","['Nancy J. Brown, Vanderbilt University']","[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT01409993","['Nancy J. Brown, Hugh J. Morgan Professor of Medicine and Pharmacology, Vanderbilt University']"]
["NCT01414426","['University of Chicago']","[' University of Chicago ']","https://clinicaltrials.gov/ct2/show/NCT01414426","['University of Chicago']"]
["NCT01431209","['Julie M Vose, MD, University of Nebraska']","[' University of Nebraska ']","https://clinicaltrials.gov/ct2/show/NCT01431209","['Julie M Vose, MD, Principal Investigator, University of Nebraska']"]
["NCT01446016","['Jenny C. Chang, MD, The Methodist Hospital System']","[' Jenny C. Chang, MD ']","https://clinicaltrials.gov/ct2/show/NCT01446016","['Jenny C. Chang, MD, Sponsor-Investigator/Principal Investigator, The Methodist Hospital System']"]
["NCT01458366","['Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )']","[' Sidney Kimmel Cancer Center at Thomas Jefferson University ']","https://clinicaltrials.gov/ct2/show/NCT01458366","['Sidney Kimmel Cancer Center at Thomas Jefferson University']"]
["NCT01460654","['Benjamin Leder, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01460654","['Benjamin Leder, MD, Associate Professor of Medicine, Massachusetts General Hospital']"]
["NCT01466686","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01466686","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01478321","['Northwestern University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT01478321","['Northwestern University']"]
["NCT01495637","[\"Mark Hall, Nationwide Children's Hospital\"]","[' Mark Hall ']","https://clinicaltrials.gov/ct2/show/NCT01495637","[\"Mark Hall, Associate Professor of Pediatrics, Nationwide Children's Hospital\"]"]
["NCT01503515","[\"Children's Oncology Group\"]","[\" Children's Oncology Group \"]","https://clinicaltrials.gov/ct2/show/NCT01503515","[\"Children's Oncology Group\"]"]
["NCT01516515","['G&E Herbal Biotechnology Co., LTD']","[' G&E Herbal Biotechnology Co., LTD ']","https://clinicaltrials.gov/ct2/show/NCT01516515","['G&E Herbal Biotechnology Co., LTD']"]
["NCT01525069","['Washington University School of Medicine']","[' Washington University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT01525069","['Washington University School of Medicine']"]
["NCT01531959","['Matthias Eikermann, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01531959","['Matthias Eikermann, Clinical Director, Critical Care Division, Massachusetts General Hospital']"]
["NCT01537029","['Texas Tech University Health Sciences Center']","[' Texas Tech University Health Sciences Center ']","https://clinicaltrials.gov/ct2/show/NCT01537029","['Texas Tech University Health Sciences Center']"]
["NCT01553019","['University of Florida']","[' University of Florida ']","https://clinicaltrials.gov/ct2/show/NCT01553019","['University of Florida']"]
["NCT01558492","['Weill Medical College of Cornell University']","[' Weill Medical College of Cornell University ']","https://clinicaltrials.gov/ct2/show/NCT01558492","['Weill Medical College of Cornell University']"]
["NCT01568918","['Michelle J. Clarke, Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01568918","['Michelle J. Clarke, Principal Investigator, Mayo Clinic']"]
["NCT01582932","['Mayne Pharma International Pty Ltd']","[' Mayne Pharma International Pty Ltd ']","https://clinicaltrials.gov/ct2/show/NCT01582932","['Mayne Pharma International Pty Ltd']"]
["NCT01587586","['PharmaEssentia']","[' PharmaEssentia ']","https://clinicaltrials.gov/ct2/show/NCT01587586","['PharmaEssentia']"]
["NCT01598831","['Asahi Kasei Pharma America Corporation']","[' Asahi Kasei Pharma America Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01598831","['Asahi Kasei Pharma America Corporation']"]
["NCT01611948","['Barbara J. Mason, The Scripps Research Institute']","[' The Scripps Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01611948","['Barbara J. Mason, Principal Investigator, The Scripps Research Institute']"]
["NCT01620190","['University of Washington']","[' University of Washington ']","https://clinicaltrials.gov/ct2/show/NCT01620190","['University of Washington']"]
["NCT01622868","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01622868","['National Cancer Institute (NCI)']"]
["NCT01631617","['National Institutes of Health Clinical Center (CC) ( National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) )']","[' National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ']","https://clinicaltrials.gov/ct2/show/NCT01631617","['National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)']"]
["NCT01640288","['Hal C Charles, Duke University']","[' Hal C Charles ']","https://clinicaltrials.gov/ct2/show/NCT01640288","['Hal C Charles, Associate Professor of Radiology, Duke University']"]
["NCT01652976","['University of Florida']","[' University of Florida ']","https://clinicaltrials.gov/ct2/show/NCT01652976","['University of Florida']"]
["NCT01657045","['SironRX Therapeutics, Inc.']","[' SironRX Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01657045","['SironRX Therapeutics, Inc.']"]
["NCT01665092","['Alan Jones, University of Mississippi Medical Center']","[' University of Mississippi Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01665092","['Alan Jones, Professor of Emergency Medicine, University of Mississippi Medical Center']"]
["NCT01676818","['University of Southern California']","[' University of Southern California ']","https://clinicaltrials.gov/ct2/show/NCT01676818","['University of Southern California']"]
["NCT01680887","['University of Pennsylvania']","[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01680887","['University of Pennsylvania']"]
["NCT01690624","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT01690624","['Boehringer Ingelheim']"]
["NCT01700049","['Scott W. Fosko, Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01700049","['Scott W. Fosko, Principal Investigator, Mayo Clinic']"]
["NCT01709981","['Binita Shah, New York University School of Medicine']","[' New York University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT01709981","['Binita Shah, Assistant Professor of Medicine, New York University School of Medicine']"]
["NCT01712620","['National Institutes of Health Clinical Center (CC)']","[' National Institutes of Health Clinical Center (CC) ']","https://clinicaltrials.gov/ct2/show/NCT01712620","['National Institutes of Health Clinical Center (CC)']"]
["NCT01720524","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01720524","['Pfizer']"]
["NCT01721655","['Courtney Brown Sweet, West Virginia University Healthcare']","[' West Virginia University Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT01721655","['Courtney Brown Sweet, Pediatric Clinical Pharmacy Specialist, West Virginia University Healthcare']"]
["NCT01734928","['Celgene']","[' Celgene ']","https://clinicaltrials.gov/ct2/show/NCT01734928","['Celgene']"]
["NCT01739764","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01739764","['Hoffmann-La Roche']"]
["NCT01741012","['Patricia Dhar, Wayne State University']","[' Wayne State University ']","https://clinicaltrials.gov/ct2/show/NCT01741012","['Patricia Dhar, Assistant Professor of Medicine, Wayne State University']"]
["NCT01747590","['Stephanie C. Licata, Ph.D., Mclean Hospital']","[' Mclean Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01747590","['Stephanie C. Licata, Ph.D., Assistant Professor, Department of Psychiatry, Mclean Hospital']"]
["NCT01754779","['Naim Maalouf, University of Texas Southwestern Medical Center']","[' University of Texas Southwestern Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01754779","['Naim Maalouf, Associate Professor of Medicine, University of Texas Southwestern Medical Center']"]
["NCT01758328","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01758328","['Memorial Sloan Kettering Cancer Center']"]
["NCT01766739","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01766739","['Memorial Sloan Kettering Cancer Center']"]
["NCT01772004","['EMD Serono']","[' EMD Serono ']","https://clinicaltrials.gov/ct2/show/NCT01772004","['EMD Serono']"]
["NCT01778946","['Paul Newhouse, Vanderbilt University Medical Center']","[' Vanderbilt University Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01778946","['Paul Newhouse, Professor, Vanderbilt University Medical Center']"]
["NCT01782989","['Paul Yates, MD, PhD, University of Virginia']","[' Paul Yates, MD, PhD ']","https://clinicaltrials.gov/ct2/show/NCT01782989","['Paul Yates, MD, PhD, Associate Professor of Ophthalmology, University of Virginia']"]
["NCT01789281","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01789281","['Novartis Pharmaceuticals']"]
["NCT01795924","['Biosuccess Biotech Co., Ltd.']","[' Biosuccess Biotech Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01795924","['Biosuccess Biotech Co., Ltd.']"]
["NCT01802970","['Baylor Research Institute']","[' Baylor Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01802970","['Baylor Research Institute']"]
["NCT01809132","['Mack Mitchell, University of Texas Southwestern Medical Center']","[' Mack Mitchell ']","https://clinicaltrials.gov/ct2/show/NCT01809132","['Mack Mitchell, Professor of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center']"]
["NCT01815138","['Lawrence Engmann, UConn Health']","[' UConn Health ']","https://clinicaltrials.gov/ct2/show/NCT01815138","['Lawrence Engmann, MD, UConn Health']"]
["NCT01822275","['Department of Radiation Oncology, University of Maryland']","[' University of Maryland ']","https://clinicaltrials.gov/ct2/show/NCT01822275","['Department of Radiation Oncology, Associate Professor, University of Maryland']"]
["NCT01825369","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT01825369","['University of California, San Francisco']"]
["NCT01835626","['Sue Yom, University of California, San Francisco']","[' Sue Yom ']","https://clinicaltrials.gov/ct2/show/NCT01835626","['Sue Yom, Associate Professor, Department of Radiation Oncology, University of California, San Francisco']"]
["NCT01836068","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01836068","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01845805","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01845805","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01849146","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01849146","['National Cancer Institute (NCI)']"]
["NCT01854385","['Jeanne Hoffman, University of Washington']","[' University of Washington ']","https://clinicaltrials.gov/ct2/show/NCT01854385","['Jeanne Hoffman, Professor- Rehabilitative Medicine: Psychology, University of Washington']"]
["NCT01859819","['New York Medical College']","[' New York Medical College ']","https://clinicaltrials.gov/ct2/show/NCT01859819","['New York Medical College']"]
["NCT01862640","['Otsuka Pharmaceutical Development & Commercialization, Inc.']","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01862640","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT01869634","['University of California, Davis']","[' University of California, Davis ']","https://clinicaltrials.gov/ct2/show/NCT01869634","['University of California, Davis']"]
["NCT01874366","['Piramal Enterprises Limited']","[' Piramal Enterprises Limited ']","https://clinicaltrials.gov/ct2/show/NCT01874366","['Piramal Enterprises Limited']"]
["NCT01879085","['Melissa Burgess, MD, University of Pittsburgh']","[' Melissa Burgess, MD ']","https://clinicaltrials.gov/ct2/show/NCT01879085","['Melissa Burgess, MD, Assistant Professor of Medicine Division of Hematology/Oncology, University of Pittsburgh']"]
["NCT01883362","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01883362","['Novartis Pharmaceuticals']"]
["NCT01888484","['Octapharma']","[' Octapharma ']","https://clinicaltrials.gov/ct2/show/NCT01888484","['Octapharma']"]
["NCT01893801","['Gayle Jameson, Pancreatic Cancer Research Team']","[' Gayle Jameson ']","https://clinicaltrials.gov/ct2/show/NCT01893801","['Gayle Jameson, Lead Principal Investigator, Pancreatic Cancer Research Team']"]
["NCT01897259","['Christine M. Kleinert Institute for Hand and Microsurgery']","[' Christine M. Kleinert Institute for Hand and Microsurgery ']","https://clinicaltrials.gov/ct2/show/NCT01897259","['Christine M. Kleinert Institute for Hand and Microsurgery']"]
["NCT01902004","['Helen Lavretsky, MD, University of California, Los Angeles']","[' University of California, Los Angeles ']","https://clinicaltrials.gov/ct2/show/NCT01902004","['Helen Lavretsky, MD, Professor, University of California, Los Angeles']"]
["NCT01904903","['Washington Hospital Center']","[' Washington Hospital Center ']","https://clinicaltrials.gov/ct2/show/NCT01904903","['Washington Hospital Center']"]
["NCT01911455","[\"Children's Hospital Medical Center, Cincinnati\"]","[\" Children's Hospital Medical Center, Cincinnati \"]","https://clinicaltrials.gov/ct2/show/NCT01911455","[\"Children's Hospital Medical Center, Cincinnati\"]"]
["NCT01911507","['University of California, Davis']","[' University of California, Davis ']","https://clinicaltrials.gov/ct2/show/NCT01911507","['University of California, Davis']"]
["NCT01917721","['Andras Bratincsak, MD, PhD, Hawaii Pacific Health']","[' Hawaii Pacific Health ']","https://clinicaltrials.gov/ct2/show/NCT01917721","['Andras Bratincsak, MD, PhD, Clinical Assistant Professor, Hawaii Pacific Health']"]
["NCT01926054","['Brad Rovin, MD, Ohio State University']","[' Ohio State University ']","https://clinicaltrials.gov/ct2/show/NCT01926054","['Brad Rovin, MD, Principle Investigator, Ohio State University']"]
["NCT01927744","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01927744","['M.D. Anderson Cancer Center']"]
["NCT01933464","['Anna Di Nardo, MD, PhD, University of California, San Diego']","[' University of California, San Diego ']","https://clinicaltrials.gov/ct2/show/NCT01933464","['Anna Di Nardo, MD, PhD, MD, PhD (Associate Professor of Medicine), University of California, San Diego']"]
["NCT01937117","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01937117","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01942837","['Mary-Ellen Taplin, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01942837","['Mary-Ellen Taplin, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT01946880","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT01946880","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01950299","['Virginia Commonwealth University']","[' Virginia Commonwealth University ']","https://clinicaltrials.gov/ct2/show/NCT01950299","['Virginia Commonwealth University']"]
["NCT01954992","['Eleison Pharmaceuticals LLC.']","[' Eleison Pharmaceuticals LLC. ']","https://clinicaltrials.gov/ct2/show/NCT01954992","['Eleison Pharmaceuticals LLC.']"]
["NCT01959698","['Roswell Park Cancer Institute']","[' Roswell Park Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01959698","['Roswell Park Cancer Institute']"]
["NCT01966666","['Adam Boxer, University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT01966666","['Adam Boxer, Prinicpal Investigator, University of California, San Francisco']"]
["NCT01967888","[u'Domp\\xe9 Farmaceutici S.p.A']","[u' Domp\\xe9 Farmaceutici S.p.A ']","https://clinicaltrials.gov/ct2/show/NCT01967888","[u'Domp\\xe9 Farmaceutici S.p.A']"]
["NCT01974765","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01974765","['Memorial Sloan Kettering Cancer Center']"]
["NCT01979523","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01979523","['National Cancer Institute (NCI)']"]
["NCT01982448","['Erica Mayer, MD, MPH, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01982448","['Erica Mayer, MD, MPH, Principal Invesitigator, Dana-Farber Cancer Institute']"]
["NCT01986075","['Frances R Levin, New York State Psychiatric Institute']","[' New York State Psychiatric Institute ']","https://clinicaltrials.gov/ct2/show/NCT01986075","['Frances R Levin, Director of Substance Use Disorder, New York State Psychiatric Institute']"]
["NCT01989507","['Damaris J. Rohsenow, Ph.D., Brown University']","[' Brown University ']","https://clinicaltrials.gov/ct2/show/NCT01989507","['Damaris J. Rohsenow, Ph.D., Principal Investigator, Brown University']"]
["NCT01994369","['Sunil Singhall, University of Pennsylvania']","[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01994369","['Sunil Singhall, Assistant Professor of Medicine, Assistant Professor of Surgery, Director Thoracic Surgery Research Laboratory, University of Pennsylvania']"]
["NCT01996826","['Reza Dana, MD, Massachusetts Eye and Ear Infirmary']","[' Reza Dana, MD ']","https://clinicaltrials.gov/ct2/show/NCT01996826","['Reza Dana, MD, Director, Cornea and Refractive Surgery Service, Massachusetts Eye and Ear Infirmary']"]
["NCT02000882","['US Oncology Research']","[' US Oncology Research ']","https://clinicaltrials.gov/ct2/show/NCT02000882","['US Oncology Research']"]
["NCT02004704","['Sanofi ( Genzyme, a Sanofi Company )']","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT02004704","['Genzyme, a Sanofi Company']"]
["NCT02010359","['University of Pennsylvania']","[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT02010359","['University of Pennsylvania']"]
["NCT02015104","['National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT02015104","['National Cancer Institute (NCI)']"]
["NCT02019940","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT02019940","['Yale University']"]
["NCT02025426","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT02025426","['Duke University']"]
["NCT02029690","['Polaris Group']","[' Polaris Group ']","https://clinicaltrials.gov/ct2/show/NCT02029690","['Polaris Group']"]
["NCT02032810","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT02032810","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT02037035","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT02037035","['Yale University']"]
["NCT02043548","['Chester Oddis, University of Pittsburgh']","[' Chester Oddis ']","https://clinicaltrials.gov/ct2/show/NCT02043548","['Chester Oddis, Chester Oddis, MD, University of Pittsburgh']"]
["NCT02046135","['James Schneider, Northwell Health']","[' Northwell Health ']","https://clinicaltrials.gov/ct2/show/NCT02046135","['James Schneider, Fellowship Director Critical Care, Northwell Health']"]
["NCT02048969","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT02048969","['Yale University']"]
["NCT02050841","['Octapharma']","[' Octapharma ']","https://clinicaltrials.gov/ct2/show/NCT02050841","['Octapharma']"]
["NCT02052440","['Denver Health and Hospital Authority']","[' Denver Health and Hospital Authority ']","https://clinicaltrials.gov/ct2/show/NCT02052440","['Denver Health and Hospital Authority']"]
["NCT02056301","['Chris Glover, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT02056301","['Chris Glover, Pediatric Anesthesiologist, Baylor College of Medicine']"]
["NCT02061293","['New York University School of Medicine']","[' New York University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT02061293","['New York University School of Medicine']"]
["NCT02062255","['Andrew Brenner, The University of Texas Health Science Center at San Antonio']","[' The University of Texas Health Science Center at San Antonio ']","https://clinicaltrials.gov/ct2/show/NCT02062255","['Andrew Brenner, Principal Investigator, The University of Texas Health Science Center at San Antonio']"]
["NCT02066311","['Meggan Mackay, Northwell Health']","[' Northwell Health ']","https://clinicaltrials.gov/ct2/show/NCT02066311","['Meggan Mackay, Associate Investigator, MD, Northwell Health']"]
["NCT02071901","['Case Comprehensive Cancer Center']","[' Case Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02071901","['Case Comprehensive Cancer Center']"]
["NCT02074436","['Ana G. Antun, MD, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT02074436","['Ana G. Antun, MD, Principal Investigator, Emory University']"]
["NCT02078102","['Sherif S. Farag, Indiana University School of Medicine']","[' Sherif S. Farag ']","https://clinicaltrials.gov/ct2/show/NCT02078102","['Sherif S. Farag, Principal Investigator, Indiana University School of Medicine']"]
["NCT02082522","['Concordia Laboratories Inc.']","[' Concordia Laboratories Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02082522","['Concordia Laboratories Inc.']"]
["NCT02089087","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02089087","['Novartis Pharmaceuticals']"]
["NCT02092324","['Kim-Hien Dao, OHSU Knight Cancer Institute']","[' OHSU Knight Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT02092324","['Kim-Hien Dao, Principal Investigator, OHSU Knight Cancer Institute']"]
["NCT02096588","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT02096588","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT02097732","['University of Michigan Rogel Cancer Center']","[' University of Michigan Rogel Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02097732","['University of Michigan Rogel Cancer Center']"]
["NCT02103894","['Danna Jennings, Molecular NeuroImaging']","[' Molecular NeuroImaging ']","https://clinicaltrials.gov/ct2/show/NCT02103894","['Danna Jennings, Principal Investigator, Molecular NeuroImaging']"]
["NCT02108964","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02108964","['Novartis Pharmaceuticals']"]
["NCT02110355","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT02110355","['Amgen']"]
["NCT02112916","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT02112916","['National Cancer Institute (NCI)']"]
["NCT02117219","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT02117219","['MedImmune LLC']"]
["NCT02120807","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02120807","['Memorial Sloan Kettering Cancer Center']"]
["NCT02124759","['Nicolas Musi, The University of Texas Health Science Center at San Antonio']","[' The University of Texas Health Science Center at San Antonio ']","https://clinicaltrials.gov/ct2/show/NCT02124759","['Nicolas Musi, Nicolas Musi, MD, The University of Texas Health Science Center at San Antonio']"]
["NCT02128906","['Dwight Heron, University of Pittsburgh']","[' Dwight Heron ']","https://clinicaltrials.gov/ct2/show/NCT02128906","['Dwight Heron, MD, FACRO, FACR, University of Pittsburgh']"]
["NCT02132247","['IBSA Institut Biochimique SA']","[' IBSA Institut Biochimique SA ']","https://clinicaltrials.gov/ct2/show/NCT02132247","['IBSA Institut Biochimique SA']"]
["NCT02135042","['NRG Oncology']","[' NRG Oncology ']","https://clinicaltrials.gov/ct2/show/NCT02135042","['NRG Oncology']"]
["NCT02140151","['Southern California Desert Retina Consultants, MC']","[' Southern California Desert Retina Consultants, MC ']","https://clinicaltrials.gov/ct2/show/NCT02140151","['Southern California Desert Retina Consultants, MC']"]
["NCT02144584","['Jennifer Majersik, University of Utah']","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT02144584","['Jennifer Majersik, M.D, University of Utah']"]
["NCT02149901","['Emily M. Garland, Vanderbilt University']","[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT02149901","['Emily M. Garland, Research Associate Professor, Vanderbilt University']"]
["NCT02153944","['National Institutes of Health Clinical Center (CC) ( National Institute of Mental Health (NIMH) )']","[' National Institute of Mental Health (NIMH) ']","https://clinicaltrials.gov/ct2/show/NCT02153944","['National Institute of Mental Health (NIMH)']"]
["NCT02158858","['Constellation Pharmaceuticals']","[' Constellation Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02158858","['Constellation Pharmaceuticals']"]
["NCT02162862","['Eva Szigethy, University of Pittsburgh']","[' Eva Szigethy ']","https://clinicaltrials.gov/ct2/show/NCT02162862","['Eva Szigethy, Associate Professor of Psychiatry, Pediatrics, and Medicine, University of Pittsburgh']"]
["NCT02166905","['Roswell Park Cancer Institute']","[' Roswell Park Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT02166905","['Roswell Park Cancer Institute']"]
["NCT02174172","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT02174172","['Hoffmann-La Roche']"]
["NCT02174549","['Teclison Ltd.']","[' Teclison Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT02174549","['Teclison Ltd.']"]
["NCT02179034","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT02179034","['Yale University']"]
["NCT02180711","['Acerta Pharma BV']","[' Acerta Pharma BV ']","https://clinicaltrials.gov/ct2/show/NCT02180711","['Acerta Pharma BV']"]
["NCT02188017","['Robert P Baughman, University of Cincinnati']","[' University of Cincinnati ']","https://clinicaltrials.gov/ct2/show/NCT02188017","['Robert P Baughman, Professor, University of Cincinnati']"]
["NCT02197416","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT02197416","['Boehringer Ingelheim']"]
["NCT02200848","['Georgetown University']","[' Georgetown University ']","https://clinicaltrials.gov/ct2/show/NCT02200848","['Georgetown University']"]
["NCT02204683","['Diana V. Do, Stanford University']","[' University of Nebraska ']","https://clinicaltrials.gov/ct2/show/NCT02204683","['Diana V. Do, Diana Do, MD, Stanford University']"]
["NCT02210325","['Cempra Inc']","[' Cempra Inc ']","https://clinicaltrials.gov/ct2/show/NCT02210325","['Cempra Inc']"]
["NCT02216890","['Seattle Genetics, Inc.']","[' Seattle Genetics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02216890","['Seattle Genetics, Inc.']"]
["NCT02221219","['John Bauer, University of Kentucky']","[' John Bauer ']","https://clinicaltrials.gov/ct2/show/NCT02221219","['John Bauer, Professor of Pediatrics, University of Kentucky']"]
["NCT02226172","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT02226172","['Pfizer']"]
["NCT02229981","['RedHill Biopharma Limited']","[' RedHill Biopharma Limited ']","https://clinicaltrials.gov/ct2/show/NCT02229981","['RedHill Biopharma Limited']"]
["NCT02236156","['Starpharma Pty Ltd']","[' Starpharma Pty Ltd ']","https://clinicaltrials.gov/ct2/show/NCT02236156","['Starpharma Pty Ltd']"]
["NCT02243007","['David Patrick Ryan, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT02243007","['David Patrick Ryan, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT02247531","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT02247531","['Hoffmann-La Roche']"]
["NCT02251431","['Baylor Research Institute']","[' Baylor Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT02251431","['Baylor Research Institute']"]
["NCT02251457","['William Arnold, Ohio State University']","[' Ohio State University ']","https://clinicaltrials.gov/ct2/show/NCT02251457","['William Arnold, Associate Professor, Ohio State University']"]
["NCT02256592","['Ma Somsouk, MD, MAS, University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT02256592","['Ma Somsouk, MD, MAS, Associate Professor, University of California, San Francisco']"]
["NCT02262026","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT02262026","['Yale University']"]
["NCT02266706","['Cubist Pharmaceuticals LLC']","[' Cubist Pharmaceuticals LLC ']","https://clinicaltrials.gov/ct2/show/NCT02266706","['Cubist Pharmaceuticals LLC']"]
["NCT02270788","[\"St. Jude Children's Research Hospital\"]","[\" St. Jude Children's Research Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT02270788","[\"St. Jude Children's Research Hospital\"]"]
["NCT02275806","['Leo W. Jenkins Cancer Center']","[' Leo W. Jenkins Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02275806","['Leo W. Jenkins Cancer Center']"]
["NCT02283060","['University of Hawaii']","[' University of Hawaii ']","https://clinicaltrials.gov/ct2/show/NCT02283060","['University of Hawaii']"]
["NCT02288507","['Jared Acoba, University of Hawaii']","[' University of Hawaii ']","https://clinicaltrials.gov/ct2/show/NCT02288507","['Jared Acoba, Principal Investigator, University of Hawaii']"]
["NCT02293941","['TaiwanJ Pharmaceuticals Co., Ltd']","[' TaiwanJ Pharmaceuticals Co., Ltd ']","https://clinicaltrials.gov/ct2/show/NCT02293941","['TaiwanJ Pharmaceuticals Co., Ltd']"]
["NCT02303405","['Charles Drew University of Medicine and Science']","[' Charles Drew University of Medicine and Science ']","https://clinicaltrials.gov/ct2/show/NCT02303405","['Charles Drew University of Medicine and Science']"]
["NCT02311361","['National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT02311361","['National Cancer Institute (NCI)']"]
["NCT02319837","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT02319837","['Pfizer']"]
["NCT02325739","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02325739","['Novartis Pharmaceuticals']"]
["NCT02342249","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02342249","['Janssen Research & Development, LLC']"]
["NCT02366819","['University of Chicago']","[' University of Chicago ']","https://clinicaltrials.gov/ct2/show/NCT02366819","['University of Chicago']"]
["NCT02373124","['Elias Dakwar, New York State Psychiatric Institute']","[' New York State Psychiatric Institute ']","https://clinicaltrials.gov/ct2/show/NCT02373124","['Elias Dakwar, Assistant Professor of Clinical Psychiatry, New York State Psychiatric Institute']"]
["NCT02401256","['Zeruesenay Desta, Indiana University']","[' Indiana University ']","https://clinicaltrials.gov/ct2/show/NCT02401256","['Zeruesenay Desta, Research Professor, Indiana University']"]
["NCT02442648","['E. Steve Woodle, University of Cincinnati']","[' E. Steve Woodle ']","https://clinicaltrials.gov/ct2/show/NCT02442648","['E. Steve Woodle, Director, Solid Organ Transplantation, University of Cincinnati']"]
["NCT02499159","['Inova Health Care Services']","[' Inova Health Care Services ']","https://clinicaltrials.gov/ct2/show/NCT02499159","['Inova Health Care Services']"]
["NCT02529813","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT02529813","['M.D. Anderson Cancer Center']"]
["NCT02594111","['VA Office of Research and Development']","[' VA Office of Research and Development ']","https://clinicaltrials.gov/ct2/show/NCT02594111","['VA Office of Research and Development']"]
["NCT02724033","['Charles W. Yates, Indiana University']","[' Indiana University ']","https://clinicaltrials.gov/ct2/show/NCT02724033","['Charles W. Yates, MD, Indiana University']"]
["NCT00851929","[]","[' Medical University of South Carolina ']","https://clinicaltrials.gov/ct2/show/NCT00851929","['Marc A. Judson, M.D., Medical University of South Carolina']"]
["NCT01341275","[]","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT01341275","['Amy B. Middleman, MD, MSEd, MPH/Associate Professor of Pediatrics, Baylor College of Medicine']"]
["NCT01697800","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01697800","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01846793","['Nymox Corporation']","[' Nymox Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01846793","['Nymox Corporation']"]
["NCT01962402","['Charles Nguyen, Southern California Institute for Research and Education']","[' Southern California Institute for Research and Education ']","https://clinicaltrials.gov/ct2/show/NCT01962402","['Charles Nguyen, Psychiatrist, Southern California Institute for Research and Education']"]
["NCT02106091","['Affimed GmbH']","[' Affimed GmbH ']","https://clinicaltrials.gov/ct2/show/NCT02106091","['Affimed GmbH']"]
["NCT02210702","['The Jones Institute']","[' The Jones Institute ']","https://clinicaltrials.gov/ct2/show/NCT02210702","['The Jones Institute']"]
["NCT02279160","['Arena Pharmaceuticals']","[' Arena Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02279160","['Arena Pharmaceuticals']"]
["NCT02438345","['Drexel University']","[' Drexel University ']","https://clinicaltrials.gov/ct2/show/NCT02438345","['Drexel University']"]
["NCT00587457","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT00587457","['MedImmune LLC']"]
["NCT00723099","['Fred Hutchinson Cancer Research Center']","[' Fred Hutchinson Cancer Research Center ']","https://clinicaltrials.gov/ct2/show/NCT00723099","['Fred Hutchinson Cancer Research Center']"]
["NCT00790764","['TCA Cellular Therapy']","[' TCA Cellular Therapy ']","https://clinicaltrials.gov/ct2/show/NCT00790764","['TCA Cellular Therapy']"]
["NCT01014767","['Tufts Medical Center']","[' Tufts Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01014767","['Tufts Medical Center']"]
["NCT01343394","['James E.Baumgartner, MD, Memorial Hermann Health System']","[' James E.Baumgartner, MD ']","https://clinicaltrials.gov/ct2/show/NCT01343394","['James E.Baumgartner, MD, Board-certified Pediatric Neurosurgeon, Memorial Hermann Health System']"]
["NCT01420965","['Samir N. Khleif, Augusta University']","[' Augusta University ']","https://clinicaltrials.gov/ct2/show/NCT01420965","['Samir N. Khleif, Cancer Center Director, Augusta University']"]
["NCT01595061","['Gynecologic Oncology Group']","[' Gynecologic Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT01595061","['Gynecologic Oncology Group']"]
["NCT01818063","['Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )']","[' Sidney Kimmel Cancer Center at Thomas Jefferson University ']","https://clinicaltrials.gov/ct2/show/NCT01818063","['Sidney Kimmel Cancer Center at Thomas Jefferson University']"]
["NCT01922076","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01922076","['National Cancer Institute (NCI)']"]
["NCT02054104","['National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT02054104","['National Cancer Institute (NCI)']"]
["NCT02162225","['Wake Forest University Health Sciences']","[' Wake Forest University Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT02162225","['Wake Forest University Health Sciences']"]
["NCT02289300","['A2 Healthcare Taiwan Corporation']","[' A2 Healthcare Taiwan Corporation ']","https://clinicaltrials.gov/ct2/show/NCT02289300","['A2 Healthcare Taiwan Corporation']"]
["NCT00100685","['Abbott']","[' Abbott ']","https://clinicaltrials.gov/ct2/show/NCT00100685","['Abbott']"]
["NCT00109850","['Southwest Oncology Group']","[' Southwest Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00109850","['Southwest Oncology Group']"]
["NCT00111306","['UCB Pharma']","[' UCB Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00111306","['UCB Pharma']"]
["NCT00124748","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00124748","['Novartis Pharmaceuticals']"]
["NCT00131404","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00131404","['Merck Sharp & Dohme Corp.']"]
["NCT00137345","['Wyeth is now a wholly owned subsidiary of Pfizer']","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00137345","['Wyeth is now a wholly owned subsidiary of Pfizer']"]
["NCT00166712","['Joseph Leventhal, Northwestern University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT00166712","['Joseph Leventhal, Associate Professor, Northwestern University']"]
["NCT00197197","[]","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00197197","['Study Director, GSK']"]
["NCT00216047","['Kathy Miller, MD, Hoosier Cancer Research Network']","[' Hoosier Cancer Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00216047","['Kathy Miller, MD, Professor, IU School of Medicine, Hoosier Cancer Research Network']"]
["NCT00237445","[]","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00237445","['Study Director, sanofi-aventis']"]
["NCT00251589","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00251589","['Merck Sharp & Dohme Corp.']"]
["NCT00262951","['Masonic Cancer Center, University of Minnesota']","[' Masonic Cancer Center, University of Minnesota ']","https://clinicaltrials.gov/ct2/show/NCT00262951","['Masonic Cancer Center, University of Minnesota']"]
["NCT00268372","['Southwest Oncology Group']","[' Southwest Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00268372","['Southwest Oncology Group']"]
["NCT00281021","['Goetz Kloecker, University of Louisville']","[' University of Louisville ']","https://clinicaltrials.gov/ct2/show/NCT00281021","['Goetz Kloecker, Associate Professor, University of Louisville']"]
["NCT00288353","['Herbert Meltzer, Vanderbilt University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT00288353","['Herbert Meltzer, Professor, Vanderbilt University']"]
["NCT00298272","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT00298272","['Biogen']"]
["NCT00304200","[]","[' Northern California Melanoma Center ']","https://clinicaltrials.gov/ct2/show/NCT00304200","['Lynn E. Spitler, MD, Sponsor/Investigator, Northern California Melanoma Center']"]
["NCT00311558","['The Cleveland Clinic']","[' The Cleveland Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00311558","['The Cleveland Clinic']"]
["NCT00318331","[]","[' Christiana Care Health Services ']","https://clinicaltrials.gov/ct2/show/NCT00318331","['Dr. Michael DePietro, Christiana Care Health Services']"]
["NCT00323635","[\"Quentin Rodney Regestein, MD, Brigham and Women's Hospital\"]","[\" Brigham and Women's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00323635","[\"Quentin Rodney Regestein, MD, Physician, Brigham and Women's Hospital\"]"]
["NCT00334763","[]","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT00334763","['Jyoti D. Patel, Robert H. Lurie Comprehensive Cancer Center at Northwestern University']"]
["NCT00335959","['Southwest Oncology Group']","[' Southwest Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00335959","['Southwest Oncology Group']"]
["NCT00351039","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00351039","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00353808","[]","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00353808","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00358982","['Mirati Therapeutics Inc.']","[' Mirati Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00358982","['Mirati Therapeutics Inc.']"]
["NCT00365222","[]","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00365222","['Marc Chamberlain, M.D., H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT00369200","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00369200","['National Cancer Institute (NCI)']"]
["NCT00374543","['Naomi M. Simon, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00374543","['Naomi M. Simon, Director, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital']"]
["NCT00381810","['Genentech, Inc.']","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00381810","['Genentech, Inc.']"]
["NCT00387348","['William Pirl, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00387348","['William Pirl, Principal Investigator, Massachusetts General Hospital']"]
["NCT00391586","['New Mexico Cancer Care Alliance']","[' New Mexico Cancer Care Alliance ']","https://clinicaltrials.gov/ct2/show/NCT00391586","['New Mexico Cancer Care Alliance']"]
["NCT00400205","['Nabil F. Saba, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT00400205","['Nabil F. Saba, Professor, Emory University']"]
["NCT00406653","[]","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT00406653","['Study Director, Bristol-Myers Squibb']"]
["NCT00414037","['Martin Paulus, University of California, San Diego']","[' University of California, San Diego ']","https://clinicaltrials.gov/ct2/show/NCT00414037","['Martin Paulus, Professor of Psychiatry, University of California, San Diego']"]
["NCT00420732","['NewLink Genetics Corporation']","[' NewLink Genetics Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00420732","['NewLink Genetics Corporation']"]
["NCT00427674","[]","[' Institute for Neurodegenerative Disorders ']","https://clinicaltrials.gov/ct2/show/NCT00427674","['John Seibyl, MD, MNI']"]
["NCT00434356","[]","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00434356","['Jai Balkissoon, M.D., Study Director, Genentech, Inc.']"]
["NCT00434993","['National Heart, Lung, and Blood Institute (NHLBI)']","[' National Heart, Lung, and Blood Institute (NHLBI) ']","https://clinicaltrials.gov/ct2/show/NCT00434993","['National Heart, Lung, and Blood Institute (NHLBI)']"]
["NCT00439946","['United Therapeutics']","[' United Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00439946","['United Therapeutics']"]
["NCT00444236","['Kathryn A. Peterson, University of Utah']","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT00444236","['Kathryn A. Peterson, MD, University of Utah']"]
["NCT00449605","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00449605","['Sanofi']"]
["NCT00456248","['Kadmon Pharmaceuticals']","[' Kadmon Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00456248","['Kadmon Pharmaceuticals']"]
["NCT00462202","['Keryx Biopharmaceuticals']","[' Keryx Biopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00462202","['Keryx Biopharmaceuticals']"]
["NCT00473967","['Albert B. Sabin Vaccine Institute']","[' Albert B. Sabin Vaccine Institute ']","https://clinicaltrials.gov/ct2/show/NCT00473967","['Albert B. Sabin Vaccine Institute']"]
["NCT00480025","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00480025","['GlaxoSmithKline']"]
["NCT00487578","['Cady, Roger, M.D.']","[' Cady, Roger, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00487578","['Cady, Roger, M.D.']"]
["NCT00492531","['Mark Gladwin, National Heart, Lung, and Blood Institute (NHLBI)']","[' National Heart, Lung, and Blood Institute (NHLBI) ']","https://clinicaltrials.gov/ct2/show/NCT00492531","['Mark Gladwin, Professor and Chair of Medicine, National Heart, Lung, and Blood Institute (NHLBI)']"]
["NCT00499902","[]","[' ARCA Biopharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00499902","['Brian Kersten, PhD, Nuvelo, Inc.']"]
["NCT00509249","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00509249","['National Cancer Institute (NCI)']"]
["NCT00511329","[\"Nationwide Children's Hospital\"]","[\" Nationwide Children's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00511329","[\"Nationwide Children's Hospital\"]"]
["NCT00521781","['The Methodist Hospital System']","[' The Methodist Hospital System ']","https://clinicaltrials.gov/ct2/show/NCT00521781","['The Methodist Hospital System']"]
["NCT00524186","['Roswell Park Cancer Institute']","[' Roswell Park Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00524186","['Roswell Park Cancer Institute']"]
["NCT00525408","['Cadila Pharnmaceuticals']","[' Cadila Pharnmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00525408","['Cadila Pharnmaceuticals']"]
["NCT00529633","['George A. Kaysen, M.D., University of California, Davis']","[' George A. Kaysen, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00529633","['George A. Kaysen, M.D., Professor of Medicine, University of California, Davis']"]
["NCT00538187","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00538187","['National Cancer Institute (NCI)']"]
["NCT00545298","['Nitric BioTherapeutics, Inc']","[' Nitric BioTherapeutics, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00545298","['Nitric BioTherapeutics, Inc']"]
["NCT00555204","['Abbott']","[' Abbott ']","https://clinicaltrials.gov/ct2/show/NCT00555204","['Abbott']"]
["NCT00557921","[]","[' Cogentus Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00557921","['Pablo Lapuerta, MD, Cogentus Pharmaceuticals']"]
["NCT00998166","['Mark Stoopler, Columbia University']","[' Columbia University ']","https://clinicaltrials.gov/ct2/show/NCT00998166","['Mark Stoopler, Associate Clinical Professor, Columbia University']"]
["NCT01004822","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01004822","['Pfizer']"]
["NCT01009931","['Rutgers, The State University of New Jersey']","[' Rutgers, The State University of New Jersey ']","https://clinicaltrials.gov/ct2/show/NCT01009931","['Rutgers, The State University of New Jersey']"]
["NCT01016054","['Astellas Pharma Inc']","[' Astellas Pharma Inc ']","https://clinicaltrials.gov/ct2/show/NCT01016054","['Astellas Pharma Inc']"]
["NCT01024244","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01024244","['Eli Lilly and Company']"]
["NCT01028911","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01028911","['Pfizer']"]
["NCT01035346","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01035346","['Pfizer']"]
["NCT01050218","[]","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01050218","['Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth']"]
["NCT01058005","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT01058005","['Biogen']"]
["NCT01066468","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01066468","['Novartis Pharmaceuticals']"]
["NCT01076556","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01076556","['National Cancer Institute (NCI)']"]
["NCT01085656","['University of Florida']","[' University of Florida ']","https://clinicaltrials.gov/ct2/show/NCT01085656","['University of Florida']"]
["NCT01087203","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01087203","['Pfizer']"]
["NCT01093118","[]","[' Talima Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01093118","['Martin Babler, Talima Therapeutics, Inc.']"]
["NCT01107145","['Centers for Disease Control and Prevention']","[' Centers for Disease Control and Prevention ']","https://clinicaltrials.gov/ct2/show/NCT01107145","['Centers for Disease Control and Prevention']"]
["NCT01110382","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01110382","['Janssen Research & Development, LLC']"]
["NCT01118663","['Cumberland Pharmaceuticals']","[' Cumberland Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01118663","['Cumberland Pharmaceuticals']"]
["NCT01125930","['Lisa E. Maier, University of Michigan']","[' Lisa E. Maier ']","https://clinicaltrials.gov/ct2/show/NCT01125930","['Lisa E. Maier, Assistant Professor, University of Michigan']"]
["NCT01138553","['Richard Schwab, University of California, San Diego']","[' University of California, San Diego ']","https://clinicaltrials.gov/ct2/show/NCT01138553","['Richard Schwab, Associate Clinical Professor of Medicine, University of California, San Diego']"]
["NCT01145755","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01145755","['AstraZeneca']"]
["NCT01151787","['Kennedy Medical Group']","[' Kennedy Medical Group ']","https://clinicaltrials.gov/ct2/show/NCT01151787","['Kennedy Medical Group']"]
["NCT01156051","[\"Thomas Rugino, Children's Specialized Hospital\"]","[\" Children's Specialized Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT01156051","[\"Thomas Rugino, Principal Investigator, Children's Specialized Hospital\"]"]
["NCT01175707","['Cubist Pharmaceuticals LLC']","[' Cubist Pharmaceuticals LLC ']","https://clinicaltrials.gov/ct2/show/NCT01175707","['Cubist Pharmaceuticals LLC']"]
["NCT01187446","['Youn Kim, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT01187446","['Youn Kim, Professor of Medicine, Stanford University']"]
["NCT01189253","['European Organisation for Research and Treatment of Cancer - EORTC']","[' European Organisation for Research and Treatment of Cancer - EORTC ']","https://clinicaltrials.gov/ct2/show/NCT01189253","['European Organisation for Research and Treatment of Cancer - EORTC']"]
["NCT01198873","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01198873","['Sanofi']"]
["NCT01204450","['UNC Lineberger Comprehensive Cancer Center']","[' UNC Lineberger Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01204450","['UNC Lineberger Comprehensive Cancer Center']"]
["NCT01205334","['Nabil Ahmed, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT01205334","['Nabil Ahmed, Assistant Professor Pediatric Hematology/Oncology Center for Cell and Gene Therapy, Baylor College of Medicine']"]
["NCT01211665","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT01211665","['Biogen']"]
["NCT01220128","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01220128","['GlaxoSmithKline']"]
["NCT01231347","['NantCell, Inc.']","[' NantCell, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01231347","['NantCell, Inc.']"]
["NCT01239355","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01239355","['National Cancer Institute (NCI)']"]
["NCT01251354","['Ipsen']","[' Ipsen ']","https://clinicaltrials.gov/ct2/show/NCT01251354","['Ipsen']"]
["NCT01261403","['Celularity Incorporated']","[' Celularity Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01261403","['Celularity Incorporated']"]
["NCT01272141","['William Read, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT01272141","['William Read, MD, Emory University']"]
["NCT01283971","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01283971","['Hoffmann-La Roche']"]
["NCT01296698","['Johnson & Johnson Consumer and Personal Products Worldwide ( McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. )']","[' McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01296698","['McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.']"]
["NCT01310803","['Endo Pharmaceuticals']","[' Endo Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01310803","['Endo Pharmaceuticals']"]
["NCT01316939","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01316939","['GlaxoSmithKline']"]
["NCT01333137","['Piramal Enterprises Limited']","[' Piramal Enterprises Limited ']","https://clinicaltrials.gov/ct2/show/NCT01333137","['Piramal Enterprises Limited']"]
["NCT01339039","[\"Patrick Y. Wen, MD, Dana-Farber/Brigham and Women's Cancer Center\"]","[' Patrick Y. Wen, MD ']","https://clinicaltrials.gov/ct2/show/NCT01339039","[\"Patrick Y. Wen, MD, Disease Center Leader, Center For Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center\"]"]
["NCT01345864","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01345864","['Pfizer']"]
["NCT01365130","['howard safran, Brown University']","[' howard safran ']","https://clinicaltrials.gov/ct2/show/NCT01365130","['howard safran, Priniciple Investigator, Brown University']"]
["NCT01365910","['Jordan Berlin, MD, Vanderbilt-Ingram Cancer Center']","[' Vanderbilt-Ingram Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01365910","['Jordan Berlin, MD, Professor of Medicine; Clinical Director, GI Oncology Program; Director, Phase I Program; Medical Director, Clinical Trials Shared Resources; Medical Oncologist, Vanderbilt-Ingram Cancer Center']"]
["NCT01384240","['Anandasabapathy, Sharmila, M.D.']","[' Anandasabapathy, Sharmila, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT01384240","['Anandasabapathy, Sharmila, M.D.']"]
["NCT01389895","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT01389895","['Amgen']"]
["NCT01402440","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01402440","['Novartis Pharmaceuticals']"]
["NCT01416948","['INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium']","[' INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01416948","['INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium']"]
["NCT01433354","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01433354","['Novartis Pharmaceuticals']"]
["NCT01436643","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01436643","['Novartis Pharmaceuticals']"]
["NCT01442714","['Bruno C. Medeiros, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT01442714","['Bruno C. Medeiros, Associate Professor Medicine Hematology, Stanford University']"]
["NCT01464593","['Celsion']","[' Celsion ']","https://clinicaltrials.gov/ct2/show/NCT01464593","['Celsion']"]
["NCT01468818","['Steven Rosenberg, M.D., National Institutes of Health Clinical Center (CC)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01468818","['Steven Rosenberg, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT01480388","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01480388","['Janssen Research & Development, LLC']"]
["NCT01495065","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01495065","['GlaxoSmithKline']"]
["NCT01500161","['Seah Lim M.D., Texas Oncology Cancer Center']","[' Texas Oncology Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01500161","['Seah Lim M.D., Principle Investigator, Texas Oncology Cancer Center']"]
["NCT01513317","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01513317","['Janssen Research & Development, LLC']"]
["NCT01524406","['High Point Pharmaceuticals, LLC.']","[' High Point Pharmaceuticals, LLC. ']","https://clinicaltrials.gov/ct2/show/NCT01524406","['High Point Pharmaceuticals, LLC.']"]
["NCT01533753","['University of Wisconsin, Madison']","[' University of Wisconsin, Madison ']","https://clinicaltrials.gov/ct2/show/NCT01533753","['University of Wisconsin, Madison']"]
["NCT01533948","['Roswell Park Cancer Institute']","[' Roswell Park Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01533948","['Roswell Park Cancer Institute']"]
["NCT01546857","['Rutgers, The State University of New Jersey']","[' Rutgers, The State University of New Jersey ']","https://clinicaltrials.gov/ct2/show/NCT01546857","['Rutgers, The State University of New Jersey']"]
["NCT01560507","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT01560507","['Duke University']"]
["NCT01570634","['Salient Pharmaceuticals Incorporated']","[' Salient Pharmaceuticals Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01570634","['Salient Pharmaceuticals Incorporated']"]
["NCT01585415","['National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01585415","['National Cancer Institute (NCI)']"]
["NCT01597440","[\"Mendel Tuchman, Children's Research Institute\"]","[' Mendel Tuchman ']","https://clinicaltrials.gov/ct2/show/NCT01597440","[\"Mendel Tuchman, MD, Children's Research Institute\"]"]
["NCT01604941","['Shire']","[' Shire ']","https://clinicaltrials.gov/ct2/show/NCT01604941","['Shire']"]
["NCT01624636","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01624636","['Novartis Pharmaceuticals']"]
["NCT01637090","['Adam Lerner, Boston Medical Center']","[' Adam Lerner ']","https://clinicaltrials.gov/ct2/show/NCT01637090","['Adam Lerner, Principal Investigator, Boston Medical Center']"]
["NCT01659138","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01659138","['Sanofi']"]
["NCT01678911","['Dr. Norman Harden, Shirley Ryan AbilityLab']","[' Shirley Ryan AbilityLab ']","https://clinicaltrials.gov/ct2/show/NCT01678911","['Dr. Norman Harden, Director, Center for Pain Studies, Shirley Ryan AbilityLab']"]
["NCT01690195","['AbbVie ( AbbVie (prior sponsor, Abbott) )']","[' AbbVie (prior sponsor, Abbott) ']","https://clinicaltrials.gov/ct2/show/NCT01690195","['AbbVie (prior sponsor, Abbott)']"]
["NCT01696045","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT01696045","['Bristol-Myers Squibb']"]
["NCT01709136","['Rakesh Sindhi, University of Pittsburgh']","[' University of Pittsburgh ']","https://clinicaltrials.gov/ct2/show/NCT01709136","['Rakesh Sindhi, Professor of Surgery, University of Pittsburgh']"]
["NCT01725256","['Aires Pharmaceuticals, Inc.']","[' Aires Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01725256","['Aires Pharmaceuticals, Inc.']"]
["NCT01732913","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT01732913","['Gilead Sciences']"]
["NCT01741142","['AbbVie ( AbbVie (prior sponsor, Abbott) )']","[' AbbVie (prior sponsor, Abbott) ']","https://clinicaltrials.gov/ct2/show/NCT01741142","['AbbVie (prior sponsor, Abbott)']"]
["NCT01755702","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01755702","['GlaxoSmithKline']"]
["NCT01767987","['Harvey Hahn, Kettering Health Network']","[' Harvey Hahn ']","https://clinicaltrials.gov/ct2/show/NCT01767987","['Harvey Hahn, Director, Cardiovascular Fellowship Training Program and Director, Cardiac Noninvasive Laboratory, Kettering Health Network']"]
["NCT01783522","['Beth Faiman, Case Comprehensive Cancer Center']","[' Beth Faiman ']","https://clinicaltrials.gov/ct2/show/NCT01783522","['Beth Faiman, Principal Investigator, Case Comprehensive Cancer Center']"]
["NCT01801917","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01801917","['Novartis Pharmaceuticals']"]
["NCT01816659","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01816659","['M.D. Anderson Cancer Center']"]
["NCT01833065","['Ferring Pharmaceuticals']","[' Ferring Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01833065","['Ferring Pharmaceuticals']"]
["NCT01848106","['Regado Biosciences, Inc.']","[' Regado Biosciences, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01848106","['Regado Biosciences, Inc.']"]
["NCT01865084","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01865084","['Eli Lilly and Company']"]
["NCT01886287","['H. Lee Moffitt Cancer Center and Research Institute']","[' H. Lee Moffitt Cancer Center and Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01886287","['H. Lee Moffitt Cancer Center and Research Institute']"]
["NCT01901302","['Cubist Pharmaceuticals LLC']","[' Cubist Pharmaceuticals LLC ']","https://clinicaltrials.gov/ct2/show/NCT01901302","['Cubist Pharmaceuticals LLC']"]
["NCT01920477","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01920477","['Novartis Pharmaceuticals']"]
["NCT01937130","['Conatus Pharmaceuticals Inc.']","[' Conatus Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01937130","['Conatus Pharmaceuticals Inc.']"]
["NCT01954030","['Annick Desjardins, Duke University']","[' Annick Desjardins ']","https://clinicaltrials.gov/ct2/show/NCT01954030","['Annick Desjardins, Associate Professor, Duke University']"]
["NCT01972516","['Susana M. Campos, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01972516","['Susana M. Campos, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT01989052","['Annick Desjardins, Duke University']","[' Annick Desjardins ']","https://clinicaltrials.gov/ct2/show/NCT01989052","['Annick Desjardins, Associate Professor of Medicine, Duke University']"]
["NCT02015637","['Melinta Therapeutics, Inc.']","[' Melinta Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02015637","['Melinta Therapeutics, Inc.']"]
["NCT02020941","['Attaya Suvannasankha, Indiana University School of Medicine']","[' Attaya Suvannasankha ']","https://clinicaltrials.gov/ct2/show/NCT02020941","['Attaya Suvannasankha, Principal Investigator, Indiana University School of Medicine']"]
["NCT02047500","['Threshold Pharmaceuticals']","[' Threshold Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT02047500","['Threshold Pharmaceuticals']"]
["NCT02076243","['Philip Friedlander, Icahn School of Medicine at Mount Sinai']","[' Icahn School of Medicine at Mount Sinai ']","https://clinicaltrials.gov/ct2/show/NCT02076243","['Philip Friedlander, Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai']"]
["NCT02088957","['UCB Pharma ( UCB BIOSCIENCES, Inc. )']","[' UCB BIOSCIENCES, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02088957","['UCB BIOSCIENCES, Inc.']"]
["NCT02111863","['Steven Rosenberg, M.D., National Institutes of Health Clinical Center (CC)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT02111863","['Steven Rosenberg, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT02138786","['Karyopharm Therapeutics Inc']","[' Karyopharm Therapeutics Inc ']","https://clinicaltrials.gov/ct2/show/NCT02138786","['Karyopharm Therapeutics Inc']"]
["NCT02154087","['Healthpoint']","[' Healthpoint ']","https://clinicaltrials.gov/ct2/show/NCT02154087","['Healthpoint']"]
["NCT02201524","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT02201524","['Pfizer']"]
["NCT02222207","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT02222207","['Bayer']"]
["NCT02234011","['Brian P. Brennan, MD, Mclean Hospital']","[' Mclean Hospital ']","https://clinicaltrials.gov/ct2/show/NCT02234011","['Brian P. Brennan, MD, M.D., Mclean Hospital']"]
["NCT02342704","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT02342704","['Biogen']"]
["NCT02786732","['Michelle Pelle, M.D., MedDerm Associates']","[' MedDerm Associates ']","https://clinicaltrials.gov/ct2/show/NCT02786732","['Michelle Pelle, M.D., Principal Investigator, MedDerm Associates']"]
["NCT00787111","[]","[' Neuropharm ']","https://clinicaltrials.gov/ct2/show/NCT00787111","['Dr. Mike Snape/ Chief Scientific Officer, Neuropharm']"]
["NCT00279422","['Facet Biotech']","[' Facet Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00279422","['Facet Biotech']"]
["NCT00360087","[]","[' Actelion ']","https://clinicaltrials.gov/ct2/show/NCT00360087","['Sponsor, Actelion']"]
["NCT00622089","[]","[' DiObex ']","https://clinicaltrials.gov/ct2/show/NCT00622089","['Bernice Welles, MD, DiObex, Inc.']"]
["NCT01190306","['Topcon Medical Systems, Inc.']","[' Topcon Medical Systems, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01190306","['Topcon Medical Systems, Inc.']"]
["NCT01013480","['Seaside Therapeutics, Inc.']","[' Seaside Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01013480","['Seaside Therapeutics, Inc.']"]
["NCT00128258","['Amit N. Patel MD MS, Amit, Patel N, M.D.']","[' Amit, Patel N, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00128258","['Amit N. Patel MD MS, Director, Amit, Patel N, M.D.']"]
["NCT01164514","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT01164514","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00538343","['Reata Pharmaceuticals, Inc.']","[' Reata Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00538343","['Reata Pharmaceuticals, Inc.']"]
["NCT00748579","['Cytokinetics']","[' Cytokinetics ']","https://clinicaltrials.gov/ct2/show/NCT00748579","['Cytokinetics']"]
["NCT01562873","['Nancy Lin, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01562873","['Nancy Lin, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00386516","['Galectin Therapeutics Inc.']","[' Galectin Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00386516","['Galectin Therapeutics Inc.']"]
["NCT01373463","[]","[' Medical University of South Carolina ']","https://clinicaltrials.gov/ct2/show/NCT01373463","['George Simon, MD, Hollings Cancer Cetner Medical University of South Carolina']"]
["NCT01752023","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01752023","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01004705","['Ferrer Internacional S.A.']","[' Ferrer Internacional S.A. ']","https://clinicaltrials.gov/ct2/show/NCT01004705","['Ferrer Internacional S.A.']"]
["NCT01913301","['Cardiovascular Clinical Studies']","[' Cardiovascular Clinical Studies ']","https://clinicaltrials.gov/ct2/show/NCT01913301","['Cardiovascular Clinical Studies']"]
["NCT02199223","['University of Utah']","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT02199223","['University of Utah']"]
["NCT00958269","[]","[' Phenomix ']","https://clinicaltrials.gov/ct2/show/NCT00958269","['Hans-Peter Guler, MD, Phenomix Corporation']"]
["NCT00592215","['Johns Hopkins University']","[' Johns Hopkins University ']","https://clinicaltrials.gov/ct2/show/NCT00592215","['Johns Hopkins University']"]
["NCT01198626","['Furiex Pharmaceuticals, Inc']","[' Furiex Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT01198626","['Furiex Pharmaceuticals, Inc']"]
["NCT01094496","['Celldex Therapeutics']","[' Celldex Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01094496","['Celldex Therapeutics']"]
["NCT00589953","['Atlantic Health System']","[' Atlantic Health System ']","https://clinicaltrials.gov/ct2/show/NCT00589953","['Atlantic Health System']"]
["NCT00954590","['Medivation, Inc.']","[' Medivation, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00954590","['Medivation, Inc.']"]
["NCT01398839","['Topcon Medical Systems, Inc.']","[' Topcon Medical Systems, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01398839","['Topcon Medical Systems, Inc.']"]
["NCT00255801","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00255801","['Memorial Sloan Kettering Cancer Center']"]
["NCT00557193","[\"Children's Oncology Group\"]","[\" Children's Oncology Group \"]","https://clinicaltrials.gov/ct2/show/NCT00557193","[\"Children's Oncology Group\"]"]
["NCT00789776","['Brenda Sandmaier, Fred Hutchinson Cancer Research Center']","[' Fred Hutchinson Cancer Research Center ']","https://clinicaltrials.gov/ct2/show/NCT00789776","['Brenda Sandmaier, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT01011439","['Tiziana Life Sciences, PLC']","[' Tiziana Life Sciences, PLC ']","https://clinicaltrials.gov/ct2/show/NCT01011439","['Tiziana Life Sciences, PLC']"]
["NCT01192828","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT01192828","['University of Colorado, Denver']"]
["NCT01332630","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01332630","['M.D. Anderson Cancer Center']"]
["NCT01494038","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT01494038","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01571284","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01571284","['Sanofi']"]
["NCT01652872","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT01652872","['Amgen']"]
["NCT01696877","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01696877","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']"]
["NCT01712490","['Takeda ( Millennium Pharmaceuticals, Inc. )']","[' Millennium Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01712490","['Millennium Pharmaceuticals, Inc.']"]
["NCT01802333","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01802333","['National Cancer Institute (NCI)']"]
["NCT01932788","['Medical University of South Carolina']","[' Medical University of South Carolina ']","https://clinicaltrials.gov/ct2/show/NCT01932788","['Medical University of South Carolina']"]
["NCT02027701","['CSL Behring']","[' CSL Behring ']","https://clinicaltrials.gov/ct2/show/NCT02027701","['CSL Behring']"]
["NCT02160145","['Otsuka Pharmaceutical Development & Commercialization, Inc.']","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02160145","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT02259114","['Oncoethix GmbH']","[' Oncoethix GmbH ']","https://clinicaltrials.gov/ct2/show/NCT02259114","['Oncoethix GmbH']"]
["NCT01779375","['RISE Study Group']","[' RISE Study Group ']","https://clinicaltrials.gov/ct2/show/NCT01779375","['RISE Study Group']"]
["NCT00923130","['Ravi A. Madan, M.D., National Institutes of Health Clinical Center (CC)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00923130","['Ravi A. Madan, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT00412932","[]","[' Daiichi Sankyo, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00412932","['William Waverczak, Daiichi Sankyo']"]
["NCT02185014","['AbbVie']","[' AbbVie ']","https://clinicaltrials.gov/ct2/show/NCT02185014","['AbbVie']"]
["NCT00924170","['Robert Kreitman, M.D., National Institutes of Health Clinical Center (CC)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00924170","['Robert Kreitman, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT01312909","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01312909","['Pfizer']"]
["NCT01526889","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01526889","['Novartis Pharmaceuticals']"]
["NCT01598896","['Kevin P. Hill, MD, MHS, Mclean Hospital']","[' Mclean Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01598896","['Kevin P. Hill, MD, MHS, Instructor in Psychiatry, Mclean Hospital']"]
["NCT01776424","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01776424","['Bayer']"]
["NCT01829217","['Geoffrey Oxnard, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01829217","['Geoffrey Oxnard, MD, Prinicipal Investigator, Dana-Farber Cancer Institute']"]
["NCT01846221","['Allison Lee, Columbia University']","[' Columbia University ']","https://clinicaltrials.gov/ct2/show/NCT01846221","['Allison Lee, Assistant Professor of Clinical Anesthesiology, Columbia University']"]
["NCT01872689","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01872689","['Hoffmann-La Roche']"]
["NCT01945866","['Jaeb Center for Health Research']","[' Jaeb Center for Health Research ']","https://clinicaltrials.gov/ct2/show/NCT01945866","['Jaeb Center for Health Research']"]
["NCT01983683","['Actelion']","[' Actelion ']","https://clinicaltrials.gov/ct2/show/NCT01983683","['Actelion']"]
["NCT02061969","['Guillermo Umpierrez, MD, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT02061969","['Guillermo Umpierrez, MD, Professor of Medicine, Emory University']"]
["NCT02101918","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT02101918","['National Cancer Institute (NCI)']"]
["NCT02155257","['Wake Forest University Health Sciences']","[' Wake Forest University Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT02155257","['Wake Forest University Health Sciences']"]
["NCT02199652","['Augusta University']","[' Augusta University ']","https://clinicaltrials.gov/ct2/show/NCT02199652","['Augusta University']"]
["NCT02260388","['University of Kansas Medical Center']","[' University of Kansas Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT02260388","['University of Kansas Medical Center']"]
["NCT02320149","['Warner Chilcott']","[' Warner Chilcott ']","https://clinicaltrials.gov/ct2/show/NCT02320149","['Warner Chilcott']"]
["NCT00621530","['Wake Forest University Health Sciences ( Wake Forest University )']","[' Wake Forest University ']","https://clinicaltrials.gov/ct2/show/NCT00621530","['Wake Forest University']"]
["NCT01217697","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT01217697","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT01569815","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01569815","['Novartis Pharmaceuticals']"]
["NCT01572701","['Molecular Insight Pharmaceuticals, Inc.']","[' Molecular Insight Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01572701","['Molecular Insight Pharmaceuticals, Inc.']"]
["NCT01575054","['Allergan']","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT01575054","['Allergan']"]
["NCT01577238","['Starpharma Pty Ltd']","[' Starpharma Pty Ltd ']","https://clinicaltrials.gov/ct2/show/NCT01577238","['Starpharma Pty Ltd']"]
["NCT01579084","['Allergan']","[' Allergan ']","https://clinicaltrials.gov/ct2/show/NCT01579084","['Allergan']"]
["NCT01582152","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01582152","['M.D. Anderson Cancer Center']"]
["NCT01582425","['Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )']","[' Astellas Pharma Global Development, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01582425","['Astellas Pharma Global Development, Inc.']"]
["NCT01585558","['Shionogi Inc. ( Shionogi )']","[' Shionogi ']","https://clinicaltrials.gov/ct2/show/NCT01585558","['Shionogi']"]
["NCT01588405","['United Therapeutics']","[' United Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01588405","['United Therapeutics']"]
["NCT01592110","['Zogenix, Inc.']","[' Zogenix, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01592110","['Zogenix, Inc.']"]
["NCT01592396","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT01592396","['MedImmune LLC']"]
["NCT01594619","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01594619","['AstraZeneca']"]
["NCT01596725","['Novavax']","[' Novavax ']","https://clinicaltrials.gov/ct2/show/NCT01596725","['Novavax']"]
["NCT01600092","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT01600092","['Merck Sharp & Dohme Corp.']"]
["NCT01603069","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01603069","['AstraZeneca']"]
["NCT01603459","['Merz Pharmaceuticals GmbH']","[' Merz Pharmaceuticals GmbH ']","https://clinicaltrials.gov/ct2/show/NCT01603459","['Merz Pharmaceuticals GmbH']"]
["NCT01607450","['Indiana University']","[' Indiana University ']","https://clinicaltrials.gov/ct2/show/NCT01607450","['Indiana University']"]
["NCT01611467","['Celgene Corporation']","[' Celgene Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01611467","['Celgene Corporation']"]
["NCT01613950","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01613950","['Novartis Pharmaceuticals']"]
["NCT01616056","['Stephanie Lee, Fred Hutchinson Cancer Research Center']","[' Fred Hutchinson Cancer Research Center ']","https://clinicaltrials.gov/ct2/show/NCT01616056","['Stephanie Lee, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT01619774","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01619774","['M.D. Anderson Cancer Center']"]
["NCT01619839","['Nektar Therapeutics']","[' Nektar Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01619839","['Nektar Therapeutics']"]
["NCT01623401","['Trius Therapeutics LLC']","[' Trius Therapeutics LLC ']","https://clinicaltrials.gov/ct2/show/NCT01623401","['Trius Therapeutics LLC']"]
["NCT01625689","['PATH ( PATH Vaccine Solutions )']","[' PATH Vaccine Solutions ']","https://clinicaltrials.gov/ct2/show/NCT01625689","['PATH Vaccine Solutions']"]
["NCT01628094","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01628094","['Hoffmann-La Roche']"]
["NCT01632709","['Dr. Norman Harden, Shirley Ryan AbilityLab']","[' Shirley Ryan AbilityLab ']","https://clinicaltrials.gov/ct2/show/NCT01632709","['Dr. Norman Harden, Principal Investigator, Shirley Ryan AbilityLab']"]
["NCT01634191","['Celgene Corporation']","[' Celgene Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01634191","['Celgene Corporation']"]
["NCT01637285","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01637285","['Pfizer']"]
["NCT01641159","['Theresa Winhusen, University of Cincinnati']","[' University of Cincinnati ']","https://clinicaltrials.gov/ct2/show/NCT01641159","['Theresa Winhusen, Associate Professor, Department of Psychiatry and Behavioral Neuroscience; CinARC Director, University of Cincinnati']"]
["NCT01643941","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01643941","['Pfizer']"]
["NCT01646125","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01646125","['Novartis Pharmaceuticals']"]
["NCT01648790","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01648790","['Eli Lilly and Company']"]
["NCT01651351","['Shire ( Baxalta now part of Shire )']","[' Baxalta now part of Shire ']","https://clinicaltrials.gov/ct2/show/NCT01651351","['Baxalta now part of Shire']"]
["NCT01654211","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01654211","['Hoffmann-La Roche']"]
["NCT01656382","['Medstar Health Research Institute']","[' Medstar Health Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01656382","['Medstar Health Research Institute']"]
["NCT01658319","['Case Comprehensive Cancer Center']","[' Case Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT01658319","['Case Comprehensive Cancer Center']"]
["NCT01660633","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT01660633","['Spectrum Pharmaceuticals, Inc']"]
["NCT01660750","['Criterium, Inc.']","[' Criterium, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01660750","['Criterium, Inc.']"]
["NCT01663961","['Astellas Pharma Inc ( Astellas Pharma Europe B.V. )']","[' Astellas Pharma Europe B.V. ']","https://clinicaltrials.gov/ct2/show/NCT01663961","['Astellas Pharma Europe B.V.']"]
["NCT01669083","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01669083","['GlaxoSmithKline']"]
["NCT01670734","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01670734","['Sanofi']"]
["NCT01673191","['Retinal Consultants of Arizona']","[' Retinal Consultants of Arizona ']","https://clinicaltrials.gov/ct2/show/NCT01673191","['Retinal Consultants of Arizona']"]
["NCT01676220","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01676220","['Sanofi']"]
["NCT01677754","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT01677754","['Hoffmann-La Roche']"]
["NCT01681121","['Jazz Pharmaceuticals']","[' Jazz Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01681121","['Jazz Pharmaceuticals']"]
["NCT01684423","['Bayer']","[' Bayer ']","https://clinicaltrials.gov/ct2/show/NCT01684423","['Bayer']"]
["NCT01686217","['Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )']","[' Astellas Pharma Global Development, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01686217","['Astellas Pharma Global Development, Inc.']"]
["NCT01688570","['Phillip Nelson, MD, Medical College of Wisconsin']","[' Medical College of Wisconsin ']","https://clinicaltrials.gov/ct2/show/NCT01688570","['Phillip Nelson, MD, Assistant Professor, Medical College of Wisconsin']"]
["NCT01691274","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01691274","['Pfizer']"]
["NCT01692301","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01692301","['Novartis Pharmaceuticals']"]
["NCT01696604","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01696604","['GlaxoSmithKline']"]
["NCT01699815","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT01699815","['Duke University']"]
["NCT01700400","['Cancer Research and Biostatistics Clinical Trials Consortium']","[' Cancer Research and Biostatistics Clinical Trials Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01700400","['Cancer Research and Biostatistics Clinical Trials Consortium']"]
["NCT01702441","['Aerpio Therapeutics']","[' Aerpio Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01702441","['Aerpio Therapeutics']"]
["NCT01704521","['Kenneth Sherman, University of Cincinnati']","[' Kenneth Sherman ']","https://clinicaltrials.gov/ct2/show/NCT01704521","['Kenneth Sherman, Kenneth E. Sherman, MD, PhD, University of Cincinnati']"]
["NCT01706926","['MedImmune LLC']","[' MedImmune LLC ']","https://clinicaltrials.gov/ct2/show/NCT01706926","['MedImmune LLC']"]
["NCT01709149","['Cytokinetics']","[' Cytokinetics ']","https://clinicaltrials.gov/ct2/show/NCT01709149","['Cytokinetics']"]
["NCT01711346","['Cerus Corporation']","[' Cerus Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01711346","['Cerus Corporation']"]
["NCT01712516","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01712516","['Novartis Pharmaceuticals']"]
["NCT01715415","['AbbVie ( AbbVie (prior sponsor, Abbott) )']","[' AbbVie (prior sponsor, Abbott) ']","https://clinicaltrials.gov/ct2/show/NCT01715415","['AbbVie (prior sponsor, Abbott)']"]
["NCT01718509","['Shire']","[' Shire ']","https://clinicaltrials.gov/ct2/show/NCT01718509","['Shire']"]
["NCT01722045","['Regeneron Pharmaceuticals']","[' Regeneron Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01722045","['Regeneron Pharmaceuticals']"]
["NCT01723241","['Topokine Therapeutics, Inc.']","[' Topokine Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01723241","['Topokine Therapeutics, Inc.']"]
["NCT01726270","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT01726270","['Boehringer Ingelheim']"]
["NCT01728792","['Takeda']","[' Takeda ']","https://clinicaltrials.gov/ct2/show/NCT01728792","['Takeda']"]
["NCT01730417","['Bennett Chin, Duke University']","[' Bennett Chin ']","https://clinicaltrials.gov/ct2/show/NCT01730417","['Bennett Chin, Principal Investigator, Duke University']"]
["NCT01734759","['Bernard Lee, Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01734759","['Bernard Lee, Principle Investigator, Mayo Clinic']"]
["NCT01736527","['Bausch & Lomb Incorporated']","[' Bausch & Lomb Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01736527","['Bausch & Lomb Incorporated']"]
["NCT01739595","['Repros Therapeutics Inc.']","[' Repros Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01739595","['Repros Therapeutics Inc.']"]
["NCT01741545","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT01741545","['Bristol-Myers Squibb']"]
["NCT01743027","['Alcon Research']","[' Alcon Research ']","https://clinicaltrials.gov/ct2/show/NCT01743027","['Alcon Research']"]
["NCT01745640","['University Hospital, Lille']","[' University Hospital, Lille ']","https://clinicaltrials.gov/ct2/show/NCT01745640","['University Hospital, Lille']"]
["NCT01749137","['Rhythm Pharmaceuticals, Inc.']","[' Rhythm Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01749137","['Rhythm Pharmaceuticals, Inc.']"]
["NCT01750268","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT01750268","['University of California, San Francisco']"]
["NCT01752985","['Bristol-Myers Squibb']","[' Bristol-Myers Squibb ']","https://clinicaltrials.gov/ct2/show/NCT01752985","['Bristol-Myers Squibb']"]
["NCT01755247","['Novan, Inc.']","[' Novan, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01755247","['Novan, Inc.']"]
["NCT01757756","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT01757756","['Pfizer']"]
["NCT01762462","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT01762462","['Sanofi']"]
["NCT01764776","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01764776","['Novartis Pharmaceuticals']"]
["NCT01767103","['ApoPharma']","[' ApoPharma ']","https://clinicaltrials.gov/ct2/show/NCT01767103","['ApoPharma']"]
["NCT01769378","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT01769378","['Eli Lilly and Company']"]
["NCT01772524","['Alder Biopharmaceuticals, Inc.']","[' Alder Biopharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01772524","['Alder Biopharmaceuticals, Inc.']"]
["NCT01775176","['Leanne Redman, Pennington Biomedical Research Center']","[' Pennington Biomedical Research Center ']","https://clinicaltrials.gov/ct2/show/NCT01775176","['Leanne Redman, Principle Investigator, Pennington Biomedical Research Center']"]
["NCT01778049","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT01778049","['Boehringer Ingelheim']"]
["NCT01783691","['NKT Therapeutics']","[' NKT Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01783691","['NKT Therapeutics']"]
["NCT01786109","['Michael Camilleri, Mayo Clinic']","[' Michael Camilleri ']","https://clinicaltrials.gov/ct2/show/NCT01786109","['Michael Camilleri, Professor of Medicine, Mayo Clinic']"]
["NCT01786512","['Amgen']","[' Amgen ']","https://clinicaltrials.gov/ct2/show/NCT01786512","['Amgen']"]
["NCT01789255","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT01789255","['National Cancer Institute (NCI)']"]
["NCT01255904","['Jason Reynolds, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT01255904","['Jason Reynolds, Assistant Professor of Pediatrics, Baylor College of Medicine']"]
["NCT01938742","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT01938742","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT01382654","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT01382654","['Merck Sharp & Dohme Corp.']"]
["NCT00721344","['Mannkind Corporation']","[' Mannkind Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00721344","['Mannkind Corporation']"]
["NCT00650338","['Santen Inc.']","[' Santen Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00650338","['Santen Inc.']"]
["NCT00659802","['Hutchison Medipharma Limited']","[' Hutchison Medipharma Limited ']","https://clinicaltrials.gov/ct2/show/NCT00659802","['Hutchison Medipharma Limited']"]
["NCT00997620","['Lyndon Mansfield, Western Sky Medical Research']","[' Western Sky Medical Research ']","https://clinicaltrials.gov/ct2/show/NCT00997620","['Lyndon Mansfield, Director, Western Sky Medical Research']"]
["NCT00319020","['Actelion']","[' Actelion ']","https://clinicaltrials.gov/ct2/show/NCT00319020","['Actelion']"]
["NCT01607294","['Esperion Therapeutics']","[' Esperion Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01607294","['Esperion Therapeutics']"]
["NCT01474720","['Oklahoma Medical Research Foundation']","[' Oklahoma Medical Research Foundation ']","https://clinicaltrials.gov/ct2/show/NCT01474720","['Oklahoma Medical Research Foundation']"]
["NCT01400139","['Purdue Pharma LP']","[' Purdue Pharma LP ']","https://clinicaltrials.gov/ct2/show/NCT01400139","['Purdue Pharma LP']"]
["NCT01454986","['Alexion Pharmaceuticals']","[' Alexion Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01454986","['Alexion Pharmaceuticals']"]
["NCT01887366","['Teva Pharmaceutical Industries']","[' Teva Pharmaceutical Industries ']","https://clinicaltrials.gov/ct2/show/NCT01887366","['Teva Pharmaceutical Industries']"]
["NCT02094534","['Oramed, Ltd.']","[' Oramed, Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT02094534","['Oramed, Ltd.']"]
["NCT02253173","['TherapeuticsMD']","[' TherapeuticsMD ']","https://clinicaltrials.gov/ct2/show/NCT02253173","['TherapeuticsMD']"]
["NCT00134966","['Novartis']","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00134966","['Novartis']"]
["NCT00717145","['Warner Chilcott']","[' Warner Chilcott ']","https://clinicaltrials.gov/ct2/show/NCT00717145","['Warner Chilcott']"]
["NCT00662818","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00662818","['Merck Sharp & Dohme Corp.']"]
["NCT00586651","['Teva Pharmaceutical Industries ( Cephalon )']","[' Cephalon ']","https://clinicaltrials.gov/ct2/show/NCT00586651","['Cephalon']"]
["NCT00825487","['ArQule']","[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT00825487","['ArQule']"]
["NCT01250496","['Rami Doukky, Rush University Medical Center']","[' Rush University Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT01250496","['Rami Doukky, Director of Nuclear Cardiology and Stress Testing Laboratories, Rush University Medical Center']"]
["NCT01554800","['Alphacore Pharma, LLC']","[' Alphacore Pharma, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01554800","['Alphacore Pharma, LLC']"]
["NCT01712204","['TWi Biotechnology, Inc.']","[' TWi Biotechnology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01712204","['TWi Biotechnology, Inc.']"]
["NCT02206711","['ViiV Healthcare']","[' ViiV Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT02206711","['ViiV Healthcare']"]
["NCT01982539","['Depomed']","[' Depomed ']","https://clinicaltrials.gov/ct2/show/NCT01982539","['Depomed']"]
["NCT00981435","['Jeffrey L Goldberg, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT00981435","['Jeffrey L Goldberg, Professor of Ophthalmology, Stanford University']"]
["NCT02253927","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT02253927","['Boehringer Ingelheim']"]
["NCT01282606","['Seikagaku Corporation']","[' Seikagaku Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01282606","['Seikagaku Corporation']"]
["NCT00300469","[]","[' Abbott ']","https://clinicaltrials.gov/ct2/show/NCT00300469","['Maureen Kelly, MD, Abbott']"]
["NCT00490516","['ACADIA Pharmaceuticals Inc.']","[' ACADIA Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00490516","['ACADIA Pharmaceuticals Inc.']"]
["NCT00968422","[]","[' Abbott ']","https://clinicaltrials.gov/ct2/show/NCT00968422","['Gerard Marek, MD, PhD, Abbott']"]
["NCT02092922","['Array BioPharma']","[' Array BioPharma ']","https://clinicaltrials.gov/ct2/show/NCT02092922","['Array BioPharma']"]
["NCT00695435","[]","[' Alcon Research ']","https://clinicaltrials.gov/ct2/show/NCT00695435","['Michael Brubaker, Alcon']"]
["NCT00214942","['Teva Pharmaceutical Industries ( Cephalon )']","[' Cephalon ']","https://clinicaltrials.gov/ct2/show/NCT00214942","['Cephalon']"]
["NCT02194179","['Boehringer Ingelheim']","[' Boehringer Ingelheim ']","https://clinicaltrials.gov/ct2/show/NCT02194179","['Boehringer Ingelheim']"]
["NCT01113593","['Dey']","[' Dey ']","https://clinicaltrials.gov/ct2/show/NCT01113593","['Dey']"]
["NCT01339260","['Helsinn Healthcare SA']","[' Helsinn Healthcare SA ']","https://clinicaltrials.gov/ct2/show/NCT01339260","['Helsinn Healthcare SA']"]
["NCT01661673","['FORUM Pharmaceuticals Inc']","[' FORUM Pharmaceuticals Inc ']","https://clinicaltrials.gov/ct2/show/NCT01661673","['FORUM Pharmaceuticals Inc']"]
["NCT01768663","['Vertex Pharmaceuticals Incorporated']","[' Vertex Pharmaceuticals Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01768663","['Vertex Pharmaceuticals Incorporated']"]
["NCT00936663","['Vijay Shivaswamy, MD, University of Nebraska']","[' University of Nebraska ']","https://clinicaltrials.gov/ct2/show/NCT00936663","['Vijay Shivaswamy, MD, Associate Professor, University of Nebraska']"]
["NCT01288521","['Sony Tuteja, University of Iowa']","[' Sony Tuteja ']","https://clinicaltrials.gov/ct2/show/NCT01288521","['Sony Tuteja, Associate, University of Iowa']"]
["NCT01412359","['Jeffrey Rudolph, University of Pittsburgh']","[' Jeffrey Rudolph ']","https://clinicaltrials.gov/ct2/show/NCT01412359","[\"Jeffrey Rudolph, Jeffrey A. Rudolph, M.D., Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh\"]"]
["NCT01804686","['Janssen Research & Development, LLC']","[' Janssen Research & Development, LLC ']","https://clinicaltrials.gov/ct2/show/NCT01804686","['Janssen Research & Development, LLC']"]
["NCT01981720","['Protalix']","[' Protalix ']","https://clinicaltrials.gov/ct2/show/NCT01981720","['Protalix']"]
["NCT02012465","['Washington University School of Medicine']","[' Washington University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT02012465","['Washington University School of Medicine']"]
["NCT02090959","['PTC Therapeutics']","[' PTC Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT02090959","['PTC Therapeutics']"]
["NCT02214615","['VA Connecticut Healthcare System']","[' VA Connecticut Healthcare System ']","https://clinicaltrials.gov/ct2/show/NCT02214615","['VA Connecticut Healthcare System']"]
["NCT02299271","['Brian Vaughan, The Christ Hospital']","[' The Christ Hospital ']","https://clinicaltrials.gov/ct2/show/NCT02299271","['Brian Vaughan, Brian Vaughan, MD, The Christ Hospital']"]
["NCT02028338","['International Partnership for Microbicides, Inc.']","[' International Partnership for Microbicides, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02028338","['International Partnership for Microbicides, Inc.']"]
["NCT02051452","['Ken Solt, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT02051452","['Ken Solt, Associate Professor of Anesthesia, Massachusetts General Hospital']"]
["NCT00267865","['National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00267865","['National Cancer Institute (NCI)']"]
["NCT00338377","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00338377","['M.D. Anderson Cancer Center']"]
["NCT00418262","['Laura J McGuinn, MD, University of Oklahoma']","[' University of Oklahoma ']","https://clinicaltrials.gov/ct2/show/NCT00418262","['Laura J McGuinn, MD, Principal Investigator, University of Oklahoma']"]
["NCT00492778","['Gynecologic Oncology Group']","[' Gynecologic Oncology Group ']","https://clinicaltrials.gov/ct2/show/NCT00492778","['Gynecologic Oncology Group']"]
["NCT00549848","[\"St. Jude Children's Research Hospital\"]","[\" St. Jude Children's Research Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00549848","[\"St. Jude Children's Research Hospital\"]"]
["NCT00590187","['Cyclacel Pharmaceuticals, Inc.']","[' Cyclacel Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00590187","['Cyclacel Pharmaceuticals, Inc.']"]
["NCT00618397","['Cindy Darnell, University of Texas Southwestern Medical Center']","[' University of Texas Southwestern Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00618397","['Cindy Darnell, Assisant Professor Pediatrics, University of Texas Southwestern Medical Center']"]
["NCT00632853","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00632853","['Alliance for Clinical Trials in Oncology']"]
["NCT00691067","['Julia Golier, Bronx Veterans Medical Research Foundation, Inc']","[' Bronx Veterans Medical Research Foundation, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00691067","['Julia Golier, Clinical Director, Mental Health Patient Care Center, Bronx Veterans Medical Research Foundation, Inc']"]
["NCT00709735","['Roger K. Pitman, MD, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00709735","['Roger K. Pitman, MD, Principal Investigator, Massachusetts General Hospital']"]
["NCT00566241","['Thomas A. Wilson, Stony Brook University']","[' Stony Brook University ']","https://clinicaltrials.gov/ct2/show/NCT00566241","['Thomas A. Wilson, Professor of Pediatrics, Stony Brook University']"]
["NCT00569296","['Roger Williams Medical Center']","[' Roger Williams Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00569296","['Roger Williams Medical Center']"]
["NCT00572156","['Ipsen']","[' Ipsen ']","https://clinicaltrials.gov/ct2/show/NCT00572156","['Ipsen']"]
["NCT00577694","['UNC Lineberger Comprehensive Cancer Center']","[' UNC Lineberger Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00577694","['UNC Lineberger Comprehensive Cancer Center']"]
["NCT00585845","[]","[' Anza Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00585845","['Dung Thai, Anza Therapeutics, Inc.']"]
["NCT00590603","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00590603","['Duke University']"]
["NCT00596947","['Simin Goral, University of Pennsylvania']","[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT00596947","['Simin Goral, Director, Polycystic Kidney Disease Clinic, University of Pennsylvania']"]
["NCT00606879","[]","[' SGX Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00606879","['Terry Rugg, MD, SGX Pharmaceuticals, Inc.']"]
["NCT00611637","['H. Kim Lyerly, Duke University']","[' H. Kim Lyerly ']","https://clinicaltrials.gov/ct2/show/NCT00611637","['H. Kim Lyerly, Professor, Gen & Thor Surgery, Duke University']"]
["NCT00615524","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00615524","['GlaxoSmithKline']"]
["NCT00621556","[]","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00621556","['Dr. Dushyant Sahani, Massachusetts General Hospital']"]
["NCT00626561","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00626561","['M.D. Anderson Cancer Center']"]
["NCT00634010","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00634010","['M.D. Anderson Cancer Center']"]
["NCT00638196","['Andrew Goodman, University of Rochester']","[' University of Rochester ']","https://clinicaltrials.gov/ct2/show/NCT00638196","['Andrew Goodman, MD, University of Rochester']"]
["NCT00646659","['European Organisation for Research and Treatment of Cancer - EORTC']","[' European Organisation for Research and Treatment of Cancer - EORTC ']","https://clinicaltrials.gov/ct2/show/NCT00646659","['European Organisation for Research and Treatment of Cancer - EORTC']"]
["NCT00658008","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00658008","['Pfizer']"]
["NCT00664586","['Erimos Pharmaceuticals']","[' Erimos Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00664586","['Erimos Pharmaceuticals']"]
["NCT00668785","['J. Michael Jumper, MD, Jumper, J. Michael, M.D.']","[' Jumper, J. Michael, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00668785","['J. Michael Jumper, MD, Principal Investigator, Jumper, J. Michael, M.D.']"]
["NCT00669136","['Lisa H. Butterfield, Ph.D., University of Pittsburgh']","[' Lisa H. Butterfield, Ph.D. ']","https://clinicaltrials.gov/ct2/show/NCT00669136","['Lisa H. Butterfield, Ph.D., Professor of Medicine, Surgery and Immunology, University of Pittsburgh']"]
["NCT00673920","['Genentech, Inc.']","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00673920","['Genentech, Inc.']"]
["NCT00681811","['Shire']","[' Shire ']","https://clinicaltrials.gov/ct2/show/NCT00681811","['Shire']"]
["NCT00687674","['Mayo Clinic']","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00687674","['Mayo Clinic']"]
["NCT00698581","['UCB Pharma']","[' UCB Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00698581","['UCB Pharma']"]
["NCT00704847","['Nordic Bioscience A/S']","[' Nordic Bioscience A/S ']","https://clinicaltrials.gov/ct2/show/NCT00704847","['Nordic Bioscience A/S']"]
["NCT00712491","['Santen Inc.']","[' Santen Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00712491","['Santen Inc.']"]
["NCT00722800","['Alexandra Kimball, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00722800","['Alexandra Kimball, Principal Investigator, Massachusetts General Hospital']"]
["NCT00729300","['National Institute on Drug Abuse (NIDA)']","[' National Institute on Drug Abuse (NIDA) ']","https://clinicaltrials.gov/ct2/show/NCT00729300","['National Institute on Drug Abuse (NIDA)']"]
["NCT00732745","['Case Comprehensive Cancer Center']","[' Case Comprehensive Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00732745","['Case Comprehensive Cancer Center']"]
["NCT00741611","['C. R. Bard']","[' C. R. Bard ']","https://clinicaltrials.gov/ct2/show/NCT00741611","['C. R. Bard']"]
["NCT00748969","['Los Angeles Biomedical Research Institute']","[' Los Angeles Biomedical Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00748969","['Los Angeles Biomedical Research Institute']"]
["NCT00756912","['Eisai Inc.']","[' Eisai Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00756912","['Eisai Inc.']"]
["NCT00759993","['Thomas L. Schwartz, M.D., State University of New York - Upstate Medical University']","[' State University of New York - Upstate Medical University ']","https://clinicaltrials.gov/ct2/show/NCT00759993","['Thomas L. Schwartz, M.D., Assoc Professor, State University of New York - Upstate Medical University']"]
["NCT00770354","[]","[' Antisoma Research ']","https://clinicaltrials.gov/ct2/show/NCT00770354","['Gary Acton, Antisoma']"]
["NCT00770601","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00770601","['Novartis Pharmaceuticals']"]
["NCT00780676","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00780676","['M.D. Anderson Cancer Center']"]
["NCT00785798","['Francine Foss, Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT00785798","['Francine Foss, Principal Investigator, Yale University']"]
["NCT00794547","['University of Michigan Rogel Cancer Center']","[' University of Michigan Rogel Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00794547","['University of Michigan Rogel Cancer Center']"]
["NCT00801931","['Columbia University']","[' Columbia University ']","https://clinicaltrials.gov/ct2/show/NCT00801931","['Columbia University']"]
["NCT00807209","['Pacira Pharmaceuticals, Inc']","[' Pacira Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00807209","['Pacira Pharmaceuticals, Inc']"]
["NCT00811174","['Octapharma']","[' Octapharma ']","https://clinicaltrials.gov/ct2/show/NCT00811174","['Octapharma']"]
["NCT00816686","['Astellas Pharma Inc']","[' Astellas Pharma Inc ']","https://clinicaltrials.gov/ct2/show/NCT00816686","['Astellas Pharma Inc']"]
["NCT00823979","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00823979","['Pfizer']"]
["NCT00832338","['Elisavet Paplomata, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT00832338","['Elisavet Paplomata, Principal Investigator, Emory University']"]
["NCT00840294","['University of Chicago']","[' University of Chicago ']","https://clinicaltrials.gov/ct2/show/NCT00840294","['University of Chicago']"]
["NCT00846521","['Yale University']","[' Yale University ']","https://clinicaltrials.gov/ct2/show/NCT00846521","['Yale University']"]
["NCT00853229","['The Cleveland Clinic']","[' The Cleveland Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00853229","['The Cleveland Clinic']"]
["NCT00862563","['Dominic Ciraulo, Boston Medical Center']","[' Boston Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00862563","['Dominic Ciraulo, Department Chair, Psychiatry, Boston Medical Center']"]
["NCT00866723","['Panagiotis Konstantinopoulos, MD, PhD, Dana-Farber Cancer Institute']","[' Beth Israel Deaconess Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00866723","['Panagiotis Konstantinopoulos, MD, PhD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00877773","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00877773","['M.D. Anderson Cancer Center']"]
["NCT00878189","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00878189","['Pfizer']"]
["NCT00881608","['Repros Therapeutics Inc.']","[' Repros Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00881608","['Repros Therapeutics Inc.']"]
["NCT00893997","['M.D. Anderson Cancer Center']","[' M.D. Anderson Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00893997","['M.D. Anderson Cancer Center']"]
["NCT00900146","['Novartis']","[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00900146","['Novartis']"]
["NCT00909688","['Wyeth is now a wholly owned subsidiary of Pfizer']","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00909688","['Wyeth is now a wholly owned subsidiary of Pfizer']"]
["NCT00924781","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00924781","['Merck Sharp & Dohme Corp.']"]
["NCT00927953","['MacroGenics']","[' MacroGenics ']","https://clinicaltrials.gov/ct2/show/NCT00927953","['MacroGenics']"]
["NCT00938236","['APT Pharmaceuticals, Inc.']","[' APT Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00938236","['APT Pharmaceuticals, Inc.']"]
["NCT00947167","['Pamela L. Kunz, Stanford University']","[' Pamela L. Kunz ']","https://clinicaltrials.gov/ct2/show/NCT00947167","['Pamela L. Kunz, Assistant Professor, Stanford University']"]
["NCT00951379","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00951379","['National Cancer Institute (NCI)']"]
["NCT00953329","['John Murray, Duke University']","[' John Murray ']","https://clinicaltrials.gov/ct2/show/NCT00953329","['John Murray, Professor of Dermatology, Duke University']"]
["NCT00953459","['European Organisation for Research and Treatment of Cancer - EORTC']","[' European Organisation for Research and Treatment of Cancer - EORTC ']","https://clinicaltrials.gov/ct2/show/NCT00953459","['European Organisation for Research and Treatment of Cancer - EORTC']"]
["NCT00953576","['Glenn Bubley, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00953576","['Glenn Bubley, MD, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00953615","[]","[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00953615","['Dr. K. Lindor, Mayo Clinic']"]
["NCT00953706","['Vertex Pharmaceuticals Incorporated']","[' Vertex Pharmaceuticals Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT00953706","['Vertex Pharmaceuticals Incorporated']"]
["NCT00954512","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00954512","['Merck Sharp & Dohme Corp.']"]
["NCT00954915","['MacroGenics']","[' MacroGenics ']","https://clinicaltrials.gov/ct2/show/NCT00954915","['MacroGenics']"]
["NCT00954993","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00954993","['Merck Sharp & Dohme Corp.']"]
["NCT00955097","['Robert C. Martin, University of Louisville']","[' University of Louisville ']","https://clinicaltrials.gov/ct2/show/NCT00955097","['Robert C. Martin, MD, University of Louisville']"]
["NCT00955266","[\"Michael Nurok, MD, PhD, Brigham and Women's Hospital\"]","[\" Brigham and Women's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00955266","[\"Michael Nurok, MD, PhD, Cardiac Anesthesiologist, Brigham and Women's Hospital\"]"]
["NCT00955305","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00955305","['National Cancer Institute (NCI)']"]
["NCT00955474","['John D. Matthews, Massachusetts General Hospital']","[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00955474","['John D. Matthews, Director of Inpatient Research & Training, Massachusetts General Hospital']"]
["NCT00956072","['European Organisation for Research and Treatment of Cancer - EORTC']","[' European Organisation for Research and Treatment of Cancer - EORTC ']","https://clinicaltrials.gov/ct2/show/NCT00956072","['European Organisation for Research and Treatment of Cancer - EORTC']"]
["NCT00956293","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00956293","['Novartis Pharmaceuticals']"]
["NCT00957034","['Warner Chilcott']","[' Warner Chilcott ']","https://clinicaltrials.gov/ct2/show/NCT00957034","['Warner Chilcott']"]
["NCT00957242","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00957242","['Duke University']"]
["NCT00957346","['Gynuity Health Projects']","[' Gynuity Health Projects ']","https://clinicaltrials.gov/ct2/show/NCT00957346","['Gynuity Health Projects']"]
["NCT00957580","['EMD Serono']","[' EMD Serono ']","https://clinicaltrials.gov/ct2/show/NCT00957580","['EMD Serono']"]
["NCT00957931","['Sandhya Kharbanda, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT00957931","['Sandhya Kharbanda, Principle Investigator, Stanford University']"]
["NCT00958022","['Ahmad Tarhini, University of Pittsburgh']","[' Ahmad Tarhini ']","https://clinicaltrials.gov/ct2/show/NCT00958022","['Ahmad Tarhini, Associate Professor of Medicine, University of Pittsburgh']"]
["NCT00958074","['Andrei Shustov, University of Washington']","[' University of Washington ']","https://clinicaltrials.gov/ct2/show/NCT00958074","['Andrei Shustov, Principal Investigator, University of Washington']"]
["NCT00958412","['Repros Therapeutics Inc.']","[' Repros Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00958412","['Repros Therapeutics Inc.']"]
["NCT00958841","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00958841","['Novartis Pharmaceuticals']"]
["NCT00958893","['Repros Therapeutics Inc.']","[' Repros Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00958893","['Repros Therapeutics Inc.']"]
["NCT00959946","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00959946","['Pfizer']"]
["NCT00960063","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00960063","['Merck Sharp & Dohme Corp.']"]
["NCT00960297","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00960297","['SCRI Development Innovations, LLC']"]
["NCT00960531","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00960531","['Pfizer']"]
["NCT00960804","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00960804","['Pfizer']"]
["NCT00961207","['Pete Antonopoulos, John H. Stroger Hospital']","[' John H. Stroger Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00961207","['Pete Antonopoulos, Clinical Pharmacist, John H. Stroger Hospital']"]
["NCT00961376","['Providence Health & Services']","[' Providence Health & Services ']","https://clinicaltrials.gov/ct2/show/NCT00961376","['Providence Health & Services']"]
["NCT00961571","['Ruth He, Georgetown University']","[' Georgetown University ']","https://clinicaltrials.gov/ct2/show/NCT00961571","['Ruth He, Assistant Professor, Georgetown University']"]
["NCT00961649","['Alcon Research']","[' Alcon Research ']","https://clinicaltrials.gov/ct2/show/NCT00961649","['Alcon Research']"]
["NCT00961753","['James Hocker, OSF Healthcare System']","[' OSF Healthcare System ']","https://clinicaltrials.gov/ct2/show/NCT00961753","['James Hocker, M.D., OSF Healthcare System']"]
["NCT00963872","['Masonic Cancer Center, University of Minnesota']","[' Masonic Cancer Center, University of Minnesota ']","https://clinicaltrials.gov/ct2/show/NCT00963872","['Masonic Cancer Center, University of Minnesota']"]
["NCT00964834","[]","[' PharmAthene, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00964834","['Valerie Riddle, M.D., Vice President and Medical Director, PharmAthene, Inc.']"]
["NCT00964990","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00964990","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00965055","['Ori Ben-Yehuda, University of California, San Diego']","[' University of California, San Diego ']","https://clinicaltrials.gov/ct2/show/NCT00965055","['Ori Ben-Yehuda, Professor of Medicine, University of California, San Diego']"]
["NCT00965419","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00965419","['Eli Lilly and Company']"]
["NCT00965458","['National Institute of Allergy and Infectious Diseases (NIAID)']","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","https://clinicaltrials.gov/ct2/show/NCT00965458","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00966992","['Washington University School of Medicine']","[' Washington University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00966992","['Washington University School of Medicine']"]
["NCT00967226","[\"Nancy Bauman, Children's Research Institute\"]","[' Nancy Bauman ']","https://clinicaltrials.gov/ct2/show/NCT00967226","[\"Nancy Bauman, Professor, George Washington University, Attending Children;s National, Children's Research Institute\"]"]
["NCT00967343","['Kiadis Pharma']","[' Kiadis Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00967343","['Kiadis Pharma']"]
["NCT00968617","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00968617","['Merck Sharp & Dohme Corp.']"]
["NCT00969722","['United Therapeutics']","[' United Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00969722","['United Therapeutics']"]
["NCT00970424","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00970424","['Forest Laboratories']"]
["NCT00971191","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00971191","['Pfizer']"]
["NCT00972023","['Barbara Ann Karmanos Cancer Institute']","[' Barbara Ann Karmanos Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00972023","['Barbara Ann Karmanos Cancer Institute']"]
["NCT00972335","['SCRI Development Innovations, LLC']","[' SCRI Development Innovations, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00972335","['SCRI Development Innovations, LLC']"]
["NCT00973024","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00973024","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00973141","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00973141","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00974818","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00974818","['Memorial Sloan Kettering Cancer Center']"]
["NCT00974922","['William B. White, UConn Health']","[' UConn Health ']","https://clinicaltrials.gov/ct2/show/NCT00974922","['William B. White, Professor of Medicine, UConn Health']"]
["NCT00975416","['National Institutes of Health Clinical Center (CC) ( National Institute on Drug Abuse (NIDA) )']","[' National Institute on Drug Abuse (NIDA) ']","https://clinicaltrials.gov/ct2/show/NCT00975416","['National Institute on Drug Abuse (NIDA)']"]
["NCT00975611","['David C. Henderson, MD, North Suffolk Mental Health Association']","[' David C. Henderson, MD ']","https://clinicaltrials.gov/ct2/show/NCT00975611","['David C. Henderson, MD, Associate Professor, North Suffolk Mental Health Association']"]
["NCT00975767","['Mirati Therapeutics Inc.']","[' Mirati Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00975767","['Mirati Therapeutics Inc.']"]
["NCT00975806","['Celgene']","[' Celgene ']","https://clinicaltrials.gov/ct2/show/NCT00975806","['Celgene']"]
["NCT00976027","['Sanofi']","[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00976027","['Sanofi']"]
["NCT00976183","['Gynecologic Oncology Associates']","[' Gynecologic Oncology Associates ']","https://clinicaltrials.gov/ct2/show/NCT00976183","['Gynecologic Oncology Associates']"]
["NCT00976508","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00976508","['Pfizer']"]
["NCT00976534","[]","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00976534","['AstraZeneca Pharmaceuticals, AstraZeneca']"]
["NCT00976677","['National Cancer Institute (NCI)']","[' National Cancer Institute (NCI) ']","https://clinicaltrials.gov/ct2/show/NCT00976677","['National Cancer Institute (NCI)']"]
["NCT00977171","['Chelsea Therapeutics']","[' Chelsea Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00977171","['Chelsea Therapeutics']"]
["NCT00977522","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00977522","['Pfizer']"]
["NCT00977561","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00977561","['Pfizer']"]
["NCT00978432","['Anne Beaven, MD, Duke University']","[' Anne Beaven, MD ']","https://clinicaltrials.gov/ct2/show/NCT00978432","['Anne Beaven, MD, Assistant Professor of Medicine, Duke University']"]
["NCT00979004","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00979004","['Pfizer']"]
["NCT00979121","['National Heart, Lung, and Blood Institute (NHLBI)']","[' National Heart, Lung, and Blood Institute (NHLBI) ']","https://clinicaltrials.gov/ct2/show/NCT00979121","['National Heart, Lung, and Blood Institute (NHLBI)']"]
["NCT00980681","['Guerbet']","[' Guerbet ']","https://clinicaltrials.gov/ct2/show/NCT00980681","['Guerbet']"]
["NCT00981318","['Barry M. Rodwick, M. D., Rodwick, Barry M., M.D.']","[' Rodwick, Barry M., M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00981318","['Barry M. Rodwick, M. D., Principal Investigator, Rodwick, Barry M., M.D.']"]
["NCT00982657","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00982657","['Pfizer']"]
["NCT00982696","['David Goldenberg, Milton S. Hershey Medical Center']","[' Milton S. Hershey Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00982696","['David Goldenberg, Associate Professor of Medicine and Surgery, Milton S. Hershey Medical Center']"]
["NCT00982995","['University of Michigan Rogel Cancer Center']","[' University of Michigan Rogel Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00982995","['University of Michigan Rogel Cancer Center']"]
["NCT00983346","['University of Utah']","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT00983346","['University of Utah']"]
["NCT00983437","['Teva Pharmaceutical Industries ( Cephalon )']","[' Cephalon ']","https://clinicaltrials.gov/ct2/show/NCT00983437","['Cephalon']"]
["NCT00983541","['University of Utah']","[' University of Utah ']","https://clinicaltrials.gov/ct2/show/NCT00983541","['University of Utah']"]
["NCT00984113","[]","[' Portola Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00984113","['Matthew W. McClure, MD, Portola Pharmaceuticals, Inc.']"]
["NCT00985374","['Hoffmann-La Roche']","[' Hoffmann-La Roche ']","https://clinicaltrials.gov/ct2/show/NCT00985374","['Hoffmann-La Roche']"]
["NCT00985621","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00985621","['Pfizer']"]
["NCT00985738","['University of Colorado, Denver']","[' University of Colorado, Denver ']","https://clinicaltrials.gov/ct2/show/NCT00985738","['University of Colorado, Denver']"]
["NCT00986960","['Robert Zivadinov, MD, PhD, University at Buffalo']","[' University at Buffalo ']","https://clinicaltrials.gov/ct2/show/NCT00986960","['Robert Zivadinov, MD, PhD, Director, Buffalo Neuroimaging Analysis Center, Professor, University at Buffalo']"]
["NCT00986999","['University of Hawaii']","[' University of Hawaii ']","https://clinicaltrials.gov/ct2/show/NCT00986999","['University of Hawaii']"]
["NCT00987545","['Novartis ( Novartis Pharmaceuticals )']","[' Novartis Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00987545","['Novartis Pharmaceuticals']"]
["NCT00988169","['Memorial Sloan Kettering Cancer Center']","[' Memorial Sloan Kettering Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00988169","['Memorial Sloan Kettering Cancer Center']"]
["NCT00990327","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00990327","['Forest Laboratories']"]
["NCT00990496","['Milton S. Hershey Medical Center']","[' Milton S. Hershey Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00990496","['Milton S. Hershey Medical Center']"]
["NCT00990509","['Chelsea Kidwell, M.D., Georgetown University']","[' Georgetown University ']","https://clinicaltrials.gov/ct2/show/NCT00990509","['Chelsea Kidwell, M.D., Professor of Neurology; Medical Director, Georgetown University Stroke Center, Georgetown University']"]
["NCT00990795","[]","[' The University of Texas Health Science Center, Houston ']","https://clinicaltrials.gov/ct2/show/NCT00990795","['Jon-Cecil Walkes, MD, University of Texas Medical School Houston']"]
["NCT00991939","['New England Research Institutes']","[' New England Research Institutes ']","https://clinicaltrials.gov/ct2/show/NCT00991939","['New England Research Institutes']"]
["NCT00992732","[]","[' HemaQuest Pharmaceuticals Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00992732","['Patrick Bobbitt, Vice President, Development, HemaQuest Pharmaceuticals, Inc.']"]
["NCT00993018","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","https://clinicaltrials.gov/ct2/show/NCT00993018","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00711997","[u'Anchiano Therapeutics Israel Ltd.']","[u'Anchiano Therapeutics Israel Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00711997","Anchiano Therapeutics Israel Ltd. "]
["NCT00750282","[u'Life Molecular Imaging SA']","[u'Life Molecular Imaging SA']","https://clinicaltrials.gov/ct2/show/NCT00750282","Life Molecular Imaging SA "]
["NCT00803569","[u'Ludwig Institute for Cancer Research']","[u'Ludwig Institute for Cancer Research']","https://clinicaltrials.gov/ct2/show/NCT00803569","Ludwig Institute for Cancer Research "]
["NCT00867100","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00867100","Valeant Pharmaceuticals International, Inc. "]
["NCT00928304","[u'Life Molecular Imaging SA']","[u'Life Molecular Imaging SA']","https://clinicaltrials.gov/ct2/show/NCT00928304","Life Molecular Imaging SA "]
["NCT00935987","[u'Sierra Oncology, Inc.']","[u'Sierra Oncology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00935987","Sierra Oncology, Inc. "]
["NCT01020838","[u'Life Molecular Imaging SA']","[u'Life Molecular Imaging SA']","https://clinicaltrials.gov/ct2/show/NCT01020838","Life Molecular Imaging SA "]
["NCT01186601","[u'Life Molecular Imaging SA']","[u'Life Molecular Imaging SA']","https://clinicaltrials.gov/ct2/show/NCT01186601","Life Molecular Imaging SA "]
["NCT01236638","[u'Sierra Oncology, Inc.']","[u'Sierra Oncology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01236638","Sierra Oncology, Inc. "]
["NCT01252186","[u\"Teva Pharmaceutical Industries ( Teva Women's Health )\"]","[u\"Teva Women's Health\"]","https://clinicaltrials.gov/ct2/show/NCT01252186","Teva Women's Health "]
["NCT01287845","[u'Life Molecular Imaging SA']","[u'Life Molecular Imaging SA']","https://clinicaltrials.gov/ct2/show/NCT01287845","Life Molecular Imaging SA "]
["NCT01360996","[u\"Karen Elkind-Hirsch, Woman's\"]","[u\"Woman's\"]","https://clinicaltrials.gov/ct2/show/NCT01360996","Karen Elkind-Hirsch, Scientific Director of Research, Woman's "]
["NCT01423058","[u'Sierra Oncology, Inc.']","[u'Sierra Oncology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT01423058","Sierra Oncology, Inc. "]
["NCT01903798","[u'Timothy Morgan, MD, Southern California Institute for Research and Education']","[u'Southern California Institute for Research and Education']","https://clinicaltrials.gov/ct2/show/NCT01903798","Timothy Morgan, MD, Chief, Hepatology, Southern California Institute for Research and Education "]
["NCT00115778",null,"[' Arcasoy, Selim, M.D. ']","https://clinicaltrials.gov/ct2/show/NCT00115778","Selim Arcasoy, MD, Columbia Unversity "]
["NCT00175123",null,"[' University of Aarhus ']","https://clinicaltrials.gov/ct2/show/NCT00175123","Bettina Jorgensen, MD, Aarhus University "]
["NCT00237068",null,"[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT00237068","Benjamin Gold, MD, Emory University "]
["NCT00577577",null,"[' Insmed Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT00577577","Christy ONeal, Study Manager, Insmed Incorporated "]
["NCT00879489",null,"[' Quantum Immunologics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00879489","Charles Broes, CEO, Quantum Immunologics, Inc. "]
["NCT00106431",null,"[' Celgene Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00106431","Jean Nichols, Ph.D., Gloucester Pharmaceuticals, Inc. "]
["NCT00132496",null,"[' Eisai Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00132496","Yufang Lu, Study Director, Eisai Medical Research Inc. "]
["NCT00157703",null,"[' MediGene ']","https://clinicaltrials.gov/ct2/show/NCT00157703","Alice Chen, MediGene "]
["NCT00161291",null,"[' University of Alabama at Birmingham ']","https://clinicaltrials.gov/ct2/show/NCT00161291","Andres Forero, M.D., UAB "]
["NCT00162045",null,"[' Lantheus Medical Imaging ']","https://clinicaltrials.gov/ct2/show/NCT00162045","Qi Zhu, MD Senior Medical Director, Lantheus Medical Imaging "]
["NCT00170053",null,"[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00170053","Thomas A. Gonwa, MD, Mayo Clinic "]
["NCT00229203",null,"[' PharmaMar ']","https://clinicaltrials.gov/ct2/show/NCT00229203","PharmaMar USA Inc. "]
["NCT00275431",null,"[' Ascenta Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00275431","Lance Leopold, Ascenta Therapeutics, Inc. "]
["NCT00288509",null,"[' Ipsen ']","https://clinicaltrials.gov/ct2/show/NCT00288509","Jean-Loic Robin, Ipsen "]
["NCT00296400",null,"[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00296400","MSD, AstraZeneca "]
["NCT00306618",null,"[' CASI Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00306618","Chief Medical Officer, EntreMed, Inc. "]
["NCT00347971",null,"[' ZymoGenetics ']","https://clinicaltrials.gov/ct2/show/NCT00347971","Muriel Siadak, ZymoGenetics "]
["NCT00352131",null,"[' ImmunoGen, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00352131","Clinical Operations, ImmunoGen, Inc. "]
["NCT00361101",null,"[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00361101","Medical Monitor, Genzyme "]
["NCT00363337",null,"[' Lindner Center of HOPE ']","https://clinicaltrials.gov/ct2/show/NCT00363337","Susan McElroy, Lindner Center of HOPE "]
["NCT00376324",null,"[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00376324","Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth "]
["NCT00384449",null,"[' Oregon Health and Science University ']","https://clinicaltrials.gov/ct2/show/NCT00384449","Christina J. Flaxel, MD, Oregon Health & Science University "]
["NCT00389285",null,"[' ZymoGenetics ']","https://clinicaltrials.gov/ct2/show/NCT00389285","Naomi Hunder, Medical Monitor, ZymoGenetics, Inc. "]
["NCT00400348",null,"[' CASI Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00400348","Chief Medical Officer, EntreMed, Inc. "]
["NCT00401687",null,"[' Lantheus Medical Imaging ']","https://clinicaltrials.gov/ct2/show/NCT00401687","Veronica Lee, MD, Lantheus Medical Imaging "]
["NCT00421642",null,"[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00421642","William Sandborn, Mayo Clinic "]
["NCT00421811",null,"[' Adherex Technologies, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00421811","Clinical Study Manager, Adherex Technologies, Inc. "]
["NCT00434629",null,"[' University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT00434629","Stephen J. Schuster, MD, University of Pennsylvania "]
["NCT00434746",null,"[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00434746","Wyeth (Registry Contact: Clinical Trial Registry Specialist, Wyeth "]
["NCT00443079",null,"[' University of California, San Diego ']","https://clinicaltrials.gov/ct2/show/NCT00443079","Heather Patton, MD, UCSD Medical Center "]
["NCT00454090",null,"[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00454090","MSD, AstraZeneca "]
["NCT00455715",null,"[' Massachusetts General Hospital ']","https://clinicaltrials.gov/ct2/show/NCT00455715","Donald Goff, MD, Massachusetts General Hospital "]
["NCT00467922",null,"[' Spectrum Health Hospitals ']","https://clinicaltrials.gov/ct2/show/NCT00467922","Dr. Anthony Senagore, Spectrum Health "]
["NCT00467935",null,"[' Retina Research Foundation ']","https://clinicaltrials.gov/ct2/show/NCT00467935","Paul Beer, MD, Retina Consultants, PLLC "]
["NCT00473928",null,"[' Potentia Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00473928","Clinical Research Director, Potentia Pharmaceuticals "]
["NCT00500539",null,"[' Novartis ']","https://clinicaltrials.gov/ct2/show/NCT00500539","external affairs, Novartis "]
["NCT00500721",null,"[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00500721","Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth "]
["NCT00517348",null,"[' Wyeth is now a wholly owned subsidiary of Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00517348","Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth "]
["NCT00525824",null,"[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00525824","Michael Cressman - Medical Science Director, AstraZeneca "]
["NCT00536016",null,"[' Jerini Ophthalmic ']","https://clinicaltrials.gov/ct2/show/NCT00536016","Jerini Ophthalmic "]
["NCT00538876",null,"[' Weill Medical College of Cornell University ']","https://clinicaltrials.gov/ct2/show/NCT00538876","Joseph Scandura, MD, Weill Cornell Medical College "]
["NCT00565539",null,"[' ZymoGenetics ']","https://clinicaltrials.gov/ct2/show/NCT00565539","Sherri Souza, Clinical Trial Manager, ZymoGenetics "]
["NCT00588393",null,"[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00588393","Eric L. Matteson, M.D., M.P. H., Mayo Clinic "]
["NCT00606749",null,"[' Kemia, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00606749","Michael R Hodges, MD, Kemia,Inc "]
["NCT00642655",null,"[' Cedars-Sinai Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00642655","Stanley C. Jordan, MD, Cedars-Sinai Medical Center "]
["NCT00651638",null,"[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT00651638","ArQule, Inc. "]
["NCT00667641",null,"[' University of Medicine and Dentistry of New Jersey ']","https://clinicaltrials.gov/ct2/show/NCT00667641","Vassiliki Karantza-Wadsworth, MD, PhD, UMDNJ/CINJ "]
["NCT00671710",null,"[' Advocate Hospital System ']","https://clinicaltrials.gov/ct2/show/NCT00671710","John Ruge, M.D., Advocate Lutheran General Hospital "]
["NCT00674791",null,"[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT00674791","Ramila Philip, Ph.D., Immunotope, Inc. "]
["NCT00736775",null,"[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00736775","Disclosures Group, Genentech, Inc. "]
["NCT00842400",null,"[' VIVUS, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00842400","Wesley Day, VP Clinical, Vivus, Inc. "]
["NCT00858156",null,"[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT00858156","Biogen Idec, Medical Director, Biogen Idec, Inc "]
["NCT00889161",null,"[\" Seattle Children's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00889161","David Suskind, MD, Seattle Children's Hospital "]
["NCT00905242",null,"[' East Carolina University ']","https://clinicaltrials.gov/ct2/show/NCT00905242","Paul Bolin, MD, East Carolina University "]
["NCT00945529",null,"[\" Nemours Children's Clinic \"]","https://clinicaltrials.gov/ct2/show/NCT00945529","Ellen Spurrier, MD, Nemours "]
["NCT01021540",null,"[' Arizona Kidney Disease and Hypertension Center ']","https://clinicaltrials.gov/ct2/show/NCT01021540","Sungchun Lee, MD, AKDHC "]
["NCT01069926",null,"[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01069926","MSD, AstraZeneca "]
["NCT01079351",null,"[' Lundbeck LLC ']","https://clinicaltrials.gov/ct2/show/NCT01079351","Lundbeck Inc. "]
["NCT01142856",null,"[' Mayo Clinic ']","https://clinicaltrials.gov/ct2/show/NCT01142856","Anthony J. Windebank, M.D., Mayo Clinic "]
["NCT01196247",null,"[' Translational Drug Development ']","https://clinicaltrials.gov/ct2/show/NCT01196247","Ramesh Ramanathan, MD, TGen "]
["NCT01209533",null,"[' Vanderbilt University ']","https://clinicaltrials.gov/ct2/show/NCT01209533","J.R. Sheller, M.D., Vanderbilt University "]
["NCT00448955",null,"[' Ardana Bioscience Ltd ']","https://clinicaltrials.gov/ct2/show/NCT00448955","Ardana Bioscience Ltd. "]
["NCT00674947",null,"[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT00674947","Julie Morrissey, Quintiles, Inc. "]
["NCT01420458",null,"[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT01420458","Medical Director, Biogen Idec "]
["NCT00281502",null,"[' Weill Medical College of Cornell University ']","https://clinicaltrials.gov/ct2/show/NCT00281502","Sam Sigal, Weill Medical College of Cornell University "]
["NCT00399243",null,"[' Diamond Headache Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00399243","Frederick Freitag, D.O., Diamond Headache Clinic "]
["NCT00624429",null,"[\" Phoenix Children's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00624429","Peggy Radford MD, Phoenix Children's Hospital "]
["NCT00751153",null,"[' Peter J. Ruane, M.D., Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00751153","Peter J Ruane, Peter J Ruane MD Inc "]
["NCT00752154",null,"[' University of California, Los Angeles ']","https://clinicaltrials.gov/ct2/show/NCT00752154","Dinesh Khanna, M.D., MS - Principal Investigator, UCLA "]
["NCT00805636",null,"[' Aposense Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT00805636","Miri Ben-Ami, MD, Aposense "]
["NCT00826527",null,"[' Seattle Urology Research Center ']","https://clinicaltrials.gov/ct2/show/NCT00826527","Jeffrey M. Frankel, MD, Seattle Urology Research Center "]
["NCT01345448",null,"[' Nanduri, Padma, M.D., FACS ']","https://clinicaltrials.gov/ct2/show/NCT01345448","Padma Nanduri, M.D., F.A.C.S. "]
["NCT00264472",null,"[' Adherex Technologies, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00264472","Clinical Study Manager, Adherex Technoloogies "]
["NCT00443573",null,"[' ARCA Biopharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00443573","Ted Love, MD, Nuvelo, Inc. "]
["NCT00909558",null,"[' Envita Medical Center, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00909558","Santo Prato, N.M. / President, Envita Medical Center, Inc. "]
["NCT00947193",null,"[' PTC Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00947193","Peter Riebling, PTC Therapeutics "]
["NCT00311246",null,"[' University of Chicago ']","https://clinicaltrials.gov/ct2/show/NCT00311246","Nadera Sweiss, MD, The University of Chicago "]
["NCT00315601",null,"[' University of Illinois at Chicago ']","https://clinicaltrials.gov/ct2/show/NCT00315601","University of Illinois at Chicago "]
["NCT00376103",null,"[' Methodist Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT00376103","Allen Sills, MD, Methodist Healthcare "]
["NCT00387153",null,"[' Myriad Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00387153","Richard Wenstrup, Myriad Therapeutics, Inc. "]
["NCT00494611",null,"[\" St. Luke's-Roosevelt Hospital Center \"]","https://clinicaltrials.gov/ct2/show/NCT00494611","Dr. Richard Whelan, St Luke's Roosevelt Medical Center "]
["NCT00543972",null,"[' Sanofi ']","https://clinicaltrials.gov/ct2/show/NCT00543972","ICD Study Director, sanofi-aventis "]
["NCT00548938",null,"[' Methodist Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT00548938","Allen Sills, MD, Methodist Healthcare "]
["NCT00577356",null,"[' Benaroya Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00577356","Jacqueline Vuky, MD, Virginia Mason Medical Center "]
["NCT00702819",null,"[' Vision Research Foundation ']","https://clinicaltrials.gov/ct2/show/NCT00702819","Michael T. Trese, MD, Vision Research Foundation "]
["NCT00735267",null,"[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00735267","Director, Clinical Trial Disclosure Group, Pfizer, Inc. "]
["NCT00490269",null,"[' National Institute on Drug Abuse (NIDA) ']","https://clinicaltrials.gov/ct2/show/NCT00490269",", NIDA Project Officer, National Institute on Drug Abuse (NIDA) "]
["NCT00104923","['California Cancer Consortium']","[' California Cancer Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00104923","California Cancer Consortium "]
["NCT00263341","['Population Council']","[' Population Council ']","https://clinicaltrials.gov/ct2/show/NCT00263341","Population Council "]
["NCT00409383","['Genta Incorporated']","[' Genta Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT00409383","Genta Incorporated "]
["NCT00449657","['Leo W. Jenkins Cancer Center']","[' Leo W. Jenkins Cancer Center ']","https://clinicaltrials.gov/ct2/show/NCT00449657","Leo W. Jenkins Cancer Center "]
["NCT00542451","['Eric Winer, MD, Dana-Farber Cancer Institute']","[' Eric Winer, MD ']","https://clinicaltrials.gov/ct2/show/NCT00542451","Eric Winer, MD, Principal Investigator, Dana-Farber Cancer Institute "]
["NCT00576680","['Jennifer Chan, MD, MPH, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00576680","Jennifer Chan, MD, MPH, Principal Investigator, Dana-Farber Cancer Institute "]
["NCT01003912","['Joanne Kurtzberg, MD, Duke University']","[' Joanne Kurtzberg, MD ']","https://clinicaltrials.gov/ct2/show/NCT01003912","Joanne Kurtzberg, MD, Professor of Pediatrics, Duke University "]
["NCT01095120","['Genta Incorporated']","[' Genta Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01095120","Genta Incorporated "]
["NCT01132014","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01132014","Abramson Cancer Center of the University of Pennsylvania "]
["NCT01191697","['Peter C. Enzinger, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT01191697","Peter C. Enzinger, MD, Principal Investigator, Dana-Farber Cancer Institute "]
["NCT01372111","['Coastal Carolina Radiation Oncology']","[' Coastal Carolina Radiation Oncology ']","https://clinicaltrials.gov/ct2/show/NCT01372111","Coastal Carolina Radiation Oncology "]
["NCT01426074","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT01426074","Abramson Cancer Center of the University of Pennsylvania "]
["NCT00818831","['Quintessence Biosciences, Inc.']","[' Quintessence Biosciences, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00818831","Quintessence Biosciences, Inc. "]
["NCT00852709","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT00852709","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins "]
["NCT01473095","['ArQule']","[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT01473095","ArQule "]
["NCT00109135","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00109135","Merck Sharp & Dohme Corp. "]
["NCT00111891","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00111891","Merck Sharp & Dohme Corp. "]
["NCT00117975","['Alliance for Clinical Trials in Oncology']","[' Alliance for Clinical Trials in Oncology ']","https://clinicaltrials.gov/ct2/show/NCT00117975","Alliance for Clinical Trials in Oncology "]
["NCT00123903","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00123903","GlaxoSmithKline "]
["NCT00125749","['Baylor Research Institute']","[' Baylor Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00125749","Baylor Research Institute "]
["NCT00131430","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00131430","Merck Sharp & Dohme Corp. "]
["NCT00188617","['University Health Network, Toronto']","[' University Health Network, Toronto ']","https://clinicaltrials.gov/ct2/show/NCT00188617","University Health Network, Toronto "]
["NCT00196989","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00196989","GlaxoSmithKline "]
["NCT00243347","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT00243347","AstraZeneca "]
["NCT00243854","['Indiana University ( Indiana University School of Medicine )']","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00243854","Indiana University School of Medicine "]
["NCT00244725","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00244725","GlaxoSmithKline "]
["NCT00250822","['New Mexico Cancer Care Alliance']","[' New Mexico Cancer Care Alliance ']","https://clinicaltrials.gov/ct2/show/NCT00250822","New Mexico Cancer Care Alliance "]
["NCT00259870","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00259870","GlaxoSmithKline "]
["NCT00265655","['Agennix']","[' Agennix ']","https://clinicaltrials.gov/ct2/show/NCT00265655","Agennix "]
["NCT00265876","['Canadian Cancer Trials Group ( NCIC Clinical Trials Group )']","[' NCIC Clinical Trials Group ']","https://clinicaltrials.gov/ct2/show/NCT00265876","NCIC Clinical Trials Group "]
["NCT00269204","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00269204","Merck Sharp & Dohme Corp. "]
["NCT00269217","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00269217","Merck Sharp & Dohme Corp. "]
["NCT00277914","['Sprout Pharmaceuticals, Inc']","[' Sprout Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00277914","Sprout Pharmaceuticals, Inc "]
["NCT00289549","['BioCryst Pharmaceuticals']","[' BioCryst Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00289549","BioCryst Pharmaceuticals "]
["NCT00291356","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00291356","GlaxoSmithKline "]
["NCT00291772","['Sponsored Programs, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00291772","Sponsored Programs, Principal Investigator, Baylor College of Medicine "]
["NCT00296530","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00296530","GlaxoSmithKline "]
["NCT00306293","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00306293","GlaxoSmithKline "]
["NCT00313079","['Steven E. Coutre, Stanford University']","[' Steven E. Coutre ']","https://clinicaltrials.gov/ct2/show/NCT00313079","Steven E. Coutre, Associate Professor of Medicine, Stanford University "]
["NCT00314873","['Indiana University ( Indiana University School of Medicine )']","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00314873","Indiana University School of Medicine "]
["NCT00317798","['JJ Ifthikharuddin, University of Rochester']","[' University of Rochester ']","https://clinicaltrials.gov/ct2/show/NCT00317798","JJ Ifthikharuddin, Principal Investigator, University of Rochester "]
["NCT00329368","['Endocyte']","[' Endocyte ']","https://clinicaltrials.gov/ct2/show/NCT00329368","Endocyte "]
["NCT00330395","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00330395","Merck Sharp & Dohme Corp. "]
["NCT00346775","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00346775","GlaxoSmithKline "]
["NCT00353457","['Abramson Cancer Center of the University of Pennsylvania']","[' Abramson Cancer Center of the University of Pennsylvania ']","https://clinicaltrials.gov/ct2/show/NCT00353457","Abramson Cancer Center of the University of Pennsylvania "]
["NCT00357253","['Pediatric Brain Tumor Consortium']","[' Pediatric Brain Tumor Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00357253","Pediatric Brain Tumor Consortium "]
["NCT00358358","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00358358","GlaxoSmithKline "]
["NCT00359281","['Aegerion Pharmaceuticals, Inc.']","[' Aegerion Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00359281","Aegerion Pharmaceuticals, Inc. "]
["NCT00361842","['Jazz Pharmaceuticals']","[' Jazz Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00361842","Jazz Pharmaceuticals "]
["NCT00364923","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00364923","Spectrum Pharmaceuticals, Inc "]
["NCT00366600","['Puma Biotechnology, Inc.']","[' Puma Biotechnology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00366600","Puma Biotechnology, Inc. "]
["NCT00368576","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00368576","GlaxoSmithKline "]
["NCT00369889","['Indiana University ( Indiana University School of Medicine )']","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00369889","Indiana University School of Medicine "]
["NCT00376038","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00376038","GlaxoSmithKline "]
["NCT00377585","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00377585","GlaxoSmithKline "]
["NCT00378833","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00378833","Merck Sharp & Dohme Corp. "]
["NCT00382733","['Accelerated Community Oncology Research Network']","[' Accelerated Community Oncology Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00382733","Accelerated Community Oncology Research Network "]
["NCT00382824","['Lahey Clinic']","[' Lahey Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00382824","Lahey Clinic "]
["NCT00387504","['California Cancer Consortium']","[' California Cancer Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00387504","California Cancer Consortium "]
["NCT00390156","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00390156","University of California, San Francisco "]
["NCT00393497","['Indiana University ( Indiana University School of Medicine )']","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00393497","Indiana University School of Medicine "]
["NCT00394836","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00394836","GlaxoSmithKline "]
["NCT00397722","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00397722","GlaxoSmithKline "]
["NCT00398580","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00398580","GlaxoSmithKline "]
["NCT00400608","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00400608","GlaxoSmithKline "]
["NCT00407563","['Accelerated Community Oncology Research Network']","[' Accelerated Community Oncology Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00407563","Accelerated Community Oncology Research Network "]
["NCT00415064","['AEterna Zentaris']","[' AEterna Zentaris ']","https://clinicaltrials.gov/ct2/show/NCT00415064","AEterna Zentaris "]
["NCT00431015","['Infinity Pharmaceuticals, Inc.']","[' Infinity Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00431015","Infinity Pharmaceuticals, Inc. "]
["NCT00431236","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00431236","GlaxoSmithKline "]
["NCT00435461","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00435461","GlaxoSmithKline "]
["NCT00436072","['Jeffrey A. Meyerhardt, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00436072","Jeffrey A. Meyerhardt, MD, Principal Investigator, Dana-Farber Cancer Institute "]
["NCT00440726","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00440726","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT00441870","['Endocyte']","[' Endocyte ']","https://clinicaltrials.gov/ct2/show/NCT00441870","Endocyte "]
["NCT00451074","[\"Jerry R. Mendell, Nationwide Children's Hospital\"]","[\" Nationwide Children's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00451074","Jerry R. Mendell, Director, Center for Gene Therapy, Nationwide Children's Hospital "]
["NCT00454532","['Bionovo']","[' Bionovo ']","https://clinicaltrials.gov/ct2/show/NCT00454532","Bionovo "]
["NCT00455039","['University of New Mexico']","[' University of New Mexico ']","https://clinicaltrials.gov/ct2/show/NCT00455039","University of New Mexico "]
["NCT00466596","['Michelle Hernandez, MD, University of North Carolina, Chapel Hill']","[' University of North Carolina, Chapel Hill ']","https://clinicaltrials.gov/ct2/show/NCT00466596","Michelle Hernandez, MD, Investigator, University of North Carolina, Chapel Hill "]
["NCT00471562","['Wake Forest University Health Sciences']","[' Wake Forest University Health Sciences ']","https://clinicaltrials.gov/ct2/show/NCT00471562","Wake Forest University Health Sciences "]
["NCT00477542","['Indiana University ( Indiana University School of Medicine )']","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00477542","Indiana University School of Medicine "]
["NCT00477945","['Indiana University ( Indiana University School of Medicine )']","[' Indiana University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00477945","Indiana University School of Medicine "]
["NCT00483301","['Jose Lutzky, Mt. Sinai Medical Center, Miami']","[' Mt. Sinai Medical Center, Miami ']","https://clinicaltrials.gov/ct2/show/NCT00483301","Jose Lutzky, Study Principal Investigator, Mt. Sinai Medical Center, Miami "]
["NCT00485277","['Bavarian Nordic, Inc.']","[' Bavarian Nordic, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00485277","Bavarian Nordic, Inc. "]
["NCT00496600","['Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey )']","[' University of Medicine and Dentistry of New Jersey ']","https://clinicaltrials.gov/ct2/show/NCT00496600","University of Medicine and Dentistry of New Jersey "]
["NCT00498745","['Puma Biotechnology, Inc.']","[' Puma Biotechnology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00498745","Puma Biotechnology, Inc. "]
["NCT00498836","['Clavis Pharma']","[' Clavis Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00498836","Clavis Pharma "]
["NCT00501735","['BioCryst Pharmaceuticals']","[' BioCryst Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00501735","BioCryst Pharmaceuticals "]
["NCT00502775","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00502775","GlaxoSmithKline "]
["NCT00503295","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00503295","Oncolytics Biotech "]
["NCT00503724","['Pediatric Brain Tumor Consortium']","[' Pediatric Brain Tumor Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00503724","Pediatric Brain Tumor Consortium "]
["NCT00509678","['Swedish Medical Center']","[' Swedish Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00509678","Swedish Medical Center "]
["NCT00516321","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00516321","GlaxoSmithKline "]
["NCT00517595","['Accelerated Community Oncology Research Network']","[' Accelerated Community Oncology Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00517595","Accelerated Community Oncology Research Network "]
["NCT00518115","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00518115","GlaxoSmithKline "]
["NCT00518739","['Merck Sharp & Dohme Corp.']","[' Merck Sharp & Dohme Corp. ']","https://clinicaltrials.gov/ct2/show/NCT00518739","Merck Sharp & Dohme Corp. "]
["NCT00524524","['ArQule']","[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT00524524","ArQule "]
["NCT00526669","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00526669","GlaxoSmithKline "]
["NCT00528684","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00528684","Oncolytics Biotech "]
["NCT00532909","['Branimir Sikic, Stanford University']","[' Branimir Sikic ']","https://clinicaltrials.gov/ct2/show/NCT00532909","Branimir Sikic, Professor of Medicine, Stanford University "]
["NCT00540553","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00540553","GlaxoSmithKline "]
["NCT00543075","['Genta Incorporated']","[' Genta Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT00543075","Genta Incorporated "]
["NCT00546871","['Shire ( Baxalta now part of Shire )']","[' Baxalta now part of Shire ']","https://clinicaltrials.gov/ct2/show/NCT00546871","Baxalta now part of Shire "]
["NCT00552396","['Innate Pharma']","[' Innate Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00552396","Innate Pharma "]
["NCT00554827","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00554827","Spectrum Pharmaceuticals, Inc "]
["NCT00557583","['Virobay Inc.']","[' Virobay Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00557583","Virobay Inc. "]
["NCT00606814","['Infinity Pharmaceuticals, Inc.']","[' Infinity Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00606814","Infinity Pharmaceuticals, Inc. "]
["NCT00608699","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00608699","GlaxoSmithKline "]
["NCT00620425","['Zogenix, Inc.']","[' Zogenix, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00620425","Zogenix, Inc. "]
["NCT00622063","['ArQule']","[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT00622063","ArQule "]
["NCT00630396","['David Hess, MD, Augusta University']","[' David Hess, MD ']","https://clinicaltrials.gov/ct2/show/NCT00630396","David Hess, MD, Professor and Chairman, Augusta University "]
["NCT00637221","['Neuropharm']","[' Neuropharm ']","https://clinicaltrials.gov/ct2/show/NCT00637221","Neuropharm "]
["NCT00640523","['BioCryst Pharmaceuticals']","[' BioCryst Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00640523","BioCryst Pharmaceuticals "]
["NCT00644332","['Gilead Sciences']","[' Gilead Sciences ']","https://clinicaltrials.gov/ct2/show/NCT00644332","Gilead Sciences "]
["NCT00645840","['University of Texas Southwestern Medical Center']","[' University of Texas Southwestern Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00645840","University of Texas Southwestern Medical Center "]
["NCT00648908","['Acorda Therapeutics']","[' Acorda Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00648908","Acorda Therapeutics "]
["NCT00649792","['Acorda Therapeutics']","[' Acorda Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00649792","Acorda Therapeutics "]
["NCT00654134","['Michelle Hernandez, MD, University of North Carolina, Chapel Hill']","[' University of North Carolina, Chapel Hill ']","https://clinicaltrials.gov/ct2/show/NCT00654134","Michelle Hernandez, MD, Assistant Professor of Pediatrics, University of North Carolina, Chapel Hill "]
["NCT00655161","['GlobeImmune']","[' GlobeImmune ']","https://clinicaltrials.gov/ct2/show/NCT00655161","GlobeImmune "]
["NCT00661414","['Lpath, Inc.']","[' Lpath, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00661414","Lpath, Inc. "]
["NCT00663910","['The Cleveland Clinic']","[' The Cleveland Clinic ']","https://clinicaltrials.gov/ct2/show/NCT00663910","The Cleveland Clinic "]
["NCT00670423","['Jennifer E. Schwartz, Indiana University']","[' Jennifer E. Schwartz ']","https://clinicaltrials.gov/ct2/show/NCT00670423","Jennifer E. Schwartz, Assistant Professor of Clinical Medicine, Indiana University "]
["NCT00671424","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00671424","GlaxoSmithKline "]
["NCT00674674","['Susan Blaney, Baylor College of Medicine']","[' Baylor College of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00674674","Susan Blaney, Professor of Pediatrics, Baylor College of Medicine "]
["NCT00679601","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00679601","Pfizer "]
["NCT00680160","['Pfizer']","[' Pfizer ']","https://clinicaltrials.gov/ct2/show/NCT00680160","Pfizer "]
["NCT00719836","['S*BIO']","[' S*BIO ']","https://clinicaltrials.gov/ct2/show/NCT00719836","S*BIO "]
["NCT00720148","['R. Donald Harvey, PharmD, Emory University']","[' Emory University ']","https://clinicaltrials.gov/ct2/show/NCT00720148","R. Donald Harvey, PharmD, PharmD, Emory University "]
["NCT00722553","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00722553","Spectrum Pharmaceuticals, Inc "]
["NCT00725686","['Quark Pharmaceuticals']","[' Quark Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00725686","Quark Pharmaceuticals "]
["NCT00728793","['Curis, Inc.']","[' Curis, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00728793","Curis, Inc. "]
["NCT00731822","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00731822","GlaxoSmithKline "]
["NCT00745550","['S*BIO']","[' S*BIO ']","https://clinicaltrials.gov/ct2/show/NCT00745550","S*BIO "]
["NCT00753038","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00753038","Oncolytics Biotech "]
["NCT00781885","['Lung Biotechnology PBC']","[' Lung Biotechnology PBC ']","https://clinicaltrials.gov/ct2/show/NCT00781885","Lung Biotechnology PBC "]
["NCT00812071","['Ellen Vitetta, University of Texas Southwestern Medical Center']","[' University of Texas Southwestern Medical Center ']","https://clinicaltrials.gov/ct2/show/NCT00812071","Ellen Vitetta, Director, University of Texas Southwestern Medical Center "]
["NCT00815607","['Ziopharm']","[' Ziopharm ']","https://clinicaltrials.gov/ct2/show/NCT00815607","Ziopharm "]
["NCT00839852","['Forest Laboratories']","[' Forest Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT00839852","Forest Laboratories "]
["NCT00850785","['Providence Health & Services']","[' Providence Health & Services ']","https://clinicaltrials.gov/ct2/show/NCT00850785","Providence Health & Services "]
["NCT00852189","['Endocyte']","[' Endocyte ']","https://clinicaltrials.gov/ct2/show/NCT00852189","Endocyte "]
["NCT00855868","['Avid Radiopharmaceuticals']","[' Avid Radiopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00855868","Avid Radiopharmaceuticals "]
["NCT00856063","['University of Arizona']","[' University of Arizona ']","https://clinicaltrials.gov/ct2/show/NCT00856063","University of Arizona "]
["NCT00857506","['Avid Radiopharmaceuticals']","[' Avid Radiopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00857506","Avid Radiopharmaceuticals "]
["NCT00861627","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00861627","Oncolytics Biotech "]
["NCT00878423","['Astex Pharmaceuticals']","[' Astex Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00878423","Astex Pharmaceuticals "]
["NCT00882180","['Alnylam Pharmaceuticals']","[' Alnylam Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00882180","Alnylam Pharmaceuticals "]
["NCT00892931","['Myrexis Inc.']","[' Myrexis Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00892931","Myrexis Inc. "]
["NCT00894010","['The Epilepsy Study Consortium']","[' The Epilepsy Study Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00894010","The Epilepsy Study Consortium "]
["NCT00920205","['Myrexis Inc.']","[' Myrexis Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00920205","Myrexis Inc. "]
["NCT00930631","['Lantheus Medical Imaging']","[' Lantheus Medical Imaging ']","https://clinicaltrials.gov/ct2/show/NCT00930631","Lantheus Medical Imaging "]
["NCT00951054","['Nippon Kayaku Co., Ltd.']","[' Nippon Kayaku Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT00951054","Nippon Kayaku Co., Ltd. "]
["NCT00951613","['Nippon Kayaku Co., Ltd.']","[' Nippon Kayaku Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT00951613","Nippon Kayaku Co., Ltd. "]
["NCT00952692","['Michael Morse, MD, Duke University']","[' Michael Morse, MD ']","https://clinicaltrials.gov/ct2/show/NCT00952692","Michael Morse, MD, Associate Professor, Duke University "]
["NCT00961090","['Diane Cantella, Allegheny Singer Research Institute']","[' Diane Cantella ']","https://clinicaltrials.gov/ct2/show/NCT00961090","Diane Cantella, co-investigator, Allegheny Singer Research Institute "]
["NCT00968240","['John A. Boockvar, Northwell Health']","[' Northwell Health ']","https://clinicaltrials.gov/ct2/show/NCT00968240","John A. Boockvar, Associate Professor, Northwell Health "]
["NCT00968656","['Farrokh Dehdashti, Washington University School of Medicine']","[' Washington University School of Medicine ']","https://clinicaltrials.gov/ct2/show/NCT00968656","Farrokh Dehdashti, Professor of Radiology, Washington University School of Medicine "]
["NCT00984464","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00984464","Oncolytics Biotech "]
["NCT00995813","[\"Patrick Javid, Seattle Children's Hospital\"]","[\" Seattle Children's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT00995813","Patrick Javid, Principal Investigator, Seattle Children's Hospital "]
["NCT00998192","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00998192","Oncolytics Biotech "]
["NCT00998946","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00998946","Spectrum Pharmaceuticals, Inc "]
["NCT01009697","['West-Ward Pharmaceutical ( Roxane Laboratories )']","[' Roxane Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT01009697","Roxane Laboratories "]
["NCT01009853","['West-Ward Pharmaceutical ( Roxane Laboratories )']","[' Roxane Laboratories ']","https://clinicaltrials.gov/ct2/show/NCT01009853","Roxane Laboratories "]
["NCT01064947","['Leon Kircik, M.D., Derm Research, PLLC']","[' Derm Research, PLLC ']","https://clinicaltrials.gov/ct2/show/NCT01064947","Leon Kircik, M.D., Principal Investigator, Derm Research, PLLC "]
["NCT01118624","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT01118624","Spectrum Pharmaceuticals, Inc "]
["NCT01121458","['Subhash Banerjee, North Texas Veterans Healthcare System']","[' North Texas Veterans Healthcare System ']","https://clinicaltrials.gov/ct2/show/NCT01121458","Subhash Banerjee, Chief- Division of Cardiology, North Texas Veterans Healthcare System "]
["NCT01127594","['Douglas Tyler, Duke University']","[' Douglas Tyler ']","https://clinicaltrials.gov/ct2/show/NCT01127594","Douglas Tyler, Professor of Surgical Oncology, Duke University "]
["NCT01149915","['Threshold Pharmaceuticals']","[' Threshold Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01149915","Threshold Pharmaceuticals "]
["NCT01158079","['Alnylam Pharmaceuticals']","[' Alnylam Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01158079","Alnylam Pharmaceuticals "]
["NCT01158157","['Cangene Corporation']","[' Cangene Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01158157","Cangene Corporation "]
["NCT01158300","['Pediatric Brain Tumor Consortium']","[' Pediatric Brain Tumor Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01158300","Pediatric Brain Tumor Consortium "]
["NCT01165905","['Onconova Therapeutics, Inc.']","[' Onconova Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01165905","Onconova Therapeutics, Inc. "]
["NCT01238952","['Nippon Kayaku Co., Ltd.']","[' Nippon Kayaku Co., Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01238952","Nippon Kayaku Co., Ltd. "]
["NCT01240967","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01240967","AstraZeneca "]
["NCT01285596","['Astellas Pharma Inc']","[' Astellas Pharma Inc ']","https://clinicaltrials.gov/ct2/show/NCT01285596","Astellas Pharma Inc "]
["NCT01314703","['CareFusion']","[' CareFusion ']","https://clinicaltrials.gov/ct2/show/NCT01314703","CareFusion "]
["NCT01338051","['Jerome Belinson, Preventive Oncology International, Inc.']","[' Preventive Oncology International, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01338051","Jerome Belinson, Jerome Belinson MD, president, Preventive Oncology International, Inc. "]
["NCT01350921","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01350921","AstraZeneca "]
["NCT01358383","['AstraZeneca']","[' AstraZeneca ']","https://clinicaltrials.gov/ct2/show/NCT01358383","AstraZeneca "]
["NCT01366417","['CareFusion']","[' CareFusion ']","https://clinicaltrials.gov/ct2/show/NCT01366417","CareFusion "]
["NCT01411267","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01411267","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT01460901","[\"Children's Mercy Hospital Kansas City\"]","[\" Children's Mercy Hospital Kansas City \"]","https://clinicaltrials.gov/ct2/show/NCT01460901","Children's Mercy Hospital Kansas City "]
["NCT01481051","['Mati Therapeutics Inc.']","[' Mati Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01481051","Mati Therapeutics Inc. "]
["NCT01528384","['Polaris Group']","[' Polaris Group ']","https://clinicaltrials.gov/ct2/show/NCT01528384","Polaris Group "]
["NCT01538537","['Onconova Therapeutics, Inc.']","[' Onconova Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01538537","Onconova Therapeutics, Inc. "]
["NCT01538563","['Onconova Therapeutics, Inc.']","[' Onconova Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01538563","Onconova Therapeutics, Inc. "]
["NCT01544322","['MEI Pharma, Inc.']","[' MEI Pharma, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01544322","MEI Pharma, Inc. "]
["NCT01550484","['Avid Radiopharmaceuticals']","[' Avid Radiopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01550484","Avid Radiopharmaceuticals "]
["NCT01584284","['Genelux Corporation']","[' Genelux Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01584284","Genelux Corporation "]
["NCT01616290","['Proteon Therapeutics']","[' Proteon Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01616290","Proteon Therapeutics "]
["NCT01925911","['Verastem, Inc.']","[' Verastem, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01925911","Verastem, Inc. "]
["NCT01947777","['Verastem, Inc.']","[' Verastem, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01947777","Verastem, Inc. "]
["NCT00621920","['C.B. Fleet Company, Inc.']","[' C.B. Fleet Company, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00621920","C.B. Fleet Company, Inc. "]
["NCT00839631","['Dendreon']","[' Dendreon ']","https://clinicaltrials.gov/ct2/show/NCT00839631","Dendreon "]
["NCT00332189","['BioMarin Pharmaceutical']","[' BioMarin Pharmaceutical ']","https://clinicaltrials.gov/ct2/show/NCT00332189","BioMarin Pharmaceutical "]
["NCT01330979","['Aerie Pharmaceuticals']","[' Aerie Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01330979","Aerie Pharmaceuticals "]
["NCT01608867","['OncoMed Pharmaceuticals, Inc.']","[' OncoMed Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01608867","OncoMed Pharmaceuticals, Inc. "]
["NCT00894894","['Astex Pharmaceuticals']","[' Astex Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00894894","Astex Pharmaceuticals "]
["NCT00441376","['Celsion']","[' Celsion ']","https://clinicaltrials.gov/ct2/show/NCT00441376","Celsion "]
["NCT00557609","['ArQule']","[' ArQule ']","https://clinicaltrials.gov/ct2/show/NCT00557609","ArQule "]
["NCT01189942","['OncoMed Pharmaceuticals, Inc.']","[' OncoMed Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01189942","OncoMed Pharmaceuticals, Inc. "]
["NCT00948961","['Celldex Therapeutics']","[' Celldex Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00948961","Celldex Therapeutics "]
["NCT01325558","['Altor BioScience']","[' Altor BioScience ']","https://clinicaltrials.gov/ct2/show/NCT01325558","Altor BioScience "]
["NCT00998322","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT00998322","Oncolytics Biotech "]
["NCT00744562","['OncoMed Pharmaceuticals, Inc.']","[' OncoMed Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00744562","OncoMed Pharmaceuticals, Inc. "]
["NCT01475279","['Tasly Pharmaceuticals, Inc.']","[' Tasly Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01475279","Tasly Pharmaceuticals, Inc. "]
["NCT01447719","['Avid Radiopharmaceuticals']","[' Avid Radiopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT01447719","Avid Radiopharmaceuticals "]
["NCT00704158","['Celldex Therapeutics ( CuraGen Corporation )']","[' CuraGen Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00704158","CuraGen Corporation "]
["NCT01105793","['FemmePharma Global Healthcare, Inc.']","[' FemmePharma Global Healthcare, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01105793","FemmePharma Global Healthcare, Inc. "]
["NCT00949559","['Esperance Pharmaceuticals Inc']","[' Esperance Pharmaceuticals Inc ']","https://clinicaltrials.gov/ct2/show/NCT00949559","Esperance Pharmaceuticals Inc "]
["NCT00412828","['Celldex Therapeutics ( CuraGen Corporation )']","[' CuraGen Corporation ']","https://clinicaltrials.gov/ct2/show/NCT00412828","CuraGen Corporation "]
["NCT01345201","['OncoMed Pharmaceuticals, Inc.']","[' OncoMed Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01345201","OncoMed Pharmaceuticals, Inc. "]
["NCT02317705","['On Target Laboratories, LLC']","[' On Target Laboratories, LLC ']","https://clinicaltrials.gov/ct2/show/NCT02317705","On Target Laboratories, LLC "]
["NCT00496860","['Altor BioScience']","[' Altor BioScience ']","https://clinicaltrials.gov/ct2/show/NCT00496860","Altor BioScience "]
["NCT00725933","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT00725933","Biogen "]
["NCT01384799","['Curis, Inc.']","[' Curis, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01384799","Curis, Inc. "]
["NCT00991562","['ImmunoGen, Inc.']","[' ImmunoGen, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00991562","ImmunoGen, Inc. "]
["NCT00268970","['Agennix']","[' Agennix ']","https://clinicaltrials.gov/ct2/show/NCT00268970","Agennix "]
["NCT00336765","['Kadmon Corporation, LLC']","[' Kadmon Corporation, LLC ']","https://clinicaltrials.gov/ct2/show/NCT00336765","Kadmon Corporation, LLC "]
["NCT01407380","['Pathway Therapeutics, Inc.']","[' Pathway Therapeutics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01407380","Pathway Therapeutics, Inc. "]
["NCT01451047","['Aderans Research Institute']","[' Aderans Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01451047","Aderans Research Institute "]
["NCT01451073","['Aderans Research Institute']","[' Aderans Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01451073","Aderans Research Institute "]
["NCT01451021","['Aderans Research Institute']","[' Aderans Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01451021","Aderans Research Institute "]
["NCT01451099","['Aderans Research Institute']","[' Aderans Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT01451099","Aderans Research Institute "]
["NCT00418821","['Sanofi ( Genzyme, a Sanofi Company )']","[' Genzyme, a Sanofi Company ']","https://clinicaltrials.gov/ct2/show/NCT00418821","Genzyme, a Sanofi Company "]
["NCT00530686","['Baylor Research Institute']","[' Baylor Research Institute ']","https://clinicaltrials.gov/ct2/show/NCT00530686","Baylor Research Institute "]
["NCT01042574","['Christopher Finch, Methodist Healthcare']","[' Methodist Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT01042574","Christopher Finch, Assistant Director, Clinical Pharmacy Services, Methodist Healthcare "]
["NCT01092585","['Genta Incorporated']","[' Genta Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01092585","Genta Incorporated "]
["NCT01215877","['Genta Incorporated']","[' Genta Incorporated ']","https://clinicaltrials.gov/ct2/show/NCT01215877","Genta Incorporated "]
["NCT01274624","['Oncolytics Biotech']","[' Oncolytics Biotech ']","https://clinicaltrials.gov/ct2/show/NCT01274624","Oncolytics Biotech "]
["NCT01688401","['Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins']","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","https://clinicaltrials.gov/ct2/show/NCT01688401","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins "]
["NCT02279394","['Irene Ghobrial, MD, Dana-Farber Cancer Institute']","[' Dana-Farber Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT02279394","Irene Ghobrial, MD, Principal Investigator, Dana-Farber Cancer Institute "]
["NCT00747669","['ZARS Pharma Inc.']","[' ZARS Pharma Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00747669","ZARS Pharma Inc. "]
["NCT00125411","['Agennix']","[' Agennix ']","https://clinicaltrials.gov/ct2/show/NCT00125411","Agennix "]
["NCT00216762","['Clifton O Bingham, Johns Hopkins University']","[' Johns Hopkins University ']","https://clinicaltrials.gov/ct2/show/NCT00216762","Clifton O Bingham, Principal Investigator, Johns Hopkins University "]
["NCT00242879","['ViiV Healthcare']","[' ViiV Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT00242879","ViiV Healthcare "]
["NCT00290407","['University of Louisville']","[' University of Louisville ']","https://clinicaltrials.gov/ct2/show/NCT00290407","University of Louisville "]
["NCT00313144","['Shire ( Baxalta now part of Shire )']","[' Baxalta now part of Shire ']","https://clinicaltrials.gov/ct2/show/NCT00313144","Baxalta now part of Shire "]
["NCT00313456","['Agennix']","[' Agennix ']","https://clinicaltrials.gov/ct2/show/NCT00313456","Agennix "]
["NCT00329329","['Agennix']","[' Agennix ']","https://clinicaltrials.gov/ct2/show/NCT00329329","Agennix "]
["NCT00366106","['Accelerated Community Oncology Research Network']","[' Accelerated Community Oncology Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00366106","Accelerated Community Oncology Research Network "]
["NCT00368329","['Daniel T. Chang, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT00368329","Daniel T. Chang, PI, Stanford University "]
["NCT00383487","['Sandy Srinivas, Stanford University']","[' Stanford University ']","https://clinicaltrials.gov/ct2/show/NCT00383487","Sandy Srinivas, Associate Professor of Medicine, Stanford University "]
["NCT00384150","['Biogen']","[' Biogen ']","https://clinicaltrials.gov/ct2/show/NCT00384150","Biogen "]
["NCT00422201","['HRA Pharma']","[' HRA Pharma ']","https://clinicaltrials.gov/ct2/show/NCT00422201","HRA Pharma "]
["NCT00429858","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT00429858","University of California, San Francisco "]
["NCT00437164","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00437164","GlaxoSmithKline "]
["NCT00439296","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00439296","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT00452387","['Accelerated Community Oncology Research Network']","[' Accelerated Community Oncology Research Network ']","https://clinicaltrials.gov/ct2/show/NCT00452387","Accelerated Community Oncology Research Network "]
["NCT00459810","['Tom Beer, OHSU Knight Cancer Institute']","[' OHSU Knight Cancer Institute ']","https://clinicaltrials.gov/ct2/show/NCT00459810","Tom Beer, Principal Investigator, OHSU Knight Cancer Institute "]
["NCT00485563","['Endocyte']","[' Endocyte ']","https://clinicaltrials.gov/ct2/show/NCT00485563","Endocyte "]
["NCT00516282","['Northwestern University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT00516282","Northwestern University "]
["NCT00532038","['ZARS Pharma Inc.']","[' ZARS Pharma Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00532038","ZARS Pharma Inc. "]
["NCT00543712","['Genentech, Inc.']","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00543712","Genentech, Inc. "]
["NCT00553813","['Cortice Biosciences, Inc.']","[' Cortice Biosciences, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00553813","Cortice Biosciences, Inc. "]
["NCT00558727","['Spectrum Pharmaceuticals, Inc']","[' Spectrum Pharmaceuticals, Inc ']","https://clinicaltrials.gov/ct2/show/NCT00558727","Spectrum Pharmaceuticals, Inc "]
["NCT00572182","['Pediatric Brain Tumor Consortium']","[' Pediatric Brain Tumor Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00572182","Pediatric Brain Tumor Consortium "]
["NCT00608777","['Leon Kircik, M.D., Derm Research, PLLC']","[' Derm Research, PLLC ']","https://clinicaltrials.gov/ct2/show/NCT00608777","Leon Kircik, M.D., Principal Investigator, Derm Research, PLLC "]
["NCT00630461","['David B. Peden, MD, University of North Carolina, Chapel Hill']","[' University of North Carolina, Chapel Hill ']","https://clinicaltrials.gov/ct2/show/NCT00630461","David B. Peden, MD, Professor of Pediatrics, University of North Carolina, Chapel Hill "]
["NCT00709618","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT00709618","GlaxoSmithKline "]
["NCT00718588","['Genentech, Inc.']","[' Genentech, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00718588","Genentech, Inc. "]
["NCT00724100","['Albany Molecular Research, Inc.']","[' Albany Molecular Research, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00724100","Albany Molecular Research, Inc. "]
["NCT00724425","['Infinity Pharmaceuticals, Inc.']","[' Infinity Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00724425","Infinity Pharmaceuticals, Inc. "]
["NCT00737113","['Mitchell Horwitz, MD, Duke University']","[' Mitchell Horwitz, MD ']","https://clinicaltrials.gov/ct2/show/NCT00737113","Mitchell Horwitz, MD, Assoc Professor of Medicine, Duke University "]
["NCT00810017","['Washington Hospital Center']","[' Washington Hospital Center ']","https://clinicaltrials.gov/ct2/show/NCT00810017","Washington Hospital Center "]
["NCT00827099","['Northside Hospital, Inc.']","[' Northside Hospital, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00827099","Northside Hospital, Inc. "]
["NCT00911326","['Navidea Biopharmaceuticals']","[' Navidea Biopharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00911326","Navidea Biopharmaceuticals "]
["NCT00981799","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT00981799","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT01026051","['Mannkind Corporation']","[' Mannkind Corporation ']","https://clinicaltrials.gov/ct2/show/NCT01026051","Mannkind Corporation "]
["NCT01158885","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01158885","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT01186328","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01186328","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT01212965","['Michael Kelly, Medical College of Wisconsin']","[' Medical College of Wisconsin ']","https://clinicaltrials.gov/ct2/show/NCT01212965","Michael Kelly, Principal Investigator, Medical College of Wisconsin "]
["NCT01241786","['Hackensack Meridian Health']","[' Hackensack Meridian Health ']","https://clinicaltrials.gov/ct2/show/NCT01241786","Hackensack Meridian Health "]
["NCT01265199","['Ascenta Therapeutics']","[' Ascenta Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT01265199","Ascenta Therapeutics "]
["NCT01300793","['University of California, San Francisco']","[' University of California, San Francisco ']","https://clinicaltrials.gov/ct2/show/NCT01300793","University of California, San Francisco "]
["NCT01403285","['immatics Biotechnologies GmbH']","[' immatics Biotechnologies GmbH ']","https://clinicaltrials.gov/ct2/show/NCT01403285","immatics Biotechnologies GmbH "]
["NCT01483690","['Therapeutic Advances in Childhood Leukemia Consortium']","[' Therapeutic Advances in Childhood Leukemia Consortium ']","https://clinicaltrials.gov/ct2/show/NCT01483690","Therapeutic Advances in Childhood Leukemia Consortium "]
["NCT01491594","['Duke University']","[' Duke University ']","https://clinicaltrials.gov/ct2/show/NCT01491594","Duke University "]
["NCT00522938","['Chroma Therapeutics']","[' Chroma Therapeutics ']","https://clinicaltrials.gov/ct2/show/NCT00522938","Chroma Therapeutics "]
["NCT00515255","['Neuropharm']","[' Neuropharm ']","https://clinicaltrials.gov/ct2/show/NCT00515255","Neuropharm "]
["NCT00703339","['Lung Biotechnology PBC']","[' Lung Biotechnology PBC ']","https://clinicaltrials.gov/ct2/show/NCT00703339","Lung Biotechnology PBC "]
["NCT00110721","['Galectin Therapeutics Inc.']","[' Galectin Therapeutics Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00110721","Galectin Therapeutics Inc. "]
["NCT00848601","['Astex Pharmaceuticals']","[' Astex Pharmaceuticals ']","https://clinicaltrials.gov/ct2/show/NCT00848601","Astex Pharmaceuticals "]
["NCT00747825","['Molecular Insight Pharmaceuticals, Inc.']","[' Molecular Insight Pharmaceuticals, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT00747825","Molecular Insight Pharmaceuticals, Inc. "]
["NCT00530868","['Christos Vaklavas, MD, University of Alabama at Birmingham']","[' University of Alabama at Birmingham ']","https://clinicaltrials.gov/ct2/show/NCT00530868","Christos Vaklavas, MD, Professor, Medicine, University of Alabama at Birmingham "]
["NCT00595088","['Anchiano Therapeutics Israel Ltd.']","[' Anchiano Therapeutics Israel Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT00595088","Anchiano Therapeutics Israel Ltd. "]
["NCT01969838","['Sierra Oncology, Inc.']","[' Sierra Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01969838","Sierra Oncology, Inc. "]
["NCT01983501","['Seattle Genetics, Inc.']","[' Seattle Genetics, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01983501","Seattle Genetics, Inc. "]
["NCT02101268","['Sierra Oncology, Inc.']","[' Sierra Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02101268","Sierra Oncology, Inc. "]
["NCT02206763","['Sierra Oncology, Inc.']","[' Sierra Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02206763","Sierra Oncology, Inc. "]
["NCT00655395","['Viron Therapeutics Inc']","[' Viron Therapeutics Inc ']","https://clinicaltrials.gov/ct2/show/NCT00655395","Viron Therapeutics Inc "]
["NCT01413087","['Anchiano Therapeutics Israel Ltd.']","[' Anchiano Therapeutics Israel Ltd. ']","https://clinicaltrials.gov/ct2/show/NCT01413087","Anchiano Therapeutics Israel Ltd. "]
["NCT00380744","['Eli Lilly and Company']","[' Eli Lilly and Company ']","https://clinicaltrials.gov/ct2/show/NCT00380744","Eli Lilly and Company "]
["NCT01012492","[u'Leslie Kean, Boston Children\\u2019s Hospital']","[u' Boston Children\\u2019s Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01012492","Leslie Kean, MD, PhD, Boston Children’s Hospital "]
["NCT01743131","[u'Leslie Kean, Boston Children\\u2019s Hospital']","[u' Boston Children\\u2019s Hospital ']","https://clinicaltrials.gov/ct2/show/NCT01743131","Leslie Kean, MD, PhD, Boston Children’s Hospital "]
["NCT01846507","[\"Sarah O'Brien, Nationwide Children's Hospital\"]","[\" Nationwide Children's Hospital \"]","https://clinicaltrials.gov/ct2/show/NCT01846507","Sarah O'Brien, Director of Experimental Therapeutics, Nationwide Children's Hospital "]
["NCT01897688","['Daniel Borja-Cacho, Northwestern University']","[' Northwestern University ']","https://clinicaltrials.gov/ct2/show/NCT01897688","Daniel Borja-Cacho, Principal Investigator, Northwestern University "]
["NCT01985087","['Shiao Yuo Woo, University of Louisville']","[' University of Louisville ']","https://clinicaltrials.gov/ct2/show/NCT01985087","Shiao Yuo Woo, Associate Professor, University of Louisville "]
["NCT02244489","['Sierra Oncology, Inc.']","[' Sierra Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02244489","Sierra Oncology, Inc. "]
["NCT02322866","['Almirall, S.A.']","[' Almirall, S.A. ']","https://clinicaltrials.gov/ct2/show/NCT02322866","Almirall, S.A. "]
["NCT02326441","['Athenex, Inc.']","[' Athenex, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02326441","Athenex, Inc. "]
["NCT01190020","['Satish Rao, University of Iowa']","[' Augusta University ']","https://clinicaltrials.gov/ct2/show/NCT01190020","Satish Rao, PI, University of Iowa "]
["NCT02173093","['Daniel W. Lee, MD, University of Virginia']","[' University of Virginia ']","https://clinicaltrials.gov/ct2/show/NCT02173093","Daniel W. Lee, MD, Principal Investigator, University of Virginia "]
["NCT00267371","['Abbott Medical Devices']","[' Abbott Medical Devices ']","https://clinicaltrials.gov/ct2/show/NCT00267371","Abbott Medical Devices "]
["NCT00496782","['ViiV Healthcare']","[' ViiV Healthcare ']","https://clinicaltrials.gov/ct2/show/NCT00496782","ViiV Healthcare "]
["NCT01998828","['Sierra Oncology, Inc.']","[' Sierra Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT01998828","Sierra Oncology, Inc. "]
["NCT01628549","['Almirall, S.A.']","[' Almirall, S.A. ']","https://clinicaltrials.gov/ct2/show/NCT01628549","Almirall, S.A. "]
["NCT01682876","['GlaxoSmithKline']","[' GlaxoSmithKline ']","https://clinicaltrials.gov/ct2/show/NCT01682876","GlaxoSmithKline "]
["NCT00996580","[\"Teva Pharmaceutical Industries ( Teva Women's Health )\"]","[\" Teva Women's Health \"]","https://clinicaltrials.gov/ct2/show/NCT00996580","Teva Women's Health "]
["NCT02124746","['Sierra Oncology, Inc.']","[' Sierra Oncology, Inc. ']","https://clinicaltrials.gov/ct2/show/NCT02124746","Sierra Oncology, Inc. "]

{"sheet":"1221","index":2,"n_rows":1222,"n_cols":4,"rows_kept":1222,"cut":false,"hidden":false,"merged":[]}
["nct_id","urllist","sponsor","responsible party"]
["NCT00385502","https://clinicaltrials.gov/ct2/show/NCT00385502","[' MacroChem Corporation ']","[]"]
["NCT00540930","https://clinicaltrials.gov/ct2/show/NCT00540930","[' Shields, Shields and Associates ']","[]"]
["NCT00532974","https://clinicaltrials.gov/ct2/show/NCT00532974","[' Epimmune ']","[]"]
["NCT00140452","https://clinicaltrials.gov/ct2/show/NCT00140452","[' Dartmouth-Hitchcock Medical Center ']","[]"]
["NCT00157326","https://clinicaltrials.gov/ct2/show/NCT00157326","[' Eli Lilly and Company ']","[]"]
["NCT00214604","https://clinicaltrials.gov/ct2/show/NCT00214604","[' AstraZeneca ']","[]"]
["NCT00326144","https://clinicaltrials.gov/ct2/show/NCT00326144","[' AstraZeneca ']","[]"]
["NCT00333281","https://clinicaltrials.gov/ct2/show/NCT00333281","[' Eli Lilly and Company ']","[]"]
["NCT00389389","https://clinicaltrials.gov/ct2/show/NCT00389389","[' AstraZeneca ']","[]"]
["NCT00449501","https://clinicaltrials.gov/ct2/show/NCT00449501","[' AstraZeneca ']","[]"]
["NCT00449527","https://clinicaltrials.gov/ct2/show/NCT00449527","[' AstraZeneca ']","[]"]
["NCT00463918","https://clinicaltrials.gov/ct2/show/NCT00463918","[' Pfizer ']","[]"]
["NCT00537615","https://clinicaltrials.gov/ct2/show/NCT00537615","[' Pfizer ']","[]"]
["NCT00557661","https://clinicaltrials.gov/ct2/show/NCT00557661","[' Nile Therapeutics ']","[]"]
["NCT00986895","https://clinicaltrials.gov/ct2/show/NCT00986895","[' Horizon Pharma Ireland, Ltd., Dublin Ireland ']","[]"]
["NCT01061970","https://clinicaltrials.gov/ct2/show/NCT01061970","[' QuatRx Pharmaceuticals Company ']","[]"]
["NCT01468324","https://clinicaltrials.gov/ct2/show/NCT01468324","[' National Cancer Institute (NCI) ']","[]"]
["NCT01736332","https://clinicaltrials.gov/ct2/show/NCT01736332","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00536692","https://clinicaltrials.gov/ct2/show/NCT00536692","[' CoMentis ']","[]"]
["NCT00992576","https://clinicaltrials.gov/ct2/show/NCT00992576","[' Mundipharma Research GmbH & Co KG ']","[]"]
["NCT00674596","https://clinicaltrials.gov/ct2/show/NCT00674596","[' Gulhane School of Medicine ']","[]"]
["NCT00973895","https://clinicaltrials.gov/ct2/show/NCT00973895","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00512083","https://clinicaltrials.gov/ct2/show/NCT00512083","[' Antisoma Research ']","[]"]
["NCT00513552","https://clinicaltrials.gov/ct2/show/NCT00513552","[' Medstar Health Research Institute ']","[]"]
["NCT00164099","https://clinicaltrials.gov/ct2/show/NCT00164099","[' Beth Israel Medical Center ']","[]"]
["NCT00206089","https://clinicaltrials.gov/ct2/show/NCT00206089","[' AstraZeneca ']","[]"]
["NCT00226330","https://clinicaltrials.gov/ct2/show/NCT00226330","[' AstraZeneca ']","[]"]
["NCT00229710","https://clinicaltrials.gov/ct2/show/NCT00229710","[' AstraZeneca ']","[]"]
["NCT00471367","https://clinicaltrials.gov/ct2/show/NCT00471367","[' AstraZeneca ']","[]"]
["NCT00486265","https://clinicaltrials.gov/ct2/show/NCT00486265","[' AstraZeneca ']","[]"]
["NCT00507806","https://clinicaltrials.gov/ct2/show/NCT00507806","[' ImaRx Therapeutics ']","[]"]
["NCT00562731","https://clinicaltrials.gov/ct2/show/NCT00562731","[' Ardana Bioscience Ltd ']","[]"]
["NCT00122005","https://clinicaltrials.gov/ct2/show/NCT00122005","[' Providence Health & Services ']","[]"]
["NCT00174525","https://clinicaltrials.gov/ct2/show/NCT00174525","[' Pharmacology Research Institute ']","[]"]
["NCT00182715","https://clinicaltrials.gov/ct2/show/NCT00182715","[' Velindre NHS Trust ']","[]"]
["NCT00214747","https://clinicaltrials.gov/ct2/show/NCT00214747","[' Biosyn ']","[]"]
["NCT00214838","https://clinicaltrials.gov/ct2/show/NCT00214838","[' Callisto Pharmaceuticals ']","[]"]
["NCT00216242","https://clinicaltrials.gov/ct2/show/NCT00216242","[' ID Biomedical Corporation, Quebec ']","[]"]
["NCT00217763","https://clinicaltrials.gov/ct2/show/NCT00217763","[' Bellus Health Inc ']","[]"]
["NCT00225537","https://clinicaltrials.gov/ct2/show/NCT00225537","[' MTmedical Institute of Health ']","[]"]
["NCT00234312","https://clinicaltrials.gov/ct2/show/NCT00234312","[' Oregon Health and Science University ']","[]"]
["NCT00235053","https://clinicaltrials.gov/ct2/show/NCT00235053","[' Allergy & Asthma Medical Group & Research Center ']","[]"]
["NCT00237523","https://clinicaltrials.gov/ct2/show/NCT00237523","[' Symbollon Pharmaceuticals ']","[]"]
["NCT00247520","https://clinicaltrials.gov/ct2/show/NCT00247520","[' Evolutec Group ']","[]"]
["NCT00248521","https://clinicaltrials.gov/ct2/show/NCT00248521","[' Institute of Cancer Research, United Kingdom ']","[]"]
["NCT00265278","https://clinicaltrials.gov/ct2/show/NCT00265278","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00274950","https://clinicaltrials.gov/ct2/show/NCT00274950","[\" Children's Cancer and Leukaemia Group \"]","[]"]
["NCT00276705","https://clinicaltrials.gov/ct2/show/NCT00276705","[\" Children's Cancer and Leukaemia Group \"]","[]"]
["NCT00287924","https://clinicaltrials.gov/ct2/show/NCT00287924","[\" Children's Cancer and Leukaemia Group \"]","[]"]
["NCT00288873","https://clinicaltrials.gov/ct2/show/NCT00288873","[' Weill Medical College of Cornell University ']","[]"]
["NCT00293501","https://clinicaltrials.gov/ct2/show/NCT00293501","[' University of Vermont ']","[]"]
["NCT00295373","https://clinicaltrials.gov/ct2/show/NCT00295373","[' Purdue University ']","[]"]
["NCT00300807","https://clinicaltrials.gov/ct2/show/NCT00300807","[' XTL Biopharmaceuticals ']","[]"]
["NCT00334672","https://clinicaltrials.gov/ct2/show/NCT00334672","[\" Children's Cancer and Leukaemia Group \"]","[]"]
["NCT00336947","https://clinicaltrials.gov/ct2/show/NCT00336947","[' Yokohama City University ']","[]"]
["NCT00347828","https://clinicaltrials.gov/ct2/show/NCT00347828","[' Ophthalmic Consultants of Boston ']","[]"]
["NCT00380679","https://clinicaltrials.gov/ct2/show/NCT00380679","[' Louisiana State University Health Sciences Center in New Orleans ']","[]"]
["NCT00383851","https://clinicaltrials.gov/ct2/show/NCT00383851","[' Attenuon ']","[]"]
["NCT00387530","https://clinicaltrials.gov/ct2/show/NCT00387530","[' University of California, San Diego ']","[]"]
["NCT00392340","https://clinicaltrials.gov/ct2/show/NCT00392340","[\" Children's Cancer and Leukaemia Group \"]","[]"]
["NCT00398450","https://clinicaltrials.gov/ct2/show/NCT00398450","[' University of California, San Diego ']","[]"]
["NCT00423397","https://clinicaltrials.gov/ct2/show/NCT00423397","[' University of California, San Diego ']","[]"]
["NCT00478465","https://clinicaltrials.gov/ct2/show/NCT00478465","[' Stanford University ']","[]"]
["NCT00482950","https://clinicaltrials.gov/ct2/show/NCT00482950","[' Phenomix ']","[]"]
["NCT00513578","https://clinicaltrials.gov/ct2/show/NCT00513578","[' The Vaccine Company ']","[]"]
["NCT00589186","https://clinicaltrials.gov/ct2/show/NCT00589186","[' National Cancer Centre, Singapore ']","[]"]
["NCT00769613","https://clinicaltrials.gov/ct2/show/NCT00769613","[' Milton S. Hershey Medical Center ']","[]"]
["NCT00838656","https://clinicaltrials.gov/ct2/show/NCT00838656","[' Warwick Medical School ']","[]"]
["NCT01445535","https://clinicaltrials.gov/ct2/show/NCT01445535","[' National Cancer Institute (NCI) ']","[]"]
["NCT00354276","https://clinicaltrials.gov/ct2/show/NCT00354276","[' Vion Pharmaceuticals ']","[]"]
["NCT00811759","https://clinicaltrials.gov/ct2/show/NCT00811759","[' Gustave Roussy, Cancer Campus, Grand Paris ']","[]"]
["NCT00070278","https://clinicaltrials.gov/ct2/show/NCT00070278","[' Cambridge University Hospitals NHS Foundation Trust ']","[]"]
["NCT00109356","https://clinicaltrials.gov/ct2/show/NCT00109356","[' Novacea ']","[]"]
["NCT00110708","https://clinicaltrials.gov/ct2/show/NCT00110708","[' PediaMed Pharmaceuticals ']","[]"]
["NCT00251849","https://clinicaltrials.gov/ct2/show/NCT00251849","[' ActivBiotics ']","[]"]
["NCT00285675","https://clinicaltrials.gov/ct2/show/NCT00285675","[' Novacea ']","[]"]
["NCT00422331","https://clinicaltrials.gov/ct2/show/NCT00422331","[' JDS Pharmaceuticals ']","[]"]
["NCT00544310","https://clinicaltrials.gov/ct2/show/NCT00544310","[' OMRIX Biopharmaceuticals ']","[]"]
["NCT00029614","https://clinicaltrials.gov/ct2/show/NCT00029614","[' University of Pittsburgh ']","[]"]
["NCT00040690","https://clinicaltrials.gov/ct2/show/NCT00040690","[' Medical Research Council ']","[]"]
["NCT00083187","https://clinicaltrials.gov/ct2/show/NCT00083187","[' Vion Pharmaceuticals ']","[]"]
["NCT00094094","https://clinicaltrials.gov/ct2/show/NCT00094094","[' Pfizer ']","[]"]
["NCT00098046","https://clinicaltrials.gov/ct2/show/NCT00098046","[' Novartis ']","[]"]
["NCT00100295","https://clinicaltrials.gov/ct2/show/NCT00100295","[' National Center for Complementary and Integrative Health (NCCIH) ']","[]"]
["NCT00102674","https://clinicaltrials.gov/ct2/show/NCT00102674","[' The Medicines Company ']","[]"]
["NCT00103402","https://clinicaltrials.gov/ct2/show/NCT00103402","[' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ']","[]"]
["NCT00103948","https://clinicaltrials.gov/ct2/show/NCT00103948","[' Eisai Limited ']","[]"]
["NCT00104078","https://clinicaltrials.gov/ct2/show/NCT00104078","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00104377","https://clinicaltrials.gov/ct2/show/NCT00104377","[' Allergy Therapeutics ']","[]"]
["NCT00104390","https://clinicaltrials.gov/ct2/show/NCT00104390","[' Allergy Therapeutics ']","[]"]
["NCT00104897","https://clinicaltrials.gov/ct2/show/NCT00104897","[' Cancer Research UK ']","[]"]
["NCT00105092","https://clinicaltrials.gov/ct2/show/NCT00105092","[' Eli Lilly and Company ']","[]"]
["NCT00105326","https://clinicaltrials.gov/ct2/show/NCT00105326","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00106314","https://clinicaltrials.gov/ct2/show/NCT00106314","[' Inflabloc Pharmaceuticals ']","[]"]
["NCT00106860","https://clinicaltrials.gov/ct2/show/NCT00106860","[' Jazz Pharmaceuticals ']","[]"]
["NCT00107003","https://clinicaltrials.gov/ct2/show/NCT00107003","[' National Cancer Institute (NCI) ']","[]"]
["NCT00107159","https://clinicaltrials.gov/ct2/show/NCT00107159","[' Jonsson Comprehensive Cancer Center ']","[]"]
["NCT00107211","https://clinicaltrials.gov/ct2/show/NCT00107211","[' Abramson Cancer Center of the University of Pennsylvania ']","[]"]
["NCT00107523","https://clinicaltrials.gov/ct2/show/NCT00107523","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00109096","https://clinicaltrials.gov/ct2/show/NCT00109096","[' Eli Lilly and Company ']","[]"]
["NCT00109161","https://clinicaltrials.gov/ct2/show/NCT00109161","[' PDL BioPharma, Inc. ']","[]"]
["NCT00109681","https://clinicaltrials.gov/ct2/show/NCT00109681","[' Actelion ']","[]"]
["NCT00110058","https://clinicaltrials.gov/ct2/show/NCT00110058","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00110422","https://clinicaltrials.gov/ct2/show/NCT00110422","[' Bristol-Myers Squibb ']","[]"]
["NCT00110487","https://clinicaltrials.gov/ct2/show/NCT00110487","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00111618","https://clinicaltrials.gov/ct2/show/NCT00111618","[' Antisoma Research ']","[]"]
["NCT00111904","https://clinicaltrials.gov/ct2/show/NCT00111904","[' Theradex ']","[]"]
["NCT00112580","https://clinicaltrials.gov/ct2/show/NCT00112580","[' Bristol-Myers Squibb ']","[]"]
["NCT00112645","https://clinicaltrials.gov/ct2/show/NCT00112645","[' Milton S. Hershey Medical Center ']","[]"]
["NCT00113204","https://clinicaltrials.gov/ct2/show/NCT00113204","[' Infinity Pharmaceuticals, Inc. ']","[]"]
["NCT00113594","https://clinicaltrials.gov/ct2/show/NCT00113594","[' Eli Lilly and Company ']","[]"]
["NCT00113750","https://clinicaltrials.gov/ct2/show/NCT00113750","[' Allergy Therapeutics ']","[]"]
["NCT00113984","https://clinicaltrials.gov/ct2/show/NCT00113984","[' National Cancer Institute (NCI) ']","[]"]
["NCT00114686","https://clinicaltrials.gov/ct2/show/NCT00114686","[' AstraZeneca ']","[]"]
["NCT00115050","https://clinicaltrials.gov/ct2/show/NCT00115050","[' Tibotec Pharmaceuticals, Ireland ']","[]"]
["NCT00115089","https://clinicaltrials.gov/ct2/show/NCT00115089","[' Rigel Pharmaceuticals ']","[]"]
["NCT00115310","https://clinicaltrials.gov/ct2/show/NCT00115310","[' NeurogesX ']","[]"]
["NCT00115817","https://clinicaltrials.gov/ct2/show/NCT00115817","[\" Brigham and Women's Hospital \"]","[]"]
["NCT00116103","https://clinicaltrials.gov/ct2/show/NCT00116103","[' Astellas Pharma Inc ']","[]"]
["NCT00116506","https://clinicaltrials.gov/ct2/show/NCT00116506","[' Dana-Farber Cancer Institute ']","[]"]
["NCT00116519","https://clinicaltrials.gov/ct2/show/NCT00116519","[' Eli Lilly and Company ']","[]"]
["NCT00116610","https://clinicaltrials.gov/ct2/show/NCT00116610","[' Poniard Pharmaceuticals ']","[]"]
["NCT00116740","https://clinicaltrials.gov/ct2/show/NCT00116740","[' Arena Pharmaceuticals ']","[]"]
["NCT00118495","https://clinicaltrials.gov/ct2/show/NCT00118495","[' QualiLife Pharmaceuticals ']","[]"]
["NCT00118625","https://clinicaltrials.gov/ct2/show/NCT00118625","[' Allergy Therapeutics ']","[]"]
["NCT00119080","https://clinicaltrials.gov/ct2/show/NCT00119080","[' Centers for Disease Control and Prevention ']","[]"]
["NCT00119301","https://clinicaltrials.gov/ct2/show/NCT00119301","[' Memorial Sloan Kettering Cancer Center ']","[]"]
["NCT00119652","https://clinicaltrials.gov/ct2/show/NCT00119652","[' AstraZeneca ']","[]"]
["NCT00119665","https://clinicaltrials.gov/ct2/show/NCT00119665","[' Bionovo ']","[]"]
["NCT00119756","https://clinicaltrials.gov/ct2/show/NCT00119756","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00120926","https://clinicaltrials.gov/ct2/show/NCT00120926","[' Mednax Center for Research, Education, Quality and Safety ']","[]"]
["NCT00121849","https://clinicaltrials.gov/ct2/show/NCT00121849","[' IDRI ']","[]"]
["NCT00121862","https://clinicaltrials.gov/ct2/show/NCT00121862","[' IDRI ']","[]"]
["NCT00122837","https://clinicaltrials.gov/ct2/show/NCT00122837","[' Eli Lilly and Company ']","[]"]
["NCT00122863","https://clinicaltrials.gov/ct2/show/NCT00122863","[' Eli Lilly and Company ']","[]"]
["NCT00122876","https://clinicaltrials.gov/ct2/show/NCT00122876","[' Light Sciences Oncology ']","[]"]
["NCT00123201","https://clinicaltrials.gov/ct2/show/NCT00123201","[' Solvay Pharmaceuticals ']","[]"]
["NCT00123253","https://clinicaltrials.gov/ct2/show/NCT00123253","[' Theratechnologies ']","[]"]
["NCT00123734","https://clinicaltrials.gov/ct2/show/NCT00123734","[' Agen Biomedical ']","[]"]
["NCT00125398","https://clinicaltrials.gov/ct2/show/NCT00125398","[' Eisai Inc. ']","[]"]
["NCT00125424","https://clinicaltrials.gov/ct2/show/NCT00125424","[' Eisai Inc. ']","[]"]
["NCT00125892","https://clinicaltrials.gov/ct2/show/NCT00125892","[' Eli Lilly and Company ']","[]"]
["NCT00125918","https://clinicaltrials.gov/ct2/show/NCT00125918","[' Eli Lilly and Company ']","[]"]
["NCT00125944","https://clinicaltrials.gov/ct2/show/NCT00125944","[' MedImmune LLC ']","[]"]
["NCT00128934","https://clinicaltrials.gov/ct2/show/NCT00128934","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00129844","https://clinicaltrials.gov/ct2/show/NCT00129844","[' Pharmacyclics LLC. ']","[]"]
["NCT00130182","https://clinicaltrials.gov/ct2/show/NCT00130182","[' Merck Sharp & Dohme Corp. ']","[]"]
["NCT00130221","https://clinicaltrials.gov/ct2/show/NCT00130221","[' John H. Stroger Hospital ']","[]"]
["NCT00132015","https://clinicaltrials.gov/ct2/show/NCT00132015","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00132600","https://clinicaltrials.gov/ct2/show/NCT00132600","[' Mekos Laboratories AS ']","[]"]
["NCT00133380","https://clinicaltrials.gov/ct2/show/NCT00133380","[' Eli Lilly and Company ']","[]"]
["NCT00134134","https://clinicaltrials.gov/ct2/show/NCT00134134","[' New York University School of Medicine ']","[]"]
["NCT00134147","https://clinicaltrials.gov/ct2/show/NCT00134147","[' Pfizer ']","[]"]
["NCT00134199","https://clinicaltrials.gov/ct2/show/NCT00134199","[' Pfizer ']","[]"]
["NCT00134394","https://clinicaltrials.gov/ct2/show/NCT00134394","[' University of Medicine and Dentistry of New Jersey ']","[]"]
["NCT00134485","https://clinicaltrials.gov/ct2/show/NCT00134485","[' Pfizer ']","[]"]
["NCT00134498","https://clinicaltrials.gov/ct2/show/NCT00134498","[' Pfizer ']","[]"]
["NCT00134511","https://clinicaltrials.gov/ct2/show/NCT00134511","[' Pfizer ']","[]"]
["NCT00135993","https://clinicaltrials.gov/ct2/show/NCT00135993","[' UCB Pharma ']","[]"]
["NCT00136045","https://clinicaltrials.gov/ct2/show/NCT00136045","[' UCB Pharma ']","[]"]
["NCT00136266","https://clinicaltrials.gov/ct2/show/NCT00136266","[' Centers for Disease Control and Prevention ']","[]"]
["NCT00136383","https://clinicaltrials.gov/ct2/show/NCT00136383","[' Duke University ']","[]"]
["NCT00136643","https://clinicaltrials.gov/ct2/show/NCT00136643","[' Laval University ']","[]"]
["NCT00137371","https://clinicaltrials.gov/ct2/show/NCT00137371","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00139061","https://clinicaltrials.gov/ct2/show/NCT00139061","[' Pfizer ']","[]"]
["NCT00139789","https://clinicaltrials.gov/ct2/show/NCT00139789","[' UCB Pharma ']","[]"]
["NCT00139880","https://clinicaltrials.gov/ct2/show/NCT00139880","[' UCB Pharma ']","[]"]
["NCT00139906","https://clinicaltrials.gov/ct2/show/NCT00139906","[' Solvay Pharmaceuticals ']","[]"]
["NCT00139919","https://clinicaltrials.gov/ct2/show/NCT00139919","[' Solvay Pharmaceuticals ']","[]"]
["NCT00141050","https://clinicaltrials.gov/ct2/show/NCT00141050","[' Novartis ']","[]"]
["NCT00141063","https://clinicaltrials.gov/ct2/show/NCT00141063","[' Novartis ']","[]"]
["NCT00141167","https://clinicaltrials.gov/ct2/show/NCT00141167","[' Pfizer ']","[]"]
["NCT00141349","https://clinicaltrials.gov/ct2/show/NCT00141349","[' Pfizer ']","[]"]
["NCT00141479","https://clinicaltrials.gov/ct2/show/NCT00141479","[' Solvay Pharmaceuticals ']","[]"]
["NCT00141505","https://clinicaltrials.gov/ct2/show/NCT00141505","[' Solvay Pharmaceuticals ']","[]"]
["NCT00141791","https://clinicaltrials.gov/ct2/show/NCT00141791","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00141830","https://clinicaltrials.gov/ct2/show/NCT00141830","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00142454","https://clinicaltrials.gov/ct2/show/NCT00142454","[' Ludwig Institute for Cancer Research ']","[]"]
["NCT00143156","https://clinicaltrials.gov/ct2/show/NCT00143156","[' Pfizer ']","[]"]
["NCT00143325","https://clinicaltrials.gov/ct2/show/NCT00143325","[' Pfizer ']","[]"]
["NCT00143481","https://clinicaltrials.gov/ct2/show/NCT00143481","[' Pfizer ']","[]"]
["NCT00144313","https://clinicaltrials.gov/ct2/show/NCT00144313","[' Centers for Disease Control and Prevention ']","[]"]
["NCT00145210","https://clinicaltrials.gov/ct2/show/NCT00145210","[' Mylan Bertek Pharmaceuticals ']","[]"]
["NCT00146003","https://clinicaltrials.gov/ct2/show/NCT00146003","[' University of Medicine and Dentistry of New Jersey ']","[]"]
["NCT00146185","https://clinicaltrials.gov/ct2/show/NCT00146185","[' AlgoRx Pharmaceuticals ']","[]"]
["NCT00146289","https://clinicaltrials.gov/ct2/show/NCT00146289","[' Boehringer Ingelheim ']","[]"]
["NCT00147329","https://clinicaltrials.gov/ct2/show/NCT00147329","[' Merrimack Pharmaceuticals ']","[]"]
["NCT00147628","https://clinicaltrials.gov/ct2/show/NCT00147628","[' Pfizer ']","[]"]
["NCT00148382","https://clinicaltrials.gov/ct2/show/NCT00148382","[' Alizyme ']","[]"]
["NCT00150215","https://clinicaltrials.gov/ct2/show/NCT00150215","[' Pfizer ']","[]"]
["NCT00151333","https://clinicaltrials.gov/ct2/show/NCT00151333","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00151528","https://clinicaltrials.gov/ct2/show/NCT00151528","[' Pfizer ']","[]"]
["NCT00151541","https://clinicaltrials.gov/ct2/show/NCT00151541","[' Allergan ']","[]"]
["NCT00151879","https://clinicaltrials.gov/ct2/show/NCT00151879","[' UCB Pharma ']","[]"]
["NCT00152386","https://clinicaltrials.gov/ct2/show/NCT00152386","[' UCB Pharma ']","[]"]
["NCT00152451","https://clinicaltrials.gov/ct2/show/NCT00152451","[' UCB Pharma ']","[]"]
["NCT00152503","https://clinicaltrials.gov/ct2/show/NCT00152503","[' UCB Pharma ']","[]"]
["NCT00153790","https://clinicaltrials.gov/ct2/show/NCT00153790","[' The Cooper Institute ']","[]"]
["NCT00156403","https://clinicaltrials.gov/ct2/show/NCT00156403","[' University of Pittsburgh ']","[]"]
["NCT00156520","https://clinicaltrials.gov/ct2/show/NCT00156520","[' University of Rochester ']","[]"]
["NCT00160121","https://clinicaltrials.gov/ct2/show/NCT00160121","[' Shire ']","[]"]
["NCT00160303","https://clinicaltrials.gov/ct2/show/NCT00160303","[' Spaulding Rehabilitation Hospital ']","[]"]
["NCT00160602","https://clinicaltrials.gov/ct2/show/NCT00160602","[' UCB Pharma ']","[]"]
["NCT00162149","https://clinicaltrials.gov/ct2/show/NCT00162149","[' Bristol-Myers Squibb ']","[]"]
["NCT00162318","https://clinicaltrials.gov/ct2/show/NCT00162318","[' Eli Lilly and Company ']","[]"]
["NCT00163085","https://clinicaltrials.gov/ct2/show/NCT00163085","[' Pfizer ']","[]"]
["NCT00165295","https://clinicaltrials.gov/ct2/show/NCT00165295","[' Dana-Farber Cancer Institute ']","[]"]
["NCT00165334","https://clinicaltrials.gov/ct2/show/NCT00165334","[' Dana-Farber Cancer Institute ']","[]"]
["NCT00165568","https://clinicaltrials.gov/ct2/show/NCT00165568","[' Dana-Farber Cancer Institute ']","[]"]
["NCT00166452","https://clinicaltrials.gov/ct2/show/NCT00166452","[' Mayo Clinic ']","[]"]
["NCT00166556","https://clinicaltrials.gov/ct2/show/NCT00166556","[' Mayo Clinic ']","[]"]
["NCT00170456","https://clinicaltrials.gov/ct2/show/NCT00170456","[' PharmAthene UK Limited ']","[]"]
["NCT00170469","https://clinicaltrials.gov/ct2/show/NCT00170469","[' PharmAthene UK Limited ']","[]"]
["NCT00171405","https://clinicaltrials.gov/ct2/show/NCT00171405","[' Novartis ']","[]"]
["NCT00171457","https://clinicaltrials.gov/ct2/show/NCT00171457","[' Novartis ']","[]"]
["NCT00171470","https://clinicaltrials.gov/ct2/show/NCT00171470","[' Novartis ']","[]"]
["NCT00174538","https://clinicaltrials.gov/ct2/show/NCT00174538","[' PriCara, Unit of Ortho-McNeil, Inc. ']","[]"]
["NCT00177398","https://clinicaltrials.gov/ct2/show/NCT00177398","[' University of Pittsburgh ']","[]"]
["NCT00181116","https://clinicaltrials.gov/ct2/show/NCT00181116","[' Johns Hopkins University ']","[]"]
["NCT00182845","https://clinicaltrials.gov/ct2/show/NCT00182845","[' Pfizer ']","[]"]
["NCT00183222","https://clinicaltrials.gov/ct2/show/NCT00183222","[' Medical University of South Carolina ']","[]"]
["NCT00183235","https://clinicaltrials.gov/ct2/show/NCT00183235","[' Medical University of South Carolina ']","[]"]
["NCT00185562","https://clinicaltrials.gov/ct2/show/NCT00185562","[' Stanford University ']","[]"]
["NCT00189150","https://clinicaltrials.gov/ct2/show/NCT00189150","[' University of Michigan ']","[]"]
["NCT00190853","https://clinicaltrials.gov/ct2/show/NCT00190853","[' Eli Lilly and Company ']","[]"]
["NCT00190866","https://clinicaltrials.gov/ct2/show/NCT00190866","[' Eli Lilly and Company ']","[]"]
["NCT00190879","https://clinicaltrials.gov/ct2/show/NCT00190879","[' Eli Lilly and Company ']","[]"]
["NCT00190918","https://clinicaltrials.gov/ct2/show/NCT00190918","[' Eli Lilly and Company ']","[]"]
["NCT00190983","https://clinicaltrials.gov/ct2/show/NCT00190983","[' Eli Lilly and Company ']","[]"]
["NCT00191412","https://clinicaltrials.gov/ct2/show/NCT00191412","[' Eli Lilly and Company ']","[]"]
["NCT00193648","https://clinicaltrials.gov/ct2/show/NCT00193648","[' Northwell Health ']","[]"]
["NCT00193687","https://clinicaltrials.gov/ct2/show/NCT00193687","[' Solvay Pharmaceuticals ']","[]"]
["NCT00193713","https://clinicaltrials.gov/ct2/show/NCT00193713","[' Solvay Pharmaceuticals ']","[]"]
["NCT00195546","https://clinicaltrials.gov/ct2/show/NCT00195546","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00198198","https://clinicaltrials.gov/ct2/show/NCT00198198","[' Indiana University School of Medicine ']","[]"]
["NCT00198289","https://clinicaltrials.gov/ct2/show/NCT00198289","[' Bristol-Myers Squibb ']","[]"]
["NCT00199433","https://clinicaltrials.gov/ct2/show/NCT00199433","[' Kyowa Kirin Pharmaceutical Development, Inc. ']","[]"]
["NCT00199446","https://clinicaltrials.gov/ct2/show/NCT00199446","[' Kyowa Kirin Pharmaceutical Development, Inc. ']","[]"]
["NCT00199888","https://clinicaltrials.gov/ct2/show/NCT00199888","[' Ludwig Institute for Cancer Research ']","[]"]
["NCT00203320","https://clinicaltrials.gov/ct2/show/NCT00203320","[' Tobinick, Edward Lewis, M.D. ']","[]"]
["NCT00206141","https://clinicaltrials.gov/ct2/show/NCT00206141","[' AstraZeneca ']","[]"]
["NCT00206154","https://clinicaltrials.gov/ct2/show/NCT00206154","[' AstraZeneca ']","[]"]
["NCT00206167","https://clinicaltrials.gov/ct2/show/NCT00206167","[' AstraZeneca ']","[]"]
["NCT00207077","https://clinicaltrials.gov/ct2/show/NCT00207077","[' Eli Lilly and Company ']","[]"]
["NCT00208169","https://clinicaltrials.gov/ct2/show/NCT00208169","[' Creighton University ']","[]"]
["NCT00210496","https://clinicaltrials.gov/ct2/show/NCT00210496","[' Janssen-Ortho LLC ']","[]"]
["NCT00210535","https://clinicaltrials.gov/ct2/show/NCT00210535","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00210548","https://clinicaltrials.gov/ct2/show/NCT00210548","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00210574","https://clinicaltrials.gov/ct2/show/NCT00210574","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00210587","https://clinicaltrials.gov/ct2/show/NCT00210587","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00210600","https://clinicaltrials.gov/ct2/show/NCT00210600","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00210704","https://clinicaltrials.gov/ct2/show/NCT00210704","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00210717","https://clinicaltrials.gov/ct2/show/NCT00210717","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00211276","https://clinicaltrials.gov/ct2/show/NCT00211276","[' Eisai Inc. ']","[]"]
["NCT00212316","https://clinicaltrials.gov/ct2/show/NCT00212316","[' University of Rochester ']","[]"]
["NCT00212810","https://clinicaltrials.gov/ct2/show/NCT00212810","[' Ortho-McNeil Neurologics, Inc. ']","[]"]
["NCT00212875","https://clinicaltrials.gov/ct2/show/NCT00212875","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00214617","https://clinicaltrials.gov/ct2/show/NCT00214617","[' Atlanta Research and Education Foundation ']","[]"]
["NCT00216294","https://clinicaltrials.gov/ct2/show/NCT00216294","[' Indiana University School of Medicine ']","[]"]
["NCT00216879","https://clinicaltrials.gov/ct2/show/NCT00216879","[' LEO Pharma ']","[]"]
["NCT00217048","https://clinicaltrials.gov/ct2/show/NCT00217048","[' Mayo Clinic ']","[]"]
["NCT00217204","https://clinicaltrials.gov/ct2/show/NCT00217204","[' McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. ']","[]"]
["NCT00217503","https://clinicaltrials.gov/ct2/show/NCT00217503","[' National Cancer Institute (NCI) ']","[]"]
["NCT00217568","https://clinicaltrials.gov/ct2/show/NCT00217568","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00219076","https://clinicaltrials.gov/ct2/show/NCT00219076","[' Novartis ']","[]"]
["NCT00219102","https://clinicaltrials.gov/ct2/show/NCT00219102","[' Novartis ']","[]"]
["NCT00219817","https://clinicaltrials.gov/ct2/show/NCT00219817","[' Helsinn Therapeutics (U.S.), Inc ']","[]"]
["NCT00219843","https://clinicaltrials.gov/ct2/show/NCT00219843","[' Provectus Pharmaceuticals ']","[]"]
["NCT00220857","https://clinicaltrials.gov/ct2/show/NCT00220857","[' Temple University ']","[]"]
["NCT00222170","https://clinicaltrials.gov/ct2/show/NCT00222170","[' University of Kansas ']","[]"]
["NCT00225615","https://clinicaltrials.gov/ct2/show/NCT00225615","[' BioMarin Pharmaceutical ']","[]"]
["NCT00226057","https://clinicaltrials.gov/ct2/show/NCT00226057","[' Oregon Health and Science University ']","[]"]
["NCT00228462","https://clinicaltrials.gov/ct2/show/NCT00228462","[' AstraZeneca ']","[]"]
["NCT00228566","https://clinicaltrials.gov/ct2/show/NCT00228566","[' Cephalon ']","[]"]
["NCT00228605","https://clinicaltrials.gov/ct2/show/NCT00228605","[' Cephalon ']","[]"]
["NCT00230516","https://clinicaltrials.gov/ct2/show/NCT00230516","[' AstraZeneca ']","[]"]
["NCT00230828","https://clinicaltrials.gov/ct2/show/NCT00230828","[' Solvay Pharmaceuticals ']","[]"]
["NCT00231218","https://clinicaltrials.gov/ct2/show/NCT00231218","[' The Cleveland Clinic ']","[]"]
["NCT00231725","https://clinicaltrials.gov/ct2/show/NCT00231725","[' Eli Lilly and Company ']","[]"]
["NCT00232154","https://clinicaltrials.gov/ct2/show/NCT00232154","[' Pfizer ']","[]"]
["NCT00232726","https://clinicaltrials.gov/ct2/show/NCT00232726","[' Clavis Pharma ']","[]"]
["NCT00232947","https://clinicaltrials.gov/ct2/show/NCT00232947","[' ID Biomedical Corporation, Quebec ']","[]"]
["NCT00233012","https://clinicaltrials.gov/ct2/show/NCT00233012","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00233025","https://clinicaltrials.gov/ct2/show/NCT00233025","[' Eli Lilly and Company ']","[]"]
["NCT00233155","https://clinicaltrials.gov/ct2/show/NCT00233155","[' NeurogesX ']","[]"]
["NCT00233961","https://clinicaltrials.gov/ct2/show/NCT00233961","[' Herbert Irving Comprehensive Cancer Center ']","[]"]
["NCT00234195","https://clinicaltrials.gov/ct2/show/NCT00234195","[' Thomas Jefferson University ']","[]"]
["NCT00234663","https://clinicaltrials.gov/ct2/show/NCT00234663","[' PTC Therapeutics ']","[]"]
["NCT00234819","https://clinicaltrials.gov/ct2/show/NCT00234819","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00235274","https://clinicaltrials.gov/ct2/show/NCT00235274","[' Indiana University School of Medicine ']","[]"]
["NCT00235625","https://clinicaltrials.gov/ct2/show/NCT00235625","[' University of Pennsylvania ']","[]"]
["NCT00237237","https://clinicaltrials.gov/ct2/show/NCT00237237","[' Novartis ']","[]"]
["NCT00237640","https://clinicaltrials.gov/ct2/show/NCT00237640","[' University of Oklahoma ']","[]"]
["NCT00238732","https://clinicaltrials.gov/ct2/show/NCT00238732","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00239135","https://clinicaltrials.gov/ct2/show/NCT00239135","[' Peplin ']","[]"]
["NCT00239148","https://clinicaltrials.gov/ct2/show/NCT00239148","[' Transition Therapeutics ']","[]"]
["NCT00239187","https://clinicaltrials.gov/ct2/show/NCT00239187","[' Transition Therapeutics ']","[]"]
["NCT00239915","https://clinicaltrials.gov/ct2/show/NCT00239915","[' Pharmacology Research Institute ']","[]"]
["NCT00241436","https://clinicaltrials.gov/ct2/show/NCT00241436","[' AstraZeneca ']","[]"]
["NCT00242164","https://clinicaltrials.gov/ct2/show/NCT00242164","[' University of Michigan ']","[]"]
["NCT00242281","https://clinicaltrials.gov/ct2/show/NCT00242281","[' Advancis Pharmaceutical Corporation ']","[]"]
["NCT00242736","https://clinicaltrials.gov/ct2/show/NCT00242736","[' AstraZeneca ']","[]"]
["NCT00243542","https://clinicaltrials.gov/ct2/show/NCT00243542","[' Allergan ']","[]"]
["NCT00244322","https://clinicaltrials.gov/ct2/show/NCT00244322","[' Eli Lilly and Company ']","[]"]
["NCT00244816","https://clinicaltrials.gov/ct2/show/NCT00244816","[' American Regent, Inc. ']","[]"]
["NCT00245245","https://clinicaltrials.gov/ct2/show/NCT00245245","[' Octagen Corporation ']","[]"]
["NCT00245258","https://clinicaltrials.gov/ct2/show/NCT00245258","[' Pfizer ']","[]"]
["NCT00245973","https://clinicaltrials.gov/ct2/show/NCT00245973","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00246207","https://clinicaltrials.gov/ct2/show/NCT00246207","[' Janssen-Ortho Inc., Canada ']","[]"]
["NCT00246233","https://clinicaltrials.gov/ct2/show/NCT00246233","[' Janssen-Ortho Inc., Canada ']","[]"]
["NCT00246467","https://clinicaltrials.gov/ct2/show/NCT00246467","[' PharmAthene UK Limited ']","[]"]
["NCT00246623","https://clinicaltrials.gov/ct2/show/NCT00246623","[' Pfizer ']","[]"]
["NCT00247572","https://clinicaltrials.gov/ct2/show/NCT00247572","[' New River Pharmaceuticals ']","[]"]
["NCT00248092","https://clinicaltrials.gov/ct2/show/NCT00248092","[' New River Pharmaceuticals ']","[]"]
["NCT00249262","https://clinicaltrials.gov/ct2/show/NCT00249262","[' American Regent, Inc. ']","[]"]
["NCT00249782","https://clinicaltrials.gov/ct2/show/NCT00249782","[' Allergan ']","[]"]
["NCT00251459","https://clinicaltrials.gov/ct2/show/NCT00251459","[' Genentech, Inc. ']","[]"]
["NCT00252291","https://clinicaltrials.gov/ct2/show/NCT00252291","[' Pharmaxis ']","[]"]
["NCT00253474","https://clinicaltrials.gov/ct2/show/NCT00253474","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00253591","https://clinicaltrials.gov/ct2/show/NCT00253591","[' Medical Research Council ']","[]"]
["NCT00254449","https://clinicaltrials.gov/ct2/show/NCT00254449","[' NeurogesX ']","[]"]
["NCT00255294","https://clinicaltrials.gov/ct2/show/NCT00255294","[' CONRAD ']","[]"]
["NCT00255606","https://clinicaltrials.gov/ct2/show/NCT00255606","[' University of Tampere ']","[]"]
["NCT00255788","https://clinicaltrials.gov/ct2/show/NCT00255788","[' NCIC Clinical Trials Group ']","[]"]
["NCT00256191","https://clinicaltrials.gov/ct2/show/NCT00256191","[' Cortice Biosciences, Inc. ']","[]"]
["NCT00256542","https://clinicaltrials.gov/ct2/show/NCT00256542","[' Urigen ']","[]"]
["NCT00257725","https://clinicaltrials.gov/ct2/show/NCT00257725","[' New York State Psychiatric Institute ']","[]"]
["NCT00258193","https://clinicaltrials.gov/ct2/show/NCT00258193","[' Ironwood Pharmaceuticals, Inc. ']","[]"]
["NCT00258375","https://clinicaltrials.gov/ct2/show/NCT00258375","[' NCIC Clinical Trials Group ']","[]"]
["NCT00258778","https://clinicaltrials.gov/ct2/show/NCT00258778","[' Protalix ']","[]"]
["NCT00259311","https://clinicaltrials.gov/ct2/show/NCT00259311","[' Eli Lilly and Company ']","[]"]
["NCT00261131","https://clinicaltrials.gov/ct2/show/NCT00261131","[' Shriners Hospitals for Children ']","[]"]
["NCT00261599","https://clinicaltrials.gov/ct2/show/NCT00261599","[' Eisai Inc. ']","[]"]
["NCT00262145","https://clinicaltrials.gov/ct2/show/NCT00262145","[' NatureGen ']","[]"]
["NCT00263562","https://clinicaltrials.gov/ct2/show/NCT00263562","[' Baylor College of Medicine ']","[]"]
["NCT00264888","https://clinicaltrials.gov/ct2/show/NCT00264888","[' PTC Therapeutics ']","[]"]
["NCT00265304","https://clinicaltrials.gov/ct2/show/NCT00265304","[' IDEA AG ']","[]"]
["NCT00265551","https://clinicaltrials.gov/ct2/show/NCT00265551","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00266318","https://clinicaltrials.gov/ct2/show/NCT00266318","[' Beth Israel Medical Center ']","[]"]
["NCT00266604","https://clinicaltrials.gov/ct2/show/NCT00266604","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00266643","https://clinicaltrials.gov/ct2/show/NCT00266643","[' Eli Lilly and Company ']","[]"]
["NCT00267254","https://clinicaltrials.gov/ct2/show/NCT00267254","[' Pfizer ']","[]"]
["NCT00267358","https://clinicaltrials.gov/ct2/show/NCT00267358","[' Helsinn Therapeutics (U.S.), Inc ']","[]"]
["NCT00268333","https://clinicaltrials.gov/ct2/show/NCT00268333","[' GERCOR - Multidisciplinary Oncology Cooperative Group ']","[]"]
["NCT00268827","https://clinicaltrials.gov/ct2/show/NCT00268827","[' AIDS Arms Inc. ']","[]"]
["NCT00269594","https://clinicaltrials.gov/ct2/show/NCT00269594","[' University of Minnesota - Clinical and Translational Science Institute ']","[]"]
["NCT00270452","https://clinicaltrials.gov/ct2/show/NCT00270452","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00270478","https://clinicaltrials.gov/ct2/show/NCT00270478","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00273429","https://clinicaltrials.gov/ct2/show/NCT00273429","[' Pharmaceutical Research Network ']","[]"]
["NCT00273442","https://clinicaltrials.gov/ct2/show/NCT00273442","[' Pharmaceutical Research Network ']","[]"]
["NCT00273455","https://clinicaltrials.gov/ct2/show/NCT00273455","[' Pharmaceutical Research Network ']","[]"]
["NCT00273702","https://clinicaltrials.gov/ct2/show/NCT00273702","[' University of Minnesota - Clinical and Translational Science Institute ']","[]"]
["NCT00273884","https://clinicaltrials.gov/ct2/show/NCT00273884","[' Xanthus Pharmaceuticals, Inc. ']","[]"]
["NCT00274326","https://clinicaltrials.gov/ct2/show/NCT00274326","[' Sanofi ']","[]"]
["NCT00275197","https://clinicaltrials.gov/ct2/show/NCT00275197","[' Pfizer ']","[]"]
["NCT00275236","https://clinicaltrials.gov/ct2/show/NCT00275236","[' UCB Pharma ']","[]"]
["NCT00276588","https://clinicaltrials.gov/ct2/show/NCT00276588","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00277498","https://clinicaltrials.gov/ct2/show/NCT00277498","[' Pfizer ']","[]"]
["NCT00277576","https://clinicaltrials.gov/ct2/show/NCT00277576","[' PowderMed ']","[]"]
["NCT00277823","https://clinicaltrials.gov/ct2/show/NCT00277823","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00278941","https://clinicaltrials.gov/ct2/show/NCT00278941","[' AstraZeneca ']","[]"]
["NCT00278967","https://clinicaltrials.gov/ct2/show/NCT00278967","[' Braintree Laboratories ']","[]"]
["NCT00279162","https://clinicaltrials.gov/ct2/show/NCT00279162","[' LEO Pharma ']","[]"]
["NCT00279214","https://clinicaltrials.gov/ct2/show/NCT00279214","[' Eli Lilly and Company ']","[]"]
["NCT00279903","https://clinicaltrials.gov/ct2/show/NCT00279903","[' Mayo Clinic ']","[]"]
["NCT00280540","https://clinicaltrials.gov/ct2/show/NCT00280540","[' Novartis ']","[]"]
["NCT00280774","https://clinicaltrials.gov/ct2/show/NCT00280774","[' University of Texas Southwestern Medical Center ']","[]"]
["NCT00281541","https://clinicaltrials.gov/ct2/show/NCT00281541","[' Astellas Pharma Inc ']","[]"]
["NCT00281866","https://clinicaltrials.gov/ct2/show/NCT00281866","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00282607","https://clinicaltrials.gov/ct2/show/NCT00282607","[' Dong-A PharmTech Co., Ltd. ']","[]"]
["NCT00282997","https://clinicaltrials.gov/ct2/show/NCT00282997","[' Pfizer ']","[]"]
["NCT00283790","https://clinicaltrials.gov/ct2/show/NCT00283790","[' Sanofi ']","[]"]
["NCT00284206","https://clinicaltrials.gov/ct2/show/NCT00284206","[' Seattle Institute for Biomedical and Clinical Research ']","[]"]
["NCT00284505","https://clinicaltrials.gov/ct2/show/NCT00284505","[' Washington University School of Medicine ']","[]"]
["NCT00285103","https://clinicaltrials.gov/ct2/show/NCT00285103","[' Santaris Pharma A/S ']","[]"]
["NCT00286806","https://clinicaltrials.gov/ct2/show/NCT00286806","[' Ascenta Therapeutics ']","[]"]
["NCT00286871","https://clinicaltrials.gov/ct2/show/NCT00286871","[' Duke University ']","[]"]
["NCT00287495","https://clinicaltrials.gov/ct2/show/NCT00287495","[' National Cancer Institute (NCI) ']","[]"]
["NCT00288652","https://clinicaltrials.gov/ct2/show/NCT00288652","[' Pfizer ']","[]"]
["NCT00289029","https://clinicaltrials.gov/ct2/show/NCT00289029","[' Bracco Diagnostics, Inc ']","[]"]
["NCT00289614","https://clinicaltrials.gov/ct2/show/NCT00289614","[' Bracco Diagnostics, Inc ']","[]"]
["NCT00290004","https://clinicaltrials.gov/ct2/show/NCT00290004","[' Pharmacyclics LLC. ']","[]"]
["NCT00290134","https://clinicaltrials.gov/ct2/show/NCT00290134","[' QuatRx Pharmaceuticals Company ']","[]"]
["NCT00290901","https://clinicaltrials.gov/ct2/show/NCT00290901","[' Pfizer ']","[]"]
["NCT00293215","https://clinicaltrials.gov/ct2/show/NCT00293215","[' Ludwig Institute for Cancer Research ']","[]"]
["NCT00293280","https://clinicaltrials.gov/ct2/show/NCT00293280","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00293410","https://clinicaltrials.gov/ct2/show/NCT00293410","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00293631","https://clinicaltrials.gov/ct2/show/NCT00293631","[' POZEN ']","[]"]
["NCT00293657","https://clinicaltrials.gov/ct2/show/NCT00293657","[' POZEN ']","[]"]
["NCT00293917","https://clinicaltrials.gov/ct2/show/NCT00293917","[' Astellas Pharma Inc ']","[]"]
["NCT00294931","https://clinicaltrials.gov/ct2/show/NCT00294931","[' SCRI Development Innovations, LLC ']","[]"]
["NCT00295308","https://clinicaltrials.gov/ct2/show/NCT00295308","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00295685","https://clinicaltrials.gov/ct2/show/NCT00295685","[' Digestive & Liver Disease Specialists ']","[]"]
["NCT00295984","https://clinicaltrials.gov/ct2/show/NCT00295984","[' National Cancer Institute (NCI) ']","[]"]
["NCT00296127","https://clinicaltrials.gov/ct2/show/NCT00296127","[' Pfizer ']","[]"]
["NCT00296218","https://clinicaltrials.gov/ct2/show/NCT00296218","[' Sanofi ']","[]"]
["NCT00296790","https://clinicaltrials.gov/ct2/show/NCT00296790","[' Sanofi ']","[]"]
["NCT00296803","https://clinicaltrials.gov/ct2/show/NCT00296803","[' Sanofi ']","[]"]
["NCT00298987","https://clinicaltrials.gov/ct2/show/NCT00298987","[' Bristol-Myers Squibb ']","[]"]
["NCT00299065","https://clinicaltrials.gov/ct2/show/NCT00299065","[' Critical Therapeutics ']","[]"]
["NCT00299715","https://clinicaltrials.gov/ct2/show/NCT00299715","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00299728","https://clinicaltrials.gov/ct2/show/NCT00299728","[' Ludwig Institute for Cancer Research ']","[]"]
["NCT00299988","https://clinicaltrials.gov/ct2/show/NCT00299988","[' Weill Medical College of Cornell University ']","[]"]
["NCT00300222","https://clinicaltrials.gov/ct2/show/NCT00300222","[' NeurogesX ']","[]"]
["NCT00301236","https://clinicaltrials.gov/ct2/show/NCT00301236","[' Novartis ']","[]"]
["NCT00301899","https://clinicaltrials.gov/ct2/show/NCT00301899","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00302224","https://clinicaltrials.gov/ct2/show/NCT00302224","[' DiObex ']","[]"]
["NCT00302250","https://clinicaltrials.gov/ct2/show/NCT00302250","[' Synvista Therapeutics, Inc ']","[]"]
["NCT00302445","https://clinicaltrials.gov/ct2/show/NCT00302445","[' Derm Research, PLLC ']","[]"]
["NCT00303940","https://clinicaltrials.gov/ct2/show/NCT00303940","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00304005","https://clinicaltrials.gov/ct2/show/NCT00304005","[' Vion Pharmaceuticals ']","[]"]
["NCT00304538","https://clinicaltrials.gov/ct2/show/NCT00304538","[' DiObex ']","[]"]
["NCT00304811","https://clinicaltrials.gov/ct2/show/NCT00304811","[' VA Medical Center, Houston ']","[]"]
["NCT00305812","https://clinicaltrials.gov/ct2/show/NCT00305812","[' NCIC Clinical Trials Group ']","[]"]
["NCT00305903","https://clinicaltrials.gov/ct2/show/NCT00305903","[' Novartis ']","[]"]
["NCT00306072","https://clinicaltrials.gov/ct2/show/NCT00306072","[' Ross Products ']","[]"]
["NCT00306254","https://clinicaltrials.gov/ct2/show/NCT00306254","[' Pfizer ']","[]"]
["NCT00306722","https://clinicaltrials.gov/ct2/show/NCT00306722","[' Eisai Inc. ']","[]"]
["NCT00306735","https://clinicaltrials.gov/ct2/show/NCT00306735","[' Eisai Inc. ']","[]"]
["NCT00306748","https://clinicaltrials.gov/ct2/show/NCT00306748","[' Ironwood Pharmaceuticals, Inc. ']","[]"]
["NCT00307749","https://clinicaltrials.gov/ct2/show/NCT00307749","[' Mitsubishi Tanabe Pharma Corporation ']","[]"]
["NCT00308243","https://clinicaltrials.gov/ct2/show/NCT00308243","[' Emphycorp ']","[]"]
["NCT00308399","https://clinicaltrials.gov/ct2/show/NCT00308399","[' Mayo Clinic ']","[]"]
["NCT00308529","https://clinicaltrials.gov/ct2/show/NCT00308529","[' SCRI Development Innovations, LLC ']","[]"]
["NCT00309049","https://clinicaltrials.gov/ct2/show/NCT00309049","[' R-Pharm ']","[]"]
["NCT00309322","https://clinicaltrials.gov/ct2/show/NCT00309322","[' Novalar Pharmaceuticals, Inc. ']","[]"]
["NCT00309335","https://clinicaltrials.gov/ct2/show/NCT00309335","[' Novalar Pharmaceuticals, Inc. ']","[]"]
["NCT00309361","https://clinicaltrials.gov/ct2/show/NCT00309361","[' Novalar Pharmaceuticals, Inc. ']","[]"]
["NCT00309686","https://clinicaltrials.gov/ct2/show/NCT00309686","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00310271","https://clinicaltrials.gov/ct2/show/NCT00310271","[' PowderMed ']","[]"]
["NCT00311519","https://clinicaltrials.gov/ct2/show/NCT00311519","[' Halozyme Therapeutics ']","[]"]
["NCT00311779","https://clinicaltrials.gov/ct2/show/NCT00311779","[' ParaPRO LLC ']","[]"]
["NCT00312026","https://clinicaltrials.gov/ct2/show/NCT00312026","[' Genentech, Inc. ']","[]"]
["NCT00312039","https://clinicaltrials.gov/ct2/show/NCT00312039","[' Achillion Pharmaceuticals ']","[]"]
["NCT00312182","https://clinicaltrials.gov/ct2/show/NCT00312182","[' Pfizer ']","[]"]
["NCT00314210","https://clinicaltrials.gov/ct2/show/NCT00314210","[' AstraZeneca ']","[]"]
["NCT00314964","https://clinicaltrials.gov/ct2/show/NCT00314964","[' Pfizer ']","[]"]
["NCT00315861","https://clinicaltrials.gov/ct2/show/NCT00315861","[' SCRI Development Innovations, LLC ']","[]"]
["NCT00315952","https://clinicaltrials.gov/ct2/show/NCT00315952","[' University of Pittsburgh ']","[]"]
["NCT00316940","https://clinicaltrials.gov/ct2/show/NCT00316940","[' Oncotherapeutics ']","[]"]
["NCT00317785","https://clinicaltrials.gov/ct2/show/NCT00317785","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00317811","https://clinicaltrials.gov/ct2/show/NCT00317811","[' Oncotherapeutics ']","[]"]
["NCT00318344","https://clinicaltrials.gov/ct2/show/NCT00318344","[' Mayo Clinic ']","[]"]
["NCT00318500","https://clinicaltrials.gov/ct2/show/NCT00318500","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00318760","https://clinicaltrials.gov/ct2/show/NCT00318760","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00319163","https://clinicaltrials.gov/ct2/show/NCT00319163","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00319670","https://clinicaltrials.gov/ct2/show/NCT00319670","[' Braintree Laboratories ']","[]"]
["NCT00320268","https://clinicaltrials.gov/ct2/show/NCT00320268","[' AstraZeneca ']","[]"]
["NCT00321490","https://clinicaltrials.gov/ct2/show/NCT00321490","[' AstraZeneca ']","[]"]
["NCT00321516","https://clinicaltrials.gov/ct2/show/NCT00321516","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","[]"]
["NCT00321581","https://clinicaltrials.gov/ct2/show/NCT00321581","[' National Cancer Institute (NCI) ']","[]"]
["NCT00322127","https://clinicaltrials.gov/ct2/show/NCT00322127","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00323102","https://clinicaltrials.gov/ct2/show/NCT00323102","[' Bracco Diagnostics, Inc ']","[]"]
["NCT00325481","https://clinicaltrials.gov/ct2/show/NCT00325481","[' MedImmune LLC ']","[]"]
["NCT00325507","https://clinicaltrials.gov/ct2/show/NCT00325507","[' Oxford BioMedica ']","[]"]
["NCT00325962","https://clinicaltrials.gov/ct2/show/NCT00325962","[' BioMarin Pharmaceutical ']","[]"]
["NCT00326105","https://clinicaltrials.gov/ct2/show/NCT00326105","[' AstraZeneca ']","[]"]
["NCT00326300","https://clinicaltrials.gov/ct2/show/NCT00326300","[' McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. ']","[]"]
["NCT00326326","https://clinicaltrials.gov/ct2/show/NCT00326326","[' Pfizer ']","[]"]
["NCT00326391","https://clinicaltrials.gov/ct2/show/NCT00326391","[' McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. ']","[]"]
["NCT00327392","https://clinicaltrials.gov/ct2/show/NCT00327392","[' Eisai Inc. ']","[]"]
["NCT00328640","https://clinicaltrials.gov/ct2/show/NCT00328640","[' University of California, San Francisco ']","[]"]
["NCT00329095","https://clinicaltrials.gov/ct2/show/NCT00329095","[' Robin, Alan L., M.D. ']","[]"]
["NCT00329147","https://clinicaltrials.gov/ct2/show/NCT00329147","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00329264","https://clinicaltrials.gov/ct2/show/NCT00329264","[' AstraZeneca ']","[]"]
["NCT00329446","https://clinicaltrials.gov/ct2/show/NCT00329446","[' AstraZeneca ']","[]"]
["NCT00330070","https://clinicaltrials.gov/ct2/show/NCT00330070","[' Inflazyme Pharmaceuticals Ltd ']","[]"]
["NCT00330486","https://clinicaltrials.gov/ct2/show/NCT00330486","[' Medical University of South Carolina ']","[]"]
["NCT00330525","https://clinicaltrials.gov/ct2/show/NCT00330525","[' Mayo Clinic ']","[]"]
["NCT00330655","https://clinicaltrials.gov/ct2/show/NCT00330655","[' Mclean Hospital ']","[]"]
["NCT00330850","https://clinicaltrials.gov/ct2/show/NCT00330850","[' ProEthic Pharmaceuticals ']","[]"]
["NCT00330993","https://clinicaltrials.gov/ct2/show/NCT00330993","[' University of Pittsburgh ']","[]"]
["NCT00331175","https://clinicaltrials.gov/ct2/show/NCT00331175","[' Pfizer ']","[]"]
["NCT00331201","https://clinicaltrials.gov/ct2/show/NCT00331201","[' Intermountain Health Care, Inc. ']","[]"]
["NCT00331227","https://clinicaltrials.gov/ct2/show/NCT00331227","[' Carolinas Healthcare System ']","[]"]
["NCT00331916","https://clinicaltrials.gov/ct2/show/NCT00331916","[' Alcon Research ']","[]"]
["NCT00332761","https://clinicaltrials.gov/ct2/show/NCT00332761","[' Pfizer ']","[]"]
["NCT00333255","https://clinicaltrials.gov/ct2/show/NCT00333255","[' Alcon Research ']","[]"]
["NCT00334126","https://clinicaltrials.gov/ct2/show/NCT00334126","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00334880","https://clinicaltrials.gov/ct2/show/NCT00334880","[' New River Pharmaceuticals ']","[]"]
["NCT00335933","https://clinicaltrials.gov/ct2/show/NCT00335933","[' Depomed ']","[]"]
["NCT00337246","https://clinicaltrials.gov/ct2/show/NCT00337246","[' Cancer Research UK ']","[]"]
["NCT00337545","https://clinicaltrials.gov/ct2/show/NCT00337545","[' Swedish Medical Center ']","[]"]
["NCT00338650","https://clinicaltrials.gov/ct2/show/NCT00338650","[' Abbott ']","[]"]
["NCT00339872","https://clinicaltrials.gov/ct2/show/NCT00339872","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00340327","https://clinicaltrials.gov/ct2/show/NCT00340327","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00343148","https://clinicaltrials.gov/ct2/show/NCT00343148","[' Sarepta Therapeutics ']","[]"]
["NCT00343408","https://clinicaltrials.gov/ct2/show/NCT00343408","[' NCIC Clinical Trials Group ']","[]"]
["NCT00343876","https://clinicaltrials.gov/ct2/show/NCT00343876","[' Intermountain Health Care, Inc. ']","[]"]
["NCT00344851","https://clinicaltrials.gov/ct2/show/NCT00344851","[' Metabolic Center of Louisiana Research Foundation ']","[]"]
["NCT00346359","https://clinicaltrials.gov/ct2/show/NCT00346359","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00346424","https://clinicaltrials.gov/ct2/show/NCT00346424","[' ARCA Biopharma, Inc. ']","[]"]
["NCT00346619","https://clinicaltrials.gov/ct2/show/NCT00346619","[' Mayo Clinic ']","[]"]
["NCT00347204","https://clinicaltrials.gov/ct2/show/NCT00347204","[' Center For Excellence In Eye Care ']","[]"]
["NCT00350103","https://clinicaltrials.gov/ct2/show/NCT00350103","[' UCB Pharma ']","[]"]
["NCT00351546","https://clinicaltrials.gov/ct2/show/NCT00351546","[' Novartis ']","[]"]
["NCT00351754","https://clinicaltrials.gov/ct2/show/NCT00351754","[' Bracco Diagnostics, Inc ']","[]"]
["NCT00352261","https://clinicaltrials.gov/ct2/show/NCT00352261","[' AstraZeneca ']","[]"]
["NCT00352313","https://clinicaltrials.gov/ct2/show/NCT00352313","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00352430","https://clinicaltrials.gov/ct2/show/NCT00352430","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00352625","https://clinicaltrials.gov/ct2/show/NCT00352625","[' Endo Pharmaceuticals ']","[]"]
["NCT00353158","https://clinicaltrials.gov/ct2/show/NCT00353158","[' National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ']","[]"]
["NCT00355550","https://clinicaltrials.gov/ct2/show/NCT00355550","[' Accera, Inc. ']","[]"]
["NCT00356382","https://clinicaltrials.gov/ct2/show/NCT00356382","[' Georgetown University ']","[]"]
["NCT00356980","https://clinicaltrials.gov/ct2/show/NCT00356980","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00357188","https://clinicaltrials.gov/ct2/show/NCT00357188","[' Bristol-Myers Squibb ']","[]"]
["NCT00357240","https://clinicaltrials.gov/ct2/show/NCT00357240","[' Bristol-Myers Squibb ']","[]"]
["NCT00357604","https://clinicaltrials.gov/ct2/show/NCT00357604","[' Bristol-Myers Squibb ']","[]"]
["NCT00357721","https://clinicaltrials.gov/ct2/show/NCT00357721","[' Bristol-Myers Squibb ']","[]"]
["NCT00357916","https://clinicaltrials.gov/ct2/show/NCT00357916","[' Peplin ']","[]"]
["NCT00361166","https://clinicaltrials.gov/ct2/show/NCT00361166","[' ACADIA Pharmaceuticals Inc. ']","[]"]
["NCT00361582","https://clinicaltrials.gov/ct2/show/NCT00361582","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00361790","https://clinicaltrials.gov/ct2/show/NCT00361790","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","[]"]
["NCT00362271","https://clinicaltrials.gov/ct2/show/NCT00362271","[' Otsuka Pharmaceutical Development & Commercialization, Inc. ']","[]"]
["NCT00362596","https://clinicaltrials.gov/ct2/show/NCT00362596","[' Centers for Disease Control and Prevention ']","[]"]
["NCT00362726","https://clinicaltrials.gov/ct2/show/NCT00362726","[' Bristol-Myers Squibb ']","[]"]
["NCT00364546","https://clinicaltrials.gov/ct2/show/NCT00364546","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00365339","https://clinicaltrials.gov/ct2/show/NCT00365339","[' Bristol-Myers Squibb ']","[]"]
["NCT00365560","https://clinicaltrials.gov/ct2/show/NCT00365560","[' Boehringer Ingelheim ']","[]"]
["NCT00365586","https://clinicaltrials.gov/ct2/show/NCT00365586","[' Endo Pharmaceuticals ']","[]"]
["NCT00365781","https://clinicaltrials.gov/ct2/show/NCT00365781","[' Ionis Pharmaceuticals, Inc. ']","[]"]
["NCT00366171","https://clinicaltrials.gov/ct2/show/NCT00366171","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00366262","https://clinicaltrials.gov/ct2/show/NCT00366262","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00366522","https://clinicaltrials.gov/ct2/show/NCT00366522","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00366652","https://clinicaltrials.gov/ct2/show/NCT00366652","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00366691","https://clinicaltrials.gov/ct2/show/NCT00366691","[' Medical University of South Carolina ']","[]"]
["NCT00367445","https://clinicaltrials.gov/ct2/show/NCT00367445","[' Pfizer ']","[]"]
["NCT00367536","https://clinicaltrials.gov/ct2/show/NCT00367536","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00367614","https://clinicaltrials.gov/ct2/show/NCT00367614","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00368238","https://clinicaltrials.gov/ct2/show/NCT00368238","[' Yale University ']","[]"]
["NCT00368563","https://clinicaltrials.gov/ct2/show/NCT00368563","[' Loreal USA ']","[]"]
["NCT00369187","https://clinicaltrials.gov/ct2/show/NCT00369187","[' Halozyme Therapeutics ']","[]"]
["NCT00369304","https://clinicaltrials.gov/ct2/show/NCT00369304","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00369434","https://clinicaltrials.gov/ct2/show/NCT00369434","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00370006","https://clinicaltrials.gov/ct2/show/NCT00370006","[' University of California, San Francisco ']","[]"]
["NCT00371800","https://clinicaltrials.gov/ct2/show/NCT00371800","[' Dartmouth-Hitchcock Medical Center ']","[]"]
["NCT00372008","https://clinicaltrials.gov/ct2/show/NCT00372008","[' Acrux DDS Pty Ltd ']","[]"]
["NCT00372931","https://clinicaltrials.gov/ct2/show/NCT00372931","[' Alcon Research ']","[]"]
["NCT00372983","https://clinicaltrials.gov/ct2/show/NCT00372983","[' Cellectar Biosciences, Inc. ']","[]"]
["NCT00373893","https://clinicaltrials.gov/ct2/show/NCT00373893","[' University of California, San Diego ']","[]"]
["NCT00374478","https://clinicaltrials.gov/ct2/show/NCT00374478","[' Boston University ']","[]"]
["NCT00374855","https://clinicaltrials.gov/ct2/show/NCT00374855","[' Eli Lilly and Company ']","[]"]
["NCT00375206","https://clinicaltrials.gov/ct2/show/NCT00375206","[' PowderMed ']","[]"]
["NCT00375739","https://clinicaltrials.gov/ct2/show/NCT00375739","[' Peplin ']","[]"]
["NCT00375960","https://clinicaltrials.gov/ct2/show/NCT00375960","[' Vernalis (R&D) Ltd ']","[]"]
["NCT00377000","https://clinicaltrials.gov/ct2/show/NCT00377000","[' Sanofi ']","[]"]
["NCT00378001","https://clinicaltrials.gov/ct2/show/NCT00378001","[' IBSA Institut Biochimique SA ']","[]"]
["NCT00378131","https://clinicaltrials.gov/ct2/show/NCT00378131","[' Helsinn Therapeutics (U.S.), Inc ']","[]"]
["NCT00378287","https://clinicaltrials.gov/ct2/show/NCT00378287","[' Janssen-Ortho Inc., Canada ']","[]"]
["NCT00378521","https://clinicaltrials.gov/ct2/show/NCT00378521","[' MediQuest Therapeutics ']","[]"]
["NCT00378768","https://clinicaltrials.gov/ct2/show/NCT00378768","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00380003","https://clinicaltrials.gov/ct2/show/NCT00380003","[' Evotec Neurosciences GmbH ']","[]"]
["NCT00380224","https://clinicaltrials.gov/ct2/show/NCT00380224","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00380900","https://clinicaltrials.gov/ct2/show/NCT00380900","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00380965","https://clinicaltrials.gov/ct2/show/NCT00380965","[' NEMA Research, Inc. ']","[]"]
["NCT00381251","https://clinicaltrials.gov/ct2/show/NCT00381251","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00381316","https://clinicaltrials.gov/ct2/show/NCT00381316","[' GE Healthcare ']","[]"]
["NCT00381433","https://clinicaltrials.gov/ct2/show/NCT00381433","[' Sarepta Therapeutics ']","[]"]
["NCT00381901","https://clinicaltrials.gov/ct2/show/NCT00381901","[' National Cancer Institute, France ']","[]"]
["NCT00382083","https://clinicaltrials.gov/ct2/show/NCT00382083","[' Mountain States Tumor and Medical Research Institute ']","[]"]
["NCT00382629","https://clinicaltrials.gov/ct2/show/NCT00382629","[' Bayhill Therapeutics ']","[]"]
["NCT00383916","https://clinicaltrials.gov/ct2/show/NCT00383916","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00384072","https://clinicaltrials.gov/ct2/show/NCT00384072","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00384280","https://clinicaltrials.gov/ct2/show/NCT00384280","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00384384","https://clinicaltrials.gov/ct2/show/NCT00384384","[' University Hospital Inselspital, Berne ']","[]"]
["NCT00384917","https://clinicaltrials.gov/ct2/show/NCT00384917","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00386087","https://clinicaltrials.gov/ct2/show/NCT00386087","[' Eli Lilly and Company ']","[]"]
["NCT00387283","https://clinicaltrials.gov/ct2/show/NCT00387283","[' Sarepta Therapeutics ']","[]"]
["NCT00387608","https://clinicaltrials.gov/ct2/show/NCT00387608","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00388791","https://clinicaltrials.gov/ct2/show/NCT00388791","[' Southern California College of Optometry ']","[]"]
["NCT00389025","https://clinicaltrials.gov/ct2/show/NCT00389025","[' Alcon Research ']","[]"]
["NCT00389350","https://clinicaltrials.gov/ct2/show/NCT00389350","[' Dartmouth-Hitchcock Medical Center ']","[]"]
["NCT00391547","https://clinicaltrials.gov/ct2/show/NCT00391547","[' Biomedical Development Corporation ']","[]"]
["NCT00393328","https://clinicaltrials.gov/ct2/show/NCT00393328","[' Bristol-Myers Squibb ']","[]"]
["NCT00394173","https://clinicaltrials.gov/ct2/show/NCT00394173","[' Novartis ']","[]"]
["NCT00396422","https://clinicaltrials.gov/ct2/show/NCT00396422","[' Alza Corporation, DE, USA ']","[]"]
["NCT00396799","https://clinicaltrials.gov/ct2/show/NCT00396799","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00397176","https://clinicaltrials.gov/ct2/show/NCT00397176","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00399685","https://clinicaltrials.gov/ct2/show/NCT00399685","[' Bristol-Myers Squibb ']","[]"]
["NCT00400777","https://clinicaltrials.gov/ct2/show/NCT00400777","[' Novartis ']","[]"]
["NCT00401219","https://clinicaltrials.gov/ct2/show/NCT00401219","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00401284","https://clinicaltrials.gov/ct2/show/NCT00401284","[' Evotec Neurosciences GmbH ']","[]"]
["NCT00401726","https://clinicaltrials.gov/ct2/show/NCT00401726","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00402506","https://clinicaltrials.gov/ct2/show/NCT00402506","[' Medicure ']","[]"]
["NCT00403533","https://clinicaltrials.gov/ct2/show/NCT00403533","[' Massachusetts General Hospital ']","[]"]
["NCT00403637","https://clinicaltrials.gov/ct2/show/NCT00403637","[' Novartis ']","[]"]
["NCT00404001","https://clinicaltrials.gov/ct2/show/NCT00404001","[' Ironwood Pharmaceuticals, Inc. ']","[]"]
["NCT00405249","https://clinicaltrials.gov/ct2/show/NCT00405249","[' Thomas Jefferson University ']","[]"]
["NCT00406965","https://clinicaltrials.gov/ct2/show/NCT00406965","[' Genentech, Inc. ']","[]"]
["NCT00407095","https://clinicaltrials.gov/ct2/show/NCT00407095","[' Solvay Pharmaceuticals ']","[]"]
["NCT00407693","https://clinicaltrials.gov/ct2/show/NCT00407693","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT00408369","https://clinicaltrials.gov/ct2/show/NCT00408369","[' Immtech Pharmaceuticals, Inc ']","[]"]
["NCT00409305","https://clinicaltrials.gov/ct2/show/NCT00409305","[' OBEcure Ltd. ']","[]"]
["NCT00410254","https://clinicaltrials.gov/ct2/show/NCT00410254","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00410592","https://clinicaltrials.gov/ct2/show/NCT00410592","[' AstraZeneca ']","[]"]
["NCT00410657","https://clinicaltrials.gov/ct2/show/NCT00410657","[' Fred Hutchinson Cancer Research Center ']","[]"]
["NCT00410709","https://clinicaltrials.gov/ct2/show/NCT00410709","[' ParaPRO LLC ']","[]"]
["NCT00411333","https://clinicaltrials.gov/ct2/show/NCT00411333","[' National Eye Institute (NEI) ']","[]"]
["NCT00411437","https://clinicaltrials.gov/ct2/show/NCT00411437","[' Pfizer ']","[]"]
["NCT00414323","https://clinicaltrials.gov/ct2/show/NCT00414323","[' Eli Lilly and Company ']","[]"]
["NCT00414622","https://clinicaltrials.gov/ct2/show/NCT00414622","[' CoMentis ']","[]"]
["NCT00414999","https://clinicaltrials.gov/ct2/show/NCT00414999","[' TargeGen ']","[]"]
["NCT00416845","https://clinicaltrials.gov/ct2/show/NCT00416845","[' Novartis ']","[]"]
["NCT00416962","https://clinicaltrials.gov/ct2/show/NCT00416962","[' Novartis ']","[]"]
["NCT00419744","https://clinicaltrials.gov/ct2/show/NCT00419744","[' AstraZeneca ']","[]"]
["NCT00419796","https://clinicaltrials.gov/ct2/show/NCT00419796","[' Novartis ']","[]"]
["NCT00420498","https://clinicaltrials.gov/ct2/show/NCT00420498","[' Yale University ']","[]"]
["NCT00422123","https://clinicaltrials.gov/ct2/show/NCT00422123","[' AstraZeneca ']","[]"]
["NCT00422175","https://clinicaltrials.gov/ct2/show/NCT00422175","[' Novartis ']","[]"]
["NCT00422214","https://clinicaltrials.gov/ct2/show/NCT00422214","[' AstraZeneca ']","[]"]
["NCT00422240","https://clinicaltrials.gov/ct2/show/NCT00422240","[' Galderma ']","[]"]
["NCT00424788","https://clinicaltrials.gov/ct2/show/NCT00424788","[' Biogen ']","[]"]
["NCT00425126","https://clinicaltrials.gov/ct2/show/NCT00425126","[' West Penn Allegheny Health System ']","[]"]
["NCT00425763","https://clinicaltrials.gov/ct2/show/NCT00425763","[' Centers for Disease Control and Prevention ']","[]"]
["NCT00426673","https://clinicaltrials.gov/ct2/show/NCT00426673","[' UCB Pharma ']","[]"]
["NCT00427544","https://clinicaltrials.gov/ct2/show/NCT00427544","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00427687","https://clinicaltrials.gov/ct2/show/NCT00427687","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00428701","https://clinicaltrials.gov/ct2/show/NCT00428701","[' AstraZeneca ']","[]"]
["NCT00431782","https://clinicaltrials.gov/ct2/show/NCT00431782","[' ARYx Therapeutics ']","[]"]
["NCT00432757","https://clinicaltrials.gov/ct2/show/NCT00432757","[' Vistakon Pharmaceuticals ']","[]"]
["NCT00432978","https://clinicaltrials.gov/ct2/show/NCT00432978","[' VA Loma Linda Health Care System ']","[]"]
["NCT00434291","https://clinicaltrials.gov/ct2/show/NCT00434291","[' TaiGen Biotechnology Co., Ltd. ']","[]"]
["NCT00434486","https://clinicaltrials.gov/ct2/show/NCT00434486","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00435526","https://clinicaltrials.gov/ct2/show/NCT00435526","[' Johns Hopkins Bloomberg School of Public Health ']","[]"]
["NCT00435968","https://clinicaltrials.gov/ct2/show/NCT00435968","[' CV Technologies ']","[]"]
["NCT00436410","https://clinicaltrials.gov/ct2/show/NCT00436410","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00436787","https://clinicaltrials.gov/ct2/show/NCT00436787","[' University of Pittsburgh ']","[]"]
["NCT00440427","https://clinicaltrials.gov/ct2/show/NCT00440427","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00440492","https://clinicaltrials.gov/ct2/show/NCT00440492","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00441415","https://clinicaltrials.gov/ct2/show/NCT00441415","[' Galderma ']","[]"]
["NCT00442260","https://clinicaltrials.gov/ct2/show/NCT00442260","[' West Virginia University ']","[]"]
["NCT00445874","https://clinicaltrials.gov/ct2/show/NCT00445874","[' Vistakon Pharmaceuticals ']","[]"]
["NCT00446784","https://clinicaltrials.gov/ct2/show/NCT00446784","[' Pfizer ']","[]"]
["NCT00446940","https://clinicaltrials.gov/ct2/show/NCT00446940","[' Bader, Ted, M.D. ']","[]"]
["NCT00447629","https://clinicaltrials.gov/ct2/show/NCT00447629","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00447681","https://clinicaltrials.gov/ct2/show/NCT00447681","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00450177","https://clinicaltrials.gov/ct2/show/NCT00450177","[' Weill Medical College of Cornell University ']","[]"]
["NCT00450502","https://clinicaltrials.gov/ct2/show/NCT00450502","[' National Cancer Institute (NCI) ']","[]"]
["NCT00451724","https://clinicaltrials.gov/ct2/show/NCT00451724","[' Rhode Island Hospital ']","[]"]
["NCT00452101","https://clinicaltrials.gov/ct2/show/NCT00452101","[' Marigot Ltd. ']","[]"]
["NCT00452179","https://clinicaltrials.gov/ct2/show/NCT00452179","[' Arena Pharmaceuticals ']","[]"]
["NCT00452504","https://clinicaltrials.gov/ct2/show/NCT00452504","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00453050","https://clinicaltrials.gov/ct2/show/NCT00453050","[' University of Oklahoma ']","[]"]
["NCT00453609","https://clinicaltrials.gov/ct2/show/NCT00453609","[' State University of New York - Upstate Medical University ']","[]"]
["NCT00453804","https://clinicaltrials.gov/ct2/show/NCT00453804","[' State University of New York - Upstate Medical University ']","[]"]
["NCT00454441","https://clinicaltrials.gov/ct2/show/NCT00454441","[' Bionovo ']","[]"]
["NCT00454870","https://clinicaltrials.gov/ct2/show/NCT00454870","[' Memory Pharmaceuticals ']","[]"]
["NCT00455442","https://clinicaltrials.gov/ct2/show/NCT00455442","[' Corcept Therapeutics ']","[]"]
["NCT00456898","https://clinicaltrials.gov/ct2/show/NCT00456898","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00458107","https://clinicaltrials.gov/ct2/show/NCT00458107","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00458289","https://clinicaltrials.gov/ct2/show/NCT00458289","[' University of Illinois at Chicago ']","[]"]
["NCT00458614","https://clinicaltrials.gov/ct2/show/NCT00458614","[\" Arkansas Children's Hospital Research Institute \"]","[]"]
["NCT00459615","https://clinicaltrials.gov/ct2/show/NCT00459615","[' U.S. Army Office of the Surgeon General ']","[]"]
["NCT00459992","https://clinicaltrials.gov/ct2/show/NCT00459992","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00460096","https://clinicaltrials.gov/ct2/show/NCT00460096","[' Kamada, Ltd. ']","[]"]
["NCT00461370","https://clinicaltrials.gov/ct2/show/NCT00461370","[' Azevan Pharmaceuticals ']","[]"]
["NCT00463879","https://clinicaltrials.gov/ct2/show/NCT00463879","[' Yale University ']","[]"]
["NCT00464789","https://clinicaltrials.gov/ct2/show/NCT00464789","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00465075","https://clinicaltrials.gov/ct2/show/NCT00465075","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00465621","https://clinicaltrials.gov/ct2/show/NCT00465621","[' Alcon Research ']","[]"]
["NCT00467142","https://clinicaltrials.gov/ct2/show/NCT00467142","[u' Institut Bergoni\\xe9 ']","[]"]
["NCT00467467","https://clinicaltrials.gov/ct2/show/NCT00467467","[' University of Minnesota - Clinical and Translational Science Institute ']","[]"]
["NCT00469300","https://clinicaltrials.gov/ct2/show/NCT00469300","[' Transport Pharmaceuticals ']","[]"]
["NCT00471419","https://clinicaltrials.gov/ct2/show/NCT00471419","[' Alcon Research ']","[]"]
["NCT00472927","https://clinicaltrials.gov/ct2/show/NCT00472927","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00473070","https://clinicaltrials.gov/ct2/show/NCT00473070","[' Alcon Research ']","[]"]
["NCT00473577","https://clinicaltrials.gov/ct2/show/NCT00473577","[' Pharmacyclics LLC. ']","[]"]
["NCT00479440","https://clinicaltrials.gov/ct2/show/NCT00479440","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00479700","https://clinicaltrials.gov/ct2/show/NCT00479700","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00479778","https://clinicaltrials.gov/ct2/show/NCT00479778","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00479999","https://clinicaltrials.gov/ct2/show/NCT00479999","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00480753","https://clinicaltrials.gov/ct2/show/NCT00480753","[' MediQuest Therapeutics ']","[]"]
["NCT00480818","https://clinicaltrials.gov/ct2/show/NCT00480818","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00483990","https://clinicaltrials.gov/ct2/show/NCT00483990","[' Plethora Solutions Ltd ']","[]"]
["NCT00488046","https://clinicaltrials.gov/ct2/show/NCT00488046","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00491543","https://clinicaltrials.gov/ct2/show/NCT00491543","[' Synvista Therapeutics, Inc ']","[]"]
["NCT00497354","https://clinicaltrials.gov/ct2/show/NCT00497354","[' Sunnybrook Health Sciences Centre ']","[]"]
["NCT00497991","https://clinicaltrials.gov/ct2/show/NCT00497991","[' AstraZeneca ']","[]"]
["NCT00498108","https://clinicaltrials.gov/ct2/show/NCT00498108","[' UCB Pharma ']","[]"]
["NCT00499538","https://clinicaltrials.gov/ct2/show/NCT00499538","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00499642","https://clinicaltrials.gov/ct2/show/NCT00499642","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00504335","https://clinicaltrials.gov/ct2/show/NCT00504335","[' Humanetics Corporation ']","[]"]
["NCT00504829","https://clinicaltrials.gov/ct2/show/NCT00504829","[' Veloxis Pharmaceuticals ']","[]"]
["NCT00507117","https://clinicaltrials.gov/ct2/show/NCT00507117","[' Walter Reed Army Medical Center ']","[]"]
["NCT00508885","https://clinicaltrials.gov/ct2/show/NCT00508885","[' Washington University School of Medicine ']","[]"]
["NCT00509210","https://clinicaltrials.gov/ct2/show/NCT00509210","[' Vertex Pharmaceuticals Incorporated ']","[]"]
["NCT00513981","https://clinicaltrials.gov/ct2/show/NCT00513981","[\" Children's Cancer and Leukaemia Group \"]","[]"]
["NCT00513994","https://clinicaltrials.gov/ct2/show/NCT00513994","[' MediQuest Therapeutics ']","[]"]
["NCT00516802","https://clinicaltrials.gov/ct2/show/NCT00516802","[' AstraZeneca ']","[]"]
["NCT00517855","https://clinicaltrials.gov/ct2/show/NCT00517855","[' Protalex, Inc. ']","[]"]
["NCT00523146","https://clinicaltrials.gov/ct2/show/NCT00523146","[' Lianyungang Kanion Group, Ltd. ']","[]"]
["NCT00523926","https://clinicaltrials.gov/ct2/show/NCT00523926","[' Tibotec BVBA ']","[]"]
["NCT00528151","https://clinicaltrials.gov/ct2/show/NCT00528151","[' Mahidol University ']","[]"]
["NCT00528905","https://clinicaltrials.gov/ct2/show/NCT00528905","[' AstraZeneca ']","[]"]
["NCT00529581","https://clinicaltrials.gov/ct2/show/NCT00529581","[' Cognition Pharmaceuticals, LLC ']","[]"]
["NCT00530881","https://clinicaltrials.gov/ct2/show/NCT00530881","[' Phenomix ']","[]"]
["NCT00531596","https://clinicaltrials.gov/ct2/show/NCT00531596","[' Somerset Pharmaceuticals ']","[]"]
["NCT00534378","https://clinicaltrials.gov/ct2/show/NCT00534378","[' U.S. Army Office of the Surgeon General ']","[]"]
["NCT00537368","https://clinicaltrials.gov/ct2/show/NCT00537368","[' Centocor, Inc. ']","[]"]
["NCT00539396","https://clinicaltrials.gov/ct2/show/NCT00539396","[' Mannkind Corporation ']","[]"]
["NCT00539890","https://clinicaltrials.gov/ct2/show/NCT00539890","[' Mannkind Corporation ']","[]"]
["NCT00541996","https://clinicaltrials.gov/ct2/show/NCT00541996","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00544934","https://clinicaltrials.gov/ct2/show/NCT00544934","[' Glycadia ']","[]"]
["NCT00550303","https://clinicaltrials.gov/ct2/show/NCT00550303","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00551616","https://clinicaltrials.gov/ct2/show/NCT00551616","[' HRA Pharma ']","[]"]
["NCT00556413","https://clinicaltrials.gov/ct2/show/NCT00556413","[\" Institut du Cancer de Montpellier - Val d'Aurelle \"]","[]"]
["NCT00557037","https://clinicaltrials.gov/ct2/show/NCT00557037","[' MEI Pharma, Inc. ']","[]"]
["NCT00559156","https://clinicaltrials.gov/ct2/show/NCT00559156","[\" Institut du Cancer de Montpellier - Val d'Aurelle \"]","[]"]
["NCT00559195","https://clinicaltrials.gov/ct2/show/NCT00559195","[' Centre Hospital Regional Universitaire de Limoges ']","[]"]
["NCT00559676","https://clinicaltrials.gov/ct2/show/NCT00559676","[' Centre Hospital Regional Universitaire de Limoges ']","[]"]
["NCT00559741","https://clinicaltrials.gov/ct2/show/NCT00559741","[' ICO Paul Papin ']","[]"]
["NCT00560898","https://clinicaltrials.gov/ct2/show/NCT00560898","[' Southern California College of Optometry ']","[]"]
["NCT00561743","https://clinicaltrials.gov/ct2/show/NCT00561743","[' Janssen-Ortho Inc., Canada ']","[]"]
["NCT00562380","https://clinicaltrials.gov/ct2/show/NCT00562380","[' Amgen ']","[]"]
["NCT00563732","https://clinicaltrials.gov/ct2/show/NCT00563732","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00563823","https://clinicaltrials.gov/ct2/show/NCT00563823","[' Cambridge University Hospitals NHS Foundation Trust ']","[]"]
["NCT00564785","https://clinicaltrials.gov/ct2/show/NCT00564785","[' IWK Health Centre ']","[]"]
["NCT00569283","https://clinicaltrials.gov/ct2/show/NCT00569283","[' Asan Medical Center ']","[]"]
["NCT00578149","https://clinicaltrials.gov/ct2/show/NCT00578149","[' Dana-Farber Cancer Institute ']","[]"]
["NCT00588913","https://clinicaltrials.gov/ct2/show/NCT00588913","[\" Tokyo Women's Medical University \"]","[]"]
["NCT00589381","https://clinicaltrials.gov/ct2/show/NCT00589381","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00599833","https://clinicaltrials.gov/ct2/show/NCT00599833","[' The Christie NHS Foundation Trust ']","[]"]
["NCT00601510","https://clinicaltrials.gov/ct2/show/NCT00601510","[u' Technische Universit\\xe4t M\\xfcnchen ']","[]"]
["NCT00618501","https://clinicaltrials.gov/ct2/show/NCT00618501","[' Asan Medical Center ']","[]"]
["NCT00627354","https://clinicaltrials.gov/ct2/show/NCT00627354","[\" Groupe D'Etude des Tumeurs Uro-Genitales \"]","[]"]
["NCT00629226","https://clinicaltrials.gov/ct2/show/NCT00629226","[' National Cancer Institute (NCI) ']","[]"]
["NCT00641589","https://clinicaltrials.gov/ct2/show/NCT00641589","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00646152","https://clinicaltrials.gov/ct2/show/NCT00646152","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00659568","https://clinicaltrials.gov/ct2/show/NCT00659568","[' London Health Sciences Centre ']","[]"]
["NCT00674024","https://clinicaltrials.gov/ct2/show/NCT00674024","[' National Cancer Institute (NCI) ']","[]"]
["NCT00676299","https://clinicaltrials.gov/ct2/show/NCT00676299","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00676910","https://clinicaltrials.gov/ct2/show/NCT00676910","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00677001","https://clinicaltrials.gov/ct2/show/NCT00677001","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00677105","https://clinicaltrials.gov/ct2/show/NCT00677105","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00678132","https://clinicaltrials.gov/ct2/show/NCT00678132","[' National Cancer Institute (NCI) ']","[]"]
["NCT00683943","https://clinicaltrials.gov/ct2/show/NCT00683943","[' National Institute of Neurological Disorders and Stroke (NINDS) ']","[]"]
["NCT00691184","https://clinicaltrials.gov/ct2/show/NCT00691184","[' NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) ']","[]"]
["NCT00697996","https://clinicaltrials.gov/ct2/show/NCT00697996","[' Stanford University ']","[]"]
["NCT00709189","https://clinicaltrials.gov/ct2/show/NCT00709189","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00709332","https://clinicaltrials.gov/ct2/show/NCT00709332","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00709605","https://clinicaltrials.gov/ct2/show/NCT00709605","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00709644","https://clinicaltrials.gov/ct2/show/NCT00709644","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00709982","https://clinicaltrials.gov/ct2/show/NCT00709982","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00727233","https://clinicaltrials.gov/ct2/show/NCT00727233","[' National Cancer Institute (NCI) ']","[]"]
["NCT00734890","https://clinicaltrials.gov/ct2/show/NCT00734890","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00738868","https://clinicaltrials.gov/ct2/show/NCT00738868","[' Centre Oscar Lambret ']","[]"]
["NCT00743782","https://clinicaltrials.gov/ct2/show/NCT00743782","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00744809","https://clinicaltrials.gov/ct2/show/NCT00744809","[' Tibotec Pharmaceuticals, Ireland ']","[]"]
["NCT00744887","https://clinicaltrials.gov/ct2/show/NCT00744887","[' Tibotec Pharmaceuticals, Ireland ']","[]"]
["NCT00745264","https://clinicaltrials.gov/ct2/show/NCT00745264","[' IDEA AG ']","[]"]
["NCT00745901","https://clinicaltrials.gov/ct2/show/NCT00745901","[' Ortho-McNeil Janssen Scientific Affairs, LLC ']","[]"]
["NCT00747695","https://clinicaltrials.gov/ct2/show/NCT00747695","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00752544","https://clinicaltrials.gov/ct2/show/NCT00752544","[' Tibotec Pharmaceuticals, Ireland ']","[]"]
["NCT00770172","https://clinicaltrials.gov/ct2/show/NCT00770172","[' Centre Francois Baclesse ']","[]"]
["NCT00771433","https://clinicaltrials.gov/ct2/show/NCT00771433","[' Centre Francois Baclesse ']","[]"]
["NCT00774735","https://clinicaltrials.gov/ct2/show/NCT00774735","[' GlaxoSmithKline ']","[]"]
["NCT00775125","https://clinicaltrials.gov/ct2/show/NCT00775125","[' Tibotec BVBA ']","[]"]
["NCT00780702","https://clinicaltrials.gov/ct2/show/NCT00780702","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00790777","https://clinicaltrials.gov/ct2/show/NCT00790777","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00791167","https://clinicaltrials.gov/ct2/show/NCT00791167","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00791193","https://clinicaltrials.gov/ct2/show/NCT00791193","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00791349","https://clinicaltrials.gov/ct2/show/NCT00791349","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00791622","https://clinicaltrials.gov/ct2/show/NCT00791622","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00791713","https://clinicaltrials.gov/ct2/show/NCT00791713","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00792025","https://clinicaltrials.gov/ct2/show/NCT00792025","[' Institut Curie ']","[]"]
["NCT00796081","https://clinicaltrials.gov/ct2/show/NCT00796081","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00804297","https://clinicaltrials.gov/ct2/show/NCT00804297","[' Albert Einstein Healthcare Network ']","[]"]
["NCT00806247","https://clinicaltrials.gov/ct2/show/NCT00806247","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00821782","https://clinicaltrials.gov/ct2/show/NCT00821782","[' Ortho-McNeil Janssen Scientific Affairs, LLC ']","[]"]
["NCT00828529","https://clinicaltrials.gov/ct2/show/NCT00828529","[' Tibotec BVBA ']","[]"]
["NCT00828789","https://clinicaltrials.gov/ct2/show/NCT00828789","[' Tibotec BVBA ']","[]"]
["NCT00828958","https://clinicaltrials.gov/ct2/show/NCT00828958","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00829309","https://clinicaltrials.gov/ct2/show/NCT00829309","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00829426","https://clinicaltrials.gov/ct2/show/NCT00829426","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00829764","https://clinicaltrials.gov/ct2/show/NCT00829764","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00829790","https://clinicaltrials.gov/ct2/show/NCT00829790","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00830024","https://clinicaltrials.gov/ct2/show/NCT00830024","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00830258","https://clinicaltrials.gov/ct2/show/NCT00830258","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00830336","https://clinicaltrials.gov/ct2/show/NCT00830336","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00830830","https://clinicaltrials.gov/ct2/show/NCT00830830","[' Sanofi ']","[]"]
["NCT00834535","https://clinicaltrials.gov/ct2/show/NCT00834535","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00834574","https://clinicaltrials.gov/ct2/show/NCT00834574","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00835484","https://clinicaltrials.gov/ct2/show/NCT00835484","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00835549","https://clinicaltrials.gov/ct2/show/NCT00835549","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00838669","https://clinicaltrials.gov/ct2/show/NCT00838669","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00840684","https://clinicaltrials.gov/ct2/show/NCT00840684","[' Institut Paoli-Calmettes ']","[]"]
["NCT00843687","https://clinicaltrials.gov/ct2/show/NCT00843687","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00844909","https://clinicaltrials.gov/ct2/show/NCT00844909","[' Centocor, Inc. ']","[]"]
["NCT00859430","https://clinicaltrials.gov/ct2/show/NCT00859430","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00859521","https://clinicaltrials.gov/ct2/show/NCT00859521","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00861510","https://clinicaltrials.gov/ct2/show/NCT00861510","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00889616","https://clinicaltrials.gov/ct2/show/NCT00889616","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00892125","https://clinicaltrials.gov/ct2/show/NCT00892125","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00910663","https://clinicaltrials.gov/ct2/show/NCT00910663","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00910923","https://clinicaltrials.gov/ct2/show/NCT00910923","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00911274","https://clinicaltrials.gov/ct2/show/NCT00911274","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00912262","https://clinicaltrials.gov/ct2/show/NCT00912262","[' NeurogesX ']","[]"]
["NCT00920296","https://clinicaltrials.gov/ct2/show/NCT00920296","[' GlaxoSmithKline ']","[]"]
["NCT00923169","https://clinicaltrials.gov/ct2/show/NCT00923169","[' National Cancer Institute (NCI) ']","[]"]
["NCT00923741","https://clinicaltrials.gov/ct2/show/NCT00923741","[' National Cancer Institute (NCI) ']","[]"]
["NCT00924092","https://clinicaltrials.gov/ct2/show/NCT00924092","[' National Cancer Institute (NCI) ']","[]"]
["NCT00972309","https://clinicaltrials.gov/ct2/show/NCT00972309","[' National Cancer Institute (NCI) ']","[]"]
["NCT00974012","https://clinicaltrials.gov/ct2/show/NCT00974012","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00974441","https://clinicaltrials.gov/ct2/show/NCT00974441","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00975897","https://clinicaltrials.gov/ct2/show/NCT00975897","[' Medical Research Council ']","[]"]
["NCT00977600","https://clinicaltrials.gov/ct2/show/NCT00977600","[' Horizon Pharma Ireland, Ltd., Dublin Ireland ']","[]"]
["NCT00994071","https://clinicaltrials.gov/ct2/show/NCT00994071","[' National Cancer Institute (NCI) ']","[]"]
["NCT01074450","https://clinicaltrials.gov/ct2/show/NCT01074450","[' Teva Pharmaceuticals USA ']","[]"]
["NCT01074463","https://clinicaltrials.gov/ct2/show/NCT01074463","[' Teva Pharmaceuticals USA ']","[]"]
["NCT01136642","https://clinicaltrials.gov/ct2/show/NCT01136642","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT01182194","https://clinicaltrials.gov/ct2/show/NCT01182194","[' Teva Pharmaceuticals USA ']","[]"]
["NCT01182207","https://clinicaltrials.gov/ct2/show/NCT01182207","[' Teva Pharmaceuticals USA ']","[]"]
["NCT01198197","https://clinicaltrials.gov/ct2/show/NCT01198197","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT01240577","https://clinicaltrials.gov/ct2/show/NCT01240577","[' National Cancer Institute (NCI) ']","[]"]
["NCT01251926","https://clinicaltrials.gov/ct2/show/NCT01251926","[' National Cancer Institute (NCI) ']","[]"]
["NCT01259479","https://clinicaltrials.gov/ct2/show/NCT01259479","[' National Cancer Institute (NCI) ']","[]"]
["NCT01271270","https://clinicaltrials.gov/ct2/show/NCT01271270","[' National Eye Institute (NEI) ']","[]"]
["NCT01287130","https://clinicaltrials.gov/ct2/show/NCT01287130","[' National Cancer Institute (NCI) ']","[]"]
["NCT01303601","https://clinicaltrials.gov/ct2/show/NCT01303601","[' China Medical University, China ']","[]"]
["NCT01313429","https://clinicaltrials.gov/ct2/show/NCT01313429","[' National Cancer Institute (NCI) ']","[]"]
["NCT01316796","https://clinicaltrials.gov/ct2/show/NCT01316796","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT01369927","https://clinicaltrials.gov/ct2/show/NCT01369927","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT01386489","https://clinicaltrials.gov/ct2/show/NCT01386489","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01437007","https://clinicaltrials.gov/ct2/show/NCT01437007","[' National Cancer Institute (NCI) ']","[]"]
["NCT01441167","https://clinicaltrials.gov/ct2/show/NCT01441167","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01445106","https://clinicaltrials.gov/ct2/show/NCT01445106","[' National Cancer Institute (NCI) ']","[]"]
["NCT01445379","https://clinicaltrials.gov/ct2/show/NCT01445379","[' National Cancer Institute (NCI) ']","[]"]
["NCT01445405","https://clinicaltrials.gov/ct2/show/NCT01445405","[' National Cancer Institute (NCI) ']","[]"]
["NCT01445522","https://clinicaltrials.gov/ct2/show/NCT01445522","[' National Cancer Institute (NCI) ']","[]"]
["NCT01468948","https://clinicaltrials.gov/ct2/show/NCT01468948","[' National Institute of Neurological Disorders and Stroke (NINDS) ']","[]"]
["NCT01629082","https://clinicaltrials.gov/ct2/show/NCT01629082","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00541073","https://clinicaltrials.gov/ct2/show/NCT00541073","[' Centre Oscar Lambret ']","[]"]
["NCT00122434","https://clinicaltrials.gov/ct2/show/NCT00122434","[' Boehringer Ingelheim ']","[]"]
["NCT00128440","https://clinicaltrials.gov/ct2/show/NCT00128440","[' Boehringer Ingelheim ']","[]"]
["NCT00112554","https://clinicaltrials.gov/ct2/show/NCT00112554","[' Vion Pharmaceuticals ']","[]"]
["NCT00282022","https://clinicaltrials.gov/ct2/show/NCT00282022","[' Vion Pharmaceuticals ']","[]"]
["NCT00963521","https://clinicaltrials.gov/ct2/show/NCT00963521","[' Institut Paoli-Calmettes ']","[]"]
["NCT00550927","https://clinicaltrials.gov/ct2/show/NCT00550927","[' Eli Lilly and Company ']","[]"]
["NCT00544349","https://clinicaltrials.gov/ct2/show/NCT00544349","[' Gustave Roussy, Cancer Campus, Grand Paris ']","[]"]
["NCT00802568","https://clinicaltrials.gov/ct2/show/NCT00802568","[' Institut Paoli-Calmettes ']","[]"]
["NCT00806767","https://clinicaltrials.gov/ct2/show/NCT00806767","[' Institut Paoli-Calmettes ']","[]"]
["NCT00820963","https://clinicaltrials.gov/ct2/show/NCT00820963","[' Centre Leon Berard ']","[]"]
["NCT00104949","https://clinicaltrials.gov/ct2/show/NCT00104949","[' Southwest Oncology Group ']","[]"]
["NCT00870558","https://clinicaltrials.gov/ct2/show/NCT00870558","[' Hospices Civils de Lyon ']","[]"]
["NCT00381875","https://clinicaltrials.gov/ct2/show/NCT00381875","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00259818","https://clinicaltrials.gov/ct2/show/NCT00259818","[' Erimos Pharmaceuticals ']","[]"]
["NCT00152022","https://clinicaltrials.gov/ct2/show/NCT00152022","[' Shire ']","[]"]
["NCT00542217","https://clinicaltrials.gov/ct2/show/NCT00542217","[' Biothera ']","[]"]
["NCT00116675","https://clinicaltrials.gov/ct2/show/NCT00116675","[' Graceway Pharmaceuticals, LLC ']","[]"]
["NCT00150592","https://clinicaltrials.gov/ct2/show/NCT00150592","[' Shire ']","[]"]
["NCT00202605","https://clinicaltrials.gov/ct2/show/NCT00202605","[' Shire ']","[]"]
["NCT00261872","https://clinicaltrials.gov/ct2/show/NCT00261872","[' National Institute on Alcohol Abuse and Alcoholism (NIAAA) ']","[]"]
["NCT00290940","https://clinicaltrials.gov/ct2/show/NCT00290940","[' Daiichi Sankyo, Inc. ']","[]"]
["NCT00110864","https://clinicaltrials.gov/ct2/show/NCT00110864","[' Wellstat Therapeutics ']","[]"]
["NCT00408538","https://clinicaltrials.gov/ct2/show/NCT00408538","[' University of California, Los Angeles ']","[]"]
["NCT01182636","https://clinicaltrials.gov/ct2/show/NCT01182636","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00489931","https://clinicaltrials.gov/ct2/show/NCT00489931","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00667771","https://clinicaltrials.gov/ct2/show/NCT00667771","[' National Institute on Alcohol Abuse and Alcoholism (NIAAA) ']","[]"]
["NCT00102271","https://clinicaltrials.gov/ct2/show/NCT00102271","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00685503","https://clinicaltrials.gov/ct2/show/NCT00685503","[' National Eye Institute (NEI) ']","[]"]
["NCT01132911","https://clinicaltrials.gov/ct2/show/NCT01132911","[' National Cancer Institute (NCI) ']","[]"]
["NCT00137891","https://clinicaltrials.gov/ct2/show/NCT00137891","[' Genzyme, a Sanofi Company ']","[]"]
["NCT00106808","https://clinicaltrials.gov/ct2/show/NCT00106808","[' Bristol-Myers Squibb ']","[]"]
["NCT00255450","https://clinicaltrials.gov/ct2/show/NCT00255450","[' AMAG Pharmaceuticals, Inc. ']","[]"]
["NCT00151918","https://clinicaltrials.gov/ct2/show/NCT00151918","[' Shire ']","[]"]
["NCT00274313","https://clinicaltrials.gov/ct2/show/NCT00274313","[' Parion Sciences ']","[]"]
["NCT00110851","https://clinicaltrials.gov/ct2/show/NCT00110851","[' Wellstat Therapeutics ']","[]"]
["NCT00532116","https://clinicaltrials.gov/ct2/show/NCT00532116","[' Somerset Pharmaceuticals ']","[]"]
["NCT00263523","https://clinicaltrials.gov/ct2/show/NCT00263523","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT00439400","https://clinicaltrials.gov/ct2/show/NCT00439400","[' Alacrity Biosciences, Inc. ']","[]"]
["NCT00121589","https://clinicaltrials.gov/ct2/show/NCT00121589","[' National Eye Institute (NEI) ']","[]"]
["NCT00358930","https://clinicaltrials.gov/ct2/show/NCT00358930","[' ArQule ']","[]"]
["NCT00303264","https://clinicaltrials.gov/ct2/show/NCT00303264","[' Forest Laboratories ']","[]"]
["NCT00248365","https://clinicaltrials.gov/ct2/show/NCT00248365","[' Kiadis Pharma ']","[]"]
["NCT00225706","https://clinicaltrials.gov/ct2/show/NCT00225706","[' Cumberland Pharmaceuticals ']","[]"]
["NCT00332137","https://clinicaltrials.gov/ct2/show/NCT00332137","[' Mayo Clinic ']","[]"]
["NCT00408109","https://clinicaltrials.gov/ct2/show/NCT00408109","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00326443","https://clinicaltrials.gov/ct2/show/NCT00326443","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00111397","https://clinicaltrials.gov/ct2/show/NCT00111397","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00150579","https://clinicaltrials.gov/ct2/show/NCT00150579","[' Shire ']","[]"]
["NCT00132392","https://clinicaltrials.gov/ct2/show/NCT00132392","[' AlgoRx Pharmaceuticals ']","[]"]
["NCT00171665","https://clinicaltrials.gov/ct2/show/NCT00171665","[' Novartis ']","[]"]
["NCT00114010","https://clinicaltrials.gov/ct2/show/NCT00114010","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00543231","https://clinicaltrials.gov/ct2/show/NCT00543231","[' Genta Incorporated ']","[]"]
["NCT00132652","https://clinicaltrials.gov/ct2/show/NCT00132652","[' Novartis ']","[]"]
["NCT00294346","https://clinicaltrials.gov/ct2/show/NCT00294346","[' Avera Pharmaceuticals ']","[]"]
["NCT00214994","https://clinicaltrials.gov/ct2/show/NCT00214994","[' Cephalon ']","[]"]
["NCT00326508","https://clinicaltrials.gov/ct2/show/NCT00326508","[' National Eye Institute (NEI) ']","[]"]
["NCT00542529","https://clinicaltrials.gov/ct2/show/NCT00542529","[' Biothera ']","[]"]
["NCT00312364","https://clinicaltrials.gov/ct2/show/NCT00312364","[' Pfizer ']","[]"]
["NCT00510419","https://clinicaltrials.gov/ct2/show/NCT00510419","[' Pfizer ']","[]"]
["NCT00300417","https://clinicaltrials.gov/ct2/show/NCT00300417","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00478179","https://clinicaltrials.gov/ct2/show/NCT00478179","[' Durect ']","[]"]
["NCT00525954","https://clinicaltrials.gov/ct2/show/NCT00525954","[' Anthera Pharmaceuticals ']","[]"]
["NCT00953901","https://clinicaltrials.gov/ct2/show/NCT00953901","[' Mayo Clinic ']","[]"]
["NCT00321061","https://clinicaltrials.gov/ct2/show/NCT00321061","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01086657","https://clinicaltrials.gov/ct2/show/NCT01086657","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01037608","https://clinicaltrials.gov/ct2/show/NCT01037608","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00108667","https://clinicaltrials.gov/ct2/show/NCT00108667","[' National Institute of Neurological Disorders and Stroke (NINDS) ']","[]"]
["NCT00121563","https://clinicaltrials.gov/ct2/show/NCT00121563","[' National Institute of Nursing Research (NINR) ']","[]"]
["NCT00115986","https://clinicaltrials.gov/ct2/show/NCT00115986","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00104247","https://clinicaltrials.gov/ct2/show/NCT00104247","[' BioMarin Pharmaceutical ']","[]"]
["NCT00952991","https://clinicaltrials.gov/ct2/show/NCT00952991","[' Mayo Clinic ']","[]"]
["NCT00170547","https://clinicaltrials.gov/ct2/show/NCT00170547","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00113620","https://clinicaltrials.gov/ct2/show/NCT00113620","[' Avanir Pharmaceuticals ']","[]"]
["NCT00332033","https://clinicaltrials.gov/ct2/show/NCT00332033","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00252005","https://clinicaltrials.gov/ct2/show/NCT00252005","[' Bristol-Myers Squibb ']","[]"]
["NCT00487916","https://clinicaltrials.gov/ct2/show/NCT00487916","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00876434","https://clinicaltrials.gov/ct2/show/NCT00876434","[' National Eye Institute (NEI) ']","[]"]
["NCT01340625","https://clinicaltrials.gov/ct2/show/NCT01340625","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00102700","https://clinicaltrials.gov/ct2/show/NCT00102700","[' ArQule ']","[]"]
["NCT00390390","https://clinicaltrials.gov/ct2/show/NCT00390390","[' Novartis ']","[]"]
["NCT00389948","https://clinicaltrials.gov/ct2/show/NCT00389948","[' Novartis ']","[]"]
["NCT00315276","https://clinicaltrials.gov/ct2/show/NCT00315276","[' Cephalon ']","[]"]
["NCT00230750","https://clinicaltrials.gov/ct2/show/NCT00230750","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00109629","https://clinicaltrials.gov/ct2/show/NCT00109629","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00108654","https://clinicaltrials.gov/ct2/show/NCT00108654","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00103350","https://clinicaltrials.gov/ct2/show/NCT00103350","[' TargeGen ']","[]"]
["NCT00265057","https://clinicaltrials.gov/ct2/show/NCT00265057","[' Adherex Technologies, Inc. ']","[]"]
["NCT00106769","https://clinicaltrials.gov/ct2/show/NCT00106769","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00322140","https://clinicaltrials.gov/ct2/show/NCT00322140","[' National Cancer Institute (NCI) ']","[]"]
["NCT00262678","https://clinicaltrials.gov/ct2/show/NCT00262678","[' Prostrakan Pharmaceuticals ']","[]"]
["NCT01041170","https://clinicaltrials.gov/ct2/show/NCT01041170","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00776711","https://clinicaltrials.gov/ct2/show/NCT00776711","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00939536","https://clinicaltrials.gov/ct2/show/NCT00939536","[' Torrent Pharmaceuticals Limited ']","[]"]
["NCT00299520","https://clinicaltrials.gov/ct2/show/NCT00299520","[' Arpida AG ']","[]"]
["NCT00179686","https://clinicaltrials.gov/ct2/show/NCT00179686","[' Celgene Corporation ']","[]"]
["NCT00113009","https://clinicaltrials.gov/ct2/show/NCT00113009","[' Valentis ']","[]"]
["NCT00108979","https://clinicaltrials.gov/ct2/show/NCT00108979","[' Forest Laboratories ']","[]"]
["NCT00240968","https://clinicaltrials.gov/ct2/show/NCT00240968","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00343733","https://clinicaltrials.gov/ct2/show/NCT00343733","[' Cephalon ']","[]"]
["NCT00456053","https://clinicaltrials.gov/ct2/show/NCT00456053","[' FibroGen ']","[]"]
["NCT00135408","https://clinicaltrials.gov/ct2/show/NCT00135408","[' Bristol-Myers Squibb ']","[]"]
["NCT00310518","https://clinicaltrials.gov/ct2/show/NCT00310518","[' ArQule ']","[]"]
["NCT01382901","https://clinicaltrials.gov/ct2/show/NCT01382901","[' American Regent, Inc. ']","[]"]
["NCT00394121","https://clinicaltrials.gov/ct2/show/NCT00394121","[' SkyePharma AG ']","[]"]
["NCT00263237","https://clinicaltrials.gov/ct2/show/NCT00263237","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00340574","https://clinicaltrials.gov/ct2/show/NCT00340574","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00248183","https://clinicaltrials.gov/ct2/show/NCT00248183","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00297713","https://clinicaltrials.gov/ct2/show/NCT00297713","[' Altus Pharmaceuticals ']","[]"]
["NCT00324389","https://clinicaltrials.gov/ct2/show/NCT00324389","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00130000","https://clinicaltrials.gov/ct2/show/NCT00130000","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00269438","https://clinicaltrials.gov/ct2/show/NCT00269438","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00102297","https://clinicaltrials.gov/ct2/show/NCT00102297","[' FibroGen ']","[]"]
["NCT00345774","https://clinicaltrials.gov/ct2/show/NCT00345774","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00250185","https://clinicaltrials.gov/ct2/show/NCT00250185","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00295581","https://clinicaltrials.gov/ct2/show/NCT00295581","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00366418","https://clinicaltrials.gov/ct2/show/NCT00366418","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00270465","https://clinicaltrials.gov/ct2/show/NCT00270465","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00943982","https://clinicaltrials.gov/ct2/show/NCT00943982","[' National Eye Institute (NEI) ']","[]"]
["NCT00644072","https://clinicaltrials.gov/ct2/show/NCT00644072","[' National Cancer Institute (NCI) ']","[]"]
["NCT00154141","https://clinicaltrials.gov/ct2/show/NCT00154141","[' Ethicon, Inc. ']","[]"]
["NCT00111072","https://clinicaltrials.gov/ct2/show/NCT00111072","[' National Institute of Dental and Craniofacial Research (NIDCR) ']","[]"]
["NCT00432770","https://clinicaltrials.gov/ct2/show/NCT00432770","[' Archemix Corp. ']","[]"]
["NCT00106600","https://clinicaltrials.gov/ct2/show/NCT00106600","[' CTI BioPharma ']","[]"]
["NCT00254202","https://clinicaltrials.gov/ct2/show/NCT00254202","[' Vanda Pharmaceuticals ']","[]"]
["NCT00669851","https://clinicaltrials.gov/ct2/show/NCT00669851","[' Acusphere ']","[]"]
["NCT00129168","https://clinicaltrials.gov/ct2/show/NCT00129168","[' Kanisa Pharmaceuticals ']","[]"]
["NCT00233909","https://clinicaltrials.gov/ct2/show/NCT00233909","[' Kanisa Pharmaceuticals ']","[]"]
["NCT00260702","https://clinicaltrials.gov/ct2/show/NCT00260702","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00489385","https://clinicaltrials.gov/ct2/show/NCT00489385","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00685854","https://clinicaltrials.gov/ct2/show/NCT00685854","[' National Eye Institute (NEI) ']","[]"]
["NCT00107822","https://clinicaltrials.gov/ct2/show/NCT00107822","[' ZARS Pharma Inc. ']","[]"]
["NCT00266669","https://clinicaltrials.gov/ct2/show/NCT00266669","[' MediQuest Therapeutics ']","[]"]
["NCT00128947","https://clinicaltrials.gov/ct2/show/NCT00128947","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00108836","https://clinicaltrials.gov/ct2/show/NCT00108836","[' Novartis Pharmaceuticals ']","[]"]
["NCT00105417","https://clinicaltrials.gov/ct2/show/NCT00105417","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00231023","https://clinicaltrials.gov/ct2/show/NCT00231023","[' National Eye Institute (NEI) ']","[]"]
["NCT00456560","https://clinicaltrials.gov/ct2/show/NCT00456560","[' Avigen ']","[]"]
["NCT00410527","https://clinicaltrials.gov/ct2/show/NCT00410527","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00482937","https://clinicaltrials.gov/ct2/show/NCT00482937","[' Nile Therapeutics ']","[]"]
["NCT00152035","https://clinicaltrials.gov/ct2/show/NCT00152035","[' Shire ']","[]"]
["NCT00128544","https://clinicaltrials.gov/ct2/show/NCT00128544","[' Novartis ']","[]"]
["NCT00101764","https://clinicaltrials.gov/ct2/show/NCT00101764","[' National Eye Institute (NEI) ']","[]"]
["NCT00101374","https://clinicaltrials.gov/ct2/show/NCT00101374","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00224406","https://clinicaltrials.gov/ct2/show/NCT00224406","[u' Domp\\xe9 Farmaceutici S.p.A ']","[]"]
["NCT00374309","https://clinicaltrials.gov/ct2/show/NCT00374309","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01324843","https://clinicaltrials.gov/ct2/show/NCT01324843","[' National Institute on Aging (NIA) ']","[]"]
["NCT00106405","https://clinicaltrials.gov/ct2/show/NCT00106405","[' Forest Laboratories ']","[]"]
["NCT00106132","https://clinicaltrials.gov/ct2/show/NCT00106132","[' National Eye Institute (NEI) ']","[]"]
["NCT00297050","https://clinicaltrials.gov/ct2/show/NCT00297050","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00272792","https://clinicaltrials.gov/ct2/show/NCT00272792","[' BioMarin Pharmaceutical ']","[]"]
["NCT00326274","https://clinicaltrials.gov/ct2/show/NCT00326274","[' Loreal USA ']","[]"]
["NCT00448292","https://clinicaltrials.gov/ct2/show/NCT00448292","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00408174","https://clinicaltrials.gov/ct2/show/NCT00408174","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00128531","https://clinicaltrials.gov/ct2/show/NCT00128531","[' GP-Pharm ']","[]"]
["NCT00427167","https://clinicaltrials.gov/ct2/show/NCT00427167","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01034020","https://clinicaltrials.gov/ct2/show/NCT01034020","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT01355016","https://clinicaltrials.gov/ct2/show/NCT01355016","[' MicroDose Therapeutx, Inc ']","[]"]
["NCT00150605","https://clinicaltrials.gov/ct2/show/NCT00150605","[' Validus Pharmaceuticals ']","[]"]
["NCT00150553","https://clinicaltrials.gov/ct2/show/NCT00150553","[' Validus Pharmaceuticals ']","[]"]
["NCT00109564","https://clinicaltrials.gov/ct2/show/NCT00109564","[' Targacept Inc. ']","[]"]
["NCT00102557","https://clinicaltrials.gov/ct2/show/NCT00102557","[' National Institute of Dental and Craniofacial Research (NIDCR) ']","[]"]
["NCT00113997","https://clinicaltrials.gov/ct2/show/NCT00113997","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00185107","https://clinicaltrials.gov/ct2/show/NCT00185107","[' Daiichi Sankyo, Inc. ']","[]"]
["NCT00171652","https://clinicaltrials.gov/ct2/show/NCT00171652","[' Novartis ']","[]"]
["NCT00273468","https://clinicaltrials.gov/ct2/show/NCT00273468","[' Prostrakan Pharmaceuticals ']","[]"]
["NCT00115752","https://clinicaltrials.gov/ct2/show/NCT00115752","[' National Institute of Nursing Research (NINR) ']","[]"]
["NCT00105404","https://clinicaltrials.gov/ct2/show/NCT00105404","[' National Eye Institute (NEI) ']","[]"]
["NCT00322283","https://clinicaltrials.gov/ct2/show/NCT00322283","[' Forest Laboratories ']","[]"]
["NCT00102258","https://clinicaltrials.gov/ct2/show/NCT00102258","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00102089","https://clinicaltrials.gov/ct2/show/NCT00102089","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00283920","https://clinicaltrials.gov/ct2/show/NCT00283920","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT00457145","https://clinicaltrials.gov/ct2/show/NCT00457145","[' National Eye Institute (NEI) ']","[]"]
["NCT00457067","https://clinicaltrials.gov/ct2/show/NCT00457067","[' National Eye Institute (NEI) ']","[]"]
["NCT00117013","https://clinicaltrials.gov/ct2/show/NCT00117013","[' National Cancer Institute (NCI) ']","[]"]
["NCT00171522","https://clinicaltrials.gov/ct2/show/NCT00171522","[' Novartis ']","[]"]
["NCT00343811","https://clinicaltrials.gov/ct2/show/NCT00343811","[' Cephalon ']","[]"]
["NCT00115154","https://clinicaltrials.gov/ct2/show/NCT00115154","[' Graceway Pharmaceuticals, LLC ']","[]"]
["NCT00542464","https://clinicaltrials.gov/ct2/show/NCT00542464","[' Biothera ']","[]"]
["NCT00250198","https://clinicaltrials.gov/ct2/show/NCT00250198","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00228540","https://clinicaltrials.gov/ct2/show/NCT00228540","[' Cephalon ']","[]"]
["NCT00455546","https://clinicaltrials.gov/ct2/show/NCT00455546","[' Anthera Pharmaceuticals ']","[]"]
["NCT00467493","https://clinicaltrials.gov/ct2/show/NCT00467493","[' Meditrina Pharmaceuticals ']","[]"]
["NCT00139620","https://clinicaltrials.gov/ct2/show/NCT00139620","[' OSI Pharmaceuticals ']","[]"]
["NCT00328380","https://clinicaltrials.gov/ct2/show/NCT00328380","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00269412","https://clinicaltrials.gov/ct2/show/NCT00269412","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00277147","https://clinicaltrials.gov/ct2/show/NCT00277147","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00903253","https://clinicaltrials.gov/ct2/show/NCT00903253","[' Link Medicine Corporation ']","[]"]
["NCT00553189","https://clinicaltrials.gov/ct2/show/NCT00553189","[' National Cancer Institute (NCI) ']","[]"]
["NCT01051934","https://clinicaltrials.gov/ct2/show/NCT01051934","[' National Cancer Institute (NCI) ']","[]"]
["NCT00335647","https://clinicaltrials.gov/ct2/show/NCT00335647","[' Immune Control ']","[]"]
["NCT00404573","https://clinicaltrials.gov/ct2/show/NCT00404573","[' Forest Laboratories ']","[]"]
["NCT00129194","https://clinicaltrials.gov/ct2/show/NCT00129194","[' Koronis Pharmaceuticals. ']","[]"]
["NCT00316511","https://clinicaltrials.gov/ct2/show/NCT00316511","[' Agenus Inc. ']","[]"]
["NCT00740090","https://clinicaltrials.gov/ct2/show/NCT00740090","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00274248","https://clinicaltrials.gov/ct2/show/NCT00274248","[' Millennium Pharmaceuticals, Inc. ']","[]"]
["NCT00334906","https://clinicaltrials.gov/ct2/show/NCT00334906","[' Forest Laboratories ']","[]"]
["NCT00384436","https://clinicaltrials.gov/ct2/show/NCT00384436","[' Forest Laboratories ']","[]"]
["NCT00384423","https://clinicaltrials.gov/ct2/show/NCT00384423","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00541489","https://clinicaltrials.gov/ct2/show/NCT00541489","[' NicOx ']","[]"]
["NCT00564538","https://clinicaltrials.gov/ct2/show/NCT00564538","[' University of Nebraska ']","[]"]
["NCT01479348","https://clinicaltrials.gov/ct2/show/NCT01479348","[' National Cancer Institute (NCI) ']","[]"]
["NCT00117728","https://clinicaltrials.gov/ct2/show/NCT00117728","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00124358","https://clinicaltrials.gov/ct2/show/NCT00124358","[' The New York Academy of Medicine ']","[]"]
["NCT00148083","https://clinicaltrials.gov/ct2/show/NCT00148083","[' University of Illinois at Chicago ']","[]"]
["NCT00202930","https://clinicaltrials.gov/ct2/show/NCT00202930","[' Tersak, Jean M., M.D. ']","[]"]
["NCT00219869","https://clinicaltrials.gov/ct2/show/NCT00219869","[' Rapoport, Alan, M.D. ']","[]"]
["NCT00229918","https://clinicaltrials.gov/ct2/show/NCT00229918","[' Edward Hines Jr. VA Hospital ']","[]"]
["NCT00270517","https://clinicaltrials.gov/ct2/show/NCT00270517","[' Enanta Pharmaceuticals ']","[]"]
["NCT00274170","https://clinicaltrials.gov/ct2/show/NCT00274170","[' C.R.Darnall Army Medical Center ']","[]"]
["NCT00282620","https://clinicaltrials.gov/ct2/show/NCT00282620","[' Hartford Hospital ']","[]"]
["NCT00282659","https://clinicaltrials.gov/ct2/show/NCT00282659","[' Hartford Hospital ']","[]"]
["NCT00302692","https://clinicaltrials.gov/ct2/show/NCT00302692","[' University of Texas Southwestern Medical Center ']","[]"]
["NCT00378638","https://clinicaltrials.gov/ct2/show/NCT00378638","[' Chap, Linnea I., M.D. ']","[]"]
["NCT00398034","https://clinicaltrials.gov/ct2/show/NCT00398034","[' James J. Peters Veterans Affairs Medical Center ']","[]"]
["NCT00405847","https://clinicaltrials.gov/ct2/show/NCT00405847","[' University of Arizona ']","[]"]
["NCT00432549","https://clinicaltrials.gov/ct2/show/NCT00432549","[' The New England Center for Headache, P.C. ']","[]"]
["NCT00441818","https://clinicaltrials.gov/ct2/show/NCT00441818","[' Tanox ']","[]"]
["NCT00444964","https://clinicaltrials.gov/ct2/show/NCT00444964","[\" Children's Mercy Hospital Kansas City \"]","[]"]
["NCT00445354","https://clinicaltrials.gov/ct2/show/NCT00445354","[' Eglin AFB Regional Hospital ']","[]"]
["NCT00448071","https://clinicaltrials.gov/ct2/show/NCT00448071","[' Wolfson Medical Center ']","[]"]
["NCT00451672","https://clinicaltrials.gov/ct2/show/NCT00451672","[' National Taiwan University Hospital ']","[]"]
["NCT00479596","https://clinicaltrials.gov/ct2/show/NCT00479596","[' Urological Sciences Research Foundation ']","[]"]
["NCT00506532","https://clinicaltrials.gov/ct2/show/NCT00506532","[' Rabin Medical Center ']","[]"]
["NCT00516464","https://clinicaltrials.gov/ct2/show/NCT00516464","[' Retina Associates, Kansas City ']","[]"]
["NCT00553592","https://clinicaltrials.gov/ct2/show/NCT00553592","[' XTL Biopharmaceuticals ']","[]"]
["NCT00720785","https://clinicaltrials.gov/ct2/show/NCT00720785","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT01417546","https://clinicaltrials.gov/ct2/show/NCT01417546","[' National Cancer Institute (NCI) ']","[]"]
["NCT01553214","https://clinicaltrials.gov/ct2/show/NCT01553214","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00110201","https://clinicaltrials.gov/ct2/show/NCT00110201","[' Ejaz, Abulate A, MD ']","[]"]
["NCT00385385","https://clinicaltrials.gov/ct2/show/NCT00385385","[' ActivBiotics ']","[]"]
["NCT00243984","https://clinicaltrials.gov/ct2/show/NCT00243984","[' Northeastern Ohio Universities College of Medicine ']","[]"]
["NCT00275405","https://clinicaltrials.gov/ct2/show/NCT00275405","[' Albany Medical College ']","[]"]
["NCT00068094","https://clinicaltrials.gov/ct2/show/NCT00068094","[' National Center for Complementary and Integrative Health (NCCIH) ']","[]"]
["NCT00096187","https://clinicaltrials.gov/ct2/show/NCT00096187","[' Gynecologic Oncology Group ']","[]"]
["NCT00102791","https://clinicaltrials.gov/ct2/show/NCT00102791","[' Icagen ']","[]"]
["NCT00103103","https://clinicaltrials.gov/ct2/show/NCT00103103","[' California Cancer Consortium ']","[]"]
["NCT00105222","https://clinicaltrials.gov/ct2/show/NCT00105222","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00106054","https://clinicaltrials.gov/ct2/show/NCT00106054","[' Pfizer ']","[]"]
["NCT00106262","https://clinicaltrials.gov/ct2/show/NCT00106262","[' Women and Infants Hospital of Rhode Island ']","[]"]
["NCT00107666","https://clinicaltrials.gov/ct2/show/NCT00107666","[' Critical Therapeutics ']","[]"]
["NCT00111150","https://clinicaltrials.gov/ct2/show/NCT00111150","[' Centers for Disease Control and Prevention ']","[]"]
["NCT00112164","https://clinicaltrials.gov/ct2/show/NCT00112164","[' University of California, San Francisco ']","[]"]
["NCT00112281","https://clinicaltrials.gov/ct2/show/NCT00112281","[' Arginox Pharmaceuticals ']","[]"]
["NCT00114946","https://clinicaltrials.gov/ct2/show/NCT00114946","[' Genentech, Inc. ']","[]"]
["NCT00116571","https://clinicaltrials.gov/ct2/show/NCT00116571","[' QLT Inc. ']","[]"]
["NCT00120172","https://clinicaltrials.gov/ct2/show/NCT00120172","[' Geriatric Oncology Consortium ']","[]"]
["NCT00120198","https://clinicaltrials.gov/ct2/show/NCT00120198","[' Geriatric Oncology Consortium ']","[]"]
["NCT00120328","https://clinicaltrials.gov/ct2/show/NCT00120328","[' Speedel Pharma Ltd. ']","[]"]
["NCT00123877","https://clinicaltrials.gov/ct2/show/NCT00123877","[' Gem Pharmaceuticals ']","[]"]
["NCT00124644","https://clinicaltrials.gov/ct2/show/NCT00124644","[' Ohio State University Comprehensive Cancer Center ']","[]"]
["NCT00124891","https://clinicaltrials.gov/ct2/show/NCT00124891","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00129948","https://clinicaltrials.gov/ct2/show/NCT00129948","[' SGX Pharmaceuticals, Inc. ']","[]"]
["NCT00137293","https://clinicaltrials.gov/ct2/show/NCT00137293","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00137332","https://clinicaltrials.gov/ct2/show/NCT00137332","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00138229","https://clinicaltrials.gov/ct2/show/NCT00138229","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00140855","https://clinicaltrials.gov/ct2/show/NCT00140855","[' Ludwig Institute for Cancer Research ']","[]"]
["NCT00143091","https://clinicaltrials.gov/ct2/show/NCT00143091","[' Pfizer ']","[]"]
["NCT00153777","https://clinicaltrials.gov/ct2/show/NCT00153777","[' CONRAD ']","[]"]
["NCT00166127","https://clinicaltrials.gov/ct2/show/NCT00166127","[' Emory University ']","[]"]
["NCT00174603","https://clinicaltrials.gov/ct2/show/NCT00174603","[' Rush University Medical Center ']","[]"]
["NCT00177775","https://clinicaltrials.gov/ct2/show/NCT00177775","[' University of Pittsburgh ']","[]"]
["NCT00178581","https://clinicaltrials.gov/ct2/show/NCT00178581","[' The University of Texas Health Science Center, Houston ']","[]"]
["NCT00195312","https://clinicaltrials.gov/ct2/show/NCT00195312","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00203723","https://clinicaltrials.gov/ct2/show/NCT00203723","[' University of California, Los Angeles ']","[]"]
["NCT00209599","https://clinicaltrials.gov/ct2/show/NCT00209599","[' Eisai Inc. ']","[]"]
["NCT00210561","https://clinicaltrials.gov/ct2/show/NCT00210561","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00216008","https://clinicaltrials.gov/ct2/show/NCT00216008","[' H. Lee Moffitt Cancer Center and Research Institute ']","[]"]
["NCT00216424","https://clinicaltrials.gov/ct2/show/NCT00216424","[' James A. Haley Veterans Administration Hospital ']","[]"]
["NCT00217152","https://clinicaltrials.gov/ct2/show/NCT00217152","[' Mayo Clinic ']","[]"]
["NCT00220909","https://clinicaltrials.gov/ct2/show/NCT00220909","[' Temple University ']","[]"]
["NCT00226824","https://clinicaltrials.gov/ct2/show/NCT00226824","[\" Parkinson's Disease and Movement Disorders Center \"]","[]"]
["NCT00229749","https://clinicaltrials.gov/ct2/show/NCT00229749","[' Sarepta Therapeutics ']","[]"]
["NCT00232206","https://clinicaltrials.gov/ct2/show/NCT00232206","[' Providence Health & Services ']","[]"]
["NCT00235651","https://clinicaltrials.gov/ct2/show/NCT00235651","[' University of Pittsburgh ']","[]"]
["NCT00236405","https://clinicaltrials.gov/ct2/show/NCT00236405","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00240734","https://clinicaltrials.gov/ct2/show/NCT00240734","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00242827","https://clinicaltrials.gov/ct2/show/NCT00242827","[' Cephalon ']","[]"]
["NCT00243308","https://clinicaltrials.gov/ct2/show/NCT00243308","[' Viron Therapeutics Inc ']","[]"]
["NCT00245440","https://clinicaltrials.gov/ct2/show/NCT00245440","[' CPL Associates ']","[]"]
["NCT00246298","https://clinicaltrials.gov/ct2/show/NCT00246298","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00250861","https://clinicaltrials.gov/ct2/show/NCT00250861","[' US Oncology Research ']","[]"]
["NCT00251186","https://clinicaltrials.gov/ct2/show/NCT00251186","[' University of Medicine and Dentistry of New Jersey ']","[]"]
["NCT00252993","https://clinicaltrials.gov/ct2/show/NCT00252993","[' Dynogen Pharmaceuticals ']","[]"]
["NCT00255333","https://clinicaltrials.gov/ct2/show/NCT00255333","[' Innovive Pharmaceuticals ']","[]"]
["NCT00265915","https://clinicaltrials.gov/ct2/show/NCT00265915","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00267267","https://clinicaltrials.gov/ct2/show/NCT00267267","[' Pfizer ']","[]"]
["NCT00267553","https://clinicaltrials.gov/ct2/show/NCT00267553","[' Intarcia Therapeutics ']","[]"]
["NCT00273338","https://clinicaltrials.gov/ct2/show/NCT00273338","[' Novacea ']","[]"]
["NCT00274495","https://clinicaltrials.gov/ct2/show/NCT00274495","[' Beth Israel Medical Center ']","[]"]
["NCT00275314","https://clinicaltrials.gov/ct2/show/NCT00275314","[' University of Pittsburgh ']","[]"]
["NCT00281125","https://clinicaltrials.gov/ct2/show/NCT00281125","[' Nevada Cancer Institute ']","[]"]
["NCT00281294","https://clinicaltrials.gov/ct2/show/NCT00281294","[' PDL BioPharma, Inc. ']","[]"]
["NCT00287066","https://clinicaltrials.gov/ct2/show/NCT00287066","[' Pfizer ']","[]"]
["NCT00287326","https://clinicaltrials.gov/ct2/show/NCT00287326","[' University of North Carolina, Chapel Hill ']","[]"]
["NCT00289601","https://clinicaltrials.gov/ct2/show/NCT00289601","[\" Brigham and Women's Hospital \"]","[]"]
["NCT00294372","https://clinicaltrials.gov/ct2/show/NCT00294372","[' Boehringer Ingelheim ']","[]"]
["NCT00294541","https://clinicaltrials.gov/ct2/show/NCT00294541","[' Icagen ']","[]"]
["NCT00301431","https://clinicaltrials.gov/ct2/show/NCT00301431","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00303433","https://clinicaltrials.gov/ct2/show/NCT00303433","[' University of Rochester ']","[]"]
["NCT00306267","https://clinicaltrials.gov/ct2/show/NCT00306267","[' Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ']","[]"]
["NCT00311987","https://clinicaltrials.gov/ct2/show/NCT00311987","[' Johns Hopkins University ']","[]"]
["NCT00312650","https://clinicaltrials.gov/ct2/show/NCT00312650","[' Women and Infants Hospital of Rhode Island ']","[]"]
["NCT00314613","https://clinicaltrials.gov/ct2/show/NCT00314613","[' Duke University ']","[]"]
["NCT00316433","https://clinicaltrials.gov/ct2/show/NCT00316433","[' Swedish Medical Center ']","[]"]
["NCT00316537","https://clinicaltrials.gov/ct2/show/NCT00316537","[' CoMentis ']","[]"]
["NCT00316550","https://clinicaltrials.gov/ct2/show/NCT00316550","[' Avera Pharmaceuticals ']","[]"]
["NCT00327080","https://clinicaltrials.gov/ct2/show/NCT00327080","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00332085","https://clinicaltrials.gov/ct2/show/NCT00332085","[' Bastyr University ']","[]"]
["NCT00343187","https://clinicaltrials.gov/ct2/show/NCT00343187","[' Allergan ']","[]"]
["NCT00343655","https://clinicaltrials.gov/ct2/show/NCT00343655","[' Pfizer ']","[]"]
["NCT00354094","https://clinicaltrials.gov/ct2/show/NCT00354094","[' Pfizer ']","[]"]
["NCT00354900","https://clinicaltrials.gov/ct2/show/NCT00354900","[' Dartmouth-Hitchcock Medical Center ']","[]"]
["NCT00367692","https://clinicaltrials.gov/ct2/show/NCT00367692","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00367783","https://clinicaltrials.gov/ct2/show/NCT00367783","[' Pfizer ']","[]"]
["NCT00379860","https://clinicaltrials.gov/ct2/show/NCT00379860","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00381602","https://clinicaltrials.gov/ct2/show/NCT00381602","[' QLT Inc. ']","[]"]
["NCT00385021","https://clinicaltrials.gov/ct2/show/NCT00385021","[' Southwestern Regional Medical Center ']","[]"]
["NCT00390975","https://clinicaltrials.gov/ct2/show/NCT00390975","[' Novartis ']","[]"]
["NCT00394316","https://clinicaltrials.gov/ct2/show/NCT00394316","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00397358","https://clinicaltrials.gov/ct2/show/NCT00397358","[' Baxter Healthcare Corporation ']","[]"]
["NCT00401947","https://clinicaltrials.gov/ct2/show/NCT00401947","[' Achillion Pharmaceuticals ']","[]"]
["NCT00414284","https://clinicaltrials.gov/ct2/show/NCT00414284","[' Community Research Initiative of New England ']","[]"]
["NCT00417677","https://clinicaltrials.gov/ct2/show/NCT00417677","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00420706","https://clinicaltrials.gov/ct2/show/NCT00420706","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00420810","https://clinicaltrials.gov/ct2/show/NCT00420810","[' H. Lundbeck A/S ']","[]"]
["NCT00425919","https://clinicaltrials.gov/ct2/show/NCT00425919","[' Wyeth is now a wholly owned subsidiary of Pfizer ']","[]"]
["NCT00426985","https://clinicaltrials.gov/ct2/show/NCT00426985","[' Endo Pharmaceuticals ']","[]"]
["NCT00427102","https://clinicaltrials.gov/ct2/show/NCT00427102","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00427427","https://clinicaltrials.gov/ct2/show/NCT00427427","[' Jonsson Comprehensive Cancer Center ']","[]"]
["NCT00428272","https://clinicaltrials.gov/ct2/show/NCT00428272","[' National Cancer Institute (NCI) ']","[]"]
["NCT00435578","https://clinicaltrials.gov/ct2/show/NCT00435578","[' Threshold Pharmaceuticals ']","[]"]
["NCT00443963","https://clinicaltrials.gov/ct2/show/NCT00443963","[' Medstar Health Research Institute ']","[]"]
["NCT00453297","https://clinicaltrials.gov/ct2/show/NCT00453297","[' Bionovo ']","[]"]
["NCT00458042","https://clinicaltrials.gov/ct2/show/NCT00458042","[' United Therapeutics ']","[]"]
["NCT00460460","https://clinicaltrials.gov/ct2/show/NCT00460460","[' AstraZeneca ']","[]"]
["NCT00464347","https://clinicaltrials.gov/ct2/show/NCT00464347","[' National Eye Institute (NEI) ']","[]"]
["NCT00465296","https://clinicaltrials.gov/ct2/show/NCT00465296","[' Medstar Health Research Institute ']","[]"]
["NCT00468611","https://clinicaltrials.gov/ct2/show/NCT00468611","[' BioMS Technology Corp. ']","[]"]
["NCT00469703","https://clinicaltrials.gov/ct2/show/NCT00469703","[' Winthrop University Hospital ']","[]"]
["NCT00469820","https://clinicaltrials.gov/ct2/show/NCT00469820","[' Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ']","[]"]
["NCT00471809","https://clinicaltrials.gov/ct2/show/NCT00471809","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00492479","https://clinicaltrials.gov/ct2/show/NCT00492479","[' Innovative Medical ']","[]"]
["NCT00504842","https://clinicaltrials.gov/ct2/show/NCT00504842","[' ImaRx Therapeutics ']","[]"]
["NCT00516750","https://clinicaltrials.gov/ct2/show/NCT00516750","[' Kyoto University ']","[]"]
["NCT00543608","https://clinicaltrials.gov/ct2/show/NCT00543608","[' Arpida AG ']","[]"]
["NCT00550849","https://clinicaltrials.gov/ct2/show/NCT00550849","[' Reata Pharmaceuticals, Inc. ']","[]"]
["NCT00559416","https://clinicaltrials.gov/ct2/show/NCT00559416","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00674557","https://clinicaltrials.gov/ct2/show/NCT00674557","[' Cancer Research UK ']","[]"]
["NCT00688805","https://clinicaltrials.gov/ct2/show/NCT00688805","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00744341","https://clinicaltrials.gov/ct2/show/NCT00744341","[' Solvay Pharmaceuticals ']","[]"]
["NCT00973804","https://clinicaltrials.gov/ct2/show/NCT00973804","[' National Cancer Institute (NCI) ']","[]"]
["NCT01324141","https://clinicaltrials.gov/ct2/show/NCT01324141","[' National Cancer Institute (NCI) ']","[]"]
["NCT01336985","https://clinicaltrials.gov/ct2/show/NCT01336985","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT01375556","https://clinicaltrials.gov/ct2/show/NCT01375556","[' National Institute on Alcohol Abuse and Alcoholism (NIAAA) ']","[]"]
["NCT01413451","https://clinicaltrials.gov/ct2/show/NCT01413451","[' National Cancer Institute (NCI) ']","[]"]
["NCT01420952","https://clinicaltrials.gov/ct2/show/NCT01420952","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT01441115","https://clinicaltrials.gov/ct2/show/NCT01441115","[' National Cancer Institute (NCI) ']","[]"]
["NCT01445340","https://clinicaltrials.gov/ct2/show/NCT01445340","[' National Cancer Institute (NCI) ']","[]"]
["NCT01656577","https://clinicaltrials.gov/ct2/show/NCT01656577","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00232167","https://clinicaltrials.gov/ct2/show/NCT00232167","[' Neurocrine Biosciences ']","[]"]
["NCT00179738","https://clinicaltrials.gov/ct2/show/NCT00179738","[' Celgene Corporation ']","[]"]
["NCT00179751","https://clinicaltrials.gov/ct2/show/NCT00179751","[' Celgene Corporation ']","[]"]
["NCT00104338","https://clinicaltrials.gov/ct2/show/NCT00104338","[' Astellas Pharma Inc ']","[]"]
["NCT00237536","https://clinicaltrials.gov/ct2/show/NCT00237536","[' Threshold Pharmaceuticals ']","[]"]
["NCT00127517","https://clinicaltrials.gov/ct2/show/NCT00127517","[' Advanced Viral Research Corp ']","[]"]
["NCT00283634","https://clinicaltrials.gov/ct2/show/NCT00283634","[' Millennium Pharmaceuticals, Inc. ']","[]"]
["NCT00269828","https://clinicaltrials.gov/ct2/show/NCT00269828","[' CTI BioPharma ']","[]"]
["NCT00283361","https://clinicaltrials.gov/ct2/show/NCT00283361","[' Zealand Pharma ']","[]"]
["NCT00333060","https://clinicaltrials.gov/ct2/show/NCT00333060","[' Othera Pharmaceuticals ']","[]"]
["NCT00365898","https://clinicaltrials.gov/ct2/show/NCT00365898","[' Purdue Pharma LP ']","[]"]
["NCT00117351","https://clinicaltrials.gov/ct2/show/NCT00117351","[' Millennium Pharmaceuticals, Inc. ']","[]"]
["NCT00258726","https://clinicaltrials.gov/ct2/show/NCT00258726","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00133432","https://clinicaltrials.gov/ct2/show/NCT00133432","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00271167","https://clinicaltrials.gov/ct2/show/NCT00271167","[' Inotek Pharmaceuticals Corporation ']","[]"]
["NCT00179725","https://clinicaltrials.gov/ct2/show/NCT00179725","[' Celgene Corporation ']","[]"]
["NCT00162214","https://clinicaltrials.gov/ct2/show/NCT00162214","[' Bristol-Myers Squibb ']","[]"]
["NCT00312351","https://clinicaltrials.gov/ct2/show/NCT00312351","[' Eyetech Pharmaceuticals ']","[]"]
["NCT00179699","https://clinicaltrials.gov/ct2/show/NCT00179699","[' Celgene Corporation ']","[]"]
["NCT00389519","https://clinicaltrials.gov/ct2/show/NCT00389519","[' Pfizer ']","[]"]
["NCT00332826","https://clinicaltrials.gov/ct2/show/NCT00332826","[' Mannkind Corporation ']","[]"]
["NCT00134667","https://clinicaltrials.gov/ct2/show/NCT00134667","[' Eyetech Pharmaceuticals ']","[]"]
["NCT00267527","https://clinicaltrials.gov/ct2/show/NCT00267527","[' ConjuChem ']","[]"]
["NCT00126893","https://clinicaltrials.gov/ct2/show/NCT00126893","[' Celgene Corporation ']","[]"]
["NCT00239200","https://clinicaltrials.gov/ct2/show/NCT00239200","[' University of Michigan Rogel Cancer Center ']","[]"]
["NCT00300027","https://clinicaltrials.gov/ct2/show/NCT00300027","[' Bristol-Myers Squibb ']","[]"]
["NCT00332748","https://clinicaltrials.gov/ct2/show/NCT00332748","[' Bristol-Myers Squibb ']","[]"]
["NCT00162253","https://clinicaltrials.gov/ct2/show/NCT00162253","[' Bristol-Myers Squibb ']","[]"]
["NCT00326131","https://clinicaltrials.gov/ct2/show/NCT00326131","[' Bristol-Myers Squibb ']","[]"]
["NCT00359450","https://clinicaltrials.gov/ct2/show/NCT00359450","[' Bristol-Myers Squibb ']","[]"]

{"sheet":"247","index":3,"n_rows":248,"n_cols":4,"rows_kept":248,"cut":false,"hidden":false,"merged":[]}
["nct_id","urllist","sponsor","responsible party"]
["NCT00532974","https://clinicaltrials.gov/ct2/show/NCT00532974","[' Epimmune ']","[]"]
["NCT00536692","https://clinicaltrials.gov/ct2/show/NCT00536692","[' CoMentis ']","[]"]
["NCT00992576","https://clinicaltrials.gov/ct2/show/NCT00992576","[' Mundipharma Research GmbH & Co KG ']","[]"]
["NCT00674596","https://clinicaltrials.gov/ct2/show/NCT00674596","[' Gulhane School of Medicine ']","[]"]
["NCT00973895","https://clinicaltrials.gov/ct2/show/NCT00973895","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00512083","https://clinicaltrials.gov/ct2/show/NCT00512083","[' Antisoma Research ']","[]"]
["NCT00354276","https://clinicaltrials.gov/ct2/show/NCT00354276","[' Vion Pharmaceuticals ']","[]"]
["NCT00811759","https://clinicaltrials.gov/ct2/show/NCT00811759","[' Gustave Roussy, Cancer Campus, Grand Paris ']","[]"]
["NCT00070278","https://clinicaltrials.gov/ct2/show/NCT00070278","[' Cambridge University Hospitals NHS Foundation Trust ']","[]"]
["NCT00109356","https://clinicaltrials.gov/ct2/show/NCT00109356","[' Novacea ']","[]"]
["NCT00110708","https://clinicaltrials.gov/ct2/show/NCT00110708","[' PediaMed Pharmaceuticals ']","[]"]
["NCT00251849","https://clinicaltrials.gov/ct2/show/NCT00251849","[' ActivBiotics ']","[]"]
["NCT00285675","https://clinicaltrials.gov/ct2/show/NCT00285675","[' Novacea ']","[]"]
["NCT00422331","https://clinicaltrials.gov/ct2/show/NCT00422331","[' JDS Pharmaceuticals ']","[]"]
["NCT00544310","https://clinicaltrials.gov/ct2/show/NCT00544310","[' OMRIX Biopharmaceuticals ']","[]"]
["NCT00541073","https://clinicaltrials.gov/ct2/show/NCT00541073","[' Centre Oscar Lambret ']","[]"]
["NCT00122434","https://clinicaltrials.gov/ct2/show/NCT00122434","[' Boehringer Ingelheim ']","[]"]
["NCT00128440","https://clinicaltrials.gov/ct2/show/NCT00128440","[' Boehringer Ingelheim ']","[]"]
["NCT00112554","https://clinicaltrials.gov/ct2/show/NCT00112554","[' Vion Pharmaceuticals ']","[]"]
["NCT00282022","https://clinicaltrials.gov/ct2/show/NCT00282022","[' Vion Pharmaceuticals ']","[]"]
["NCT00963521","https://clinicaltrials.gov/ct2/show/NCT00963521","[' Institut Paoli-Calmettes ']","[]"]
["NCT00550927","https://clinicaltrials.gov/ct2/show/NCT00550927","[' Eli Lilly and Company ']","[]"]
["NCT00544349","https://clinicaltrials.gov/ct2/show/NCT00544349","[' Gustave Roussy, Cancer Campus, Grand Paris ']","[]"]
["NCT00802568","https://clinicaltrials.gov/ct2/show/NCT00802568","[' Institut Paoli-Calmettes ']","[]"]
["NCT00806767","https://clinicaltrials.gov/ct2/show/NCT00806767","[' Institut Paoli-Calmettes ']","[]"]
["NCT00820963","https://clinicaltrials.gov/ct2/show/NCT00820963","[' Centre Leon Berard ']","[]"]
["NCT00104949","https://clinicaltrials.gov/ct2/show/NCT00104949","[' Southwest Oncology Group ']","[]"]
["NCT00870558","https://clinicaltrials.gov/ct2/show/NCT00870558","[' Hospices Civils de Lyon ']","[]"]
["NCT00381875","https://clinicaltrials.gov/ct2/show/NCT00381875","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00259818","https://clinicaltrials.gov/ct2/show/NCT00259818","[' Erimos Pharmaceuticals ']","[]"]
["NCT00152022","https://clinicaltrials.gov/ct2/show/NCT00152022","[' Shire ']","[]"]
["NCT00542217","https://clinicaltrials.gov/ct2/show/NCT00542217","[' Biothera ']","[]"]
["NCT00116675","https://clinicaltrials.gov/ct2/show/NCT00116675","[' Graceway Pharmaceuticals, LLC ']","[]"]
["NCT00150592","https://clinicaltrials.gov/ct2/show/NCT00150592","[' Shire ']","[]"]
["NCT00202605","https://clinicaltrials.gov/ct2/show/NCT00202605","[' Shire ']","[]"]
["NCT00261872","https://clinicaltrials.gov/ct2/show/NCT00261872","[' National Institute on Alcohol Abuse and Alcoholism (NIAAA) ']","[]"]
["NCT00290940","https://clinicaltrials.gov/ct2/show/NCT00290940","[' Daiichi Sankyo, Inc. ']","[]"]
["NCT00110864","https://clinicaltrials.gov/ct2/show/NCT00110864","[' Wellstat Therapeutics ']","[]"]
["NCT00408538","https://clinicaltrials.gov/ct2/show/NCT00408538","[' University of California, Los Angeles ']","[]"]
["NCT01182636","https://clinicaltrials.gov/ct2/show/NCT01182636","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00489931","https://clinicaltrials.gov/ct2/show/NCT00489931","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00667771","https://clinicaltrials.gov/ct2/show/NCT00667771","[' National Institute on Alcohol Abuse and Alcoholism (NIAAA) ']","[]"]
["NCT00102271","https://clinicaltrials.gov/ct2/show/NCT00102271","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00685503","https://clinicaltrials.gov/ct2/show/NCT00685503","[' National Eye Institute (NEI) ']","[]"]
["NCT01132911","https://clinicaltrials.gov/ct2/show/NCT01132911","[' National Cancer Institute (NCI) ']","[]"]
["NCT00137891","https://clinicaltrials.gov/ct2/show/NCT00137891","[' Genzyme, a Sanofi Company ']","[]"]
["NCT00106808","https://clinicaltrials.gov/ct2/show/NCT00106808","[' Bristol-Myers Squibb ']","[]"]
["NCT00255450","https://clinicaltrials.gov/ct2/show/NCT00255450","[' AMAG Pharmaceuticals, Inc. ']","[]"]
["NCT00151918","https://clinicaltrials.gov/ct2/show/NCT00151918","[' Shire ']","[]"]
["NCT00274313","https://clinicaltrials.gov/ct2/show/NCT00274313","[' Parion Sciences ']","[]"]
["NCT00110851","https://clinicaltrials.gov/ct2/show/NCT00110851","[' Wellstat Therapeutics ']","[]"]
["NCT00532116","https://clinicaltrials.gov/ct2/show/NCT00532116","[' Somerset Pharmaceuticals ']","[]"]
["NCT00263523","https://clinicaltrials.gov/ct2/show/NCT00263523","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT00439400","https://clinicaltrials.gov/ct2/show/NCT00439400","[' Alacrity Biosciences, Inc. ']","[]"]
["NCT00121589","https://clinicaltrials.gov/ct2/show/NCT00121589","[' National Eye Institute (NEI) ']","[]"]
["NCT00358930","https://clinicaltrials.gov/ct2/show/NCT00358930","[' ArQule ']","[]"]
["NCT00303264","https://clinicaltrials.gov/ct2/show/NCT00303264","[' Forest Laboratories ']","[]"]
["NCT00248365","https://clinicaltrials.gov/ct2/show/NCT00248365","[' Kiadis Pharma ']","[]"]
["NCT00225706","https://clinicaltrials.gov/ct2/show/NCT00225706","[' Cumberland Pharmaceuticals ']","[]"]
["NCT00332137","https://clinicaltrials.gov/ct2/show/NCT00332137","[' Mayo Clinic ']","[]"]
["NCT00408109","https://clinicaltrials.gov/ct2/show/NCT00408109","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00326443","https://clinicaltrials.gov/ct2/show/NCT00326443","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00111397","https://clinicaltrials.gov/ct2/show/NCT00111397","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00150579","https://clinicaltrials.gov/ct2/show/NCT00150579","[' Shire ']","[]"]
["NCT00132392","https://clinicaltrials.gov/ct2/show/NCT00132392","[' AlgoRx Pharmaceuticals ']","[]"]
["NCT00171665","https://clinicaltrials.gov/ct2/show/NCT00171665","[' Novartis ']","[]"]
["NCT00114010","https://clinicaltrials.gov/ct2/show/NCT00114010","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00543231","https://clinicaltrials.gov/ct2/show/NCT00543231","[' Genta Incorporated ']","[]"]
["NCT00132652","https://clinicaltrials.gov/ct2/show/NCT00132652","[' Novartis ']","[]"]
["NCT00294346","https://clinicaltrials.gov/ct2/show/NCT00294346","[' Avera Pharmaceuticals ']","[]"]
["NCT00214994","https://clinicaltrials.gov/ct2/show/NCT00214994","[' Cephalon ']","[]"]
["NCT00326508","https://clinicaltrials.gov/ct2/show/NCT00326508","[' National Eye Institute (NEI) ']","[]"]
["NCT00542529","https://clinicaltrials.gov/ct2/show/NCT00542529","[' Biothera ']","[]"]
["NCT00312364","https://clinicaltrials.gov/ct2/show/NCT00312364","[' Pfizer ']","[]"]
["NCT00510419","https://clinicaltrials.gov/ct2/show/NCT00510419","[' Pfizer ']","[]"]
["NCT00300417","https://clinicaltrials.gov/ct2/show/NCT00300417","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00478179","https://clinicaltrials.gov/ct2/show/NCT00478179","[' Durect ']","[]"]
["NCT00525954","https://clinicaltrials.gov/ct2/show/NCT00525954","[' Anthera Pharmaceuticals ']","[]"]
["NCT00953901","https://clinicaltrials.gov/ct2/show/NCT00953901","[' Mayo Clinic ']","[]"]
["NCT00321061","https://clinicaltrials.gov/ct2/show/NCT00321061","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01086657","https://clinicaltrials.gov/ct2/show/NCT01086657","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01037608","https://clinicaltrials.gov/ct2/show/NCT01037608","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00108667","https://clinicaltrials.gov/ct2/show/NCT00108667","[' National Institute of Neurological Disorders and Stroke (NINDS) ']","[]"]
["NCT00121563","https://clinicaltrials.gov/ct2/show/NCT00121563","[' National Institute of Nursing Research (NINR) ']","[]"]
["NCT00115986","https://clinicaltrials.gov/ct2/show/NCT00115986","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00104247","https://clinicaltrials.gov/ct2/show/NCT00104247","[' BioMarin Pharmaceutical ']","[]"]
["NCT00952991","https://clinicaltrials.gov/ct2/show/NCT00952991","[' Mayo Clinic ']","[]"]
["NCT00170547","https://clinicaltrials.gov/ct2/show/NCT00170547","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00113620","https://clinicaltrials.gov/ct2/show/NCT00113620","[' Avanir Pharmaceuticals ']","[]"]
["NCT00332033","https://clinicaltrials.gov/ct2/show/NCT00332033","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00252005","https://clinicaltrials.gov/ct2/show/NCT00252005","[' Bristol-Myers Squibb ']","[]"]
["NCT00487916","https://clinicaltrials.gov/ct2/show/NCT00487916","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00876434","https://clinicaltrials.gov/ct2/show/NCT00876434","[' National Eye Institute (NEI) ']","[]"]
["NCT01340625","https://clinicaltrials.gov/ct2/show/NCT01340625","[' Teva Pharmaceuticals USA ']","[]"]
["NCT00102700","https://clinicaltrials.gov/ct2/show/NCT00102700","[' ArQule ']","[]"]
["NCT00390390","https://clinicaltrials.gov/ct2/show/NCT00390390","[' Novartis ']","[]"]
["NCT00389948","https://clinicaltrials.gov/ct2/show/NCT00389948","[' Novartis ']","[]"]
["NCT00315276","https://clinicaltrials.gov/ct2/show/NCT00315276","[' Cephalon ']","[]"]
["NCT00230750","https://clinicaltrials.gov/ct2/show/NCT00230750","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00109629","https://clinicaltrials.gov/ct2/show/NCT00109629","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00108654","https://clinicaltrials.gov/ct2/show/NCT00108654","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00103350","https://clinicaltrials.gov/ct2/show/NCT00103350","[' TargeGen ']","[]"]
["NCT00265057","https://clinicaltrials.gov/ct2/show/NCT00265057","[' Adherex Technologies, Inc. ']","[]"]
["NCT00106769","https://clinicaltrials.gov/ct2/show/NCT00106769","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00322140","https://clinicaltrials.gov/ct2/show/NCT00322140","[' National Cancer Institute (NCI) ']","[]"]
["NCT00262678","https://clinicaltrials.gov/ct2/show/NCT00262678","[' Prostrakan Pharmaceuticals ']","[]"]
["NCT01041170","https://clinicaltrials.gov/ct2/show/NCT01041170","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT00776711","https://clinicaltrials.gov/ct2/show/NCT00776711","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00939536","https://clinicaltrials.gov/ct2/show/NCT00939536","[' Torrent Pharmaceuticals Limited ']","[]"]
["NCT00299520","https://clinicaltrials.gov/ct2/show/NCT00299520","[' Arpida AG ']","[]"]
["NCT00179686","https://clinicaltrials.gov/ct2/show/NCT00179686","[' Celgene Corporation ']","[]"]
["NCT00113009","https://clinicaltrials.gov/ct2/show/NCT00113009","[' Valentis ']","[]"]
["NCT00108979","https://clinicaltrials.gov/ct2/show/NCT00108979","[' Forest Laboratories ']","[]"]
["NCT00240968","https://clinicaltrials.gov/ct2/show/NCT00240968","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00343733","https://clinicaltrials.gov/ct2/show/NCT00343733","[' Cephalon ']","[]"]
["NCT00456053","https://clinicaltrials.gov/ct2/show/NCT00456053","[' FibroGen ']","[]"]
["NCT00135408","https://clinicaltrials.gov/ct2/show/NCT00135408","[' Bristol-Myers Squibb ']","[]"]
["NCT00310518","https://clinicaltrials.gov/ct2/show/NCT00310518","[' ArQule ']","[]"]
["NCT01382901","https://clinicaltrials.gov/ct2/show/NCT01382901","[' American Regent, Inc. ']","[]"]
["NCT00394121","https://clinicaltrials.gov/ct2/show/NCT00394121","[' SkyePharma AG ']","[]"]
["NCT00263237","https://clinicaltrials.gov/ct2/show/NCT00263237","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00340574","https://clinicaltrials.gov/ct2/show/NCT00340574","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00248183","https://clinicaltrials.gov/ct2/show/NCT00248183","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00297713","https://clinicaltrials.gov/ct2/show/NCT00297713","[' Altus Pharmaceuticals ']","[]"]
["NCT00324389","https://clinicaltrials.gov/ct2/show/NCT00324389","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00130000","https://clinicaltrials.gov/ct2/show/NCT00130000","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00269438","https://clinicaltrials.gov/ct2/show/NCT00269438","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00102297","https://clinicaltrials.gov/ct2/show/NCT00102297","[' FibroGen ']","[]"]
["NCT00345774","https://clinicaltrials.gov/ct2/show/NCT00345774","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00250185","https://clinicaltrials.gov/ct2/show/NCT00250185","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00295581","https://clinicaltrials.gov/ct2/show/NCT00295581","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00366418","https://clinicaltrials.gov/ct2/show/NCT00366418","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00270465","https://clinicaltrials.gov/ct2/show/NCT00270465","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00943982","https://clinicaltrials.gov/ct2/show/NCT00943982","[' National Eye Institute (NEI) ']","[]"]
["NCT00644072","https://clinicaltrials.gov/ct2/show/NCT00644072","[' National Cancer Institute (NCI) ']","[]"]
["NCT00154141","https://clinicaltrials.gov/ct2/show/NCT00154141","[' Ethicon, Inc. ']","[]"]
["NCT00111072","https://clinicaltrials.gov/ct2/show/NCT00111072","[' National Institute of Dental and Craniofacial Research (NIDCR) ']","[]"]
["NCT00432770","https://clinicaltrials.gov/ct2/show/NCT00432770","[' Archemix Corp. ']","[]"]
["NCT00106600","https://clinicaltrials.gov/ct2/show/NCT00106600","[' CTI BioPharma ']","[]"]
["NCT00254202","https://clinicaltrials.gov/ct2/show/NCT00254202","[' Vanda Pharmaceuticals ']","[]"]
["NCT00669851","https://clinicaltrials.gov/ct2/show/NCT00669851","[' Acusphere ']","[]"]
["NCT00129168","https://clinicaltrials.gov/ct2/show/NCT00129168","[' Kanisa Pharmaceuticals ']","[]"]
["NCT00233909","https://clinicaltrials.gov/ct2/show/NCT00233909","[' Kanisa Pharmaceuticals ']","[]"]
["NCT00260702","https://clinicaltrials.gov/ct2/show/NCT00260702","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00489385","https://clinicaltrials.gov/ct2/show/NCT00489385","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00685854","https://clinicaltrials.gov/ct2/show/NCT00685854","[' National Eye Institute (NEI) ']","[]"]
["NCT00107822","https://clinicaltrials.gov/ct2/show/NCT00107822","[' ZARS Pharma Inc. ']","[]"]
["NCT00266669","https://clinicaltrials.gov/ct2/show/NCT00266669","[' MediQuest Therapeutics ']","[]"]
["NCT00128947","https://clinicaltrials.gov/ct2/show/NCT00128947","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00108836","https://clinicaltrials.gov/ct2/show/NCT00108836","[' Novartis Pharmaceuticals ']","[]"]
["NCT00105417","https://clinicaltrials.gov/ct2/show/NCT00105417","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00231023","https://clinicaltrials.gov/ct2/show/NCT00231023","[' National Eye Institute (NEI) ']","[]"]
["NCT00456560","https://clinicaltrials.gov/ct2/show/NCT00456560","[' Avigen ']","[]"]
["NCT00410527","https://clinicaltrials.gov/ct2/show/NCT00410527","[' National Institutes of Health Clinical Center (CC) ']","[]"]
["NCT00482937","https://clinicaltrials.gov/ct2/show/NCT00482937","[' Nile Therapeutics ']","[]"]
["NCT00152035","https://clinicaltrials.gov/ct2/show/NCT00152035","[' Shire ']","[]"]
["NCT00128544","https://clinicaltrials.gov/ct2/show/NCT00128544","[' Novartis ']","[]"]
["NCT00101764","https://clinicaltrials.gov/ct2/show/NCT00101764","[' National Eye Institute (NEI) ']","[]"]
["NCT00101374","https://clinicaltrials.gov/ct2/show/NCT00101374","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00224406","https://clinicaltrials.gov/ct2/show/NCT00224406","[u' Domp\\xe9 Farmaceutici S.p.A ']","[]"]
["NCT00374309","https://clinicaltrials.gov/ct2/show/NCT00374309","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01324843","https://clinicaltrials.gov/ct2/show/NCT01324843","[' National Institute on Aging (NIA) ']","[]"]
["NCT00106405","https://clinicaltrials.gov/ct2/show/NCT00106405","[' Forest Laboratories ']","[]"]
["NCT00106132","https://clinicaltrials.gov/ct2/show/NCT00106132","[' National Eye Institute (NEI) ']","[]"]
["NCT00297050","https://clinicaltrials.gov/ct2/show/NCT00297050","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00272792","https://clinicaltrials.gov/ct2/show/NCT00272792","[' BioMarin Pharmaceutical ']","[]"]
["NCT00326274","https://clinicaltrials.gov/ct2/show/NCT00326274","[' Loreal USA ']","[]"]
["NCT00448292","https://clinicaltrials.gov/ct2/show/NCT00448292","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00408174","https://clinicaltrials.gov/ct2/show/NCT00408174","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00128531","https://clinicaltrials.gov/ct2/show/NCT00128531","[' GP-Pharm ']","[]"]
["NCT00427167","https://clinicaltrials.gov/ct2/show/NCT00427167","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT01034020","https://clinicaltrials.gov/ct2/show/NCT01034020","[' National Institute on Drug Abuse (NIDA) ']","[]"]
["NCT01355016","https://clinicaltrials.gov/ct2/show/NCT01355016","[' MicroDose Therapeutx, Inc ']","[]"]
["NCT00150605","https://clinicaltrials.gov/ct2/show/NCT00150605","[' Validus Pharmaceuticals ']","[]"]
["NCT00150553","https://clinicaltrials.gov/ct2/show/NCT00150553","[' Validus Pharmaceuticals ']","[]"]
["NCT00109564","https://clinicaltrials.gov/ct2/show/NCT00109564","[' Targacept Inc. ']","[]"]
["NCT00102557","https://clinicaltrials.gov/ct2/show/NCT00102557","[' National Institute of Dental and Craniofacial Research (NIDCR) ']","[]"]
["NCT00113997","https://clinicaltrials.gov/ct2/show/NCT00113997","[' National Heart, Lung, and Blood Institute (NHLBI) ']","[]"]
["NCT00185107","https://clinicaltrials.gov/ct2/show/NCT00185107","[' Daiichi Sankyo, Inc. ']","[]"]
["NCT00171652","https://clinicaltrials.gov/ct2/show/NCT00171652","[' Novartis ']","[]"]
["NCT00273468","https://clinicaltrials.gov/ct2/show/NCT00273468","[' Prostrakan Pharmaceuticals ']","[]"]
["NCT00115752","https://clinicaltrials.gov/ct2/show/NCT00115752","[' National Institute of Nursing Research (NINR) ']","[]"]
["NCT00105404","https://clinicaltrials.gov/ct2/show/NCT00105404","[' National Eye Institute (NEI) ']","[]"]
["NCT00322283","https://clinicaltrials.gov/ct2/show/NCT00322283","[' Forest Laboratories ']","[]"]
["NCT00102258","https://clinicaltrials.gov/ct2/show/NCT00102258","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00102089","https://clinicaltrials.gov/ct2/show/NCT00102089","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00283920","https://clinicaltrials.gov/ct2/show/NCT00283920","[' National Institute of Mental Health (NIMH) ']","[]"]
["NCT00457145","https://clinicaltrials.gov/ct2/show/NCT00457145","[' National Eye Institute (NEI) ']","[]"]
["NCT00457067","https://clinicaltrials.gov/ct2/show/NCT00457067","[' National Eye Institute (NEI) ']","[]"]
["NCT00117013","https://clinicaltrials.gov/ct2/show/NCT00117013","[' National Cancer Institute (NCI) ']","[]"]
["NCT00171522","https://clinicaltrials.gov/ct2/show/NCT00171522","[' Novartis ']","[]"]
["NCT00343811","https://clinicaltrials.gov/ct2/show/NCT00343811","[' Cephalon ']","[]"]
["NCT00115154","https://clinicaltrials.gov/ct2/show/NCT00115154","[' Graceway Pharmaceuticals, LLC ']","[]"]
["NCT00542464","https://clinicaltrials.gov/ct2/show/NCT00542464","[' Biothera ']","[]"]
["NCT00250198","https://clinicaltrials.gov/ct2/show/NCT00250198","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00228540","https://clinicaltrials.gov/ct2/show/NCT00228540","[' Cephalon ']","[]"]
["NCT00455546","https://clinicaltrials.gov/ct2/show/NCT00455546","[' Anthera Pharmaceuticals ']","[]"]
["NCT00467493","https://clinicaltrials.gov/ct2/show/NCT00467493","[' Meditrina Pharmaceuticals ']","[]"]
["NCT00139620","https://clinicaltrials.gov/ct2/show/NCT00139620","[' OSI Pharmaceuticals ']","[]"]
["NCT00328380","https://clinicaltrials.gov/ct2/show/NCT00328380","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00269412","https://clinicaltrials.gov/ct2/show/NCT00269412","[' Valeant Pharmaceuticals International, Inc. ']","[]"]
["NCT00277147","https://clinicaltrials.gov/ct2/show/NCT00277147","[' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ']","[]"]
["NCT00903253","https://clinicaltrials.gov/ct2/show/NCT00903253","[' Link Medicine Corporation ']","[]"]
["NCT00553189","https://clinicaltrials.gov/ct2/show/NCT00553189","[' National Cancer Institute (NCI) ']","[]"]
["NCT01051934","https://clinicaltrials.gov/ct2/show/NCT01051934","[' National Cancer Institute (NCI) ']","[]"]
["NCT00335647","https://clinicaltrials.gov/ct2/show/NCT00335647","[' Immune Control ']","[]"]
["NCT00404573","https://clinicaltrials.gov/ct2/show/NCT00404573","[' Forest Laboratories ']","[]"]
["NCT00129194","https://clinicaltrials.gov/ct2/show/NCT00129194","[' Koronis Pharmaceuticals. ']","[]"]
["NCT00316511","https://clinicaltrials.gov/ct2/show/NCT00316511","[' Agenus Inc. ']","[]"]
["NCT00740090","https://clinicaltrials.gov/ct2/show/NCT00740090","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00274248","https://clinicaltrials.gov/ct2/show/NCT00274248","[' Millennium Pharmaceuticals, Inc. ']","[]"]
["NCT00334906","https://clinicaltrials.gov/ct2/show/NCT00334906","[' Forest Laboratories ']","[]"]
["NCT00384436","https://clinicaltrials.gov/ct2/show/NCT00384436","[' Forest Laboratories ']","[]"]
["NCT00384423","https://clinicaltrials.gov/ct2/show/NCT00384423","[' Epix Pharmaceuticals, Inc. ']","[]"]
["NCT00541489","https://clinicaltrials.gov/ct2/show/NCT00541489","[' NicOx ']","[]"]
["NCT00110201","https://clinicaltrials.gov/ct2/show/NCT00110201","[' Ejaz, Abulate A, MD ']","[]"]
["NCT00385385","https://clinicaltrials.gov/ct2/show/NCT00385385","[' ActivBiotics ']","[]"]
["NCT00232167","https://clinicaltrials.gov/ct2/show/NCT00232167","[' Neurocrine Biosciences ']","[]"]
["NCT00179738","https://clinicaltrials.gov/ct2/show/NCT00179738","[' Celgene Corporation ']","[]"]
["NCT00179751","https://clinicaltrials.gov/ct2/show/NCT00179751","[' Celgene Corporation ']","[]"]
["NCT00104338","https://clinicaltrials.gov/ct2/show/NCT00104338","[' Astellas Pharma Inc ']","[]"]
["NCT00237536","https://clinicaltrials.gov/ct2/show/NCT00237536","[' Threshold Pharmaceuticals ']","[]"]
["NCT00127517","https://clinicaltrials.gov/ct2/show/NCT00127517","[' Advanced Viral Research Corp ']","[]"]
["NCT00283634","https://clinicaltrials.gov/ct2/show/NCT00283634","[' Millennium Pharmaceuticals, Inc. ']","[]"]
["NCT00269828","https://clinicaltrials.gov/ct2/show/NCT00269828","[' CTI BioPharma ']","[]"]
["NCT00283361","https://clinicaltrials.gov/ct2/show/NCT00283361","[' Zealand Pharma ']","[]"]
["NCT00333060","https://clinicaltrials.gov/ct2/show/NCT00333060","[' Othera Pharmaceuticals ']","[]"]
["NCT00365898","https://clinicaltrials.gov/ct2/show/NCT00365898","[' Purdue Pharma LP ']","[]"]
["NCT00117351","https://clinicaltrials.gov/ct2/show/NCT00117351","[' Millennium Pharmaceuticals, Inc. ']","[]"]
["NCT00258726","https://clinicaltrials.gov/ct2/show/NCT00258726","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00133432","https://clinicaltrials.gov/ct2/show/NCT00133432","[' National Institute of Allergy and Infectious Diseases (NIAID) ']","[]"]
["NCT00271167","https://clinicaltrials.gov/ct2/show/NCT00271167","[' Inotek Pharmaceuticals Corporation ']","[]"]
["NCT00179725","https://clinicaltrials.gov/ct2/show/NCT00179725","[' Celgene Corporation ']","[]"]
["NCT00162214","https://clinicaltrials.gov/ct2/show/NCT00162214","[' Bristol-Myers Squibb ']","[]"]
["NCT00312351","https://clinicaltrials.gov/ct2/show/NCT00312351","[' Eyetech Pharmaceuticals ']","[]"]
["NCT00179699","https://clinicaltrials.gov/ct2/show/NCT00179699","[' Celgene Corporation ']","[]"]
["NCT00389519","https://clinicaltrials.gov/ct2/show/NCT00389519","[' Pfizer ']","[]"]
["NCT00332826","https://clinicaltrials.gov/ct2/show/NCT00332826","[' Mannkind Corporation ']","[]"]
["NCT00134667","https://clinicaltrials.gov/ct2/show/NCT00134667","[' Eyetech Pharmaceuticals ']","[]"]
["NCT00267527","https://clinicaltrials.gov/ct2/show/NCT00267527","[' ConjuChem ']","[]"]
["NCT00126893","https://clinicaltrials.gov/ct2/show/NCT00126893","[' Celgene Corporation ']","[]"]
["NCT00239200","https://clinicaltrials.gov/ct2/show/NCT00239200","[' University of Michigan Rogel Cancer Center ']","[]"]
["NCT00300027","https://clinicaltrials.gov/ct2/show/NCT00300027","[' Bristol-Myers Squibb ']","[]"]
["NCT00332748","https://clinicaltrials.gov/ct2/show/NCT00332748","[' Bristol-Myers Squibb ']","[]"]
["NCT00162253","https://clinicaltrials.gov/ct2/show/NCT00162253","[' Bristol-Myers Squibb ']","[]"]
["NCT00326131","https://clinicaltrials.gov/ct2/show/NCT00326131","[' Bristol-Myers Squibb ']","[]"]
["NCT00359450","https://clinicaltrials.gov/ct2/show/NCT00359450","[' Bristol-Myers Squibb ']","[]"]

{"sheet":"500 sample","index":4,"n_rows":501,"n_cols":5,"rows_kept":501,"cut":false,"hidden":false,"merged":[]}
["nct_id","responsible_party_top","sponsor_top","urllist","responsible_party_bottom"]
["NCT00678379","[u'Jonathan R. Moss, Vanderbilt University Medical Center']","[u'Vanderbilt University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00678379","['Jonathan R. Moss, Resident Physician, Vanderbilt University Medical Center']"]
["NCT00678392","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00678392","['Pfizer']"]
["NCT00678418","[u'Alkermes, Inc.']","[u'Alkermes, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00678418","['Alkermes, Inc.']"]
["NCT00678457","[]","[u'University of Virginia']","https://clinicaltrials.gov/ct2/show/NCT00678457","['Bankole Johnson, DSc, M.D., Ph.D., University of Virginia']"]
["NCT00678561","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00678561","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00678652","[u'U.S. Army Medical Research and Materiel Command']","[u'U.S. Army Medical Research and Materiel Command']","https://clinicaltrials.gov/ct2/show/NCT00678652","['U.S. Army Medical Research and Materiel Command']"]
["NCT00678769","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00678769","['National Cancer Institute (NCI)']"]
["NCT00678886","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00678886","['GlaxoSmithKline']"]
["NCT00678977","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00678977","['GlaxoSmithKline']"]
["NCT00679094","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00679094","['National Cancer Institute (NCI)']"]
["NCT00679133","[u'Mirati Therapeutics Inc.']","[u'Mirati Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679133","['Mirati Therapeutics Inc.']"]
["NCT00679172","[u'Emergent BioSolutions']","[u'Emergent BioSolutions']","https://clinicaltrials.gov/ct2/show/NCT00679172","['Emergent BioSolutions']"]
["NCT00679211","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679211","['Genentech, Inc.']"]
["NCT00679263","[u'MediciNova']","[u'MediciNova']","https://clinicaltrials.gov/ct2/show/NCT00679263","['MediciNova']"]
["NCT00679302","[u'St. Louis University']","[u'St. Louis University']","https://clinicaltrials.gov/ct2/show/NCT00679302","['St. Louis University']"]
["NCT00679341","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00679341","['Hoffmann-La Roche']"]
["NCT00679354","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00679354","['National Cancer Institute (NCI)']"]
["NCT00679367","[u'Vaishali Sanchorawala, Boston Medical Center']","[u'Boston Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00679367","['Vaishali Sanchorawala, Principal Investigator, Boston Medical Center']"]
["NCT00679380","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679380","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00679432","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00679432","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00679523","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00679523","['Karl Beutner, MD, PhD, Anacor Pharmaceuticals, Inc.']"]
["NCT00679588","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00679588","['Sanofi']"]
["NCT00679731","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00679731","['AbbVie (prior sponsor, Abbott)']"]
["NCT00679770","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00679770","['Pfizer']"]
["NCT00679939","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00679939","['GlaxoSmithKline']"]
["NCT00679965","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00679965","['Pfizer']"]
["NCT00680017","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00680017","['AstraZeneca']"]
["NCT00680043","[u'Affymax']","[u'Affymax']","https://clinicaltrials.gov/ct2/show/NCT00680043","['Affymax']"]
["NCT00680095","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00680095","['Pfizer']"]
["NCT00680121","[u'Ann Manzardo, PhD, University of Kansas']","[u'University of Kansas']","https://clinicaltrials.gov/ct2/show/NCT00680121","['Ann Manzardo, PhD, Assistant Professor, University of Kansas']"]
["NCT00680134","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00680134","['Pfizer']"]
["NCT00680186","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00680186","['Boehringer Ingelheim']"]
["NCT00680342","[u'National Center for Complementary and Integrative Health (NCCIH)']","[u'National Center for Complementary and Integrative Health (NCCIH)']","https://clinicaltrials.gov/ct2/show/NCT00680342","['National Center for Complementary and Integrative Health (NCCIH)']"]
["NCT00680407","[u'Madaus Inc']","[u'Madaus Inc']","https://clinicaltrials.gov/ct2/show/NCT00680407","['Madaus Inc']"]
["NCT00680472","[u'Hisamitsu Pharmaceutical Co., Inc.']","[u'Hisamitsu Pharmaceutical Co., Inc.']","https://clinicaltrials.gov/ct2/show/NCT00680472","['Hisamitsu Pharmaceutical Co., Inc.']"]
["NCT00680498","[u'Illinois Retina Associates']","[u'Illinois Retina Associates']","https://clinicaltrials.gov/ct2/show/NCT00680498","['Illinois Retina Associates']"]
["NCT00680589","[]","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00680589","['Jedd Wolchok, MD, Memorial Sloan-Kettering Cancer Center']"]
["NCT00680667","[u'Masonic Cancer Center, University of Minnesota']","[u'Masonic Cancer Center, University of Minnesota']","https://clinicaltrials.gov/ct2/show/NCT00680667","['Masonic Cancer Center, University of Minnesota']"]
["NCT00680706","[u'Howard Smithline, Baystate Medical Center']","[u'Baystate Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00680706","['Howard Smithline, Chief, Emergency Medicine Research, Baystate Medical Center']"]
["NCT00680758","[u'Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center']","[u'Vanderbilt-Ingram Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00680758","['Ingrid Mayer, MD, Assistant Professor of Medicine; Clinical Director, Breast Cancer Program; Medical Oncologist, Vanderbilt-Ingram Cancer Center']"]
["NCT00680784","[u'Hisamitsu Pharmaceutical Co., Inc.']","[u'Hisamitsu Pharmaceutical Co., Inc.']","https://clinicaltrials.gov/ct2/show/NCT00680784","['Hisamitsu Pharmaceutical Co., Inc.']"]
["NCT00680940","[u'Cadila Pharnmaceuticals']","[u'Cadila Pharnmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00680940","['Cadila Pharnmaceuticals']"]
["NCT00681109","[u'Reza Dana, MD, Massachusetts Eye and Ear Infirmary']","[u'Reza Dana, MD']","https://clinicaltrials.gov/ct2/show/NCT00681109","['Reza Dana, MD, Principal Investigator, Massachusetts Eye and Ear Infirmary']"]
["NCT00681317","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00681317","['Mark A. Smith, MD, PhD, Medical Science Sr.Director, AstraZeneca Pharmaceuticals']"]
["NCT00681356","[]","[u'Anesiva, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00681356","['Lisa Renick, CRA, Anesiva, Inc,']"]
["NCT00681395","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00681395","['AstraZeneca']"]
["NCT00681408","[u'Stephen Caldwell, MD, University of Virginia']","[u'University of Virginia']","https://clinicaltrials.gov/ct2/show/NCT00681408","['Stephen Caldwell, MD, Professor, Department of Gastroenterology, University of Virginia']"]
["NCT00681824","[u'Baxter Healthcare Corporation']","[u'Baxter Healthcare Corporation']","https://clinicaltrials.gov/ct2/show/NCT00681824","['Baxter Healthcare Corporation']"]
["NCT00681889","[u'Reza Dana, MD, Massachusetts Eye and Ear Infirmary']","[u'Reza Dana, MD']","https://clinicaltrials.gov/ct2/show/NCT00681889","['Reza Dana, MD, Professor of Ophthalmology, Massachusetts Eye and Ear Infirmary']"]
["NCT00681915","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00681915","['Mark A. Smith, MD, PhD Medical Science Sr. Director, AstraZeneca Pharmaceuticals']"]
["NCT00682097","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00682097","['Hoffmann-La Roche']"]
["NCT00682448","[u'Jeffrey Rado, MD, Rush University Medical Center']","[u'Rush University Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00682448","['Jeffrey Rado, MD, MD, Rush University Medical Center']"]
["NCT00682461","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00682461","['GlaxoSmithKline']"]
["NCT00682643","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00682643","['GlaxoSmithKline']"]
["NCT00682734","[u'Benjamin W. Friedman, MD, Montefiore Medical Center']","[u'Montefiore Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00682734","['Benjamin W. Friedman, MD, Associate professor, Montefiore Medical Center']"]
["NCT00682981","[u'Teva Pharmaceutical Industries ( Gemin X )']","[u'Gemin X']","https://clinicaltrials.gov/ct2/show/NCT00682981","['Gemin X']"]
["NCT00683163","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00683163","['University of California, San Francisco']"]
["NCT00683241","[u'Abramson Cancer Center of the University of Pennsylvania']","[u'Abramson Cancer Center of the University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00683241","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT00683280","[u'UConn Health']","[u'UConn Health']","https://clinicaltrials.gov/ct2/show/NCT00683280","['UConn Health']"]
["NCT00683423","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00683423","['Study Director, Bristol-Myers Squibb']"]
["NCT00683475","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00683475","['Eli Lilly and Company']"]
["NCT00683592","[]","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00683592","['Carol R. Reed, MD, PGxHealth, LLC']"]
["NCT00683657","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00683657","['AstraZeneca']"]
["NCT00683800","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00683800","['Director, Clinical Trial Disclosure Group, Pfizer, Inc']"]
["NCT00683852","[u'Maurizio Fava, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00683852","['Maurizio Fava, MD, Executive Vice Chair, Department of Psychiatry; Executive Director, Clinical Trials Network and Institute (CTNI); Director, Depression Clinical and Research Program (DCRP), Massachusetts General Hospital']"]
["NCT00683878","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00683878","['AstraZeneca']"]
["NCT00683956","[u'Stanford University']","[u'Stanford University']","https://clinicaltrials.gov/ct2/show/NCT00683956","['Stanford University']"]
["NCT00684008","[]","[u'Cytheris, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00684008","['Marcel R.M. van den Brink, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center']"]
["NCT00684021","[u'Dr Lemuel A Moye III, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00684021","['Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston']"]
["NCT00684060","[u'Dr Lemuel A Moye III, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00684060","['Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston']"]
["NCT00684177","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00684177","['GlaxoSmithKline']"]
["NCT00684554","[u'Frances R Levin, New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00684554","['Frances R Levin, Director of Substance Use Disorder, New York State Psychiatric Institute']"]
["NCT00684918","[u'Teva Pharmaceutical Industries ( Gemin X )']","[u'Gemin X']","https://clinicaltrials.gov/ct2/show/NCT00684918","['Gemin X']"]
["NCT00685113","[u'Teva Pharmaceutical Industries ( Duramed Research )']","[u'Duramed Research']","https://clinicaltrials.gov/ct2/show/NCT00685113","['Duramed Research']"]
["NCT00685178","[u'Johns Hopkins University']","[u'Johns Hopkins University']","https://clinicaltrials.gov/ct2/show/NCT00685178","['Johns Hopkins University']"]
["NCT00685360","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00685360","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00685399","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00685399","['Novartis Pharmaceuticals']"]
["NCT00685412","[u'Inovio Pharmaceuticals']","[u'Inovio Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00685412","['Inovio Pharmaceuticals']"]
["NCT00685698","[u'TaiGen Biotechnology Co., Ltd.']","[u'TaiGen Biotechnology Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00685698","['TaiGen Biotechnology Co., Ltd.']"]
["NCT00685737","[]","[u'Pharmena North America']","https://clinicaltrials.gov/ct2/show/NCT00685737","['Charles Ballow, Pharm D. FACCP, Buffalo Clinical Research Center']"]
["NCT00685815","[u'American Regent, Inc.']","[u'American Regent, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00685815","['American Regent, Inc.']"]
["NCT00685906","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00685906","['Jay Horrow, MD, Medical Science Director, AZD6140, AstraZeneca Pharmaceuticals']"]
["NCT00686075","[u'MedImmune LLC']","[u'MedImmune LLC']","https://clinicaltrials.gov/ct2/show/NCT00686075","['MedImmune LLC']"]
["NCT00686218","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00686218","['City of Hope Medical Center']"]
["NCT00686634","[u'Charles Drew University of Medicine and Science']","[u'Charles Drew University of Medicine and Science']","https://clinicaltrials.gov/ct2/show/NCT00686634","['Charles Drew University of Medicine and Science']"]
["NCT00686803","[u'Palatin Technologies']","[u'Palatin Technologies']","https://clinicaltrials.gov/ct2/show/NCT00686803","['Palatin Technologies']"]
["NCT00686855","[u'Nathaniel S. Treister, DMD, DMSc, Dana-Farber Cancer Institute']","[u\"Brigham and Women's Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00686855","['Nathaniel S. Treister, DMD, DMSc, Principal Investigator, Dana-Farber Cancer Institute']"]
["NCT00686868","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00686868","['GlaxoSmithKline']"]
["NCT00686933","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00686933","['AbbVie (prior sponsor, Abbott)']"]
["NCT00686959","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00686959","['Eli Lilly and Company']"]
["NCT00686998","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00686998","['AstraZeneca']"]
["NCT00687167","[]","[u'Mutual Pharmaceutical Company, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00687167","['Kristin Arnold, Vice President R&D, Mutual Pharmaceutical Company, Inc.']"]
["NCT00687245","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00687245","['Tore Lind, MD, Medical Science Director Nexium and GI Established Brands, AstraZeneca Pharmaceuticals']"]
["NCT00687271","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00687271","['Merck Sharp & Dohme Corp.']"]
["NCT00687297","[u'PrECOG, LLC.']","[u'PrECOG, LLC.']","https://clinicaltrials.gov/ct2/show/NCT00687297","['PrECOG, LLC.']"]
["NCT00687622","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00687622","['GlaxoSmithKline']"]
["NCT00687687","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00687687","['Sanofi']"]
["NCT00687739","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00687739","['University of Colorado, Denver']"]
["NCT00687765","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00687765","['Sanofi']"]
["NCT00687830","[u'The Cleveland Clinic ( Cleveland Clinic Florida )']","[u'Cleveland Clinic Florida']","https://clinicaltrials.gov/ct2/show/NCT00687830","['Cleveland Clinic Florida']"]
["NCT00687908","[]","[u'Galderma']","https://clinicaltrials.gov/ct2/show/NCT00687908","['Jean-Charles DHUIN Clinical Trial Manager, Galderma']"]
["NCT00688064","[]","[u'Galderma']","https://clinicaltrials.gov/ct2/show/NCT00688064","['Jean-Charles DHUIN Clinical Trial Manager, Galderma']"]
["NCT00688272","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00688272","['GlaxoSmithKline']"]
["NCT00688324","[u'Robert W. Buchanan, University of Maryland']","[u'University of Maryland']","https://clinicaltrials.gov/ct2/show/NCT00688324","['Robert W. Buchanan, Chief, Maryland Psychiatric Research Center, Outpatient Research Program, University of Maryland']"]
["NCT00688376","[]","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00688376","['Margaret Moline, PhD, Eisai Medical Research Inc.']"]
["NCT00688428","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00688428","['Tore Lind, MD, Medical Science Director NEXIUM and GI Established Brands, AstraZeneca Pharmaceuticals']"]
["NCT00688441","[]","[u'Capnia, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00688441","['Kristen Yen, Associate Director, Clinical, Capnia, Inc.']"]
["NCT00688493","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00688493","['AstraZeneca']"]
["NCT00688519","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00688519","['Stiefel, a GSK Company']"]
["NCT00688636","[u'Miguel Regueiro, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00688636","['Miguel Regueiro, Professor of Medicine, University of Pittsburgh']"]
["NCT00688688","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00688688","['Astellas Pharma Inc']"]
["NCT00688701","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00688701","['Sanofi']"]
["NCT00688753","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00688753","['Novartis Pharmaceuticals']"]
["NCT00688831","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00688831","['Helen Lunde, MD, Medical Science Director, Emerging Arrythmias & Lipids, AstraZeneca']"]
["NCT00688857","[]","[u'Essentialis, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00688857","['Neil M Cowen, PhD/Chief Scientific Officer, Essentialis, Inc']"]
["NCT00688909","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00688909","['Novartis Pharmaceuticals']"]
["NCT00689078","[u'ORA, Inc.']","[u'ORA, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00689078","['ORA, Inc.']"]
["NCT00689104","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00689104","['Astellas Pharma Inc']"]
["NCT00689117","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00689117","['Stiefel, a GSK Company']"]
["NCT00689221","[u'EMD Serono']","[u'EMD Serono']","https://clinicaltrials.gov/ct2/show/NCT00689221","['EMD Serono']"]
["NCT00689273","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00689273","['Pfizer']"]
["NCT00689299","[u'Antigen Laboratories, Inc.']","[u'Antigen Laboratories, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00689299","['Antigen Laboratories, Inc.']"]
["NCT00689481","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00689481","['Stiefel, a GSK Company']"]
["NCT00689507","[u'Applied Molecular Evolution']","[u'Applied Molecular Evolution']","https://clinicaltrials.gov/ct2/show/NCT00689507","['Applied Molecular Evolution']"]
["NCT00689728","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00689728","['Eli Lilly and Company']"]
["NCT00690092","[]","[u'Nielsen BioSciences, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00690092","['Harry S. Nielsen, Ph.D., Allermed Laboratories, Inc.']"]
["NCT00690235","[u'Carol A. Tamminga, University of Texas Southwestern Medical Center']","[u'University of Texas Southwestern Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00690235","['Carol A. Tamminga, Principal Investigator, University of Texas Southwestern Medical Center']"]
["NCT00690378","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00690378","['Pfizer']"]
["NCT00690404","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00690404","['Rolf Karlsten, M.D., Medical Science Director, Emerging Neuroscience, AstraZeneca Pharmaceuticals']"]
["NCT00690430","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00690430","['Novartis Pharmaceuticals']"]
["NCT00690443","[u'Aegerion Pharmaceuticals, Inc.']","[u'Aegerion Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00690443","['Aegerion Pharmaceuticals, Inc.']"]
["NCT00690612","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00690612","['James Hainer, MD, Sr. Director - Medical Research, Study Team Physician, AstraZeneca, LP']"]
["NCT00690625","[]","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00690625","['Ashwini Khante, University Of Washington']"]
["NCT00690716","[u'Capnia, Inc.']","[u'Capnia, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00690716","['Capnia, Inc.']"]
["NCT00690807","[]","[u'Provectus Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00690807","['Eric Wachter, Vice President, Provectus Pharmaceuticals, Inc.']"]
["NCT00690820","[]","[u'Solvay Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00690820","['Djenane Bennett, Solvay Pharmaceuticals']"]
["NCT00690833","[u'Wake Forest University Health Sciences ( Wake Forest University )']","[u'Wake Forest University']","https://clinicaltrials.gov/ct2/show/NCT00690833","['Wake Forest University']"]
["NCT00691054","[u'University of Miami']","[u'University of Miami']","https://clinicaltrials.gov/ct2/show/NCT00691054","['University of Miami']"]
["NCT00691210","[u\"Owen A. O'Connor, Columbia University\"]","[u'Columbia University']","https://clinicaltrials.gov/ct2/show/NCT00691210","[\"Owen A. O'Connor, Professor of Medicine and Experimental Therapeutics; Director, Center for Lymphoid Malignancies, Columbia University\"]"]
["NCT00691301","[u'Gynecologic Oncology Group']","[u'Gynecologic Oncology Group']","https://clinicaltrials.gov/ct2/show/NCT00691301","['Gynecologic Oncology Group']"]
["NCT00691392","[u'Centers for Disease Control and Prevention']","[u'Centers for Disease Control and Prevention']","https://clinicaltrials.gov/ct2/show/NCT00691392","['Centers for Disease Control and Prevention']"]
["NCT00691483","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00691483","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00691678","[u'Dawn L. Hershman, Columbia University']","[u'Dawn L. Hershman']","https://clinicaltrials.gov/ct2/show/NCT00691678","['Dawn L. Hershman, Associate Professor of Medicine & Epidemiology, Columbia University']"]
["NCT00691704","[u'Cristina Gasparetto, Duke University']","[u'Cristina Gasparetto']","https://clinicaltrials.gov/ct2/show/NCT00691704","['Cristina Gasparetto, Associate Professor of Medicine, Duke University']"]
["NCT00691873","[]","[u'University of Mississippi Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00691873","['Gailen D. Marshall, MD, PhD, University of Mississippi Medical Center']"]
["NCT00691938","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00691938","['Washington University School of Medicine']"]
["NCT00691964","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00691964","['AbbVie (prior sponsor, Abbott)']"]
["NCT00692016","[]","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00692016","['Therapeutic Area Head, Bayer Consumer Care Inc.']"]
["NCT00692159","[]","[u'Tracon Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00692159","['Bryan Leigh, MD, Medical Monitor, TRACON Pharmaceuticals Inc.']"]
["NCT00692185","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00692185","['New York State Psychiatric Institute']"]
["NCT00692341","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00692341","['Pfizer']"]
["NCT00692445","[u'Targacept Inc.']","[u'Targacept Inc.']","https://clinicaltrials.gov/ct2/show/NCT00692445","['Targacept Inc.']"]
["NCT00692484","[u'CareFusion']","[u'CareFusion']","https://clinicaltrials.gov/ct2/show/NCT00692484","['CareFusion']"]
["NCT00692640","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00692640","['Sanofi']"]
["NCT00692770","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00692770","['Bayer']"]
["NCT00692900","[u'Robert Edwards, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00692900","['Robert Edwards, Principal Investigator, University of Pittsburgh']"]
["NCT00692913","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00692913","['Merck Sharp & Dohme Corp.']"]
["NCT00692926","[u'Joanne Kurtzberg, MD, Duke University']","[u'Joanne Kurtzberg, MD']","https://clinicaltrials.gov/ct2/show/NCT00692926","['Joanne Kurtzberg, MD, Professor of Pediatrics, Duke University']"]
["NCT00693056","[]","[u'Rexahn Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00693056","['Hyungjoo Lee / Associate Director, Product Development Management, Rexahn Pharmaceuticals, Inc.']"]
["NCT00693095","[u'John Sampson, Duke University']","[u'John Sampson']","https://clinicaltrials.gov/ct2/show/NCT00693095","['John Sampson, Professor Neurosurgery, Duke University']"]
["NCT00693225","[u'Yvonne Romero, Mayo Clinic']","[u'Yvonne Romero']","https://clinicaltrials.gov/ct2/show/NCT00693225","['Yvonne Romero, Yvonne Romero, MD, Mayo Clinic']"]
["NCT00693420","[]","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00693420","['Therapeutic Area Head, Allergan, Inc.']"]
["NCT00693433","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00693433","['National Cancer Institute (NCI)']"]
["NCT00693485","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00693485","['Allergan']"]
["NCT00693602","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00693602","[\"St. Jude Children's Research Hospital\"]"]
["NCT00693667","[u'PhytoHealth Corporation']","[u'PhytoHealth Corporation']","https://clinicaltrials.gov/ct2/show/NCT00693667","['PhytoHealth Corporation']"]
["NCT00693706","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00693706","['GlaxoSmithKline']"]
["NCT00693719","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00693719","['University of Arizona']"]
["NCT00693992","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00693992","['National Cancer Institute (NCI)']"]
["NCT00694044","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00694044","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00694057","[]","[u'Harbor Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00694057","['Dwight Stickney, MD - Chief Medical Officer, Hollis-Eden Pharmaceuticals']"]
["NCT00694096","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00694096","['University of Utah']"]
["NCT00694109","[u'Kastle Therapeutics, LLC']","[u'Kastle Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00694109","['Kastle Therapeutics, LLC']"]
["NCT00694122","[u'David M. Nathan, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00694122","['David M. Nathan, MD, Director, Diabetes Center, Massachusetts General Hospital']"]
["NCT00694135","[]","[u'Eyegate Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00694135","['Stephen From, President and Chief Executive Officer, Eyegate Pharmaceuticals, Inc.']"]
["NCT00694161","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00694161","['Pfizer']"]
["NCT00694174","[]","[u\"Children's Hospital of Michigan\"]","https://clinicaltrials.gov/ct2/show/NCT00694174","[\"Victoria Tutag Lehr, Pharm.D., Children's Hospital of Michigan, The Detroit Medical Center\"]"]
["NCT00694213","[]","[u'Vical']","https://clinicaltrials.gov/ct2/show/NCT00694213","['Don Guterwill, BS, MT, Senior Clinical Project Manager, Vical Incorporated']"]
["NCT00694369","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00694369","['Merck Sharp & Dohme Corp.']"]
["NCT00694382","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00694382","['Sanofi']"]
["NCT00694590","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00694590","['Genzyme, a Sanofi Company']"]
["NCT00694629","[u'Centers for Disease Control and Prevention']","[u'Centers for Disease Control and Prevention']","https://clinicaltrials.gov/ct2/show/NCT00694629","['Centers for Disease Control and Prevention']"]
["NCT00694707","[u'Forest Laboratories']","[u'Forest Laboratories']","https://clinicaltrials.gov/ct2/show/NCT00694707","['Forest Laboratories']"]
["NCT00694798","[u'Cadila Pharnmaceuticals']","[u'Cadila Pharnmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00694798","['Cadila Pharnmaceuticals']"]
["NCT00694928","[u'Lumara Health, Inc.']","[u'Lumara Health, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00694928","['Lumara Health, Inc.']"]
["NCT00694980","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00694980","['Genentech, Inc.']"]
["NCT00695071","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00695071","['Stiefel, a GSK Company']"]
["NCT00695110","[]","[u'Clarus Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00695110","['Robert E. Dudley, PhD, President and CEO, Clarus Therapeutics, Inc., Clarus Therapeutics, Inc.']"]
["NCT00695292","[u'SCRI Development Innovations, LLC']","[u'SCRI Development Innovations, LLC']","https://clinicaltrials.gov/ct2/show/NCT00695292","['SCRI Development Innovations, LLC']"]
["NCT00695305","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00695305","['GlaxoSmithKline']"]
["NCT00695500","[u'Vijay Ramchandani, Ph.D., National Institute on Alcohol Abuse and Alcoholism (NIAAA)']","[u'Vijay Ramchandani, Ph.D.']","https://clinicaltrials.gov/ct2/show/NCT00695500","['Vijay Ramchandani, Ph.D., Clinical Investigator and Chief, Section on Human Psychopharmacology, National Institute on Alcohol Abuse and Alcoholism (NIAAA)']"]
["NCT00695578","[u'Wake Forest University Health Sciences ( Wake Forest University )']","[u'Wake Forest University']","https://clinicaltrials.gov/ct2/show/NCT00695578","['Wake Forest University']"]
["NCT00695604","[u'University of Chicago']","[u'University of Chicago']","https://clinicaltrials.gov/ct2/show/NCT00695604","['University of Chicago']"]
["NCT00695630","[]","[u'University of Washington']","https://clinicaltrials.gov/ct2/show/NCT00695630","['Peter Milgrom/Professor of Dental Public Health Sciences, University of Washington']"]
["NCT00695669","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00695669","['GlaxoSmithKline']"]
["NCT00695851","[]","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00695851","['Susan Slovin, MD, Memorial Sloan-Kettering Cancer Center']"]
["NCT00695955","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00695955","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00696020","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00696020","['Boehringer Ingelheim']"]
["NCT00696072","[u'Bristol-Myers Squibb']","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00696072","['Bristol-Myers Squibb']"]
["NCT00696137","[u'BioDelivery Sciences International']","[u'BioDelivery Sciences International']","https://clinicaltrials.gov/ct2/show/NCT00696137","['BioDelivery Sciences International']"]
["NCT00696176","[u'University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00696176","['University of Pittsburgh']"]
["NCT00696241","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00696241","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00696293","[u'Jordan F. Karp, University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00696293","['Jordan F. Karp, Associate professor, University of Pittsburgh']"]
["NCT00696384","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00696384","['Takeda']"]
["NCT00696410","[u'Jennifer Cowger , MD, MS, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00696410","['Jennifer Cowger , MD, MS, Assistant Professor, study Coinvestigator, University of Michigan']"]
["NCT00696436","[]","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00696436","['Sr. VP, Clinical Science, Takeda Global Research & Development Center, Inc.']"]
["NCT00696475","[]","[u'Essentialis, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00696475","['Neil M Cowen, PhD/Chief Scientific Officer, Essentialis']"]
["NCT00696488","[u'Wake Forest University Health Sciences ( Wake Forest University )']","[u'Wake Forest University']","https://clinicaltrials.gov/ct2/show/NCT00696488","['Wake Forest University']"]
["NCT00696696","[u'New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00696696","['New York University School of Medicine']"]
["NCT00696709","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00696709","['Merck Sharp & Dohme Corp.']"]
["NCT00696800","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00696800","['Merck Sharp & Dohme Corp.']"]
["NCT00696878","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00696878","['Merck Sharp & Dohme Corp.']"]
["NCT00697073","[u'Santhera Pharmaceuticals']","[u'Santhera Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00697073","['Santhera Pharmaceuticals']"]
["NCT00697099","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00697099","['Sanofi']"]
["NCT00697138","[u'Craig Rush, University of Kentucky']","[u'University of Kentucky']","https://clinicaltrials.gov/ct2/show/NCT00697138","['Craig Rush, Princpal Investigator, University of Kentucky']"]
["NCT00697203","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00697203","['Hoffmann-La Roche']"]
["NCT00697515","[u'Shire']","[u'Shire']","https://clinicaltrials.gov/ct2/show/NCT00697515","['Shire']"]
["NCT00697541","[u'Galderma']","[u'Galderma']","https://clinicaltrials.gov/ct2/show/NCT00697541","['Galderma']"]
["NCT00697671","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00697671","[\"St. Jude Children's Research Hospital\"]"]
["NCT00697710","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00697710","['Shionogi']"]
["NCT00697788","[u'Erik S. Shank, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00697788","['Erik S. Shank, MD, Pediatric Anesthesiologist, Massachusetts General Hospital']"]
["NCT00697801","[u'Allergan']","[u'Allergan']","https://clinicaltrials.gov/ct2/show/NCT00697801","['Allergan']"]
["NCT00697892","[u'Fran Aweeka, University of California, San Francisco']","[u'Fran Aweeka']","https://clinicaltrials.gov/ct2/show/NCT00697892","['Fran Aweeka, Sponsor-Investigator, University of California, San Francisco']"]
["NCT00698022","[u'Corcept Therapeutics']","[u'Corcept Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00698022","['Corcept Therapeutics']"]
["NCT00698035","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00698035","['University of California, San Francisco']"]
["NCT00698230","[u'Incyte Corporation']","[u'Incyte Corporation']","https://clinicaltrials.gov/ct2/show/NCT00698230","['Incyte Corporation']"]
["NCT00698243","[u'Astellas Pharma Inc']","[u'Astellas Pharma Inc']","https://clinicaltrials.gov/ct2/show/NCT00698243","['Astellas Pharma Inc']"]
["NCT00698451","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","[u'Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00698451","['Johnson & Johnson Pharmaceutical Research & Development, L.L.C.']"]
["NCT00698464","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00698464","['Novartis Pharmaceuticals']"]
["NCT00698516","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00698516","['GlaxoSmithKline']"]
["NCT00698724","[]","[u'Bp Consulting, Inc']","https://clinicaltrials.gov/ct2/show/NCT00698724","[\"Dr. Gills, St. Luke's Cataract and Laser Institute\"]"]
["NCT00698763","[]","[u'Orion Corporation, Orion Pharma']","https://clinicaltrials.gov/ct2/show/NCT00698763","['Juha Ellmen, Clinical Program Leader, Orion Pharma']"]
["NCT00698776","[u'Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00698776","['Yale University']"]
["NCT00698841","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00698841","['Eli Lilly and Company']"]
["NCT00698945","[]","[u'Bp Consulting, Inc']","https://clinicaltrials.gov/ct2/show/NCT00698945","['Dr. Bacharach, North Bay Eye Associates, Inc.']"]
["NCT00699010","[u'Acura Pharmaceuticals Inc.']","[u'Acura Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00699010","['Acura Pharmaceuticals Inc.']"]
["NCT00699153","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00699153","['Bausch & Lomb Incorporated']"]
["NCT00699517","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00699517","['Sanofi']"]
["NCT00699582","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00699582","['Eisai Inc.']"]
["NCT00699751","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00699751","['Bayer']"]
["NCT00699777","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00699777","['Warner Chilcott']"]
["NCT00699803","[u'Bausch & Lomb Incorporated']","[u'Bausch & Lomb Incorporated']","https://clinicaltrials.gov/ct2/show/NCT00699803","['Bausch & Lomb Incorporated']"]
["NCT00699907","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00699907","['University of Arizona']"]
["NCT00699972","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00699972","['Eisai Inc.']"]
["NCT00699998","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00699998","['Eli Lilly and Company']"]
["NCT00700115","[u'Ighovwerha Ofotokun, Emory University']","[u'Emory University']","https://clinicaltrials.gov/ct2/show/NCT00700115","['Ighovwerha Ofotokun, Associate Professor of Medicine, Emory University']"]
["NCT00700206","[u'Telik']","[u'Telik']","https://clinicaltrials.gov/ct2/show/NCT00700206","['Telik']"]
["NCT00700310","[u'Eisai Inc.']","[u'Eisai Inc.']","https://clinicaltrials.gov/ct2/show/NCT00700310","['Eisai Inc.']"]
["NCT00700375","[]","[u'Osaka General Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00700375","['Hiromichi Ueda, Osaka General Medical Center']"]
["NCT00700427","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00700427","['Eli Lilly and Company']"]
["NCT00700479","[]","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00700479","['Stuart Katz, Yale School of Medicine']"]
["NCT00700635","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00700635","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00700713","[u'Sanofi ( Sanofi Pasteur, a Sanofi Company )']","[u'Sanofi Pasteur, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00700713","['Sanofi Pasteur, a Sanofi Company']"]
["NCT00700817","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00700817","['Novo Nordisk A/S']"]
["NCT00700921","[u'E Rand Sutherland, National Jewish Health']","[u'National Jewish Health']","https://clinicaltrials.gov/ct2/show/NCT00700921","['E Rand Sutherland, Chair of Pulmonary Medicine, National Jewish Health']"]
["NCT00700999","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00700999","['US Department of Veterans Affairs']"]
["NCT00701129","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00701129","['Genzyme, a Sanofi Company']"]
["NCT00701220","[]","[u'Ohio State University']","https://clinicaltrials.gov/ct2/show/NCT00701220","['Philip Binkley, MD, MPH, The Ohio State University/ Division of Cardiovascular Medicine']"]
["NCT00701311","[u'Kenneth Peters, MD, William Beaumont Hospitals']","[u'Kenneth Peters, MD']","https://clinicaltrials.gov/ct2/show/NCT00701311","['Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals']"]
["NCT00701389","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00701389","['Merck Sharp & Dohme Corp.']"]
["NCT00701415","[u'Sanofi ( Genzyme, a Sanofi Company )']","[u'Genzyme, a Sanofi Company']","https://clinicaltrials.gov/ct2/show/NCT00701415","['Genzyme, a Sanofi Company']"]
["NCT00701636","[u'Los Angeles Biomedical Research Institute']","[u'Los Angeles Biomedical Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00701636","['Los Angeles Biomedical Research Institute']"]
["NCT00701675","[u'VA Office of Research and Development']","[u'VA Office of Research and Development']","https://clinicaltrials.gov/ct2/show/NCT00701675","['VA Office of Research and Development']"]
["NCT00701688","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00701688","[\"St. Jude Children's Research Hospital\"]"]
["NCT00701727","[]","[u'Radiant Research']","https://clinicaltrials.gov/ct2/show/NCT00701727","['Michael H. Davidson, MD, FACC, Radiant Research']"]
["NCT00701779","[u'Paul F. Siami, MD, Siami, Paul F., M.D.']","[u'Siami, Paul F., M.D.']","https://clinicaltrials.gov/ct2/show/NCT00701779","['Paul F. Siami, MD, Medical Director, Research Institute of Deaconess Clinic, Siami, Paul F., M.D.']"]
["NCT00701857","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00701857","['University of Arizona']"]
["NCT00701883","[u'CymaBay Therapeutics, Inc.']","[u'CymaBay Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00701883","['CymaBay Therapeutics, Inc.']"]
["NCT00701909","[u'University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00701909","['University of California, San Francisco']"]
["NCT00702052","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00702052","['Novartis Pharmaceuticals']"]
["NCT00702143","[u'Avid Radiopharmaceuticals']","[u'Avid Radiopharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00702143","['Avid Radiopharmaceuticals']"]
["NCT00702299","[u'University of Arizona']","[u'University of Arizona']","https://clinicaltrials.gov/ct2/show/NCT00702299","['University of Arizona']"]
["NCT00702325","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00702325","['AstraZeneca']"]
["NCT00702403","[u'Paul Carpenter, Fred Hutchinson Cancer Research Center']","[u'Fred Hutchinson Cancer Research Center']","https://clinicaltrials.gov/ct2/show/NCT00702403","['Paul Carpenter, Principal Investigator, Fred Hutchinson Cancer Research Center']"]
["NCT00702507","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00702507","['Stiefel, a GSK Company']"]
["NCT00702650","[]","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00702650","['Chief Medical Officer, Eli Lilly']"]
["NCT00702676","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00702676","['Hans A Eriksson, MD, Medical Science Director, AstraZeneca Pharmaceuticals']"]
["NCT00702689","[u'Edward Cowen, M.D., National Institutes of Health Clinical Center (CC)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00702689","['Edward Cowen, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)']"]
["NCT00702884","[u'Tony Bekaii-Saab, Ohio State University Comprehensive Cancer Center']","[u'Tony Bekaii-Saab']","https://clinicaltrials.gov/ct2/show/NCT00702884","['Tony Bekaii-Saab, Principal Investigator, Ohio State University Comprehensive Cancer Center']"]
["NCT00702949","[u'Alliance for Clinical Trials in Oncology']","[u'Alliance for Clinical Trials in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00702949","['Alliance for Clinical Trials in Oncology']"]
["NCT00703118","[u'Tibotec BVBA']","[u'Tibotec BVBA']","https://clinicaltrials.gov/ct2/show/NCT00703118","['Tibotec BVBA']"]
["NCT00703170","[u'Washington University School of Medicine']","[u'Washington University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00703170","['Washington University School of Medicine']"]
["NCT00703183","[u'Acucela Inc.']","[u'Acucela Inc.']","https://clinicaltrials.gov/ct2/show/NCT00703183","['Acucela Inc.']"]
["NCT00703261","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00703261","['Merck Sharp & Dohme Corp.']"]
["NCT00703300","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00703300","['National Cancer Institute (NCI)']"]
["NCT00703391","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00703391","['AstraZeneca']"]
["NCT00703469","[]","[u'Bristol-Myers Squibb']","https://clinicaltrials.gov/ct2/show/NCT00703469","['Study Director, Bristol-Myers Squibb']"]
["NCT00703534","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00703534","['Debra Silberg, MD, Director of Clinical Research, AstraZeneca Pharmaceuticals']"]
["NCT00703573","[u'Shionogi Inc. ( Shionogi )']","[u'Shionogi']","https://clinicaltrials.gov/ct2/show/NCT00703573","['Shionogi']"]
["NCT00703586","[u'Rockefeller University']","[u'Rockefeller University']","https://clinicaltrials.gov/ct2/show/NCT00703586","['Rockefeller University']"]
["NCT00703638","[u'Masonic Cancer Center, University of Minnesota']","[u'Masonic Cancer Center, University of Minnesota']","https://clinicaltrials.gov/ct2/show/NCT00703638","['Masonic Cancer Center, University of Minnesota']"]
["NCT00703677","[u'Westat']","[u'Westat']","https://clinicaltrials.gov/ct2/show/NCT00703677","['Westat']"]
["NCT00703703","[u'Novartis']","[u'Novartis']","https://clinicaltrials.gov/ct2/show/NCT00703703","['Novartis']"]
["NCT00703807","[u'Maysa Abu-Khalaf, Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00703807","['Maysa Abu-Khalaf, Principal Investigator, Yale University']"]
["NCT00703846","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00703846","['Stiefel, a GSK Company']"]
["NCT00703885","[u'Murray B. Stein, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00703885","['Murray B. Stein, Professor, University of California, San Diego']"]
["NCT00703976","[u'University of Pittsburgh']","[u'University of Pittsburgh']","https://clinicaltrials.gov/ct2/show/NCT00703976","['University of Pittsburgh']"]
["NCT00704054","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00704054","['Merck Sharp & Dohme Corp.']"]
["NCT00704080","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00704080","['Sanofi']"]
["NCT00704184","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00704184","['Merck Sharp & Dohme Corp.']"]
["NCT00704262","[u'LEO Pharma']","[u'LEO Pharma']","https://clinicaltrials.gov/ct2/show/NCT00704262","['LEO Pharma']"]
["NCT00704379","[u'Ricardo Jorge, MD, Baylor College of Medicine']","[u'Baylor College of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00704379","['Ricardo Jorge, MD, Professor, Baylor College of Medicine']"]
["NCT00704405","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00704405","['Merck Sharp & Dohme Corp.']"]
["NCT00704431","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00704431","['GlaxoSmithKline']"]
["NCT00704483","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00704483","['Novartis Pharmaceuticals']"]
["NCT00704912","[u'Richard S. Legro, M.D., Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00704912","['Richard S. Legro, M.D., Professor, Obstetrics and Gynecology and Public Health Sciences, Milton S. Hershey Medical Center']"]
["NCT00705003","[u'Maurizio Fava, MD, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00705003","['Maurizio Fava, MD, Fava, Maurizio MD., Massachusetts General Hospital']"]
["NCT00705250","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00705250","['Memorial Sloan Kettering Cancer Center']"]
["NCT00705341","[u'Janet Holbrook, Johns Hopkins Bloomberg School of Public Health']","[u'Johns Hopkins Bloomberg School of Public Health']","https://clinicaltrials.gov/ct2/show/NCT00705341","['Janet Holbrook, Associate Professor, Johns Hopkins Bloomberg School of Public Health']"]
["NCT00705523","[u'Jennifer Plebani, National Institute on Drug Abuse (NIDA)']","[u'University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00705523","['Jennifer Plebani, Principal Investigator, National Institute on Drug Abuse (NIDA)']"]
["NCT00705536","[u'Halozyme Therapeutics']","[u'Halozyme Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00705536","['Halozyme Therapeutics']"]
["NCT00705653","[u'Progen Pharmaceuticals']","[u'Progen Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00705653","['Progen Pharmaceuticals']"]
["NCT00705679","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00705679","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00705757","[u'Deepak P. Edward, Summa Health System']","[u'Summa Health System']","https://clinicaltrials.gov/ct2/show/NCT00705757","['Deepak P. Edward, PI, Summa Health System']"]
["NCT00705783","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00705783","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00705874","[u'Progen Pharmaceuticals']","[u'Progen Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00705874","['Progen Pharmaceuticals']"]
["NCT00705939","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00705939","['Pfizer']"]
["NCT00706121","[u'Southwest Oncology Group']","[u'Southwest Oncology Group']","https://clinicaltrials.gov/ct2/show/NCT00706121","['Southwest Oncology Group']"]
["NCT00706225","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00706225","['Director, Clinical Trial Disclosure Group, Pfizer, Inc']"]
["NCT00706342","[u'Rigel Pharmaceuticals']","[u'Rigel Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00706342","['Rigel Pharmaceuticals']"]
["NCT00706433","[u'DUSA Pharmaceuticals, Inc.']","[u'DUSA Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706433","['DUSA Pharmaceuticals, Inc.']"]
["NCT00706537","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00706537","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00706654","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","[u'Otsuka Pharmaceutical Development & Commercialization, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706654","['Otsuka Pharmaceutical Development & Commercialization, Inc.']"]
["NCT00706719","[u'Repros Therapeutics Inc.']","[u'Repros Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706719","['Repros Therapeutics Inc.']"]
["NCT00706732","[u'AlphaVax, Inc.']","[u'AlphaVax, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00706732","['AlphaVax, Inc.']"]
["NCT00706810","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00706810","['University of Utah']"]
["NCT00706836","[u'Murray B. Stein, University of California, San Diego']","[u'University of California, San Diego']","https://clinicaltrials.gov/ct2/show/NCT00706836","['Murray B. Stein, Professor, University of California, San Diego']"]
["NCT00706849","[u'Kastle Therapeutics, LLC']","[u'Kastle Therapeutics, LLC']","https://clinicaltrials.gov/ct2/show/NCT00706849","['Kastle Therapeutics, LLC']"]
["NCT00706914","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00706914","['AstraZeneca']"]
["NCT00707031","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00707031","['Sanofi']"]
["NCT00707057","[]","[u'SCOLR Pharma, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00707057","['Stephen Turner, President & CEO, SCOLR Pharma, Inc.']"]
["NCT00707278","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00707278","['University of Utah']"]
["NCT00707499","[u'Lantheus Medical Imaging']","[u'Lantheus Medical Imaging']","https://clinicaltrials.gov/ct2/show/NCT00707499","['Lantheus Medical Imaging']"]
["NCT00707538","[]","[u'Lantheus Medical Imaging']","https://clinicaltrials.gov/ct2/show/NCT00707538","['Dana Washburn, MD, Lantheus Medical Imaging']"]
["NCT00707642","[]","[u'Hawaii Biotech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00707642","['Beth-Ann Coller, Ph.D., Hawaii Biotech']"]
["NCT00707863","[u'Indiana University ( Indiana University School of Medicine )']","[u'Indiana University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00707863","['Indiana University School of Medicine']"]
["NCT00707889","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00707889","['AbbVie (prior sponsor, Abbott)']"]
["NCT00707980","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00707980","['Takeda']"]
["NCT00707993","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00707993","['Takeda']"]
["NCT00708006","[u'Human Genome Sciences Inc.']","[u'Human Genome Sciences Inc.']","https://clinicaltrials.gov/ct2/show/NCT00708006","['Human Genome Sciences Inc.']"]
["NCT00708071","[u'Baxter Healthcare Corporation']","[u'Baxter Healthcare Corporation']","https://clinicaltrials.gov/ct2/show/NCT00708071","['Baxter Healthcare Corporation']"]
["NCT00708084","[u'Crucell Holland BV']","[u'Crucell Holland BV']","https://clinicaltrials.gov/ct2/show/NCT00708084","['Crucell Holland BV']"]
["NCT00708097","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00708097","['GlaxoSmithKline']"]
["NCT00708110","[u'ViiV Healthcare']","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00708110","['ViiV Healthcare']"]
["NCT00708123","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00708123","['GlaxoSmithKline']"]
["NCT00708149","[u'Far Eastern Memorial Hospital']","[u'Far Eastern Memorial Hospital']","https://clinicaltrials.gov/ct2/show/NCT00708149","['Far Eastern Memorial Hospital']"]
["NCT00708162","[u'Gilead Sciences']","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00708162","['Gilead Sciences']"]
["NCT00708175","[u'Takeda']","[u'Takeda']","https://clinicaltrials.gov/ct2/show/NCT00708175","['Takeda']"]
["NCT00708201","[u'Cubist Pharmaceuticals LLC']","[u'Cubist Pharmaceuticals LLC']","https://clinicaltrials.gov/ct2/show/NCT00708201","['Cubist Pharmaceuticals LLC']"]
["NCT00708227","[u\"Kathryn Blake, PharmD, Nemours Children's Clinic\"]","[u\"Nemours Children's Clinic\"]","https://clinicaltrials.gov/ct2/show/NCT00708227","[\"Kathryn Blake, PharmD, Senior Research Scientist, Nemours Children's Clinic\"]"]
["NCT00708292","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00708292","['Novartis Pharmaceuticals']"]
["NCT00708305","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00708305","['GlaxoSmithKline']"]
["NCT00708422","[u'Alcon Research']","[u'Alcon Research']","https://clinicaltrials.gov/ct2/show/NCT00708422","['Alcon Research']"]
["NCT00708435","[u'CSL Behring']","[u'CSL Behring']","https://clinicaltrials.gov/ct2/show/NCT00708435","['CSL Behring']"]
["NCT00708604","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00708604","['City of Hope Medical Center']"]
["NCT00708682","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00708682","['Wyeth is now a wholly owned subsidiary of Pfizer']"]
["NCT00708721","[u'University of Utah']","[u'University of Utah']","https://clinicaltrials.gov/ct2/show/NCT00708721","['University of Utah']"]
["NCT00708903","[u'Puma Biotechnology, Inc.']","[u'Puma Biotechnology, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00708903","['Puma Biotechnology, Inc.']"]
["NCT00708916","[u'Elizabeth Camacho, New York University School of Medicine']","[u'New York University School of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00708916","['Elizabeth Camacho, PRS, New York University School of Medicine']"]
["NCT00709020","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00709020","['City of Hope Medical Center']"]
["NCT00709098","[u'Actelion']","[u'Actelion']","https://clinicaltrials.gov/ct2/show/NCT00709098","['Actelion']"]
["NCT00709371","[u'Orexigen Therapeutics, Inc']","[u'Orexigen Therapeutics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00709371","['Orexigen Therapeutics, Inc']"]
["NCT00709436","[u'Hospira, now a wholly owned subsidiary of Pfizer']","[u'Hospira, now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00709436","['Hospira, now a wholly owned subsidiary of Pfizer']"]
["NCT00709488","[u'Light Sciences Oncology']","[u'Light Sciences Oncology']","https://clinicaltrials.gov/ct2/show/NCT00709488","['Light Sciences Oncology']"]
["NCT00709514","[u'Oneness Biotech Co., Ltd.']","[u'Oneness Biotech Co., Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00709514","['Oneness Biotech Co., Ltd.']"]
["NCT00709540","[]","[u'Acceleron Pharma, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00709540","['Matthew L Sherman MD, Acceleron Pharma Inc.']"]
["NCT00709800","[]","[u'Vical']","https://clinicaltrials.gov/ct2/show/NCT00709800","['Don Guterwill, BS, MT, Senior Clinical Project Manager, Vical Incorporated']"]
["NCT00709826","[u'Tragara Pharmaceuticals, Inc.']","[u'Tragara Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00709826","['Tragara Pharmaceuticals, Inc.']"]
["NCT00709852","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00709852","['Bayer']"]
["NCT00709865","[u'Biogen']","[u'Biogen']","https://clinicaltrials.gov/ct2/show/NCT00709865","['Biogen']"]
["NCT00709904","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00709904","['Sanofi']"]
["NCT00709956","[u'Actelion']","[u'Actelion']","https://clinicaltrials.gov/ct2/show/NCT00709956","['Actelion']"]
["NCT00710021","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00710021","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00710034","[u'University of Minnesota - Clinical and Translational Science Institute']","[u'University of Minnesota - Clinical and Translational Science Institute']","https://clinicaltrials.gov/ct2/show/NCT00710034","['University of Minnesota - Clinical and Translational Science Institute']"]
["NCT00710125","[u'Gem Pharmaceuticals']","[u'Gem Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00710125","['Gem Pharmaceuticals']"]
["NCT00710333","[]","[u'Renovo']","https://clinicaltrials.gov/ct2/show/NCT00710333","['Amanda Hilton Senior Clinical Research Manager, Renovo Ltd']"]
["NCT00710385","[u'New York State Psychiatric Institute']","[u'New York State Psychiatric Institute']","https://clinicaltrials.gov/ct2/show/NCT00710385","['New York State Psychiatric Institute']"]
["NCT00710580","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00710580","['AbbVie (prior sponsor, Abbott)']"]
["NCT00710593","[u'University of North Carolina, Chapel Hill']","[u'University of North Carolina, Chapel Hill']","https://clinicaltrials.gov/ct2/show/NCT00710593","['University of North Carolina, Chapel Hill']"]
["NCT00710684","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00710684","['GlaxoSmithKline']"]
["NCT00710710","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00710710","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00710814","[u'Judith Korner, Columbia University']","[u'Columbia University']","https://clinicaltrials.gov/ct2/show/NCT00710814","['Judith Korner, Associate Professor of Medicine, Columbia University']"]
["NCT00710970","[u'Seth Lerner, Baylor College of Medicine']","[u'Seth Lerner']","https://clinicaltrials.gov/ct2/show/NCT00710970","['Seth Lerner, Professor, Baylor College of Medicine']"]
["NCT00711009","[u'Abbott']","[u'Abbott']","https://clinicaltrials.gov/ct2/show/NCT00711009","['Abbott']"]
["NCT00711035","[u'Helen Heslop, Baylor College of Medicine']","[u'Baylor College of Medicine']","https://clinicaltrials.gov/ct2/show/NCT00711035","['Helen Heslop, Principal Investigator, Baylor College of Medicine']"]
["NCT00711165","[]","[u'Creighton University']","https://clinicaltrials.gov/ct2/show/NCT00711165","['Thomas B. Casale, MD, Creighton University']"]
["NCT00711191","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00711191","['Hoffmann-La Roche']"]
["NCT00711386","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00711386","['GlaxoSmithKline']"]
["NCT00711464","[u'Michael Minzenberg, MD, University of California, Davis']","[u'University of California, Los Angeles']","https://clinicaltrials.gov/ct2/show/NCT00711464","['Michael Minzenberg, MD, Associate Professor of Clinical Psychiatry, University of California, Davis']"]
["NCT00711477","[u'Orexigen Therapeutics, Inc']","[u'Orexigen Therapeutics, Inc']","https://clinicaltrials.gov/ct2/show/NCT00711477","['Orexigen Therapeutics, Inc']"]
["NCT00711490","[u'National Institutes of Health Clinical Center (CC) ( National Eye Institute (NEI) )']","[u'National Eye Institute (NEI)']","https://clinicaltrials.gov/ct2/show/NCT00711490","['National Eye Institute (NEI)']"]
["NCT00711516","[u'Teva Pharmaceutical Industries ( Cephalon )']","[u'Cephalon']","https://clinicaltrials.gov/ct2/show/NCT00711516","['Cephalon']"]
["NCT00711529","[u'Shannon MacLaughlan, Women and Infants Hospital of Rhode Island']","[u'Women and Infants Hospital of Rhode Island']","https://clinicaltrials.gov/ct2/show/NCT00711529","['Shannon MacLaughlan, Shannon MacLaughlan, M.D., Women and Infants Hospital of Rhode Island']"]
["NCT00711802","[u'Cubist Pharmaceuticals LLC']","[u'Cubist Pharmaceuticals LLC']","https://clinicaltrials.gov/ct2/show/NCT00711802","['Cubist Pharmaceuticals LLC']"]
["NCT00711971","[u'Ellen Mozurkewich, University of Michigan']","[u'University of Michigan']","https://clinicaltrials.gov/ct2/show/NCT00711971","['Ellen Mozurkewich, Adjunct Assistant Professor, University of Michigan']"]
["NCT00712114","[]","[u'Harbor Therapeutics']","https://clinicaltrials.gov/ct2/show/NCT00712114","['Nanette Onizuka-Handa/Sr. Vice President, Regulatory Affairs and Quality, Hollis-Eden Pharmaceuticals']"]
["NCT00712166","[]","[u'Gilead Sciences']","https://clinicaltrials.gov/ct2/show/NCT00712166","['Mark Bresnik, MD, Director, Clinical Research, Gilead Sciences, Inc.']"]
["NCT00712348","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00712348","['Pfizer']"]
["NCT00712439","[]","[u'Depomed']","https://clinicaltrials.gov/ct2/show/NCT00712439","['Lynne Rowe, Depomed']"]
["NCT00712465","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00712465","['Helen Lunde, MD, Medical Science Director, Emerging Arrhythmia and Lipids, AstraZeneca']"]
["NCT00712673","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00712673","['Sanofi']"]
["NCT00712725","[u'Merck Sharp & Dohme Corp.']","[u'Merck Sharp & Dohme Corp.']","https://clinicaltrials.gov/ct2/show/NCT00712725","['Merck Sharp & Dohme Corp.']"]
["NCT00712803","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","[u'National Institute of Allergy and Infectious Diseases (NIAID)']","https://clinicaltrials.gov/ct2/show/NCT00712803","['National Institute of Allergy and Infectious Diseases (NIAID)']"]
["NCT00712855","[u'GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )']","[u'Human Genome Sciences Inc., a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00712855","['Human Genome Sciences Inc., a GSK Company']"]
["NCT00712985","[u'Allan Lipton, Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00712985","['Allan Lipton, MD, Milton S. Hershey Medical Center']"]
["NCT00713284","[u'V. Ram Peddi, California Pacific Medical Center Research Institute']","[u'California Pacific Medical Center Research Institute']","https://clinicaltrials.gov/ct2/show/NCT00713284","['V. Ram Peddi, Medical Doctor, California Pacific Medical Center Research Institute']"]
["NCT00713310","[u'Warner Chilcott']","[u'Warner Chilcott']","https://clinicaltrials.gov/ct2/show/NCT00713310","['Warner Chilcott']"]
["NCT00713336","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00713336","['Dr Thomas Morris, Medical Science Director, AstraZeneca, AstraZeneca Pharmaceuticals']"]
["NCT00713349","[u'Healthpoint']","[u'Healthpoint']","https://clinicaltrials.gov/ct2/show/NCT00713349","['Healthpoint']"]
["NCT00713479","[u'Steve Shoptaw, University of California, Los Angeles']","[u'University of California, Los Angeles']","https://clinicaltrials.gov/ct2/show/NCT00713479","['Steve Shoptaw, Professor, University of California, Los Angeles']"]
["NCT00713518","[u'Quark Pharmaceuticals']","[u'Quark Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00713518","['Quark Pharmaceuticals']"]
["NCT00713544","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00713544","['AstraZeneca']"]
["NCT00713583","[u'Joy Schmitz, The University of Texas Health Science Center, Houston']","[u'The University of Texas Health Science Center, Houston']","https://clinicaltrials.gov/ct2/show/NCT00713583","['Joy Schmitz, Professor - Psychiatry, Behavioral Sciences, The University of Texas Health Science Center, Houston']"]
["NCT00713609","[u'GlaxoSmithKline ( Stiefel, a GSK Company )']","[u'Stiefel, a GSK Company']","https://clinicaltrials.gov/ct2/show/NCT00713609","['Stiefel, a GSK Company']"]
["NCT00713648","[u'Novo Nordisk A/S']","[u'Novo Nordisk A/S']","https://clinicaltrials.gov/ct2/show/NCT00713648","['Novo Nordisk A/S']"]
["NCT00713791","[]","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00713791","['Dr Thomas Morris, Medical Science Director, AstraZeneca, AstraZeneca Pharmaceuticals']"]
["NCT00713830","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00713830","['Sanofi']"]
["NCT00714103","[u'M.D. Anderson Cancer Center']","[u'M.D. Anderson Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00714103","['M.D. Anderson Cancer Center']"]
["NCT00714116","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00714116","['Pfizer']"]
["NCT00714181","[u'Abramson Cancer Center of the University of Pennsylvania']","[u'Abramson Cancer Center of the University of Pennsylvania']","https://clinicaltrials.gov/ct2/show/NCT00714181","['Abramson Cancer Center of the University of Pennsylvania']"]
["NCT00714493","[u'Centocor Ortho Biotech Services, L.L.C.']","[u'Centocor Ortho Biotech Services, L.L.C.']","https://clinicaltrials.gov/ct2/show/NCT00714493","['Centocor Ortho Biotech Services, L.L.C.']"]
["NCT00714714","[u'Valeant Pharmaceuticals International, Inc.']","[u'Valeant Pharmaceuticals International, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00714714","['Valeant Pharmaceuticals International, Inc.']"]
["NCT00715078","[u'Dendreon']","[u'Dendreon']","https://clinicaltrials.gov/ct2/show/NCT00715078","['Dendreon']"]
["NCT00715104","[u'Dendreon']","[u'Dendreon']","https://clinicaltrials.gov/ct2/show/NCT00715104","['Dendreon']"]
["NCT00715117","[u'Milton S. Hershey Medical Center']","[u'Milton S. Hershey Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00715117","['Milton S. Hershey Medical Center']"]
["NCT00715182","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00715182","['Novartis Pharmaceuticals']"]
["NCT00715208","[u'Millennium Pharmaceuticals, Inc.']","[u'Millennium Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00715208","['Millennium Pharmaceuticals, Inc.']"]
["NCT00715624","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00715624","['Sanofi']"]
["NCT00715676","[]","[u'Deltanoid Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00715676","['Hector F. DeLuca, President and Chief Executive Officer, Deltanoid Pharmaceuticals']"]
["NCT00715793","[u'Hussein Tawbi, University of Pittsburgh']","[u'Hussein Tawbi']","https://clinicaltrials.gov/ct2/show/NCT00715793","['Hussein Tawbi, Principal Investigator, University of Pittsburgh']"]
["NCT00715871","[u'Smoke-Break, Inc.']","[u'Smoke-Break, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00715871","['Smoke-Break, Inc.']"]
["NCT00715910","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00715910","['GlaxoSmithKline']"]
["NCT00716014","[]","[u'Pachyonychia Congenita Project']","https://clinicaltrials.gov/ct2/show/NCT00716014","['Sancy Leachman/Principal Investigator, PC Project']"]
["NCT00716092","[]","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00716092","['Boehringer Ingelheim, Study Chair, Boehringer Ingelheim']"]
["NCT00716274","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00716274","['Eli Lilly and Company']"]
["NCT00716456","[u'Memorial Sloan Kettering Cancer Center']","[u'Memorial Sloan Kettering Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00716456","['Memorial Sloan Kettering Cancer Center']"]
["NCT00716521","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00716521","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00716534","[u'AbbVie ( AbbVie (prior sponsor, Abbott) )']","[u'AbbVie (prior sponsor, Abbott)']","https://clinicaltrials.gov/ct2/show/NCT00716534","['AbbVie (prior sponsor, Abbott)']"]
["NCT00716547","[]","[u'IDEA AG']","https://clinicaltrials.gov/ct2/show/NCT00716547","['Dr. Claudia Himly / Director of Clinical Operations, IDEA AG']"]
["NCT00716716","[u'Bioverativ Therapeutics Inc.']","[u'Bioverativ Therapeutics Inc.']","https://clinicaltrials.gov/ct2/show/NCT00716716","['Bioverativ Therapeutics Inc.']"]
["NCT00716859","[]","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00716859","['Director, Clinical Trial Disclosure Group, Pfizer Inc']"]
["NCT00717067","[]","[u'ViiV Healthcare']","https://clinicaltrials.gov/ct2/show/NCT00717067","['Director, Clinical Trial Disclosure Group, Pfizer, Inc.']"]
["NCT00717197","[u'University of Florida']","[u'University of Florida']","https://clinicaltrials.gov/ct2/show/NCT00717197","['University of Florida']"]
["NCT00717236","[u'UCB Pharma']","[u'UCB Pharma']","https://clinicaltrials.gov/ct2/show/NCT00717236","['UCB Pharma']"]
["NCT00717262","[]","[u'HemaQuest Pharmaceuticals Inc.']","https://clinicaltrials.gov/ct2/show/NCT00717262","['Susan Perrine, MD/ Chief Scientific Officer, HemaQuest Pharmaceuticals, Inc.']"]
["NCT00717288","[u'Kathleen Dungan, Ohio State University']","[u'Ohio State University']","https://clinicaltrials.gov/ct2/show/NCT00717288","['Kathleen Dungan, Assistant Professor of Medicine, Ohio State University']"]
["NCT00717340","[u'AVEO Pharmaceuticals, Inc.']","[u'AVEO Pharmaceuticals, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00717340","['AVEO Pharmaceuticals, Inc.']"]
["NCT00717366","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00717366","['Hoffmann-La Roche']"]
["NCT00717457","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00717457","['Hoffmann-La Roche']"]
["NCT00717704","[u'Washington Hospital Center']","[u'Washington Hospital Center']","https://clinicaltrials.gov/ct2/show/NCT00717704","['Washington Hospital Center']"]
["NCT00717756","[u'howard safran, Brown University']","[u'Brown University']","https://clinicaltrials.gov/ct2/show/NCT00717756","['howard safran, Principle Investigator, Brown University']"]
["NCT00718094","[u'Gerald W. Dryden, Jr., University of Louisville']","[u'University of Louisville']","https://clinicaltrials.gov/ct2/show/NCT00718094","['Gerald W. Dryden, Jr., Principal investigator, University of Louisville']"]
["NCT00718159","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00718159","['Eli Lilly and Company']"]
["NCT00718172","[u'National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) )']","[u'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']","https://clinicaltrials.gov/ct2/show/NCT00718172","['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']"]
["NCT00718224","[u'Sanofi']","[u'Sanofi']","https://clinicaltrials.gov/ct2/show/NCT00718224","['Sanofi']"]
["NCT00718419","[u'Eli Lilly and Company']","[u'Eli Lilly and Company']","https://clinicaltrials.gov/ct2/show/NCT00718419","['Eli Lilly and Company']"]
["NCT00718601","[u'Geron Corporation']","[u'Geron Corporation']","https://clinicaltrials.gov/ct2/show/NCT00718601","['Geron Corporation']"]
["NCT00718666","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00718666","['GlaxoSmithKline']"]
["NCT00718692","[u'Symphogen A/S']","[u'Symphogen A/S']","https://clinicaltrials.gov/ct2/show/NCT00718692","['Symphogen A/S']"]
["NCT00718718","[u'Centocor, Inc.']","[u'Centocor, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00718718","['Centocor, Inc.']"]
["NCT00718731","[]","[u'Wyeth is now a wholly owned subsidiary of Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00718731","['Director, Clinical Trial Disclosure Group, Wyeth']"]
["NCT00718757","[u\"St. Jude Children's Research Hospital\"]","[u\"St. Jude Children's Research Hospital\"]","https://clinicaltrials.gov/ct2/show/NCT00718757","[\"St. Jude Children's Research Hospital\"]"]
["NCT00718770","[u'University of Colorado, Denver']","[u'University of Colorado, Denver']","https://clinicaltrials.gov/ct2/show/NCT00718770","['University of Colorado, Denver']"]
["NCT00718861","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00718861","['Novartis Pharmaceuticals']"]
["NCT00719043","[u'GlaxoSmithKline']","[u'GlaxoSmithKline']","https://clinicaltrials.gov/ct2/show/NCT00719043","['GlaxoSmithKline']"]
["NCT00719095","[]","[u'University of Vermont Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00719095","['Stacey C. Sigmon, Ph.D., University of Vermont']"]
["NCT00719108","[u'Wockhardt']","[u'Wockhardt']","https://clinicaltrials.gov/ct2/show/NCT00719108","['Wockhardt']"]
["NCT00719134","[u'Rami Burstein, Beth Israel Deaconess Medical Center']","[u'Beth Israel Deaconess Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00719134","['Rami Burstein, Professor, Beth Israel Deaconess Medical Center']"]
["NCT00719160","[u'Karl Insogna, Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00719160","['Karl Insogna, Professor of Medicine, Yale University']"]
["NCT00719186","[u'Heping Zhang, Yale University']","[u'Yale University']","https://clinicaltrials.gov/ct2/show/NCT00719186","['Heping Zhang, Principal Investigator, Yale University']"]
["NCT00719212","[u'Translational Research in Oncology']","[u'Translational Research in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00719212","['Translational Research in Oncology']"]
["NCT00719264","[u'Novartis ( Novartis Pharmaceuticals )']","[u'Novartis Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00719264","['Novartis Pharmaceuticals']"]
["NCT00719381","[u'Paul Beringer, University of Southern California']","[u'Paul Beringer']","https://clinicaltrials.gov/ct2/show/NCT00719381","['Paul Beringer, Associate Professor, University of Southern California']"]
["NCT00719407","[u'Yvonne Wu, University of California, San Francisco']","[u'University of California, San Francisco']","https://clinicaltrials.gov/ct2/show/NCT00719407","['Yvonne Wu, Professor of Neurology and Pediatrics, University of California, San Francisco']"]
["NCT00719420","[]","[u'University of North Texas Health Science Center']","https://clinicaltrials.gov/ct2/show/NCT00719420","['Dr. Lori A. Fischbach, University of North Texas Health Science Center']"]
["NCT00719472","[u'Genentech, Inc.']","[u'Genentech, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00719472","['Genentech, Inc.']"]
["NCT00719550","[u'Amgen']","[u'Amgen']","https://clinicaltrials.gov/ct2/show/NCT00719550","['Amgen']"]
["NCT00719563","[u'Alliance for Clinical Trials in Oncology']","[u'Alliance for Clinical Trials in Oncology']","https://clinicaltrials.gov/ct2/show/NCT00719563","['Alliance for Clinical Trials in Oncology']"]
["NCT00719602","[u'International Maternal Pediatric Adolescent AIDS Clinical Trials Group']","[u'International Maternal Pediatric Adolescent AIDS Clinical Trials Group']","https://clinicaltrials.gov/ct2/show/NCT00719602","['International Maternal Pediatric Adolescent AIDS Clinical Trials Group']"]
["NCT00719680","[u'CSL Behring']","[u'CSL Behring']","https://clinicaltrials.gov/ct2/show/NCT00719680","['CSL Behring']"]
["NCT00719693","[u'AstraZeneca']","[u'AstraZeneca']","https://clinicaltrials.gov/ct2/show/NCT00719693","['AstraZeneca']"]
["NCT00719706","[u'Brian P. Brennan, MD, Mclean Hospital']","[u'Mclean Hospital']","https://clinicaltrials.gov/ct2/show/NCT00719706","['Brian P. Brennan, MD, Associate Director of Translational Neuroscience Research, Mclean Hospital']"]
["NCT00719810","[u'Melinta Therapeutics, Inc.']","[u'Melinta Therapeutics, Inc.']","https://clinicaltrials.gov/ct2/show/NCT00719810","['Melinta Therapeutics, Inc.']"]
["NCT00719862","[]","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00719862","['Harry Sacks, MD Vice President, Medical and Scientific Affairs']"]
["NCT00720018","[u'Teva Pharmaceutical Industries ( NuPathe Inc. )']","[u'NuPathe Inc.']","https://clinicaltrials.gov/ct2/show/NCT00720018","['NuPathe Inc.']"]
["NCT00720057","[u'Bayer']","[u'Bayer']","https://clinicaltrials.gov/ct2/show/NCT00720057","['Bayer']"]
["NCT00720109","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00720109","['National Cancer Institute (NCI)']"]
["NCT00720122","[u'Madhusmita Misra, Massachusetts General Hospital']","[u'Massachusetts General Hospital']","https://clinicaltrials.gov/ct2/show/NCT00720122","['Madhusmita Misra, Asssociate Professor of Pediatrics, Massachusetts General Hospital']"]
["NCT00720135","[u'City of Hope Medical Center']","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00720135","['City of Hope Medical Center']"]
["NCT00720174","[u'National Cancer Institute (NCI)']","[u'National Cancer Institute (NCI)']","https://clinicaltrials.gov/ct2/show/NCT00720174","['National Cancer Institute (NCI)']"]
["NCT00720304","[u'Case Comprehensive Cancer Center']","[u'Case Comprehensive Cancer Center']","https://clinicaltrials.gov/ct2/show/NCT00720304","['Case Comprehensive Cancer Center']"]
["NCT00720382","[u'Meda Pharmaceuticals']","[u'Meda Pharmaceuticals']","https://clinicaltrials.gov/ct2/show/NCT00720382","['Meda Pharmaceuticals']"]
["NCT00720434","[u'Pfizer']","[u'Pfizer']","https://clinicaltrials.gov/ct2/show/NCT00720434","['Pfizer']"]
["NCT00720499","[u'Boehringer Ingelheim']","[u'Boehringer Ingelheim']","https://clinicaltrials.gov/ct2/show/NCT00720499","['Boehringer Ingelheim']"]
["NCT00720564","[]","[u'City of Hope Medical Center']","https://clinicaltrials.gov/ct2/show/NCT00720564","['Jana Portnow, City of Hope Comprehensive Cancer Center']"]
["NCT00720577","[]","[u'ev3']","https://clinicaltrials.gov/ct2/show/NCT00720577","['Neil Hattangadi M.D. , Vice President, Molecular Programs, FoxHollow Technologies ( Ev3)']"]
["NCT00720759","[u'VA Office of Research and Development ( US Department of Veterans Affairs )']","[u'US Department of Veterans Affairs']","https://clinicaltrials.gov/ct2/show/NCT00720759","['US Department of Veterans Affairs']"]
["NCT00720798","[u'Hoffmann-La Roche']","[u'Hoffmann-La Roche']","https://clinicaltrials.gov/ct2/show/NCT00720798","['Hoffmann-La Roche']"]
["NCT00721006","[u'TCA Cellular Therapy']","[u'TCA Cellular Therapy']","https://clinicaltrials.gov/ct2/show/NCT00721006","['TCA Cellular Therapy']"]
["NCT00721045","[u'Mesoblast, Ltd.']","[u'Mesoblast, Ltd.']","https://clinicaltrials.gov/ct2/show/NCT00721045","['Mesoblast, Ltd.']"]

{"sheet":"138 out of 500 sample","index":5,"n_rows":139,"n_cols":6,"rows_kept":139,"cut":false,"hidden":false,"merged":[]}
["nct_id","responsible_party_bottom","last_name","role","authority","urllist"]
["NCT00678379","Jonathan R. Moss, Resident Physician, Vanderbilt University Medical Center","Jonathan R Moss, MD, MPH","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00678379"]
["NCT00678457","Bankole Johnson, DSc, M.D., Ph.D., University of Virginia","Bankole Johnson, DSc, MD, PhD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00678457"]
["NCT00679367","Vaishali Sanchorawala, Principal Investigator, Boston Medical Center","David C. Seldin, MD, PhD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00679367"]
["NCT00679523","Karl Beutner, MD, PhD, Anacor Pharmaceuticals, Inc.","Karl Beutner, MD, PhD","Study Director","United States: Food and Drug Administration,Mexico: Ministry of Health","https://clinicaltrials.gov/ct2/show/NCT00679523"]
["NCT00680121","Ann Manzardo, PhD, Assistant Professor, University of Kansas","Ann Manzardo, PhD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00680121"]
["NCT00680589","Jedd Wolchok, MD, Memorial Sloan-Kettering Cancer Center","Jedd Wolchok, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00680589"]
["NCT00680706","Howard Smithline, Chief, Emergency Medicine Research, Baystate Medical Center","Howard Smithline, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00680706"]
["NCT00680758","Ingrid Mayer, MD, Assistant Professor of Medicine; Clinical Director, Breast Cancer Program; Medical Oncologist, Vanderbilt-Ingram Cancer Center","Ingrid Mayer, MD","Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00680758"]
["NCT00681109","Reza Dana, MD, Principal Investigator, Massachusetts Eye and Ear Infirmary","Reza Dana, MD, MPH, MSc","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00681109"]
["NCT00681317","Mark A. Smith, MD, PhD, Medical Science Sr.Director, AstraZeneca Pharmaceuticals","Sylvan J. Hurewitz, MD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00681317"]
["NCT00681356","Lisa Renick, CRA, Anesiva, Inc,","Shaun Comfort, MD","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00681356"]
["NCT00681408","Stephen Caldwell, MD, Professor, Department of Gastroenterology, University of Virginia","Stephen H Caldwell, MD","Principal Investigator","United States: Food and Drug Administration,United States: Federal Government","https://clinicaltrials.gov/ct2/show/NCT00681408"]
["NCT00681889","Reza Dana, MD, Professor of Ophthalmology, Massachusetts Eye and Ear Infirmary","Reza Dana, M.D., MPH","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00681889"]
["NCT00681915","Mark A. Smith, MD, PhD Medical Science Sr. Director, AstraZeneca Pharmaceuticals","Sylvan J. Hurewitz, MD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00681915"]
["NCT00682448","Jeffrey Rado, MD, MD, Rush University Medical Center","Jeffrey T Rado, M.D.","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00682448"]
["NCT00682734","Benjamin W. Friedman, MD, Associate professor, Montefiore Medical Center","Benjamin W. Friedman, MD, MS","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00682734"]
["NCT00683592","Carol R. Reed, MD, PGxHealth, LLC","Carol R Reed, MD","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00683592"]
["NCT00683852","Maurizio Fava, MD, Executive Vice Chair, Department of Psychiatry; Executive Director, Clinical Trials Network and Institute (CTNI); Director, Depression Clinical and Research Program (DCRP), Massachusetts General Hospital","Maurizio Fava, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00683852"]
["NCT00684008","Marcel R.M. van den Brink, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center","Marcel van den Brink, MD, PhD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00684008"]
["NCT00684021","Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston","Robert Simari, MD","Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00684021"]
["NCT00684060","Dr Lemuel A Moye III, Professor - School of Public Health, The University of Texas Health Science Center, Houston","Robert Simari, MD","Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00684060"]
["NCT00684554","Frances R Levin, Director of Substance Use Disorder, New York State Psychiatric Institute","Erik W Gunderson, M.D.","Principal Investigator","United States: Federal Government","https://clinicaltrials.gov/ct2/show/NCT00684554"]
["NCT00685737","Charles Ballow, Pharm D. FACCP, Buffalo Clinical Research Center","Charles H Ballow, Pharm D.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00685737"]
["NCT00685906","Jay Horrow, MD, Medical Science Director, AZD6140, AstraZeneca Pharmaceuticals","Kathleen Butler, MD|Audrey , Martinez, MD","Study Director|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00685906"]
["NCT00686855","Nathaniel S. Treister, DMD, DMSc, Principal Investigator, Dana-Farber Cancer Institute","Nathaniel Treister, DMD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00686855"]
["NCT00687167","Kristin Arnold, Vice President R&D, Mutual Pharmaceutical Company, Inc.","James D Carlson, Pharm.D.","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00687167"]
["NCT00687245","Tore Lind, MD, Medical Science Director Nexium and GI Established Brands, AstraZeneca Pharmaceuticals","Marta Illueca|Lynne Durborow","Study Director|Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00687245"]
["NCT00687908","Jean-Charles DHUIN Clinical Trial Manager, Galderma","Diane Thiboutot, MD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board,Canada: Health Canada,Canada: Ethics Review Committee","https://clinicaltrials.gov/ct2/show/NCT00687908"]
["NCT00688064","Jean-Charles DHUIN Clinical Trial Manager, Galderma","Linda Stein Gold, MD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board,Canada: Health Canada,Canada: Ethics Review Committee","https://clinicaltrials.gov/ct2/show/NCT00688064"]
["NCT00688324","Robert W. Buchanan, Chief, Maryland Psychiatric Research Center, Outpatient Research Program, University of Maryland","Bernard A Fischer, M.D.","Principal Investigator","United States: Institutional Review Board,United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00688324"]
["NCT00688376","Margaret Moline, PhD, Eisai Medical Research Inc.","Margaret Moline, Ph.D","Study Director","United States: Food and Drug Administration,European Union: European Medicines Agency","https://clinicaltrials.gov/ct2/show/NCT00688376"]
["NCT00688428","Tore Lind, MD, Medical Science Director NEXIUM and GI Established Brands, AstraZeneca Pharmaceuticals","Jörgen Naesdal, M.D.|Christopher Billings ., D.O","Study Director|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00688428"]
["NCT00688441","Kristen Yen, Associate Director, Clinical, Capnia, Inc.","S. David Miller, MD","Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00688441"]
["NCT00688636","Miguel Regueiro, Professor of Medicine, University of Pittsburgh","Miguel D Regueiro, M.D.","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00688636"]
["NCT00688831","Helen Lunde, MD, Medical Science Director, Emerging Arrythmias & Lipids, AstraZeneca","Helen Lunde, MD|Marianne Hartford, MD, PhD","Study Director|Principal Investigator","United States: Food and Drug Administration,Sweden: Medical Products Agency","https://clinicaltrials.gov/ct2/show/NCT00688831"]
["NCT00688857","Neil M Cowen, PhD/Chief Scientific Officer, Essentialis, Inc","Alan K. Copa, Pharm. D.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00688857"]
["NCT00690092","Harry S. Nielsen, Ph.D., Allermed Laboratories, Inc.","Harry S Nielsen, Ph.D.|Royce Johnson, M.D.|Neil Ampel, M.D.|Brad Sawtelle, M.D.|Stephen Kernerman, D.O.","Study Director|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00690092"]
["NCT00690235","Carol A. Tamminga, Principal Investigator, University of Texas Southwestern Medical Center","Carol A Tamminga, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00690235"]
["NCT00690404","Rolf Karlsten, M.D., Medical Science Director, Emerging Neuroscience, AstraZeneca Pharmaceuticals","Eleanor Lisbon, MD, MPH|Heather Wray, MB, ChB, FFPM|Ivan Eggens, MD","Principal Investigator|Study Chair|Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00690404"]
["NCT00690612","James Hainer, MD, Sr. Director - Medical Research, Study Team Physician, AstraZeneca, LP","Franz Schaefer, MD","Principal Investigator","United States: Food and Drug Administration,Belgium: Federal Agency for Medicinal Products and Health Products,France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis),Germany: Federal Institute for Drugs and Medical Devices,Italy: Ministry of Health,Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,Ukraine: State Pharmacological Center - Ministry of Health","https://clinicaltrials.gov/ct2/show/NCT00690612"]
["NCT00690625","Ashwini Khante, University Of Washington","Ashwini V Khante, DDS","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00690625"]
["NCT00690807","Eric Wachter, Vice President, Provectus Pharmaceuticals, Inc.","Alicia Barba, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00690807"]
["NCT00690820","Djenane Bennett, Solvay Pharmaceuticals","Global Clinical Director Solvay","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00690820"]
["NCT00691678","Dawn L. Hershman, Associate Professor of Medicine & Epidemiology, Columbia University","Dawn Hershman, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00691678"]
["NCT00691704","Cristina Gasparetto, Associate Professor of Medicine, Duke University","Cristina Gasparetto, MD|David Hurd, MD|Peter M Voorhees, MD|Jeffrey A. Zonder, MD","Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00691704"]
["NCT00691873","Gailen D. Marshall, MD, PhD, University of Mississippi Medical Center","Gailen D. Marshall, MD/PhD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00691873"]
["NCT00692159","Bryan Leigh, MD, Medical Monitor, TRACON Pharmaceuticals Inc.","Bryan Leigh, MD","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00692159"]
["NCT00692900","Robert Edwards, Principal Investigator, University of Pittsburgh","Robert P Edwards, MD|Kristin Zorn, MD","Principal Investigator|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00692900"]
["NCT00692926","Joanne Kurtzberg, MD, Professor of Pediatrics, Duke University","Joanne Kurtzberg, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00692926"]
["NCT00693056","Hyungjoo Lee / Associate Director, Product Development Management, Rexahn Pharmaceuticals, Inc.","Hyungjoo Hugh Lee, MS","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00693056"]
["NCT00693095","John Sampson, Professor Neurosurgery, Duke University","Gordana Vlahovic, MD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00693095"]
["NCT00693225","Yvonne Romero, Yvonne Romero, MD, Mayo Clinic","Yvonne Romero, M.D.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00693225"]
["NCT00694057","Dwight Stickney, MD - Chief Medical Officer, Hollis-Eden Pharmaceuticals","Dwight R. Stickney, MD","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00694057"]
["NCT00694122","David M. Nathan, MD, Director, Diabetes Center, Massachusetts General Hospital","David M Nathan, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00694122"]
["NCT00694135","Stephen From, President and Chief Executive Officer, Eyegate Pharmaceuticals, Inc.","C. Stephen Foster, MD|Michael Raizman, MD","Principal Investigator|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00694135"]
["NCT00694213","Don Guterwill, BS, MT, Senior Clinical Project Manager, Vical Incorporated","Don Guterwill, BS, MT","Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00694213"]
["NCT00695110","Robert E. Dudley, PhD, President and CEO, Clarus Therapeutics, Inc., Clarus Therapeutics, Inc.","Ronald S Swerdloff, M.D.|Gregory Flippo, M.D.|Steven J. Kulback, M.D.|Sherwyn Schwartz, M.D.","Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00695110"]
["NCT00695500","Vijay Ramchandani, Ph.D., Clinical Investigator and Chief, Section on Human Psychopharmacology, National Institute on Alcohol Abuse and Alcoholism (NIAAA)","Vijay A Ramchandani, Ph.D.","Principal Investigator","United States: Federal Government,United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00695500"]
["NCT00695630","Peter Milgrom/Professor of Dental Public Health Sciences, University of Washington","Peter M Milgrom, DDS","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00695630"]
["NCT00695851","Susan Slovin, MD, Memorial Sloan-Kettering Cancer Center","Susan Slovin, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00695851"]
["NCT00696293","Jordan F. Karp, Associate professor, University of Pittsburgh","Jordan F Karp, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00696293"]
["NCT00696410","Jennifer Cowger , MD, MS, Assistant Professor, study Coinvestigator, University of Michigan","Keith D Aaronson, MD, MS|Jennifer A Cowger, MD, MS","Principal Investigator|Study Chair","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00696410"]
["NCT00696475","Neil M Cowen, PhD/Chief Scientific Officer, Essentialis","Harold Bays, MD|Alan Forker, MD|Cynthia Huffman, MD|Michael Koren, MD|Andrew Lewin, MD|Thomas Littlejohn, MD|David Morin, MD|Eli Roth, MD|Evan Stein, MD|Philip Toth, MD|Craig Thompson, MD|Glibert Weiner, MD","Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00696475"]
["NCT00697138","Craig Rush, Princpal Investigator, University of Kentucky","Craig R Rush, Ph.D.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00697138"]
["NCT00697788","Erik S. Shank, MD, Pediatric Anesthesiologist, Massachusetts General Hospital","Erik S Shank, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00697788"]
["NCT00697892","Fran Aweeka, Sponsor-Investigator, University of California, San Francisco","Francesca T Aweeka, PharmD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00697892"]
["NCT00698763","Juha Ellmen, Clinical Program Leader, Orion Pharma","Irja Korpela|Risto O. Roine, M.D., Ph.D.","Study Director|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00698763"]
["NCT00698945","Dr. Bacharach, North Bay Eye Associates, Inc.","Jason Bacharach, M.D","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00698945"]
["NCT00700115","Ighovwerha Ofotokun, Associate Professor of Medicine, Emory University","Igho Ofotokun, MD, MSc","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00700115"]
["NCT00700375","Hiromichi Ueda, Osaka General Medical Center","Takahisa Yamada, directorate","Study Chair","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00700375"]
["NCT00700479","Stuart Katz, Yale School of Medicine","Stuart Katz, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00700479"]
["NCT00700921","E Rand Sutherland, Chair of Pulmonary Medicine, National Jewish Health","E Rand Sutherland, MD, MPH","Principal Investigator","United States: Institutional Review Board,United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00700921"]
["NCT00701220","Philip Binkley, MD, MPH, The Ohio State University/ Division of Cardiovascular Medicine","Philip Binkley, MD, MPH","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00701220"]
["NCT00701311","Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals","Kenneth Peters, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00701311"]
["NCT00701727","Michael H. Davidson, MD, FACC, Radiant Research","Michael H Davidson, Md. FACC","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00701727"]
["NCT00701779","Paul F. Siami, MD, Medical Director, Research Institute of Deaconess Clinic, Siami, Paul F., M.D.","Paul F Siami, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00701779"]
["NCT00702403","Paul Carpenter, Principal Investigator, Fred Hutchinson Cancer Research Center","Paul Carpenter","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00702403"]
["NCT00702676","Hans A Eriksson, MD, Medical Science Director, AstraZeneca Pharmaceuticals","Catherine Datto, MD","Study Director","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00702676"]
["NCT00702689","Edward Cowen, M.D., Principal Investigator, National Institutes of Health Clinical Center (CC)","Edward W Cowen, M.D.","Principal Investigator","United States: Federal Government,United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00702689"]
["NCT00702884","Tony Bekaii-Saab, Principal Investigator, Ohio State University Comprehensive Cancer Center","Tanios Bekaii-Saab, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00702884"]
["NCT00703534","Debra Silberg, MD, Director of Clinical Research, AstraZeneca Pharmaceuticals","Debra Silberg, MD|Nimish Vakil, MD","Study Director|Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00703534"]
["NCT00703807","Maysa Abu-Khalaf, Principal Investigator, Yale University","Maysa Abu-Khalaf, M.D.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00703807"]
["NCT00703885","Murray B. Stein, Professor, University of California, San Diego","Murray B Stein, MD, MPH","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00703885"]
["NCT00704379","Ricardo Jorge, MD, Professor, Baylor College of Medicine","Ricardo E. Jorge, MD","Principal Investigator","United States: Federal Government","https://clinicaltrials.gov/ct2/show/NCT00704379"]
["NCT00704912","Richard S. Legro, M.D., Professor, Obstetrics and Gynecology and Public Health Sciences, Milton S. Hershey Medical Center","Richard S Legro, M.D.|Christos Coutifaris, M.D., Ph.D.","Principal Investigator|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00704912"]
["NCT00705003","Maurizio Fava, MD, Fava, Maurizio MD., Massachusetts General Hospital","Maurizio Fava, MD|Andrew A Nierenberg, MD","Principal Investigator|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00705003"]
["NCT00705341","Janet Holbrook, Associate Professor, Johns Hopkins Bloomberg School of Public Health","Kaharu Sumino, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00705341"]
["NCT00705523","Jennifer Plebani, Principal Investigator, National Institute on Drug Abuse (NIDA)","Jennifer G Plebani, PhD","Principal Investigator","United States: Federal Government,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00705523"]
["NCT00705757","Deepak P. Edward, PI, Summa Health System","Deepak P Edward, MD|Smajo Osmanovic, MD","Principal Investigator|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00705757"]
["NCT00706836","Murray B. Stein, Professor, University of California, San Diego","Murray B Stein, MD, MPH","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00706836"]
["NCT00707057","Stephen Turner, President & CEO, SCOLR Pharma, Inc.","Steven E Christensen, D.D.S.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00707057"]
["NCT00707538","Dana Washburn, MD, Lantheus Medical Imaging","Jamshid Maddahi, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00707538"]
["NCT00707642","Beth-Ann Coller, Ph.D., Hawaii Biotech","Jay Winship, M.D.","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00707642"]
["NCT00708916","Elizabeth Camacho, PRS, New York University School of Medicine","Andrew G Franks, Jr., MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00708916"]
["NCT00709540","Matthew L Sherman MD, Acceleron Pharma Inc.","Michelle Ababa, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00709540"]
["NCT00709800","Don Guterwill, BS, MT, Senior Clinical Project Manager, Vical Incorporated","Don Guterwill, BS, MT","Study Chair","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00709800"]
["NCT00710333","Amanda Hilton Senior Clinical Research Manager, Renovo Ltd","V V Young, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00710333"]
["NCT00710814","Judith Korner, Associate Professor of Medicine, Columbia University","Judith Korner, MD,PhD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00710814"]
["NCT00710970","Seth Lerner, Professor, Baylor College of Medicine","Seth P. Lerner, M.D.","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00710970"]
["NCT00711035","Helen Heslop, Principal Investigator, Baylor College of Medicine","Helen Heslop, MD","Principal Investigator","United States: Food and Drug Administration,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00711035"]
["NCT00711165","Thomas B. Casale, MD, Creighton University","Thomas B Casale, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00711165"]
["NCT00711464","Michael Minzenberg, MD, Associate Professor of Clinical Psychiatry, University of California, Davis","Michael J. Minzenberg, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00711464"]
["NCT00711529","Shannon MacLaughlan, Shannon MacLaughlan, M.D., Women and Infants Hospital of Rhode Island","Shannon D MacLaughlan, MD|Don S Dizon, MD","Principal Investigator|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00711529"]
["NCT00711971","Ellen Mozurkewich, Adjunct Assistant Professor, University of Michigan","Ellen Mozurkewich, MD, MS","Principal Investigator","United States: Institutional Review Board,United States: Food and Drug Administration,United States: Federal Government","https://clinicaltrials.gov/ct2/show/NCT00711971"]
["NCT00712114","Nanette Onizuka-Handa/Sr. Vice President, Regulatory Affairs and Quality, Hollis-Eden Pharmaceuticals","Dwight Stickney, MD","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00712114"]
["NCT00712166","Mark Bresnik, MD, Director, Clinical Research, Gilead Sciences, Inc.","Claire Wainwright, MD|Ron Gibson, MD","Principal Investigator|Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00712166"]
["NCT00712439","Lynne Rowe, Depomed","Rekha Sathyanarayana","Study Director","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00712439"]
["NCT00712465","Helen Lunde, MD, Medical Science Director, Emerging Arrhythmia and Lipids, AstraZeneca","Helen Lunde, MD|Marianne Hartford, MD, PhD","Study Director|Principal Investigator","Sweden: Medical Products Agency,United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00712465"]
["NCT00712985","Allan Lipton, MD, Milton S. Hershey Medical Center","Allan Lipton, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00712985"]
["NCT00713284","V. Ram Peddi, Medical Doctor, California Pacific Medical Center Research Institute","V. Ram Peddi, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00713284"]
["NCT00713336","Dr Thomas Morris, Medical Science Director, AstraZeneca, AstraZeneca Pharmaceuticals","Raj Chetty, MD","Principal Investigator","United States: Food and Drug Administration,United Kingdom: Medicines and Healthcare Products Regulatory Agency","https://clinicaltrials.gov/ct2/show/NCT00713336"]
["NCT00713479","Steve Shoptaw, Professor, University of California, Los Angeles","Edythe D London, PhD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00713479"]
["NCT00713583","Joy Schmitz, Professor - Psychiatry, Behavioral Sciences, The University of Texas Health Science Center, Houston","Joy M Schmitz, Ph.D.","Principal Investigator","United States: Federal Government","https://clinicaltrials.gov/ct2/show/NCT00713583"]
["NCT00713791","Dr Thomas Morris, Medical Science Director, AstraZeneca, AstraZeneca Pharmaceuticals","Sylvan Hurewitz","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00713791"]
["NCT00715676","Hector F. DeLuca, President and Chief Executive Officer, Deltanoid Pharmaceuticals","Wendy A Bedale, Ph.D.","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00715676"]
["NCT00715793","Hussein Tawbi, Principal Investigator, University of Pittsburgh","Hussein Tawbi, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00715793"]
["NCT00716014","Sancy Leachman/Principal Investigator, PC Project","Sancy A Leachman, MD, PhD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00716014"]
["NCT00716547","Dr. Claudia Himly / Director of Clinical Operations, IDEA AG","IDEA AG Clinical Trial","Study Director","United States: Food and Drug Administration,Germany: Federal Institute for Drugs and Medical Devices,United Kingdom: Medicines and Healthcare Products Regulatory Agency,United Kingdom: National Health Service,United Kingdom: Research Ethics Committee,Czech Republic: Ethics Committee,Czech Republic: State Institute for Drug Control,Poland: Ministry of Health,Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products","https://clinicaltrials.gov/ct2/show/NCT00716547"]
["NCT00717262","Susan Perrine, MD/ Chief Scientific Officer, HemaQuest Pharmaceuticals, Inc.","Robin Downey, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00717262"]
["NCT00717288","Kathleen Dungan, Assistant Professor of Medicine, Ohio State University","Kathleen M Dungan, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00717288"]
["NCT00717756","howard safran, Principle Investigator, Brown University","Howard Safran, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00717756"]
["NCT00718094","Gerald W. Dryden, Jr., Principal investigator, University of Louisville","Gerald W Dryden, MD, MSPH","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00718094"]
["NCT00719095","Stacey C. Sigmon, Ph.D., University of Vermont","Stacey C. Sigmon, Ph.D.","Principal Investigator","United States: Federal Government,United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00719095"]
["NCT00719134","Rami Burstein, Professor, Beth Israel Deaconess Medical Center","Rami Burstein, PhD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00719134"]
["NCT00719160","Karl Insogna, Professor of Medicine, Yale University","Karl Insogna, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00719160"]
["NCT00719186","Heping Zhang, Principal Investigator, Yale University","Esther Eisenberg, MD, MPH|Nanette Santoro, MD|Richard Legro, MD|Robert Brzyski, MD, PhD|Peter Casson, MD|Michael Diamond, MD|Heping Zhang, PhD|Gregory M Christman, MD|Christos Coutifaris, MD|William D Schlaff, MD","Study Director|Study Chair|Principal Investigator|Study Director|Study Director|Study Director|Study Director|Study Director|Study Director|Study Director","United States: Food and Drug Administration,United States: Federal Government","https://clinicaltrials.gov/ct2/show/NCT00719186"]
["NCT00719381","Paul Beringer, Associate Professor, University of Southern California","Paul M Beringer, Pharm.D.","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00719381"]
["NCT00719407","Yvonne Wu, Professor of Neurology and Pediatrics, University of California, San Francisco","Yvonne W Wu, MD, MPH","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00719407"]
["NCT00719420","Dr. Lori A. Fischbach, University of North Texas Health Science Center","Lori A Fischbach, PhD, MPH|Pelayo Correa, MD|Luis E Bravo, MD","Principal Investigator|Study Chair|Study Director","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00719420"]
["NCT00719706","Brian P. Brennan, MD, Associate Director of Translational Neuroscience Research, Mclean Hospital","Brian P Brennan, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00719706"]
["NCT00719862","Harry Sacks, MD Vice President, Medical and Scientific Affairs","Lewis M Fredane, MD","Study Director","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00719862"]
["NCT00720122","Madhusmita Misra, Asssociate Professor of Pediatrics, Massachusetts General Hospital","Madhusmita Misra, MD","Principal Investigator","United States: Food and Drug Administration","https://clinicaltrials.gov/ct2/show/NCT00720122"]
["NCT00720564","Jana Portnow, City of Hope Comprehensive Cancer Center","Jana Portnow, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00720564"]
["NCT00720577","Neil Hattangadi M.D. , Vice President, Molecular Programs, FoxHollow Technologies ( Ev3)","David Kandzari, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00720577"]
["NCT00698724","\"Dr. Gills, St. Lukes Cataract and Laser Institute\"","James Gills, MD","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00698724"]
["NCT00708227","\"Kathryn Blake, PharmD, Senior Research Scientist, Nemours Childrens Clinic\"","Kathryn Blake, Pharm.D.","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00708227"]
["NCT00691210","\"Owen A. OConnor, Professor of Medicine and Experimental Therapeutics; Director, Center for Lymphoid Malignancies, Columbia University\"","Owen A O'Connor, MD, Ph.D.","Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00691210"]
["NCT00694174","\"Victoria Tutag Lehr, Pharm.D., Childrens Hospital of Michigan, The Detroit Medical Center\"","Victoria Tutag Lehr, Pharm.D.|Josef Cortez, M.D.","Principal Investigator|Principal Investigator","United States: Institutional Review Board","https://clinicaltrials.gov/ct2/show/NCT00694174"]